About ISEV
The International Society for Extracellular Vesicles is the leading professional society
for researchers and scientists involved in the study of microvesicles and exosomes.
With nearly 1000 members, ISEV continues to be the leader in advancing the study of
extracellular vesicles. Founded in 2012 in Sweden, ISEV has since moved its headquarters
to the USA. Through its programmes and services, ISEV provides essential training
and research opportunities for those involved in exosome and microvesicle research.
Mission statement
Advancing extracellular vesicle research globally.
Vision
Our vision is to be the leading advocate and guide of extracellular vesicle research
and to advance the understanding of extracellular vesicle biology.
ISEV2019 Annual Meeting
The International Society for Extracellular Vesicles is the premier international
conference of extracellular vesicle research, covering the latest in exosomes, microvesicles
and more. With an anticipated 1000 attendees, ISEV2019 will feature presentations
from the top researchers in the field, as well as providing opportunities for talks
from students and early career researchers.
ISEV2019 International Organizing Committee
IOC Chair: Hidetoshi Tahara, Ph.D. (Japan); Andrew Hill, Ph.D. (Australia), Carolina
Soekmadji, Ph.D. (Australia), Cherie Blenkiron, Ph.D. (New Zealand), Edit Buzas, Ph.D.
(Hungary), Hang Hubert Yin, Ph.D. (China), Juan Falcon Perez, Ph.D. (Spain), Kazunari
Akiyoshi, Ph.D. (Japan), Kenneth W. Witwer, Ph.D. (USA), Kyoko Hida, Ph.D. (Japan),
Lei Zheng (China), Marca Wauben, Ph.D. (The Netherlands), Mariko Ikuo, Ph.D. (Japan),
Masahiko Kuroda, M.D., Ph.D. (Japan), Nobuyoshi Kosaka, Ph.D. (Japan), Ryou-u Takahashi,
Ph.D. (Japan), Sai-Kiang Lim, Ph.D. (Singapore), Susmita Sahoo, Ph.D. (USA), Takahiro
Ochiya, Ph.D. (Japan), Tang-Long Shen, Ph.D. (Taiwan), Yong Song Gho, Ph.D. (Korea)
and Yoshinobu Takakura, Ph.D. (Japan)
Journal of extracellular vesicles: Editors-in-Chief
Clotilde Thery, Ph.D. (France)
10.1080/20013078.2019.1593587-UF0001
Plenary Session 1: Standardizations Chairs: Andrew Hill; Hidetoshi TaharaLocation:
Level 3, Hall B
NanoCosmos: extracellular vesicles as nanosized extracellular organelles delivering
the complex messages between cells and organisms
Yong Song Gho
Department of Life Sciences, POSTECH, Pohang, Republic of Korea
The secretion of nanosized lipid bilayered extracellular vesicles is a universal cellular
process occurring from simple organisms to complex multicellular organisms. Recent
progress in this area has revealed that extracellular vesicles play multifaceted pathophysiological
functions by delivering the complex messages between cells and organisms, suggesting
that extracellular vesicles are NanoCosmos, i.e., extracellular organelles that play
diverse roles in intercellular and interkingdom communication. This presentation briefly
introduces our last 20 year’s comprehensive research on extracellular vesicles derived
from host, bacteria, diet and environments including their physical, biochemical and
biological complex properties (http://evpedia.info). Then, this presentation focuses
on our recent progress in novel extracellular vesicle-mimetic technologies for targeted
drug delivery, theranostics and epigenetic reprogramming as well as for adjuvant-free,
non-toxic vaccine delivery system against bacterial infection. Furthermore, bacterial
extracellular vesicle-based cancer immunotherapy will be introduced. Based on the
concept of emergent properties of heterogeneous extracellular vesicles, future research
directions to decode the complexity of extracellular vesicle-mediated intercellular
communication network, either at the single vesicle level or at a systems level as
a whole, and the secret of life will be briefly introduced.
Symposium Session 1: Cardiovascular Disease Thursday 25 April 2019 Chairs: J. Brian
Byrd; Pia SiljanderLocation: Level B1, Hall B 11:00–12:30
OT01.01
Extracellular vesicles mediate neutrophil cell deployment from the spleen following
acute myocardial infarction
Naveed Akbar and Robin Choudhury
University of Oxford, Oxford, UK
Introduction: Acute myocardial infarction (AMI) mobilizes monocytes from the splenic
reserve and induces transcriptional activation en route to the injured myocardium,
possibly through interactions involving plasma liberated extracellular vesicles (EVs).
Neutrophils also reside in the spleen and are the first cells to arrive at sites of
injury and mediate further damage. Here, we describe neutrophil deployment from the
spleen in AMI and by endothelial cell (EC)-derived EVs.
Methods: Patients provided informed consent as part of the Oxford Acute Myocardial
Infarction Study. EV were isolated using ultra centrifugation (120,000g 2 h) and characterized
for size and concentration by Nanoparticle Tracking Analysis, EV markers (TSG101,
ALIX, CD63/CD69) by western blot, and microRNAs (miRNAs) by RT-qPCR. Mouse and human
EC were used in vitro to derive EC-EV.
Results: Patients presenting with AMI (n = 15) have 2.2-fold more plasma EV at time
of injury vs. a 6-month follow-up measurement (P = 0.008). Plasma EVs at the time
of presentation correlate significantly with the extent of ischemic injury (R = 0.046,
P = 0.006) and plasma neutrophils (R = 0.37, P = 0.017). Experimental AMI in wild
type, naïve (C57B6/J) mice induces splenic-neutrophil deployment (P = 0.004). Human
plasma EV-miRNAs are significantly altered post-AMI. AMI plasma EV-miRNA-mRNA targets
(IPA, Qiagen) are significantly over represented when compared to neutrophil Gene
Ontology terms for degranulation (P < 0.001), activation (P < 0.001), chemotaxis (P = 0.008)
and migration (P = 0.008). Human EC releases more EV after inflammatory stimulation
(control 2.4 × 108 ± 4.9 x 107 EVs/mL vs. tumour necrosis factor-alpha stimulated,
1.4 × 109 ± 3.0 × 108 EVs/mL, P = 0.003) and contains many of the miRNAs enriched
in human plasma-EV following AMI. Mouse EC-EV tail vein injected into otherwise wild-type,
naïve mice mobilize splenic neutrophils to peripheral blood (P < 0.001).
Summary/Conclusion: Neutrophils appear at sites of injury in the immediate hours after
ischemic injury. Neutrophil interactions with EC-EV may mediate their splenic liberation
and transcriptional programming following AMI, en route to the injured myocardium.
The splenic neutrophil reserve may be a novel therapeutic target in AMI.
Funding: British Heart Foundation.
OT01.02
In vivo characterization of endogenous cardiovascular extracellular vesicles and their
response to ischaemic injury
Aaron Scott
a, Costanza Emanuelib and Rebecca Richardsonc
aUniversity of Bristol, Uffculme, UK; bImperial College London, London, UK; cUniversity
of Bristol, Bristol, UK
Introduction: Cardiomyocytes and endothelial cells are counted among the cell types
that secrete extracellular vesicles (EVs). EVs mediate the targeted transfer of lipids,
proteins and nucleic acids by traversing the extracellular milieu. Recent studies
suggest that EVs play a functional role in cardiovascular disease and cardiac repair.
For example, a population of exosomes carrying proangiogenic miRNAs was found in the
pericardial fluid of patients undergoing heart surgery. Further investigation will
be required to determine which cardiac cells are producing these EVs, the cell type
receiving them and the functional relevance of this.
Methods: A complete understanding of this process requires a comprehensive in vivo
model. The zebrafish is an amenable vertebrate model with genetic tractability and
optical transparency allowing for subcellular observation in a living organism. The
use of stable transgenic lines with cell-type-specific promoters driving the expression
of membrane tethered fluorophores allows labelling of the cell membrane and the EVs
produced by individual cell types. Light sheet microscopy permits cardiovascular-specific
EVs to be tracked in vivo and an established ischaemic injury model allows EV profiles
from uninjured, injured and repairing/regenerating cardiac tissue to be determined
and compared.
Results: Live imaging of transgenic zebrafish with endothelial cell-derived EVs labelled
with mCherry reveals large numbers of EVs in the peripheral circulation, interactions
with downstream endothelial cells and release in to the blood flow from filopodia-like
protrusions. Cardiomyocyte-derived EVs are observed in the pericardial fluid surrounding
the heart and are often seen interacting with cells of the pericardial wall. Additionally,
a modified FACS protocol reveals how cardiomyocyte-derived EV numbers fluctuate in
response to cardiac injury.
Summary/Conclusion: This data present exciting opportunities to further dissect the
cargo being carried by these EVs in a vertebrate model of human disease.
Funding: British Heart Foundation.
OT01.03
Enhanced fibrinolysis and altered extracellular vesicles after remote ischaemic preconditioning
in non-diabetic coronary artery disease patients
Caroline J. Reddel
a, Jerrett Laub, Gabrielle Penningc, Vivien Chend and Leonard Kritharidese
aANZAC Research Institute, University of Sydney, Concord Repatriation General Hospital,
Concord, Australia; bDepartment of Cardiology, Concord Repatriation General Hospital,
Concord, Australia; cANZAC Research Institute, University of Sydney, Concord Repatriation
General Hospital, Concord, Australia; dANZAC Research Institute and Department of
Haematology, Concord Repatriation General Hospital, Concord, Australia; eANZAC Research
Institute and Department of Cardiology, Concord Repatriation General Hospital, Concord,
Australia
Introduction: Brief non-harmful ischaemia, remote ischaemic preconditioning (RIPC)
has been shown to confer benefit to patients with coronary artery disease (CAD). Some
studies indicate lesser benefit in patients with diabetes. RIPC may enhance fibrinolysis.
Hypothesis: RIPC causes an increase in fibrinolytic potential through release of fibrinolytic
factors from the endothelium or fibrinolysis-supporting extracellular vesicles (EVs)
and this effect is less evident in patients with diabetes.
Methods: Patients at Concord Hospital with suspected CAD gave written informed consent
and were administered RIPC (sphygmomanometer on the arm, 3 × 5 min cycles, n = 31)
or sham (n = 29) before angiography, with recruitment ongoing. Blood was collected
pre- and immediately post-RIPC/sham and platelet-free plasma generated. Global coagulation/fibrinolytic
potential was measured by overall haemostatic potential assay (Reddel et al. Thromb
Res. 2013; 131(5): 457–462) and various fibrinolytic factors by ELISA. EV were assessed
by flow cytometry (Reddel et al. Thromb Haemost. 2018; 118(4): 723–733) using fluorescent
surface markers for phosphatidylserine and cell origin including platelets (CD41a),
leukocytes (CD45) and MAC-1 (CD11b). Positive events were defined with supernatant
of ultracentrifuged pooled normal plasma as negative control. Changes pre–post RIPC
were assessed by paired t-test. The study was approved by the local ethics committee.
Results: In the whole population, there was no effect of RIPC on fibrinolytic factors
but a decrease in platelet-derived EV. However, in non-diabetic patients and not in
diabetic patients, RIPC increased overall fibrinolytic potential and CD45+ and CD11b+
EV. These effects were not seen after sham treatment.
Summary/Conclusion: There is a global increase in fibrinolytic potential after RIPC
treatment in CAD patients without diabetes mellitus, which may be contributed to by
increased leukocyte-derived EV and/or decreased platelet-derived EV. Ongoing work
aims to directly identify this contribution in patients who undergo RIPC.
OTO1.04
Urinary extracellular vesicle concentration, microRNA-155 expression and inflammatory
surface marker expression are altered in patients with symptomatic coronary artery
disease
Stephen Fitzsimons
a, Silvia Oggerob, Niall Mahonc, Nicola Ryanc, Mauro Perrettid and Orina Beltona
aUniversity College Dublin, Dublin, Ireland; bQueen Mary University of London, London,
UK; cThe Mater Misericordiae University Hospital, Dublin, Ireland; dWilliam Harvey
Research institute, Queen Mary University of London, London, UK
Introduction: Urinary extracellular vesicles (uEVs) (exosomes, microvesicles and apoptotic
bodies) have potential as diagnostic and prognostic biomarkers. In atherosclerosis,
the underlying cause of heart attack and stroke, EV release can be dysregulated and
their contents can mediate pro-inflammatory effects. Several markers have been previously
identified on uEV including exosome markers CD63 and CD9, CD45 (leukocyte marker),
CD61 (platelet marker), CD14 (monocyte/macrophage marker) and α/β integrins. The selectively
packaged cargo of these membrane bound carriers include microRNAs (miRs). miR-21 and
miR-155 are key regulatory miRs that are upregulated in immune cells and are released
in EVs following exposure to pro-inflammatory stimuli. miR-155 has been reported to
have pro-atherogenic effects and miR-155 deficiency in murine models results in reduced
atherosclerotic lesion burden.
Methods: Urine was collected from patients diagnosed with coronary artery disease
(CAD), classified as symptomatic (non-ST-elevation myocardial infarction, ST-elevation
myocardial infarction or unstable angina) or asymptomatic (stable angina). uEVs from
symptomatic and asymptomatic patients were isolated via benchtop centrifugation. The
concentration and size of uEVs were analysed via the NanoSight NS300 (n = 15 per group).
The expression of miR-155 and miR-21 was investigated by RT-qPCR (n = 10 per group).
uEV surface marker expression was analysed by ImageStreamX MK2 Imaging Flow Cytometer
(12 per group).
Results: uEV concentration in symptomatic patients (median; 6.46E+9 particles/mL)
was significantly decreased (p < 0.05) compared to asymptomatic patients (median;
1.25E+10 particles/mL). CD11B+ uEVs were increased and CD16+ uEVs were decreased in
the symptomatic patients (p < 0.01). In addition, the concentration of CD45+ EVs were
increased in symptomatic patients (p < 0.001). Although uEV miR-21 was unchanged,
miR-155 expression was significantly increased in the symptomatic group (p < 0.05).
Summary/Conclusion: uEV concentration, miR-155 expression and surface marker expression
have diagnostic and prognostic potential. As CAD severity increases, uEV concentration
is reduced, surface marker expression is altered and uEV miR-155 expression is increased.
Funding: The Irish Research Council.
OT01.05
Circulating extracellular vesicle-associated microRNAs as predictive biomarkers of
cardiovascular complications in end-stage renal disease
Dakota D. Gustafson
a, Jessica Fitzpatrickb, Jason Fishc and Rulan Parekhb
aDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto,
ON, Canada; bChild Health Evaluative Sciences, Research Institute, The Hospital for
Sick Children, Toronto, ON, Canada; cToronto General Hospital Research Institute,
University Health Network, Toronto, ON, Canada
Introduction: Chronic kidney disease affects roughly three million Canadians and is
accompanied by considerable human suffering, premature death and costly medical care.
The incidence of ESRD and its associated cardiovascular (CV) complications continues
to rise despite improved treatments for the primary etiologies of diabetes and hypertension.
Methods: We are using multiple biological approaches to better understand the organ-level
effects of extracellular vesicle (EV)/miRNA dysregulation and gather the detailed
mechanistic insight necessary for the development of an integrative CV risk prediction
model for diabetic ESRD patients. The foundation of this study is the Predictors of
Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) cohort (n = 571);
a cohort of ESRD patients followed over four years, with a repository of clinical
data with matched biological samples. ExoQuick was used for the isolation of EVs from
plasma, and their properties characterized through NanoSight analysis, western blotting
and electron microscopy. A high-throughput microfluidics RT-qPCR platform (n = 420)
was used to examine potential associations between miRNA and clinical outcomes. We
then validated functionality on human coronary endothelial cells (n = 12, coronary
artery disease vs. control) using mRNA-Seq.
Results: EV analysis revealed diabetic ESRD patients have increased circulating vesicle
concentrations; in addition to having vesicles of a larger mean size. Data from our
clinically translatable microfluidics-based RT-qPCR methodology identified numerous
potential microRNA biomarkers for CV complications of ESRD. Following miRNA identification,
we utilized penalized regression models to generate a panel of miRNAs which may serve
as CV-risk predictors for diabetic ESRD patients. In particular, miR-23b-3p appears
to be significantly associated with coronary artery disease severity.
Summary/Conclusion: This data will be weighted with the novel biomarker data and fully
integrated to build a clinical risk prediction model for the development of CV complications
in ESRD and reassessed in a new cohort (D4 Cohort) replicate the findings and validate
the risk prediction model.
Funding: This work was funded by AstraZeneca and the Canadian Vascular Network.
OT01.06
Live tracking system for endogenous exosomes
Weijia Luoa, Yuan Daia, Kelsey Andradea, Megha Chandnab, Pamela Ulloa-Francoc and
Jiang Chang
a
aTexas A&M University College of Medicine, Houston, USA; bUniversity of Texas-Austin,
Houston, USA; cTrinity College, Hartford, USA
Introduction: Exosomes are emerging new category of messengers that communicating
among cells, tissues and organs. Understanding the kinetic of exosome communication
in vivo is a critical foundation for studying exosome functions and developing exosome-based
drug-delivery models. Current studies of exosome in vivo trafficking largely rely
on the administration of exogenous exosomes labelled by fluorescent dyes or proteins.
These methods may not fully represent endogenous exosome kinetics due to ex vivo exosome
manipulation. Here, we established the first inducible endogenous exosome tracking
mouse model that tracks endogenous exosome released by cardiomyocytes in vivo.
Methods: We generated a transgenic mouse expressing the bioluminescent reporter Nano-luciferase
(NanoLuc)-fusion protein. The ultrasensitive and stable NanoLuc reporter has a 150-fold
stronger signal compared to the traditional Firefly and Renilla luciferases and the
longest luminescent half-life amongst all known luciferases. We fused NanoLuc reporter
with exosome surface marker CD63 for specific labelling of exosomes. Then, the cardiomyocyte-specific
αMHC promoter followed by a loxP-STOP-loxP cassette was engineered for precise spatial
labelling of exosomes originating from cardiomyocytes. We then crossed the cardiomyocyte-specific
mouse with a tamoxifen-inducible Cre mouse (R26CreERT2) to achieve an inducible system.
The exosome labelling and distribution were assessed by luciferase assay and noninvasive
bioluminescent live imaging.
Results: CD63NanoLuc expression was tightly controlled and only detected in cardiomyocytes
upon induction. The endogenous exosomes released from cardiomyocytes were labelled
and detected in vitro in cell culture supernatant, and in vivo in animal plasma. A
signature distribution profile of the endogenous cardiomyocyte-releasing exosomes
was achieved.
Summary/Conclusion: This exosome tracking model enables elucidating the endogenous
exosome trafficking pattern, and allows the study of exosome behaviour under different
conditions. It will provide a powerful tool for the exploration of the biological
functions, mechanisms and clinical applications of exosomes in a broad spectrum of
research.
Funding: AHA Innovative Project Award: 18IPA34180012.
Symposium Session 2: Nucleic Acid Biomarkers in Human Disease Chairs: Robert Kitchen;
Louise LaurentLocation: Level B1, Lecture Room 11:00–12:30
OT02.01
miRNA exosomal biomarkers in brain derived and serum exosomes associated with neurodegenerative
diseases
Lesley Cheng
a, Xia Lib, James Doeckec, Laura Vellad, Natasha Vassileffe, Mitch C. Shambrooka,
Robyn Sharplesf, Saima Zafarg, Inga Zerrh, Catriona McLeani, Malcolm Horned, Colin
Mastersd, Kevin Barnhamd and Andrew Hillj
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science,
La Trobe University, VIC, Australia, Melbourne, Australia; bDepartment of Mathematics
and Statistics, La Trobe Institute for Molecular Science, La Trobe University, VIC,
Australia, Melbourne, Australia; cCSIRO Digital Productivity Flagship/The Australian
E-Health Research Centre, Herston, Queensland, Australia, Brisbane, Australia; dThe
Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville,
Victoria, Australia; eThe Department of Biochemistry and Genetics, La Trobe Institute
for Molecular Science, La Trobe University, Bundoora, Victoria, Australia; fThe Department
of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Bundoora, Victoria, Australia; gDepartment of Neurology, Clinical Dementia Centre,
University Hospital Göttingen, Göttingen, Germany; hThe Florey Institute of Neuroscience
and Mental Health, The University of Melbourne, Parkville, Victoria, Australia., Melbourne,
Australia; iThe Department of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Bundoora, Victoria, Australia
Introduction: Several blood-based tests have been explored to detect Alzheimer’s disease
(AD) and other neurogenerative diseases; however, evidence is required to determine
whether blood sampling is an appropriate specimen to diagnose brain diseases. Exosomes
are small extracellular membrane vesicles packaged with RNA and protein cargo. Previously
we isolated serum exosomes from AD patients which displayed an abnormal composition
of 16 specific microRNA (miRNA) biomarkers compared to controls.
Methods: To provide evidence that our serum exosomal miRNA biomarkers are suitable
for the detection of a brain condition, we also profiled exosomes isolated from post-mortem
human AD (n = 8), PD (n = 8), ALS (n = 7) and control (n = 5–8 per group) brain tissues
using next-generation sequencing.
Results: Brain-derived exosomes (BDEs) were found to contain a unique profile of small
RNA, including miRNA, compared to whole tissue. Furthermore, all 16 AD serum biomarkers,
identified in our previous study, were detected in BDEs, together with differentiators
for PD, ALS and CJD diagnosis in serum and in some cases neural-derived exosomes.
Summary/Conclusion: This work has identified highly specific panels of miRNA that
is both present in the brain and blood of AD, PD, ALS and CJD patients. The miRNA
candidates can be used to develop a blood-based diagnostic test highly relevant to
a brain disease, equivalent to noninvasive brain biopsy.
Funding: National Health and Medical Research Council, Australia MND, Australia Creutzfeldt-Jakob
disease Support Group Network, Australia Dementia Centre for Research Collaboration,
Australia
OT02.02
Brain-derived extracellular vesicle microRNA signatures associated with in utero and
postnatal oxycodone exposure: Implications for altered synaptogenesis
Victoria Schaala, Dalia Mooreb, Peng Xiaoa, Sowmya V. Yelamanchilib, Gurudutt Pendyala
a
aUniversity of Nebraska Medical Center, Omaha, USA; bDepartment of Pharmacology and
Experimental Neuroscience, University of Nebraska Medical Center, Omaha, USA
Introduction: Oxycodone (oxy) is a semi-synthetic opioid commonly used as a pain medication
which also is a widely abused prescription drug. While very limited studies have examined
the effect of in utero oxy (IUO) exposure on neurodevelopment, a significant gap in
knowledge is the effect of IUO compared with postnatal oxy (PNO) exposure on synaptogenesis
– a key process in the formation of synapses during brain development in the exposed
offspring. In the present study, we isolated and characterized brain-derived extracellular
vesicle (BDE)-associated microRNA cargo from the brains of IUO and PNO offspring using
RNA seq. Several key miRNAs unique to both the IUO and PNO groups were identified
and validated using RT-PCR. To further gain mechanistic insights, we characterized
the miRNA cargo effects on changes in synaptic architecture using in vitro primary
neurons during a key stage of brain development.
Methods: Density gradient EV isolations from brain tissue, transmission electron microscopy,
RT-PCR, in vitro primary neuronal cultures and spine density analysis.
Results: Transmission electron microscopy revealed an increase in BDE sizes in both
the PNO and IUO groups suggesting that oxy exposure can affect BDE size thus indicating
differential expression of molecular cargo. Next, RNA-Seq identified novel and distinct
BDE miRNAs unique to IUO and PNO which were further validated by RT-PCR. Bioinformatics
analysis on these differentially expressed BDEs, revealed key Gene Ontology terms
involved in neurodevelopment such as neuron projection development, neuronal morphogenesis,
pallium/cerebellum development in the IUO offspring. To determine, if BDEs impacted
the synaptodendritic architecture, we treated 14 days in vitro rat cortical primary
neurons with equal amounts of P14 BDEs from the three groups. Confocal imaging of
dendritic spines showed a significant reduction on treatment with PNO BDEs and which
was further exacerbated on treatment with the IUO BDEs.
Summary/Conclusion: We conclude that BDEs from PNO and IUO offspring carry potentially
distinct BDE miRNA cargo that subsequently damage the synaptodendritic architecture
and could further lead to neuronal dysfunction at a key stage of neurodevelopment.
Funding: Start-up funds and NIH/NIDA.
OT02.03
Development of a high-performance urine exosomal-mRNA signature for identification
of bladder cancer
Sudipto Chakrabortty
a, Robert Kitchena, James Hurleya, Georg Stollb, Xuan Zhangc, Mikkel Noerholmd, Seth
Yua and Johan Skoge
aExosome Diagnostics, Inc, Waltham, USA; bExosome Diagnostics, GmbH, Martinsried,
Germany; cNeuology and Radiology Services and program in Neuroscience, Harvard Medical
School, Massachusetts General Hospital, Boston, USA; dExosome Diagnostics, GmbH, Martinsried,
Germany; eExosome Diagnostics, Inc., Waltham, Massachusetts, USA
Introduction: Blood in the urine is a common symptom of bladder cancer but of individuals
who present with haematuria on average only 8% will have cancer. Moreover, up to 70%
of patients with a prior bladder tumour will experience a relapse. The majority of
these individuals will therefore undergo invasive and expensive testing (cystoscopy
& CT scan) to confirm the presence of a tumour, either for first diagnosis or active
surveillance of recurrence. A low-cost, noninvasive urine test capable of preventing
unnecessary biopsies is a challenging but attractive proposition.
Methods: Here, we present results from a clinical study in which exosomal mRNAs were
profiled from voided urine, collected prior to diagnosis, from individuals suspected
of having either newly diagnosed or relapsed bladder cancer. We selected 81 individuals
for the clinical study, 44 of whom were diagnosed with mostly early stage bladder
cancer. The remaining individuals were healthy or diagnosed with a non-cancerous urinary
disease.
Results: We identified a 16-mRNA signature by mining over 25,000 public and proprietary
RNA-seq datasets, using a machine learning approach to rank genes based on dysregulation
in bladder cancer, presence in urine exosomes and stability to haematuria. Using this
signature, we trained a classifier to differentiate samples based on presence/absence
of bladder cancer, optimized for negative predictive value (NPV). The model performs
well in both newly diagnosed and recurrent cases, even in low-grade disease, with
an overall performance of 100% NPV at 46% specificity. As the model is based solely
on exosomal mRNA abundance, the score provides entirely new information that would
enable a clinician to further improve specificity by considering standard of care
parameters.
Summary/Conclusion: Exosomal mRNAs have been used to diagnose other malignancies but
this represents the first application of this form of liquid biopsy to bladder cancer.
While performance must be validated in a larger clinical trial, this signature could
prevent ~50% of unnecessary biopsies, provide a noninvasive means of monitoring relapse
and reduce the financial burden of early stage bladder cancer care.
OT02.04
Genome-wide methylation profiling of extracellular vesicle DNA allows brain tumour
classification
Franz Lennard. Ricklefs
a, Cecile Maireb, Katharina Kolbeb, Mareike Holzb, Manfred Westphalb, Ullrich Schüllerb
and Katrin Lamszusb
aUniversity medical center Hamburg-Eppendorf, Hamburg, Germany; bUniversity Medical
Center Hamburg-Eppendorf, Hamburg, Germany
Introduction: Genome-wide methylation profiling has recently been developed into a
tool that allows subtype tumour classification in central nervous system (CNS) tumours.
Extracellular vesicles (EVs) are released by CNS tumour cells protecting their cargo,
including DNA, from degradation rendering EVs as optimal biomarkers to define subgroups,
stratify patients and monitor therapy by liquid biopsy. It is unclear, however, if
DNA derived from glioma EVs reflects genome-wide methylation profiles and mutational
statuses that would allow tumour classification.
Methods: DNA was isolated from glioma cell cultures (GSC) EVs, GSCs and matched tumour
samples (n = 3). EVs were isolated through differential ultracentrifugation and classified
by nanoparticle tracking analysis (NTA), immunoblotting, imaging flow cytometry (IFCM),
multiplex EV assay and electron microscopy. Genome-wide DNA methylation profiling
was performed using a 850-k Illumina EPIC array and classified by the DKFZ brain tumour
classifier.
Results: GSCs secrete diverse EVs as measures by IFCM and multiplex EV assay that
are high for common EV markers (a.e. CD9, CD63 and CD81). The range of EVs was 120–150 nm
measured by NTA. Genome-wide methylation profiles of GSC EVs in addition to copy number
alterations and mutations matched their parental GSC and original tumour sample, being
Glioblastoma, IDH wildtype or mutant, with additional subclass analyses. Specifically,
MGMT methylation statuses could be obtained through EV DNA.
Summary/Conclusion: Here we report, that EV DNA reflects the tumour methylation class
as well as most copy number variations and mutations present in the parental cells
and the original tumour. DNA EV methylation profiles may therefore be used to detect
and classify CNS tumours.
Funding: FLR received a scholarship of the German Academic Foundation.
OT02.05
Methamphetamine use disorder alters plasma extracellular vesicle characteristics and
microRNA expression
Ursula Sandaua, John Nolan
b, Xiao Shic, Tracy Swansonc, Marilyn Huckansd, William Schutzerd, Kylie Sagee, Jodi
Lapidusf, Jennifer Loftisd, Aaron Janowskyg and Julie A. Saugstada
aDepartment of Anesthesiology & Perioperative Medicine, Oregon Health & Science University,
Portland, USA; bScintillon Institute, San Diego, USA; cVA Portland Health Care System,
and Department of Psychiatry, Oregon Health & Science University, Portland, USA; dVA
Portland Health Care System, Department of Psychiatry, and Methamphetamine Abuse Research
Center, Oregon Health & Science University, Portland, USA; eBiostatistics & Design
Program, Oregon Health and Science University, Portland, USA; fBiostatistics & Design
Program, Oregon Health and Science University, Oregon Health & Science University
– Portland State University School of Public Health, Portland, USA; gVA Portland Health
Care System, Departments of Psychiatry and Behavioral Neuroscience, and Methamphetamine
Abuse Research Center, Oregon Health & Science University, Portland, USA
Introduction: Methamphetamine’s (MA) rewarding properties and addictive potential
are correlated with increased synaptic dopamine availability following alterations
in dopamine and vesicular monoamine transporter function. We examined plasma extracellular
vesicle (EV) number, size, protein markers and miRNA content in human subjects who
are actively using MA.
Methods: Plasma samples from 10 adults with active MA dependence (MA-ACT), and 10
non-dependent controls (CTL) were obtained from the Methamphetamine Abuse Research
Center Biorepository at Oregon Health & Science University and the VA Portland Health
Care System. We used single Vesicle Flow Cytometry to directly measure plasma EV concentration
and size. We used size-exclusion chromatography (iZON Science) to isolate plasma EVs.
EV total RNA isolated by mirVana™ PARIS™ RNA Kit (ThermoFisher) was analysed on TaqMan®
Array Human MicroRNA A + B Cards Set v3.0 (ThermoFisher). MiRNA expression was compared
between MA-ACT and CTL using two-sample t-tests for miRNA expressed in at least 50%
of samples in at least one of the two groups. Tobacco use was controlled for.
Results: The data show that in MA-ACT (n = 5) vs. CTL (n = 5), four of the five MA-ACT
have an increase in total plasma EVs relative to all five CTL. The average EV concentration
in MA users (2 × 108 ± 4.5 × 107 EV/μL) is trending to increased levels, relative
to CTL (7.5 × 107 ± 0.9 × 107 EV/μL). EV counts relative to size show a range of EVs
with a mode of ~110 nm in both MA-ACT and CTL plasma, and equivalent median EV size.
Of 226 miRNA in the EVs, there are 30 miRNAs that meet have area under the curve (AUC)
>0.65 and median difference >1, and 47 miRNAs with AUC >0.65 and mean difference >1.
Twenty-three of these miRNAs overlap and are the current focus of target prediction.
Summary/Conclusion: EV miRNA expression in subjects with MA use disorder was significantly
different than in control participants, suggesting that MA may affect EV communication
among cells. The differential miRNA expression also implicates a role for EVs in behavioural
and physiological effects specific to MA and suggests that there may be changes in
expression of miRNAs that are relevant to specific drugs of addiction, as well as
to a spectrum of drug-mediated addiction disorders.
OT02.06
Use of extracellular vesicles purified from lymphatic exudative seroma as surrogate
markers of melanoma residual disease
Susana Garcia-Silva
a, Alberto Benito-Martínb, Sara Sanchez-Redondoc, Alberto hernandez-Barrancoa, Pilar
Ximénez-Embúnd, Laura Noguésa, Ana Isabel Amora, Kay Brinkmanne, Marina S Mazariegosc,
Jasminka Boskovichf, Mercedes Robledog, Johan Skogh, Mikkel Noerholme, Javier Muñozi,
Pablo L. Ortiz-Romeroj, José Luis Rodríguez-Peraltok, Piotr Rutkowskil and Héctor
Peinadoa
aMicroenvironment and Metastasis Laboratory, Molecular Oncology Programme. Spanish
National Cancer Research Center (CNIO), 28029 Madrid, Spain, Madrid, USA; bChildren‘s
Cancer and Blood Foundation Laboratories, Departments of Pediatrics, Weill Cornell
Medicine, New York, NY 10021, USA, New york, USA; cMicroenvironment and Metastasis
Laboratory, Molecular Oncology Programme. Spanish National Cancer Research Center
(CNIO), 28029 Madrid, Spain, MAdrid, USA; dProteomics Unit – ProteoRed-ISCIII, Spanish
National Cancer Research Centre (CNIO), Madrid 28029, Spain, Madrid, USA; eExosome
Diagnostics, GmbH, Martinsried, Germany, Martinsried, USA; fElectron Microscopy Unit,
Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain, MAdrid, USA;
gHereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO),
Madrid 28029, Spain, Madrid, USA; hExosome Diagnostics, Inc., Waltham, Massachusetts,
USA, Waltham, USA; iSpanish National Cancer Research Centre, Madrid, South Georgia
& South Sandwich Islands; jDepartment of Dermatology, Medical School, Universidad
Complutense, Instituto i + 12, Hospital Universitario 12 de Octubre, Madrid 28041,
Spain, Madrid, USA; kDepartment of Pathology, Medical School, Universidad Complutense,
Instituto i + 12, Hospital Universitario 12 de Octubre, Madrid 28041, Spain, Madrid,
USA; lMaria Sklodowska-Curie Institute – Oncology Center, Department of Soft Tissue/Bone
Sarcoma and Melanoma, Warsaw, Poland, Varsaw, USA
Introduction: Liquid biopsies in melanoma patients have the potential to improve prognosis.
Exudative seroma obtained in the drainage implanted post-lymphadenectomy has never
been explored as a source of biomarkers. The use of circulating extracellular vesicles
(EVs) as surrogate markers of residual disease could be a novel and powerful non-invasive
tool.
Methods: Exosomes were purified by ultracentrifugation from exudative seroma obtained
after lymphadenectomy from stage III melanoma patients, were analysed by nanosight
analysis and electron microscopy, and compared to plasma in a total of 92 samples.
We profiled the proteomic profiles of exudative seroma- and plasma-derived exosomes
by mass spectrometry. Extracellular vesicle-associated nucleic acids (EV-NAs) and
analysed BRAFV600E by an allele-specific PCR in exudative seroma samples as a novel
parameter to detect residual disease
Results: We found that exudative seroma is a novel biofluid highly enriched in EVs,
higher size and increased DNA cargo in comparison to plasma. Proteomic analysis of
seroma-derived exosomes demonstrated that they are enriched in melanoma oncogenic
pathways together with immune-related pathways; however, proteomic analysis did not
allow identify biomarkers of relapse or progression. Importantly, detection of BRAFV600E
mutation in seroma-derived EVs obtained 24–48 hours post-lymphadenectomy identified
patients at risk of relapse significantly (Log rank p = .0067) in a cohort of 17 stage
III melanoma patients followed up for 700 days.
Summary/conclusion: Our data show for the first time that exudative seroma obtained
post-lymphadenectomy is a novel biofluid enriched on EVs and DNA that can be interrogated
for melanoma markers and BRAF mutation. Analysis of BRAFV600 mutation identified patients
at risk of relapse with high significance. These data support that our approach could
be a novel factor to detect residual disease right after surgery in stage III melanoma
patients. Our analysis could be a novel approach to aid oncologists to identify high-risk
groups of patients post-lymphadenectomy and improve patient outcome.
Funding: MINECO, NIH, Starr Foundation, Ramon y Cajal Programme, AECC, FERO foundation,
and MINECO-REDiEX.
Symposium Session 3: EVs in Cancer Metastasis and Angiogenesis Chairs: Kyoko Hida;
Alissa WeaverLocation: Level 3, Hall B 11:00–12:30
OT03.01
Stem cell-derived extracellular vesicles increase cancer stem cell sensitivity to
tyrosine kinase inhibitors through Akt/mTOR/PTEN-combined modulation
Benedetta Bussolati
a, Valentina Fonsatob, Michela De Lenac, Stefania Trittad, Alessia Brossab, Ruggero
Calvettie, Ciro Tettaf and Giovanni Camussig
aDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin,
Italy; bMolecular Biotechnology Center, University of Torino, Torino, Italy; cMolecular
Biotechnology Center, University of Torino, Torino, Italy; dUniversità di Torino,
Nichelino, Italy; eDepartment of Molecular Biotechnology and Health Sciences, Torino,
Italy; fUnicyte srl, Turin, Italy; gDepartment of Medical Sciences, University of
Turin, Turin, Italy
Introduction: Cancer Stem Cells (CSCs) are a small cell population able to sustain
the maintenance and recurrence of tumours. In consideration of the high drug resistance
and tumour initiating capability, targeting CSCs represents an important approach
to eradicate tumours. We previously showed a pro-apoptotic effect of extracellular
vesicles (EVs) derived from human liver stem cells. In this study, we evaluated whether
HLSC-EVs could act in synergy with tyrosine kinase inhibitor drugs (TKIs) on apoptosis
of CSCs isolated from renal carcinomas.
Methods: We administered HLSC-EVs and TKIs to renal CSCs, as co-incubation or sequential
administration. TKIs were also loaded in EVs. Intracellular phosphoproteins were evaluated
in the CSC lysates by the magnetic bead-based immunoassays Bio-Plex Pro cell-signalling
assay and confirmed by Western Blot analysis.
Results: We found that HLSC-EVs in combination with Sunitinb or Sorafenib significantly
increased renal CSCs apoptosis induced by low TKI dose. At variance, no synergistic
effect was observed when bone marrow mesenchymal stem cell-derived EVs were used.
CSC apoptosis was also enhanced when TKIs were loaded in HLSC-EVs. In particular,
renal CSCs chemosensitivity to TKIs was enhanced when HLSC-EVs were either co-administered
with TKIs or added after, but not before. By a mechanistic point of view, Akt/mTOR
and Erk and Creb intracellular pathways, known to be pivotal in the induction of tumour
growth and survival, appeared modulated as consequence of TKIs/HLSC-EVs co-administration
as well as by EV post-administration.
Summary/Conclusion: Our results indicated that HLSC-EVs and TKIs have a synergistic
anti-tumour effect on renal CSCs inducing an enhancement of apoptosis by a combined
effect on intracellular pathways pivotal in the induction of tumour growth and survival.
This effect appear to be due to an EV-dependent enhancement of TKI induced mechanisms
and not to epigenetic changes induced by EV leading to increased TKI sensitivity.
This study provides a rational for a combined use in tumour treatment.
Funding: This study was supported by Associazione Italiana per la Ricerca sul Cancro
(A.I.R.C.), project IG2012 and by grant no. 071215 from Unicyte.
OT03.02
Exosomal nidogen 1 drives liver cancer metastasis by inducing secretion of tumour
necrosis factor receptor 1 from activated lung fibroblasts
Xiaowen Mao, Sze Keong Tey and Judy Yam
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: Hepatocellular carcinoma (HCC) is an aggressive tumour with metastasis
as a signature in the advanced stage. Acquisition of migratory and invasive behaviours
is fundamental to cancer cells to metastasize. A supportive microenvironment for the
colonization of incoming disseminated cancer cells during metastasis is also indispensable.
Exosome shedding has emerged as an important channel for intercellular communication
in tumour microenvironment during metastasis.
Methods: Exosomes derived from HCC cell lines were functionally characterized by in
vitro and in vivo assays. Proteomic profiling and expression level of exosomal proteins
were analysed by mass spectrometry and enzyme-linked immunosorbent assay (ELISA),
respectively. The study of interplay between exosomes, HCC cells and lung fibroblasts
were carried out using functional assays, immunofluorescent staining and ELISA.
Results: Exosomes derived from metastatic HCC cells augmented cell migration and invasiveness.
In animal model, metastatic-exosomes promoted liver tumour formation, increased incidence
of distant metastasis to lungs as well as facilitated colonization of hepatoma cells
in lungs and enhanced the permeability of pulmonary vasculature. Proteomic profiling
of exosomes identified nidogen 1 (NID1) as a functional component responsible for
the promoting effect of metastatic-exosomes. Our data showed that suppression of exosomal
NID1 (exo-NID1) significantly diminished the biological activities of metastatic-exosomes.
Apart from HCC cells, exo-NID1 enhanced the growth and induced activation of lung
fibroblasts. Tumour necrosis factor receptor 1 (TNFR1), found to be released by lung
fibroblast pretreated with metastatic-exosomes, showed potent effect in promoting
HCC cell motility. Notably, the level of exo-NID1 was well correlated with the metastatic
potential of parental HCC cells. Encouragingly, the level of NID1 in circulating exosomes
of HCC late stage patients was higher than those at early stage.
Summary/Conclusion: Our study reveals the novel role of NID1, in the form of exosomes,
in HCC metastasis and illuminates the expression profile of exosomal NID1 with clinical
significance. Our study implicates that targeting signalling pathway mediated by exosomes
of metastatic HCC as a therapeutic strategy for HCC.
Funding: RGC GRF (17,113,116) and SKLLR IRF 2017.
OT03.03
Cancer extracellular vesicles create functional heterogeneity of cancer-associated
fibroblasts in gastric cancer
Yutaka Naito
a, Yusuke Yamamotob, Akiko Kogurec, Iwao Shimomurad, Minami Kumazakic and Takahiro
Ochiyad
aDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute,
London, UK; bDivision of Molecular and Cellular Medicine, National Cancer Center Research
Institute, Tokyo, USA; cDivision of Molecular and Cellular Medicine, National Cancer
Center Research Institute, Tokyo, Japan; dDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku, Japan
Introduction: Cancer-associated fibroblasts (CAFs) are the major stromal components
in the various types of malignancies. It has been recognized that the functional heterogeneity
of CAFs provide an appropriate microenvironment for tumour progression. However, it
is still largely unknown how functional heterogeneity of CAF is governed by tumour
cells. In this study, we investigated the role of extracellular vesicles (EVs) on
the formation of CAF functional heterogeneity.
Methods: We treated EVs derived from high-metastatic diffuse-type gastric cancer (DGC)
cells or low-metastatic DGC cells to the fibroblasts. By comparing transcriptome profiles
of fibroblasts with the EVs, we sought to understand how high-metastatic DGC cells
created an appropriate microenvironment for the metastasis.
Results: Our whole-transcriptome analysis of fibroblasts revealed that high metastatic
DGC cell-derived EVs strongly induced the expression of inflammatory chemokines such
as CXCL1 and CXCL8. However, it is not observed in the fibroblast treated with EVs
from low-metastatic DGC. Interestingly, both cancer-derived EVs did not affect the
expression of alpha-smooth muscle actin (α-SMA), a typical marker of myofibroblast
phenotype. When fibroblasts were treated with TGFβ, α-SMA was clearly induced but
suppressed inflammatory chemokine expression in the fibroblasts. Immunocytochemical
analysis of CXCL8 and α-SMA showed distinct populations of activated fibroblasts in
the co-culture with high-metastatic DGC, suggesting that functional heterogeneity
was generated by EVs. We also identified that various miRNAs including miR-193b were
enriched in high metastatic DGC cell-derived EVs to induce chemokine expression in
fibroblasts.
Summary/Conclusion: Our findings suggest that the intercellular crosstalk of high-metastatic
DGC and fibroblasts via EVs contributes to forming the appropriate tumour microenvironment
toward the metastasis.
OT03.04
Extracellular vesicles from obese human adipose tissue alter the invasive and proliferative
properties of prostate cancer cells
Anca D. Dobrian
a, Ryan Huyck, Bronson Haynes, Vanessa Correll, Avennette Pinto, James Reed, Matthew
Freedman, William McPheat, Julius O. Nyalwidheb, O. John Semmesb
aEastern Virginia Medical School, Norfolk, USA; bLeroy T. Canoles Jr. Cancer Research
Center, Eastern Virginia Medical School, Norfolk, USA
Introduction: Obesity increases the risk and aggressiveness of multiple cancers including
prostate cancer. Adipose tissue (AT) is a rich source of extracellular vesicles (EVs)
that were shown to contribute to vascular and metabolic pathologies. Here we characterized
the miRNA and proteome of EV isolated from human visceral (V) and subcutaneous (S)
fat of bariatric subjects and explored their mechanistic effects on molecular and
functional phenotypes of metastatic prostate cancer cells.
Methods: Paired S and V AT collected intraoperatively were used to isolate EVs by
ultracentrifugation (n = 27). DIO-labelled EV-S or EV-V was incubated overnight with
PC3-ML metastatic prostate cancer cells. EV uptake, proliferation, migration and invasion
were quantified by fluorescence microscopy, BrdU incorporation, wound healing and
invasion assays, respectively. The miRNA and proteome cargo of EVs were measured using
the Nanostring platform and LC/MS/MS. Changes in gene expression in recipient PC3-ML
cells were determined using Nanostring.
Results: EV-S and EV-V produced similar effects on recipient PC3-ML cells. EVs increased
cell proliferation by ~1.8-fold (p < 0.05); had no effect on cell migration but dramatically
decreased cell invasion by 2.5-fold (p < 0.01) compared to untreated controls. Gene
expression in recipient PC3-ML cells showed significant two to three fold decrease
in expression of 8 MMPs without changes in TIMP expression. Mesenchymal markers Snail
and Zeb were also significantly decreased and seven glycolytic and PPP enzymes were
1.5- to 2.5-fold increased. Consistent with these changes, the miRNA cargo of EVs
was shown to target all the above pathways and the top pathways detected in the EV
proteome were metabolism and energy production.
Summary/Conclusion: AT EVs appear to induce a mesenchymal to epithelial transition
in prostate cancer cells. This study reveals a novel role of EVs from human AT on
metastasis and suggests a new mechanistic link between obesity and prostate cancer.
Funding: Commonwealth of Virginia Health Research Board.
OT03.05
Novel vesicular mediators of peritoneal metastases
Shelly Loewenstein
a, Fabian Gerstenhaberb, Nir Lubezkyb, Eran Nizrib, Joseph Klausnerb, Noam Shomronc,
Guy Lahatb
aTel Aviv Sourasky Medical Center, Tel Aviv, Israel; bSurgery Division, Tel Aviv Sourasky
Medical Center, Tel-Aviv, Israel; cTel Aviv university, Tel Aviv, Israel
Introduction: Malignant progression results from a dynamic crosstalk between stromal
and cancer cells. Recent data suggest that this crosstalk is mediated by exosomes,
nanovesicles secreted by various cell types which allow the transfer of proteins,
and nucleic acids between cells. We investigated the potential role of omental fat
exosomes in gastric cancer peritoneal metastasis.
Methods: Omental fat exosomes were produced from fresh human omental fat specimens.
Proliferation, migration, invasion and chemoresistance were used to evaluate the phenotypic
behaviour of omental-exosomes treated gastric cancer cells. Using a comprehensive
cytokine array, we identified the proteome of omental-exosomes. Exosomal miRNAs were
profiled using NanoString technology. A xenograft model was used to evaluate in vivo
effects of omental-exosomes on gastric cancer tumour growth.
Results: Initially, we demonstrate a robust uptake of omental fat exosomes by gastric
cancer cells. We show that these exosomes enhance gastric cancer cell proliferation,
migration and invasion. We also revealed that the number of exosomes is directly related
to their effect on gastric cancer cells. We further show that omental fat exosomes
induce gastric cancer cellular chemoresistance to platinum-based therapy, and that
omental exosomes augment gastric cancer xenograft tumour growth in-vivo. Using a cytokine
array, we characterized the proteome of omental fat exosomes compared to SC exosomes.
miRNA profiling identified several established oncomiRs. These vesicles carry numerous
proteins and miRNAs implicated in cellular adhesion and chemotaxis, tumour growth
and motility as well as chemoresistance; some of these molecules have been reported
as pro-tumourigenic factors in gastric cancer. Finally, we demonstrate that omental
fat-exosomes increase the expression of transcription factors, mRNA of extracellular
matrix proteins and adhesion molecules within gastric cancer cells.
Summary/Conclusion: These observations demonstrate for the first time the uptake of
omental fat exosomes by cancer cells; these vesicles carry different molecules which
promote gastric cancer cellular aggressiveness in vitro and in vivo. Taken together,
our data imply that omental fat exosomes might play a role in gastric cancer peritoneal
spread.
OT03.06
Non-SUMOylated Cx43 changes the recruitment of cellular components into exosomes switching
the role of these vesicles in metastatic melanoma
Adrián Varela-Vázqueaa, María D. Mayán Santos
b, Amanda Guitián-Caamañoc, Alejandro Castro-Iglesiasd, Tamara Camino Martíneze, Susana
B. Bravo-Lópezf, María Pardog, Teresa Calleja-Chucláh and Eduardo Fonsecac
aCellCOM research group. Instituto de Investigación Biomédica de A Coruña (INIBIC).
Servizo Galego de Saúde (SERGAS), A Coruña, Spain; bTranslational Research in Cell
Communication and Signalling (CellCOM). Instituto de Investigación Biomédica de A
Coruña (INIBIC). Xubias de Arriba, 84 15006 A Coruña, Spain., A Coruña, Spain; cCellCOM
research group. Instituto de Investigación Biomédica de A Coruña (INIBIC). Servizo
Galego de Saúde (SERGAS), A Coruña, Spain; dTranslational Research in Cell Communication
and Signalling (CellCOM). Instituto de Investigación Biomédica de A Coruña (INIBIC),
A Coruña, Spain; eGrupo Obesidómica.Instituto de Investigación Sanitaria de Santiago
de Compostela (IDIS). Complejo Hospitalario Universitario de Santiago. Travesía da
Choupana s/n. 15706, Santiago de Compostela, Spain, Santiago de Compostela, Spain;
fProteomics laboratory. Instituto de Investigación Sanitaria de Santiago de Compostela
(IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), A Coruña,
Spain; gGrupo Obesidómica. Instituto de Investigación Sanitaria de Santiago de Compostela
(IDIS). Complejo Hospitalario Universitario de Santiago. Travesía da Choupana s/n.
15706, Santiago de Compostela, Spain, Santiago de Compostela, Spain; hServicio de
Farmacia Hospitalaria. CH-Universitario A Coruña (XXIAC). Servizo Galego de Saúde
(SERGAS), Universidade da Coruña. Xubias de Arriba, 84 15006 A Coruña, Spain., A Coruña,
Spain
Introduction: Connexin43 (Cx43), a transmembrane protein involved in cell communication
and signalling, has been described as a tumour suppressor factor in melanoma, however
its role in disease progression remains under debate. Extracellular vesicles (EVs)
released by melanoma cells provide signals and “educate” distant cells. The presence
of Cx43 in EVs provides these particles with an additional capacity to exchange small
molecules such as RNAs, metabolites or ions with target cells via gap junction channels
(GJs).In this study, we have investigated the role of exosomal Cx43 in metastatic
melanoma.
Methods: Protein levels and activity were studied by western-blot, immunofluorescence,
colony formation and proliferation and migration assays. GJIC by Scrape loading. EVs
were isolated by ultracentrifugation and analysed using the NanoSight and electron
microscopy. Their content was analysed by mass spectrometry (MS) and by RNA-seq.
Results: Low levels and SUMOylated Cx43 in BRAF-mutant human melanoma cells was associated
with cytoplasmic distribution and low incidence of dye coupling (GJIC). Ectopic Cx43
gene expression using vectors restored Cx43 membrane localization, raised GJIC and
increased Cx43 in the EVs. EVs isolated from BRAF-mutant melanoma cells overexpressing
Cx43 only contains the non-SUMOylated Cx43. When different melanoma cell lines were
exposed to exosomes containing Cx43, these EVs significantly decreased cell proliferation
and blocked colonies growth. The effect of exosomal Cx43 was compared to the overexpression
of the protein. The presence of Cx43 in EVs significantly increased the sensitivity
of BRAF-mutant metastatic melanoma to drugs such as BRAF/MEK inhibitors. The RNA and
proteomic component identified by RNA-Seq and MS revealed that exosomal Cx43 through
its scaffolding function could be involved in the recruitment of proteins and small
RNAs to the EVs switching the messages and therefore the role of these EVs in melanoma.
Summary/Conclusion: Our results indicate that exosomal particles containing Cx43 are
potent vehicles to combat metastatic melanoma. Further understanding of the role of
Cx43 in EVs will have implications for the development of new therapeutic strategies.
For instance, we demonstrated their ability as drug carriers to combat metastasic
melanoma when these vesicles contain Cx43.
Symposium Session 4: EV Biogenesis I Chairs: Nobuyoshi Kosaka; Clotilde ThéryLocation:
Level B1, Hall A 11:00–12:30
OT04.01
Linking the trafficking of CD63 and CD9 to their secretion mechanisms into extracellular
vesicles
Mathilde Mathieu
a, José Ignacio Valenzuelab, Mathieu Maurina, Mabel Jouvea, Nathalie Nevoa, Gaëlle
Boncompaina, Franck Perezb and Clotilde Theryc
aInstitut Curie, INSERM U932, Paris, France; bInstitut Curie, umr144, Paris, France;
3Institue Curie, Paris, France
Introduction: A major challenge in the study of extracellular vesicles is to characterize
and separate the different extracellular vesicle (EV) subtypes of a different origin.
Indeed, small EVs from the plasma membrane or from endosomes cannot be separated with
the classical EV isolation methods. Moreover, even if some of their molecular mechanisms
of secretion are known, it is challenging to find specific mechanisms for one particular
subtype (see perspective article: Mathieu et al. Nat cell Biol 2019, in press). Understanding
how markers of subtypes of EVs are directed to similar or different EVs could help
to differentiate them, eventually to describe their specific functions. At least two
different populations of small EVs were previously described, one carrying the three
tetraspanins CD63, CD9 and CD81, and one with CD9 only (Kowal et al. PNAS 2016).
Methods: We chose to study in HeLa cells the trafficking of CD63 and CD9 and its link
with their secretion in EVs, using the RUSH system to synchronize and follow their
post-Golgi trafficking (Boncompain et al. Nat Methods 2012). We used the RUSH system
to perform live-cell imaging, electron microscopy, immunofluorescence and flow cytometry
analyses at different steps of trafficking, and to analyse EVs secreted after a specific
time of trafficking.
Results: Despite their presence in the same EVs, CD63 and CD9 do not traffic to the
same final compartments. While CD63 is endosomal, CD9 is located on the plasma membrane.
We showed that CD9 could be found transiently with CD63 in intracellular compartments
before reaching the plasma membrane (PM), while CD63 goes to the PM before being internalized.
By forcing stable expression of CD63 at the PM, or impairing post-Golgi and endosomal
trafficking, we observed increased secretion of CD63+ but not CD9+ EVs.
Summary/Conclusion: Our results demonstrate that small EVs can form both at the PM
and inside multivesicular endosomes. Our tools can be used to determine the respective
effects of drugs and gene silencing on secretion of each of these EVs
OT04.02
Interdependency of the multiple endosomal sorting mechanisms influencing exosome biogenesis
Roberta Palmullia, Guillaume van Nielb, Frederik Verweijb, Xavier Heilingensteina,
Eric Rubinsteinc and Graça Raposoa
aInstitut Curie, PSL Research University, CNRS UMR144, Paris, France; bCPN, Centre
for Psychiatry and Neuroscience, Hôpital Saint-Anne, Universite´ Descartes, INSERM
U894, Paris, France; cInserm U935 (ex. U1004) – Paul Brousse Hospital – André Lwoff
Institute, Villejuif, France
Introduction: Exosomes are generated as intraluminal vesicles (ILVs) in the multivesicular
endosome (MVE). In the endosomal system, protein cargoes either are sequestered to
ILVs by inward budding or exit the system by outward budding. Sorting to ILVs is mediated
by various machineries, whose interdependency is poorly understood, and is likely
counterbalanced by recycling mechanisms that retrieve protein from MVEs. We have taken
profit of the particular role of CD63 in the balance between ESCRT-dependent and -independent
biogenesis of ILVs and in the sorting of ApoE in melanoma cells to elucidate the interdependency
of different sorting mechanisms influencing exosome composition.
Methods: After siRNA depletion of reported key actors of exosome production, EVs released
by melanoma cells were isolated by differential ultracentrifugation and floatation
on density gradient and characterized using biochemistry and electron microscopy.
ILV biogenesis and sorting of specific cargoes throughout the endosomal system was
assessed by immunofluorescence or electron microscopy after high-pressure freezing.
Results: Our data show that melanoma cells secrete subpopulations of exosomes with
different density and composition. Investigation of known key regulators of in- or
outward budding in MVEs differently affected exosome subpopulations. In particular,
CD63 modulates ApoE secretion on exosomes and its cellular localization, suggesting
that CD63 is a master regulator of cargo trafficking in the endosomal system.
Summary/Conclusion: Our data highlight that exosomes biogenesis is not only dependent
on ILV budding but also on a global regulation of endosomal homeostasis. Our study
provides a better perception of the interconnections existing between sorting of cargoes
to ILVs and their retrieval from the endosomal system. This broader view is crucial
to understand the precise roles of reported regulators of exosomes biogenesis that
are broadly used by the community.
OT04.03
A bright, versatile live cell reporter of exosome secretion and uptake
Bong Hwan Sung
a and Alissa Weaverb
aVanderbilt University, Nashville, USA; bDepartment of Cell and Developmental Biology,
Vanderbilt University School of Medicine, Nashville, USA
Introduction: Small extracellular vesicles (EVs) called exosomes affect a variety
of autocrine and paracrine cellular phenotypes. Understanding the function of exosomes
in these processes requires a variety of tools. We previously constructed a live-cell
reporter, pHLuorin-CD63 that allowed dynamic monitoring of exosome secretion in migrating
and spreading cells. However, there were some caveats to its use, including relatively
low fluorescent expression in cells and the inability to make cell lines that stably
express the protein.
Methods: By incorporating a stabilizing mutation in the pHLuorin moiety, M153R, pHLuorin-CD63
now exhibits higher and stable expression in cells and superior monitoring of exosome
secretion. Cancer cells stably expressing pHLuorin_M153R-CD63 were imaged using a
variety of microscopy techniques including a confocal and wide-field microscopy and
a correlative light-electron microscopy.
Results: pHLuorin_M153R-CD63 was exclusively detected in exosome-enriched small EV
preparations. Live-cell imaging revealed pHLuorin_M153R-CD63-positive puncta left
behind migrating cells suggesting the deposition consists of exosomes. Those puncta
and trails were not only positive for other exosome markers such as Alix and TSG101
but also correspond to small EVs observed by a scanning electron microscope. In addition,
follower cells exhibited pathfinding behaviour over pHLuorin_M153R-CD63 deposits.
Incorporation of mScarlet, a non-pH-sensitive red fluorescent tag, to pHLuorin_M153R-CD63
further improves the ability to track trafficking and secretion of multivesicular
bodies (MVBs) in cells allowing visualization of trafficking to the leading edge of
migrating cells and uptake of external exosome deposits.
Summary/Conclusion: Using pHLuorin_M153R-CD63 construct, we demonstrate superior visualization
of exosome secretion in multiple contexts and identify a role for exosomes in promoting
leader-follower behaviour in collective migration. By incorporating a further non-pH-sensitive
red fluorescent tag, this reporter allows visualization of the entire exosome lifecycle,
including MVB trafficking, exosome secretion, exosome uptake and endosome acidification.
This new reporter will be a useful tool for understanding both autocrine and paracrine
roles of exosomes.
OT04.04
An explanation for “PS-negative” extracellular vesicles: endogenous annexin-a5 from
the cytosol cover externalized phosphatidylserines on plasma membranes
Anis Khiat, Dominique Charue, Sihem Sadoudi, Sylvain Le Jeune, Marie Lê-Hoang, Chantal
Boulanger, Olivier P. Blanc-brude
INSERM ‘ParCC’ Paris-Cariovascular Research Center, Hôpital Européen Georges Pompidou,
Assistance Publique-Hôpitaux de Paris, and Université Sorbonne, Paris, France
Introduction: Stressed cells shed extracellular vesicles (EVs) thought to bear externalized
phosphatidylserine (PS) at their surface and promote inflammation, coagulation and
tissue injury. Conversely, endogenous cytosolic annexins, such as annexin-A5, orchestrate
vesicle trafficking and membrane repair within multiple cell types, via Ca2+-dependent
binding to intracellular PS. We hypothesized that endogenous annexin-A5 binds to PS
during vesiculation and gets externalized with PS at the surface of EVs.
Methods: We purified healthy plasma and red blood cells and induced Ca2+-mediated
vesiculation. We assessed annexin-A5 and EV distribution in supernatants by Western
blots, FACS, ELISA, cryo-TEM.
Results: (1) About 20% cytosolic annexin-A5 leaked out during vesiculation, but cytoskeletal
proteins were not released. (2) We separated supernatant EVs from “free” proteins
by size-exclusion chromatography and quantified EV-bound vs. “free” annexin-A5. All
annexin-A5 remained bound to EVs. Other cytosolic proteins (haemoglobin) bound to
EVs only partly. FACS with anti-annexin-A5 antibodies revealed the presence of annexin-A5
at the EV surface. (3) We measured EV-bound and “free” annexin-A5 in plasma, vs PS-,
PS+, CD235a+ and annexin-A5+ EVs, and made similar observations. Our study suggests
that endogenous annexin-A5 can cover externalized PSs on EVs in the presence of Ca2+.
Summary/Conclusion: This new mechanism of PS-neutralization may explain previous reports
of apparently “PS-negative” EVs. Conventional detection of EVs with EXOgenous fluorescent
annexin-A5 (FACS) may thus depend on PS not being engaged by endogenous annexin-A5
prior to detection. The physiopathological relevance of endogenous PS neutralization
may complement enzyme- and ATP-mediated internalization of PS in healthy cells. PS
neutralization may become critical when internalization mechanisms are overwhelmed,
and serve to restrain PS-mediated reactions and enforce anti-inflammatory and anti-thrombotic
control when the integrity of a few cells only is compromised. On the other hand,
dysfunctional annexin-A5 or calcium metabolism may contribute to the release of pro-inflammatory
and pro-thrombotic PS+ EVs.
Funding: Funded by Fondation pour la Recherche Médicale and Sorbonne University.
OT04.05
Identification of EV secretion-associated gene involved in melanoma progression by
microRNA-based screening
Nobuyoshi Kosaka
a, Fumihiko Urabeb, Tomofumi Yamamotoc, Yurika Sawad and Takahiro Ochiyaa
aDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Shinjyuku-ku, Japan; bDivision of Molecular and Cellular Medicine,
National Cancer Center Research Institute, Tokyo, Japan; cDepartment of Molecular
and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo,
Japan; dDepartment of Molecular and Cellular Medicine, Institute of Medical Science,
Tokyo Medical University, Tokyo, Japan
Introduction:It has been shown that extracellular vesicles (EVs) derived from cancer
cells dictate their surrounding microenvironmental cells or distant cells in the future
metastatic organs for the benefit of cancer cells. Thus, revealing the molecular mechanisms
underlying the production of EVs would prove to be a valuable contribution for establishing
EV-targeted therapy against cancer. However, the precise mechanism of EV production,
especially in cancer cells, remains unclear. Here, we established a microRNA-based
screening system to identify the molecules involved in EV production from melanoma
cells.
Methods: Melanoma cell lines, A375 cells, were used in this study. Combined with the
ultra-sensitive EV detection method (Yoshioka), ExoScreen, we have screened nearly
2000 miRNAs in melanoma cells. To confirm the results of ExoScreen, we employed the
nanoparticle tracking analysis. Target genes of miRNAs were identified by the combination
of gene expression analysis and target prediction bioinformatics.
Results: miRNAs which suppressed the secretion of EVs from melanoma cells were identified
after the screening of nearly 2000 miRNAs. To understand the molecular mechanisms
mediated by these miRNAs, the target genes of these miRNAs were identified and evaluated
for their contribution to EV production in cancer cells. Indeed, attenuation of these
target genes declined the secretion of EVs from melanoma cells, suggesting the contribution
of these genes in EV production/secretion. Furthermore, the expression of these genes
was higher in melanoma tumour tissues compared with that in normal tissues.
Summary/Conclusion: These findings suggest that the miRNAs and their target genes
were involved in EV production/secretion, resulting in the promotion of cancer progression.
OT04.06
Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle
subtypes
Morayma Temoche-Diaza, Matthew Shurtleffa, Ryan Nottinghamb, Jun Yaob, Alan Lambowitzb,
Randy Schekmana
aUniversity of California, Berkeley, Berkeley, USA; bUniversity of Texas, Austin,
Austin, USA
Introduction: Extracellular vesicles (EVs) encompass a variety of vesicles secreted
to the extracellular space. EVs have been implicated in promoting tumour metastasis
but the molecular compositions of tumour-derived EV sub-types and the mechanisms by
which molecules are sorted into EVs remain mostly unknown. As such dissecting different
EV sub-populations and analysing the molecular mechanisms behind active cargo sorting
is needed.
Methods: The highly metastatic breast cancer cell line, MDA-MB-231, was used as the
model cell line for this study. Iodixanol linear gradient allowed for the separation
of EV sub-populations. miRNA profiling and TGIRT-sequencing was used to study the
miRNA content of the distinct EV sub-populations. Cell fractionation and cell-free
miRNA packaging reconstitutions, coupled with in vivo confirmation, in cultured cells,
were used to study the molecular mechanisms of miRNA sorting.
Results: We found that at least two distinct EV sub-populations are released by MDA-MB-231
cells. Their differential biochemical properties suggest different sub-cellular origins
(endosomes vs. direct budding from the plasma membrane). Moreover, they are governed
by distinct mechanisms of miRNA sorting (active vs. passive). By using biochemical
and genetic tools, we found that the Lupus La protein is responsible for mir122 sorting
into EVs in vitro and in vivo. Moreover, in vitro studies showed that the Lupus La
protein interacts with mir122 with very high affinity. Finally, we uncovered the mir122
motifs required for mir122-La high affinity interaction, and therefore mir122 sorting
into EVs.
Summary/Conclusion: Two EV sub-populations with distinct sub-cellular origins, are
released by MDA-MB-231 cells. Their differential sub-cellular origin is coupled with
two distinct mechanisms of miRNA sorting. The Lupus La protein is responsible for
the active sorting of mir122 into EVs in vitro and in vivo.
Funding: Howard Hughes Medical Institute (HHMI).
Oral with Poster Session 1 Chairs: Uta Erdbrügger; Kenneth WitwerLocation: Level B1,
Hall B 13:30–15:00
OWP1.01=PS10.10
miR-1227 alters extracellular vesicle shedding
Andrew R. Chin
a, Minyung Kima, Valentina R. Minciacchib, Tatyana Vagnera, Javier Mariscala, Cristiana
Spinellia, Mandana Zandiana, Paolo Gandellinic, Nadia Zaffaronic, Shivani Sharmad,
Sungyong Youa and Dolores Di Vizioa
aCedars Sinai Medical Center, West Hollywood, USA; bCedars Sinai Medical Center, Frankfurt,
Germany; cFondazione IRCCS Istituto Nazionale Tumori, Milan, USA; dUniversity of California,
Los Angeles, Los Angeles, USA
Introduction: Extracellular vesicles (EVs) play a key role in cancer development and
metastasis by influencing the behaviour of the primary tumour and by aiding the establishment
of a pre-metastatic niche in distant organs. This process is due to the EV-mediated
functional transfer of biologically active molecules including microRNA (miRNA). miR-1227
is a poorly characterized miRNA that is enriched in EV secreted by prostate cancer
(PC) cells in comparison to non-tumorigenic prostate epithelial cells. However, the
role of miR-1227 in cancer is poorly understood. Our objective is to determine the
role of miR-1227 in PC.
Methods: RNA sequencing from miR-1227 stably expressing PC cells, RISCTRAP Immunoprecipitation
of miR-1227 bound mRNA and five different in silico miRNA target prediction methods
were used to identify putative miR-1227 targets. Exosomes and large oncosomes (LO)
were isolated by differential ultracentrifugation followed by density gradient purification.
Atomic force microscopy and TRPS were used to quantify exosomes and LO secreted by
PC cells stably expressing miR-1227 or vector control.
Results: A comparative analysis between different EV subtypes indicates that miR-1227
is enriched in LO, a class of EV that are secreted by highly invasive and metastatic
amoeboid-migrating cells. LO carry more RNA than the more widely studied exosomes
indicating that LO may be a more robust source of EV-encapsulated miRNA. Gene ontology
analysis from miR-1227 targets identified by RNA sequencing from miR-1227 stably expressing
PC cells, RISCTRAP Immunoprecipitation of miR-1227 bound mRNA, and in silico miRNA
target prediction highlighted several genes related to EV secretion. miR-1227 alters
the localization of exosome and LO markers in multiple cancer cell lines, and induces
the shedding of LO while inhibiting the shedding of exosomes. Furthermore, miR-1227
induces the migration of poorly migratory cancer cells and increases the expression
of tumour supportive cytokines.
Summary/Conclusion: Together these data hint that miR-1227 may promote prostate cancer
progression through several mechanisms including alteration of EV shedding.
Funding: 2017–2022 R01CA218526.
2018–2020 Chesapeake Urology Associates Sanford J. Siegel, MD Prostate Cancer Research
Scholarship
2018–2020 Luke Wu-Jei Chang Discovery Fund
2016–2019 PI DoD PCRP Award PC150836
OWP1.02=PF11.14
MSC exosome works through a multi-faceted mechanism of action in joint repair
Shipin Zhang
a, Yedan Wangb, Francis Keng Lin Wongc, Ming Wangb, Ruenn Chai Laid, James Hoi Po
Huib, Sai Kiang Limd and Wei Seong Toha
aFaculty of Dentistry, National University of Singapore, Singapore, Singapore; bDepartment
of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore,
Singapore, Singapore; cDepartment of Orthopaedic Surgery, Sengkang General Hospital,
Singhealth, Singapore,Singapore; dInstitute of Medical Biology, Agency for Science,
Technology and Research, Singapore, Singapore
Introduction: MSC exosome is increasingly accepted as the principal agent that underpins
the therapeutic efficacy of mesenchymal stem cell (MSC) in tissue repair. Here, we
aim to elucidate the mechanism of action (MoA) of MSC exosome in immunocompetent rat
models of osteochondral defect and osteoarthritis (OA).
Methods: Exosomes were purified from conditioned medium of human MSCs by size fractionation.
Osteochondral defect creation or anterior cruciate ligament transection to induce
OA were performed in 72 adult rats. Thereafter, weekly 100-µl intra-articular injections
of 100-µg exosome or PBS vehicle were given. Analysis included weight distribution,
histology, immunohistochemistry and cytokine assay. Cellular assays using chondrocytes
were performed to determine the exosome-activated cellular processes and signalling
pathways.
Results: We observed that exosome-mediated repair of osteochondral defects was characterized
by increased cellular infiltration and proliferation, enhanced matrix synthesis, together
with a regenerative M2 macrophage phenotype and a reduction in pro-inflammatory cytokines
IL-1β and TNF-α. In OA joints, MSC exosome mediated an early suppression of pain and
degeneration with reduced inflammation, followed by sustained proliferation and matrix
restoration that led to cartilage and subchondral bone regeneration. Using chondrocyte
cultures, we could attribute some of these cellular activities during exosome-mediated
joint repair to exosomal CD73-mediated adenosine activation of AKT and ERK signalling.
These effects were partially abrogated by wortmannin or U0126, which inhibited AKT
and ERK phosphorylation, respectively. The role of exosomal CD73 was confirmed using
CD73 inhibitor and theophylline that showed inhibition of exosome-induced AKT and
ERK phosphorylation.
Summary/Conclusion: Our observations suggest that MSC exosome works through a multi-faceted
MoA that involved multiple cellular processes to restore joint homeostasis and promote
regeneration.
Funding: National Medical Research Council Singapore (NMRC/CNIG/1168/2017 and NMRC/CIRG/1480/2017).
OWP1.03=PS03.11
Identification of extracellular vesicles as biomarkers for myocardial infraction by
flow cytometry and automated data processing
Aleksandra Gasecka
a, Edwin van der Polb, Frank Coumansc, Kinga Plutad, Grzegorz Opolskid, Krzysztof
J. Filipiake, Rienk Nieuwlandc
a1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland;
bAmsterdam UMC, University of Amsterdam, Department of Biomedical Engineering and
Physics, Amsterdam, Netherlands; cAmsterdam UMC, University of Amsterdam, Laboratory
of Experimental Clinical Chemistry, Amsterdam, Netherlands; d1st Chair and Department
of Cardiology, Medical University of Warsaw, Warsaw, Poland; e1st Chair and Department
of Cardiology, Medical University of Warsaw, Warsaw, Poland
Introduction: Acute myocardial infarction (AMI) is a major cause of death. To diagnose
AMI, measuring troponin concentration is the gold standard. Since troponin is unspecific
for AMI, novel biomarkers for AMI are urgently needed. After the onset of AMI, platelets,
endothelial cells and blood cells release specific extracellular vesicles (EVs). Our
aim is to identify these EVs as biomarkers for AMI diagnosis and treatment monitoring.
Methods: The study was approved by the medical ethics committee. Venous blood was
collected 24 h, 72 h and 6 months after AMI from fasting patients (n = 60, 64.5 ± 10.8 years,
68% male) and healthy controls (n = 30, 57.7 ± 6.6 years, 62% male). Flow cytometry
(Apogee A60 Micro) was used to determine plasma concentrations of EVs labelled with
antibodies for activated platelets (CD61, CD62p; PEVs), endothelial cells (CD146;
EEVs) and red blood cells (CD235a; RBC-EVs). Processing of 1,224 flow cytometry data
files was performed using in-house developed, automated software (MATLAB R2018a),
enabling flow rate stabilization, diameter and refractive index determination, MESF
calibration, fluorescent gate determination and statistics reporting.
Results: Between AMI patients and controls, PEV concentrations in plasma were comparable
(p = ns), EEV concentrations increased (p < 0.0001) and RBC-EV concentrations decreased
(p < 0.0001). Antiplatelet drug ticagrelor decreased concentrations of PEVs (p = 0.03),
compared to less potent clopidogrel but did not affect EEVs and RBC-EVs. In turn,
concentrations of EEVs, but not PEVs and RBC-EVs, positively correlated with the dose
of atorvastatin (p < 0.001). The antioxidative β-blocker carvedilol increased concentrations
of RBC-EVs, compared to nebivolol (p = 0.05) but did not affect PEVs and EEVs.
Summary/Conclusion: Flow cytometry and automated data processing were used to find
biomarkers for AMI based on EVs in plasma. During treatment, ticagrelor decreased
PEV concentrations, atorvastatin increased EEV concentrations and carvedilol increased
RBC-EV concentrations, suggesting that EVs might be used to monitor AMI treatment.
AMI patients differed from controls regarding EEV and RBC-EV concentrations, but not
PEVs, likely because blood was collected 24 h after the start of antiplatelet therapy.
In follow-up studies, it is crucial to collect blood prior to treatment.
OWP1.04=PF11.15
Exosome mediated enhancement of cellular therapy in acute myelogenous leukemia (AML)
Theo Borgovan
a, Peter Quesenberryb, Mike Deltatto; Sicheng Wenc, Mark Doonerb
aBrown University Department of Hematology Oncology; Rhode Island Hospital, Pawtucket,
USA; bBrown University Department of Hematology Oncology; Rhode Island Hospital, providence,
USA; cBrown University/ Rhode Island Hospital, Providence, USA
Introduction: Of the AML patients able to tolerate curative therapy with chemotherapy
and stem cell transplant many are challenged by treatment related toxicities as well
as graft vs. host disease. There is novel work exploring the utility of haploidentical
cellular therapy infusion in order to incite purposeful recipient immune response
and subsequent cytokine storm to treat refractory AML. Our group has demonstrated
the healing potential of bone marrow derived mesenchymal stem cell extracellular vesicles
(MSC-EVs) across multiple disease states, most recently demonstrating the pro-apoptoic
signalling imparted by these nanoparticles on nascent leukemic cells in vivo; as well
as the potentiating effects of MSC-EVs when used as an adjunct to standard cytarabine
chemotherapy. We have also shown the protective role of hMSC EV on radiated BM and
stem cell recovery.
Methods: Kasumi AML cells lines were seeded with MSC-derived EVs. Vesicles were isolated
using an established differential centrifugation technique, and were co-cultured with
Kasumi cells for various time points. To study cellular viability, we used a fluorescence-based
method for quantifying viable cells.
We also explored various modes of death EVs may illicit via a tri-dye Abcam assay
designed to simultaneously monitor apoptotic, necrotic and healthy cells. Both assays
were used to measure viability and apoptosis in similar experiments employing cytarabine
Results: AML cell Proliferation Decreased after 1–6 days of co-culture with hMSC-derived
EVs.
Apoptosis is the primary mode of death induced.
AML cell proliferation decreased synergistic after 1–6 days of co-culture with hMSC-derived
EVs ± Cytarabine.
Summary/Conclusion: MSCs inhibits the proliferation of the AML cell line in vitro
and work synergistically with cytarabine chemotherapy to promote apoptotic death in
AML cell lines. Our prior work has shown that MSC-EVs can abate the effects of toxic
chemo/radiation and serve to protect stem cell allowing for quicker recover in cell
blood counts.
Based on the innate ability of MSC-EV to directly alter the cellular machinery of
abnormal leukemic cell and of nascent immune cells our corollary hypothesis is that
BM-derived MSC-EVs may serve as suitable alternative to conditioning chemo/radiation
in the AML setting and will enhance the effects seen by cellular therapy infusion.
Funding: t32.
OWP1.05=PF12.09
Extracellular vesicles derived from amniotic fluid stem cells rescue impaired foetal
lung development via the release of microRNAs
Lina Antounians, Vincenzo Catania, Benjamin Liu, Areti Tzanetakis, Louise Montalva
and Augusto Zani
The Hospital for Sick Children, Toronto, Canada
Introduction: Incomplete lung development, also known as pulmonary hypoplasia (PH),
is a recognized cause of neonatal death. To date, there is no effective treatment
that promotes foetal lung growth and maturation. Herein, we describe a stem cell-based
approach that enhances foetal lung development via the administration of extracellular
vesicles (EVs) derived from amniotic fluid stem cells (AFSCs) in rat models of PH.
Moreover, we report the microRNAs present in AFSC-EVs that are responsible for these
beneficial effects.
Methods: AFSC-EVs were isolated by ultracentrifugation from conditioned medium (CM)
of c-Kit+ rat AFSC that were grown in exosome-depleted FBS for 18h. AFSC-EVs were
assessed for size (nanoparticle tracking analysis), morphology (TEM), and expression
of CD63, Hsp70, Flo-1 and TSG101 (Western).
Ex vivo: Pregnant dams were gavaged nitrofen at E9.5 to induce foetal PH. At E14.5,
foetal lungs were harvested, and incubated with culture medium alone, AFSC-CM, or
AFSC-EVs. Foetal lungs from untreated dams served as control. Lungs were compared
for terminal bud density and surface area at 72 h, by two independent investigators.
In vitro
: Foetal rat lung organoids were generated with epithelial cells from normal and hypoplastic
lungs. Organoids were cultured for 10 days in either medium alone or medium supplemented
with AFSC-EVs. Lung organoids from untreated normal pups served as control. Organoids
were assessed for proliferation (Ki67) and markers of epithelial cell differentiation
via immunofluorescence.
RNA-sequencing: RNA was isolated using SeraMir, constructed into libraries (CleanTag
Small RNA) and sequenced on NextSeq High Output single-end sequencing run.
Results: Administration of AFSC-EVs increased terminal bud density and surface area
of lung explants back to control levels and promoted lung epithelial cell differentiation
in lung organoids (increased SPC and CC10 expression). AFSC-EVs contain 901 microRNAs,
some of which are crucial for foetal lung development, such as miR17 ~ 92 cluster.
Summary/Conclusion: Administration of AFSC-EVs rescues impaired foetal lung development
in experimental models of PH. AFSC-EV regenerative ability is exerted via the release
of miRNAs some of which regulate genes involved in foetal lung development. AFSC-EVs
represent a promising therapeutic strategy for PH in foetuses.
Funding: CIHR-SickKids Foundation.
OWP1.06=PS01.11
Extracellular vesicles from Fat-laden hypoxic hepatocytes activates pro-fibrogenic
signals in Hepatic Stellate Cells
Alejandra Hernandez
a, Yana Gengb, Daniel Cabrerac, Nancy Solisd, Han Moshagee and Marco Arresed
aPontificia Universidad Católica de Chile; University Medical Center of Groningen,
Groningen, Netherlands; bUMCG, Groningen, Netherlands; cPontificia Universidad Católica
de Chile/Universidad Bernardo O´Higgins, SANTIAGO, Chile; dPontificia Universidad
Católica de Chile, Santiago, Chile; eUniversity Medical Center Groningen, Groningen,
Netherlands
Introduction
/
Background: Transition from isolated steatosis to non-alcoholic steatohepatitis is
a key issue in non-alcoholic fatty liver disease (NAFLD). Recent observations in patients
with obstructive sleep apnoea syndrome (OSAS), suggest that hypoxia may contribute
to disease progression mainly through activation of hypoxia inducible factor 1α (HIF-1α)-related
pathways. Release of extracellular vesicles (EV) by injured hepatocytes may be involved
in NAFLD progression. Aim: to explore whether hypoxia modulates the release of EV
from free fatty acid (FFA)-exposed hepatocytes and assess cellular crosstalk between
hepatocytes and LX-2 cells (human hepatic stellate cell line).
Methods: HepG2 cells were treated with FFAs (250 μM palmitic acid + 500 μM oleic acid)
and chemical hypoxia (CH) was induced with Cobalt (II) Chloride, which is an inducer
of HIF-1α. Induction of CH was confirmed by Western blot (WB) of HIF-1α. EV isolation
and quantification was performed by ultracentrifugation and nanoparticle tracking
analysis respectively. EV characterization was performed by electron microscopy and
WB of CD-81 marker. LX-2 cells were treated with 15 μg/ml of EV from hepatocytes obtained
from different groups and markers of pro-fibrogenic signalling were determined by
quantitative PCR (qPCR), WB and immunofluorescence (IF).
Results: FFA and CH-treatment of HepG2 cells increased gene expression of IL-1β and
TGF-β1 in HepG2 cells and increased the release of EV compared to non-treated HepG2
cells. Treatment of LX-2 cells with EV from FFA-treated hypoxic HepG2 cells increased
gene expression of TGF-β1, CTGF, α-SMA and Collagen1A1 compared to LX-2 cells treated
with EV from non-treated hepatocytes or LX-2 cells exposed to EV-free supernatant
from FFA-treated hypoxic HepG2 cells. Moreover, EV from FFA-treated hypoxic HepG2
cells increased Collagen1A1 and α-SMA protein levels.
Summary/Conclusion: CH promotes EV release from HepG2 cells. EV from hypoxic FFA-treated
HepG2 cells evoke pro-fibrotic responses in LX-2 cells. Further genomic and proteomic
characterization of EV released by steatotic cells under hypoxia are necessary to
further delineate their role in the crosstalk between hepatocytes and stellate cells
in the setting of NAFLD and OSAS.
Funding: FONDECYT 1150327–1150311.
OWP1.07=PS08.07
Exploration of the surface modification of outer membrane vesicles
Maximilian Richtera, Eleonora Diamantib, Anna Hirschb, Gregor Fuhrmannc
aHelmholtz-Institute for Pharmaceutical Research Saarland, Biogenic Nanotherapeutics,
Saarbruecken, Germany; bHelmholtz-Institute for Pharmaceutical Research Saarland,
Drug Design and Optimization, Saarbruecken, Germany; 3Helmholtz-Institute for Pharmaceutical
Research Saarland, BION, Saarbruecken, Germany
Introduction: Introducing bacteria-binding small molecules to the surface of outer
membrane vesicles (OMVs) could greatly improve their potential for antimicrobial drug
delivery too difficult to treat bacteria. Among the small number of studies on surface
modification of OMVs, very few deal with small molecules. The aim of the present study
is to evaluate different methods of introducing bacteria specific targeting moieties
to OMVs. We assessed the modification of surface proteins using N-hydroxysuccinimide
(NHS) esters, well established for mammalian extracellular vesicles (EVs), cholesterol
insertion, mainly applied for liposomes, and the novel application of diazo-transfer
followed by click-chemistry.
Methods: OMVs were obtained from model myxobacteria by differential ultracentrifugation
(UC) followed by size-exclusion chromatography (SEC). For cholesterol insertion and
NHS ester-modification, purified OMVs were incubated with either cholesteryl PEG 2,000
FITC or sulfo cyanine7 NHS ester. For diazo transfer the pellet after UC was incubated
with a diazo transfer agent and the OMVs subsequently conjugated with DBCO-AF594.
Unincorporated dye was removed by SEC. Liposomes were composed of DMPC and DPPC in
2:3 molar ratio. Results represent correlated fluorescence intensity and particle
number.
Results: Treatment with sulfo cyanine7 NHS ester led to the modification with 547 ± 163
molecules per OMVs, compared to 18 ± 1 for the control using sulfo cyanine7 acid.
Cholesterol insertion introduced 4 ± 1 molecules per OMV, compared to 101 ± 23 for
liposomes. First results for the diazo-transfer showed 71 dye-molecules per OMV, with
32 for the control.
Summary/Conclusion: Of the three methods, NHS ester-modification displayed the highest
efficiency, similar to published results for mammalian EVs. In comparison, diazo transfer
only yielded ~13% of the dye-molecules per particle. However, there are still many
parameters to be optimized for this method, including OMV concentration and incubation
period. Cholesterol insertion was unsuccessful for OMVs, probably owing to their membrane
structure. In this study, we aim to get important insights into the modification of
OMVs for bacterial targeting and EV-surface engineering in general.
Funding: This project was funded by Studienstiftung des Deutschen Volkes and Bundesministerium
fuer Bildung und Forschung.
OWP1.08=LBT02.03
Isolation of neuron-specific extracellular vesicles
Dmitry Ter-Ovanesyan
a, Maia Kipmanb, Emma Kowalc, Ju Hyun Leeb, Wendy Trieub, Aviv Regevd, David Waltb
and George Churchb
aHarvard, Cambridge, USA; bWyss Institute, Boston, USA; cMIT, Cambridge, USA; dBroad
Institute, Cambridge, USA
Introduction: Human biological fluids contain extracellular vesicles (EVs) from different
cell types. It would be incredibly useful to be able to isolate EVs that originated
from specific cell types for diagnostic purposes as a way to gain molecular information
(RNA, protein) from inaccessible cell types non-invasively.
Methods: We have developed a general framework for identifying EV surface markers
that can be used for immuno-isolation of cell type specific EVs. As a proof of principle,
we have applied this framework to the isolation of neuron-derived EVs from human cerebrospinal
fluid or plasma. In addition to the computational analysis, we have developed an in-vitro
system of human neurons differentiated from human induced pluripotent (iPS) cells.
We performed mass spectrometry on EVs isolated from these neurons to identify neuron-specific
proteins. We also used this system to develop a robust immune-isolation method for
neuron EV markers.
Results: We have characterized the proteins present in neuron exosomes by mass spectrometry
and then used computational analysis of published gene expression and proteomics data
to come up with a list of candidate neuron-specific EV markers. After developing methods
for immuno-isolation of neuron EVs with these markers, we applied our methods to human
cerebrospinal fluid and plasma.
Summary/conclusion: We have developed a framework for the isolation of cell type specific
EVs through the combination of an experimental in vitro system and computational analysis
of gene expression and proteomics data. We have applied this framework to the isolation
of neuron-specific EVs in human biological fluids. We envision these methods being
broadly applicable to the development of novel diagnostic biomarkers for a variety
of diseases.
OWP1.09=LBT01.01
Coagulation influences properties of extracellular vesicles isolated from autologous
blood derived products
Andrea De Luna
a, Alexander Otahala, Olga Kutenb, Zsombor Laczac and Stefan Nehrera
aDanube University Krems, Krems, Austria; bOrthoSera GmbH, Krems, Austria; cOrthosera
GmbH, Krems, Austria
Introduction: Platelet rich plasma (PRP) is the most commonly used blood derivative
in clinics due to its high concentration of platelets and perceived high growth factor
levels. Drawbacks of using PRP are discrepancies among preparation protocols and the
presence of cells (platelets, leucocytes) which can evoke cellular processes (e.g.
inflammation) when injected into the host. One possibility is to isolate only the
active components of blood derivatives which may overcome this problem. In the current
study, we focused on extracellular vesicles (EVs) isolated from two autologous blood
derivatives, PRP and hyperacute serum and investigated whether the clotting cascade
influences EV properties.
Methods: EVs were isolated from citrate-anticoagulated PRP (CPRP) and hyperacute serum
using differential ultracentrifugation followed by a size exclusion chromatography.
Particle concentration and size were determined by nanoparticle tracking analysis
(NTA). Cryo-electronmicrosopy was performed to visualize isolated EVs. Expression
of miRNAs transported within EVs as well as in their respective input material was
analysed by qPCR.
Results: NTA revealed higher particle concentrations and bigger sized EVs within CPRP
compared to hyperacute serum. These findings were confirmed by cryo-electronmicroscopy.
Profound differences were detected regarding miRNA expression between the two blood
derivatives. In total, 126 miRNAs were identified which were expressed both in input
material as well as in the corresponding EVs. The correlation between miRNAs in EVs
and input material was higher in CPRP compared to hyperacute serum meaning that in
hyperacute serum miRNAs were identified which were higher expressed in EVs than in
the corresponding input material.
Summary/conclusion: EVs from autologous blood products represent a novel and cell-free
regeneration approach. We observed that the clotting cascade (plasma versus serum)
has an influence on concentration, size and miRNA expression patterns of EVs. These
differences might have an impact on the biological mode of action of blood-derived
products used in clinics.
Funding: Financial support was received from the European Fund for Regional Development
(EFRE) and the Science Fund of Lower Austria. miRNA expression analysis was performed
by TAmiRNA GmbH. Cryo-electronmicroscopy was conducted at the Core Facility of the
Vienna Bio-Center.
OWP1.10=LBF02.01
Type-2 transglutaminase affects calcium homeostasis in neurons and is released in
association with astrocytes-derived exosomes
Elisa Tonoli
a, Ilaria Pradab, Claudia Verderioc and Elisabetta Verderioa
aNottingham Trent University, Nottingham, United Kingdom; bCNR Institute of Neuroscience,
Milan, Italy., Milan, Italy; cCNR Institute of Neuroscience, Milan, Italy, Milan,
Italy
Introduction: Type-2 transglutaminase (TG2) has been linked to calcium (Ca2+) dysregulation
in conditions such as neurodegeneration. Recent evidences suggest that extracellular
vesicles (EVs) contribute to the onset and progression of neurological diseases, and
we have recently shown that TG2 is a cargo of EVs in biological fluids (Furini et
al., 2018). Here, we hypothesise that TG2 could be released by EVs, interact with
neurons and affect neuronal Ca2+ homeostasis.
Methods: Primary hippocampal neurons were established from E18 rat embryos. Extracellular
TG2 was modulated in neurons either by lipofectamine transfection of a TG2-EGFP construct
or by addition of purified TG2. Intracellular Ca2+ concentration ([Ca2+]i) was assessed
by live imaging in fura-2/AM-loaded neurons. EVs were isolated from primary astrocytes
(60 DIV) by serial centrifugation, characterised by western blotting (flotillin-2
and alix) and nanoparticle tracking analysis (ZetaView). Experiments to assess TG2
influence on exosomes-to-neural cells interactions, using a Renilla sensor based on
miR-146a-5p-transfer, are still ongoing.
Results: Increase of extracellular TG2 levels in neurons induced an influx of extracellular
Ca2+ ions, leading to a significant raise in basal [Ca2+]i both in normal conditions
(ΔF340/380 = 0.126 ± 0.014; N = 23; p < 10–5) and with inhibited synaptic transmission
(tetrodotoxin) (ΔF340/380 = 0.058 ± 0.005; N = 33; p < 10–5). Nifedipine, a blocker
of L-type voltage-operated Ca2+ channels (VOCCs), partially prevented TG2-dependent
Ca2+ response (average inhibition 36%; N = 21; p < 10–5), suggesting that Ca2+ influx
may occur through L-type VOCCs. To identify the source of extracellular TG2, we analysed
EVs isolated from rat primary astrocytes, previously reported to release TG2 into
the matrix especially in inflammatory conditions. TG2 was detected in astrocytic exosomes
(but not in ectosomes) only upon LPS stimulus, and not in the EVs-free medium, suggesting
that TG2 is a cargo of exosomes during neuroinflammation.
Summary/conclusion: TG2 is externalised through astrocyte-derived exosomes upon neuroinflammatory
stimuli. Extracellular TG2 mediates the opening of L-type VOCCs in neurons and sets
basal [Ca2+]i at higher levels, which could have a significant impact on neuronal
activity in neuroinflammation.
Funding: John Turland PhD bursary (NTU) and IBRO travel fund.
OWP1.11=LBT01.02
Ev-avogadro project: towards a liposomal concentration standard for extracellular
vesicle research
Gergo Bartaa, Diana Kitkaa, Andras Wachaa, Judith Mihalya, Attila Botaa, Krisztina
Nemetha, Pal Szaboa, Jean-Luc Fraikinb and Zoltan Varga
c
aResearch Centre for Natural Sciences HAS, Budapest, Hungary; bSpectradyne LLC, Torrance,
USA; cResearch Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest,
Hungary
Introduction: There is an unmet need for standardization of concentration measurements
in the field of extracellular vesicles (EVs). Liposomes may serve an ideal reference
system for EVs, but the determination of the number concentration of liposomes from
first principles was not attempted so far. Inspired by the International Avogadro
project, we aimed to determine the concentration of liposomes with well-defined size
and composition via counting the number of phospholipid molecules in these “nanospheres”.
Methods: Liposomes composed of phosphocholine and phosphoglycerol were prepared by
the extrusion method. Wide-angle X-ray scattering (WAXS) was used to determine the
area-per-lipid value. The size distribution of the liposomes was determined by microfluidic
resistive pulse sensing (MRPS) and freeze-fracture combined TEM. Small-angle X-ray
scattering (SAXS), differential scanning calorimetry (DSC) and infrared spectroscopy
(IR) were used to prove the unilamellarity, the ideal miscibility of the lipids and
the ordered packing of the hydrocarbon chains of the lipids, respectively. Concentration
of the lipids was determined by liquid chromatography–mass spectrometry (LC-MS).
Results: The prepared liposomes proved to be unilamellar with narrow size distribution
(83 nm avg.), as obtained by MRPS and TEM. DSC and IR measurements confirmed that
the phospholipid bilayer of these liposomes is in the liquid-ordered phase, hence
the area-per-lipid of 0.41 nm2 was determined from WAXS measurements. Using the concentration
of phospholipids from LC-MS measurements, the number concentration of liposomes was
determined (8E+13 1/mL).
Summary/conclusion: Liposomes containing saturated phospholipids are in the liquid-ordered
phase, which can be utilized to determine the area-per-lipid using WAXS. This value,
together with the independently determined size, and lipid concentration can be used
to calculate the number concentration of liposomes. As the light scattering properties
of liposomes matches that of EVs, liposome-based standards for optical measurements
of EVs can be obtained with the presented techniques.
Funding: This work was supported under grant numbers PD 121326 and NVKP_16-1-2016-0007
by NKFIH (Hungary). ZV was supported by the János Bolyai Research Fellowship.
OWP1.12=LBF02.02
Plasma exosomes regulate proliferation and migration of vascular smooth muscle cells
Kosuke Otani
a, Mai Yokoyab, Muneyoshi Okadac and Hideyuki Yamawakib
aLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University,
Towada, Japan; bKitasato University, Towada, Japan; cKitasato University, School of
Veterinary Medicine, Laboratory of Veterinary Pharmacology, Towada, Japan
Introduction: We previously reported that systolic blood pressure in spontaneously
hypertensive rats, an animal model of essential hypertension, was partly modulated
by circulating exosomes (BBRC 2018). Vascular wall remodelling regulated by proliferation
and migration of vascular smooth muscle cells (VSMCs) mediates development of hypertension.
We aimed to clarify the effects of plasma exosomes derived from SHR and control Wistar
Kyoto Rats (WKY) on proliferation and migration of VSMCs.
Methods: Exosomes were isolated from rat plasma by an ultracentrifuge method, and
identified through measurement of particle size distribution by a tunable resistance
pulse sensing. For exploring exosome internalization in VSMCs, the isolated exosomes
were labelled with PKH67 dye and observed by a fluorescence microscopy. Proliferation
and migration of SMCs were determined by a bromodeoxyuridine incorporation and Boyden
chamber assay, respectively. Actin cytoskeleton was visualized by a rhodamine-phalloidin
staining. Expression of protein and microRNA in exosomes was determined by Western
blotting and microarray, respectively.
Results: There was no difference in size and concentration of plasma exosomes between
WKY and SHR. Exosomes were incorporated into VSMCs, while the internalization of SHR
exosomes was significantly lower than WKY exosomes. Both WKY and SHR exosomes similarly
stimulated proliferation, migration and cytoskeletal changes such as formation of
filopodia and lamellipodia in VSMCs. Heparin, an inhibitor of exosome internalization,
completely blocked the migration and proliferation. Protein expression of CD9 and
CD63, an exosomal marker, was significantly higher in exosomes from WKY than SHR.
The expression of several microRNAs in SHR exosomes changed compared with WKY exosomes.
Summary/conclusion: These results suggest that plasma exosomes play physiological,
but not pathological, role on VSMCs irrespective of their origin (normotensive or
hypertensive rats). Further research is required for determining whether the changes
in molecular profiles of circulating exosomes mediate the development of high blood
pressure in SHR.
OWP1.13=LBF01.02
Colorectal cancer cell-derived exosome enhances microenvironmental angiogenesis through
modulation of intracellular metabolism
Atsushi Ikeda
a, Satoshi Nagayamab and Koji Uedac
aCancer proteomics group, Cancer Precision Medicine Center, Japanese Foundation for
Cancer Research, Tokyo, Japan; bDepartment of Gastroenterological Surgery, Cancer
Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; cCancer
Proteomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer
Research, Tokyo, Japan
Introduction: For improvement of prognosis of colorectal cancer (CRC), detection at
an earlier stage of CRC is essential. Exosomes are nanovesicles secreted from plasma
membrane, and have potential to be served as biomarker carriers. In this study, we
performed proteomic profiling of exosomes secreted from viable CRC tissues.
Methods: To identify early detection biomarkers for CRC, we performed comprehensive
proteome analysis of tissue-exudative extracellular vesicles (Te-EVs), which were
obtained from culture media of freshly resected viable CRC tissue or adjacent normal
mucosa (n = 17). Among the identified Te-EV proteins, we narrowed down the biomarker
candidate by selecting proteins which are statistically upregulated (p < .05, fold
change > 5.0) in Te-EVs from CRC tissues than those from adjacent normal tissues.
Then we performed functional analysis of the biomarker candidate specifically.
Results: Comprehensive LC/MS analysis identified 6,149 Te-EV proteins, in which 641
proteins showed significant upregulation in Te-EVs from CRC tissues (p < .05, fold
change > 5. 0) compared to those from adjacent normal mucosa. We focused especially
on GAM (p = 7.0 × 10–5, fold change = 7.4) as a novel biomarker candidate. GAM protein
was significantly overexpressed in CRC tissues compared with adjacent normal mucosa.
In EV-sandwich ELISA assay, the expression level of GAM on plasma EVs from CRC patients
was significantly higher than that from healthy donors in EV-sandwich ELISA assay
(n = 133, p = 4.0 × 10–7). In addition, the uptake of GAM-overexpressing EVs enhanced
vascular endothelial cell growth and angiogenesis through modulation of nitric oxide
metabolism.
Summary/conclusion: EV-GAM might have great potential as a target for both CRC diagnosis
and therapy. Our strategy for identification of exosomal biomarker by proteomic profiling
of Te-EV proteins can be applied to other cancers.
OWP1.14=LBS02.01
Annexin V binding modulates the response of macrophages to mesenchymal stromal cell-derived
extracellular vesicles
Michele Grassi
a, Michela Pozzobonb, Melania Scarpac, Damiana Incendid, Alessia Giarraputoe, Anna
Maria Tolomeoa, Marcin Jurgaf, Andrea Porzionatog and Maurizio Muracah
aDepartment of Women’s and Children’s Health – University of Padova, Padova, Italy;
bUniversity of Padova, Padova, Italy; cIstituto Oncologico Veneto IOV-IRCCS, Padova,
Italy; dUniversity di Padova Department DNS, Padova, Italy; eUniversity of Padova,
Padova, Italy; fThe Cell Factory, Niel, Belgium; gDepartment of Neuroscience, University
of Padua, Padova, Italy; hUniversity of Padova, Padova, Italy
Introduction: We have previously shown that Annexin a5 (An5) binding to mesenchymal
stromal cell-derived extracellular vesicles (MSC-EVs) enhances the anti-inflammatory
properties of these nanoparticles in an animal model of colitis. However, the mechanisms
underlying these effects are unknown. Here, we investigated the immunoregulatory effect
of MSC-EVs with and without An5 binding on activated macrophages in vitro.
Methods: Macrophages were isolated from mouse bone marrow and activated by INFgamma
and LPS. Clinical grade Wharton Jelly-derived MSC-EVs were obtained from The Cell
Factory (Esperite NV, Niel, Belgium) and quantified by Resistive Pulse Sensing analysis.
5,0E+05 macrophages were incubated with PBS (vehicle only, control, group 1) 5,0E+08
MSC-EVs (group 2), 5,0E+08 MSC-EVs added with 2 ug An5 (group 3) or with 2 ug free
An5 (group 4). After 24 h, the cells were analysed by flow cytometry and RNA was extracted
for RT-PCR analysis.
Results: Incubation with MSC-EVs significantly increased only the expression of IL-10
in IFN-gamma/LPS-activated macrophages. Incubation with An5-MSC-EVs resulted in a
significant induction in the expression of both pro- and anti-inflammatory cytokines,
including TNF-alfa, IL-1Beta, IL-6, IL-10 and TGFbeta1. Incubation with free An5 induced
only pro-inflammatory cytokines without affecting IL-10 and TGFbeta1 expression. The
iNOS2/Arg1 ratio was reduced in both EV-treated groups, indicating a shift from M1
to M2 polarization.
Summary/conclusion: In conclusion, both MSC-EVs and An5-MSC-EVs shift the macrophage
phenotype from M1 to M2. The combined induction of TGFbeta1 and IL-10, observed only
in An5-MSC-EV-stimulated macrophages, might be related to the immune-modulating characteristics
of these modified EVs that contribute to the therapeutic effects observed in vivo.
Funding: The BROAD MEDICAL RESEARCH PROGRAM AT CCFA supported this work
OWP1.15=LBS03.01
Membrane-radiolabelled exosomes for comparative biodistribution analysis in immunocompetent
and immunodeficient mice – A novel and universal approach
Farid N. Faruqua, Julie Wanga, Lizhou Xub, Luke McNicklea, Ming-Yiu Chonga, Mark Gurneyc,
Aled Claytonc, Lesley A. Smythd, Robert Hidera, Jane Sosabowskie and Khuloud Al-Jamal
a
aKing‘s College London, London, United Kingdom; bSchool of Cancer and Pharmaceutical
Sciences, King‘s College London, London, United Kingdom; cCardiff University, Cardiff,
United Kingdom; dUniversity of East London, London, United Kingdom; eQueen Mary University
of London, London, United Kingdom
Introduction: Exosomes have gained interest as novel drug nanocarriers due to their
biological origin and role in intercellular biomolecule delivery. In-depth knowledge
of their in vivo biodistribution is therefore essential. This work aimed to develop
a reliable and universal method to radiolabel exosomes to study in vivo biodistribution
in mice.
Methods: Melanoma (B16F10 cells)-derived exosomes (ExoB16) were isolated and characterised
for size, yield, purity, exosomal markers and morphology using Nanoparticle Tracking
Analysis (NTA), protein measurements, flow cytometry and electron microscopy. Two
radiolabelling approaches were explored – intraluminal labelling (111Indium entrapment
via tropolone shuttling); and membrane labelling (111Indium chelation by covalently
attached bifunctional chelator). Labelling efficiency and stability was assessed by
gel filtration and thin layer chromatography. Melanoma-bearing immunocompetent (C57BL/6)
and immunodeficient (NSG) mice were injected intravenously with radiolabelled ExoB16
(1x1011 particles) followed by metabolic cages study, whole body SPECT-CT imaging
and ex vivo gamma counting at 1, 4 and 24 h post-injection.
Results: Membrane-labelled ExoB16 (ML-ExoB16) showed superior radiolabelling efficiency
and radiochemical stability compared to intraluminal-labelled ExoB16 (IL-ExoB16).
Both IL- and ML-ExoB16 showed prominent accumulation in liver and spleen. IL-ExoB16
showed higher tumour accumulation than ML- ExoB16 (6.7% and 0.6% ID/g tissue, respectively),
with the former showing similar value as its free tracer ([111]Trop). The superior
stability of the membrane-labelling approach rendered its result more reliable and
was used to compare ExoB16 biodistribution in melanoma-bearing immunocompromised (NSG)
mice. Similar biodistribution profile was observed in both C57BL/6 and NSG mice, where
prominent accumulation was seen in liver and spleen, apart from the lower tumour accumulation
observed in the NSG mice.
Summary/conclusion: Membrane radiolabelling of exosomes is a reliable approach that
allows for both live imaging and quantitative biodistribution studies to be performed
on potentially all exosome types without engineering parent cells.
Oral with Poster Session 2 Chairs: Kazunari Akiyoshi; Muller FabbriLocation: Level
B1, Lecture Room 13:30–15:00
OWP2.01=PS08.08
Identification of common EV markers in plasma using high-resolution flow cytometry
Anders Askeland
a, Jaco Bothab, Rikke Wehner Rasmussenb and Aase Handbergb
aAalborg University Hospital, Aalborg, Denmark; bDepartment of Clinical Biochemistry,
Aalborg University Hospital, Aalborg, Denmark
Introduction: Recent advancements in flow cytometry (FCM) have led to the development
of high-resolution FCMs dedicated to the analysis of small particles (hFCM). hFCM
studies have predominantly focused on the analysis of EVs expressing phosphatidylserine
(PS). PS is enriched in microvesicles (MVs), wherein it is involved in lipid rearrangements
responsible for MV budding. While PS also is expressed on exosomes, it is unknown
whether it can be used as a universal marker for smaller EVs. In this study, we attempted
to characterize proteins enriched in smaller EVs (CD9, CD63, CD81 and ADAM 10) and
the relative co-expression of PS with each of these markers.
Methods: FCM analysis was performed on an Apogee A60 Micro-PLUS. In brief, platelet-poor
plasma (PPP) from healthy individuals was stained with lactadherin-FITC (PS+) and
one of several EV surface markers enriched in smaller EVs. To evaluate the precise
differences in PS and specific EV marker expression, the analysis was performed twice,
(1) triggering on lactadherin and (2) each EV marker (CD9-PE, CD81-PE, CD63-PE, ADAM10-PE),
separately. All antibodies were matched with appropriate isotope controls and centrifuged
at 17,000g for 10 min prior to antibody labelling. EVs were defined as lactadherin
or EV surface marker positive events ≤1000 nm.
Results: Initial results indicate that CD9 is highly expressed on EVs and is not universally
associated to PS. Triggering on PS revealed that 34.7% of all events were CD9 positive
(CD9+|PS+). Conversely, triggering on CD9 resulted in a 2.1-fold increase in total
events, where 17.0% of events were PS+ (CD9+|PS+). Inferring size from silica nanospheres,
it appeared that populations containing CD9 (CD9+|PS+ and CD9+|PS-) were smaller (94.4–99.7%
<180 nm) compared to populations that did not (PS+|CD9-; 85.6% <180 nm & 95.2% <300 nm).
Interestingly, we did not detect CD81, CD63 or ADAM10 on EVs. We hypothesize that
this is due to a low abundance of these markers in PPP from healthy individuals.
Summary/Conclusion: Our findings demonstrate that hFCM can be used for the characterization
of smaller EVs in PPP. Furthermore, we find that CD9+EVs do not universally express
PS. From this point on, we plan to study enrichment of these EV phenotypes following
a number of EV purification protocols, and determine whether EV isolation enable a
more extensive characterization of smaller EVs.
OWP2.02=PS08.09
Software to automate calibration and processing of flow cytometry data in clinical
studies
Edwin van der Pol
s, Frank Coumansb, Leonie de Rondc, Aleksandra Gaseckad, Najat Hajjie, Rienk Nieuwlandb
and Ton van Leeuwenf
aAmsterdam UMC, University of Amsterdam, Department of Biomedical Engineering and
Physics, Amsterdam, Netherlands; bAmsterdam UMC, University of Amsterdam, Laboratory
of Experimental Clinical Chemistry, Amsterdam, Netherlands; cAmsterdam University
Medical Centers, Amsterdam, USA; d1st Chair and Department of Cardiology, Medical
University of Warsaw, Warsaw, Poland; eAmsterdam University Medical Centers, Amsterdam,
Netherlands; fdAmsterdam UMC, University of Amsterdam, Department of Biomedical Engineering
and Physics, Amsterdam, Netherlands
Introduction: In search of new biomarkers, flow cytometers are used in clinical studies
to measure the concentration of specific extracellular vesicles (EVs). Flow cytometers
measure light scattering and fluorescence of single EVs in a fluid stream. However,
to realize data interpretation and comparison, light scattering and fluorescence signals
and the flow rate require calibration. Moreover, flow cytometers generate large datasets.
For example, a clinical study involving 60 patients, 30 controls, and 8 antibody labels
covers 1224 data files, >33 gigabytes of data and >0.3 billion events. To manually
calibrate and analyse such a dataset would take days if not weeks and is prone to
human mistakes. Therefore, an urgent need exists for software to automate calibration
and processing of flow cytometry data.
Methods: We have developed software (MATLAB R2018a) to automatically process multiple
.fcs files and (1) relate two scatter signals to the diameter in nm and refractive
index (RI) of EVs, (2) express fluorescence signals in terms of molecules of equivalent
soluble fluorochrome, (3) export calibrated channels to new .fcs files, (4) recognize
unstable flow rates, (5) determine fluorescence thresholds, (6) apply gates, (7) create
PDFs with scatter plots and (8) report statistics. We are using clinical studies to
validate and apply the software.
Results: Compared to manual thresholding, automatic thresholding results in a systematic
decrease in counts of 10% and a maximum difference of 14% (n = 5). Using a high-end
laptop, data processing takes typically a minute or several seconds per .fcs file
with or without PDF reporting, respectively. Flow rate monitoring is useful for 61%
of the data. The platelet marker CD61 stains 7% of the events with an RI >1.42, which
are lipoproteins, and the concentration of these lipoproteins differed 4000-fold between
individuals.
Summary/Conclusion: We have developed software to automate calibration and processing
of flow cytometry data in clinical studies, thereby reducing analyses time, preventing
human mistakes and providing new insights. For example, non-specific labelling of
antibodies to lipoproteins together with variations in lipoprotein concentrations
emphasize the relevance of fasting before venipuncture. Our next step is to extend
the software with machine learning.
Funding: NWO-TTW VENI 15924.
OWP2.03=PS08.10
Conventional, high-resolution and imaging flow cytometry: potentials, pitfalls and
solutions for EV characterization
Jaco Botha, Rikke Wehner Rasmussen, Mathilde Sanden and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Introduction: Flow cytometry (FCM) has long been a preferred method for characterizing
EVs, however their small size have limited the applicability of conventional FCM to
some extent. Thus, high-resolution and imaging FCMs have been developed but not yet
systematically evaluated. The aim of this presentation is to describe the applicability
of high-resolution and imaging FCM in the context of EV characterization and the most
significant pitfalls potentially influencing data interpretation.
Methods: (1) First, we present a side-by-side comparison of three different cytometry
platforms on characterising EVs from blood plasma regarding sensitivity, resolution
and reproducibility: a conventional FCM, a high-resolution FCM and an imaging FCM.
(2) Next, we demonstrate how different pitfalls can influence the interpretation of
results on the different cytometry platforms. (3) Finally, we propose controls, solutions
or workarounds for understanding and limiting the influence of each of these pitfalls.
Results: (1) High-resolution FCM and imaging FCM displayed greater sensitivity and
resolution compared to conventional FCM when measuring a mixture of nanospheres. Equally,
both methods could detect larger concentrations of specific EV phenotypes than conventional
FCM, where imaging FCM outperformed high-resolution FCM. Within day variability (n = 20
aliquots) was similar for conventional and high-resolution FCM, while imaging FCM
had a markedly larger variability. Between day variability (n = 5 × 5 aliquots) was
similar for all three platforms. (2) The three most substantial pitfalls variably
influencing interpretation of results on the three platforms are non-specific binding
of labels, antibody aggregates, and entities in the sample (i.e. lipoproteins) binding
EV-defining dyes. (3) The most important strategies for circumventing these pitfalls
are stringent matching, gating and comparison of antibodies and isotype controls,
high-speed centrifugation of antibodies and labels prior to staining, and the use
and interpretation of stained buffer controls and detergent treated samples.
Summary/Conclusion: High-resolution and imaging FCM hold great potential for EV characterization.
However, increased sensitivity also leads to new artefacts and pitfalls. The solutions
proposed in this presentation provide useful strategies for circumventing these.
OWP2.04=PS08.11
Convolutional neural networks for classification of tumour derived extracellular vesicles
Wooje Lee
a, Aufried Lenferinka, Cees Ottob and Herman Offerhausa
aUniversity of Twente, Enschede, Netherlands; bMedical Cell Biophysics, University
of Twente, Enschede, Netherlands
Introduction: Raman spectroscopy probes molecular vibration and thus reveals chemical
information of a sample without labelling. This optical technique can be used to study
the chemical composition of diverse extracellular vesicles (EVs) subtypes. EVs have
a complex chemical structure and heterogeneous nature so that we need a smart way
to analyse/classify the obtained Raman spectra. Machine learning (ML) can be a solution
for this problem. ML is a widely used strategy in the field of computer vision. It
is used for recognizing patterns and images as well as classifying data. In this research,
we applied ML to classify the EVs’ Raman spectra.
Methods: With Raman optical tweezers, we obtained Raman spectra from four EV subtypes
– red blood cell, platelet PC3 and LNCaP – derived EVs. To classify them by their
origin, we used a convolutional neural network (CNN). We adapted the CNN to one-dimensional
spectral data for this application.
The ML algorithm is a data hungry model. The model requires a lot of training data
for accurate prediction. To further increase our substantial dataset, we performed
data augmentation by adding randomly generated Gaussian white noise.
The model has three convolutional layers and fully connected layers with five hidden
layers. The Leaky rectified linear unit and the hyperbolic tangent are used as activation
functions for the convolutional layer and fully connected layer, respectively.
Results: In previous research, we classified EV Raman spectra using principal component
analysis (PCA). PCA was not able to classify raw Raman data, but it can classify preprocessed
data. CNN can classify both raw and preprocessed data with an accuracy of 93% or higher.
It allows to skip the data preprocessing and avoids artefacts and (unintentional)
data biasing by data processing.
Summary/Conclusion: We performed Raman experiments on four different EV subtypes.
Because of its complexity, we applied a ML technique to classify EV spectra by their
cellular origin. As a result of this approach, we were able to classify EVs by cellular
origin with a classification accuracy of 93%.
Funding: This work is part of the research programme [Cancer-ID] with project number
[14197] which is financed by the Netherlands Organization for Scientific Research
(NWO).
OWP2.05=PS08.12
Microfluidic electrochemical aptasensor for detection of breast cancer-derived exosomes
in biofluids
Leila Kashefi-Kheyrabadi, Sudesna Chakravarty, Junmoo Kim, Kyung-A Hyun, Seung-Il
Kim and Hyo-Il Jung
Yonsei University, Seoul, Republic of Korea
Introduction: Exosomes are nano-sized extracellular vesicles, which are emerging as
potential noninvasive biomarkers for early diagnosis of cancer. However, the small
size and heterogeneity of the exosomes remain significant challenges to their quantification
in the biofluids. In the present research, a microfluidic electrochemical biosensing
system (MEBS) is introduced to detect ultra-low levels of breast cancer cell-derived
exosomes (BCE).
Methods: Fabrication procedure of MEBS comprises three main steps: first, biosensing
surface was prepared by immobilizing EPCAM binding aptamer (EBA) on a nanostructured
carbon electrode. The nanostructured surface (NS) consists of 2-D nanomaterials including
MoS2 nano-sheets, graphene nano-platelets, and a well-ordered layer of electrodeposited
gold nanoparticles. The NS was well characterized with FESEM and EDX. FESEM analysis
showed a well-ordered gold nano-structuring for 50 nM of gold solution. Furthermore,
EDAX analysis confirmed >60% coverage of gold nanoparticles on NS compared to bare
carbon electrode. At the second step, a herringbone structured microfluidic channel,
which is able to enrich BCE was designed and fabricated. Finally, microfluidic channel
was integrated to biosensing surface. Different concentrations of exosome solutions
was introduced and enriched to biosensing surface (SPCE/NS/GNP/EBA) using microchannel.
After capturing BCEs on the sensing surface a secondary aptamer labelled with silver
nanoparticles (SNPs) as redox reporter was introduced to the sensing surface.
Results: Direct electro-oxidation of SNPs was monitored as analytical signal. The
unique design of microchannel in combining with high specific interaction between
BCE and EBA provided a high sensitive detection of BCE as low as ~100 exosomes/μL.
Summary/Conclusion: The unique design of MEBS provides a highly sensitive accurate
platform for detection of ultra-low levels of cancer-derived exosomes. This tool holds
great potential for early cancer diagnosis in clinical applications.
OWP2.06=PS08.13
A software suite allowing standardized analysis and reporting of fluorescent and scatter
measurements from flow cytometers
Joshua Welsh and Jennifer C. Jones
Translational Nanobiology Section, Laboratory of Pathology, National Cancer Institute,
National Institutes of Health, Bethesda, USA
Introduction: Single vesicle analysis using flow cytometry is an extremely powerful
technique to allow identification of unique proteins in biological samples, as well
as enumerating the changes in concentrations. While small particle analysis (for viruses
and large microparticles) using flow cytometry has been conducted for several decades,
there is no comprehensive method for standardization of such studies. Therefore, we
developed a suite of flow cytometry post-acquisition analysis software (FCMPASS) tools
that enable the conversion of scatter and fluorescent axes to standardized units using
appropriate controls, writing standardized units to .fcs files for sharing upon publication
with open repositories, and exporting templates of obtained data.
Methods: Standalone software packages for scatter and fluorescent standardization
were built using MATLAB. The scatter software is based upon Mie modelling and is capable
of predicting the optical collection angle of the instrumentation and reporting the
Mie modelling criteria in a standardized way, making it possible to reproduce the
models and flow cytometry settings. Fluorescent standardization data uses least-squares
linear regression to enable conversions of arbitrary unit scales to molecules of equivalent
soluble fluorophore (MESF) using MESF calibration beads.
Results: The FCMPASS software converts arbitrary fluorescence units to MESF units
and writes them to data files for clearer reporting and sharing of data. FCMPASS also
converts arbitrary scatter units to a measurement of scattering cross-section using
modelling software that predicts the collection angle of the instruments and normalizes
the data automatically.
Summary/Conclusion: Utilization of our FCMPASS software can help the EV flow cytometry
more easily implement standardization into their experimental analysis and the use
of the output templates can make reporting more consistent. While currently available
MESF controls can be further optimized for small particles, we believe their utilization
along with the other controls, can bring a new era to the reporting of EV research
using flow cytometry. This will be particularly useful for future comparison and validation
of translational studies and will enable better understanding and utilization of EVs
across a broad range of disciplines.
OWP2.07=PF05.08
Biogenesis of JC polyomavirus associated extracellular vesicles depends on neutral
sphingomyelinase 2
Jenna Morris-Love
a, Bethany O’Harab, Gretchen Geea, Aisling Duganb, Benedetta Assettac, Sheila Haleya
and Walter Atwooda
aBrown University, Providence, USA; bAssumption College, Worcester, USA; cBrown Univerisity,
Providence, USA
Introduction: JC polyomavirus is a non-enveloped virus that causes progressive multifocal
leukoencephalopathy (PML) in immunocompromised patients. JCPyV infects cells by first
binding to the major attachment receptor lactoseries tetrasaccharide C (LSTc), followed
by the serotonin receptor 5-hydroxytryptamine type 2 required for entry. In PML, JCPyV
undergoes lytic infection in oligodendrocytes and astrocytes, both of which have been
shown to lack LSTc. Further, deep sequencing has shown that viral quasispecies existing
in PML patients contain mutations in the sialic acid binding pocket of the major viral
capsid protein, rendering these virions incapable of binding LSTc. We have recently
demonstrated that JCPyV is packaged into extracellular vesicles (EVs) that can spread
the virus, potentially overcoming this paradox. Here, we begin to characterize the
biogenesis of this EV-virus association by examining endosomal sorting complexes required
for transport (ESCRT) proteins and neutral sphingomyelinase 2 (nSMase2).
Methods: Cambinol was used to specifically target nSMase2 activity. Knockdown cell
lines were created with shRNA targeted against ALIX, TSG101 or SMPD3. SMPD3 was also
targeted using CRISPR/Cas9 genetic knockout in separate cell lines. Knockdown was
confirmed by qPCR and/or Western blot, and knockout by next generation sequencing.
EV were concentrated by differential centrifugation and evaluated by transmission
electron microscopy, Western blot, nanoparticle tracking analysis, infection and qPCR
for protected viral genomes. Infection was scored by immunofluorescence analysis with
antibodies against the major viral capsid protein VP1.
Results: We found that depletion of nSMase2 by cambinol, genetic knockdown or knockout
caused a reduction in spread of JCPyV over time. Knockdown and knockout SMPD3 cell
lines produced less infectious EV. In the absence of nSMase2, cells produced more
EV but there were fewer protected genomes associated with the EV. Knockdown of Alix
or TSG101 had no effect on the infectivity of EV or the production of EV.
Summary/Conclusion: Overall, our studies found that biogenesis of JCPyV associated
EVs depends upon the enzymatic activity of nSMase2 and not the ESCRT-related proteins
Alix or TSG101.
Funding: NIH R01NS043097.
OWP2.08=PF05.09
Exosomes mediate the antiviral activity of interferon-β against Zika virus infection
Shuang Li, Shilin Li and Limin Chen
Provincial Key Laboratory for Transfusion-Transmitted Infectious Diseases, Institute
of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical
College, Chengdu, China (People’s Republic)
Introduction: IFNβ-induced exosomes (Exo-IFNβ) may impact on viral dissemination or
antiviral immunity and therefore involve in the pathogenesis of many infectious pathogens.
However, little is known about its underlying mechanisms. To better understand how
Exo-IFNβ perform its antiviral effect, we employed RNA sequencing analysis to explore
the exosomal expression profiles of lncRNA and mRNA related to viral infections. We
hypothesized that exosomes can regulate viral infection through transmitting enclosed
specific lncRNAs into neighbouring cells to inhibit viral replication.
Methods: Exosomes were purified from A549 with/without IFNβ treatment by serial centrifugation
followed by sucrose density gradient purification, and characterized by TEM and Western
Blot. ELISA assay were performed on purified exosome fractions to demonstrate that
they are free of IFNβ. Zika virus (ZIKV) replication was assayed by real-time PCR.
Results: ZIKV replication was significantly suppressed in A549 cells pretreated with
Exo-IFNβ followed by ZIKV infection. Moreover, we found that anti-ZIKV effect of Exo-IFNβ
is IFN-independent because ZIKV replication was also decreased in U5A cells (IFN-α/β
receptor IFNAR deficient) pre-treated with Exo-IFNβ. Similar results were observed
in Dengue virus and HCV infections. RNA sequencing analysis found several lncRNAs
and mRNAs were differentially expressed and function annotation and pathway analysis
demonstrated that the differentially expressed genes were involved in many functions
and pathways, including antiviral infection. To validate the RNA sequencing analysis
results, some lncRNAs were selected to test their expression levels by qPCR. We are
in the process of deciphering the mechanism employed by these exosomal lncRNAs in
antiviral activity independent of inteferon.
Summary/Conclusion: We believe that understanding the antiviral functional molecules
wrapped in exosomes may help design exosomes as efficient vehicles for antiviral therapy.
Funding: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
(2016-12M-3-025)
OWP2.09=PS02.09
Deciphering the role of extracellular vesicles on the blood–brain barrier during Zika
virus infection
Antonios Fikatas, Sam Noppen, Peter Vervaeke, Jordi Doijen, Mohammed Benkheil, Christophe
Pannecouque and Dominique Schols
Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Belgium, Belgium
Introduction: The association of Zika virus (ZIKV) with severe neurological disorders
has gained increased interest over the last decade. However, the mechanism by which
ZIKV crosses the blood–brain barrier (BBB) and reaches the brain remains to be elucidated.
It is known that viruses incorporate viral material in extracellular vesicles (EVs)
as a spreading strategy. These membrane-enclosed vesicles play a vital role in intercellular
communication. Currently, there is a lack of knowledge on the possible involvement
of EVs in ZIKV pathogenesis. Our study aims to unravel the role of EVs in ZIKV RNA
transmission to the brain, via the BBB.
Methods: Human brain microvascular endothelial cells (HBMEC/D3) were used in our study
since they represent the BBB in vitro. Three different EV isolation methods (precipitation
kit, density gradient and size exclusion chromatography combined with the density
gradient) were performed. Western blot, Transmission electron microscopy and Nanosight
tracking analysis confirmed the presence of EVs in the supernatant of HBMEC/D3 cells.
The presence of ZIKV RNA in infected-EVs (IEVs) was evaluated by immunofluorescence
and qPCR. In addition, the effect of IEVs on the BBB was assessed using a label-free
impedance-based biosensor (ECIS, Applied BioPhysics).
Results: We confirmed the presence of viral components in our IEVs, including the
NS1 and E proteins of ZIKV. The obtained IEVs were able to reinfect susceptible cells,
even after being pretreated with RNase A. This indicates that the viral RNA resides
inside the IEVs. Using impedance measurements on HBMEC/D3 cell monolayers, we observed
that IEVs, as well as virus control caused similar and temporal disturbances on the
monolayer’s integrity within 30 min post infection. No disturbances were seen upon
addition of non-infected EVs.
Summary/Conclusion: Our study demonstrates that EVs-derived from ZIKV-infected cells
are able to transfer proteins and viral RNA to recipient cells. Since both IEVs and
viral particles can induce similar changes on barrier’s integrity it is possible that
IEVs are involved in an alternative mechanism of ZIKV transmission.
OWP2.10=PF12.10
HIV-specific antibody mediated targeting of ENV+ tissues by exosomes
Zou Xue, Yuan M’eng, Zheng Nan and Wu Zhiwei
Nanjing University, Nanjing, China (People’s Republic)
Introduction: Antiretroviral therapy can effectively suppress HIV replication in the
peripheral blood to an undetectable level. However, efforts to eradicate the latent
virus in reservoirs remain a challenge and are a major obstacle in the treatment of
HIV patients. Exosomes exhibit huge promise as an endogenous drug delivery nanosystem
for delivering drugs to reservoir tissues given their unique properties, including
low immunogenicity, innate stability, high delivery efficiency and mostly importantly
the ability to penetrate solid tissues due to their lipophilic properties.
Methods: In this study, we engineered and expressed the ScFv of a high affinity HIV-specific
monoclonal antibody, 10E8, on exosome surface. Exosomes from 293T cells were loaded
with curcumin via saponin, with efficient up to 34%. 10E8ScFv-expressing exosomes
(10E8-Exo) showed highly efficient targeting of and curcumin delivery to CHO cell
that expresses a trimeric gp140 on its surface (ENV+ cells) in vitro as demonstrated
by confocal imaging and flow cytometry. We showed that 10E8-Exo could effectively
bind to CHO cell that expresses a trimeric gp140 on its surface. The exosomes loaded
with curcumin, a chemical that was shown to kill HIV-infected cells, showed specific
killing of the trimeric gp140-expressing CHO cells. In an NCG mouse model that was
grafted with the tumorigenic gp140-CHO cells and developed solid tissue tumours intravenously
injected 10E8-Exo targeted the ENV-expressing tissues and delivered curcumin to induce
a strong suppression of the ENV+ tumour growth with a low toxicity.
Results: Our results demonstrated that engineered exosomes can deliver anti-HIV agents
to solid tissues by specifically targeting cells expressing viral env and induce cell
killings.
Summary/Conclusion: It suggesting that such an approach can be developed for eradicating
virus-infected cells in tissue reservoir.
Funding: This study was supported by The National Key Research and Development Program
of China (2016YFC1201000), Nature Science Foundation of Jiangsu Province (BY2015069-02)
and National Nature Science Foundation of China (81672020). The funders had no role
in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
OWP2.11=PS02.10
In vivo testing of OMV-based vaccine prototypes against Gallibacterium anatis
Fabio Antenucci
a, Homa Arakb, Jianyang Gaob, Toloe Allahghadryb, Ida Thøfnerb and Anders Miki Bojesenc
aUniversity of Copenhagen, København S, Denmark; bUniversity of Copenhagen, Copenhagen,
Denmark; cUniversity of Copenhagen, Copenhagen, USA
Introduction: Outer membrane vesicles (OMVs) are produced by the majority of Gram-negative
bacteria. Thanks to the antigenic similarity between OMVs and the bacterial outer
membrane, OMVs have proven to be promising for the development of novel vaccines against
bacterial pathogens. In this work, we describe the testing of OMV-based vaccine prototypes
against Gallibacterium anatis, a Gram-negative pathogen of great veterinary interest.
Methods: OMVs were isolated from a G. anatis hypervesiculating mutant using a modified
version of the Hydrostatic Filtration protocol described by Musante et al. (2014).
120 16-week-old Lohmann-Brown chickens were divided in six groups and immunized twice
intramuscularly with different combinations of buffer (controls), OMVs and selected
recombinant immunogens. Two weeks after second immunization, the effectiveness of
the immunization regimes adopted was tested by challenging the animals intraperitoneally
with live CFUs from a heterologous G. anatis strain. One week post-challenge, the
animals were sacrificed and an established lesion score model was used during necropsy
to evaluate the clinical outcome of infection.
Results: Statistical analysis of the recorded lesion scores showed that the group
immunized with G. anatis OMVs presented an average total score of 2.95, as opposed
to an average total score of 8.77 in the control group. The approximately three-fold
reduction in total average lesion score observed demonstrates that immunization with
G. anatis OMVs is able to effectively decrease the morbidity of G. anatis infection
in the immunized animals.
Summary/Conclusion: Our results show that G. anatis OMVs represent a promising candidate
for the development of cost-effective vaccination strategies for the prevention of
G. anatis infections in a cross-serovar manner. Accordingly, we hypothesize that dose/response
optimization and the enrichment of G. anatis OMVs with selected immunogens should
result in an improvement of the effectiveness of the vaccination regime proposed.
Funding: This research project is being funded by a grant from Huvepharma (https://www.huvepharma.com/).
OWP2.12=PT05.04
Identification of a protein that presumably controls bacterial vesiculation in response
to the extracellular environments
Fumiaki Yokoyama
a, Jun Kawamotoa, Chen Chena, Tomoya Imaib and Tatsuo Kuriharaa
aInstitute for Chemical Research, Kyoto University, Uji, Japan; bResearch Institute
for Sustainable Humanosphere, Kyoto University, Uji, Japan
Introduction: Many bacteria utilize extracellular membrane vesicles (EMVs) for survival
in their growing environments through communication with others, pathogenesis, and
biofilm formation. Therefore, the amounts and the components of EMVs should be tuned
in response to the conditions. Although several vesiculation mechanisms are suggested,
little is known how bacteria control vesiculation in response to the environments.
A bacterium Shewanella sp. HM13 has nine fold higher lipid-secretion capability in
EMV fractions than Escherichia coli, and its EMVs contain a major protein (P49), which
is not required for vesicle production. We used mutant EMVs that lack P49 to identify
minor components of EMVs that may control vesiculation.
Methods: EMVs were subjected to 2D gel-based proteomics by peptide mass fingerprinting.
Within the identified proteins, the function of a sensor protein homolog, HM1275,
was analysed by swarming assay and lipid-staining to quantify EMVs produced in various
media. Changes in the number of EMVs depending on culture media were quantified by
tunable resistive pulse sensing method.
Results: A protein with a PAS domain and a methyl-accepting chemotaxis protein (MCP)
sensing domain, HM1275, was identified in the EMVs. Although some MCPs are related
to flagellar motility by binding some attractants, the flagellar motility of Delta-hm1275
was not significantly different from that of WT. Although the amounts of EMVs produced
by WT were increased in response to the concentration of casamino acids in poor nutrient
medium, those by Delta-hm1275 were not.
Summary/Conclusion: A putative sensor protein, HM1275, was identified in EMVs and
may recognize the extracellular environments by binding signal molecules in casamino
acids to control vesiculation. Although further studies are required to reveal the
signals and the sensing pathways, the results obtained in this study indicate that
bacterial vesiculation is controlled by extracellular environments, and artificial
control of vesiculation with extracellular signals would be useful in applications
such as suppression of vesicle-dependent pathogenicity.
Funding: Japan Society for Promotion of Science Research Fellowship for Young Scientists
OWP2.13=PT05.05
Prokaryotic BAR domain-like protein BdpA promotes outer membrane extensions
Daniel A. Phillips
a, Lori Zacharoffb, Cheri Hamptonc, Grace Chongb, Brian Eddied, Anthony Malanoskid,
Shuai Xub, Lauren Ann Metskase, Lina Birdf, Grant Jensene, Lawrence Drummyc, Moh El-Naggarb
and Sarah Glavend
aAmerican Society for Engineering Education – U.S. Naval Research Laboratory, Washington,
USA; bUniversity of Southern California, Los Angeles, USA; cMaterials and Manufacturing
Directorate, Air Force Research Laboratory, Dayton, USA; dU.S. Naval Research Laboratory,
Washington, USA; eCalifornia Institute of Technology, Pasadena, USA; fNational Research
Council, Washington, USA
Introduction: Bin/Amphiphysin/RVS (BAR) domains belong to a superfamily of membrane-associated
coiled-coil proteins that influence membrane curvature. BAR domains are ubiquitous
in eukaryotes and associated with membrane curvature formation, vesicle biogenesis/trafficking,
protein scaffolding and intracellular signalling. While advances in protein domain
prediction have facilitated the identification of several BAR domain proteins, they
have yet to be characterized in bacteria. Here we identified a putative BAR domain-containing
protein enriched in the outer membrane vesicles (OMVs) of Shewanella oneidensis MR-1,
a dissimilatory metal-reducing bacteria known to produce outer membrane extensions
(OMEs) that are suspected to facilitate long distance extracellular electron transfer
(EET) but whose physiological relevance and mechanism of formation remain unknown.
Methods: Purified S. oneidensis OMVs were prepared by filtration and ultracentrifugation
for comparative proteomics with cell-associated outer membrane proteins or for electrochemical
measurements. Protein domains were predicted using HMMSCAN and CDD-search. OME formation
and phenotype analyses were performed in situ by confocal and cryo-electron microscopy.
Results: The putative BAR domain-like protein BdpA was highly enriched in OMVs compared
to cell-associated outer membranes. During OME biogenesis, WT S. oneidensis OMEs progress
from elongated vesicle chains to narrow, tubule-like extensions while ΔbdpA OMEs remain
as disordered vesicle chains. Purified OMVs from these strains are electrochemically
active, with redox signals consistent with multiheme outer membrane cytochromes, supporting
the role of OMEs in EET. Heterologous BdpA expression promotes OME formation in Marinobacter
atlanticus and Escherichia coli, suggesting BdpA membrane sculpting activity is inducible
and transferrable.
Summary/Conclusion: The ability of BdpA to promote OME formation and maturation into
tubules in vivo supports BdpA as a comparator for BAR domain protein activity in bacteria.
Funding: US DoD Synthetic Biology for Military Environments (SBME) Applied Research
for the Advancement of Science and Technology Priorities (ARAP)
NSF Dimensions: DEB-1542527
US DOE: DE-FG02-13ER16415
OWP2.14=PF07.10
Isolation of extracellular vesicles from extracellular matrix based hydrogel 3D cell
cultures
Jens Luoto
a, Lea Sistonenb and Eva Henrikssonb
aCell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University,
Turku, Finland; bTurku Centre for Biotechnology, University of Turku and Åbo Akademi
University, Turku, Finland
Introduction: Cancer-derived extracellular vesicles (EVs) are commonly studied and
isolated from two-dimensional (2D) cell cultures. Nevertheless, three-dimensional
(3D) culture systems with extracellular matrix (ECM) provide physiologically more
relevant system to mimic in vivo tumour growth and progression of invasion. However,
there are currently no methods to efficiently isolate EVs from ECM-based 3D cultures.
For that purpose, we established a protocol for isolating EVs from cancer cells growing
in a 3D ECM-based hydrogel.
Methods: Human prostate cancer PC3 cells were grown in 3D to form spheroids in a commercially
available ECM-based hydrogel and the growth media was collected every two days for
a period of 14 days, during which the spheroids grew invasive. The respective media
were differentially centrifuged at 2, 10 and 100 Kg and the pellets were resuspended
in PBS. The EVs were analysed by western blotting (WB) against the common EV markers
CD81, CD63 and CD9.
Results: Our preliminary data shows a step-wise increase of the EV markers in the
media as the PC3 spheroids formed, expanded and invaded to the surrounding 3D ECM.
The EVs produced by non-invasive or invasive spheroids are currently being characterized
with nano tracking analysis, electron microscopy and WB.
Summary/Conclusion: This study demonstrates that EVs can be isolated from 3D ECM-based
hydrogel cell cultures, which recapitulate the tissue architecture of solid tumours.
Our results suggest that 3D cancer cell cultures have dynamic EV secretion determined
by the phenotype of the spheroids. Taken together, we present a novel protocol for
EV isolation from a 3D culture system and provide a platform to investigate EVs from
in vivo mimicking conditions.
Funding: This project is funded by Magnus Ehrnrooth Foundation, K. Albin Johansson
Foundation and Åbo Akademi University.
OWP2.15=PT07.07
Diagnostic microRNA biomarkers from circulating extracellular vesicles for early detection
of pneumonia and severe secondary complications
Stefanie Hermann
a, Benedikt Kirchnera, Dominik Buschmannb, Melanie Märtec, Florian Brandesc, Stefan
Kotschoted, Michael Bonine, Marlene Reithmairf, Matthias Kleing, Gustav Schellingc
and Michael Pfafflh
aDivision of Animal Physiology and Immunology, School of Life Sciences Weihenstephan,
Technical University of Munich, Germany; bTUM School of Life Sciences Weihenstephan,
Division of Animal Physiology and Immunology, Freising, Germany; cDepartment of Anesthesiology,
University Hospital, Ludwig-Maximilians-University Munich, München, Germany; dIMGM
Laboratories GmbH, Planegg, Germany; eIMGM Laboratories GmbH, Planegg, Germany, Martinsried,
USA; fInstitute of Human Genetics, University Hospital, Ludwig-Maximilians-University
Munich, München, Germany; gDepartment of Neurology, University Hospital, Ludwig-Maximilians-University
Munich, München, Germany; hAnimal Physiology and Immunology, School of Life Sciences
Weihenstephan, Technical University of Munich, Freising, Germany
Introduction: Pneumonia remains one of the most deadly communicable diseases, causing
three million deaths worldwide in 2016. Extracellular vesicles (EVs) are pivotal during
signal transfer in the pathogenesis of inflammatory lung diseases. Since identifying
pneumonia is particularly challenging in high risk groups (e.g. the elderly or infants),
which often present with atypical symptoms and are at high risk for secondary complications
such as sepsis or acute respiratory distress syndrom (ARDS), new approaches for early
diagnosis are required. In this study we identified EV microRNAs (miRNAs) as potential
biomarkers for inflammatory changes of the pulmonary tissue.
Methods: Our study included 13 patients with community-acquired pneumonia, 14 ARDS
patients, 22 patients with sepsis and 31 healthy controls. After precipitating EVs
from 1 mL serum, total RNA was extracted. Subsequent to library preparation and small
RNA-Seq, differential gene expression analysis was performed using DESeq2. Data were
filtered by mean miRNA expression of ≥50 reads, minimum twofold up or down regulation
and adjusted p-value ≤0.05.
Results: The mean relative miRNA frequency varied slightly between the different groups
and was highest in volunteers. Short sequences (<16 nucleotides), probably degradation
products from longer coding and non-coding RNA species, were predominantly detected
in patients. Based on unsupervised clustering, patients could be distinctly separated
from healthy individuals. Although 21 miRNAs were significantly regulated in all patient
groups compared to healthy controls, different disorders showed unique miRNA expression
profiles. Distinct miRNA subsets were identified, which are applicable to indicate
disease progression from limited inflammation present in pneumonia to severe inflammatory
changes as seen in ARDS and sepsis.
Summary/Conclusion: This study shows that EV miRNA biomarkers have potential for diagnosis
of pneumonia and to indicate disease progression towards severe lung injury. Our findings
are of clinical relevance, as the timely diagnosis of pneumonia can be challenging,
and secondary complications such as ARDS and sepsis might be prevented by early intervention
and treatment.
Funding: This study was supported by the German Federal Ministry for Economic Affairs
and Energy under the programme “Zentrales Innovationsprogramm Mittelstand”.
Oral with Poster Session 3 Chairs: Michael Pfaffl; Ryuichi OnoLocation: Level B1,
Hall A 13:30–14:15
OWP3.01=LBT02.02
Using plasma to identify neural biomarker for antidepressant response in a treatment
resistant cohort
Corina Nagy
a, Saumeh Saeedib, Jean-Francois Therouxc, Marina Wakidc, Naguib Mechawarc and Gustavo
Tureckib
aDHRC- McGill University, Verdun, Canada; bMcGill University, Verdun, Canada; cMcGill
University, Verdun, Canada
Introduction: Small extracellular vesicles (SEV) have emerged as candidate biomarkers
in many complex diseases. An important characteristic of SEVs is their ability to
bidirectionally cross the blood-brain barrier. This is particularly important in the
context of major depressive disorder (MDD), where biomarkers are obtained from peripheral
tissue and have been hard to relate to changes in brain functioning. 60% of MDD patients
do not respond to their first antidepressant drug therapy (ADT) and treatment options
are entirely at the discretion of the physician. Findings that can predict ADT response
as well as provide insight into central mechanistic changes could revolutionize MDD
treatment. The aim of this study is to profile exosomal microRNA (miRNA) in the context
of ADT response in people with treatment-resistant depression. miRNA can act as biomarkers
and might influence recipient cells to provide insight on disease-relevant mechanistic
changes.
Methods: This pilot uses plasma from 10 controls and 10 patients with MDD (5 ADT responders
(RES), and 5 non-responders (NRES)) from baseline (T0, before treatment). SEVs were
isolated using a size exclusion column from Izon Science (Christchurch, New Zealand).
Each isolation was divided into a “whole exosome” fraction and an immunoprecipitated
“(NDE)” fraction using neural marker L1CAM. Quantitation and size determination was
done using Tunable Resistive Pulse Sensing (TRPS) on the qNano gold. RNA was also
extracted from SEVs from both fractions. The 4N-small RNA-Seq (Galas) protocol was
used for library preparation.
Results: We found that the range of SEVs in the NDE fraction was smaller than the
pool of all exosomes combined. Further, SEVs from all depressed patients were significantly
smaller than controls irrespective of the fractions. Our sequencing results showed
an increase of miR-151a-3p and miR-3168 in NRES, and miR-22-3p in RES. These results
were specific to the NDE fraction.
Summary/conclusion: We have identified three potential biomarkers for ADT response
which are uniquely present in the neural-derived fraction of peripheral SEVs.
Funding: Canadian Institutes of Health Research
OWP3.02=PT09.13
Immunocapturing of tumour-derived extracellular vesicles on micropatterned and antibody-conjugated
surfaces for individual correlative light, probe and electron measurements
Pepijn Beekman
a, Agustin Enciso-Martinezb, Cees Ottob and Séverine Le Gacc
aWageningen University, Wageningen, Netherlands; bMedical Cell Biophysics, University
of Twente, Enschede, Netherlands; cApplied Microfluidics for BioEngineering Research,
University of Twente, The Netherlands, Enschede, Netherlands
Introduction: Tumor-derived extracellular vesicules (tdEVs) are promising biomarkers
for cancer patient management. The screening of blood samples for tdEVs shows prognostic
power comparable to screening of tumour cells. However, due to the overlap in size
between tdEVs, non-cancer EVs, lipoproteins and cell debris, new approaches, not only
based on size, are required for the reliable isolation of tdEVs and their quantification.
We report an integrated analysis methodology to study single tdEVs using correlative
data from scanning electron microscopy (SEM), Raman imaging and atomic force microscopy
(AFM) to obtain a comprehensive dataset allowing identifying features unique to tdEVs.
Methods: Indium tin oxide (ITO)-coated fused silica was selected for its low Raman
background. Substrates (1 × 1 cm2) featuring position-dependent markings (“navigation
marks”) patterned by photolithography were modified with a monolayer of amino dodecyl
phosphonic acid. The amine moieties were next reacted with poly(ethylene glycol) diglycidyl
ether, forming an anti-biofouling layer. Anti-EpCAM antibodies were subsequently covalently
bound on this surface. Samples of both tdEVs obtained from LNCaP cell lines and RBC-derived
EVs were then introduced to the surfaces. Finally, non-specifically bound EVs were
washed away before SEM, AFM and Raman measurements were performed.
Results: Multiple objects were captured on the fully functionalized ITO surfaces,
according to SEM imaging, while in negative control experiments (lacking functionalization
or lacking antibody or using EpCAM-negative EVs), no object was detected. Principal
component analysis of their Raman spectra, previously demonstrated to be able to distinguish
tdEVs from RBC-derived EVs, revealed the presence of characteristic lipid bands (e.g.
2851 cm−1) in the captured tdEVs. AFM showed a surface coverage of ∽4 × 105 EVs per
mm2 with a size distribution similar to that found by NTA.
Summary/Conclusion: A platform was developed for multi-modal analysis of selectively
isolated tdEVs for their multimodal analysis. In the future, the scope of this platform
will be extended to other combinations of probe, light and electron microscopy techniques
to relate additional parameters describing the captured EVs.
Funding: Funded by NWO Perspectief.
OWP3.03=PT09.14
The development of a scalable extracellular vesicle subset characterization pipeline
Joshua Welsh
a, Julia Kepleyb and Jennifer C. Jonesa
aTranslational Nanobiology Section, Laboratory of Pathology, National Cancer Institute,
National Institutes of Health, Bethesda, USA; bTranslational Nanobiology Lab, Laboratory
of Pathology, National Cancer Institute, National Institutes of Health, Bethesda,
USA
Introduction: Liquid biopsies offer an important alternative to tumour biopsies that
may be limited by the challenges of invasive procedures. We hypothesize that circulating
Extracellular Vesicles (EVs) and their cargo may provide a useful surrogate biopsy
method. Due to their small diameter (30–1000 nm), EVs migrate from the tissue into
the peripheral circulation and provide a snapshot of the producing cells. Our lab
has developed a first-in-class pipeline to use single cell – omics methods to characterize
EV heterogeneity with high-sensitivity by combining multiplex assays and our custom
MultiPlex Analysis post-acquisition analysis software (MPAPASS), with subsequent high-resolution,
single EV flow cytometric (FCM) methods.
Methods: A stan-dalone software package was developed in MATLAB to allow importation
of multiplex flow cytometry output data. The package enables data quality screening
of detection antibodies, bead recovery and data normalization methods. The software
is equipped to handle large data sets comprising hundreds/thousands of phenotypes
and samples. Data can be visualized in a variety of ways along with clustering using
multidimensional data analysis techniques. All software outputs can be exported in
a standardized templates containing metadata for reporting, as well as uploaded into
atlases such as Genboree, where multiplex data can be stratified by RNAseq datasets.
Analysis using this pipeline has been conducted using human samples from a variety
of mediums including CSF, serum and plasma comparing EV phenotypes.
Results: Our multiplex approach and MPAPASS software allows the use of single cell
-omics tools for EV subset analysis in a manner that will elucidate the biological
significance and function of different types of EVs. This high-throughput pipeline
evaluates hundreds of EV protein profiles and will allow evaluation of millions of
RNA:protein profiles in an unprecedented manner. Integration of RNA sequencing with
protein characterization could provide an entirely new way of understanding EV regulation
and function.
Summary/Conclusion: Our data show this form of EV profiling provides a way to monitor
clinical responses early in the course of treatment, which may ultimately improve
patient care and outcomes.
OWP3.04=PS04.13
An integrated microfluidic device for selective exosome isolation from human plasma
Hogyeong Gwaka, Junmoo Kimb, Leila Kashefi-Kheyrabadib, Seung-Il Kimb, Kyung-A Hyun
b and Hyo-Il Jungb
aSchool of Mechanical Engineering, Yonsei University, Seoul, Republic of Korea; bYonsei
University, Seoul, Republic of Korea
Introduction: Extracellular vesicles released by many cell types circulate in blood
vessel and play a key role in intercellular communication. Exosomes are 30–150 nm
membrane vesicles and are also shed by both normal and cancer cells. Cancer cells
are known as very heterogeneous, so exosomes are also heterogeneous and have different
surface expression markers. Cancer-derived exosomes contain unique cargo determined
by the molecular characteristics of cancer cells. Therefore, it is very important
to selectively separate exosomes depending on surface expression for downstream analysis.
We designed an integrated microfluidic chip for selective exosome isolation. The microfluidic
chip consists of Hoof Structure (HS) for mixing exosomes and two different sized aptamer-coated
particles and Multi-Orifice Flow Fractionation (MOFF) for separating each particle.
Methods: Biotinylated EpCAM aptamer was immobilized on the surface of 7 μm streptavidin-coated
polystyrene particle and HER2 on 15 μm. The HS has the circular expansion channel
on the 1st layer to generate expansion vortices and the two curvature channels on
the 2nd layer to make chaotic advection. It makes transverse flow and mixes two particles
without particle focusing phenomenon. The 100-nm (exosome), 7- and 15-μm fluorescence
particles were used to test mixing performance between exosomes and particles in the
HS. The MOFF was designed by a series of contraction/expansion microchannels for continuous
size-based separation. Separation performance was tested by using the 7- and 15-μm
fluorescence microparticles in the MOFF.
Results: The mixing efficiency was the highest at the flow rate 150 μL/min. Each exosome
was continuously captured by aptamer-conjugated particle in the HS channel. The capture
efficiency of EpCAM positive exosome was 96.9% and HER 2 was 68.09%. Two particles
were separated in the integrated microfluidic device at the same flow rate. Also,
96.26% of 15-μm microparticles were positioned into the centre of the channel and
89.48% of 7 μm microparticles were separated on both sides of the channel.
Summary/Conclusion: Each exosome was continuously captured by mixing aptamer-conjugated
particle in the HS. Exosome-conjugated microparticles were successfully separated
by inertial force in MOFF. This analysis of each exosome will shed light on diagnosis
and therapy of cancers.
OWP3.05= PF10.11
Aqueous two-phase system to isolate extracellular vesicles for prostate cancer diagnosis
Hyunwoo Shin
a, Jiyoon Kima, Mee Young Kimb, Yong Hyun Parkb, Yong Goo Kimc, Ji Youl Leeb and Jaesung
Parkd
aPOSTECH, Pohang, Republic of Korea; bDepartment of Urology, Seoul St. Mary’s Hospital,
The Catholic University of Korea, Seoul, Republic of Korea; cDepartment of Laboratory
Medicine, Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea,
Seoul; dDepartment of Mechanical Engineering, POSTECH, Pohang, Republic of Korea
Introduction: Analysing extracellular vesicles (EVs) is an attractive means in prostate
cancer diagnosis. However, existing methods of EVs isolation have low efficiency,
purity and long process time, which induce low diagnostic ability. To approach the
problems, we adapt a two-phase system to diagnose prostate cancer by isolating EVs
from patients’ urine. Using the two-phase system, prostate hyperplasia (BPH) patients
and prostate cancer (PCA) patients were diagnosed, and the diagnostic ability was
compared with conventional diagnostic methods.
Methods: Forty-two prostate cancer (PCA) patients and 20 benign prostate hyperplasia
(BPH) patients’ urine, plasma, saliva was collected and used for identifying EVs isolation
ability of aqueous two-phase system (ATPS) and for comparing diagnostic ability of
ATPS with conventional diagnosis.
Results: With an optimized ATPS, EVs were isolated with an efficiency of approximately
90%. In addition, the EV-isolation time was within approximately 30 min, and the purity
of EVs in ATPS was approximately two times better than achieved with a conventional
methods, ultracentrifugation and polymeric precipitation. After the ATPS isolated
EVs from patients’ body fluid, PCR and ELISA were utilized to detect EVs derived from
prostate cancer cells. The expression levels of RNA and protein markers of prostate
cancer were compared, and the relationship between expression levels and clinical
data was analysed. The results demonstrated that diagnostic ability based on ATPS
was better than other conventional methods (serum PSA and sediments). Moreover, sensitivity
increased by at least 10%, and specificity was improved by at least 20% compared to
conventional methods.
Summary/Conclusion: High quality and quantity of EVs can be obtained from patients’
body fluid using ATPS. Using the abundant sources, which contains cancer-related protein
and genes, we can perform a diagnosis with high specificity and sensitivity. Therefore,
ATPS offers a powerful tool for more specific and sensitive diagnosis.
OWP3.06=PS05.11
In vitro and in vivo investigation of extracellular vesicles (EVs) as biomarker carriers
in the diagnosis of early Alzheimer’s disease
Soraya Moradi-Bachiller
a, Miriam Cianib, Roberta Zanardinib, Luisa Benussib, Roberta Ghidonib, J. Mark Cooperc,
Gianluigi Forlonia and Diego Albania
aDepartment of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS,
Milan, Italy; bMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di
Dio Fatebenefratelli, Brescia, Italy; cDepartment of Clinical Neurosciences, Faculty
of Brain Sciences, University College London – Institute of Neurology, London, UK
Introduction: Extracellular vesicles (EVs) represent an ideal source of biomarkers
due to their role in cellular communication and their ability to carry protein aggregates.
The most investigated EVs are exosomes, active entities secreted from cells and able
to cross the blood brain barrier. Several neurodegeneration-involved molecules may
undergo intercellular spreading through exosome release. In Alzheimer’s disease (AD),
before clinical signs appear, several proteins implicated in exo- and endocytic pathways
are altered. In this scenario, the identification of a correlation between variations
in proteins carried by EVs and the progression of AD is the main aim of our project.
Methods: We performed exosome isolation and characterization from H4-SW glioma cells
(a cell model featuring mutated β-amyloid overexpression), as well as in mouse- (triple-transgenic
mouse model for familial AD) and human-plasma samples (Mild Cognitive Impairment (MCI)
and AD subjects). In every case, a differential centrifugation protocol was applied
and exosomes were then characterized using Nanoparticle Tracking Analysis with the
NanoSight. We then explored exosome content, specifically Amyloid Precursor Protein
(APP) and its proteolytic fragments, Microtubule Associated Protein Tau (tau), Progranulin
(PGRN protein), Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2)
and α-synuclein (α-syn), using Western blot and ELISA. L1CAM and CD63 were evaluated
to define the neural-derived exosomes amount in human samples.
All the samples were collected after ethical committee approval respecting Helsinki’s
declaration. Informed consents were provided by all the subjects.
Results: Our preliminary results show that APP, PGRN and sTREM2 are carried by H4-
and human plasma-derived EVs. H4-SW cell-culture medium and 3Tg mouse plasma had a
decrease in the EVs number release (≈1*10e8 EVs/mL) in comparison to control (≈7*10e8 EVs/mL).
This decrease was not found in human plasma samples.
Summary/Conclusion: EVs purified from H4-glioma cellular AD model, 3xTg mouse-, MCI-
and AD-plasma samples carry proteins relevant for neurodegenerative diseases (NDs).
EVs release is reduced in cellular and animal AD-models.
Funding: Horizon 2020 Marie Sklodowska-Curie Innovative Training Networks – Blood
Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease.
OWP3.07=PF12.07
Shed microvesicles released from human primary and metastatic colorectal cancer cell
lines contain key cancer progression proteins and RNA species
Wittaya Suwakulsiri
a, Alin Raia, Rong Xua, Maoshan Chena, David Greeningb and Richard Simpsona
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science,
La Trobe University, Melbourne, Australia, Melbourne, Australia; bDepartment of Biochemistry
and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne,
Australia
Introduction: Extracellular vesicles (EVs) function in bidirectional cell–cell communication
and contribute to the sustained growth, invasion and metastasis of cancer cells within
the tumour microenvironment (TME). EVs comprise two main classes – exosomes and shed
microvesicles (sMVs, also termed microparticles and ectosomes) – with distinct modes
of biogenesis. Within each EV class, subtypes exist that can be distinguished by their
distinct protein/ RNA signatures. Whilst much is known about exosome cargo content
and functionality, sMVs are poorly understood.
Methods: Here, we compare protein/ RNA profiles and functionality of sMVs and exosomes
secreted from human primary (SW480) and metastatic (SW620) colorectal cancer cell
lines. Milligram amounts of EVs were purified from cell culture media using a combination
of differential ultracentrifugation/ isopycnic iodixanol density centrifugation. Label-free
quantitative mass spectrometry was performed to obtain protein profiles for SW480-derived
and SW620-derived sMVs.
Results: We show that sMVs, unlike exosomes, are ALIX-, TSG101-, CD63- and CD9- and
contain a different suite of key cancer progression modulators. Protein/ RNA signatures
for SW480-derived sMVs and exosomes differ from each other and also from their SW620-derived
counterparts. SW480-derived sMVs are enriched in ITGA/B, ANXA1, CLDN7, CD44 and EGFR/NOTCH
signalling networks, while SW620-derived sMVs are enriched in PRKCA, MACC1, FGFR4
and MTOR/MARCKS signalling networks. Fibroblast invasion capabilities of SW480-derived
and SW620-derived sMVs are comparable.
Summary/Conclusion: Furthermore, we report for the first time a comprehensive biochemical/
functional analysis of a hitherto undescribed subpopulation of sMVs. We anticipate
our in vitro findings will be a starting point for more sophisticated studies aimed
at elucidating the biochemical and functional properties of EV subtypes in vivo. The
emerging roles of specific EV subtypes in the TME we believe will alter our view of
cancer biology and might present new targets for therapeutic intervention.
Funding: Funding support from La Trobe University, Melbourne, Australia.
OWP3.08=PF12.08
Mass spectrometry analysis of small extracellular vesicles isolated from ovarian cancer
ascites
Anna Kotrbová
a, Kristina Gomoryovaa, David Potesilb, Vit Weinbergerc, Igor Crhac, Eva Jandakovad,
Lubos Minarc, Zbynek Zdrahalb, Vítězslav Bryjaa and Vendula Pospíchalovaa
aDepartment of Experimental Biology, Faculty of Science, Masaryk University, Brno,
Czech Republic; bCore Facility Proteomics, Central European Institute of Technology,
Masaryk University, Brno, Czech Republic; cDepartment of Obstetrics and Gynecology,
Faculty Hospital Brno, Brno, Czech Republic; dDepartment of Pathology, University
Hospital Brno, Brno, Czech Republic
Introduction: High-grade serous carcinoma of the ovaries, fallopian tube and peritoneum
(HGSC) is the deadliest gynaecological malignancy with 5-year survival rate below
30%. HGSC is frequently accompanied by ascites, a pathological accumulation of fluid
in the peritoneum, which can be exploited as a liquid biopsy containing not only cancer
cells, but also the tumour microenvironment including extracellular vesicles (EVs).
Tumour cells produce substantially more EVs than healthy cells, thus malignant ascites
is the source of enriched pool of EVs of HGSC origin.
Methods: Ascitic fluids depleted of cells were fractioned using size-exclusion chromatography
and two fractions – containing and not containing EVs – were further analysed. In
parallel, small EVs were also isolated from ascitic fluids using differential ultracentrifugation
followed by purification step in sucrose/D2O cushion. In total, 24 malignant ascites
and 5 non-malignant ascites were used for EV isolation and further analysed using
high-resolution hybrid mass spectrometer Orbitrap Fusion Lumos Tribrid. The subsequent
data visualization and statistical analyses were performed using in-house-developed
pipelines in KNIME environment.
Results: We identified 2441 proteins, in total, in the EVs from the ascites among
which 21 were present in all 29 EV samples and not in non-vesicular fractions. Several
of these proteins were specifically enriched in small EVs in malignant ascites in
comparison with non-malignant ascites. These proteins are now being evaluated as biomarkers.
Summary/Conclusion: Using advanced mass spectrometry, we identified candidate proteins
which are specifically enriched in small EVs of HGSC. These proteins warrant further
investigation as they may act as important players in HGSC progression as well as
serve as potential prognostic/diagnostic/screening biomarkers of HGSC.
Funding: Czech Science Foundation, Grant No. GJ17-11776Y.
OWP3.09=PT09.12
Identification of single tumour-derived extracellular vesicles by means of optical
tweezers and Raman spectroscopy
Agustin Enciso-Martinez
a, Edwin van der Polb, Aufried Lenferinkc, Leon Terstappena and Cees Ottoa
aMedical Cell Biophysics, University of Twente, Enschede, Netherlands; bAmsterdam
UMC, University of Amsterdam, Department of Biomedical Engineering and Physics, Amsterdam,
Netherlands, Amsterdam, Netherlands; cUniversity of Twente, Enschede, Netherlands
Introduction: EVs derived from cancer cells play a role in tumour cell proliferation,
migration, invasion and metastasis. Their presence in body fluids, such as blood,
makes them potential biomarkers for cancer disease. However, the identification of
single tdEVs can be challenging due to their heterogeneity, their ultra-small size,
their size overlap with many other normal EVs and contaminants in body fluids and
the lack of knowledge on their chemical composition.
Methods: Synchronized optical tweezers and Raman spectroscopy have enabled a study
of individual EVs. The new method detects individual trapping events from Rayleigh
scattering. The synchronous recording of Raman scattering enabled the acquisition
of Raman spectra of both individual and multiple EVs, disclosing their chemical composition.
Furthermore, Mie light scattering theory has been used to relate the Rayleigh scattering
intensity to the size of trapped EVs.
Results: The light scattered of trapped EVs gave rise to step-wise time traces that
can be used to distinguish individual trapping events from accumulative cluster events
due to the discrete nature of the steps which correspond to single trapping events.
Next, we confirmed the trapping of individual EVs derived from PC3 cells, red blood
cells, platelets and blood plasma by acquiring both, Rayleigh and Raman scattering
signals. While the step-wise trend in the Rayleigh scattering signal suggests trapping
of single particles, the Raman scattering signal demonstrates the nature of the trapped
EVs. Through principal component analysis (PCA), the main spectral variations among
the four EV types were identified. The principal component scores grouped the PC3-derived
EVs in a separate cluster from the rest of the EVs.
Summary/conclusion: We have developed an automated single particle optical tweezers
– Raman and Rayleigh scattering setup to trap and release single EVs over time. We
demonstrated single-EV trapping by simultaneous acquisition of Rayleigh and Raman
scattering. PCA enabled the identification of single-EVs derived from the cancer cell
line PC3. This discloses chemical information as a step towards the identification
and characterization of single tumour-derived EVs in blood.
Funding: Cancer ID – project number 14193, (partially) financed by the Netherlands
Organisation for Scientific Research (NWO)
Symposium Session 5: EVs in Infectious Diseases Chairs: Shilpa Buch; Vera TangLocation:
Level B1, Hall A 14:15–15:00
OT05.01
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
Heikki Saari
a, Tiia Turunenb, Mikko Turunenb, Matti Jalasvuoric, Sarah Butcherd, Seppo Ylä-Herttualab,
Tapani Viitalaa, Vincenzo Cerulloa, Pia Siljandere and Marjo Yliperttulaa
aDivision of Pharmaceutical Biosciences and Drug Research Program, Faculty of Pharmacy,
University of Helsinki, Helsinki, Finland; bA.I.Virtanen Institute for Molecular Sciences,
University of Eastern Finland, Kuopio, Finland; cDepartment of Biological and Environmental
Science, Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland; dFaculty
of Biological and Environmental Sciences, Molecular and Integrative Bioscience Research
Programme, and Helsinki Institute of Life Sciences, Institute of Biotechnology, University
of Helsinki, Helsinki, Finland; eEV-group, Molecular and Integrative Biosciences Research
Programme, Faculty of Biological and Environmental Sciences, University of Helsinki,
Helsinki, Finland
Introduction: Extracellular vesicles (EVs) have been showcased as auspicious candidates
for delivering therapeutic cargo, including oncolytic viruses for cancer treatment.
Delivery of oncolytic viruses in EVs could provide considerable advantages, hiding
the viruses from the immune system and providing alternative entry pathways into cancer
cells. Here we describe the secretion and viral cargo of EVs secreted by cancer cells
infected with an oncolytic adenovirus (IEVs, infected cell-derived EVs) as a function
of time after infection.
Methods: IEV-containing cell culture medium was collected from A549 and PC-3 cancer
cell cultures every 24 h after being infected with an oncolytic adenovirus and IEVs
were isolated by iodixanol density gradient centrifugation. IEVs were then characterized
by cryo-TEM, NTA, immunoblotting and qPCR for structural properties and viral components
and their infectivity was confirmed by cytotoxicity assay and TEM of IEV-treated cells.
Results: IEVs were secreted already before the lytic release of virions and their
structure resembled normally secreted EVs, suggesting that they were not just apoptotic
fragments of infected cells. IEVs were able to carry the viral genome and induce infection
in other cancer cells. The amount of viral cargo associated with IEVs increased as
the infection progressed, although no intact virions were observed in any of the IEVs
visualized by cryo-TEM. The amount of viral cargo also appeared to be density-dependent,
in that heavier IEVs contained more viral DNA and protein per vesicle.
Summary/Conclusion: Given that adenovirus is a DNA-virus that is assembled in the
nucleus and released via induced lytic cell death, the generation of infective EVs
as prescribed here suggests that part of the produced viral DNA is secreted via IEVs
before cell lysis. As such, the role of EVs in the life cycle of adenoviruses may
be an important part of the successful infection and may also be harnessed for cancer-
and gene-therapy as vectors of viral DNA invisible to the immune system.
OT05.02
Bacterial growth stage regulates the size, composition and biological functions of
membrane vesicles
Lauren Zavana, Natalie Bittoa, Ella Johnstona, David Greeningb and Maria Kaparakis-Liaskos
a
aDepartment of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne,
Australia; bDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Australia
Introduction: Outer membrane vesicles (OMVs) are naturally released by all Gram-negative
bacteria as part of their normal growth and contain many of the components found in
their parent bacterium, including DNA, RNA and proteins. To date, few studies have
compared the proteome of OMVs to that of their parent bacterium and examined how it
changes throughout bacterial growth. In this study, we aimed to elucidate the contribution
of bacterial growth stage on the size, composition and biological functions of Helicobacter
pylori OMVs.
Methods: OMVs were purified from H. pylori cultures grown to early log, mid log or
stationary phase of bacterial growth, and their size and protein composition were
analysed using NTA and proteomics, respectively. The ability of OMVs isolated from
various growth stages to stimulate an inflammatory response in human epithelial cells
was determined by ELISA.
Results: We found that OMVs became less heterogeneous in size throughout bacterial
growth. We showed that the proteome of OMVs was vastly different to that of their
parent bacterium from each time point, suggesting that there is preferential cargo
packaging of bacterial proteins into OMVs. Gene ontology and enrichment analyses identified
that bacterial growth stage regulated the type of proteins packaged into OMVs, as
early log and stationary phase OMVs were enriched in proteins required for metabolic
pathways, whereas late log phase OMVs contained proteins contributing to cell signalling.
Finally, we identified that bacterial growth stage affected the inflammatory response
mediated by OMVs in host epithelial cells, highlighting that bacterial growth stage
regulates the subsequent biological functions of OMVs.
Summary/Conclusion: Our findings identify that bacterial growth stage regulates the
size, protein cargo composition and biological functions of H. pylori OMVs, and that
therefore OMVs from various growth stages are not comparable. Collectively, these
findings emphasise the importance of considering bacterial growth stage from which
OMVs are isolated from, as this will ultimately affect their protein content and biological
functions. We are currently determining whether bacterial growth stage also regulates
the composition and functions of Gram-positive bacterial membrane vesicles.
Funding: Australian Research Council.
OT05.03
Can exosomes be used to predict where patients are on the tuberculosis disease spectrum?
Nicole Kruh-Garcia, Gustavo Diaz, Cristian Oliva Aviles and Karen Dobos
Colorado State University, Fort Collins, USA
Introduction: Mycobacterium tuberculosis (Mtb), the causative agent of the disease
tuberculosis (TB), is a highly successful human pathogen. Mtb has the ability to survive
within the host macrophage. In response to the challenges of the intracellular environment,
the bacteria secretes a dynamic subset of proteins reflective of its metabolic state,
some of which are entrapped in exosomes and released from the host cell. Our ultimate
goal is to improve upon the current diagnostics to facilitate early and rapid diagnosis
of active disease, which is a key to timely drug invention and further spread of the
disease. Using serum exosomes, we aimed to determine if a proteomic fingerprint can
be used to discriminate between individuals with TB from non-TB, as well as to classify
TB suspects – individuals with pulmonary symptoms but without detectible mycobacteria
in their sputum.
Methods: Hyper Reaction Monitoring Mass Spectrometry (HRM-MS) was applied to a sample
set of serum exosomes isolated from four groups: TB negative (healthy non-endemic
and TB-suspect endemic) and TB positive (smear negative or positive, all culture positive)
individuals. This allowed us to decipher a host protein profile that is common with
exosomes from individuals who have sputum confirmed TB and distinct from those of
whom do not. Peptide intensities were normalized and differences were in abundance,
which were determined by t-test.
Results: Nine proteins – including FCGR3A and α-2-HS-glycoprotein, show distinct patterns,
either increasing or decreasing with disease severity. Using adaptive least absolute
shrinkage and selection operator (Lasso) we are able to discriminate TB patients from
healthy and TB suspects using nine proteins. Application of the model to a test set
of smear and culture negative TB suspect serum exosomes, we found that nine were consistent
with the negative diagnosis, while one surpassed the threshold for positivity. When
the same sample was screened for the presence of mycobacterial peptides using our
published targeted MS assays, it was positive for several Mtb peptides.
Summary/Conclusion: These results indicate that a novel assay detecting a combination
of host and Mtb proteins can discriminate TB positivity with greater sensitivity than
the current sputum diagnostics.
Funding: Bill and Melinda Gates Foundation Fund #: OPP1039688.
Symposium Session 6: EV Engineering I Chairs: Hang Hubert Yin; Siyang ZhengLocation:
Level 3, Hall B 13:30–15:00
OT06.01
Designed EVs for intracellular delivery of therapeutic antibodies
Oscar Wiklander
a, Dhanu Guptaa, Joel Nordina, Heena Sharmab, Xiuming Lianga, Giulia Corsoa, Dara
Mohammada, Rim Jawada, André Görgensc and Samir El Andaloussid
aClinical Research Center, Department for Laboratory Medicine, Karolinska Institutet,
Stockholm, Sweden; bEvox Therapeutics Limited, Oxford, UK; cKarolinska Institutet,
Department of Laboratory Medicine, Stockholm, Sweden; dDepartment of Laboratory Medicine,
Clinical Research Center, Karolinska Institutet, Stockholm, Sweden
Introduction: Extracellular vesicles (EV) can be engineered to display various targeting
and therapeutic moieties. Their ability to also act as a natural vector to shuttle
cargo over biological barriers offers a unique platform for the development of a new
class of therapeutics. Here, we introduce a novel concept consisting of antibody coupled
therapeutic EV in order to target tissues or intracellular pathways.
Methods: By engineering EV to express an Fc-binding moiety (Fc-EV), antibodies can
be displayed on the surface of the vesicles. We have extensively evaluated the capacity
of these EV to bind antibodies by immuno-electron microscopy, cellular uptake of labelled
antibodies/EV and flow cytometry analysis, which indicates that EVs can be decorated
with antibodies. As a proof of concept, antibodies bound to Fc-EV, were assessed in
inflammatory models as well as in cancer settings.
Results: Delivery of anti-STAT3 antibodies in an in vitro STAT3 dependent inflammatory
reporter model was assessed, with promising results showing inhibition of STAT3 transcriptional
activity. Furthermore, intracellular delivery of anti-STAT3 antibody using Fc-EV displays
a dose dependent growth inhibition in pancreatic ductal adenocarcinoma (PDAC) cells.
The Fc-EV platform can also be utilized for decorating EVs with cancer targeting antibodies,
a feature that can be harnessed to address the differences in uptake displayed by
different cancers. Certain cancer types are known to rapidly internalize EV, whereas
other cancer types, such as malignant melanoma are known to take up EV to a very low
extent, if taken up at all. Our results show that antibodies targeting surface molecules
of cancer cells also aid the internalization of EV into cancer cells, thus further
indicating the potential of utilizing EV as therapeutic vectors. In order to achieve
specific targeting to B16F10 malignant melanoma cells, we have decorated the EV surface
with antibody targeting surface proteins that are known to be displayed on B16F10
cells, which lead to cellular association of EV to these cells.
Summary/Conclusion: Overall the Fc-EV platform offers the prospective of combining
antibody and EV technology, with potential applications including tissue and cell
targeting as well as intracellular delivery of functional antibodies.
OT06.02
Extracellular vesicles derived from AT-MSCs mediated miR-424 delivery promote apoptosis
via the PD-L1/PD-1 pathway in TNBC
Yueyuan Zhou
a, Nobuyoshi Kosakab, Zhongdang Xiaoc and Takahiro Ochiyab
ayueyuanzhou16@hotmail.com, Tokyo, Japan; bDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku, Japan; cSoutheast
University, Nanjing, China (People’s Republic)
Introduction: Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)
showed great potential as the delivery vehicle of drugs including miRNAs based on
its low immunogenicity and natural homing ability. Triple-negative breast cancer (TNBC)
is an aggressive and invasive subtype that has limited treatment options. Meanwhile,
TNBC is immunogenic with a greater percentage of tumour-infiltrating lymphocytes and
increased expression of the programmed death-ligand 1 (PD-L1) in the tumour microenvironment.
The aim of our study is to apply MSC-EVs to modulate the expression of PD-L1 via the
delivery of miR-424 and contribute to the immunotherapy for TNBC.
Methods: EVs generated from adipose tissue-derived MSCs (AT-MSCs) were isolated by
differential centrifugation and characterized by western blot, nanoparticle tracking
analysis and transmission electron microscopy. Before EV collection, AT-MSCs were
modified to overexpress miR-424 through electroporation, and miRNA mimics transfection.
The miRNAs targeting PD-L1 was predicted according to in silico analysis. The direct
regulation of miR-424 on PD-L1 was verified via the 3’-UTR luciferase report assays.
The purified EVs were added to the recipient MDA-MB-231 cells (MM-231). The expression
of PD-L1 mRNA and protein was analysed via qRT-PCR and western blot, respectively.
Results: We found that miR-424 directly regulated the expression of PD-L1 through
the binding to PD-L1 3’UTR. Furthermore, the expression of PD-L1 in MM-231 cells was
down-regulated and the expression of miR-424 in MM-231 was up-regulated after coculture
with exosomes derived from normal AT-MSCs, and AT-MSCs with miR-424 overexpression.
Moreover, the cell viabilities of MM-231 were decreased after coculture with exosomes
or transfected with miR-424 mimics.
Summary/Conclusion: EVs derived from AT-MSCs could transfer functional miR-424 to
TNBC cell lines and promote the apoptosis via decreased immune-negative PD-L1/PD-1
pathway.
Funding: This work was supported by Project for Cancer Research and Therapeutic Evolution
[P-CREATE; grant number:17cm0106402h0002], MEXT KAKENHI [Grant-in-Aid for Young Scientists
(A); grant number: 17H04991] and China Scholarship Council [grant number: 201706090122].
OT06.03
Exosomal delivery of NF-κB repressor delays LPS-induced preterm birth in mouse models
Samantha Sheller-Miller
a, Kyungsun Choi, George Saade, Chulhee Choib and Ramkumar Menon
aUniversity of Texas Medical Branch, Galveston, USA; bKAIST, Daejeon, Republic of
Korea
Introduction: Intraamniotic infection and inflammation are associated with spontaneous
preterm birth (PTB) and preterm premature rupture of the membranes (pPROM). In this
study, we tested engineered extracellular vesicles, or exosomes, cargoing an inhibitor
to pro-inflammatory transcription factor (NF-kB), called super-repressor (SR) IkB,
to prolong gestation in an infection (LPS)-induced PTB mouse model.
Methods: HEK293T (human embryonic kidney cell) derived exosomes were engineered to
contain SR using a protein loading via optically reversible protein–protein interaction
(EXPLORs) method (Yim, et al 2016). In this method, SR is actively incorporated into
exosomes during biogenesis. These exosomes were isolated, quantified and used for
our studies. Intraperitoneal (IP) injection of either LPS (100 g) or PBS were performed
in CD-1 mice on gestational day 15 followed by injection of PBS, SR exosomes (1 × 1010)
or naïve exosomes (exosomes derived from HEK293T cells under normal culture conditions,
1 × 1010) every 2 h for a total of five injections. Treatment groups (Group 1-LPS+PBS;
Group 2-LPS+SR; Group 3-LPS+naïve, and Group 4-PBS) were monitored for preterm birth.
Upon delivery of at least one pup in Group 1, mice were euthanized, and maternal plasma,
uterus and cervix were collected for cytokine analysis using Luminex (IL-1β, IL-8
and IL-10) and Western blot for NF-B activation via RelA phosphorylation (P-NF-B),
respectively. Survival graphs were created in GraphPad and one-way ANOVA was performed
to determine statistical significance (P < 0.05).
Results: Animals injected with PBS delivered at the expected gestational age (19.5
days). LPS and LPS + naïve-induced PTB within 10 h; however, injection of SR exosomes
prolonged delivery by an average of 21 h in this model. Consistently lower levels
of pro-inflammatory cytokines, IL-1β and IL-8, were seen in maternal plasma of LPS + SR
compared to LPS mice, while anti-inflammatory cytokine, IL-10, levels were significantly
increased in LPS + SR mice compared to LPS (P = 0.01) and PBS controls (P < 0.0001).
In the cervix and uterus, P-NF-B expression was significantly decreased in LPS + SR
compared to LPS (P = 0.005, P = 0.03) (Figure 2B).
Summary/Conclusion: Exosomes can be engineered to carry pharmaceutical agents that
can dampen the infection-induced inflammation associated with PTB and pPROM.
OT06.04
Technologies for loading RNA-based therapeutics into extracellular vesicles for drug
delivery
Olga Shatnyeva
a, Anders Gunnarssonb, Euan Gordonc, Elisa Lázaro-Ibáñezd, Lavaniya Kunalingamc, Xabier
Osteikoetxeae, Kristina Friisc, Marcello Marescac and Niek Dekkerb
aAstraZeneca, Molndal, Sweden; bAstraZeneca, Mölndal, Sweden; cAstrazeneca, Mölndal,
Sweden; dAstraZeneca, molndal, Sweden; eAstraZeneca, Macclesfield, UK
Introduction: Extracellular vesicles (EVs) have emerged as a very potent new delivery
system for drug delivery. Recent advances in RNA-based therapeutics have broadened
the scope of cellular targeting of currently undruggable genes. Current approaches
for RNA loading of EVs suffer from poor efficacy. Our study combines bioengineering
of the therapeutic EVs with post-isolation RNA. We will here present data showing
(1) the use of RNA binding proteins (RBP) fused to EV protein markers for in vitro
loading of EVs with tagged RNA cargo and (2) post-isolation incubation of EVs with
RNA-loaded lipid nanoparticles (LNP).
Methods: A library of targeted RNAs fused to a specific RNA binding protein (RBP)
sequence was generated, varying the position of recognition site. Surface plasmon
resonance was used to characterize the modified sgRNAs for binding to the RBP. Activity
of the hybrid sgRNA was also confirmed for functional gene editing with Cas9. Expi293F
cells were co-transfected with the set of modified sgRNAs and RBP fused to EV proteins
followed by EV purification by differential ultracentrifugation. EVs were characterized
by nanoparticle tracking analysis, Western blotting and single molecule microscopy.
Efficiency of sgRNA loading into EVs was determined using qPCR. Post-isolation loading
of sgRNA with Expi293 EVs by co-incubation and functional delivery of sgRNA cargo
in HEK293 cells were also evaluated.
Results: The introduction of RNA recognition elements into sgRNA sequence did not
interfere with binding to RBP. Fusions between RBP and EV proteins resulted into efficient
incorporation of RBP in EVs. Co-expression of sgRNA resulted in selective targeting
of sgRNA to EVs. Additionally, EVs from cells co-expressing sgRNA and RBP contained
10-fold more sgRNA compared to EV from cells who only expressed sgRNA. Loading of
synthetic sgRNA cargo with 40% encapsulation efficiency was achieved by incubation
of EVs with LNPs and the resulting particles led to functional uptake in HepG2 cells.
Summary/Conclusion: Here, we compare different techniques for therapeutic cargo loading
and delivery into target cells. All approaches for RNA loading into EVs demonstrates
proof of principle. We envision that this approach will be useful for RNA loading
for therapeutic applications.
OT06.05
Engineering designer exosomes produced efficiently by mammalian cells in situ and
their application for the therapy of Parkinson’s disease
Ryosuke Kojima
a, Daniel Bojarb and Martin Fusseneggerc
aGraduate School of Medicine, The University of Tokyo. JST PRESTO, Tokyo, Japan; bETH
Zurich, Department of Biosystems Science and Engineering, Basel, Switzerland; cETH
Zurich, Department of Biosystems Science and Engineering. University of Basel, Faculty
of Science, Basel, Switzerland
Introduction: Exosomes are cell-derived extracellular nanovesicles 50–150 nm in size,
which serve as intercellular information transmitters in various biological contexts,
and are candidate therapeutic agents as a new class of drug delivery vesicles. However,
inefficiency of exosome cargo transfer, such as transfer of mRNA contained in exosomes,
and lack of methods to create designer exosomes has hampered the development of sophisticated
therapeutic interventions.
Methods: We have developed a set of synthetic-biology-inspired genetic devices that
enable efficient customizable in situ-production of designer exosomes in engineered
mammalian cells, and pursued their therapeutic applications.
Results: The developed synthetic devices that can be genetically encoded in exosome
producer cells (named “EXOtic (EXOsomal Transfer Into Cells) devices”) enhance exosome
production, specific mRNA packaging and delivery of the mRNA into the cytosol of recipient
cells. Synergistic use of these devices with a targeting moiety significantly enhanced
functional mRNA delivery into recipient cells, enabling efficient cell-to-cell communication
without the need to concentrate exosomes. Further, the engineered exosome producer
cells implanted in living mice could consistently deliver mRNA to the brain. Moreover,
therapeutic catalase mRNA delivery by designer exosomes attenuated neurotoxicity and
neuroinflammation in both an in vitro and in vivo Parkinson’s disease model.
Summary/Conclusion: These results indicate the potential usefulness of the EXOtic
devices for RNA delivery-based therapeutic applications. (Nat. Commun. 2018, 9, 1305)
Funding: This work was supported by the European Research Council (ERC) advanced grant
[ProNet, no. 321381] and in part by the National Centre of Competence in Research
(NCCR) for Molecular Systems Engineering (to M.F.). R.K. was supported by a postdoctoral
fellowship from the Human Frontier Science Program.
OT06.06
Protein engineering for loading of Extracellular Vesicles
Xabier Osteikoetxea
a, Josia Steina, Elisa Lázaro-Ibáñezb, Gwen O´Driscollc, Olga Shatnyevad, Rick Daviesa
and Niek Dekkerc
aAstraZeneca, Macclesfield, UK; bAstraZeneca, molndal, Sweden; cAstraZeneca, Mölndal,
Sweden; dAstraZeneca, Molndal, Sweden
Introduction: To date various reports have shown the utility of extracellular vesicles
(EVs) for delivery of therapeutic protein cargo. Currently, the most common strategies
for loading therapeutic cargoes occur after EV isolation mixing EVs with desired cargo
and subjecting to passive incubation, electroporation, freeze-thaw cycling, sonication,
extrusion, or membrane permeabilization with saponin among various techniques. An
alternative approach is to modify releasing cells to secrete EVs containing the desired
cargo with minimal impact on native EVs by post-isolation treatments. In this study,
we designed different constructs to compare Cre and Cas9 loading efficiency into EVs
using (1) light-induced dimerization systems (Cryptochrome 2 (CRY2), Phytochrome B
(PHYB), and Vivid-based “Magnets” (Mag)), (2) fusion to EV associated proteins (CD9,
CD63, CD81, Rab5), (3) lipidation motifs (Myristoylation, Palmitoylation, Prenylation)
and (4) a novel motif “mXO”.
Methods: For EV production human Expi293F cell line was transiently transfected with
plasmid constructs using PEI MAX 40K. EVs were then isolated by differential ultracentrifugation
followed by iodixanol gradient and characterized using nanoparticle tracking analysis,
western blotting and transmission electron microscopy. Functionality of engineered
Cre and Cas9 cargo was assessed in reporter cell assays using fluorescent microscopy,
qPCR and Sanger sequencing followed by TIDE analysis.
Results: Light-induced dimerization using CRY2 resulted in better EV cargo loading
for both Cre and Cas9 than PHYB and Mag systems. Among the EV associated proteins
and lipidation motifs tested CD9, CD81, Myristoylation and mXO were most efficient
at recruiting Cre and Cas9 cargo by light-induced dimerization. Using CRY2 in combination
with CD9 or mXO we achieved loading efficiencies of 10–34 Cre molecules per EV and
23–30 Cas9 molecules per EV.
Summary/Conclusion: Cre and Cas9 loading into EVs by producing cells is feasible using
protein engineering with light-induced dimerization. Of the designs investigated CRY2-induced
light dimerization and CD9 and mXO motif were most effective resulting in multiple
copies of functional Cre and Cas9 loaded per EV. We envision that this approach will
be useful for protein loading in a variety of therapeutic applications.
OT06.07
Engineered extracellular vesicles for drug delivery
Niek Dekkera
, Elisa Lázaro-Ibáñezb, Olga Shatnyevac, Nikki Heathd and Xabier Osteikoetxeae
aAstraZeneca, Mölndal, Sweden; bAstraZeneca, molndal, Sweden; cAstraZeneca, Molndal,
Sweden; dAstraZeneca, Vancouver, Canada; eAstraZeneca, Manchester, United Kingdom
Abstract: Extracellular Vesicles (EVs) represent an exciting opportunity as biological
delivery vehicle for therapeutic cargo with excellent safety, low intrinsic immunogenicity,
cell-specific tropism and biological delivery efficiency.
Methods: There are multiple approaches for the introduction of protein and RNA cargo
into EVs, including physical, chemical and cell engineering. We have engineered Expi293F
suspension cells with transient expression of fusion proteins for reversible loading
with protein cargo with examples for Cre recombinase and Cas9 for CRISPR gene editing.
Results: We have developed a single molecule fluorescence microscopy technique to
quantify cargo loading at a single particle level, showing excellent loading for GFP
fusions with CD63 with on average 70 copies of the fusion protein per particle. Functional
delivery of Cre recombinase, as measured in a reporter cell line, was dependent on
addition of small molecule or peptide enhancers of endosomal escape. Using RNA-binding
proteins fused to exosomal markers we were able to enrich EVs with RNA cargo with
up to 10-fold higher loading of sgRNA compared to loading from passive mass redistribution.
Human Expi293F cell-derived EVs did not trigger any significant immune response in
vitro in human blood. The in vivo assessment following a single intravenous administration
of these EVs in BALB/c mice did not reveal marked haematological changes, cytokine
induction or histopathological effects. Labelling of EVs using fluorescent mCherry,
luminescent NanoLuc or radio-isotope 111Indium marker allowed for on line analysis
of bio-distribution in vivo.
Summary/conclusion: Opportunities of naïve and engineered EVs for drug discovery and
their potential for therapeutic applications will be discussed.
PT01: Cellular and Organ Targeting Thursday Poster SessionChairs: Charles Lai; Ikuhiko
NakaseLocation: Level 3, Hall A15:30–16:30
PT01.01
Role of circulating extracellular vesicles in brain function and behaviour
Eisuke Dohi, Indigo Rose, Takashi Imai, Rei Mitani, Eric Choi, Dillon Muth, Zhaohao
Liao, Kenneth Witwer and Shinichi Kano
Johns Hopkins University School of Medicine, Baltimore, USA
Introduction: Accumulating evidence suggests that extracellular vesicles (EVs) circulate
in the blood and affect cellular functions in an organ distant from their origins.
In neuroscience, systemic circulating factors such as cytokines/chemokines, hormones
and metabolites have been shown to modulate brain function and behaviour. They are
also utilized as biomarkers to reflect brain disease status. Nonetheless, it remains
unclear whether circulating EVs modulate brain function and behaviour.
Methods: We used mouse models to study the effects of EVs from specific cell types
on brain function and behaviour. Because circulating EVs are extremely heterogeneous,
we focused on immunodeficient mice that lack specific lymphocytes (T and B cells).
We assessed the changes in their circulating EVs and examined their potential impact
on the corresponding behavioural and neuronal dysregulation.
Results: As expected, immunodeficient mice lack the expression of T and B cell-related
markers in the EV containing fractions from the peripheral blood. Immunodeficient
mice also displayed social behavioural deficits, accompanying by enhance c-Fos immunoreactivity
in the excitatory neurons in the medial prefrontal cortex (mPFC). Notably, transfer
of splenocytes from wild-type (WT) rescued the behavioural deficits, serum EVs and
brain c-Fos expression patterns in immunodeficient mice. Further analysis on the molecular
mechanisms is in progress.
Summary/Conclusion: Our study has revealed a potential periphery-brain communication
via EVs under physiological condition. Future studies are required to identify the
cellular targets of circulating EVs and their ascending routes in the brain.
Funding: NIMH R01.
PT01.03
In vivo tracking and monitoring of extracellular vesicles with a new non-lipophilic
dye
Sam Noppen
a, Gareth R Willisb, Antonios Fikatasa, Archana Guptac, Amirali Afsharic, Christophe
Pannecouquea and Dominique Scholsa
aLaboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Leuven, Belgium;
bDepartment of Pediatrics, Harvard Medical School, MA, Boston, USA; cSystem Biosciences
(SBI), Palo Alto, CA, USA
Introduction: Extracellular vesicles (EVs) are gaining increasing interest as drug
delivery vehicles. However, there is still a lack of knowledge about the in vivo fate
of exogenous delivered EVs. Noninvasive optical imaging is an important tool to analyse
the biodistribution of EVs. Currently, one of the most popular techniques is to directly
label EVs with fluorescent lipophilic dyes. A major drawback is that the dye itself
rather than EVs is detected. Hence, there is a need for other dyes that overcome these
limitations. A new non-lipophilic near infrared (NIR) dye, ExoGlow-Vivo (SBI), was
tested in vivo in mice.
Methods: EVs from human PBMC, HEK and MCF7 cells were labelled with ExoGlow-Vivo,
precipitated with Exoquick-TC (SBI) and injected intravenously (i.v.) in adult SCID
mice. Human mesenchymal stem cell (MSC)-derived EVs were labelled with ExoGlow-Vivo
dye, washed via ultracentrifugation and injected i.v. in post-natal day-4 FVB mice.
Fluorescent images were acquired with an IVIS® Spectrum (PerkinElmer).
Results: Spectral unmixing of ExoGlow-Vivo revealed optimal excitation/emission at
745/820 nm. Biodistribution studies in SCID mice showed the liver as main targeted
organ. A high fluorescent signal was measured in the bladder but almost completely
disappeared within 4 h. Ex vivo imaging of dissected organs confirmed the liver as
the main organ, followed by spleen and kidneys. No difference in biodistribution was
observed between PBMC, HEK and MCF7-derived EVs. MSC-derived EVs accumulated preferentially
in the liver of post-natal mice. Interestingly, ex vivo imaging revealed high positive
staining in the lungs. This may be associated with recent observations that found
MSC-derived EVs ameliorate core features of experimental bronchopulmonary dysplasia.
Summary/Conclusion: ExoGlow-Vivo has excellent NIR properties for in vivo imaging
with almost negligible background. This non-lipophilic dye is ideal for biodistribution
and kinetic studies of exogenous delivered EVs. However, uptake of most EVs by liver
supplants the signal of other organs.
PT01.04
Exosomal lipids applicable to cancer targeting
Yuki Toda
a, Saeka Ukaia, Akari Kobayashia, Shin-ya Moritab, Shigekuni Hosogia and Eishi Ashiharaa
aDepartment of Clinical and Translational Physiology, Kyoto Pharmaceutical University,
Kyoto, Japan; bDepartment of Pharmacy, Shiga University of Medical Science Hospital,
Kyoto, Japan
Introduction: Cancer-targeting technologies must be a crucial technology to develop
diagnosis and therapy of cancers. Many basic and clinical studies highlighted lots
of cancer-associated proteins and expected their ligands to honour the drug carrier
with selectivity; however, their targeting potential were not tolerable of advanced
trials. We have previously identified glioblastoma-derived exosomes (Exo-U251) that
were more effectively internalized into some types of cancer cell lines than into
non-cancer cells. Because this tropism was still maintained in the lack of protein
ligand interaction of the exosomes with cells, we focused on their lipid components.
Methods: Ultrapure exosomes (about 100 nm vesicles expressing CD63 in d = 1.16 mg/L
fraction) were collected from cell culture media using density-gradient ultracentrifugation.
Exosomal lipids were extracted by Bligh & Dyer method and reconstructed into liposomes
(Exolip-U251) using extrusion method. Each amount of lipid components was analysed
by enzymatic fluorometric assay [Morita S.Y. and Terada T. Sci. Rep., 5:11737, 2015].
Exosomes or reconstructed liposomes were fluorescent-labelled and applied to cancer
or non-cancer cells to evaluate the internalization efficiency using an image analysis
of a laser scanning microscopy. Exolip-U251 conjugating siRNA was prepared by Exo-Fect
reagent. Doxorubicin (DOX) was encapsulated into liposomes using remote-loading method.
Results: The enzymatic fluorometric assays revealed the uniqueness of the exosomal
lipid components according to the cells from which they are derived. The tropism of
Exo-U251 lipid-reconstructed liposomes (Exolip-U251) partly mimicked that of the original
exosomes. The siRNA conjugated Exolip-U251 was effectively delivered into the inside
of cells, but did not suppress the target gene expression. By contrast, DOX-loaded
Exolip-U251 significantly suppressed the proliferation of U251 cells. Thus, the encapsulation
was critical for the agents to internalize more effectively into cancer cells.
Summary/Conclusion: The tropism of exosomes is partially regulated by their own lipid
components and, mimicking this approach would lead to promising cancer-targeting technologies.
Funding: MEXT-Supported Program for the Strategic Research Foundation at Private Universities
PT01.05
The exosome that are released from mechanical stress-stimulated osteocyte induces
osteoclastegenesis
Tomohiro Itoh
a and Yukihiro Akaob
aGraduate School of Bioresources, Mie University, Tsu, Japan; bGifu University Graduate
School of Drug Discovery and Medical Information Sciences, Gifu, Japan
Introduction: Osteocyte, which is the most abundant cell in bone tissues, is well
known as a mechanical stress receiving cell. During bone remodelling, bone resorptionby
osteoclasts precedes bone formation by osteoblasts. However, its mechanism is still
unknown. In this study, we examined whether exosome released from osteocyte by MS
stimulation are involved in osteoclast differentiation.
Methods: MC3T3-E1 cells or MLO-Y4 cells were seeded on 3D scaffold and grown to 70–80%
confluence. The cells were exposed to pressure of 1.5 MPa for 1 h at 37°C consisting
a hydrostatic pressure system. After cultivation, the cultured media harvested and
then isolated then centrifuged at 8,000 ×g for 30 min at 4°C to remove cell debris.
The extracellular exosomes were pelleted in a final ultracentrifugation at 100,000 ×g
for 1 h at 4°C. Pelleted exosomes were resuspended in PBS and ultracentrifuged again.
The size distribution of exosomes was examined using a NanoSight Tracking Analysis
LM20 System. The amount of osteoclast differentiation was estimated by TRACP staining.
The MLO-Y4 cell vesicle membrane and vesicle internal protein profiles were analysed
by nano-LC-MS/MS based shotgun proteomics.
Results: The vesicles isolated from mechanical stress-loaded MC3T3-E1 cells facilitated
the mechanical stress-loaded osteoblast differentiation, but no effect against normal
MC3T3-E1 cells. Though the vesicles isolated from mechanical stress-loaded MLO-Y4
cells had no effect against osteoblast differentiation, these vesicles significantly
induced osteoclast differentiation. To characterize the mechanisms by which mechanical
stress-loaded MLO-Y4 cell vesicles induces osteoclast differentiation in murine macrophage
RAW264 cells, we analysed vesicle membrane and vesicle internal proteins by nano-LC-MS/MS-based
shotgun proteomics. As a result, Protein X was only detected in mechanical stress-loaded
MLO-Y4 cell vesicles.
Summary/Conclusion: Our data indicated that mechanical stress-loaded MLO-Y4 cells
vesicles are acting as one of osteoclast differentiation mechanisms. Now, we are further
investigating whether Protein X is involved in osteoclast differentiation.
Funding: This work was supported by a Grant-in-Aid for Scentific Research (C) [No.
18K11019] from Japan Society for the Promotion of Science (JSPS).
PT01.06
A label-free aptasensor for electrochemical detection of gastric cancer exosomes
lI Zhiyang
a and He Nongyueb
aNanjing Drum Tower Hospital Clinical College, Nanjing, China (People’s Republic);
bSoutheast University, Nanjing, USA
Introduction: Emerging evidence indicates exosomes derived from gastric cancer cells
enhances tumour migration and invasion through the modulation of tumour microenvironment.
Here we represent a label-free electrochemical aptasensor for specific detection of
gastric cancer exosomes. This platform contains an anti-CD63 antibody modified gold
electrode and a gastric cancer exosome specific aptamer. The aptamer is linked to
a primer sequence which is complementary to a G-quadruplex circular template. The
presence of target exosomes could trigger rolling circle amplification and produce
multiple G-quadruplex units. This HRP mimicking DNAzyme could catalyses the reduction
of H2O2 and generate electrochemical signal. This aptasensor exhibits high selectivity
and sensitivity towards gastric cancer exosomes with a linear response range from
4.8 × 103 to 4.8 × 106 exosomes/mL. Therefore, we expect this electrochemical apatasensor
to become a useful tool for the early diagnosis of gastric cancer.
Methods: First of all, several gastric cancer cell or cancer overexpressed protein
aptamers were screened in order to select gastric cancer exosome specific aptamer.
Then different kinds of exosomes were captured in the anti CD-63 antibody modified
gold electrode. Among these exosomes, only gastric cancer exosomes could trigger RCA
to achieve the generation of large amount of G-quadruplex units. The products were
then incubated with hemin to form hemin-G-quadruplex structures and catalysed H2O2
system to produce electrochemical signal. The aptasensor was also validated in terms
of the linearity and repeatability to demonstrate its potential in practice.
Results: Anti-CD63, which can bind to the exosome surface marker was used as the capture
probe. And the joint effects of hemin/G-quadruplex DNAzyme towards H2O2 reduction
and signal amplification produced by RCA reaction was used to generate significantly
strong electrochemical and colorimetric response.
Summary/Conclusion: In this work, we developed an electrochemical and colorimetric
aptasensor for specific detection of gastric cancer exosomes. A specific gastric cancer
exosome aptamer was selected and used as the detection probe. The aptasensor exhibits
specificity towards target exosomes and high sensitivity.
PT02: EVs in reproduction and pregnancy Chairs: Nanbert Zhong, Qi ChenLocation: Level
3, Hall A15:30–16:30
PT02.01
Placenta extracellular vesicles: a potential protective role against oxidative damage
Qi Chen
a, Chunlin Sub and Larry Chamleya
aThe University of Auckland, Auckland, New Zealand; bFudan University of China, Shanghai,
China (People’s Republic)
Introduction: Extracellular vesicles (EVs) are lipid-enclosed packages of cellular
contents including RNAs, protein and DNA that are produced by all eukaryotic cells
to facilitate intercellular communication and regulation. Upon reaching their target
cells, EVs may deliver their cargo and can induce signalling to alter the behaviour
of target cells. During pregnancy, a large number of EVs are extruded from placenta
(a foetal organ) into maternal circulation. Placental EVs are implicated in maternal
immunosuppression and tissue repair. In this study we investigated whether placental
EVs can prevent cell damage.
Methods: EVs were isolated from first trimester placental explants (range from 8–12 weeks
of gestation) and separated into micro- and nano-EVs by differential centrifugation.
Human endometrium epithelial cells (HEE) were cultured for 18 h in the presence or
absence of placental micro- or nano-EVs. After removal of excess EVs by washing with
PBS, HEE cells were treated with 1 mM H2O2 for 30 min and then the H2O2 was removed
by washing. The culture was continued for 18 h and proliferation of HEE was measured
by Alamar Blue assay. The expression of H2AX, a marker of DNA damage in HEE cells
was measured by IHC.
Results: The proliferation of HEE was significantly reduced when HEE cells were treated
with 1 mM H2O2. However this reduction of proliferation was significantly reversed
by pre-treatment with either micro- or nano-placental EVs. In addition, the expression
of H2AX was higher in HEE cells that had been treated with 1 mM H2O2, but higher expression
of H2AX was reduced in HEE cells that had been pre-treated with either micro- or nano-EVs.
Summary/Conclusion: In this study, we found that pre-treatment with placental EVs
can reduce the adverse effects of H2O2 on HEE cell proliferation death and DNA damage.
Our data suggest placental EVs have the ability to protective cells against oxidative
damage. In pregnancy this property of placental EVs may assist the function of maternal
cells that are exposed to increased oxidative stress.
PT02.02
Maternal serum miRNA biomarkers for detection of placenta accreta
Rebecca R. Adami
a, Louise Laurent
b, Victoria Frattoc, Srimeenakshi Srinivasana, Cuong Trana, Peter DeHoffa, Melissa
Westermannd, Allison O’Learye, Deborah Wingd and Gladys Ramosa
aUCSD, San Diego, USA; bUCSD, La Jolla, USA; cNaval Medical Center, San Diego, USA;
dUCI, Irvine, USA; eUCSF, San Francisco, USA
Introduction: Failure to diagnose placenta accreta spectrum (PAS) prior to delivery
is associated with worse outcomes. However, use of ultrasound and magnetic resonance
imaging for this diagnosis is costly and imprecise. We hypothesize that levels of
specific cell-free miRNAs in the maternal blood will differ among women with PAS,
placenta previa and normal placentation.
Methods: Women with suspected PAS, previa or normal placentation were prospectively
recruited at three academic centres in the UC foetal Consortium. PAS was confirmed
by pathologic evaluation. Maternal serum was collected antenatally, and total RNA
was extracted, subjected to small RNA sequencing, and mapped to the miRBase human
miRNA database. Groupwise differential expression analysis identified 13 candidate
miRNAs, which were used to generate a support vector regression model for classification.
The small RNA sequencing results for these candidate miRNAs were validated using qPCR.
Results: 60 women were recruited: 18 PAS, 15 placenta previa and 27 normal placentation.
The median gestational age at sample collection was 30w3d (IQR 28w–33w) and did not
differ among groups (p = 0.13). The abundance of total miRNA reads as a percentage
of all reads in the small RNA sequencing data was highest among women with PAS and
lowest in normal placentation. Thirteen differentially expressed candidate miRNAs
were identified. Support vector regression accurately classified samples into the
three categories.
Summary/Conclusion: The percent total miRNA was significantly higher in maternal serum
in cases of PAS compared to normal placentation. Thirteen candidate miRNAs were differentially
expressed among groups and were used in a training model to accurately classify samples.
Our results suggest that maternal serum miRNAs have the potential to serve as biomarkers
for accurate antenatal diagnosis of PAS. Studies in a larger independent cohort are
needed for validation of these results.
PT02.03
Effects of medium term storage on placental extracellular vesicles
Larry Chamley, Julie Wang and Cherie Blenkiron
The University of Auckland, Auckland, New Zealand
Introduction: Studies on the function of isolated extracellular vesicles (EVs) are
growing exponentially. However, as yet there is no consensus on how best to store
EVs. We hereby conducted a term study to examine the stability of various cargos carried
by placental EVs when stored at 4°C.
Methods: First-trimester placental tissues were cultured for 24 h in medium supplemented
with fluorescent cell tracker CMTPX (1 µg/mL). Debris was removed by centrifugation
at 2000 ×g. Micro EVs were harvested by centrifugation at 20,000×g and subsequently
nano-EVs were harvested following centrifugation at 200,000×g. The EVs were resuspended
in PBS then aliquoted and stored at 4oC. CMTPX signal strength was examined by flow
cytometry (AriaII) weekly. DNA was extracted, fortnightly, using Purelink Genomic
DNA kit and measured using a Qubit dsDNA assay; and total proteins were isolated,
fortnightly, with RIPA and quantified using BCA assay.
Results: The proportions of micro and nano-EVs showing similar intensity of CMTPX
signals did not change significantly for 3 months (n > 5) but an inconsistent and
sample-dependent decline was observed thereafter. In contrast, the DNA content of
EVs was stable for only 2 weeks. DNA quantities extracted from micro and nano-EVs
declined by 40% and 60%, respectively, at week four compared to DNA extracted from
freshly isolated EVs and thereafter remained stable until 8 weeks. Total protein in
micro EVs was stable for 2 months. Whereas there was a 20% decline in the total protein
extracted from nano-EVs by week 2 but levels remained stable thereafter. Finally,
the corresponding placental tissues also stored at 4oC and processed in parallel showed
continuous decline in both DNA and protein quantities.
Summary/Conclusion: The CMPTX label incorporated into placental EVs may be stable
for 3 months when stored at 4oC. However, the DNA of both micro and nano-EVs was less
stable with a rapid decline upon storage. There was a marked difference in the stability
of EV-associated protein with the protein content of nano-EVs being less stable than
that of micro-EVs. Notably the total protein content of placental micro-EVs was remarkably
stable when the EVs were stored at 4oC. Further work is required to assess the intactness/functionality
of placental EVs after storage.
Funding: Marsden Fund of the Royal Society of New Zealand
PT02.04
Deciphering embryo-maternal communication; the dynamics of first contact between progenitor
and progeny
Kasun Godakumara
a, Masoumeh Es-haghib, Keerthie Dissanayakeb, Freddy Lättekivib, Andres Salumetsc,
Ülle Jaakmad and Alireza Fazelib
aDepartment of Pathophysiology, Institute of Biomedicine and Translational Medicine,
University of Tartu, Tartu, Estonia; bDepartment of Pathophysiology, Institute of
Biomedicine and Translational Medicine, University of Tartu, Estonia; cCompetence
Centre on Health Technologies, Tartu, Estonia; dInstitute of Veterinary Medicine and
Animal Sciences, Estonian University of Life Sciences, Tartu, Estonia
Introduction: Failure of implantation has long been identified as a major challenge
of assisted reproductive technologies. It is hypothesized that the embryo alters the
endometrium to elevated receptivity by embryo-maternal cross talk. In previous communications,
we have shown that RNA originating from JAr (analogue for trophoblast) cell line,
packaged in extracellular vesicles (EVs) are transferred to RL95–2 (an analogue for
endometrium) cell line and induce alterations in specific endometrial Zinc Finger
Protein 81 (ZNF81) transcript. The objective of the current study was to test the
hypothesis that only EVs from viable embryo alter ZNF81 transcript in the RL95-2 cell
line.
Methods: Human embryos were produced by classic in vitro fertilization (IVF) or intracytoplasmic
sperm injection (ICSI). They were cultured individually for 20 h in Fert™ media (day
1), 48 h (day-3) in Cleav™ media and additionally 48 h in Blast™ media (day-5). At
day-3, embryos with equal size blastomeres and no fragmentation were considered as
normal. At day 5, embryos with identifiable inner cell mass, trophoblast and blastocyst
cavity were considered normal while embryos forming mass of degrading cells were considered
degraded. Conditioned media was collected from 6 normal day-3 embryos (three of which
degraded by day 5), day-5 normal (n = 3) and degraded (n = 3) embryos, Cleav™ and
Blast™ media. EVs were isolated using a sequential centrifugation and size-exclusion
chromatography. A monolayer of RL95-2 cells (analogue for endometrium) was treated
with isolated EVs. The change of gene expression of ZNF 81 and control genes (beta-actin,
beta-2-microglobulin) in RL95-2 cells were measured using qPCR with absolute quantification.
Results: Results exhibited that EVs derived both from day-5 normal blastocysts and
day-3 embryos that undergo normal development significantly downregulated ZNF 81 expression
in endometrial cells compared to untreated controls, cells treated with Cleave™ and
Blast™ media EVs, cells treated with day-5 degraded embryos and day-3 embryos degrading
on day-5 EVs. Control genes did not exhibit a significant change of expression.
Summary/Conclusion: RL95-2 cells respond in different manners to EVs from normal and
degraded human embryos. These findings can facilitate development of biomarkers for
differentiating viable and degraded embryos at early stages after IVF.
PT03: EV Nucleic Acid Biomarkers Chairs: Louise Laurent; Guoku HuLocation: Level 3,
Hall A15:30–16:30
PT03.01
Circulating exosomal miRNAs as potential biomarkers for evaluation of preterm brain
injury
Kenta HT Choa, Bing Xub, Nina Zengb, Randall F. D’Souzac, Cherie Blenkirond and Mhoyra
Fraser
b
aDepartment of Physiology, Faculty of Medical and Health Sciences, The University
of Auckland; bDepartment of Physiology, Faculty of Medical and Health Sciences, The
University of Auckland, Auckland, New Zealand; cDiscipline of Nutrition, Faculty of
Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; dThe
University of Auckland, Auckland, New Zealand
Introduction: Insults such as oxygen deprivation occurring in utero or during delivery
have profound consequences on the neurological outcome of premature infants. This
is a serious clinical problem, because treatment is a time-critical emergency and
should be commenced within 6 h following injury. However, we simply do not know which
preterm infants to treat due to the lack of sensitive biomarkers. Using our foetal
sheep model of preterm brain injury, we sought to isolate exosomes from foetal plasma
to establish whether they contain miRNA biomarkers that are associated with clinically
significant neurologic outcomes.
Methods: Chronically instrumented singleton foetal sheep at 0.7 gestation (term 145 days)
received asphyxia induced by umbilical cord occlusion for 25 min. Size-exclusion chromatography
(qEV) was performed for isolation and purification of extracellular vesicles (EVs)
from plasma collected 4 h after occlusion from asphyxia (n = 10) and sham control
(n = 10) foetuses. EV fractions were assessed for purity and quantity by nanoparticle
tracking analysis and western blot against major EV protein markers. For biomarker
identification, miRNA expression profiles from plasma EV fractions were determined
by Affymetrix v4 microarrays.
Results: Umbilical cord occlusion was associated with significant brain injury to
areas commonly affected by asphyxia in preterm infants. Plasma EVs were characterised
as rich in CD63 and HSP70, size ~100 nm, and with an exosome-like morphology by TEM.
Profiling of EV-miRNAs revealed significant differences (log2 fold change > 2 or <
−2 and p value < 0.05) between the asphyxia and sham control foetal groups. Strikingly,
the majority of miRNAs differentially abundant with asphyxial-induced brain injury
were less abundant, including miR-30b-5p, miR-30a-5p, miR-27a, let-7f, miR-223/3p,
miR-221, miR-22-3p, miR-151–3p, miR-411–5p and miR-532 whereas only one miRNA (miR-455-3p)
was more abundant.
Summary/Conclusion: To the best of our knowledge, this study is the first to determine
the usefulness of plasma exosomal miRNAs as biomarkers for the prediction of preterm
brain injury. Our data reveal a unique plasma-derived exosomal miRNA profile, which
may aid the early diagnosis of preterm brain injury.
Funding: Neurological Foundation of New Zealand.
PT03.04
Identification and Verification of Differentially Expressed MicroRNAs in the plasma
microvesicles for the Diagnosis of moyamoya Disease
Mi Jeong Oh
a, Eun Hee Kima, Yeon Hee Chob, Dong Hee Kimc, Ji Hee Sungb, Eun Kyoung Shina and
Oh Young Bangd
asamsung medical center, Seoul, Republic of Korea; bsamsung medical center, seoul,
Republic of Korea; cSungkyunkwan University, seoul, Republic of Korea; dSamsung medical
center, Seoul, Republic of Korea
Introduction: There is no well-recognized miRNA biomarker for accurately predicting
outcome in the presence of moyamoya disease (MMD), a unique cerebrovascular occlusive
disease of unknown etiology1,2. We performed a study of the significance of miRNAs
expression in the plasma microvesicles (MVs) of MMD patients.
Methods: The plasma MVs were purified from 38 healthy donors, 22 intracranial atherosclerotic
stenosis (ICAS) patients and 40 moyamoya disease (MMD) patients. Plasma MVs were isolated
using ultracentrifugation. We perfomed miR expression analysis using miRNome miScript
miRNA PCR Array. Specific miRNAs were validated using real-time polymerase chain reaction,
with normalization to an exogenous control (cel-miR-39). The angiogenic effects were
measured by over-expressing or inhibiting specific miRNAs.
Results: MiRNA profiles using miRNome miScript miRNA PCR array of three pooled plasma
MV samples from patients with MMD, ICAS and controls revealed 222 differentially expressed
serum miRNAs, including 115 upregulated and 107 downregulated miRNAs. In an independent
MMD cohort, qRT-PCR confirmed that miR-A was significantly upregulated. Hsa-miR-A
in the MMD group exhibited greater performance than ICAS group (AUC 0.735) in ROC
curve analysis. To select target genes of specific miRNAs, we performed computational
miR target prediction analysis (TargetScan) and found the seed sequence of CAV1 3’-UTR
interacting with hsa-miR-A. The deregulation of miR-A by the transfection of HUVECs
with pre-miR-A was significantly decreased tube formation of HUVECs. In addition,
miR-A inhibited tube formation by suppressing the expression of CAV1at the posttranscriptional
level, respectively, resulting in defective angiogenesis and MMD pathogenesis.
Summary/Conclusion: Hsa-miR-A is markedly elevated in plasma MV of patients with MMD.
The potential role of these microRNAs in the pathogenesis of MMD can contribute to
find new diagnostic and therapeutic target of MMD.
Funding: This study was supported by a grant from the Korean Healthcare Technology
R&D Project, Ministry of Health & Welfare (HI17C1256) and Basic Science Research Program,
the Ministry of Science, ICT and Future Planning (2018M3A9H1023675).
PT03.05
Micro RNA- 451-5p in urinary exosomes for non-invasive monitoring of reno-protective
response
Manju Kumari, Aradhana Mohan, Ravi S. Singh, Rajni Sharma and Swasti Tiwari
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Introduction: MicroRNA-451 in urinary exosomes (UE) had been demonstrated as a sensitive
predictor of kidney injury in diabetic rats by us. Here, we determined whether miR-451
in UE could also assess severity of kidney injury and/or reno-protective response
to therapy.
Methods: Streptozotocin-induced (STZ, 50 mg/kg of body weight, i.p) type-1 diabetic
rats were fed with normal chow diet (DM) or high cholesterol diet (DM + HCD), to increase
the severity of nephropathy. Half rats in DM + HCD group were treated with atorvastatin
(AT, 20 mg/kg body weight, DM + HCD + AT) for 8 weeks and rest remained untreated.
After 8 weeks, urine was collected for exosomes-enrichment and albumin to creatinine
ratio (ACR). Primary cultures of human proximal tubular cells (hPC) and their secreted
exosomes were also studied. Taqman-based real-time qPCR was done for miR-451-5p.
Results: At the end of the study, DM + HCD had significantly higher ACR while lower
renal miR-451 levels, relative to DM and DM + HCD + AT rats. In addition, a strong
negative correlation of renal miR-451 was found with ACR. In contrast to kidney tissue,
UE analysis revealed a positive correlation of miR-451 levels with ACR in these rats.
Moreover, miR-451 in UE was significantly higher DM + HCD rats relative to DM and
DM + HCD + AT rats. In vitro studies confirmed the direct effect of hyperglycaemia
/ mechanical on miR-451 expression.
Summary/Conclusion: Severity of kidney injury in rats is associated with lower renal
miR-451 and higher UE miR-451. Statin attenuated renal injury and miR-451 levels in
UE, while improving renal levels. MiR 451 analysis in UE may assess therapeutic response
of reno-protective drugs non-invasively
Funding: Funded by ICMR and DBT, Govt. of India.
PT03.06
Circulating miR-451a is a useful biomarker for haemolysis
Yukichi Takada, Tatsuki Shibuta and Tsukuru Umemura
International University of Health and Welfare, Okawa City, Japan
Introduction: Red blood cells (RBCs) are circulating enucleated cells, and its main
component is haemoglobin carrying O2/CO2. RBCs contain erythroid lineage-specific
microRNA (miRNA), miR-451a. Biogenesis of miR-451a depends on the activity of Ago2,
and also circulating miR-451a is mainly Ago2-bound, non-exosome miRNA. For utilizing
circulating miR-451a for diagnosis of anaemia which is caused by destruction of RBCs
(haemolysis), it is important to evaluate distribution pattern of circulating miR-451a.
Methods: We analysed 120 remnant serum samples obtained from routine blood drawing
for laboratory testing. The study was done under permission of The Ethical Committies
of International University of Health and Welfare and Kohoukai Takagi Hospital. Serum
miRNAs were analysed using TaqMan microRNA assay kits and RT-qPCR (ABI 7500fast).
Exosomes were obtained using the ultracentrifugation method and the precipitation
method.
Results: We analysed 120 remnant serum samples obtained from routine blood. The sensitive
Hb detection method using 414 nm absorbance (NanoDrop2000, ThermoFischer) showed that
100% of blood sampling had haemolysis. The levels of serum miR-451a also increased
in all samples. Ultracentrifugation method and precipitation method showed more than
90% of serum miR-451a is in the non-exosome fraction.
Summary/Conclusion: miR-451 is a unique miRNA which is in the non-exosome fraction.
The measurement of serum miR-451a is a sensitive and specific biomarker for haemolysis.
Funding: This work was supported in part by a grant from the Japan Society for the
Promotion of Science (JSPS KAKENHI Grant Number: JP17K09020).
PT03.07
Circumventing qPCR inhibition to improve amplification of exosomal miRNAs in preterm
foetal sheep heparinised plasma
Bing Xu
a, Mhoyra Fraser
1 and Kenta HT Cho
b
aDepartment of Physiology, Faculty of Medical and Health Sciences, The University
of Auckland, Auckland, New Zealand; bDepartment of Physiology, Faculty of Medical
and Health Sciences, The University of Auckland
Introduction: Exosomal miRNAs have been identified in plasma, which has led to an
interest in their potential as biomarkers of neural injury responses in survivors
of prematurity. The chronically catheterized preterm foetal sheep model is a uniquely
versatile model to advance our understanding of the pathophysiological mechanisms
underlying preterm brain injury and develop new therapeutic strategies. However, to
ensure patency of catheters implanted into foetal vessels heparinised saline is infused
continually. Heparin can confound detection of plasma miRNAs. Here we present an optimal
procedure to collect and detect exosomal miRNAs in foetal plasma that improves sensitivity
and performance of qRT-PCR.
Methods: Size-exclusion chromatography (SEC; qEV) and commercial ExoRNeasy were performed
for isolation and purification of extracellular vesicles (EVs) on foetal plasma collected
in K2EDTA tubes in which varying amounts of heparin or enoxaparin (0–160 IU/mL) had
been added post-thawing. RNA was extracted from qEV fractions (miRNeasy), ExoRNeasy
EVs, or from whole plasma (miRNeasy) and treated with or without heparinase I to remove
contaminating heparin. Levels of endogenous miR-16 and let-7a were measured using
qRT-PCR.
Results: Important differences in EV-miRNA abundance were observed between isolation
methods. Heparinase I treatment improved detectability of the miRNAs in a dose-dependent
manner in heparin/non-heparin spiked whole plasma and when isolated using the ExoRNeasy
kit. Strikingly, SEC removed endogenous heparin from non-heparin spiked plasma collected
from catheters infused with low-dose heparin and this effect was not improved by heparinise
I. Further, SEC partially removed contaminating effects of heparin in heparin spiked
whole plasma.
Summary/Conclusion: Treatment of foetal sheep plasma with heparinase I enables utilisation
of qRT-PCR for reliable miRNA quantification. SEC also enables removal of inhibitory
heparin and therefore should be considered as a standard step for isolation and detection
of EV-miRNAs in foetal plasma.
Funding: Neurological Foundation of New Zealand.
PT03.09
A particle-based multiplex RT-qPCR for measuring circadian rhythm-associated genes
Kim Mi Yeon
a, Jung Seungwona, Kim Junsuna, Lee Heon Jungb and Kim Sangkyunga
aMolecular Recognition Research Center, Materials and Life Science Research Division,
KIST, Seoul, Republic of Korea; bSleep-Wake Disorders Center, Korea University Anam
Hospital, Seoul, Republic of Korea
Introduction: Biological clocks which regulate the expression of genes related to
the circadian metabolism of living organisms are directly linked to human health and
disease. Many studies also have suggested to analyse mental health issues such as
depression and bipolar disorder through molecular analysis of circadian rhythm-associated
genes recently. These genes are generally analysed by reverse-transcription real-time
PCR (RT-qPCR) but conventional methods require considerable time, cost and amount
of the sample to figure out multiple genes at the same time.
Methods: We introduce a sensitive and multiplex RT-qPCR using hydrogel particles.
One of the primer pair used in RT which captures and reverse-transcribes the target
RNA is immobilized in the particle. The other primer is stored not to react during
RT and released when amplification begins. This strategy can help the RT process to
avoid non-specific products as well as the amplification to occur effectively.
Results: In order to see RT-qPCR efficiency, PER3 RNA which is synthesized via in
vitro transcription (IVT) of complementary DNA, and total RNA extracted from LNCAP
cell were tested with serial dilution. As a result, they showed high amplification
efficiency of 95% and 98%, respectively. In addition, the expression level of genes
was successfully measured even from a single cell. Expression pattern of 8 circadian
rhythm-associated genes was acquired from total RNA of circadian rhythm-synchronized
HeLa cells. In addition, exosomal RNAs were monitored same cells every four hours
for 48 h in order to obtain molecular circadian rhythm cycles. Each gene showed unique
pattern of expression.
Summary/Conclusion: For non-invasive diagnosis, clinical sample of human epithelial
cells, saliva exosome and hair cells were confirmed particular patterns. Further study
will emphasize to take a snapshot of molecular circadian rhythm through the combination
of expression levels of associated genes measured at a certain time point for diagnosis
of the mood disorder.
PT04: EV Nucleic Acid Cancer Biomarkers Chairs: Christian Preußer; Harry HolthoferLocation:
Level 3, Hall A15:30–16:30
PT04.01
Unveiling of extracellular exosomal miRNA profiles of breast cancer
Shang-Che Kuo
a, Ko-Chien Chena, Takahiro Ochiyab, Wen-Hung Kuoc, King-Jen Changd, Kuo-Kan Liange
and Tang-Long Shena
aNational Taiwan University, Taipei, Taiwan (Republic of China); bDepartment of Molecular
and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku,
Japan; cNational Taiwan University Hospital, Taipei, Taiwan (Republic of China); dTaiwan
Adventist Hospital, Taipei, Taiwan (Republic of China); eAcademia Sinica, Taipei,
Taiwan (Republic of China)
Introduction: In an era of precision medicine, biomarker discovery is indispensable
for early detection, therapeutic efficacy monitoring and outcome prediction. MicroRNAs
within patient serum exosome have emerged as significantly measurable biomarkers,
which abundantly existed in the form of liquid biopsies, for several diseases, including
cancers. They are essential regulators of global mRNA expression in cells. Aberrant
regulation of miRNA can enables resulting in tumour initiation, drug resistance and
metastasis in cancer. miRNA assays are convenient for large-scale studies covering
multiple miRNA targets and realistic in screening across diverse breast cancer types
for early detection or factors that drive cancer progression.
Methods: In this study, we collected patient serum samples from four major molecular
subtypes: luminal A, luminal B, HER2+ and triple negative types, and breast cancer
patients with benign tumour and ductal carcinoma in situ (DCIS). Microarray analysis
of miRNA expression was utilized and unique serum miRNA signatures between non-cancer
(including benign, DICS) and breast cancer patients were identified with differential
expression analysis and the common features selection method – elastic net. All combinations
of selected miRNAs were modelled with three different approaches, including generalized
linear model (GLM), linear discriminant analysis (LDA) and support vector machine
(SVM).
Results: To analyse more generally, we applied various normalization methods and got
different outcomes after feature selection. All the selections were used to fit prediction
models. After applying the filter criteria based on accuracy evaluation by 10-fold
cross-validation, the top selected miRNAs showed the consistency of different prediction
methods, and the union of these selections was used in the further modelling. The
results confirmed that few miRNAs are enough to implement early detection at high
accuracy.
Summary/Conclusion: Through identifying these heterogeneous compositions of the cancer
cells, understanding of the molecular mechanisms underlying these identified biomarkers,
which is essential in developing effective treatments and translational research,
could be established.
PT04.03
Hypoxia may promote tumour aggressiveness and extracellular vesicle-mediated cell-to-cell
communication in multiple myeloma
Kyung Ju Ryu
a, Ji Young Leeb, Sung Won Limb, Chaehwa Parkc, Kihyun Kimd and Seok Jin Kimc
aSungkyunkwan University, Seoul, Republic of Korea; bSamsung Medical Center, Seoul,
Republic of Korea; cSungkyunkwan University, Samsung Medical Center, Seoul, Republic
of Korea; dSungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea
Introduction: Hypoxia is one of important features of tumour microenvironment, and
tumour cells under hypoxia can acquire aggressive characteristics including drug resistance.
Thus, tumour progression and resistance to therapy are associated with hypoxic tumour
microenvironment. Multiple myeloma (MM) is a neoplasm of bone marrow plasma cells.
Bone marrow is hypoxic compared to other organs, thus, tumour aggressiveness of MM
could be closely associated with hypoxic microenvironment. Extracellular vesicle is
a small vesicles containing a wide range of functional proteins, mRNAs and miRNAs
that are actively secreted via exocytosis. In this study, we investigated the effect
of hypoxia on the EV formation of MM cells to identify the underlying mechanism of
tumour aggressiveness in MM cells.
Methods: We conducted a long-term culture of MM cell lines under hypoxic conditions
(1% and 2% of O2 for 4 weeks), and compared with same MM cell lines cultured under
normal oxygen concentration (20%). The RNA expression profiles of MM cells under hypoxia
were also compared with that of cultured cells under normal oxygen condition. The
EV derived from MM cells was isolated using ExoQuick‐TC solution and assessed by transmission
electron microscopy, Nanoparticle tracking analysis and Western blot.
Results: The overexpression of HIF-1α was demonstrated in MM cells under long-term
hypoxia, and the expression of stem cell markers were more increased in MM cells under
hypoxic condition compared to normal oxygen concentration The RNA sequencing showed
up-regulation of gene associated with production of EV in hypoxic cultured cells.
When we measured EV from hypoxic cultured MM cells, the amount of EV was significantly
higher in hypoxic MM cells than normoxic control group. To identify specific alterations
associated with hypoxic MM cells, we profiled miRNAs derived from EV of hypoxic MM
cell lines and those of normoxic MM cell lines. These results identified eight miRNAs
with significantly different expression between MM cells – derived EV.
Summary/Conclusion: We demonstrated the characteristics of long-term hypoxic MM cell-derived
EV. The EV-mediated cell-to-cell communication under hypoxia might be associated with
the content of miRNA in MM cell-derived EV, and it might influence tumour aggressiveness
of MM cells.
PT04.04
Deep sequencing identified serum exosomal miR-181a-5p as an indicator for bone-metastatic
prostate cancer
Yanqing Wang
a, Yu-Xiang Fangb, Baijun Donga, Wei-Qiang Gaob and Wei Xuea
aDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University,
Shanghai, China (People’s Republic); bState Key Laboratory of Oncogenes and Related
Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of
Medicine, Shanghai Jiao Tong University, Shanghai, China (People’s Republic)
Introduction: Prostate cancer (PCa) is the most common male malignancy worldwide with
high heterogeneity from tumorigenesis to metastasis. Although bone metastasis is the
most critical metastatic event, at present, there has been no specific and accurate
biomarker for its diagnosis or differentiation at an early stage of PCa. Given the
fact that the profiling change of exosomal miRNAs can work as a biomaker for metastasis
in multiple tumours, we seek to identify exosomal miRNAs in patient’s serum as indicators
for bone-metastatic PCa.
Methods: The profiling change of serum exosomal miRNAs in patients with either benign
prostatic hyperplasia (BPH) or localized or bone-metastatic PCa was detected by miRNA-seq
and miRNA-chip array, respectively. Prospective miRNAs were further confirmed using
TaqMan miRNA assay in two independent validation cohorts of total 127 patients with
either BPH or localised or bone-metastasic PCa. Logistic regression analysis was performed
to evaluate the diagnostic association of candidates with bone metastasis. Accuracy
estimate of each candidate for the diagnosis of bone-metastatic PCa was quantified
using the area under the receiver-operating characteristic curve (AUC).
Results: By miRNA-seq and miRNA-chip array, we found four prospective exosomal miRNAs
including miR-181a-5p with significant differences between localized and bone-metastatic
PCa groups (p<0.05, fold change ≥1.5 or ≤0.5). In the validation cohorts, logistic
regression analyses indicated that miR-181a-5p and miR-320a were significantly associated
with bone-metastatic PCa. The AUC analyses identified miR-181a-5p as the best biomarker
with the AUCs 93.1% for diagnosis of PCa and 73.9% for that of tumour bone metastasis.
Summary/Conclusion: Serum exosomal miR-181a-5p is a promising diagnostic biomarker
for bone-metastatic PCa. Further validation is needed.
Funding: National Natural Science Foundation of China (81630073 to W-QG, 81874097
to Y-XF, 81672850 to BD, 81572536 and 81772742 to WX)
PT04.05
Exosomal miRNAs and proteins signature as prognostic biomarkers for early stage epithelial
ovarian cancer
Shayna Sharma
a, Andrew Laia, Dominic Guanzonb, Terry Morganc, Lewis Perrind, John Hooperd and Carlos
Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland
Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University
of Queensland, Brisbane, Australia; bExosome Biology Laboratory, Centre for Clinical
Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane
and Women’s Hospital, The University of Queensland, Brisbane, Australia; cDepartment
of Pathology and Obstetrics, Oregon Health and Science University, Portland, OR, USA;
dMater Health Services, South Brisbane, QLD, Australia, Brisbane, Australia
Introduction: Epithelial Ovarian Cancer (EOC) is the leading gynaecological malignancy
worldwide due to the limitations of current detection tests. The 5-year survival rate
with early detection is 90% compared to 20% with late detection. Unfortunately, only
30% of the cases are detected early. Thus, it is essential to develop a novel and
minimally invasive method to identify patients at an early stage. Exosomes have shown
promise as biomarkers as they encapsulate vital information. Therefore, the aims of
this study were to (i) determine the content of circulating exosomes at early stages
of EOC, and (ii) to determine the prognostic performance of an early-ovarian cancer
screening test to identify women at risk of developing EOC.
Methods: Exosomes were isolated from the plasma of patients with either benign disease
(n = 50) or Stage I/II EOC (n = 28), through differential centrifugation and size
exclusion chromatography. Exosomes were characterized using Nanoparticle Tracking
Analysis, Western Blot and Electron Microscopy. Exosomal proteins were profiled using
Liquid Chromatography–Mass Spectrometry (LC-MS/MS) and SWATH analysis. An Illumina
TrueSeq Small RNA Library Prep kit was used for exosomal miRNA profiling. A binomial
classification algorithm was generated using a boosted logistic regression analysis
(WEKA machine learning software (ver 3.6.12)) of the results obtained from the benign
and Stage I/II samples. The algorithm was built using 5 miRNAs and 5 proteins identified
through circulating exosome profiling. The expression of specific miRNAs was confirmed
using RT-qPCR to validate the miRNA sequencing results.
Results: miRNAs and proteins were identified as being differentially expressed across
EOC progression. The algorithm that we built delivered discrimination between women
with EOC (Stage I/II) compared to benign. The classification efficiency was assessed
by ROC curve analysis (area under the curve (AUC) was 0.785 ± 0.091 (p = 0.0106))
with positive and negative predictive values of 75% and 76%, respectively.
Summary/Conclusion: We propose that the combined measurement of exosomal miRNAs and
proteins might allow for the early identification of women with EOC, distinguishing
between patients with benign disease and patients with Stage I/II EOC. Future directions
involve the validation of the proposed miRNAs and proteins in a larger cohort.
Funding: OCRF.
PT04.06
Circulating Extracellular vesicle (EV)-encapsulated microRNAs as a biomarker of breast
cancer
Clodagh O’Neilla, Róisín Dwyer
b, Sonja Khana, Katie E. Gilliganc and Peter Dockeryb
aNational University of Ireland, Galway, Galway, Ireland; bNUI Galway, Galway, Ireland;
3National University of Ireland Galway, Galway, Ireland
Introduction: Early detection of breast cancer is the key to improve patient survival.
There is currently no robust biomarker available to detect breast cancer. Extracellular
vesicle encapsulated microRNAs (EV-miR) provide novel potential in this field. EVs
are tiny nanoparticles released by all cells in the body that contain various bioactives
including miRNA, believed to reflect the characteristics of the parent cell. Evidence
suggests that tumour associated EVs have a distinct miRNA expression profile from
normal cells, and could hold novel biomarker potential.
Methods: This study aimed to determine the circulating EV-miR profile of tumour-bearing
animals compared to healthy controls, and relate this to the EV-miR profile secreted
by tumour cells in vitro. EVs were isolated from the supernatant of HCC-1954 breast
cancer cells expressing luciferase (HCC-luc). EVs were also harvested from healthy
BALB/c nude mice or those bearing mammary fat pad HCC-luc tumours. Serum and media
EVs were isolated by differential centrifugation, followed by microfiltration and
ultracentrifugation. EVs were characterised by Nanoparticle Tracking Analysis (NTA),
western blot and Transmission Electron Microscopy (TEM). Next-Generation Sequencing
(NGS) targeting miRNA was preformed to compare the HCC-luc EV-miR profile in vitro
and in vivo.
Results: EVs were successfully isolated and demonstrated to express CD63, CD9 and
CD81. Using NTA, size distribution was confirmed to be of the predicted range of 30–120 nm.
A range of miRNA was detected in the HCC-luc EVs in vitro. Interestingly, nine of
these miRNAs were present at significantly higher levels in the EVs than the cells
from which they were released, e.g. miR-184 and let-7c. Initial analysis revealed
that a number of miRNAs packaged into EVs by HCC-luc cells In Vitro were also detectable
in circulating EVs isolated from tumour-bearing animals.
Summary/Conclusion: EVs are thought to represent a fingerprint of the cell from which
they are released, and hold great potential as biomarkers for breast cancer detection.
Further understanding of miRNA trafficking and transfer in EVs will shed light on
their true potential in the cancer biomarker and therapeutic setting.
Funding: I am funded by the National Breast Cancer Research Institute (NBCRI).
PT04.07
Role of exosomal microRNA as a biomarker for extranodal NK/T-cell lymphoma
Kyung Ju Ryu
a, Chaehwa Parkb, Won Seog Kimb and Seok Jin Kimb
aSungkyunkwan University, Seoul, Republic of Korea; bSungkyunkwan University, Samsung
Medical Center, Seoul, Republic of Korea
Introduction: Extranodal natural killer (NK)/T-cell lymphoma (ENKTL) is one of aggressive
subtype of non-Hodgkin lymphoma, and all tumour cells are inarguably infected with
Epstein–Barr virus. The cell to cell interaction and association with tumour microenvironment
could be important for this disease entity. Exosomes are small membrane vesicles of
30–150-nm diameter that plays an important role in the tumour microenvironment, and
they are actively secreted by most cell types, including cancer cells. In particular,
the intra-exosomal microRNA is known as being important for intercellular communications.
However, the clinical significance of exosomal miRNAs in ENKTL has not been examined.
Thus, we characterized exosomal miRNAs in ENKTL and analysed their effect on the outcomes
of patients.
Methods: We isolated exosomes from ENKTL patient serum and lymphoma cell lines using
ExoQuick and analysed by transmission electron microscopy, Nanoparticle tracking analysis
(NTA) and Western blot. We performed exosomal microRNA profiling via the nCounter
miRNA expression assay on exosomes from 45 ENKTL patients and lymphoma cell lines.
Results: We isolated and characterized exosomes from NKTL patient serum and cell lines
using ExoQuick, and analysed by TEM, NTA and Western blot. The serum-derived exosomes
had a diameter of 95.84 ± 11.37 nm and exosome concentrations ranged from 0.25 to
14 × 1012/mL. We verified exosomes morphology and size using TEM, and detected exosomal
markers, including Alix, and CD63 by western bolt. We performed miRNA microarrays
to compare exosomal miRNAs of patients with ENKTL having good and bad prognosis. As
shown in the microarray results, we found various miRNAs that were differentially
contained in the serum – derived exosomes of NKTL poor relative to good subjects.
These results identified 30 miRNAs with significantly different expression between
NKTL samples. Five of these miRNAs were up-regulated and 25 ware down-regulated in
the serum-derived exosomes of NKTL bad compared to the good subjects (p value < 0.
05). We identified two exosomal miRNA signatures, has-miR-320e and miR-4516, that
were associated with poor outcomes with regard to OS and PFS.
Summary/Conclusion: Our study provides that exosomal miRNA, miR-320e and miR-4516,
may serve as potential diagnostic and prognostic biomarker in NKTL.
PT04.08
Cancer-derived exosomes enriched from patient plasma strongly mirror parent tumour
and enable subtyping of early stage breast cancer via liquid biopsy
Christine Coticchia
a, Robert Kitchenb, Sudipto Chakraborttyb, Douglas Robertsa, Lisa Bedfordc, Sunita
Badolac, Sylvie Vincentc, Seth YuB and Johan Skogd
aExosome Diagnostics, Waltham, USA; bExosome Diagnostics, Inc, Waltham, USA; cTakeda,
Cambridge, USA; dExosome Diagnostics, Inc., Waltham, MA, USA
Introduction: Tumour-derived molecular signatures of breast cancer (BCa) have accelerated
personalized medicine as prognostic and predictive indicators leading to improved
clinical outcomes. Currently, molecular profiling is performed on biopsied breast
tumour tissue but our goal of “liquid biopsy” is to obtain disease-relevant genetic
material non-invasively by capturing exosomes, cfDNA, or protein from bodily fluids.
Unfortunately, a major limitation of liquid biopsy stems from the scarcity of disease-relevant
material compared to background. Here we describe an enrichment process in plasma
capable of isolating cancer specific exosomal subpopulations originating from early
stage breast tumours.
Methods: Tumour-specific surface markers on exosomes were targeted and enriched from
plasma obtained from stage I/II ER positive / HER2 negative BCa patients and age-matched
controls. RNA-sequencing was performed on total RNA isolated from 15 BCa tumour tissues
(FFPE) and 15 patient-matched plasma exosome samples (with and without exosome enrichment).
We also sequenced RNA from 12 healthy breast tissues (FFPE) and plasma exosomes from
10 healthy post-menopausal women (with and without tumour exosome enrichment). RNA-seq
data were used for gene-level differential abundance analysis.
Results: Tumour-derived exosome enrichment was observed in 63% of the BCa patients
with detectible levels of the target antigens in their plasma. RNA-seq gene expression
profiles of these enriched exosomes were highly correlated with those of the breast
tumour FFPE samples. Tumour-enriched exosomal RNA abundance clustered most tightly
with the FFPE tissue derived from the same patient; even more so than BCa FFPE samples
correlated to each other. The strength of the correlation between BCa enriched plasma
exosomes and matched patient tissue was sufficient to enable correct tumour subtyping
(by both PAM50 & IntClust gene targets) using only the enriched plasma exosomal RNA.
Summary/Conclusion: Tumour-specific exosome enrichment improved plasma-derived exosomal
RNA signal to noise and revealed RNA profiles that closely reflect the donor tumour,
thus enabling the detection and characterization of early stage breast cancers.
PT04.09
Exosomes: the same team for hepatocellular carcinoma development on the background
of HCV and ergotism?
Alisa Petkevich, Alexandr Abramov, Mohamed Kadle and Vadim Pospelov
Peoples’ Friendship University of Russia (RUDN University), Moscow, Russia
Introduction: Hepatocellular carcinoma (HCC) may be caused by a wide variety of reasons,
two possible of them are hepatitis C virus infection (HCV) and alkaloids contained
in the ergot (Claviceps). Anyway, not all of the individuals infected with HCV or
living in regions endemic for ergot develop HCC so it is reasonable to develop biomarker
panel for identification of risk groups for HCC. Exosomes seem to be an ideal source
of such biomarkers as far as they contain exactly the information molecules packed
by cells during its physiological (or pathological) functioning.
Methods: 48 plasmas of patients with HCC from Somalia (from a region with a high degree
of ergot alkaloides in food), and 18 plasmas of HCC (Russia) on the background of
cirrhosis due to HCV. Exosomes were isolated from plasma by differential ultracentrifugation
following free-flow electrophoresis. MiRNA let-7a-5p, −224-5p, −106b-3p, −126-5p,
−122-5p, −16-5p and −34a-5p were determined in exosomes by qPCR-RT. Same free miRNA
from plasma were determined. PD-L1 expression was assessed on the surface of exosomes
by TEM and HR-FCM. PD-L1 expression was also assessed on the surface of exosomes isolated
from plasma of healthy donors (n = 8).
Results: There was a slight difference in exosomal miRNA profile of plasma from HCC
on the background of HCV and on the background of HCV and living in ergot region.
PD-L1 expression on the surface of exosomes from HCC plasmas were higher (MV 35,8%
for both HCC groups, MV 5% for healthy donors group). Plasma free miRNA profiles were
different inside every HCC group.
Summary/Conclusion: According to our results, exosomal miRNA identification in HCC
patients seem to be more accurate than plasma free miRNAs, further research is needed
in order to identify whether it is reasonable to use both free and exosomal miRNAs.
The difference in miRNA profiles of HCC patients on the background of HCV or alkaloids
of ergot may allow supposing different epigenetics dysregulation happen in HCC depending
on the trigger factor.
PT04.10
Exosomal sorting of circRNA promotes cancer progression and serves as a novel biomarker
for gastric cancer
Rong Li
a, Junyi Wangb, Xu Zhangb, Hui Qianc and Wen Rong Xud
aJiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine,
Jiangsu University, Zhenjiang, China, Zhenjiang, China (People’s Republic); bZhenjiang
Key Laboratory of High Technology Research on Exosomes Foundation and Transformation
Application, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School
of Medicine, Jiangsu University, Zhenjiang, China (People’s Republic); cZhenjiang,
China (People’s Republic); dZhenjiang Key Laboratory of High Technology Research on
Exosomes Foundation and Transformation Application, Jiangsu Key Laboratory of Medical
Science and Laboratory Medicine, School of Medicine, Jiangsu University, ZhenJiang,
China (People’s Republic)
Introduction: Exosomes are critical mediators of intercellular communication and promising
biomarker for cancer. However, whether the release of exosomes has an effect on donor
cells has not been well investigated. In this study, we aimed to identify the clinical
values of exosomal circRNAs in gastric cancer (GC). Meanwhile, we explored the biological
roles and mechanisms during GC cells selectively sorting exosomal circRNAs.
Methods: Database circ2Traits and starBase v2.0 were used to screen potential GC related
circRNAs and validated their expression levels in over 50 paired serum or exosomes
from GC patients and healthy volunteers, or 100 cancer tissues and adjacent normal
tissues from GC patients. Receiver operating characteristic curve, clinicopathological
features analysis and overall survival (OS) and disease-free survival (DFS) curve
were made to evaluate the clinical relevance of these circRNAs and select circ1477
as potential biomarker for further studies. Circ1477 overexpression and knockdown
experiments were conducted to assess the effects on GC progression in vitro and in
vivo. RIP, luciferase assay, RNA FISH and rescue experiments were applied to demonstrate
its molecular mechanism.
Results: We found that the level of circ1477 in serum or serum exosomes of GC patients
was significantly higher than that in healthy volunteers. Whereas, the level of circ1477
in cancer tissues and was remarkably lower compared to adjacent normal tissues of
GC patients, which was associated with lymph node metastasis and prognosis. Also,
the expression of circ1477 was observed to be decreased in GC cell lines while increased
in their derived exosomes, suggesting that circ1477 could be selectively sorted into
exosomes by GC cells. Furthermore, cytoplasmic circ1477 could suppress the migration
and invasion of GC cells acting as miRNA sponges while knockdown of it could reverse
these effects.
Summary/Conclusion: Taken together, our findings indicate that tumour suppressive
circ1477 could be selectively sorted into exosomes to promote tumour progression and
serve as a potential biomarker for gastric cancer.
Funding: National Natural Science Foundation of China: (81572075); Technology Development
Project of Jiangsu University (20180361)
PT04.11
Development of non-invasive tests for prostate cancer
David J. Whittaker
a, Bianca Dobsona, Clare Eltona, Damian Whitea, Nancy Frédérickxa, Nicola Jacksona,
Niha Phukana, Mike Herberta, Rebecca Girvana, Lia Boottena, Genevieve Johnstonb, Dug
Yeo Hana, Ben Currana, Jennifer Barnesa, Robert Mitchella and Keith Hudsonb
aCaldera Health, Auckland, New Zealand; bCaldera Health, Auckland, USA
Introduction: Prostate cancer (PC) is the most common non-skin cancer in males and
is fast becoming the most frequently diagnosed cancer in men. Despite significant
advances in diagnosis and treatment PC remains a leading cause of cancer deaths. Analysis
of PSA in blood has long been used for early diagnosis and monitoring but is flawed
by low sensitivity and a high rate of false positives, with negative health consequences
including the overtreatment of many indolent prostate cancer tumours. Caldera Health
is developing non-invasive liquid biopsy tests for prostate cancer to improve upon
and replace the controversial serum PSA test.
Methods: Through a series of clinical studies, Caldera Health has identified promising
RNA biomarkers for PC diagnosis. Preliminary experiments indicated that in urine a
far greater proportion of prostate RNA is localised in extracellular vesicles (EVs)
than in cellular material. A simple and reliable process was optimised to concentrate
urinary EVs and a novel method was developed to specifically isolate the EV’s of prostatic
origin with high efficiency. Subsequently a clinical study was performed using qRT-PCR
to quantify RNA biomarkers in approximately 300 urine samples collected from men scheduled
for prostate biopsy tests. The clinical study participants provided informed consent
and the study was approved by recognised medical ethics committees in New Zealand
and Australia.
Results: Comparison of the qPCR data for prostate, bladder and kidney-specific genes
indicated our prostate vesicle isolation method successfully reduces contamination
with vesicles from both kidney and bladder. The clinical study data was used to develop
accurate prostate cancer diagnostic models.
Summary/Conclusion: Caldera Health has identified EV RNA biomarkers associated with
prostate cancer and developed a novel method to specifically isolate prostate-derived
EVs from urine. We have tested multiple biomarkers and developed gene signatures identifying
prostate cancer with high sensitivity and specificity.
PT05: EV Biogenesis Chairs: Imre Mager, Hollis ClineLocation: Level 3, Hall A15:30–16:30
PT05.01
Uncovering the role of heparan sulphate proteoglycans in extracellular vesicle biogenesis:
potential tools for improved therapies
Rebecca L. Morgan
a, Rebecca Holleyb, Jason Webberc, David Oniond, Cathy Merryd and Oksana Kehoee
aKeele University, Nottingham, UK; bThe University of Manchester, Manchester, UK;
cCardiff University, Cardiff, UK; dUniversity of Nottingham, Nottingham, UK; dKeele
University, Oswestry, UK
Introduction: Many cell types deliver therapeutic effects by secreting extracellular
vesicles (EVs). Therefore, EVs could be used as an alternative approach to cell-based
therapies, overcoming many cell-associated challenges. EVs could be optimised to generate
potent therapies through manipulating the mechanisms driving EV biogenesis. We aim
to prove this concept by altering the heparan sulphate (HS) chains found on syndecan,
a key component in the syndecan-syntenin-ALIX mechanism. We predict that HS is involved
in cargo selection due to its ability to form interactions with a wide range of factors.
In addition, the structure of HS influences the activity of heparanase, a regulator
in the rate of EV production. Therefore, structural alterations to HS could allow
the cargo (thus therapeutic activity) to be modulated whilst simultaneously increasing
EV yields.
Methods: MCF-7s mutated to alter expression of HS biosynthetic enzymes were generated
using CRISPR-Cas9. Wild type and mutant MCF-7s were cultured in bioreactors using
media containing EV-depleted Knockout Serum Replacement. EVs were isolated by differential
ultracentrifugation and characterised using Transmission Electron Microscopy (TEM),
Nanoparticle Tracking Analysis (NTA) and Western Blot.
Results: A FACS-based method has been developed to characterise and sort EVs based
on their displayed HS. The cargo and functional activity of the sorted populations
was then assessed. Since heparanase influences EV production rates, MCF-7s were incubated
with a heparanase inhibitor (OGT2115). Subsequent alterations to soluble, cellular
and vesicular HS composition was analysed by fluorescent labelling and SAX-HPLC identification.
EV size and concentration was assessed using TEM and NTA.
Summary/Conclusion: Optimising EVs may generate highly efficacious and cost-effective
treatments in comparison to those based on the producer cell line. Alterations to
the HS structures on syndecan could be an ideal method for optimisation.
Funding: This PhD project is funded by EPSRC and MRC.
PT05.02
Augmentation by GnRH of ectosome containing annexin A5 formation by blebbing of pituitary
gonadotropes and its biological effect
Mitsumori Kawa “a” minami
a, Fungbun Numfab, Makoto Sugiyamac, Ryota Terashimad and Shiro Kurusue
aVeterinary Physiology, Faculty of veterinary medicine, Okayama University of Science,
Imabari, Ehime, Japan; bKhon Kaen University, Towada, Japan; cKitasato University,
Towada, Japan; dVeterinary Physiology, Kitasato University, Towada, Japan; eVeterinary
Physiology, Kitasato University, Towada, Japan
Introduction: We have demonstrated that gonadotropin releasing hormone (GnRH) stimulates
the synthesis of annexin A5 (ANXA5), a member of annexin family protein, in the pituitary
gonadotropes and ANXA5 augments GnRH stimulation of gonadotropin secretion. It is,
however, obscure how ANXA5 augments gonadotropin release at gonadotropes. As ANXA5
was demonstrated both in and out of cells, in the present study, we examined translocation
of ANXA5 in response to GnRH stimulation in relation to the release of luteinizing
hormone (LH).
Methods: Rat pituitary tissues, primary pituitary cells and LβT2 gonadotrope cells
were used. The conditioned medium was sequentially centrifuged at 20,000 ×g and 110,000
×g to obtain ectosome and exosome respectively. Immunochemistry for ANXA5 and LHβ
were performed. Transmission electron-microscope (TEM) was also used.
Results: GnRH agonist (GnRHa) administration showed the formation of blebs containing
ANXA5 on LβT2 cells and primary pituitary cells after only 10 and 30 min incubation.
Hemi-pituitary gland was cultured with GnRHa and TEM showed that the boundary of GnRHa
stimulated gonadotrope-like cell became obscure with many bubble like particles after
30 min incubation. The 20,000 ×g and 110,000 ×g particles were increased by the GnRHa
treatment. ANXA5 was detected dominantly in 20,000 ×g pellet after treatment with
GnRHa. It increased until 180 min. ANXA5 in 110,000 ×g pellet was also shown at 180 min.
GnRHa treated 20,000 ×g particulate fraction significantly stimulated LH release in
a dose dependent manner. Extracellular vesicle fraction prepared from plasma of one-week
ovariectomized rats, in which GnRH secretion was expected to be augmented, showed
significant increase of ANXA5 in the 20,000 ×g pellet. The blebbing induced by GnRH
was inhibited by H89, protein kinase A inhibitor. It is suggested that Gαs signalling
is necessary for GnRH stimulation of blebbing.
Summary/Conclusion: Present study clearly demonstrates a hormonal regulation of ectosome
formation and a novel mechanism of cell–cell communication by means of ANXA5 including
ectosome.
PT05.03
Investigation into a novel role for the prolyl isomerase cyclophilin A during Extracellular
vesicle signaling in cancer
Yunjie Wu
a, Kieran Brennanb and Margaret M. Mc Geea
aUCD School of Biomolecular & Biomedical Science, Conway Institute, University College
Dublin, Dublin, Ireland; bUniversity College Dublin, Ireland
Introduction: Extracellular vesicles (EVs) released from cells mediate local and systemic
cell–cell communication via the horizontal transfer of functional protein, DNA and
RNA into recipient cells. Evidence reveals that tumour-derived EVs mediated intercellular
communication between tumour cells and normal cells within the tumour microenvironment
to initiate metastatic niche formation. Thus, disruption of EV-mediated tumour-niche
interactions is a novel strategy for metastasis prevention. However, significant challenges
in EV biology must be overcome for the translation of EVs into the clinic; in particular,
in understanding their biogenesis and mechanism of action within the tumour microenvironment.
The prolyl isomerase Cyclophilin A is overexpressed in a large variety of cancers
and is associated with an aggressive phenotype of metastasis and chemoresistance.
Unpublished data from our lab revealed that loss of CypA expression significantly
reduced tumour growth and metastasis in vivo supporting a role in tumour progression.
In this study, potential functions of CypA in EV biology and function are investigated.
Methods: EV Isolation: Differential Ultracentrifugation, Optiprep Density Gradient
EV characterization: Nanosight Tracking Analysis, Flow cytometry, Transmission Electron
Microscopy, Mass spectrometry EV identification: Western Blot, Co-immunoprecipitation
Results: CypA is found to be enriched in cancer-derived EVs in a range of solid and
haematopoietic malignancies. In addition, CypA is predominantly found in EVs within
a specific density range. Moreover, homozygous loss of CypA expression reduces the
number of EVs within a specific size range. Investigation of CypA interacting proteins
by mass spectrometry reveals potential functions in EV cargo loading.
Summary/Conclusion: This study reveals a potential role for CypA in EV biogenesis,
and highlights its potential as a novel EV target for the prevention of tumour progression.
Significance of this study is that CypA could be a potential target for EV release.
This work contributes to the understanding of CypA-dependent EV subtype for its biology
and function during cancer metastasis and may reveal novel strategies for the generation
of targeted EV subtype therapeutics.
Funding: UCD-CSC Scholarship (not include travel funding).
PT05.04=OWP2.12
Identification of a protein that presumably controls bacterial vesiculation in response
to the extracellular environments
Fumiaki Yokoyama
a, Jun Kawamotoa, Chen Chena, Tomoya Imaib and Tatsuo Kuriharaa
aInstitute for Chemical Research, Kyoto University, Uji, Japan; bResearch Institute
for Sustainable Humanosphere, Kyoto University, Uji, Japan
Introduction: Many bacteria utilize extracellular membrane vesicles (EMVs) for survival
in their growing environments through communication with others, pathogenesis and
biofilm formation. Therefore, the amounts and the components of EMVs should be tuned
in response to the conditions. Although several vesiculation mechanisms are suggested,
little is known how bacteria control vesiculation in response to the environments.
A bacterium Shewanella sp. HM13 has 9-fold higher lipid-secretion capability in EMV
fractions than Escherichia coli, and its EMVs contain a major protein (P49), which
is not required for vesicle production. We used mutant EMVs that lack P49 to identify
minor components of EMVs that may control vesiculation.
Methods: EMVs were subjected to 2D gel-based proteomics by peptide mass fingerprinting.
Within the identified proteins, the function of a sensor protein homolog, HM1275,
was analysed by swarming assay and lipid-staining to quantify EMVs produced in various
media. Changes in the number of EMVs depending on culture media were quantified by
tunable resistive pulse sensing method.
Results: A protein with a PAS domain and a methyl-accepting chemotaxis protein (MCP)
sensing domain, HM1275, was identified in the EMVs. Although some MCPs are related
to flagellar motility by binding some attractants, the flagellar motility of Delta-hm1275
was not significantly different from that of WT. Although the amounts of EMVs produced
by WT were increased in response to the concentration of casamino acids in poor nutrient
medium, those by Delta-hm1275 were not.
Summary/conclusion: A putative sensor protein, HM1275, was identified in EMVs and
may recognize the extracellular environments by binding signal molecules in casamino
acids to control vesiculation. Although further studies are required to reveal the
signals and the sensing pathways, the results obtained in this study indicate that
bacterial vesiculation is controlled by extracellular environments, and artificial
control of vesiculation with extracellular signals would be useful in applications
such as suppression of vesicle-dependent pathogenicity.
Funding: Japan Society for Promotion of Science Research Fellowship for Young Scientists
PT05.05=OWP2.13
Prokaryotic BAR domain-like protein BdpA promotes outer membrane extensions
Daniel A. Phillips
a, Lori Zacharoffb, Cheri Hamptonc, Grace Chongb, Brian Eddied, Anthony Malanoskid,
Shuai Xub, Lauren Ann Metskase, Lina Birdf, Grant Jensene, Lawrence Drummyc, Moh El-Naggarb
and Sarah Glavend
aAmerican Society for Engineering Education – U.S. Naval Research Laboratory, Washington,
USA; bUniversity of Southern California, Los Angeles, USA; cMaterials and Manufacturing
Directorate, Air Force Research Laboratory, Dayton, USA; dU.S. Naval Research Laboratory,
Washington, USA; eCalifornia Institute of Technology, Pasadena, USA; fNational Research
Council, Washington, USA
Introduction: Bin/Amphiphysin/RVS (BAR) domains belong to a superfamily of membrane-associated
coiled-coil proteins that influence membrane curvature. BAR domains are ubiquitous
in eukaryotes and associated with membrane curvature formation, vesicle biogenesis/trafficking,
protein scaffolding and intracellular signalling. While advances in protein domain
prediction have facilitated the identification of several BAR domain proteins, they
have yet to be characterized in bacteria. Here, we identified a putative BAR domain-containing
protein enriched in the outer membrane vesicles (OMVs) of Shewanella oneidensis MR-1,
a dissimilatory metal-reducing bacteria known to produce outer membrane extensions
(OMEs) that are suspected to facilitate long distance extracellular electron transfer
(EET) but whose physiological relevance and mechanism of formation remain unknown.
Methods: Purified S. oneidensis OMVs were prepared by filtration and ultracentrifugation
for comparative proteomics with cell-associated outer membrane proteins or for electrochemical
measurements. Protein domains were predicted using HMMSCAN and CDD-search. OME formation
and phenotype analyses were performed in situ by confocal and cryo-electron microscopy.
Results: The putative BAR domain-like protein BdpA was highly enriched in OMVs compared
to cell-associated outer membranes. During OME biogenesis, WT S. oneidensis OMEs progress
from elongated vesicle chains to narrow, tubule-like extensions while ΔBdpA OMEs remain
as disordered vesicle chains. Purified OMVs from these strains are electrochemically
active, with redox signals consistent with multiheme outer membrane cytochromes, supporting
the role of OMEs in EET. Heterologous BdpA expression promotes OME formation in Marinobacter
atlanticus and Escherichia coli, suggesting BdpA membrane sculpting activity is inducible
and transferrable.
Summary/conclusion: The ability of BdpA to promote OME formation and maturation into
tubules in vivo supports BdpA as a comparator for BAR domain protein activity in bacteria.
Funding: US DoD Synthetic Biology for Military Environments (SBME) Applied Research
for the Advancement of Science and Technology Priorities (ARAP)
NSF Dimensions: DEB-1542527
US DOE: DE-FG02-13ER16415
PT06: EV Cancer Immunology Chairs: Jason Webber; Koichi FurukawaLocation: Level 3,
Hall A15:30–16:30
PT06.01
Development of CD40L-modified small extracellular vesicles for the effective induction
of anti-tumour immune response
Wen Liu
a, Yuki Takahashib, Masaki Morishitac, Makiya Nishikawad and Yoshinobu Takakurab
aKyoto University, Kyoto, Japan; bGraduate School of Pharmaceutical Sciences, Kyoto
University, Kyoto, Japan; cKyoto Pharmaceutical University, kyoto, Japan; dTokyo University
of Science, Noda, Japan
Introduction: Tumour-derived small extracellular vesicles (sEVs) are anticipated to
be a novel cancer vaccine because of their inherent encapsulation of tumour antigens.
In this research, tumour-derived sEVs were modified with CD40 ligand (CD40L), which
is a ligand for CD40 expressed on dendritic cells (DCs) and can activate DCs, in order
to induce effective tumour antigen-specific immune response.
Methods: B16-BL6 murine melanoma cells were selected as sEVs-producing cells. Plasmid
vector encoding a fusion protein of CD40L and lactadherin (LA), named as CD40L-LA,
was constructed. B16-BL6 cells were transfected with the CD40L-LA-expressing plasmid
vector and CD40L-modified sEVs (CD40L-sEVs) were collected from the culture medium
of the transfected cells. The collected sEVs were characterized by using western blot,
zeta sizer and transmission electron microscope (TEM). CD40L-sEVs labelled with PKH67
were added to DCs and the uptake of CD40L-sEVs was evaluated by flow cytometer. CD40L-sEVs
were added to DCs and the cytokine release from the cells was measured by ELISA. Presentation
of melanoma antigens contained in sEVs were evaluated by measuring cytokine release
from melanoma antigen gp100-specific T cells, which were co-incubated with CD40L-sEVs
added DCs. The concentrations of cytokines in the culture medium were determined using
ELISA.
Results: The negatively charged sEVs with a diameter of approximately 100 nm were
successfully modified with CD40L. CD40L-sEVs were more efficiently taken up by DCs
than unmodified sEVs. DCs added with CD40L-sEVs produced more TNF-alpha and IL-12
than those added with unmodified sEVs. Moreover, CD40L-modification of sEVs improved
the melanoma antigen presentation efficiency of DCs, which was demonstrated by increased
IL-2 secretion from melanoma antigen gp100-specific T cells.
Summary/Conclusion: It was shown that CD40L-modified sEVs can be used to induce effective
anti-tumour immune response.
PT06.02
Development of Interferon γ-loaded tumour cell-derived extracellular vesicles applicable
to cancer vaccine therapy
Naoki Nakagawa
a, Yuki Takahashib and Yoshinobu Takakurab
aGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; bGraduate
School of Pharmaceutical Sciences, Kyoto University, kyoto, Japan
Introduction: Extracellular vesicles (EVs) contain various substances such as proteins
and nucleic acids derived from their producing cells. As tumour cell-derived EV (TEV)
contains tumour antigens, TEV is expected to be used as a cancer vaccine. However,
since the immune activation ability of TEV is low, it is difficult to induce effective
anti-tumour immunity by simple administration of TEV alone. Hence, in this study,
we attempted to enhance the immune activation ability of TEV by loading Interferon
(IFN)-γ.
Methods: A plasmid vector encoding a fusion protein of lactadherin that specifically
bind to phosphatidylserine contained in EV membrane and mouse IFN-γ was prepared and
the vector was transfected into a mouse melanoma cell line B16BL6 cells. Then, IFN-γ-loaded
TEV (γ-TEV) was collected from the supernatant of the transfected cells by ultracentrifugation.
IFN-γ loaded on the collected TEVs was detected by Western blotting and ELISA. IFN-γ
biological activity of IFN-γ loaded on γ-TEV was evaluated by a reporter assay. In
addition, γ-TEV was added to the mouse dendritic cell line, DC 2.4, and mRNA and protein
expression levels of antigen presentation-related genes were analysed using RT-qPCR
and FACS analysis. Finally, splenocytes of mice that had received intradermal administration
of γ-TEV were collected and the amount of IFN-γ produced from the splenocytes incubated
with B16BL6 antigens was measured.
Results: It was confirmed that IFN-γ was successfully loaded to TEV. In addition,
the reporter assay confirmed that the biological activity of IFN-γ was retained in
γ-TEV. Addition of γ-TEV to DC 2.4 increased mRNA and protein expression of MHC class
I and CD86 compared to TEV alone group, which suggests that immune activation ability
of TEV was increased by loading IFN-γ. Furthermore, in the splenocytes assay, the
amount of IFN-γ production was significantly increased in the γ-TEV administration
group compared with the group administered with simple mixture of IFN-γ and unmodified
TEV.
Summary/Conclusion: These results indicated that IFN-γ loading to TEV is an effective
approach for cancer immunotherapy using TEV.
PT06.03
Apoptotic neuroblastoma derived extracellular vesicles can prime mesenchymal stem
cells to decrease regulatory T cells differentiation
Anita KY. Li and Godfrey Chan
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: There are many ongoing studies investigating tumour derived extracellular
vesicles (EVs). Yet in cancer patients receiving chemotherapy, a majority of the tumour
are undergoing apoptosis and the difference between health cancer and dying cancers
EVs are still unknown. Apoptotic tumour cells can secrete EVs containing different
messages to the tumour microenvironment and effect the surrounding cells in a different
way. Mesenchymal stem cell (MSC) is a heterogeneous multipotent stem cell found within
the tumour microenvironment and can regulating the immune system. The aim of this
study is to investigate the role of apoptotic EVs on mesenchymal stem cell immunomodulatory
function in a tumour microenvironment.
Methods: EVs were obtained from both healthy SK-N-LP neuroblastoma cell line and those
treated with the chemo drug cisplatin for 24 h. EVs were isolated from ultracentrifugation
at 16,000 g for larger EVs and 100,000 g for smaller EVs. The characterization of
the different populations of EVs was performed by western blot and nanoparticles tracking
analysis. Neuroblastoma derived EVs were then co-cultured with immortalized human
MSC (hTMSC) for 48 h. The immunomodulatory function of hTMSC was determined by their
effect on T cells isolated from PBMC.
Results: T cells co-cultured with hTMSC have an increase in FoxP3 expression whereas
hTMSC that has been primed with apoptotic EVs from neuroblastoma showed a significant
decrease in FoxP3 expression. The DAMP molecule HMGB1 was found to be present in apoptotic
EVs, whilst being absent in healthy neuroblastoma EVs.
Summary/Conclusion: Although MSCs are commonly known to have an immunosuppressive
function, after the uptake of EVs derived from apoptotic neuroblastoma, MSC was able
to switch to an immunostimulatory phenotype and decreasing Treg differentiation. Dying
tumour cells may package danger signals and alarmins in their EVs thereby activating
immune response in the tumour microenvironment.
Funding: The Edward & Yolanda Wong Research Fund
PT06.04
Chronic Lymphocytic Leukaemia-derived small extracellular vesicles: a potential strategy
for immune escape
Ernesto Gargiulo
a, Sandrine Piersonb, Bassam Janjia, Jérôme Paggettia and Etienne Moussaya
aLuxembourg Institute of Health (LIH), Department of Oncology, Luxembourg, Luxembourg;
bLuxembourg Institute of Health (LIH), Department of Oncology, Luxembourg, Luxembourg
Introduction: Chronic Lymphocytic Leukaemia (CLL) is the most common adult leukaemia
and characterized by the accumulation of abnormal B lymphocytes. CLL cell survival
and proliferation are highly dependent on interactions with the microenvironment.
Thus, to identify effective strategies to impair tumour proliferation, it is essential
to understand the communication between CLL and surrounding tissues.
Methods: To obtain a biological representation of small extracellular vesicles (small
Evs) in the tumour microenvironment, we established a new protocol allowing us to
isolate highly pure small Evs directly from the spleen of leukemic mice. Small Evs
quality and sample purity were evaluated with qNano (TRPS principle), western blot
and conventional bead-based flow cytometry. Next, we screened a wide range of immune
checkpoint ligands on the surface of CLL-derived small Evs and corresponding receptors
on the surface of T cells.
Results: We have succeeded in isolating small Evs generated by CLL cells in vivo.
Our screen suggested the presence on immune checkpoint ligands directly anchored on
tumour-derived small Evs. Furthermore, we identified a promising pair ligand-receptor
potentially implicated in immune escape. Validation of candidates from the screen
is currently being performed through FACS, iFACS and EM. These techniques will allow
us to better define tumour-derived small Evs populations presenting different immune
checkpoints and to visualize single small Evs with high resolution.
Summary/Conclusion: In this project, we aimed to isolate and characterize CLL-derived
small Evs to define their involvement in tumour development, with focus on the evaluation
of their impact on CLL immune escape.
Altogether, this study will give insight into the specific immune and stromal cells
involved in CLL development, with emphasis on their involvement in tumour-derived
small Ev-mediated tumour immune escape.
Funding: This project is funded by the Fonds National de la Recherche (FNR) INTER/DFG/16/11509946/EV-RNA/Moussay.
Sandrine Pierson and Jérôme Paggetti are supported by the FNR INTER/DFG/16/11509946/EV-RNA/Moussay.
Ernesto Gargiulo is supported by the grant FNR Luxembourg PRIDE15/10675146/CANBIO.
PT06.05
Interaction via exosome miRNAs between myelodysplatic cell and normal Treg
Tatsuki Shibuta, Yukichi Takada and Tsukuru Umemura
International University of Health and Welfare, Okawa City, Japan
Introduction: Myelodysplastic Syndrome (MDS) is a clonalhematopoietic disease and
develops leukaemia in some cases. Thus, MDS is a malignant hematopoietic disease and
its prevalence ratio is increasing in Japan. Hematopoietic microenvironment such as
bone marrow niche is a crucial factor for maintaining leukaemic stem cells. To understand
mechanisms of interactions between leukaemic stem cells and microenvironment is important
for the treatment of hematopoietic malignancies.
In this study, to develop the new therapies and diagnostic methods for MDS, we focused
on the effect of exosomes released from MDS cells on peripheral T lymphocytes.
Methods: MDS cell line (MDS-L) was kindly provided by Kasawaki Medical University
and normal peripheral blood mononuclear cells were obtained from healthy volunteer
donors. Exosomes from MDS cells were purified by using miRCURY Exosome Cell/Urine/CSF
Kit and labelled by PKH67. Extracted miRNAs were analysed by microarray method (Genopal,
Mitsubishi Chemical, Japan). Cell surface antigens were analysed by FACS Aria II and
fluorescence conjugated antibodies.
Results: miRNA-microarray analysis showed that nine miRNAs were abundant in exosomes
from MDS cells and were not detected in MDS cells. Exosomes labelled with PKH67 dye
were added to liquid culture of regulatory T cells (Treg) that were sorted from normal
peripheral blood. The exosomes were detected in cytosol of Treg by fluorescent microscopy.
Microarray analysis of miRNAs in Treg intaking MDS-exosomes showed that significant
increases of 9 miRNAs in MDS-exosomes. The conditioned medium of MDS-exosomes treated
Treg culture reduced the population of activated CD4 cells (CD38 positive cells was
39%; control 68%).
Summary/Conclusion: Our data suggested that exosomes from MDS cells affected the function
of regulatory T cells via miRNA transfer. MDS exosomes may effect on immune cells
to avoid the exclusion from cancer-immune system, and may be a target for the new
therapies or diagnostic methods.
Funding: This work was supported in part by a grant from the Japan Society for the
Promotion of Science (JSPS KAKENHI Grant Number: JP17K09020 and 17H07059).
PT06.06
Mechanism of antitumor immunity activation by ‘artificial neoantigen’-presenting exosomes
Yoshiyuki Koyama
a, Tomoko Itoa, Masazumi Eriguchia, Aya Hasegawab, Wakana Ouchic, Toshio Inabab and
Kikuya Sugiurab
aJapan Anti-tuberculosis Association, Shin-Yamanote Hospital, Tokyo, Japan; bOsaka
Prefecture University, Osaka, Japan; cOsaka Prefecture University, Tokyo, Japan
Introduction: Tumour-derived exosomes are known to have same antigens as the parent
tumour cells, and were expected as cancer vaccines. However, treatment with those
exosomes often failed to elicit antitumor immune responses, probably owing to a weak
immunogenicity of the tumour-associated antigens (TAAs). TAAs can be divided into
two categories, overexpressed self-antigens and tumour-specific mutated neoantigens.
Recently, it was found that immunotherapy was effective only in patients whose tumours
had neoantigens with high immunogenicity. However, most tumours do not have such efficient
neoantigens. To overcome the disadvantage, we have developed an “artificial neoantigen
strategy“. Previously, we prepared the exosomes expressing strong bacterial antigen,
as an “artificial neoantigen” by transformation of the original cultured cells with
a gene of the Mycobacterium tuberculosis antigen, early secretory antigenic target-6
(ESAT-6). Injection of the exosomes induced significant antitumor activity in tumour
bearing mice. Here we investigated the mechanism of antitumor immunity activation
by the ”artificial neoantigen”-presenting exosomes.
Methods: Mouse B16 melanoma cells were transfected with ESAT-6, and secreted ESAT-6
antigen-presenting exosomes (ESAT-Ex) were isolated. Cultured mouse DCs were treated
with the exosomes and expression of costimulatory molecules and cytokines was assessed.
Antitumor activity of the ESAT-Ex-stimulated DCs was evaluated in tumour bearing mice.
In vivo immune activating ability of ESAT-Ex was investigated by co-incubation of
the lymphocytes taken from the ESAT-Ex-treated mice with B16 tumour cells. Immuno-stimulation
by the fibroblasts-secreted ESAT-Ex was also studied.
Results: The DCs stimulated with ESAT-Ex showed enhanced CD80 and CD86 presentation,
and exhibited significantly improved antitumor activity in tumour-bearing mice. When
the lymphocytes harvested from the mice injected with ESAT-Ex were co-incubated with
B16 cells, they intensely accumulated around the tumour cells, and secreted higher
level of IFN-gamma. Increased uptake of thymidine was also observed.
Summary/Conclusion: “Artificial neoantigen”-presenting exosomes effectively stimulated
DCs and evoked antitumor immunity. They are expected as novel cancer vaccines.
Funding: This work was supported by JSPS KAKENHI Grant Number 16K01394.
PT06.07
Outer membrane vesicles of Tannerella
forsythia induce inflammatory response in periodontal tissue cells
Sunjin An
Department of Oral Microbiology and Immunology, School of Dentistry, Seoul National
University, Seoul, Republic of Korea
Introduction: Tannerella forsythia, a Gram-negative oral bacterium, is one of the
major periodontal pathogens which can cause inflammatory responses. Inflammasome is
crucial for host defence against pathogens, but excessive inflammasome activation
can lead to tissue damage. Outer membrane vesicles (OMVs) are derived from the cell
envelope of Gram-negative bacteria. OMVs can contain DNA, RNA, lipopolysaccharide,
proteins, toxins and peptidoglycan. T. forsythia induces maturation of IL-1α/IL-1β
and cell death via activation of caspase-1/4 in THP-1 macrophages and human gingival
fibroblasts (HGFs). The aim of this study was to investigate whether T. forsythia
OMVs are involved in inflammasome activation which may contribute to periodontitis,
a chronic inflammatory disease.
Methods: T. forsythia OMVs were isolated using Exo-bacteria OMVs isolation kit. THP-1
macrophages differentiated with PMA and HGFs were treated with T. forsythia and OMVs
at various does. The expression of caspase-1/4 and pro-inflammatory cytokines was
determined by immunoblotting and ELISA, respectively. Cell death was measured by LDH
cytotoxicity assay kit.
Results: T. forsythia OMVs activated caspase-1 and −4, resulting in increased IL-1α
and IL-1β release and inflammatory cell death. The OMVs also induced the expression
of IL-6 and IL-8.
Summary/Conclusion: The results indicated that T. forsythia OMVs may play an important
role in inflammatory response in T. forsythia-infected cells.
Funding: This work was supported by National Research Foundation of Korea grants (No.
NRF-2018R1A5A2024418 and NRF-2018R1A2A2A05018558).
PT06.09
Specific decrease of CD19+extracellular vesicles enhances post-chemotherapeutic CD8+T
cell responses
Fanghui Zhang, Xuefeng Fei and Zhijian Cai
Institute of Immunology, School of Medicine, Zhejiang University, Hangzhou, China
(People’s Republic)
Introduction: Chemotherapy has long been related with induction of systemic immunosuppression.
Systemic immunosuppression greatly affects chemotherapeutic antitumor effect. Therefore,
amelioration of systemic immunosuppression following chemotherapy is necessary to
improve post-chemotherapeutic antitumour immunity.
Methods: CD19+EVs were isolated and identified by EM, NTA, FACS and western blotting.
CD19+EVs functions on degrading ATP and their immunosuppressive functions were assessed
in vitro and in vivo. The effects of CD19+EVs on antitumour effect of chemotherapy
were detected by transfer of exogenous EVs into tumour mice or in Rab27a or Hif1a
conditional knockout tumour mice. The effects of CD19+EVs on antitumor effect of chemotherapy
were also evaluated in humanized NSG mice by knocking down Rab27a with inactivated
EBVs loading with Rab27a siRNA.
Results: CD19+extracellular vesicles (EVs) from B cells hydrolyse ATP from chemotherapy-treated
tumour cells into adenosine by CD39 and CD73, resulting in impaired CD8+T cell responses.
Serum CD19+EVs increase in tumour mice and patients. Patients with fewer serum CD19+EVs
have a better prognosis following chemotherapy. Up-regulated HIF-1α promotes B cells
releasing CD19+EVs by inducing Rab27a mRNA transcription. Rab27a or HIF-1α deficiency
in B cells inhibits CD19+EV production and strikingly improves chemotherapeutic antitumor
effect. Knockdown of Rab27a in B cells by inactivated Epstein-Barr viruses carrying
Rab27a siRNA greatly improves chemotherapeutic efficacy in humanized NSG mice.
Summary/Conclusion: Our findings unravel a mechanism underlying systematic immunosuppression
after chemotherapy. Combination of chemotherapy and iEBVs/Rab27a siRNA holds high
potential for cancer treatment.
Funding: This work was supported by grants from the National Key Basic Research Program
of China (2015CB943301), the National Key R&D Program of China (2016YFA0501800), and
the National Natural Science Foundation of China (31770951 and 31670877).
PT07: EVs in Acute and Chronic Inflammatory Disorders Chairs: Eric Boilard; Aleksandra
GaseckaLocation: Level 3, Hall A15:30–16:30
PT07.01
Circulating microvesicles as potential biomarkers of Acute Respiratory Distress Syndrome
in Sepsis
Marcelo Fernando do Nascimentoa, Ana Cláudia Aparecida Santos Nussbaumb, Ludhmila
Abrahao Hajjarc, Luciano Cesar Pontes Azevedod, José Mauro Vieira Juniord, Daniel
Deheinzelind, Roger Chammasc, Juliana Monte. Real
c
aInstituto do Servidor Publico Estadual, Santo André, Brazil; bHospital do Coracao,
sao paulo, Brazil; cInstituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil;
dHospital Sirio-Libanes, Sao Paulo, Brazil
Introduction: Acute respiratory distress syndrome (ARDS) is a clinical condition of
sudden respiratory failure in critically ill patients. ARDS-related mortality rate
is higher when is associated with Sepsis (>50%). Recently, we screened 754 miRNAs
and discovered a different cargo transported by circulating extracellular vesicles
(EVs) and exosomes from patients with sepsis, remarkably in those who progressed to
death. The early sequence of events of respiratory failure after the onset of sepsis
are still unknown. Our hypothesis is that lung should signal through EVs that it is
being affected by SIR.
Methods: Blood samples were obtained from septic patients with (n = 8) and without
ARDS (n = 5) at 24 h of intensive care unit (ICU) admission and 3 days later at Sirio-Libanes
Hospital. Pulmonary originated sepsis was not considered. Eight patients under mechanical
ventilation (MV) without pulmonary disease and 12 healthy volunteers were used as
controls. Plasma was 0.22 µM filtered, EVs were isolated by ultracentrifugation and
analysed by nanoparticle tracking analysis. Based on our previous data, 48 miRNAs
were measured by Taqman Low Density PCR array and normalized by RNU6.
Results: The main population of EVs peaked at size of 155–165 nm with no difference
in the mean concentration between groups. Patients with sepsis + ARDS showed a significant
decrease in plasma EVs 3 days after ICU stay (234 to 137 x 10e8/mL, p = 0.0175). Compared
to healthy donors, sepsis promotes an even significant alteration of EVs-miRNAs when
it is associated with ARDS. Comparing all samples from patients with sepsis + ARDS
to sepsis only, nine miRNAs are transported in smaller amounts: miR-766 (−35.7, p = 0.002),
miR-127 (−23.8, p = 0.001), miR-340 (−13.5, p = 0.006), miR-29b (−12.8, p = 0.001),
miR-744 (−7.1, p = 0.05), miR-618 (−4.0, p = 0.02), miR-598 (−3.8, p = 0.035), miR-1260
(−2.5, p = 0.035); and miR-885-5p is expressed at higher levels (9.5; p = 0.028).
In paired samples, the set of altered miRNAs is generally different (p < 0.05) between
sepsis + ARDS (miR-148a, −193a-5p, 199a-3p, −222, −25, −340, 744) or sepsis only (miR-1183,
−1267, −1290, −17, −192, −199a-3p, −25, −485-3p, −518d, −720).
Summary/Conclusion: Circulating EV-miRNAs cargo could be potential biomarkers of lung
inflammation during sepsis in patients who will require MV.
Funding: FAPESP.
PT07.02
Innate/ inflammatory cross talk between macrophages (Mps) and RPE cells are mediated
by exosomes secreted by RPE cells: Proposal of new trait for the pathogenesis of age-related
macular degeneration (AMD)
Atsushi Mukai
a, Eiko Itoa, Morio Uenoa, Shigeru Kinoshita, Chie Sotozonoa and Junji Hamuroa
aDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan;
bDepartment of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural
University of Medicine, Kyoto, Japan
Introduction: The pathogenesis of AMD is aggravated by chronic inflammation. Intact
RPE down-regulates the production of TNF-alpha by choroid-infiltrating Mps, whereas
degenerated RPE by oxidative stress were devoid of this regulatory function. Subsequently,
locally produced TNF-alpha induces the production of some pro-inflammatory cytokines
and angiogenic factor VEGF by RPE (Yamawaki et al., 2016). This implies that innate/inflammatory
cross talk between Mps and RPE may be the indispensable trait for AMD pathogenesis.
The purpose of this study is to elucidate the signal that causes up-regulated TNF-alpha
production in congenital / inflammatory crosstalk between Mps and RPE.
Methods: Mps cell line RAW 264.7(RAW) was co-cultured with primary RPE taken from
C57BL/6 mice. Some cytokines in the culture supernatants (CSs) were quantified by
ELISA. The expression profiles of complement-associated genes, TNF-alpha, and angiogenesis-associated
genes (VEGF & PEDF) were analysed by qRT-PCR. For the preparation of exosomes (Exo),
CSs were harvested after co-cultures of RAW with primary RPE, then Exo in each CSs
were purified by either EVsecondTM or ultracentrifugation. The incorporation of the
Exo either into RPE or RAW was histologically quantified using Qdot 655 streptavidin
conjugated biotinylated Exo.
Results: Elevated levels of CD63 positive Exo in co-cultures were detected by western
blot or FACS analysis. The produced Exo in co-culture CSs were incorporated solely
into RAW, but not into RPE. The semi-purified Exo, but not the Exo depleted residual
CSs enhanced the secretion of MCP-1 and IL-6 in co-culture of Mps and RPE, while the
enhancement of VEGF are similarly detected by the Exo deprived residual CSs. Most
remarkable elevation was observed in TNF-alpha production by RAW in a dose-dependent
manner even in the absence of RPE. The down-regulated TNF-production by RAW in the
presence of RPE was not reconstituted by the addition of Exo even in the co-culture.
Summary/Conclusion: Exosome displays a critical role in the triggering of vicious
inflammatory cytokines cycle through the elevation of TNF- production by Mps.
Currently, in order to construct an experimental system closer to the pathology of
AMD, we are studying a co-culture system using human Mps and human iPS-derived RPE.
PT07.03
Epithelial exosomes regulated by phosphatase Shp2 promote macrophage activation
Yuefei Zhang
a, Yiqing Lib, Dacheng Gongb, Hongqiang Chengb, Xue Zhangc and Yuehai Keb
aZhejiang University, Hangzhou, China (People’s Republic); bZhejiang University, School
of Medicine, Hangzhou, China (People’s Republic); cZhejiang University, School of
Medicine, Hangzhou, China (People’s Republic)
Introduction: Acute lung injury (ALI) and its more severe form, acute respiratory
distress syndrome (ARDS), are life-threatening diseases that are associated with high
mortality rates due to treatment limitations. Increasing researches suggest exosomes
play an important role in pathogenesis, diagnosis and treatment of ALI. However, it’s
not clear how exosomes are formed, secreted, transferred during ALI. Phosphorylation
of signalling proteins are reported to control exosome biogenesis (e.g. syntenin phosphorylation
promotes exosome formation). Shp2 is a widely expressed cytoplasmic phosphatase which
can regulate signalling pathway by its dephosphorylation function. Here we reveal
that Shp2 inhibits the biogenesis of epithelial exosomes which have proinflammatory
effects on macrophages during ALI. It’s uncovered in our study that Shp2 is a protective
factor of ALI by inhibiting release of proinflammatory epithelial exosomes.
Methods: Exosomes were isolated by differential ultracentrifugation and filtration,
and they were characterized by nanoparticle tracking analysis (NTA), transmission
electron microscopy (TEM) and western blot (e.g. CD9, CD63, CD81, ALIX, TSG101). In
vitro transwell system for exosome transfer model indicated the direction of exosome
transfer. Nanoscale flow cytometry (CytoFLEX) was used for detecting exosome subpopulation.
Results: Exosomes were increased in Bronchoalveolar Lavage Fluid (BALF) of LPS-induced
ALI murine model. In vitro transwell system revealed that exosomes were transferred
from epithelial cells to macrophages in inflammation environment. Shp2 was revealed
to inhibit the biogenesis of epithelial exosomes without changing their size and subpopulation.
Adaptor protein Gab2, which can bind Shp2, was found to interact with Syntenin. It
suggests that with the help of adaptor Gab2, Shp2 was involved in dephosphorylating
syntenin whose phosphorylation can facilitate exosome biogenesis. Shp2-disruption
derived epithelial exosomes promoted macrophage inflammation, thus aggravating ALI.
Summary/Conclusion: Our study shows that phosphatase Shp2 inhibits proinflammatory
epithelial exosome release, which can promote M1-macrophage polarization. It offers
a potential target for ALI mechanism study and treatment.
PT07.04
Detection of CD11b-expressing exosomes in plasma of mice with sepsis
Yasunori Fujita, Kyojiro Kawakami and Masafumi Ito
Research Team for Mechanism of Ageing, Tokyo Metropolitan Institute of Gerontology,
Itabashi-ku, Japan
Introduction: Cells communicate with each other through extracellular vesicles including
exosomes, which contain host cell-derived molecules such as proteins, lipids and nucleic
acids. Secreted exosomes migrate not only to neighbouring cells but also to distant
organs. Monocyte and macrophage have been reported to secret exosomes that modulate
immune responses. However, the characteristics of monocyte/macrophage-derived exosomes
in blood during systemic immune response remain largely unknown. In this study, we
characterized exosomes released from monocyte/macrophage-like cells and determined
the temporal change in monocyte/macrophage-derived exosomes in plasma of mice with
sepsis.
Methods: Exosomes collected by ultracentrifugation from the conditioned medium of
lipopolysaccharide (LPS)-stimulated murine monocyte/macrophage-like RAW264.7 cells
were subjected to quantitative proteomic analysis using iTRAQ labelling and LC-MALDI-TOF/TOF.
Plasma exosomes isolated from LPS-injected mice were analysed by Western blot analysis.
CD11b-expressing exosomes in plasma were measured by sandwich ELISA. Plasma TNF-α
level was determined by ELISA.
Results: Proteomic analysis showed that monocyte/macrophage marker proteins such as
CD11b, CD14 and F4/80 were detected in exosomes from RAW264.7 cells. Glucose metabolism-related
proteins including GLUT1, PKM2 and GAPDH increased in exosomes from LPS-stimulated
cells compared with those from non-treated cells. Western blot analysis demonstrated
that GLUT1 and CD11b were significantly increased in plasma exosomes from LPS-injected
mice. After LPS stimulation, TNF-α transiently increased, whereas CD11b-expressing
exosomes increased and remained high in plasma of mice with sepsis.
Summary/Conclusion: We characterized monocyte/macrophage-derived exosomes in plasma
of mice with sepsis and developed a sandwich ELISA for detection of CD11b-expressing
exosomes in plasma, which could be a novel marker for systemic immune response as
well as sepsis.
Funding: JSPS KAKENHI Grant Number JP17K01888.
PT07.05
Systemic inflammatory activity and proteome analysis of extracellular vesicles from
faeces
Kyongsu Parka, Jaewook Leeb, Yein Jun
a, Daekyum Kima, Jungwook Kima and Yong Song Ghoc
aPohang University of Science and Technology (POSTECH), Pohang, Republic of Korea;
bDepartment of Life Sciences, Pohang University of Science and Technology (POSTECH),
Pohang, Republic of Korea; cDepartment of Life Sciences, Pohang University of Science
and Technology, Pohang, Republic of Korea
Introduction: Substantial quantities of bacteria reside in the gastrointestinal tract.
Severe inflammatory responses are induced when the bacteria went through the peritoneum
from the gastrointestinal tract. In this study, extracellular vesicles isolated from
faeces (fEVs) were assessed to see whether they could mediate inflammatory responses.
In addition, proteomic compositions of fEVs were further investigated.
Methods: The faeces of wild-type mice were utilized to isolate fEVs. The fEVs were
characterized with transmission electron microscopy, dynamic light scattering, ELISA,
and Western blot. The fEVs were intraperitoneally administered into the mice, and
the number of infiltrated cells as well as the concentrations of TNF-α and IL-6 were
measured from the peritoneal lavage fluid, serum, and bronchoalveolar lavage fluids.
Proteomic analyses on the fEVs were conducted by the combination of one-dimensional
SDS-PAGE and LC-MS/MS.
Results: Significant amounts of fEVs were isolated from mouse faeces, and the fEVs
were derived from bacteria and host cells. Upon intraperitoneal administration, the
fEVs mediated peritoneal, systemic, and pulmonary inflammation by increasing the numbers
of infiltrated immune cells and the pro-inflammatory cytokines such as TNF-α and IL-6
in the peritoneal lavage fluid, serum, and bronchoalveolar lavage fluid. Proteomic
analyses on the fEVs identified a total of 295 proteins, comprising 222 bacterial
proteins and 73 murine proteins.
Summary/Conclusion: The fEVs derived from bacterial and host cells could mediate local
and systemic inflammation, and composed of bacterial and host proteins. These results
shed lights on the roles of commensal bacterial EVs in the pathogenesis of inflammatory
diseases.
Funding: National Research Foundation of Korea (NRF) Herman Krefting Foundation for
Allergy and Asthma Research, Lundberg Foundation
PT07.06
Opioid-mediated release of astrocytic EV miR-23 induces pericyte migration and blood-brain
barrier breach
Shilpa Buch, Ke Liao, Fang Niu and Guoku Hu
University of Nebraska Medical Center, Omaha, USA
Introduction: Pericytes are important constituents of the cerebrovascular unit and
play a key role in maintaining the integrity of the blood-brain barrier. It is well
recognized that drugs of abuse such as opioids can result in breach of the BBB, ultimately
leading to enhanced monocyte transmigration and ensuing neuroinflammation. Mechanism(s)
by which pericytes contribute to morphine-mediated neuroinflammation, however, remains
less understood.
Methods: EVs were isolated from morphine-stimulated mouse/human primary astrocytes
using the standard differential ultracentrifugation method and characterized by transmission
electron microscopy, NanoSight & western blot analyses. Among the various miRs dysregulated
in morphine-stimulated astrocyte EV cargo, miR-23 was found to be upregulated by real-time
PCR. Confocal microscopy identified uptake of astrocytic EVs by pericytes. Functional
assessment of astrocytic EV uptake by pericytes involved cell migration using Boyden
chamber and wound healing assays. Additionally, an in vitro 3D model comprising of
pericytes and human endothelial cells was also used to assess astrocyte EV-mediated
migration of pericytes in presence of morphine.
Results: Exposure of astrocytes to morphine induced the expression and secretion of
miR-23 in the EVs, which, upon uptake by the pericytes resulted in their migration.
Additionally, in the pericytes that had taken up morphine stimulated astrocyte EVs,
there was downregulation of phosphatase and tensin homologue (PTEN), a target of miR-23.
Summary/Conclusion: Our findings indicate that morphine-mediated dysregulation of
miRNA expression in the CNS involves astrocyte-pericyte communication via the extracellular
vesicles, leading, in turn, to loss of pericyte coverage at the BBB.
Funding: This work was supported by grants DA040397, MH112848 (S.B.) and DA042704,
DA046831 (G.H.) from the National Institutes of Health. The support by Nebraska Center
for Substance Abuse Research is acknowledged.
PT07.07=OWP2.15
Diagnostic microRNA biomarkers from circulating extracellular vesicles for early detection
of pneumonia and severe secondary complications
Stefanie Hermann
a, Benedikt Kirchnerb, Dominik Buschmannc, Melanie Märted, Florian Brandesd, Stefan
Kotschotee, Michael Boninf, Marlene Reithmairg, Matthias Kleinh, Gustav Schellingd
and Michael Pfaffld
aDivision of Animal Physiology and Immunology, School of Life Sciences Weihenstephan,
Technical University of Munich, Freising, Germany; bAnimal Physiology and Immunology,
School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Freising,
Germany; cTUM School of Life Sciences Weihenstephan, Division of Animal Physiology
and Immunology, Freising, Freising, Germany; dDepartment of Anesthesiology, University
Hospital, Ludwig-Maximilians-University Munich, München, Germany; eIMGM Laboratories
GmbH, Planegg, Martinsried, Germany; fIMGM Laboratories GmbH, Planegg, Germany, Martinsried,
USA; gInstitute of Human Genetics, University Hospital, Ludwig-Maximilians-University
Munich, München, Germany; hDepartment of Neurology, University Hospital, Ludwig-Maximilians-University
Munich, München, Germany
Introduction: Pneumonia remains one of the most deadly communicable diseases, causing
three million deaths worldwide in 2016. Extracellular vesicles (EVs) are pivotal during
signal transfer in the pathogenesis of inflammatory lung diseases. Since identifying
pneumonia is particularly challenging in high risk groups (e.g. the elderly or infants),
which often present with atypical symptoms and are at high risk for secondary complications
such as sepsis or acute respiratory distress syndrome (ARDS), new approaches for early
diagnosis are required. In this study we identified EV microRNAs (miRNAs) as potential
biomarkers for inflammatory changes of the pulmonary tissue.
Methods: Our study included 13 patients with community-acquired pneumonia, 14 ARDS
patients, 22 patients with sepsis and 31 healthy controls. After precipitating EVs
from 1 ml serum, total RNA was extracted. Subsequent to library preparation and small
RNA-Seq, differential gene expression analysis was performed using DESeq2. Data were
filtered by mean miRNA expression of ≥ 50 reads, minimum twofold up or down regulation
and adjusted p-value ≤ 0.05.
Results: The mean relative miRNA frequency varied slightly between the different groups
and was highest in volunteers. Short sequences (< 16 nucleotides), probably degradation
products from longer coding and non-coding RNA species, were predominantly detected
in patients. Based on unsupervised clustering, patients could be distinctly separated
from healthy individuals. Although 21 miRNAs were significantly regulated in all patient
groups compared to healthy controls, different disorders showed unique miRNA expression
profiles. Distinct miRNA subsets were identified, which are applicable to indicate
disease progression from limited inflammation present in pneumonia to severe inflammatory
changes as seen in ARDS and sepsis.
Summary/conclusion: This study shows that EV miRNA biomarkers have potential for diagnosis
of pneumonia and to indicate disease progression towards severe lung injury. Our findings
are of clinical relevance, as the timely diagnosis of pneumonia can be challenging,
and secondary complications such as ARDS and sepsis might be prevented by early intervention
and treatment.
Funding: This study was supported by the German Federal Ministry for Economic Affairs
and Energy under the program “Zentrales Innovationsprogramm Mittelstand”.
PT08: EVs in Metabolism and Metabolic Diseases Chairs: Sophie Rome; Alena IvanovaLocation:
Level 3, Hall A15:30–16:30
PT08.01
Elevated levels of platelet and endothelial extracellular vesicles in type 1 diabetes,
a cohort study of 236 patients
Karin Bergen
a, Katherina Aguilera Gaticab, Fariborz Mobarrezc, Gun Jörneskogd, Håkan Wallénb and
Sara Tehranid
aKarolinska Institutet, Department of Clinical Sciences, Danderyd University Hospital,
Division of Nephrology, Stockholm, Sweden; bKarolinska Institutet, Department of Clinical
Sciences, Danderyd University Hospital, Division of Cardiology, Stockholm, Sweden;
cKarolinska Institutet, Department of Medicine, Rheumatology Unit, Karolinska University
Hospital, Sweden, Stockholm; dKarolinska Institutet, Department of Clinical Sciences,
Danderyd University Hospital, Division of Internal Medicine, Stockholm, Sweden, Stockholm,
Sweden
Introduction: We have recently presented data on increased levels of circulating extracellular
vesicles (EVs) in patients with type 1 diabetes. In the same cohort, we have now analysed
subpopulations of platelet- and endothelial EVs in relation to diabetic microangiopathy
and sex.
Methods: Two hundred and thirty-six patients (107 women) and 100 healthy controls
matched for age, sex and body mass index (BMI) gave written informed consent to the
study. Plasma platelet EV (PEV) and endothelial EV (EEV) levels were assessed using
flow cytometry with labelled antibodies directed against platelet (CD42a and CD61)
and endothelial specific (CD144 and CD62E) antigens. EV expression of procoagulant
phosphatidylserine (PS) and tissue factor (TF) were assessed using lactadherin (lac)
and CD142 antibody. The study was approved by the local ethics committee.
Results: PEV and EEV levels with or without expression of procoagulant PS and TF were
statistically higher among patients than in controls (p < 0.05 for all). The patients
had about 50% higher PEV levels and up to a 50-fold increase in EEV levels compared
to controls. No statistically significant differences were found between PEV or EEV
levels in patients with or without clinical microangiopathy. Healthy women had lower
PS+, PS− and total PEV levels compared to healthy men (p < 0.05 for all), whereas
no differences between sex were found in the patients. PEV and EEV levels in patients
did not correlate with glycaemic control (HbA1c), BMI, blood pressure, blood lipids
or diabetes duration.
Summary/Conclusion: Elevated levels of PEVs and EEVs found in patients with type 1
diabetes are unrelated to clinical microangiopathy, indicating that type 1 diabetes
is a procoagulant state per se. Comparison of PEV levels between the sexes showed
a more favourable phenotype in healthy women compared with healthy men, while no sex
differences were found among patients. This could be linked to the loss of female
protection against cardiovascular disease in type 1 diabetes.
Funding: Berth von Kantzow Foundation, Swedish Diabetes Foundation, Wallenius Foundation,
Swedish Heart-Lung Foundation, Foundation of Women and Health
PT08.02
Role of extracellular vesicles in the regulation of inflammation and metabolism in
obesity
Takahisa Nakamura
a, Ahlee Kimb, Esam Salemb, Kazutoshi Murakamib and Vishnupriya Borrab
aCincinnati Children’s Hospiltal Medical Center, Cincinnati, USA; bCincinnati Children’s
Hospital Medical Center, Cincinnati, USA
Introduction: The worldwide prevalence of obesity has reached pandemic proportions.
Obesity has strong inflammatory underpinnings, which are associated with the development
of type 2 diabetes (T2D) and non-alcoholic steatohepatitis (NASH). However, the mechanisms
by which obesity provokes aberrant inflammation have yet to be clearly defined. Extracellular
vesicles (EVs), including exosomes and microvesicles, are a novel mode of tissue-to-tissue
communication. Recent studies indicate that EVs are involved in many pathophysiological
events including inflammatory responses and metabolic dysfunctions. We hypothesize
that EVs play critical roles in the induction of obesity-associated aberrant inflammation
and the development of metabolic diseases.
Methods: To investigate the role of EVs in the pathogenesis of obesity, we have taken
systematical approaches including novel computational methods, analyses of EVs collected
from human obese patients undergoing bariatric surgery, utilization of novel mouse
models monitoring cell type-specific EVs, and cellular-based EV functional assays.
Results: Using novel computational methods, we have identified strong associations
with EV-related genes in metabolic syndrome associated with T2D. Our analyses of EVs
from adolescent obese patients undergoing bariatric surgery have shown that serum
EV concentration is inversely correlated to metabolic improvements in glucose metabolism
and inflammation post-surgery, with unique EVs’ extracellular RNA (exRNA) profiles.
Further, our newly established mouse models monitoring specific cell type-derived
EVs in vivo indicates that in obesity, EVs from metabolic tissues behave like a pathogen
and induce inflammation.
Summary/Conclusion: While the research of EVs has attracted much attention, therapeutic
targeting and significance of EVs in metabolic diseases are still a controversial
area of research. By utilizing our novel mouse models coupled with access to human
samples, our systematical approaches allow to propose novel mechanisms by which pathologic
EVs induce aberrant inflammation and deteriorate metabolism in obesity.
PT08.03
Characterization of exosomal proteins derived from contracting skeletal muscle as
potential mediators of beneficial metabolic effects of exercise
Henrike Sell, Elisabetta De Filippo, Sonja Hartwig, Lucia Mastrototaro, Maria Apostolopoulou,
Dominik Pesta, Julia Szendrödi, Hadi Al-Hasani, Stefan Lehr and Michael Roden
German Diabetes Center, Düsseldorf, Germany
Introduction: Exercise training improves glucose metabolism and insulin sensitivity
supporting the concept that lifestyle modification is useful for patients to prevent
and treat type 2 diabetes. Skeletal muscle also releases circulating factors following
exercise affecting metabolism of other organs probably involving the release of exosomes.
However, little is known about muscle-specific release of exosomes and the differential
protein content of exosomes during exercise. Thus, we aimed to identify exosomal proteins
regulated by exercise in vitro and in vivo and to discover pathways regulated by exosomal
cargo.
Methods: Exosomes from human skeletal muscle cells (hSkMC), contracted by electrical
pulse stimulation (EPS), were isolated by differential ultracentrifugation/ultrafiltration.
Exosomes were also isolated by size exclusion chromatography from plasma of patients
with and without type 2 diabetes on high intensity interval training (HIIT). In order
to allow reliable label-free quantification of the very limited muscle exosomal material,
we performed proteomic profiling using data independent acquisition (DIA) on an OrbitrapTM
Fusion Lumos instrument. Spectronaut TM Pulsar software was used to integrate spectral
libraries and perform quantitative proteomic profiling of exosomes derived from different
human primary cells as well as human serum and plasma.
Results: EPS stimulated the release of exosomes from hSkMC and regulated the release
of 408 exosomal proteins. Ingenuity pathway analysis (IPA) revealed significant regulation
of, e.g. integrin, vascular endothelial growth factor, Liver X receptor/Retinoid X
receptor and PI 3-kinase/Akt signalling by these proteins. HIIT regulated the amount
of 62 exosomal plasma proteins in vivo, of which nine candidates were also similarly
regulated by EPS in vitro. IPA links these exosomal proteins to pathways involved
in metabolic diseases and lipid metabolism.
Summary/Conclusion: We identified various exercise-regulated exosomal proteins with
predicted metabolic effects. Further analysis of these novel tissue-specific candidates
will help to better understand systemic metabolic effects of exercise.
PT08.04
Transcriptome and proteome of extracellular vesicles derived from cellular targets
of diabetic kidney disease
Karina A. Barreiro
a, Abigail Layb, Wei Liangc, Xiaomeng Xud, Sihui Luod, Tillmann Borkc, Richard Cowarde,
Denis Delicf, Tobias B. Huberg and Harry Holthöferh
aFIMM, University of Helsinki, Helsinki, Finland; bUniversity of Bristol, Bristol,
UK; cUniversity Hospital Freiburg, Freiburg, Germany; dInstitute for Molecular Medicine
Finland (FIMM), University of Helsinki, Helsinki, Finland; eBristol Univ Medical School,
Bristol, UK, Bristol, UK; fBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach a.d.
Riss, Germany; gIII. Department of Medicine, University Medical Center Hamburg-Eppendorf,
Hamburg, Germany, Hamburg, Germany; hProfessor
Introduction: Kidney disease (DKD) is common, costly and the most feared complication
of long standing diabetes. Its root causes remain unknown. Interestingly the characteristic
changes in circulating glucose levels in this disease appear to alter the signature
of extracellular vesicles as found in the urine. Here we wanted to explore the EV
secretion pattern by key DKD target cells in the glomerulus (podocytes, endothelial
and mesangial cells) and proximal tubular cells by harvesting the entire EV repertoire
using Hydrostatic Filtration Dialysis (HFD).
Methods: We used cell culture media from podocytes, proximal tubule, mesangial and
glomerular endothelial cells in four conditions: (1) Insulin sensitive, (2) Insulin
resistant, (3) Insulin receptor transfected and insulin sensitive, (4) Insulin receptor
transfected and insulin resistant. EVs were isolated from 50 mL of cell culture media,
respectively, by HFD. Quality of the EV yield was verified with negative staining
Electron Microscopy (EM) and Western blotting (WB). Vesicle concentration was determined
by Nanoparticle Tracking Analysis (NTA). Isolated RNAs were profiled with Bioanalyzer
Pico kit and subjected to miRNAseq and RNAseq. EV proteins were analysed using tandem
mass tag labelling.
Results: The isolated EVs appeared typical at EM and were positive for the EV-marker
TSG101 in WB. RNA quantity and quality proved appropriate for both miRNA and RNAseq.
Different treatments affected characteristically the vesiculation from the investigated
target cells of diabetes. Ninety-six EV miRNAs could characteristically discriminate
between the cell types and special treatments studied. Some EV miRNAs showed treatment
effects and the analysis of their target genes using KEGG disease database showed a
clear link to kidney diseases. Integrated miRNA-mRNA and protein analysis was also
performed.
Summary/Conclusion: EV analysis provides a novel approach to reveal valuable pathophysiology,
pathway and signalling information of cultured disease target cells. Changes in EV
miRNAs, mRNA and proteomics may thus give valuable insight into mechanisms and targets
to insulin resistance on DKD target cells.
Funding: BEAt-DKD, Paulo Foundation and Novo Nordisk Foundation.
PT08.05
Effects of an acute exercise on circulating extracellular vesicles: tissue-, gender-
and BMI-related differences
Jacopo Mariania, Antonello Rigamontia, Silvano Cellaa, Alessandra De Colb, Federica
Rotac, Sabrina Cicolinib, Gabriella Tringalib, Roberta De Michelib, Valentina Bollatia,
Sartorio Alesandrob and Mario Barilani
d
aUniversity of Milan, Department of Clinical Sciences and Community Health, Milan,
Italy; bIstituto Auxologico Italiano, Experimental Laboratory for Auxo-endocrinological
Research, Verbania and Milan, Italy; cEPIGET LAB, Department of Clinical Sciences
and Community Health, Università degli Studi di Milano, Milan, Italy; dUnit of Regenerative
Medicine – Cell Factory, Department of Transfusional Medicine and Hematology, Fondazione
IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (MI), Italy; Università degli
Studi di Milano, Milan, Italy
Introduction: Exercise is recognized to evoke multisystemic adaptations that, particularly
in obese subjects, reduce body weight, improve gluco-metabolic control, counteract
sarcopenia and lower the risk of cardiometabolic diseases. Understanding the molecular
mechanisms of exercise-induced benefits is of great interest due to the ensuing therapeutic
implications against obesity.
Aims: To characterize extracellular vesicles (EVs) in obese (F/M = 8/8; age = 21.0 ± 8.5 years,
BMI = 37.9 ± 6.0 kg/m2) and normal-weight (F/M = 4/4; age = 25.1 ± 8.2 years, BMI = 20.9 ± 1.5 kg/m2)
subjects who underwent a moderate-intensity (60% VO2max for 30 min or until exhaustion)
exercise on a treadmill
Methods: Blood samples were drawn before, at the end and during post-exercise recovery
period (3 and 24 h). EVs were analysed by Nanosight and flow cytometry after labelling
with the following markers: CD14+ (monocyte), CD61+ (platelet), CD62E+ (activated
endothelium), CD105+ (resting endothelium), HERVW+ (human endogenous retrovirus W),
SCG+ (muscle) and FABP+ (adipose tissue).
Results: After exercise, 100–200 nm EVs significantly decreased (p < 0.01). There
was a significantly higher post-exercise release of these EVs in normal-weight than
obese subjects (p = 0.025). Considering the 30–130 nm size range, there was a significant
lower release of EVs in females than males (p < 0.01). After exercise, the 130–700 nm
EVs significantly decreased (p = 0.016). There was a higher release of these EVs in
females than males (p = 0.05). After exercise, CD61+ EVs significantly decreased in
all subjects (p = 0.02). SCG+ EVs were increased after exercise (p = 0.06). There
were no significant associations of other biomarkers
Summary/Conclusion: An acute exercise induces changes in the release of plasma EVs,
which are tissue-, gender- and BMI-specific, suggesting that the exercise-related
benefits might depend upon a complex interaction of tissue, endocrine and metabolic
factors
Funding: The study was supported by Progetti di Ricerca Corrente, Istituto Auxologico
Italiano, IRCCS, Milan, Italy.
PT08.06
Profiling of extracellular vesicles from human hepatic stellate cells
Cristina Zivko
a, Gina Valentinoa, Kathrin Fuhrmannb, Gregor Fuhrmannc and Paola Luciania
aFriedrich Schiller University Jena, Jena, Germany; bHIPS, Saarbrücken, Germany; cHelmholtz-Institut
for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany
Introduction: The role of extracellular vesicles (EVs) in intercellular communication
makes them particularly interesting in the research of many pathologies, especially
those diagnosed invasively. In this study we evaluated differences in the EVs shed
from human hepatic stellate cells (HSCs) in their different phenotypical states, since
the activation of HSCs plays a pivotal role in the progression of hepatic fibrosis,
for which liver biopsy is still the diagnostic gold standard.
Methods: Protocols were optimized as to induce the different activation states in
the cells; untreated HSCs were compared to their activated and quiescent counterparts.
EVs were isolated from conditioned cell culture medium (CCM) after differential centrifugation
followed by an ultracentrifugation (UC) step, and they were purified by size exclusion
chromatography (SEC). The purification was evaluated by protein content determination
by bicinchoninic acid (BCA) assay. The concentration and size distribution profiles
of EVs in the SEC fractions were determined by nanoparticle tracking analysis (NTA).
EV-morphology was observed by scanning and cryogenic transmission electron microscopy
(SEM and cryo-TEM).
Results: Purification by SEC resulted in a distinct resolution between EVs and protein
aggregates as determined by BCA assay. Protein content associated with EVs was only
detectable in the SEC-fractions with the highest EV-yields and was comparable in all
groups. Differently treated HSCs yielded EVs in similar amounts and size distributions.
Quantile subtraction of the distribution curve obtained from untreated cells shows
that activated HSCs produce smaller EVs (80–150 nm) more prominently than quiescent
cells. SEM imaging confirmed the polydispersity in the samples.
Summary/Conclusion: EVs originating from differently treated HSCs were isolated and
characterized in terms of yield, size, morphology and general protein content. Our
results were consistently indicative of differences in EV populations originating
from the same cells in either healthy or diseased state (quiescent or activated respectively),
thus creating an important basis for the potential non-invasive detection of liver
diseases.
Funding: The Phospholipids Research Center is gratefully acknowledged for its support
to the project and Lipoid GmbH for the endowment to the University of Jena.
PT08.07
Role of exosomal miR-15a in diabetic retinopathy
Tengku Ain Kamalden, Anne Macgregor-Das, Nurliza Khaliddin, Nur Musfirah Mahmud, Adib
Redzuan, Adil Mohamed, Hayatun Syamila Jamil, Nadia Hanib, Nur Hasyimah Azemi and
Samarjit Das
University of Malaya, Kuala Lumpur, Malaysia
Introduction: Diabetic retinopathy is a debilitating complication of diabetes mellitus
which results in irreversible blindness. Currently treatment is only initiated when
significant damage from diabetic retinopathy has occurred. Early signs of damage typically
remain unnoticed until it has reached advanced stages of disease. Identifying early
biomarkers of disease will allow clinicians to detect the progression of disease before
the onset of complications. Circulating microRNA contained in extracellular vesicles
such as exosomes are potential early biomarkers and can be targeted to prevent diabetes
from progressing. The aim of our project is to validate and determine the role of
miR-15a as a potential early biomarker in diabetic retinopathy.
Methods: This project was approved by the University of Malaya Medical Centre (UMMC)
Medical Research Ethical Committee. A total of about 100 subjects (controls and patients
with Type 2 DM) was recruited from UMMC, Kuala Lumpur. All subjects underwent complete
eye examination and graded for diabetic retinopathy. Clinical information collected
included HbA1C, renal function testing, hypertension and smoking. Extracellular vesicle
(EV) isolation was performed using differential ultracentrifugation and quantified.
Results: In this study, we analysed miR-15a concentrations in plasma and exosomal-enriched
fractions using droplet digital and real-time PCR. There was no difference in microRNA
levels in plasma observed. However, there was a significant increase in exosomal concentration
(average diameter <130nM) in patients with diabetic retinopathy compared to controls
(p < 0.05). There was also an increasing trend of miR-15a level among diabetic patients
compared to controls.
Summary/Conclusion: The findings from this study corroborated with our previous findings
of increase in miR-15a levels in diabetes prior to the onset of retinopathy compared
to controls. This suggests that miR-15a is involved in the early development of diabetic
microvascular complications and may be a potential biomarker for early complications
of diabetes.
Funding: 1. Bayer Global Ophthalmology Award Program Grant. 2. University of Malaya
Special Research Fund (BKS056-2017). 3. BioRad Institutional Funding (Materials and
Lab consumables). 4. Fulbright Visiting Research Scholar Grant
PT08.08
The effects of outer membrane vesicles delivered from Porphyromonas gingivalis on
hepatic glucose metabolisms
Kaya Yoshida
a, Mariko Seyamab, Natsumi Fujiwarab, Hirohiko Okamurac and Kazumi Ozakid
aDepartments of Oral Healthcare Education, Institute of Biomedical Sciences, Tokushima
University Graduate School, Tokushima, Japan; bDepartments of Oral Healthcare Promotion,
Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima,
Japan; cDepartment of Oral Morphology, Okayama University Graduate School of Medicine,
Dentistry and Pharmaceutical Sciences, Tokushima, Japan; dDepartments of Oral Healthcare
Promotion, Institute of Biomedical Sciences, Tokushima University Graduate School,
Tokushima, Japan
Introduction: The outer membrane vesicles (OMVs) of Porphyromaons gingivalis (Pg),
a gram-negative bacteria known as a major pathogen of periodontal diseases, include
its virulence factors and regulate the aetiology of periodontal diseases by affecting
microbial environment and the host cells in the oral cavity. However, it is unknown
whether Pg OMVs in oral cavity could translocate to distant organ and affect the systemic
diseases, whereas periodontal diseases are well known to influence the develop of
diabetes mellitus. To elucidate the mechanisms by which periodontal diseases progress
diabetes mellitus, we identified Pg OMV cargo proteins and verified its effects on
the insulin signalling in vitro. We also analysed the translocation of Pg OMVs to
the organ, and assessed the changes of hepatic glucose matabolisms in Pg OMV-treated
mice.
Methods: We identified the OMV cargo proteins by LC-MS/MS analyses. The effects of
Pg OMV on the insulin signalling in HepG2 cells is analysed by western blot. The organ
distribution of OMV was analysed by IVIS sectrum after injecting intraperitoneally
Cy7-labelled Pg OMV. We also estimated the insulin sensitivity using glucose tolerance
test (GTT), insulin tolerance test (ITT) in mice treated with Pg OMV for 3 weeks.
Results: Pg selectively sorted its specific proteases such as arginine-specific gingipain
(Rgp) and lysine-specific gingipain (Kgp) into OMVs. The treatment with Pg OMV attenuated
the insulin signalling in HepG2 cells, and its effects were eliminated by OMVs from
gingipain-deleated Pg. A Cy7 fluorescent signal was detected in the liver in mice
injected with Cy7-labelled-Pg OMVs. The exposure of Pg OMVs for 3 weeks slightly increased
casual blood glucose and insulin tolerance level in mice.
Summary/Conclusion: Pg OMVs packaging gingipains were delivered to the liver, resulting
in the reduction of insulin sensitivity. These capabilities of Pg OMVs may contribute
to the progress of diabetes mellitus.
PT09: Advances in EV Quantification and Characterization Chairs: Randy Carney; Edwin
van der PolLocation: Level 3, Hall A15:30–16:30
PT09.01
Extracellular vesicle concentrations in human plasma and serum as revealed by microfluidic
resistive pulse sensing and size exclusion chromatography coupled with on-line fluorescence
detection
Diana Kitkaa, Zoltan Varga
b, Gergo Bartab, Judith Mihalya and Jean-Luc Fraikinc
aRCNS HAS, Budapest, Hungary; bResearch Centre for Natural Sciences, Hungarian Academy
of Sciences, Budapest, Hungary; cSpectradyne LLC, Torrance, USA
Introduction: Blood is one of the most important sources of EVs in biomarker applications.
However, there is a huge variation in the reported values of EV concentrations in
plasma and serum in the current literature. Therefore, there is a continuous demand
for new techniques for accurate determination of EV concentration. The aim of this
study was to characterize EVs in normal plasma and serum using novel techniques such
as microfluidic resistive pulse sensing (MRPS) and size exclusion chromatography (SEC)
coupled with on-line fluorescence detection.
Methods: To obtain cell free serum and plasma, blood was collected from healthy volunteers
using serum activator and EDTA vacutainer tubes, respectively. Cells were removed
by centrifugation at 2500 x g twice. Samples were further purified with a Sepharose
CL-2B gravity column and analysed by MRPS using the nCS1 instrument (Spectradyne LLC,
USA). For the fluorescence SEC experiments, samples were labelled with PE-conjugated
anti-CD61 and analysed with a JASCO (Japan) liquid chromatography system supplemented
with an FP-2020 fluorescence detector and using a 1 mL column filled with CL-2B gel.
Results: The particle concentrations of serum and plasma determined by MRPS in the
65–250 nm size range were 2.06E+10 1/mL and 1.77E+10 1/mL, respectively. In the 250–2000 nm
range, we found 2.22E+8 1/mL and 5.50E+7 1/mL for serum and plasma. These concentrations
correspond to 0.29 E+10 1/mL increase for the smaller size range, and 1.67E+8 1/mL
for the larger size range, which can be accounted for the EVs produced during clotting.
Fluorescence SEC experiments with PE-CD61 revealed that the percentage of CD61 bound
to EVs increased from 2.25% (plasma) to 36% (serum). Using these data, we obtained
that one platelet-derived EV contains approx. 15 CD61 glycoproteins in average.
Summary/Conclusion: By the combination of MRPS and fluorescence SEC we quantified
the overall particle concentrations in serum and plasma, and using a platelet-specific
fluorescently labelled antibody, we determined the average number of CD61 glycoproteins
on platelet-derived EVs formed during blood clotting.
Funding: This work was supported under grant numbers PD 121326 and NVKP_16-1-2016-0007
by NKFIH (Hungary). ZV was supported by the János Bolyai Research Fellowship.
PT09.02
The nanobioanalytical platform, a tuneable tool for a sensitive detection & characterization
of extracellular vesicles subsets from biological samples
Balasubramaniam Namasivayama, Yu-Wen Wub, Liling Delilab, Annie Frelet-Barranda, Thierry
Burnoufb, Celine Elie-Caillea and Wilfrid Boireau
a
aFEMTO-ST Institute, UBFC, CNRS, Besançon, France; bCollege of Biomedical Engineering,
Taipei Medical University, Taipei, Taiwan (Republic of China)
Introduction: The NanoBioAnalytical (NBA) platform is an established, calibrated and
label-free system to characterize Extracellular Vesicles (EVs), without limitation
in size, in different biological samples [1, 2]. NBA benefits were recently highlighted
in latest MISEV guidelines [3]. The NBA platform combines biodetection and phenotyping
of EVs subsets by immunocapture monitored by Surface Plasmon Resonance (SPR) on biochip,
followed by EVs quantitation and sizing thanks to metrological evaluation by Atomic
Force Microscopy (AFM). Our aim is to push the limit of the NBA to address clinical
studies involving EVs.
Methods: We emphasise here the performance of the NBA platform for establishing its
dynamic range and limit of detection (LOD) for blood derived EVs. Concentration of
EVs was first determined in solution by Tunable Resistive Pulse Sensing; NBA sensitivity
and reliability was then studied by SPR on biochips presenting a-CD41 antibody arrays.
Finally, even on 1000-fold diluted samples, reliable and complementary information
to SPR measurements on size distribution, counting and shape deciphering could be
obtained by AFM.
Results: Optimizing different factors (flow rate, density of receptors on the surface,
etc.) enabled detection of blood derived EVs at dynamic range from 106 to 109 particles
/mL on a-CD41 surface. The determination of the LOD of EVs and their subsets size
distribution at different capture levels are currently in progress.
Summary/Conclusion: The NBA platform is modular and capable of detecting EVs reliably
even in highly diluted samples. Such characterization and correlation studies are
crucial for accurate and comprehensive characterization of EVs in biological samples
with good reproducibility.
References
1. Obeid et al., B&B. 2017. 93:250–259
2. Obeid et al., NBM. 2019 (in revision)
3. Thery et al., JEV. 2018. 8;1535750
Funding: Region Franche-Comté 2017–2020.
PT09.04
Multi-parametric single vesicle analysis using an interferometric imaging platform
George Daaboul
a, Veronica Sanchezb, Aditya Dhandeb, Chetan Soodb, Gregg Lithgowb, Francis Fordjourc,
Stephen Gouldc and David Freedmanb
aNanoView Biosciences, Brighton, USA; bNanoView Biosciences, Boston, USA; cJohn Hopkins
University, Baltimore, USA
Introduction: Current single vesicle analysis techniques like electron microscopy
and atomic force microscopy require high expertise and are limited in throughput.
Flow cytometry (FC), which is regularly used to for single cell analysis and sorting,
has limited sensitivity in light scatter mode for detection of highly abundant populations
of EVs smaller than a 100 nm. Recent publications show that the exosome average diameter
is around 50 nm, which has been measured by super-resolution imaging, nanoFCM, and
TEM. The more sensitive fluorescence-based detection of EVs is also difficult because
EVs could have much less than 10 epitopes of the marker of interest, a limit for most
FC systems.
Methods: To address the limitation in single vesicles analysis we have developed a
technique that can size, enumerate, and co-localize 4 markers (surface and cargo)
on single vesicles across 10 different subpopulations on a single sensor surface.
The technique is termed SP-IRIS and commercialized as ExoView™ by NanoView Biosciences.
EvoView™ relies on a bilayer substrate (silicon/silicon dioxide) that forms a common
path interferometer for enhanced nanoparticle analysis. The calculated fluorescence
detection limit approaches single fluorescence sensitivity established using fluorescent
polystyrene nanoparticles (20–200nm diameter) corresponding to 180–110,000 MESF.
Results: A tetraspanin assay was developed on the ExoView™ platform for the detection
of CD81, CD63, CD9 positive vesicles directly from cell culture samples without the
need for purification. We can also permeabilize the vesicles to probe the cargo of
individual vesicles. To validate the detection of tetraspanins and internal cargo
proteins we used knockout cell lines as negative controls. The assay can also be used
for detection of vesicles from other biological fluids like urine, plasma, CSF, and
saliva. We demonstrated that most tetraspanin positive vesicles have a diameter around
50 nm, which agrees with TEM, versus the widely reported diameter of 100nm in the
literature.
Summary/Conclusion: The ExoView platform is a scalable single vesicle analysis platform
that can size, enumerate and run multi-parametric co-localization experiments directly
from sample. The platform can be applied for basic research as well as biomarker discovery
for liquid-biopsy applications.
PT09.05
Quantification of circulating extracellular vesicles from human plasma by utilizing
a membrane-based microfluidic system
Yi-Sin Chen
a, Gwo-Bin Leea and Chihchen Chenb
aDepartment of Power Mechanical Engineering, National Tsing Hua University, Taiwan,
Hsinchu, Taiwan (Republic of China); bInstitution of NanoEngineering and MicroSystems,
National Tsing Hua University, Hsinchu, Taiwan (Republic of China)
Introduction: Extracellular vesicles (EVs) have served as biomarkers for cancer diagnosis
and prognosis based on their carried cargos such as proteins and nucleic acids. To
accurately and specifically quantify tumour-derived EVs from complex biofluids such
as human plasma is potentially significant for precise diagnosis. Many techniques
for EVs quantification have been developed in the past decade, including nanoparticles
tracking analysis, total internal reflection fluorescence microscopy, flow cytometry
and enzyme-linked immunosorbent assays (ELISA). However, bulky and expensive instruments
are required for these approaches. Therefore, this study provides a simple and low-cost
approach to quantify circulating EVs from human plasma by using the ELISA method and
a fluorescent microscope on a membrane-based integrated microfluidic platform.
Methods: In this study, a membrane-based integrated microfluidic platform was used
for EVs collection, enrichment and fluorescent detection process. A track-etched membrane
filter with a pore size of 0.03 μm that could enrich EVs and deplete small molecules
during washing steps was packaged in a polydimethylsiloxane-based microfluidic platform.
After EVs enriching, an on-chip ELISA assay was performed involving the following
steps including (1) anti-CD63 antibody (EPR5702) incubation, (2) horseradish peroxidase
(HRP) conjugated anti-rabbit antibody incubation, and (3) tetramethylrhodamine-labelled
tyramide incubation. It is worth noting that tyramide molecules could be accumulated
on the surface of EVs to amplify the fluorescent signal and observed under a fluorescent
microscope. With this approach, absolute quantification of EVs with high specificity
could be achieved.
Results: The experimental results showed that CD63-positive circulating EVs in human
plasma could be individually observed under a fluorescent microscope. By using imaging
software (ImageJ) to perform image analysis, the total number of EVs could be quantified
such that the concentration of EVs in plasma could be measured.
Summary/Conclusion: The developed method could be used to quantify EVs with high specificity
and could be widely used in most general laboratory for precise diagnosis of circulating
EVs from human plasma.
Funding: Ministry of Science and Technology of Taiwan (MOST 106–2221-E-007–001, MOST
107–2221-E-007–013-MY3)
PT09.06
Electrophoretic separation of EVs using a microfluidic platform
Takanori Ichiki and Hiromi Kuramochi
The University of Tokyo, Tokyo, Japan
Introduction: Absence of adequate tools for analysing and/or identifying mesoscopic-sized
particles ranging from tens to hundreds of nanometres is the potential obstacle in
both fundamental and applied studies of extracellular vesicles (EVs), and hence, there
is a growing demand for a novel analytical method of nanoparticles with good reproducibility
and ease of use.
Methods: In the last several years, we reported the usefulness of electrophoretic
mobility as an index for typing individual EVs based on their surface properties.
To meet the requirement of separation and recovery of different types of EVs, we demonstrate
the use of micro-free-flow electrophoresis (micro-FFE) devices for this purpose. Since
the 1990s, micro-FFE devices have been developed to allow for smaller sample volume
and reagent consumption. To solve several technical problems involving the generation
of electrolysis gas on the electrodes, most of the micro-FFE devices reported in the
past were fabricated using elaborate micromachining process on silicon or glass substrates.
However, high-cost micromachining processes were required, and these were not suitable
for mass production.
Results: Based on these backgrounds, we recently developed a polymer-based easy-to-fabricate
micro-FFE device and overcame the problems mentioned above. In this presentation,
we will introduce the application of this device to EV separations in this presentation.
Electrophoretic separation of Sk-Br-3 derived exosomes expressed with HER2 antigen
were demonstrated with and without the combination use of the anti-HER2 antibody for
molecular specific separation.
Summary/Conclusion: The present method will be one of the promising candidates for
separating favourable types of EVs from heterogeneous samples.
Funding: Center of Innovation Program (COI STREAM) from Japan Science and Technology
Agency (JST)
PT09.07
Size distribution of extracellular vesicles by microfluidic resistive pulse sensing
and small-angle neutron scattering
Zoltan Varga
a, Bence Feherb, Diana Kitkac, Vitaliy Pipichd and Jean-Luc Fraikine
aResearch Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary;
bEötvös Loránd University, Budapest, Hungary; cRCNS HAS, Budapest, Hungary; dJülich
Centre for Neutron Science JCNS, Garching, Germany; eSpectradyne LLC, Torrance, USA
Introduction: Accurate size determination of extracellular vesicles (EVs) is still
challenging because of the detection limit and sensitivity of the methods used for
their characterization. In this study, we used two novel techniques such as microfluidic
resistive pulse sensing (MRPS) and small-angle neutron scattering (SANS) for the size
determination of reference liposome samples and red blood cell derived EVs (REVs)
and compared the obtained mean diameter values with those measured by dynamic light
scattering (DLS).
Methods: Liposomes were prepared by extrusion using polycarbonate membranes with 50
and 100 nm pore sizes (SSL-50, SSL-100). REVs were isolated from red blood cell concentrate
supernatant by centrifugation at 16.000 x g and further purified with a Sepharose
CL-2B gravity column. MRPS experiments were performed with the nCS1 instrument (Spectradyne
LLC, USA). SANS measurements were performed at the KWS-3 instrument operated by Jülich
Centre for Neutron Science at the FRMII (Garching, Germany). DLS measurements were
performed using a W130i instrument (Avid Nano Ltd., UK).
Results: MRPS provided particle size distributions with mean diameter values of 69,
96 and 181 nm for SSL-50 and SSL-100 liposomes and for the REV sample, respectively.
The values obtained by SANS (58, 73 and 132 nm, respectively) are smaller than the
MRPS results, which can be explained by the fact that the hydrocarbon chain region
of the lipid bilayer gives the highest scattering contribution in case of SANS, which
corresponds to a smaller diameter than the overall size determined by MRPS. In contrast,
DLS provided the largest diameter values, namely 109, 142 and 226 nm, respectively.
Summary/Conclusion: Size determination methods based on different physical principles
can result in large variation of the reported mean diameter of liposomes and EVs.
Optical methods are biased due to their size-dependent sensitivity. SANS can be used
for mono disperse samples only. In case of resistive pulse sensing, the microfluidic
design overcomes many practical problems accounted with this technique, and as a single
particle, non-optical method, it is less affected by the above-mentioned drawbacks.
Funding: This work was supported under grant numbers PD 121,326 and NVKP_16-1–2016-0007
by NKFIH (Hungary). ZV was supported by the János Bolyai Research Fellowship.
PT09.09
Analysis of intracellular dynamics of exosomes and changes of surface markers
Takeo Shimasaki and Satoko Yamamoto
Kanazawa Medical University, Uchinada, Japan
Introduction: In the biological study, a standard method for observing natural interactions
between cells is co-culturing technique. The existing co-culture research method is
generally classified into two main groups depending on the state of adhesion between
cells: direct co-culture or indirect co-culture. In indirect co-culture, standard
methods for filter separation of cells include methods using vertical-insert type
co-culture plate (VTCP) named after the structure or trademark (i.e. cell-culture
insert, Transwell). These methods have been used in many studies thus far, its application
to exosomes research has been limited. It is difficult to obtain high-quality images
of cells in the upper culture chamber due to the short focal length of the microscope.
We developed a novel cell culturing chamber (horizontal connection type co-culture
plate; HTCP). HTCP made it possible to analyse intracellular kinetics and changes
in surface markers of exosomes.
Methods: To examine the essential interactions of exosomes, we evaluated the uptake
of extracellular exosomes using this HTCP. Culturing cells with GFP-labelled exosomes
in only one container and detecting the presence of GFP in cells in the adjoining
container.
Also, various chemicals were added, and analysis was made on changes in the kinetics
of exosome and changes in surface markers.
Results: It was possible to confirm the exosome passed through the filter and to identify
the origin of exosomes and to analyse the distribution of the exosome in the cells.
We found that the amount of exosome secreted by cells increased by an agent. As a
result of the analysis, although the amount of CD63 per one exosome was decreased,
the amount of CD63 per one cell was increased.
Summary/Conclusion: This fact indicates that there may be no point in comparing the
amount of protein or miRNA contained in exosomes. Detailed data will be presented
at this workshop.
PT09.10
Protease biomarker detection using functionalized bioplastic-based biosensors
Richard Kelwick
a, Alexander Webbb, Yizhou Wanga, Fiona Allanb and Paul Freemontc
aImperial College London, London, UK; bNatural History Museum London, London, UK;
cThe London DNA Foundry, Imperial College London, London, UK
Introduction: Extracellular vesicles (EVs) are potentially the “seeds”, that were
famously metaphorized by Dr Stephen Paget in 1889 when he noted that particular primary
tumours preferentially metastasized to particular organs. EV-associated metalloproteinases
conceivably play important roles in priming metastatic sites. Indeed, many studies
demonstrate the complex roles that metalloproteinases have in cancer biology. EVs
can be readily accessed from patient liquid biopsies and an analysis of EV-associated
metalloproteinase biomarkers may enable early-stage cancer detection.
Methods: In order to detect EV-associated metalloproteinases we developed a library
of biosensors. These biosensors utilize PhaC-reporter fusion proteins that are bound
to microbially manufactured bioplastic beads. These PhaC-fusions also incorporate
specific metalloproteinase cleavage sites. In the presence of a specific metalloproteinase,
the reporter protein is cleaved off the bioplastic bead – resulting in a loss of bead
fluorescence that can be measured using high-throughput flow cytometry. These biosensors
were assayed using either recombinant proteinases or isolated EVs from in vitro cancer
models.
Results: Human metalloproteinase recognition motifs were identified in the literature
and a total of 70 different metalloproteinase biosensors were designed. A control
biosensor (PhaC-112L-T-G) detected 0.5 U of tobacco etch virus protease (AcTEV) activity
and the PhaC-112L-P14-G biosensor, despite some background off-target activity, was
able to detect 0.033 mU of recombinant MMP14 activity. Membrane-bound metalloproteinases
MMP14 and ADAM10 were also detected in EVs isolated (ultracentrifugation) from in
vitro cancer models.
Summary/Conclusion: Our biosensors detected EV-associated metalloproteinases and could
serve as useful research tools for EV-biomarker discovery.
Funding: Dr Richard Kelwick is funded by a Royal Society of Edinburgh Enterprise Fellowship
and an Imperial Confidence in Concept 2018 grant. We also acknowledge the support
of Engineering and Physical Science Research Council (EPSRC) grants [EP/L011573/1;
EP/P028519/1] and the Biotechnology and Biological Sciences Research Council (BBSRC)
Foundry grant [BB/L027852/1].
PT09.11
Single exosome size analysis using super resolution microscopy
Xia Li
a, Mina Hoorfarb and Isaac Lia
aUniversity of British Columbia Okanagan, Kelowna, Canada bDepartment of Chemistry,
University of British Columbia Okanagan, Kelowna, Canada
Introduction: Exosomes are a type of extracellular vesicle (EV) with diameters of
30–150 nm and are secreted from most cell types. Owing to their significant role as
cellular messengers and potential applications in disease detection, treatment and
targeted delivery, growing efforts have been made in this relatively new field. However,
exosome research is hindered by significant challenges including inefficient separation
methods, difficulties in characterization and lack of definitive biomarkers. Particularly,
exosomes are difficult to visualize since their small size falls below the resolution
limit of conventional microscopes (~200 nm).
Methods: Recent progress in super-resolution has provided novel tools in exosome characterization.
In this study, we present a single platform to capture pre-coarsely isolated exosomes
onto an imaging flow chamber through specific anti-bodies and perform super-resolution
imaging on the same device. Specifically, the surface of the imaging chamber is passivated
with anti-CD 63 to capture the DiD stained vesicles. The acquisition of the raw image
series was done using total internal reflection fluorescence microscopy (TIRF) with
a 642-nm diode laser for excitation. Two types of super-resolution techniques were
tested including super resolution radial fluctuations (SRRF) and stochastic optical
reconstruction microscopy (STORM).
Results: The size of single exosomes in the final images were estimated by the full-width
at half-maximum (FWHM) of Gaussian fitted to the distribution of single molecules.
We have found that the resolution limit of the single particle is reduced to 70 nm.
The preliminary data from SRRF and STORM showed the particle size and size distribution
were compared to nanoparticle tracking analysis (NTA) results.
Summary/Conclusion: This method provides in-depth size analysis of single exosomes
below the diffraction limit. Additionally, capturing exosomes from coarsely isolated
samples via specific antibodies would reduce the time required for sequential ultracentrifugation,
the current standard technique for exosome isolation. Finally, this imaging chamber
presents a versatile platform for protein profiling as the captured exosomes can be
labelled with specific antibody-dye conjugates to reveal the surface proteins contents.
PT09.12=OWP3.09
Identification of single tumour-derived extracellular vesicles by means of optical
tweezers and Raman spectroscopy
Agustin Enciso-Martinez
a, Edwin van der Polb, Aufried Lenferinkc, Leon Terstappena and Cees Ottoa
aMedical Cell Biophysics, University of Twente, Enschede, Netherlands; bAmsterdam
UMC, University of Amsterdam, Department of Biomedical Engineering and Physics, Amsterdam,
Amsterdam, Netherlands; cUniversity of Twente, Enschede, Netherlands
Introduction: EVs derived from cancer cells play a role in tumour cell proliferation,
migration, invasion and metastasis. Their presence in body fluids, such as blood,
makes them potential biomarkers for cancer disease. However, the identification of
single tdEVs can be challenging due to their heterogeneity, their ultra-small size,
their size overlap with many other normal EVs and contaminants in body fluids and
the lack of knowledge on their chemical composition.
Methods: Synchronized optical tweezers and Raman spectroscopy have enabled a study
of individual EVs. The new method detects individual trapping events from Rayleigh
scattering. The synchronous recording of Raman scattering enabled the acquisition
of Raman spectra of both individual and multiple EVs, disclosing their chemical composition.
Furthermore, Mie light scattering theory has been used to relate the Rayleigh scattering
intensity to the size of trapped EVs.
Results: The light scattered of trapped EVs gave rise to step-wise time traces that
can be used to distinguish individual trapping events from accumulative cluster events
due to the discrete nature of the steps which correspond to single trapping events.
Next, we confirmed the trapping of individual EVs derived from PC3 cells, red blood
cells, platelets and blood plasma by acquiring both, Rayleigh and Raman scattering
signals. While the step-wise trend in the Rayleigh scattering signal suggests trapping
of single particles, the Raman scattering signal demonstrates the nature of the trapped
EVs. Through principal component analysis (PCA), the main spectral variations among
the four EV types were identified. The principal component scores grouped the PC3-derived
EVs in a separate cluster from the rest of the EVs.
Summary/conclusion: We have developed an automated single particle optical tweezers
– Raman and Rayleigh scattering setup to trap and release single EVs over time. We
demonstrated single-EV trapping by simultaneous acquisition of Rayleigh and Raman
scattering. PCA enabled the identification of single-EVs derived from the cancer cell
line PC3. This discloses chemical information as a step towards the identification
and characterization of single tumour-derived EVs in blood.
Funding: Cancer ID – project number 14193, (partially) financed by the Netherlands
Organisation for Scientific Research (NWO)
PT09.13=OWP3.02
Immunocapturing of tumour-derived extracellular vesicles on micropatterned and antibody-conjugated
surfaces for individual correlative light, probe and electron measurements
Pepijn Beekman
a, Agustin Enciso-Martinezb, Cees Ottob and Séverine Le Gacc
aWageningen University, Wageningen, Netherlands; bMedical Cell Biophysics, University
of Twente, Enschede, Netherlands; cApplied Microfluidics for BioEngineering Research,
University of Twente, The Netherlands, Enschede, Netherlands
Introduction: Tumour-derived extracellular vesicles (tdEVs) are promising biomarkers
for cancer patient management. The screening of blood samples for tdEVs shows prognostic
power comparable to screening of tumour cells. However, due to the overlap in size
between tdEVs, non-cancer EVs, lipoproteins and cell debris, new approaches, not only
based on size, are required for the reliable isolation of tdEVs and their quantification.
We report an integrated analysis methodology to study single tdEVs using correlative
data from scanning electron microscopy (SEM), Raman imaging (RI) and atomic force
microscopy (AFM) to obtain a comprehensive dataset allowing identifying features unique
to tdEVs.
Methods: Indium tin oxide (ITO)-coated fused silica was selected for its low Raman
background. Substrates (1 x 1 cm2) featuring position-dependent markings (“navigation
marks”) patterned by photolithography were modified with a monolayer of amino dodecyl
phosphonic acid. The amine moieties were next reacted with poly(ethylene glycol) diglycidyl
ether, forming an anti-biofouling layer. Anti-EpCAM antibodies were subsequently covalently
bound on this surface. Samples of both tdEVs obtained from LNCaP cell lines and RBC-derived
EVs were then introduced to the surfaces. Finally, non-specifically bound EVs were
washed away before SEM, AFM and Raman measurements were performed.
Results: Multiple objects were captured on the fully functionalized ITO surfaces,
according to SEM imaging, while in negative control experiments (lacking functionalization
or lacking antibody or using EpCAM-negative EVs), no object was detected. Principal
component analysis of their Raman spectra, previously demonstrated to be able to distinguish
tdEVs from RBC-derived EVs, revealed the presence of characteristic lipid bands (e.g.
2851 cm−1) in the captured tdEVs. AFM showed a surface coverage of ∼4 × 10^5 EVs per
mm2 with a size distribution similar to that found by NTA.
Summary/conclusion: A platform was developed for multi-modal analysis of selectively
isolated tdEVs for their multi-modal analysis. In the future, the scope of this platform
will be extended to other combinations of probe, light and electron microscopy techniques
to relate additional parameters describing the captured EVs.
Funding: Funded by NWO Perspectief
PT09.14=OWP3.03
The development of a scalable extracellular vesicle subset characterization pipeline.
Joshua Welsh
a, Julia Kepleyb and Jennifer C. Jonesa
aTranslational Nanobiology Section, Laboratory of Pathology, National Cancer Institute,
National Institutes of Health, Bethesda, USA; bTranslational Nanobiology Lab, Laboratory
of Pathology, National Cancer Institute, National Institutes of Health, Bethesda,
USA
Introduction: Liquid biopsies offer an important alternative to tumour biopsies that
may be limited by the challenges of invasive procedures. We hypothesize that circulating
Extracellular Vesicles (EVs) and their cargo may provide a useful surrogate biopsy
method. Due to their small diameter (30-1000 nm), EVs migrate from tissue into the
peripheral circulation and provide a snapshot of the producing cells. Our lab has
developed a first-in-class pipeline to use single cell – omics methods to characterize
EV heterogeneity with high-sensitivity by combining multiplex assays and our custom
MultiPlex Analysis post-acquisition analysis software (MPAPASS), with subsequent high-resolution,
single EV flow cytometric (FCM) methods.
Methods: A standalone software package was developed in MATLAB to allow importation
of multiplex flow cytometry output data. The package enables data quality screening
of detection antibodies, bead recovery and data normalization methods. The software
is equipped to handle large data sets comprising hundreds/thousands of phenotypes
and samples. Data can be visualized in a variety of ways along with clustering using
multidimensional data analysis techniques. All software outputs can be exported in
a standardized templates containing metadata for reporting, as well as uploaded into
atlases such as Genboree, where multiplex data can be stratified by RNAseq datasets.
Analysis using this pipeline has been conducted using human samples from a variety
of mediums including CSF, serum, and plasma comparing EV phenotypes.
Results: Our multiplex approach and MPAPASS software allows the use of single cell
-omics tools for EV subset analysis in manner that will elucidate the biological significance
and function of different types of EVs. This high-throughput pipeline evaluates hundreds
of EV protein profiles and will allow evaluation of millions of RNA:protein profiles
in an unprecedented manner. Integration of RNA sequencing with protein characterization
could provide an entirely new way of understanding EV regulation and function.
Summary/conclusion: Our data show this form of EV profiling provides a way to monitor
clinical responses early in the course of treatment, which may ultimately improve
patient care and outcomes.
PT10: EVs and Stem Cells Chairs: Takashi Asada; Myung-Shin LeeLocation: Level 3, Hall
A15:30–16:30
PT10.01
3D culture of dental pulp pluripotent-like stem cells (DPPSC) improves their pluripotency
and provides a serum-free culture condition for exosome production
Farid N. Faruqua, Khuloud Al-Jamal
a, Shuai Zhoub, Noor Samia, Fatemeh Gheidaric and Maher Atarid
aKing’s College London, London, UK; bKing’s College London, XuZhou, China (People’s
Republic); cKing’s College London, Tehran, Iran; dUniversitat Internacional de Catalunya,
Barcelona, Spain
Introduction: Exosomes from stem cells have been identified as a novel cell-free therapeutic
for regenerative medicine. Culturing them in a serum-free condition for exosome isolation
still poses a major challenge. This work focused on the establishment of a 3D culture
of Dental Pulp Pluripotent-like Stem Cells (DPPSC) – a newly characterized pluripotent-like
stem cell from adult tissue, for exosome production.
Methods: DPPSC were initially cultured in monolayer (2D) in their basal medium with
four different supplementations: human serum (HS), exosome-depleted human serum (ED-HS),
and two different serum replacements (SR1 & SR2). Morphology and growth rate of cells
were analysed by bright-field microscopy and regular cell counting. DPPSC were then
transferred to a microwell culture plate for 3D culture in the four differentially
supplemented media and maintained for 24 days. Spheroid formation and morphology was
observed throughout culture using bright-field microscopy. Spheroids were harvested
on Day 24 and the expression of pluripotency genes Oct4A and Nanog were analysed by
qPCR. Vesicles isolated from DPPSC conditioned-medium were characterized for size,
yield and exosomal markers using Nanoparticle Tracking Analysis (NTA) and dot blot.
Results: In 2D culture, only DPPSC cultured in the default HS medium proliferated
and showed the expected morphology. In 3D culture, DPPSC in SR1 medium formed spheroids
of similar morphology and size to that of HS medium. Significantly smaller spheroids
were formed by DPPSC in ED-HS medium, while DPPSC barely formed spheroids in SR2 medium.
qPCR analysis showed that while expression of Oct4A gene in DPPSC cells from 2D and
3D culture (both in HS and SR1 media) was similar, expression of Nanog in DPPSC spheroids
in SR1 medium was significantly higher than the spheroids in HS medium and the cells
from 2D culture. Vesicles isolated from DPPSC spheroid in SR1 conditioned medium from
Day 1–12 and Day 13–24 of culture showed sizes that fall within the exosomal size
range, and are positive for the exosomal markers CD81, CD9 and CD63. Vesicle yield
for Day 13–24 was higher than that of Day 1–12, but a larger percentage of particles
from the latter were positive for the three exosomal markers.
Summary/Conclusion: 3D spheroid culture of DPPSC in SR1 medium showed improvement
in pluripotency, and allows for a serum-free culture for exosome production.
PT10.02
Increased exosome secretion is essential for myeloma stem cells to survive in hypoxic
condition
Sayaka Nakayama, Yuki Toda, Shigekuni Hosogi and Eishi Ashihara
Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University,
Kyoto-shi, Japan
Introduction: Cancer stem cells (CSCs) of the highly tumorigenic cell population are
critically associated with the poor prognosis of patients in various types of cancer.
In our previous study, the multiple myeloma (MM) cells which were chronically cultured
in a hypoxic condition (over 6 months, 1% oxygen) exhibited stem cell characteristics.
It suggests that MM stem cells are capable of adapting to hypoxic stress although
the adaptation mechanism remains unclear. We focused on the excessive secretion of
exosomes from hypoxia-adapted MM cells (HA-MM cells). Exosomes are considered as a
garbage bin to remove unnecessary molecules from the cytoplasm to maintain cellular
homeostasis, as well as a novel intercellular communication tool.
Methods: GW4869, an inhibitor of the ceramide-mediated inward budding of the multivesicular
bodies for exosome biogenesis, was applied to analyse the response to a deficiency
of exosome secretion from their reduced production in HA-MM cells.
Results: GW4869 increased the rate of Annexin V positive (apoptotic) cells and induced
the expression of fragmented PARP in HA-MM cells, but not in parental cells cultured
in a normoxic condition (20% oxygen). With the addition of HA-MM-derived exosomes,
GW4869-induced apoptosis was not attenuated. From these results, HA-MM cells are likely
to release exosomes to maintain the intracellular environment in a state of homeostasis,
but not to receive them for autocrine signal. Hexokinase 2 (HK2) generates glucose-6-phosphate,
which is further metabolized by both the glycolytic pathway and the pentose phosphate
pathway (PPP). PPP plays a major role in supplying NADPH for detoxification of intracellular
reactive oxygen species (ROS). The upregulated HK2 protein expression in HA-MM cells
was diminished by GW4869. With dichlorodihydrofluorescein staining assay, GW4869 increased
intracellular ROS production in HA-MM cells. Thus, the failure of exosome secretion
might alter the energy metabolism leading to ROS-associated apoptosis.
Summary/Conclusion: Enhancement of exosome secretion is a survival strategy for hypoxic
adaptation in MM stem cells. This study could provide a critical insight to develop
a novel strategy for CSC-targeted therapy.
Funding: MEXT-Supported Program for the Strategic Research Foundation at Private Universities
PT10.04
Extracellular vesicles released from human iPSC-derived 3D retinas contain small RNAs
with roles in development and differentiation
Miguel Flores-Bellver
a, Jing Zhoub, Xiufeng Zhongc, Alberto Benito-Martínd, Jason Mightyb, Jiang Qiane,
Jianbo Pane, Hao Wub, Bo-Juen Chenf, Alice Liangg, Héctor Peinadoh, Maria Valeria
Canto-Soleriand Stephen Redentij
aCellSight – Ocular Stem Cell and Regeneration Program, Department of Ophthalmology,
University of Colorado, Denver, USA; bLehman College, Biology Doctoral Program, The
Graduate School and University Center, City University of New York, New York, USA;
cState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University,
Guangzhou, China; dChildren’s Cancer and Blood Foundation Laboratories, Departments
of Pediatrics, Weill Cornell Medicine, New York, NY, USA; eWilmer Eye Institute. Johns
Hopkins University School of Medicine, Baltimore, USA; fNew York Genome Center, New
York, USA; gNew York University Langone Medical Center, New York, USA; hMicroenvironment
and Metastasis Laboratory, Molecular Oncology Programme. Spanish National Cancer Research
Center (CNIO), Madrid, Spain; iCellSight – Ocular Stem Cell and Regeneration Program,
Department of Ophthalmology, University of Colorado, Aurora, USA; jLehman College,
Biology & Biochemistry Doctoral Program, The Graduate School and University Center,
City University of New York, New York, USA
Introduction: Noncoding small RNAs in the retina regulate gene expression by targeting
and repressing mRNA. Small RNAs are secreted in extracellular vesicles (EVs). Analysis
of EVs released from developing retinal tissue is an essential step in elucidating
the role of EV molecular cargo and signalling during retinogenesis. A number of canonical
genes are associated with retinal cell fate determination during development, but
EV-mediated gene regulation in the retinal microenvironment remains undefined. In
this study, we characterize the microRNA, tRNA, and piRNA composition of EVs secreted
from human induced pluripotent stem cell (hiPSCs) – derived 3D retinas at three developmental
time points that correlate with hallmarks of retinal cell differentiation and lamination
in vivo.
Methods: Retinal organoids were generated from hiPSCs. We selected three developmental
time points (day 42, 63 and 90) that represent distinctive stages during normal retinal
cell fate specification and lamination. We analysed the release rate, concentration,
morphology and content (miRNA, tRNA and pi-RNA) of EVs released from human hiPSCs-derived
3D retinas.
Results: The genetic signalling, developmental time course and morphogenesis of these
retinal organoids were comparable to those of developing human retinas in vivo. According
to Gene Ontology analysis, miRNA targets at the earliest stage of development were
more relevant to early differentiation and cell morphogenesis, whereas miRNA targets
at the later stages were more relevant to cell proliferation, cell differentiation,
and cell migration.
Summary/Conclusion: For the first time, this work demonstrates the rate of release
and concentration of EVs from developing hiPSC-derived 3D retinal tissue. We report
a large variety of small RNAs in EVs from hiPSC-derived 3D retinas, including miRNAs,
tRNAs and piRNAs. The full range of small RNAs detected in our EVs may act as regulatory
elements to modulate gene activity and may serve as biomarkers of normal development.
This work represents the first sequencing analysis of small RNA species contained
in hiPSC-derived 3D retinas and their released EVs.
Funding: NIH (R21 EY026752, SC3 GM113782); Research to Prevent Blindness; Challenge
Grant to the Department of Ophthalmology, CU; NIH/NEI R01EY022631.
PT10.05
Xeno-free manufacturing of MSC-EVs in scalable bioreactor culture
Katrina Adlerza, Josephine Lembonga, Tim Olsena, Jon Rowley
a and Taby Ahsanb
aRoosterBio. Inc., Frederick, USA; bRoosterBio, Inc., Frederick, USA
Introduction: There have been over 800 clinical trials using mesenchymal stem/stromal
cells (MSCs) for therapeutic applications. Due to their similar therapeutic effects
to MSCs and potential as a key bioactive agent in regenerative medicine applications,
MSC-derived extracellular vesicles (MSC-EVs) are being increasingly investigated as
a clinical therapy for a broad range of indications. It was recently found that the
number of exosomes released from 2M MSCs in 48 h is equivalent to a single dose for
a rodent. Hence, most indications would require a MSC production lot size that is
hardly achievable in 2D culture. Therefore, larger scalable bioreactor systems will
be crucial to generate enough EVs for clinical doses. This study developed a protocol
for xeno-free (XF) scalable MSC-EV manufacturing and compared MSC-EV characteristics
from 2D culture and various bioreactor scales.
Methods: Human Bone Marrow-Derived MSCs (hBM-MSC) were cultured on microcarriers in
suspension using 0.1, 3 and 15L bioreactors. After cell inoculation, a bioreactor
feed was added on Day 3, and cultures switched to an EV collection media on Day 4.
After 1, 2 and 3 days, the collection medium was analysed for metabolites, particle
size, and particle concentration. The MSC-EVs in the conditioned medium was also evaluated
for protein expression of Alix, CD63, and CD81, RNA expression and wound healing capability.
Results: A protocol was developed for manufacturing MSC-EVs in an XF fed-batch bioreactor
culture, resulting in cell yield of >0.5M cells/mL within 4 days. We demonstrated
that this process was directly scalable from the small (0.1L) to development (3L)
and pilot scale (15L) bioreactors, maintaining similar cell density. To remove the
residual particles from the expansion media, an additional wash step before the switch
to the collection media was required in bioreactors. With a similar collection process
and comparable cell density, we expect to see consistent EV production per cell at
these different scales of manufacturing systems.
Summary/Conclusion: Optimizing EV yield will become increasingly important as EVs
become used in the clinic. We have developed a scalable fed-batch process for large
scale expansion of hMSCs and a protocol for EV production in suspension bioreactors.
Funding: This work was funded by RoosterBio, Inc.
PT10.06
Proteomic analysis of extracellular vesicles from MSC cultured with stroke serum
Yeon Hee Cho
a, Eun Hee Kima, Dong Hee Kimb, Ji Hee Sunga, Mi Jeong Oha, Eun Kyoung Shina and Oh
Young Banga
aSamsung Medical Center, Seoul, Republic of Korea; bSungkyunkwan University, Seoul,
Republic of Korea
Introduction: Serum from stroke patients increases mesenchymal stem cells trophism
towards the infarcted brain area and increased the proliferation rate and the neurorestorative
capacity of MSCs. Our previous study confirmed that intravenous infusion of MSC-EVs
is more advantageous than MSCs as a safe treatment. EVs are lipid enclosed vesicular
structures that contain bioactive RNAs, DNA and proteins, which possess therapeutic
molecules similar to MSCs. Therefore, we hypothesized that the certain proteins containing
EV released from stroke serum cultured MSCs may affect the neurogenesis and angiogenesis
of recipient cells.
Methods: EVs were purified from conditioned media of MSC cultured with FBS (FBS-MSC)
and MSC cultured with stroke serum (SS-MSC). These EVs were characterized by nanoparticle
tracking analysis. EV protein profiling in conditioned media was systematically compared
through utilizing LC-MS/MS-based label-free quantification. Real-time PCR was performed
to determine the difference in the gene expression in each cell. The protein concentration
in the EV was confirmed by ELISA.
Results: A total of 1068 proteins were identified from SS-MSC-EV and FBS-MSC-EV through
LC-MS. According to statistical analysis, 22 proteins were found to be more than 2-fold
(p < 0.05) upregulated in SS-MSC_EV. ITGA5, CLU, and CTSB were significantly increased
of SS-MSC gene expression levels compared to FBS-MSC. Among the candidate proteins,
clusterin (CLU) was found to be upregulated in EVs from SS-MSC compared to those from
FBS-MSC.
Summary/Conclusion: These results suggest that SS-MSC_EVs containing clusterin may
promote intercellular communication and affect neurogenesis and angiogenesis of recipient
cells.
Funding: This study was supported by a grant from the Korean Healthcare Technology
R&D Project, Ministry of Health & Welfare (HI17C1256) and Basic Science Research Program,
the Ministry of Science, ICT and Future Planning (2018M3A9H1023675).
PT10.07
Adipose-derived Stem/Stromal Cell secretome, containing both soluble factors and extracellular
vesicles, exerts chondroprotective effects in vitro
Chiara Giannasi
a, Stefania Niadaa, Sara Casatib and Anna Brinic
aIRCCS Istituto Ortopedico Galeazzi, Milano, Italy; bDepartment of Biomedical, Surgical
and Dental Sciences, University of Milan, Milano, Italy; cDepartment of Biomedical,
Surgical and Dental Sciences, University of Milan. IRCCS Istituto Ortopedico Galeazzi,
Milano, Italy
Introduction: Up to now several clinical trials have shown the safety and efficacy
of the intra-articular injection of Adipose-derived Mesenchymal Stem/Stromal Cells
(ASCs) in contrasting osteoarthritis. Since ASCs act predominantly through paracrine
mechanisms, their secretome represents a promising cell-free alternative. Here we
identified anti-hypertrophic and anti-catabolic effects of ASC conditioned medium
(ASC-CM) on TNFα-stimulated human primary articular chondrocytes (CHs).
Methods: CHs were treated with 10 ng/mL TNFα and/or ASC-CM administered at a 1:5 recipient:donor
cell ratio. Cell viability was assessed up to day 9. The activity, expression and/or
release of hypertrophy markers (MMP-13, Collagen X and Osteocalcin), catabolic mediators
(MMP-3) and cartilage-protective factors were assessed up to day 3 by enzymatic assays,
qRT-PCR, Western Blot and multiplex immunoassays.
Results: ASC-CM blunted TNFα-induced hypertrophy, reducing the enhanced levels of
MMP-13 activity (−61%), Osteocalcin (−37%) and Collagen X (−18%). In addition, also
MMP-3 activity was diminished by −59%. We associated the observed reduction of MMP-3
and MMP-13 activity to the abundancy of TIMPs (Tissue Inhibitors of MMPs) in ASC secretome,
rather than to a direct down-modulation of their expression and/or release. Moreover,
ASC-CM contains high levels of OPG and DKK-1, other known chondroprotective factors.
Summary/Conclusion: ASC-CM is rich in cartilage-protective factors and exerts anti-hypertrophic
and anti-catabolic effects on TNFα-stimulated CHs. These evidences open the way for
its possible clinical use as a cell-free approach in contrasting osteoarthritis. We
are currently investigating through a differential proteomic analysis if the recognized
chondroprotective effectors are enriched in the vesicular rather than the soluble
component of the secretome.
PT10.08
Epigenetic alterations in mesenchymal stem cells by osteosarcoma derived extracellular
vesicles
Roman Kornilov, Sippy Kaur, Bettina I. Mannerström, Ahmed Abu-Shahba, Iftekhar Chowdhury,
Snehadri Sinha and Riitta Seppänen-Kaijansinkko
Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki
University Hospital, Helsinki, Finland
Introduction: Extracellular vesicles (EVs) are central to intercellular communication
and play an important role in cancer progression and development. Osteosarcoma (OS)
is an aggressive bone tumour, characterized by presence of malignant mesenchymal cells.
Specific tumour-driving genetic alterations associated with OS development are poorly
understood. The cell of origin for OS also remain unknown but cells of the mesenchymal
stem cell (MSC) osteogenic lineage are likely candidates, thus indicating that MSCs
and the OS stroma cells may be related cell types. Therefore, this study set out to
examine the contribution of EV-mediated intercellular crosstalk of MSC and OS.
Methods: MSCs and pre-osteoblasts were treated with OS-EVs at different time points,
and the epigenetic signature of OS-EVs was assessed by LINE-1 and tumour suppressor
genes methylation analysis. In addition, surface markers and gene and expression of
specific genes related to bone microenvironment remodelling (MMP1, VEGF-A, ICAM1)
were also evaluated.
Results: Our data indicated that OS-EVs mediated LINE-1 hypomethylation in MSCs, whereas
an opposite effect was seen in pre-osteoblast, indicating that MSCs but not pre-osteoblasts
were more susceptible to epigenetic transformation. Thus, OS-EVs dictated the fate
of MSCs by modulating the epigenetic status, and also influenced the expression of
genes related to bone microenvironment remodelling.
Summary/Conclusion: Overall, this study provided evidence that epigenetic regulation
may appear to be an early event in the transformation of MSCs. Elucidating the mechanisms
of EV-mediated communication may lead to new avenues for therapeutic exploitation.
Funding: This research was supported by University of Helsinki project funding (WBS490302,
WBS73714112), Helsinki University Hospital State funding for university-level health
research (Y1014SUL05, TYH2016130), the Finnish Dental Society Apollonia, Egyptian
Ministry of Higher Education (MoHE) and Selma and Maja-Lisa Selander foundation.
PT10.09
Comprehensive proteomics and microRNA analyses of adult neural stem cell derived exosomes
after stroke
Xianshuang Liu
a, Michael Choppb, Chao Lia, Wan Long Pana, Bao Yan Fana, Albert M Levinc, Rui Lan
Zhanga and Zheng Gang Zhanga
aDepartment of Neurology, Henry Ford Health System, Detroit, MI, USA; bDepartment
of Physics, Oakland University, Rochester, MI, USA; cDepartment of Public Health Sciences,
Center for Bioinformatics, Henry Ford Health System, Detroit, MI, USA
Introduction: Neural stem cells (NSC) are known to facilitate healing of ischemic
brain tissues. Recent studies show that NSC derived exosomes function as paracrine
effectors to promote neurovascular remodelling including angiogenesis and axonal outgrowth
after stroke; nevertheless, the contents of the non-stroke and post stroke NSC exosome
proteome and miRNA cargo have not been determined.
Methods: NSC derived exosomes were purified from conditioned media of cultured NSCs
harvested from the subventricular zone of non-ischemic and ischemic rats, respectively.
Liquid chromatography mass spectrometry (LCMS) and miRNA array were employed to comprehensively
characterize the protein and miRNA contents of NSCs and their derived exosomes after
stroke. Bioinformatic analyses were performed using Ingenuity Pathway Analysis (IPA).
Results: Exosome markers including CD63, CD9, Alix and size distribution (50–200nm)
were verified with Western blot, transmission electron microscopy (TEM) and Nanosight,
respectively. In total, proteomics analysis yielded 2409 and 1770 proteins identified
in ischemic NSC and NSC derived exosomes, respectively. Bioinformatics analysis identified
that 52, 39 and 31 proteins in the NSCs-derived exosomes were related to regulating
neuronal cell proliferation, migration and differentiation, respectively. In addition,
318 miRNAs were identified in ischemic NSCs with 26% of miRNAs (84 miRNAs) overlapped
with parent NSCs. Gene ontology analysis showed that up- and down-regulated miRNAs
with the fold change above 1.5 were highly related to inflammation, invasion, cell
proliferation, cell cycle, cell death, differentiation, etc. The top three upregulated
miRNAs were validated in ischemic NSC-exosomes using real-time RT-PCR.
Summary/Conclusion: Collectively, the results of our proteomic and miRNA analysis,
to our knowledge, demonstrate for the first time that NSC derived exosomes contain
a robust profile of protein and miRNA effectors. These data provide a platform for
beginning to understand the mechanism by which NSCs are activated after cerebral ischemia,
and may lead to a deeper mechanistic understanding of their role in tissue repair
after neural injury.
Funding: NIH RO1 DK102861, American Heart Association (AHA) grant 18IPA34170331, NINDS
RO1 NS075156 and RO1 NS088656.
PT10.10
Anion exchange chromatographic isolation of iPSC-MSC derived extracellular vesicles
ameliorated allergic asthma in mice
Shubin Fang, Hongyu Zhang, Yongdong Lin and Qingling Fu
Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University,
Guangzhou, China (People’s Republic)
Introduction: The extracellular vesicles (EVs) derived from mesenchymal stem cells
have been shown to elicited similar therapeutic effects to their patent cells in many
diseases. However, the difficulties in the large-scale preparation of high-purity
EVs largely limited its clinical application in the future. We sought to apply a novel
anion chromatography for the isolation of iPSC-MSC EVs, and explored the effects and
mechanisms of iPSC-MSC EVs in the therapy for asthma.
Methods: The EV-enriched supernatants were collected for the isolation of the iPSC-MSC
EVs using the anion chromatography. The morphologies of EVs were characterized by
transmission electron microscope, the markers of EVs were assayed by western blot
and flow cytometry. The anti-inflammatory effects of the EVs were determined using
the macrophage assay. Also, the uptake activities of macrophages on RPF-iPSC-MSC EVs
were determined. Finally, the asthma mouse model was developed and the iPSC-MSC EVs
were administrated intravenously. The lung pathology, the levels of inflammatory cytokines
in the bronchoalveolar lavage fluids (BALF) and the polarization of lung macrophages
were evaluated.
Results: We successfully obtained concentrated iPSC-MSC EVs after the isolation and
the final concentration of EVs was about 200 µg/mL (Bradford) and 10–15*1011/mL (Nanosight).
The iPSC-MSC EVs were morphologically intact and were positive for the markers including
CD9/63/81, Alix and TSG101. Most of the preparations of iPSC-MSC EVs could significantly
decreased the level of IL-6 in the macrophage assay. The Raw 264.7 macrophages began
to uptake iPSC-MSC EVs at 4 h and the uptake activities peaked at 12 h and then receded
at 24 h. Also, our in vivo study showed that splenic macrophages started to uptake
iPSC-MSC EVs at 4 h and the uptake activities were augmented at 24 h. In addition,
the iPSC-MSC EVs significantly reduced the inflammatory infiltration, the epithelial
goblet cell numbers, the levels of inflammatory cytokines and inflammatory cells in
the BALF as well as the polarizations of pulmonary macrophages.
Summary/Conclusion: Our results showed that the anion exchange chromatography was
a promising method for the large preparation of iPSC-MSC EVs, which could possibly
be an alternative therapy for asthma in the future.
Funding: NSFC (81322012, 81373174, 81471832, 81671882 and 81770984)
PT10.11
Characterization and miRNA expression profiles of exosomes from HLA homozygous haplotype
dental pulp cells and iPS cells
Yuta Shimizu
a, Tomoko Kawaguchib, Shuhei Otaric, Izumi Kurodad, Yuki Kuranagae, Hideya Kawasakif,
Takahiko Hariyamaf, Toshiyuki Shibatab, Takahiro Kunisadad, Toshiaki Shibutanic, Yukihiro
Akaoe and Ken-ichi Tezukag
aAsahi University School of Dentistry, Department of Periodontology, Mizuho, Japan;
bGraduate School of Medicine Department of Oral and Maxillofacial Science, Gifu, Japan;
cAsahi University School of Dentistry Department of Periodontology, Gifu, Mizuho,
Japan; dGifu University Graduate School of Medicine Department of Tissue and Organ
Development Regeneration and Advanced Medical Science, Gifu, Japan; eGifu University
Graduate School of Drug Discovery and Medical Information Sciences, Gifu, Japan; fHamamatsu
University School of Medicine Depatment of Preeminent Medical Photonics Education
& Research Center Institute for NanoSuit Research, Hamamatsu, Japan; gGifu University
Graduate School of Medicine Department of Tissue and Organ Development Regeneration
and Advanced Medical Science, Gifu, Japan and Center for Highly Advanced Integration
of Nano and Life Sciences, Gifu University (G-CHAIN), Gifu, Japan
Introduction: Human leucocyte antigen (HLA) has played an important role to distinguish
between self and non-self in the immune system. HLA homozygous cell of the multi-locus
has been considered to be less likely to be rejected in the allograft. In recent years,
the diameter to 100 nm of the extracellular vesicles called exosomes, to cellular
functions secreted from iPS cells or tissue stem cells, partially responsible, such
an immune response and during communication tools it has been reported to play a role
as a tissue repair. In this study, we compared the exosomes from HHH-DP HLA homozygous
haplotypes from cell-derived HHH-iPS cells (HHH) pulp (DP) cells and exosomes.
Methods: Three lines of HHH-DP cells established at Gifu University and HHH-iPS cells
derived from these cells were used. DP and iPS cells were cultured in serum-free conditions.
Exosomes were purified from culture supernatants by ultracentrifugation. Purified
exosomes were subjected to particle size determination with a nanoparticle analysis
system (Nanosight LM10), exosome markers and HLA class I evaluation by Western blotting
(WB), and miRNA expression analysis, and results were compared. HHH-iPS cell exosomes
were also examined if teratomas were formed in immunodeficient mice.
Results: Nanosight LM10 confirmed that the particle size peaks were nearly identical
at ~100 nm. WB revealed that both DP cell exosomes and iPS cell exosomes expressed
CD81 and HLA class I, but expression levels of CD81 and HLA class I were lower in
iPS cell exosomes. The miRNA analysis showed that some miRNAs differed between cells
and between exosomes. In assessment of teratoma forming ability, no tumour formation
was observed.
Summary/Conclusion: HHH-DP cell exosomes and HHH-iPS cell exosomes were found to have
different surface antigens and miRNA expression profiles. HHH-iPS cell exosomes showed
a reduced level of HLA expression and no teratoma formation, and thus are potentially
useful for therapeutic purpose.
PT11: EV Based Cancer Therapeutics Chairs: AC Matin; Eva RhodeLocation: Level 3, Hall
A15:30–16:30
PT11.01
Cellular and secreted extracellular vesicles-encapsulated miRNAs in the 4T1 murine
model of breast cancer
Katie E. Gilligana, Róisín Dwyer
b, Clodagh O’Neillc, Eimer o’Connellb and Peter Dockeryb
aNational University of Ireland Galway, Galway, Ireland; bNUI Galway, Galway, Ireland;
cNational University of Ireland, Galway, Ireland
Introduction: Extracellular vesicles (EVs) are secreted by all cells and are known
to contain a range of genetic material such as microRNAs (miRNAs). EVs have been implicated
in mediating intercellular communication to support breast cancer progression and
also highlighted as a potential biomarker of disease. This study aimed to investigate
the miRNA profile of EVs released by 4T1 breast cancer cells in vitro and to relate
this to the circulating EV profile of an animal model of this disease.
Methods: 4T1 cells were cultured in EV-depleted media, and secreted EVs isolated through
sequential differential centrifugation, micro-filtration and ultracentrifugation.
EVs were also isolated from the sera of balb/c mice bearing 4T1 tumours. EVs were
characterized by Nanoparticle Tracking Analysis (NTA), Western Blot and Transmission
Electron Microscopy (TEM). RNA was extracted from all cells and EVs using the MagNA
pure compact and Next-Generation Sequencing (NGS) targeting miRNA was performed. Targets
of interest were validated by Polymerase Chain Reaction (PCR).
Results: EVs were successfully isolated from all samples with the majority of vesicles
falling within the range of exosomes (30–120 nm). Western blot analysis confirmed
the presence of tetraspanins CD63, CD81 and CD9. The characteristic size and shape
(cup) of EVs were visualized by TEM. Over 380 previously annotated miRNAs were detected
in the 4T1 secreted EVs, with 11 novel putative miRNA sequences identified. Twenty-five
miRNAs were found to be differentially expressed between the cells and their secreted
EVs. Interestingly, of these, 14 miRNAs were present at a significantly higher level
in the EVs compared to the cells. Including a range of miRNA previously associated
with cancer progression, e.g. miR-486-5p. Gene ontology enrichment identified a range
of key biological processes that could potentially be regulated by the EV-miR profile
detected such as tumour proliferation and bone cell resorption.
Summary/Conclusion: Analysis of EVs from animals bearing 4T1 tumours is ongoing to
determine whether the EV-miR profile could serve as a biomarker of disease. The data
presented demonstrates the selective packaging of tumour associated miRNAs into EVs
which could play an important role in disease progression.
Funding: Irish Research Council, Government of Ireland Postgraduate Scholar 2016 GOIPG/2016/978.
PT11.03
Delivery of miR-185 enriched EVs from MSCs inhibits the progression of OPMD
Lin Wanga, Yuanyuan Wangb, Jiaqi Wangb, Congcong Miaob, Haimei Sunb, Yu Zhou
c and Xiaobing Guana
aCapital Medical University, Beijing, USA; bCapital Medical University, Beijing, China
(People’s Republic); cBeijing Ludaopei Institute of Haematology, Beijing, China (People’s
Republic)
Introduction: Oral leucoplakia is one of the most common oral potentially malignant
disorders (OPMD) and its malignant transformation is associated with chronic inflammation.
It is clear that the tumour microenvironment, which is largely orchestrated by inflammatory
cells, is an indispensable participant in the fostering proliferation, survival and
migration. Extracellular vesicles (EVs) shuttle complex molecular cargo between producer
and recipient cells resulting in epigenetic regulation of cell function. EVs derived
from mesenchymal stem cells (MSCs) have been found to promote therapeutic activities
that are comparable to MSCs themselves.
Methods: Bone marrow derived MSCs were transfected with high copy numbers of miR-185
mimics and EVs were harvested using Genexosome Isolation kit. miR185 enriched EVs
were characterized and applied on the buccal mucosa in the OPMD model exposed to 7,12-dimethylbenz
anthracene (DMBA). Pathological analysis of the buccal mucosa was studied, and the
topical and serum levels of inflammatory cytokines and chemokines were measured. In
addition, the expression levels of caspase 3 and 9 were examined.
Results: EVs released from genetically modified MSCs had ~25-fold higher expression
levels of miR-185 than the control. Confocal microscopic imaging revealed that the
PKH26 fluorescence labelled EVs principally localized in the buccal mucosa after administration.
After treatment with miR-185 enriched EVs for 3 or 5 weeks, the topical inflammation
severity in buccal mucosa was remarkably attenuated, the levels of IL-6, IL-1β, JE,
MIP-1a, MIP-2 and TREM-1 were decreased, and the numbers of inflammatory cells were
reduced as well. Pathological analysis of the buccal tissue showed significantly decreased
numbers of cells with hyperplasia or dysplasia after treatment. In addition, miR185
enriched EVs led to significantly increased levels of caspase 3 and 9 in the buccal
tissue, indicating miR185 promotes the activation of apoptotic pathway.
Summary/Conclusion: miR-185 enriched EVs from MSCs are anti-inflammatory and anti-proliferative,
and promote apoptosis. Genetically modified MSC-derived EVs have significant potential
as a novel therapy for oral leucoplakia.
PT11.04
Identification of exosome secretion inhibitor for cancer therapy
Jong-In Kim, Eun-Ju Im, Chan-Hyeong Lee and Moon-Chang Baek
School of medicine, Kyungpook National University, Daegu, Republic of Korea
Introduction: Exosomes are nanosize secreting vesicles that can internalize and interact
with other cells to initiate physiological and pathological signalling pathways. Especially,
tumour-cell derived exosomes (TDXs) activate tumour-related mechanism such as proliferation,
metastasis and drug resistance. We hypothesized that inhibition of exosome secretion
may have beneficial effects in the treatment of cancer. Here, we found an old drug
which inhibits exosome secretion from various cancer cells.
Methods: Human breast cancer and Human melanoma cancer cell lines were cultured. Immunoblotting
was performed with primary antibodies against RAB27A and beta-actin. Cells were seeding
in 24 well plates then treated candidate drugs for 24 h. Cell viability was measured
by MTT assay. Exosomes were isolated by serial centrifugation method, then resuspended
in PBS for further experiments. Exosome concentration was analysed by NTA.
Results: Exosome secretion was significantly decreased by drug treatment. In addition,
this drug affected protein expression of RAB27A in various cancer cell lines. Moreover,
migration and invasion activity of cancer cells were markedly suppressed by drug,
suggesting that this drug has possibility to be used for anti-cancer therapy.
Summary/Conclusion: These findings demonstrate that a drug to inhibit exosome secretion
selectively in cancer cells could be used for the therapy of various cancers. Importantly,
our study offers a new mechanistic insight into drug development by the inhibition
of exosome secretion.
Funding: This work was supported by the National Research Foundation of Korea (NRF)
grant funded by the Korea government (2014R1A5A2009242)
This research was supported by the Bio &Medical Technology Development Program of
the National Research Foundation (NRF) funded by the Ministry of science & ICT (2017M3A9G8083382)
PT11.05
Platelet-derived microparticles as an oriented bullet for cancer treatment
Yu-Wen Wu and Thierry Burnouf
College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan (Republic
of China)
Introduction: Platelets (PLTs) and PLTs-derived microparticles (PMPs), released by
PLTs upon thrombin activation, interact closely with cancer cells in the tumour microenvironment.
Some researchers have been used synthetic nanoparticles loaded with anticancer agents
and coated with whole PLT membranes for cancer therapy. However, isolating PLT membranes
and synthesizing nanoparticles coatings sufficient for translational applications.
Further, procedures for isolating PLT membranes may denature proteins, which may alter
targeting specificity and incur an adverse risk of immunogenicity in patients. Therefore,
our aim is to isolate and evaluate the ability of PMPs to serve as Trojan Horse carriers
of anticancer drugs for cancer treatment.
Methods: PLT concentrates were centrifuged at 3000 × g for 15 min at 24 ± 3°C and
the pellet (PLTs) was suspended in thrombin in Tyrode’s buffer (0.1U/mL) to induce
activation and incubated at 37°C for 1 h. The solution was then centrifuged at 3000 × g
for 10 min at 24 ± 3°C to remove PLTs and the supernatant (PMPs) was centrifuged at
20,000 × g for 90 min at 18°C. The PMPs pellet was resuspended in platelet additive
solution (PAS) and stored at −80°C. PMPs were thawed at 37°C then incubated with 100 μM
doxorubicin (DOX) in PAS at 37°C for 1 h. The supernatant was centrifuged at 20,000 × g
for 90 min at 18°C. The pellet of PMPs loaded with DOX (PMPDs) was resuspended in
PAS. The sizes and the concentrations of PMPs and PMPDs were measured using a nanoparticle
tracking analysis (NTA). Data were analysed using NTA software. Transportation of
DOX from PMPDs to breast cancer cell lines was observed by deconvolution microscopy.
Results: NTA results revealed that the mean size of PMPDs (234.1 ± 48.01 nm) was slightly
larger compared with that of PMPs (200.1 ± 57.71 nm) and that DOX incorporation did
not influence the quantification of PMPs. The concentration of them was no significant
difference. The size distributions and images of PMPs and PMPDs indicated the absence
of aggregated PMPs associated with DOX loading. When incubated with MCF-7 and MDA-MB-231
cells, PMPDs transferred DOX to the nuclei of cancer cells within 30 min.
Summary/Conclusion: These results support the potential clinical use of PMPDs as novel
cell-based “Trojan Horse” anti-cancer therapeutic strategy.
Funding: This study was supported by the Ministry of Science and Technology.
PT11.06
Design of an exosome-based drug delivery system transporting anticancer peptides for
targeting breast metastases in the brain
Filipa Oliveiraa, Julia Skalskaa, Tiago Figueiraa, Patrícia Napoleãoa, Érica Mellob,
David Andreuc, Valdirene Gomesb, Miguel Castanhoa and Diana Gaspar
a
aInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade
de Lisboa, Lisboa, Portugal; bLaboratório de Fisiologia e Bioquímica de Microrganismos
do Centro de Biociências e Biotecnologia da Universidade Estadual do Norte Fluminense
Darcy Ribeiro, Rio de Janeiro, Brazil; 3Department of Experimental and Health Sciences,
Pompeu Fabra University, Barcelona Biomedical Research Park, Barcelona, Spain
Introduction: The treatment of breast cancer brain metastases can be addressed with
the effective delivery of anti-tumoural drugs into the brain. The development of a
drug delivery system (DDS) that can physiologically match the cell membrane, decrease
the development of immune responses and that crosses biological barriers is significantly
valuable for treating metastatic breast cancer (MBC). When compared to other nanoparticle
delivery vehicles, exosomes represent an interesting approach to conventional DDS.
In the present work, exosomes from breast cells were isolated and biophysically characterized.
In addition, their interaction with anticancer peptides (ACPs) was unravelled envisioning
the design of a DDS for MBC.
Methods: Exosomes from breast cell lines were isolated using a commercially available
kit and biophysically characterized with transmission electron microscopy (TEM), atomic
force microscopy (AFM), flow cytometry, Western Blot and dynamic light scattering.
The interaction of PvD1 and vCPP2319 ACPs with the breast cells and respective exosomes
was also followed with surface plasmon resonance (SPR) as to detail peptide’s binding
to the different exosomes.
Results: Results suggests an intracellular target for vCPP2319 cytotoxic activity
on breast cancer cells. The binding of the peptides to both membranes of human cells
and exosomes results in cell death and in strong binding, respectively, pointing to
the potential ability of these breast exosomes in transporting ACPs, which in turn
are highly effective towards tumour cells.
Summary/Conclusion: Even though more studies are currently in development, the combination
of potential ACPs with human-derived exosomes are shown as a potential source for
a highly selective and effective DDS aiming to attack breast tumour cells located
in the brain.
Funding: Fundação para a Ciência e a Tecnologia (FCT I.P., Portugal) is acknowledged
for funding – PTDC/BBBBQB/1693/2014. F. O., J. S. and T. F. acknowledge FCT I.P.,
Portugal for fellowships PD/BD/135046/2017, PD/BD/114177/2016 and SFRH/BD/5283/2013,
respectively. Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)
is acknowledged for funding: call H2020-MCA-RISE-2014, Grant agreement 644, 167, 2015–2019.
PT11.07
Embryonic stem cells-derived exosomes endowed with targeting properties as chemotherapeutics
delivery vehicles for glioblastoma therapy
Xiaozheng Ling, Qingwei Zhu, Yunlong Yang, Yang Wang, Zhifeng Deng
Shanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai, China (People’s
Republic)
Introduction: Glioma treatment is severely hindered by blood brain barrier (BBB) which
leads to very limited on-target activity of therapeutic agents. Exosomes are nanosized
extracellular vesicles with efficient BBB penetration ability and presents a promising
drug carrier for glioma treatment. However, several reports have demonstrated that
injected exosomes mainly distribute in liver and spleen rather than brain. In this
study, we find embryonic stem cell derived exosomes (ES-Exos) show broad spectrum
anti-tumour ability including glioma, and thus we further use ES-Exos as paclitaxel
(PTX) carrier and modify them with tumour targeting ligand cRGD.
Methods: CCK-8 analysis and flow cell analysis were used to test the anti-tumour ability
of ES-Exos. cRGD was incorporated onto the surface of ES-Exos by post-insertion methods
with cRGD-DSPE-PEG2000 (cRGD-Exos), and PTX was loaded into cRGD-Exos by co-incubation
to get cRGD-Exos-PTX. In situ glioma model of mice was built by injecting glioma cells
in brain. In vivo imaging was used to test the biodistribution of cRGD-Exos-PTX. Further,
subcutaneous tumour of mice was also built to evaluate the anti-tumour ability of
ES-Exos and cRGD-Exos-PTX.
Results: Our results showed that ES-Exos could inhibit tumour cell proliferation of
broad spectrum, including U87, U251, A549, HCC, HepG2, B16, MDA-MB-231 and DU145.
Flow cell analysis showed that ES-Exos induced tumour cell apoptosis. Furthermore,
after cRGD modification, cRGD-Exos showed enhanced tumour cell uptake compared with
ES-Exos. And in vivo imaging analysis demonstrated that more cRGD-Exos distributed
in glioma site in mice brain. And mice with in situ glioma treated with cRGD-Exos-PTX
lived more longer than the group treated with Exos-PTX. Finally, cRGD-Exos-PTX showed
the beat anti-tumour ability in subcutaneous tumour model.
Summary/Conclusion: In this study, we demonstrate that ES-Exos is antineoplastic,
and their tumour site distribution is enhanced by cRGD modification. cRGD-Exos-PTX
is an efficient therapeutic agent for glioma treatment.
Funding: NSFC Project No. 81671209 and No. 81471243.
PT11.08
Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced
tumour penetration and antitumor efficacy
Yeonsun Hong, Yoon Kyoung Kim and Yoosoo Yang
Korea Institute of Science and Technology, Seoul, Republic of Korea
Introduction: As biochemical and functional studies of membrane protein remain a challenge,
there is growing interest in the application of nanotechnology to solve the difficulties
of developing membrane protein therapeutics. Exosome, composed of lipid bilayer enclosed
nanosized extracellular vesicles, is a successful platform for providing a native
membrane composition.
Methods: Exosome Preparation and Characterization – DLS, western blot, TEM Enzymatic
Activity Assay in vitro and in vivo HA Depletion Analysis Tumour Blood Flow Biodistribution
Imaging of Dox Fluorescence Distribution in Tumours Evaluation of Anti-tumour Effect
in Mouse Model.
Results: This study reports an enzymatic exosome, which harbours native PH20 hyaluronidase
(Exo-PH20), which is able to penetrate deeply into tumour foci via hyaluronan degradation,
allowing tumour growth inhibition and increased T cell infiltration into the tumour.
This exosome-based strategy is developed to overcome the immunosuppressive and anticancer
therapy-resistant tumour microenvironment, which is characterized by an overly accumulated
extracellular matrix. Notably, this engineered exosome with the native glycosylphosphatidylinositol-anchored
form of hyaluronidase has a higher enzymatic activity than a truncated form of the
recombinant protein. In addition, the exosome-mediated codelivery of PH20 hyaluronidase
and a chemotherapeutic (doxorubicin) efficiently inhibits tumour growth. This exosome
is designed to degrade hyaluronan, thereby augmenting nanoparticle penetration and
drug diffusion.
Summary/Conclusion: Here, we developed the engineered exosome that facilitates its
own penetration into the HA-containing tumour ECM. Enabling chemical drugs, nanoparticles,
and immune cells to penetrate deeply into tumour foci is a challenging goal of studies
aimed at achieving antitumor therapeutic efficacy. The exosome-triggered infiltration
of cytotoxic T cells into tumour tissues, which was observed in the present work,
could induce an adaptive immune response to help combat cancer. Moreover, we provide
a general strategy that may be used to decorate exosomal surfaces with natural-state
membrane-bound proteins.
PT11.09
Surface engineering of exosomes to block HIV infection
Pooja Bhardwaja, Shivani Desaia, Ali Danesha, Amirali Afsharib, Archana Guptab and
Satish K. Pillai
a
aVitalant Research Institute, San Francisco, USA; bSystem Biosciences (SBI), Palo
Alto, CA, USA
Introduction: While lifelong antiretroviral therapy has dramatically reduced the morbidity
and mortality of HIV infection, treated individuals still experience immune dysregulation
and chronic inflammation, driving interest in alternative therapeutic and curative
strategies. Exosomes, extracellular membrane vesicles 30–100 nm in size, have shown
promise as engineerable therapeutic agents for a broad range of diseases. We aimed
to engineer exosomes with the capacity to block HIV infection as a novel antiviral
approach.
Methods: Exosomes were isolated from 1 mL of healthy donor plasma using polymer-based
precipitation and column purification. Nanoparticle tracking analysis was used to
determine the abundance and size of particles. Exosomes were quantified by fluorometer,
and 200 µg protein equivalents were decorated with single-chain variable fragment
(scFv)-C1C2 fusion proteins with complementarity determining regions targeting the
HIV envelope protein. The HIV-1 NL4-3 EGFP reporter virus was incubated with decorated
exosomes for 2 h at 1:1, 1:2 and 1:4 ratios. Virus was incubated with no exosomes,
undecorated exosomes, or anti-PD-1 scFv-decorated exosomes as negative controls. Jurkat
E6.1 cells and primary human CD4+T cells were infected with virus-exosome preparations
via spinoculation, and GFP fluorescence was measured by flow cytometry to determine
infection levels after 72 h.
Results: Our engineered anti-HIV scFv-decorated exosomes significantly inhibited HIV
infection in Jurkat cells with respect to all negative controls (n = 3; p < 0.05,
paired t-test). Anti-HIV scFv-decorated exosomes potently inhibited HIV infection
in primary human CD4 + T cells (n = 2 donors) in a dose-dependent manner, suppressing
up to 87% of infection in the absence of toxicity.
Summary/Conclusion: Engineering exosomes ex vivo represents a promising therapeutic
approach for HIV infection. Future work will test the capacity of our designer exosomes
to inhibit HIV replication in vivo in humanized mouse models. Beyond viral suppression,
we will determine if designer exosomes can accelerate the clearance of HIV latently-infected
cells, the main obstacle to a cure for HIV infection.
Funding: NIH P01AI131374 and R01GM117901
PT11.10
Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after
loco-regional treatment
Lizhou Xua, Julie Wangb, Farid N. Faruqub, Kee Limb, Adam Waltersb, Claire Wellsb
and Khuloud Al-Jamal
b
aSchool of Cancer and Pharmaceutical Sciences, King’s College London, London, UK;
bKing’s College London, London, UK
Introduction: Pancreatic cancer (PC) remains one of the most aggressive and devastating
malignancies, predominantly due to the absence of a valid biomarker for diagnosis
and limited therapeutic options for advanced disease. Exosomes (Exo) as cell-derived
vesicles are widely used as natural nanocarriers for drug delivery. P21-activated
kinase 4 (PAK4) is oncogenic when overexpressed, promoting cell survival, migration
and anchorage-independent growth. In this study, we validate PAK4 as a therapeutic
target in an in vivo PC tumour mouse model using Exo nanocarriers following intra-tumoural
administration.
Methods: PC derived Exo were firstly isolated by ultracentrifugation on sucrose cushion
and characterized for their surface marker expression, size, number, purity and shape.
siRNA was encapsulated into Exo via electroporation and dual uptake of Exo and siRNA
was investigated by flow cytometry and confocal microscopy. In vitro siPAK4 silencing
in PC cells was assessed by western blotting, flow cytometry, and in vitro scratch
assay. In vivo efficacy (tumour growth delay and mouse survival) of siPAK4 was evaluated
in PC bearing NSG mouse model. Ex vivo tumours were examined using Haematoxylin and
eosin (H&E) staining and immunohistochemistry.
Results: High quality PC derived PANC-1 Exo were obtained. siRNA was incorporated
in Exo with 16.5% loading efficiency. Exo and siRNA co-localization in cells was confirmed
by in vitro imaging. PAK4 knock-down was successful at 30 nm Exo-siPAK4 at 24 h post-incubation
in vitro. Intra-tumoral administration of Exo-siPAK4 (1 µg siPAK4 and 7.7 × 1011 Exo,
each dose, two doses) reduced PC tumour growth and enhanced mice survival (p < 0.001),
with minimal toxicity observed compared to polyethylenimine (PEI) used as a commercial
transfection reagent. H&E staining of tumours showed significant tissue apoptosis
in siPAK4 treated groups.
Summary/Conclusion: PAK4 interference prolongs survival of PC bearing mice suggesting
its candidacy as a new therapeutic target in PC. PANC-1 Exo demonstrated comparable
efficacy but safer profile than PEI as in vivo RNAi transfection reagent.
Funding: The K. C. Wong Education Foundation and The Marie Skłodowska-Curie actions,
“Horizon 2020” project, EU (H2020-MSCA-IF-2016).
PT12: EV Based Therapeutics Chairs: Mario Gimona; Saara LaitinenLocation: Level 3,
Hall A15:30–16:30
PT12.02
Exosomes from adipocyte-derived stem cells reduce the oxidative stress through the
mitochondrial uncoupling in pantothenate kinase 2 mutation in vitro models
Chien Tai Hong
a and Ruey Meei Wub
aShuang Ho Hospital-Taipei Medical University, New Taipei City, Taiwan (Republic of
China); bNational Taiwan University, Taipei, Taiwan (Republic of China)
Introduction: The exosome is a promising novel therapy for human diseases. Exosomes-derived
from mesenchymal stem cell is thought to contain plenty of unique microRNA, which
is specific for boosting cellular repair and regeneration. Neurodegenerative diseases
are characterized by the neuronal pre-mature apoptosis and the lack of the ability
of regeneration. It is hypothesized that the supplement of exosomes-derived from the
stem cells could activate the expression of neuroprotective gene/protein expression,
resume the impaired cellular function and reverse the degenerative process.
Methods: Patient with pantothenate kinase 2 (PANK2) mutation-related neurodegeneration
with brain iron accumulation was recruited and the leukocytes were immortalized to
establish the in vitro models. The adipose-derived stem cell (ADSC) was obtained from
the healthy donors and the exosomes were isolated from the culture medium at confluent.
Results: The PANK2 mutation resulted in the elevated oxidative stress and depolarization
of mitochondria. Exosome treatment (5 μg of exosome suspension upon 3*106 leukocytes)
for 24 h up-regulated the protein level of mitochondrial uncoupling protein 2 and
3, as well as boosted the mitochondrial biogenesis, assessed by the protein level
of PGC-1α and TOMM20. Those proteins were undatable in the exosomes themselves. Mitochondrial
uncoupling proteins are responsible for the dissipating of mitochondrial membrane
potential and down-regulation of the oxidative phosphorylation from respiration, which
is the major source of free radical and oxidative stress. Exosome treatment for 24 h
led to the obvious mitochondrial depolarization, assessed by JC-1 and further reduction
of the oxidative stress, assessed by the H2DCFDA.
Summary/Conclusion: The exosomes from ADSC were able to reduce the oxidative stress
through manipulating mitochondrial functions. The effect is speculated to achieve
by the modulation of genetic expression in the recipient cells.
Funding: Minister of Science and Technology, Taiwan (MOST 107–2314-B-038 −086 -MY2)
PT12.03
Extracellular vesicle-secretion system based on agarose gel encapsulation of cells
for cell therapy
Mami Hiranoa, Masaya Hagiwarab, Nahoko Bailey Kobayashic, Tetsuhiko Yoshidac, Eiichi
N. Kodamad and Ikuhiko Nakase
a
aGraduate School of Science, Osaka Prefecture University, Sakai-shi, Japan; bNanoSquare
Research Institute, Osaka, Japan; cInstitute for Advanced Sciences, Toagosei Co.,
Ltd., Tsukuba, Japan; dTohoku University School of Medicine, Sendai, Japan
Introduction: Extracellular vesicles (exosomes, EVs, 30 ~ 200 nm in diameter) are
released from various types of cells. Because EVs carry functional molecules such
as e.g. microRNAs and enzymes, EVs play crucial roles in cell-to-cell communication.
On the other hand, EVs have pharmaceutical advantages as carriers for intracellular
delivery of therapeutic molecules, including, e.g. encapsulation of natural and/or
artificial therapeutic/diagnostic molecules, controlled immunoreaction, effective
usage of cell-to-cell communication routes, infinite secretion and expression of functional
proteins in EV membranes. We are currently developing cell encapsulated gel system
for secretion of functional EVs in cell therapy. In this research, agarose gels, which
has been widely used in cell culture and chamber, is used for encapsulation of cells
that secrete functional EVs from the gels. We here demonstrate our methods for cell
encapsulation in the gels and cellular uptake efficacy of secreted EVs from the gels.
Methods: CD63 (EV marker protein)-GFP stably expressing HeLa cells were encapsulated
using collagen and agarose gels. Secreted EVs from the gel system were separated using
ultracentrifuge and analysed by western blotting, zeta potential, DLS and electron
microscope (TEM). Cellular uptake of secreted EVs from the gels was observed using
confocal laser scanning microscope.
Results: In the experimental optimization for encapsulation of cells in gels, we successfully
attained CD63-GFP stably expressing HeLa cells-encapsulated agarose (1.5%) gels (e.g.
5 × 104 cells can be encapsulated in approx. 2 mm × 25 mm × 25 mm sheet-like gel).
DLS analysis showed 30 ~ 100 nm EVs secreted from the gels, and zeta potential of
the EVs was average −17 mV. Western blotting confirmed expression of exosomal marker
proteins (e.g. CD63 and CD81). A431 cells (human epidemoid carcinoma) were cultured
with the CD63-GFP stably expressing HeLa cells-encapsulated agarose gels for 24 h,
and efficient cellular uptake of secreted EVs (CD63-GFP-EVs) from the gels were observed
using confocal laser scanning microscope.
Summary/Conclusion: Although we have to conduct further optimization in this system
as next step to obtain sophisticated methodology, these experimental techniques and
findings will contribute to development for cell therapy based on EVs as basic studies.
PT12.04
Extracellular vesicles from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced
acute lung injury
Yue Zhou, Pengfei Li, Andrew Goodwin, James Cook, Perry Halushka, Eugene Chang and
Hongkuan Fan
Medical University of South Carolina, Charleston, USA
Introduction: The acute respiratory distress syndrome is characterized by disruption
of the alveolar-capillary barrier resulting in accumulation of proteinaceous oedema
and increased inflammatory cells in the alveolar space. We previously found that extracellular
vesicles (EVs) from endothelial progenitor cells (EPCs) prevent endothelial dysfunction
and lung injury in sepsis due to their encapsulation of miRNA-126. However, the effects
of EPC EVs in acute lung injury (ALI) remains unknown.
Methods: To determine if EPC EVs would have beneficial effects in ALI, intratracheal
administration of lipopolysaccharide (LPS) was used to induce ALI in mice. Lung permeability,
inflammation and the role of miRNA-126 in alveolar epithelial barrier function were
examined.
Results: The intratracheal administration of EPC EVs reduced lung injury following
LPS-induced ALI at 24 and 48 h. Compared to placebo, intratracheal administration
of EPC EVs significantly reduced the cell number, protein concentration and cytokines/chemokines
in the bronchoalveolar lavage fluid, indicating a reduction in permeability and inflammation.
Further, EPC EVs reduced myeloperoxidase activity and reduced the lung injury score,
demonstrating protection against lung injury. Murine fibroblast (NIH3T3) EVs, which
do not contain abundant miRNA-126, did not provide these beneficial effects. In human
small airway epithelial cells, we found that overexpression of miRNA-126-3p can target
phosphoinositide-3-kinase regulatory subunit 2, while overexpression of miRNA-126-5p
inhibits the inflammatory cytokine HMGB1 and permeability factor VEGFα. Interestingly,
both miR-126-3p and 5p increase the expression of tight junction proteins suggesting
a potential mechanism by which miRNA-126 may mitigate LPS-induced lung injury.
Summary/Conclusion: Our data demonstrated that human EPC EVs are beneficial in LPS-induced
ALI mice, in part through the delivery of miRNA-126 into the injured alveolus.
Funding: 1R01GM113995 (HF), 1R01GM130653 (HF), 1K23HL135263-01A1 (AG), UL1TR001451
(PVH)
PT12.05
Hsa_circ_0000077-overexpressing extracellular vesicle: a new tool to prevent cartilage
degeneration
Shi-Cong Tao and Shang-Chun Guo
Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
(People’s Republic)
Introduction: Trauma and degeneration of articular cartilage (AC) could trigger the
morbidity of one of the leading disabling disease, osteoarthritis (OA). One of the
most difficult issues in treatment is the poor self-healing ability of AC. Extracellular
vesicle (EV) transplantation has received more and more attention as potential cell-free
therapeutic approaches to promote tissue healing. In our preliminary study, we found
that decreased expression of hsa_circ_0000077 (circ77) was closely related to OA.
And circ77-overexpression in chondrocytes can prevent the chondrocyte degeneration.
In this study, EVs derived from circ77-overexpressing synovium mesenchymal stem cells
(SMSC-77-EVs) were used to promote cartilage regeneration.
Methods: CCK-8, qPCR and western blotting (WB) were used to investigate the biological
functions of SMSC-77-EVs on the proliferation and cartilage regeneration. Furthermore,
interleukin 1β (IL-1β) were used to simulate the inflammatory conditions of OA, and
then, the protective effects of SMSC-77-EVs were confirmed by CCK-8, qPCR and WB.
Results: CCK-8 assay confirmed that SMSC-77-EVs enhanced the proliferation of chondrocytes,
compared with normal control and EVs derived from synovium mesenchymal stem cells
which were transfected by empty vectors (SMSC-Empty-EVs). WB and qPCR assays confirmed
that SMSC-77-EVs enhanced the expression levels of cartilage related proteins including
Type II collagen (Col-II), aggrecan (ACAN) and SOX9, compared with normal control
and SMSC-Empty-EVs. IL-1β significantly inhibited the proliferation and cartilage
regeneration-related proteins (Col-II, ACAN and SOX9). SMSC-77-EVs could observably
restrain the harmful effects of IL-1β, while SMSC-Empty-EVs showed limited ability.
Summary/Conclusion: These findings suggest that the novel SMSC-77-EVs provides the
preferable function in promoting the repair of cartilage damage. The use of SMSC-77-EVs
would represent a development trend of cell-free therapies, using engineered EVs (or
modularized EVs), for promoting cartilage regeneration.
Funding: The National Natural Science Foundation of China [Nos. 81871834, 81802226
and 81301589], and Shanghai Jiao Tong University K.C.Wong Medical Fellowship Fund
supported this work.
PT12.06
Lymphangiogenesis induced by exosomes derived from adipose-derived mesenchymal stem
cells
Kensuke Tashiro
a, Yusuke Yoshiokab and Takahiro Ochiyab
aJichi Medical Unversity, Tochigi, Japan; bDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku, Japan
Introduction: Lymphedema is chronic oedema of limbs caused by the accumulation of
lymphatic fluid and characterized by a progressive disorder of the smooth muscle cells
of the lymphatic channels. Transplantation of adipose-derived mesenchymal stem cells
(ADSCs) has been reported to improve the severity of lymphedema, however, the detailed
mechanism has not been elucidated yet. Extracellular vesicles(EVs) derived from mesenchymal
stem cells have been reported to have functions such as cancer development, angiogenesis,
suppression of inflammation, regeneration of damaged organs and treatment of degenerative
disease. ADSCs are thought to be promising source of regenerative medicine, and EVs
derived from ADSCs are thought to have similar effects as well. Here, we analysed
lymphangiogenesis induced by EVs derived from ADSCs for treatment of chronic lymphedema.
Methods: EVs derived from ADSCs were isolated by ultracentrifugation. The effect of
EVs to lymphatic endothelial cells (LECs) were analysed in proliferation assay, migration
assay and tube formation assay. Gene expression analyses were also performed by qRT-PCR.
LECs were treated with PBS as control, VEGF-C(10 ng/ml) and ADSC-EVs(100 μg/ml) one
time in each assay. The incubation time was 48 h in proliferation assay, 16 h in migration
assay, 8 h in tube formation assay and 12 and 24 h in qRT-PCR.
Results: ADSC-EVs group showed almost one point five to twice increase of proliferation,
migration and tube formation function compared to PBS group. Furthermore, gene expressions
for lymphatic markers such as VEGFR-3, Lyve-1, Podoplanin, Prox-1 were also shown
almost two to five times increase in the ADSC-EVs group.
Summary/Conclusion: The present study showed lymphangiogenic effects of EVs derived
from ADSCs, which lead to new treatment options for chronic lymphedema. Further studies
are needed to elucidate what kind of molecular in ADSC-EVs works in LEC. In vivo studies
using mouse lymphedema model are also needed to confirm the biological function of
ADSC-EVs. EVs for cell free therapy are less potential risk compared to stem cell
transplantation and could be promising tool for patients suffering from lymphedema.
Funding: JSPS Kakenhi; Takeda Science Foundation.
PT12.07
Embryonic stem cell-derived extracellular vesicle-mimetic nanovesicles rescue erectile
function by enhancing penile neurovascular regeneration in the streptozotocin-induced
diabetic mouse
Kang-Moon Song
a, Mi-Hye Kwon
a, Guonan Yina, Kalyan Ghataka, Nguyen Nhat Minha, Min Ji Choia, Jiyeon Ocka, Yong
Song Ghob, Ji-Kan Ryua and Jun-Kyu Suha
aNational Research Center for Sexual Medicine and Department of Urology, Inha University
School of Medicine, incheon, Republic of Korea; bDepartment of Life Sciences, Pohang
University of Science and Technology, Pohang, Republic of Korea
Introduction: Extracellular vesicles (EV)-mimetic nanovesicles (NVs) contains a variety
of protein, mRNA and miRNA and is known to play an important role in intercellular
communication as a bio-nanoparticle with a diameter of 40 to 100 nm. Recent studies
have demonstrated the therapeutic potential of EV-mimetic NVs in a variety of animal
models for cardiovascular diseases and neuropathies. The aim of this study was to
investigate effectiveness of embryonic stem cell (ESC)-derived EV-mimetic NVs in restoring
erectile function in diabetic mice.
Methods: Diabetes was induced by intraperitoneal injection of streptozotocin into
8-week-old C57BL/6 male mice. At 8 weeks after the induction of diabetes, the animals
were distributed into 7 groups: control non-diabetic mice and diabetic mice receiving
two successive intracavernous injections of HEPES-buffered saline (HBS, days −3 and
0; 20 μL) or ESC-derived EV-mimetic NVs (ESC-NVs, days −3 and 0; 0.1 μg, 0.5 μg, 1 μg,
2 μg, or 5 μg in 20 μL of HBS, respectively). Two week after treatment, we measured
erectile function by electrical stimulation of the cavernous nerve. The penis was
then harvested for histological and biochemical studies. We also examined the effects
of ESC-Exo in primary cultured mouse cavernous endothelial cells (MCEC) and pericytes
(MCP) in vitro; and in cultured aortic ring and major pelvic ganglion (MPG) ex vivo.
Results: Intracavernous injections of ESC-NVs significantly improved erectile function
in diabetic mice, which reached up to 90% of control values. ESC-NVs induced significant
restoration of cavernous contents of endothelial cells, smooth muscle cells, pericytes,
and neuronal cells in diabetic condition. Moreover, ESC-NVs promoted micro-vascular
sprouting from aortic ring and accelerated tube formation in primary cultured MCEC
and MCP mono-culture or co-culture system in vitro.
Summary/Conclusion: ESC-NVs successfully restored erectile function through enhanced
cavernous angiogenesis and neural regeneration in diabetic mice. It will be a better
strategy to use ESC-NVs than ESCs for the treatment of retractable erectile dysfunction
although it remains to be solved for future clinical application of ESCs.
PT12.08
Human adipose tissue-derived mesenchymal stem cell exosomes for the treatment of liver
fibrosis
Sol Shin, Soyoung Son, Gyeongtaek Lim, Seunglee Kwon and Jaehyung Park
aSungkyunkwan University, Suwon, Republic of Korea
Introduction: Liver fibrosis, often leading to liver cirrhosis and cancer, is a challenging
health issue for which there are no effective medicines. Conventional therapies are
merely symptomatic treatment. Hence, there have been lots of efforts to develop better
therapeutic strategies. Cell therapy based on mesenchymal stem cells (MSCs) is one
of the attractive options. MSCs hold immunomodulatory properties and multipotency.
However, cell transplantation has limitations such as teratoma formation and low cell
viability in vivo condition. In order to overcome these limitations, we suggest MSCs
derived exosome-based therapy for treating liver fibrosis.
Methods: Exosome-derived from ADSCs (A-exo) was purified using a tangential flow filtration
system. The physical characteristics of A-exo were investigated using DLS, TEM and
NTA. The protein concentration of A-exo was determined by BCA assay. The effect of
A-Exo on the expression level of α-SMA was evaluated by IF analysis. Mice were received
thioacetamide intraperitoneally. Fluorescently labelled A-exo was administered to
mice and whole-body fluorescence was observed in order to evaluate the in vivo distribution.
The therapeutic efficacy of A-exo was determined by measuring the level of ALT, ALP,
TBIL and TP in blood of mice. A-exo was injected intravenously three times and blood
was collected after final injection.
Results: When hepatic stellate cells were activated with TGF-β1, the expression level
of α-SMA was significantly increased. While, the level was remarkably decreased depending
on the treatment concentration of A-Exo. A-exo treatment significantly decreased expression
mRNA of pro-fibrogenic marker: α-SMA, Collagen I and MMP-2. After systemic administration
of exosome, a substantial accumulation of A-Exo at liver was observed in both the
normal and mice model of liver fibrosis. Furthermore, liver function of A-exo treated
group was restored to normal. These results showed A-exo had the high therapeutic
efficacy.
Summary/Conclusion: In this study, we investigate the potential of stem cell-derived
exosome as the new therapeutic approach for liver fibrosis treatment. A-exo has similar
bioactive capacity to its origin cell, mesenchymal stem cell. The beneficial effect
of A-exo was confirmed in vitro and in vivo tests. The superior therapeutic efficacy
was displayed in A-exo treated mouse group.
PT12.09
HucMSC exosome confer protection against ultraviolet radiation induced acute photodamage
via modulation of SIRT1 pathway
Peipei Wu
a, Hui Qianb and Wen Rong Xuc
aJiangsu university, Zhenjiang City, China (People’s Republic); 2ZhenJiang, China
(People’s Republic); cZhenjiang Key Laboratory of High Technology Research on Exosomes
Foundation and Transformation Application, Jiangsu Key Laboratory of Medical Science
and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China
(People’s Republic)
Introduction: Exosomes are nano-sized membrane vesicles secreted by most cells, including
human umbilical cord mesenchymal stem cells (hucMSC). hucMSC derived exosomes (hucMSC-ex)
have been reported to significantly facilitate skin regeneration, resembling the effect
of parental cells. However, the role of hucMSC-ex in ultraviolet radiation (UV) induced
skin damage and the underlying mechanisms are largely unknown.
Methods: Herein, we examined the benefit of hucMSC-ex in a rat acute skin photodamage
model.
Results: We found that the subcutaneous injection of hucMSC-ex (1 mg) elicited noted
antioxidant and anti-inflammatory effects against UV induced DNA damage and apoptosis
in vivo. Further studies shown that sirtuin1(SIRT1) expression level in skin keratinocytes
(HaCaT) decreased in a time- and dose-dependent manner under oxidative stress in vitro,
however, the treatment of hucMSC-ex reverses this phenomenon. Activation of SIRT1
significantly attenuated UV and H2O2-induced cytotoxic damage by inhibiting oxidative
stress and promoting autophagy activation. Furthermore, we also discovered that the
cytoprotection function provided by hucMSC-ex carried 14–3-3ζ was potential associated
with modulation of SIRT1 dependent antioxidant response.
Summary/Conclusion: Collectively, our findings indicated that hucMSC-ex is a new potential
agent for preventing and/or treating UV-induced skin photodamage and ageing.
Funding: Zhenjiang Key Laboratory of Exosomes Foundation and Transformation Application
High-tech Research, china: (ss2018003). National Natural Science Foundation of China:
(BE2016717).
PT12.10
Anti-melanogenic effect screening for natural plant-derived exosome-like nanovesicles
Ruri Leea, Yeon Juhun
b, Kim Kimina, Min seo yunc and Kim Jung Ahc
aUniversity of brain education, Cheon-an, Republic of Korea; buniversity of brain
education, cheon-an, Republic of Korea; ckorea basic science institute, ochang, Republic
of Korea
Introduction: Demand for whitening agents is increasing due to their anti-melanogenic
effects by improving skin darkness and decreasing melanin production in the cosmetics
industry. However, there have been side effects and high toxicity issue as well as
poor skin penetration. Therefore, many researchers have focused on natural plants
as an alternative chemo-therapeutics agent to avoid various side effects. Recently,
it is known that exosome-like nanovesicles have biocompatibility and excellent drug
delivery capacity. In this study, leaves and stems-derived exosome-like nanovesicles
were isolated from Dendropanax Morbifera and we have found that inhibition of those
nanovesicles on melanin products.
Methods: Exosome-like nanovesicles from leaves and stems were isolated and identified
size using DLS and NTA. These shapes were observed by TEM. The anti-melanogenic effect
was verified by evaluating the melanin content and tyrosinase activity on melanoma
cell. Also, western blot was used to observe melanogenesis-related protein expression.
In addition to, cellular melanin formation was confirmed using TEM. The human epidermal
model was used to evaluate the inhibition of melanogenesis.
Results: The leaves and stems-derived exosome-like nanovesicles are able to suppress
cellular melanin content melanoma cells. Also, melanogenesis protein expression was
reduced with leaves- and stems-derived exosome-like nanovesicles. These results suggest
that leaves- and stems-derived exosome-like nanovesicles of the D. morbifera could
be a candidate of natural substances for anti-melanogenic agents.
Summary/Conclusion: The leaves and stems-derived exosome-like nanovesicles are able
to suppress cellular melanin content melanoma cells. Also, tyrosinase activity and
melanogenesis protein expression were reduced with leaves- and stems- derived exosome-like
nanovesicles. These results suggest that leaves- and stems-derived exosome-like nanovesicles
of the D. morbifera could be a candidate of natural substances for anti-melanogenic
agents.
Funding: This work was supported by the Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science
and Technology (NRF-2016R1C1B2013345).
PT12.11
Stem cell extracellular vesicles as therapeutics for autoimmunity
Weian Zhao
a, Milad Riazifar
b, Rezaa Mohammadib and Jan Lotvallc
aUniversity of California, Irvine, Irvine, USA; bUC Irvine, IRVINE, USA; cUniversity
of Gothenburg, Gothenburg, Sweden
Introduction: Stem cells including mesenchymal stem cells (MSC) hold great potential
in treating autoimmune disorders. However, their clinical translation has been hindered
due to incomplete understanding of mechanisms of action (MOA) and potential safety
concerns. Recent evidence revealed that some of the MSC MOA may be associated with
extracellular vesicles (EV),
Methods: We investigated MSC derived exosomes in immune modulation in a multiple sclerosis
experimental autoimmune encephalomyelitis (EAE) a mouse model in vivo as well as in
T cell proliferation suppression and Treg induction in vitro.
Results: Our results indicated that that intravenous administration of exosomes produced
by MSCs stimulated by IFNγ (IFNγ-Exo) (i) enhanced the mean clinical score of EAE
mice compared to PBS control, (ii) home into the spinal cords and reduced demyelination,
(iii) decreased neuroinflammation and (iv) upregulated the number of CD4+/CD25+/FOXP3+regulatory
T cells (Tregs). In addition, we found that IFNγ-Exo significantly reduced the proliferation
of T-cells in vitro and reduced production of proinflammatory factors including IL-6,
IL-17 and IL-22 while enhanced the production of Indoleamine 2,3-dixygenase (IDO),
a key player in MSC-mediated immunosuppression.
Summary/Conclusion: Our findings suggest that stem cell derived EVs can serve as promising
candidates in treating autoimmune and neurodegenerative diseases.
Funding: National Institute of Health (1DP2CA195763-01; #NS082174).
PT12.12
Biocompatible myxobacteria-derived outer membrane vesicles show inherent antibacterial
activity against gram-negative and gram-positive microbes
Adriely Goes
a, Eilien Schulza, Philipp Lapuhsa, Robert Richterb, Fabian Panterc, Marcus Kochd,
Rolf Müllerc, Kathrin Fuhrmanne and Gregor Fuhrmanne
aHelmholtz Institute for Pharmaceutical Research Saarland, Biogenic Nanotherapeutics
(BION), Saarbrücken, Germany; bHelmholtz-Institute for Pharmaceutical Research Saarland,
Department of Drug Delivery (DDEL), Saarbrücken, Germany; cHelmholtz Institute for
Pharmaceutical Research Saarland, Department of Microbial Natural Products (MINS),
Saarbrücken, Germany; dLeibniz Institute for New Materials (INM), Saarbrücken, Germany;
eHelmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany;
6Helmholtz-Institut for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany
Introduction: Myxobacteria are gram-negative bacteria that live in the soil and can
be found in different habitats and they have been explored for their capability of
providing natural products with great potential for antimicrobial therapy. We investigated
the antimicrobial activity of OMVs isolated from the myxobacterial strains Cystobacter
velatus (Cbv34) and Cystobacter ferrugineus (Cbfe23) against E. coli DH5-alpha and
S. aureus Newman. Cbv34 and Cbfe23 are producers of the antibacterial compound cystobactamid
that we hypothesized to be naturally loaded into the OMVs they shed.
Methods: The OMVs were isolated by differential centrifugation and size-exclusion
chromatography. Particle size, distribution, concentration and morphology were analysed
by nanoparticle tracking analysis and cryo-transmission electron microscopy. Particle
interaction and uptake into macrophages (THP-1) and lung alveolar epithelial cells
(A549) was investigated by confocal laser scanning microscopy and flow cytometry.
Cytotoxicity and viability assays were performed using PrestoBlue and lactate dehydrogenase
assays. The antibacterial activity of the OMVs was assessed by overnight incubation
with E. coli or S. aureus, followed by optical density measurement and CFU determination.
The OMVs content was investigated by liquid chromatography coupled mass spectrometry.
Results: Both OMVs did not induce cytotoxicity or negatively influenced the viability
of THP-1 and A549 cells even at concentrations of 10,000 OMVs/cell. Cbv34 and Cbfe23
OMVs showed a bactericidal activity against E. coli and S. aureus. The antibacterial
effect of Cbv34 OMVs remained potent upon storage at 4°C for 4 weeks. The presence
of cystobactamid in Cbv34 OMVs was confirmed by MS. Using flow cytometry and labelled
OMVs, we observed 60% positive cells for Cbv34 OMVs and 40% positive cells for Cbfe23
OMVs with THP-1, and 50% positive A549 cells for Cbv34 OMVs after 4 h of incubation.
Summary/Conclusion: The biocompatibility, inherent bacterial activity and uptake into
mammalian cells may be promising for the treatment of infections, especially those
induced by intracellular S. aureus. However, their mechanism of action needs further
investigation.
Funding: This work was supported by the Federal Ministry for Research and Education
through the NanoMatFutur programme.
PT12.13
Placental MSCs and their exosomes as vehicles for the Na/I symporter (hNIS): a new
theragnostic agent
Alejandra Crespo-Barredaa, Miguel Quintanillab, Maite Iglesiasc, Antonio de la Viejad
and Pilar Martin-Duque
e
aInstituto Aragonés de Ciencias de la Salud/ Universidad Francisco de Vitoria, Majadahonda,
Spain; bInstituto de Investigaciones Biomedicas Alberto Sols, Madrid, Spain; cUniversidad
Francisco de Vitoria, Madrid, Spain; dInstituto de Salud Carlos III, Madrid, Spain;
5Instituto Aragonés de Ciencias de la Salud/ IIS Aragón/ Fundación Araid, Zaragoza,
Spain
Introduction: The Na > I symporter gene (hNIS) is expressed in the thyroid and allows
the accumulation of iodine from the diet, to form T3 and T4 hormones. Moreover, it
is widely used (i) as a reporter gene for molecular imaging (when the positron emitter
isotope is I124 for PET or Tc99 for SPECT) or (ii) as a therapeutic gene for cancer
therapy, mediated by the accumulation of 1131. An unresolved challenge is how to direct
this gene specifically to the tumoral area.
Previously, our group demonstrated the migratory capacity of placental mesenchymal
stem cells (MSCs), carrying an adenovirus expressing hNIS to tumours, with good results
as a theragnostic tool. However, as hNIS is expressed at the placental tissue (because
it transfers iodine to the foetus from the maternal blood), in this work we decided
to study whether placental MSCs and their derivatives (exosomes) (1) express hNIS
endogenously and therefore transfers the imaging and therapeutic potentials when administered
with radioactive iodine (2) are capable to reach the tumoral areas when they are intravenously
injected due to the tumoral tissues extravasation.The aim of this research was to
develop a new anti-tumoural therapy by the combination of the advantages of both NIS
and the human placental MSCs (hPMSCs).
Methods: Here, we used two approaches using the endogenous hNIS expression, first
in hPMSCs but also on its exosomes. For both cases, we determined in vitro NIS location
and functionality but also we followed those vectors by SPECT CT and studied their
antitumoral effect after radioactive iodine injection.
Results: We proved that human placenta MSCs and their exosomes have endogenous expression
of NIS, migrate specifically to the tumour and their endogenous expression of NIS
is enough to visualized in vivo cells and exosomes accumulation and to see significant
therapeutic effect on cancer treatment with 131I.
Summary/Conclusion: Our findings highlight the possibility to use endogenous expression
of NIS as therapy and opening a wide range of new possibilities to treat cancer.
Funding: This work has been funded by Universidad Francisco de Vitoria, Instituto
de Salud Carlos lll and Instituto Aragonés de Ciencias de la Salud
LBT01: Late Breaking- Technological advances Chairs: M. Selim Unlu, Olga ShatnyevaLocation:
Level 3, Hall A15:30–16:30
LBT01.01=OWP1.09
Coagulation influences properties of extracellular vesicles isolated from autologous
blood derived products
Andrea De Luna
a, Alexander Otahala, Olga Kutenb, Zsombor Laczac and Stefan Nehrera
aDanube University Krems, Krems, Austria; bOrthoSera GmbH, Krems, Austria; cOrthosera
GmbH, Krems, Austria
Introduction: Platelet rich plasma (PRP) is the most commonly used blood derivative
in clinics due to its high concentration of platelets and perceived high growth factor
levels. Drawbacks of using PRP are discrepancies among preparation protocols and the
presence of cells (platelets, leuxcocytes) which can evoke cellular processes (e.g.
inflammation) when injected into the host. One possibility is to isolate only the
active components of blood derivatives which may overcome this problem. In the current
study we focused on extracellular vesicles (EVs) isolated from two autologous blood
derivatives, PRP and hyperacute serum and investigated whether the clotting cascade
influences EV properties.
Methods: EVs were isolated from citrate-anticoagulated PRP (CPRP) and hyperacute serum
using differential ultracentrifugation followed by a size exclusion chromatography.
Particle concentration and size were determined by nanoparticle tracking analysis
(NTA). Cryo-electronmicroscopy was performed to visualize isolated EVs. Expression
of miRNAs transported within EVs as well as in their respective input material was
analysed by qPCR.
Results: NTA revealed higher particle concentrations and bigger sized EVs within CPRP
compared to hyperacute serum. These findings were confirmed by cryo-electronmicroscopy.
Profound differences were detected regarding miRNA expresion between the two blood
derivatives. 126 miRNAs were identified which were expressed both in input material
as well as in the corresponding EVs. The correlation between miRNAs in EVs and input
material was higher in CPRP compared to hyperacute serum meaning that in hyperacute
serum miRNAs were identified which were higher expressed in EVs than in the corresponding
input material.
Summary/conclusion: EVs from autologous blood products represent a novel and cell
free regeneration approach. We observed that the clotting cascade (plasma versus serum)
has an influence on concentration, size and miRNA expression patterns of EVs. These
differences might have an impact on the biological mode of action of blood derived
products used in clinics.
Funding: Financial support was received from the European Fund for Regional Development
(EFRE) and the Science Fund of Lower Austria. miRNA expression analysis was performed
by TAmiRNA GmbH. Cryo-electronmicroscopy was conducted at the Core Facility of the
Vienna Bio-Center.
LBT01.02=OWP1.11
Ev-avogadro project: towards a liposomal concentration standard for extracellular
vesicle research
Gergo Bartaa, Diana Kitkaa, Andras Wachaa, Judith Mihalya, Attila Botaa, Krisztina
Nemetha, Pal Szaboa, Jean-Luc Fraikinb and Zoltan Varga
c
aResearch Centre for Natural Sciences HAS, Budapest, Hungary; bSpectradyne LLC, Torrance,
USA; cResearch Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest,
Hungary
Introduction: There is an unmet need for standardization of concentration measurements
in the field of extracellular vesicles (EVs). Liposomes may serve an ideal reference
system for EVs, but the determination of the number concentration of liposomes from
first principles was not attempted so far. Inspired by the International Avogadro
project, we aimed to determine the concentration of liposomes with well-defined size
and composition via counting the number of phospholipid molecules in these “nanospheres”.
Methods: Liposomes composed of phosphocholine and phosphoglycerol were prepared by
the extrusion method. Wide-angle X-ray scattering (WAXS) was used to determine the
area-per-lipid value. The size distribution of the liposomes was determined by microfluidic
resistive pulse sensing (MRPS) and freeze-fracture combined TEM. Small-angle X-ray
scattering (SAXS), differential scanning calorimetry (DSC), and infrared spectroscopy
(IR) were used to prove the unilamellarity, the ideal miscibility of the lipids and
the ordered packing of the hydrocarbon chains of the lipids, respectively. Concentration
of the lipids was determined by liquid chromatography–mass spectrometry (LC-MS).
Results: The prepared liposomes proved to be unilamellar with narrow size distribution
(83 nm avg.), as obtained by MRPS and TEM. DSC and IR measurements confirmed that
the phospholipid bilayer of these liposomes is in the liquid-ordered phase, hence
the area-per-lipid of 0.41 nm2 was determined from WAXS measurements. Using the concentration
of phospholipids from LC-MS measurements, the number concentration of liposomes was
determined (8E+13 1/mL).
Summary/conclusion: Liposomes containing saturated phospholipids are in the liquid-ordered
phase, which can be utilized to determine the area-per-lipid using WAXS. This value,
together with the independently determined size, and lipid concentration can be used
to calculate the number concentration of liposomes. As the light scattering properties
of liposomes matches that of EVs, liposome based standards for optical measurements
of EVs can be obtained with the presented techniques.
Funding: This work was supported under grant numbers PD 121326 and NVKP_16-1-2016-0007
by NKFIH (Hungary). ZV was supported by the János Bolyai Research Fellowship.
LBT01.03
Standards for EV research
John Nolan
a, Erika Duggana, Ngoc Dob, Franklin Monzonb, Jean-Luc Fraikinc and Tom Maslanikd
aScintillon Institute, San Diego, USA; bSpectradyne, Torrance, USA; cSpectradyne LLC,
Torrance, USA; dCellarcus Biosciences Inc, San Diego, USA
Introduction: Progress in understanding the origins, composition, and effects of extracellular
vesicles (EVs) depends on the reproducibility and rigor of experimental results. Standards
can improve experimental rigor and reproducibility and promote data sharing. To address
the needs for standards for single EV analysis, we have developed a set of standardized
vesicle preparations and characterized them with respect to number, size, and cargo
using a suite of single EV characterizations methods.
Methods: We prepared synthetic lipid vesicles with a lipid composition approximating
that of a mammalian cell plasma membrane and extruded through a nucleopore membrane
(100 nm mean pore diameter). We prepared cell-derived EVs from washed red blood cells
(RBCs) and platelets (PLTs), and from cultured cell lines using centrifugation and
ultrafiltration. EV size and number were evaluated using microfluidic resistive pulse
spectroscopy (MRPS), nanoparticle tracking analysis (NTA), cryo-electron microscopy
(cryo-EM), conventional light scatter-based flow cytometry (FC), and fluorescence-based
vesicle flow cytometry (VFC). EV surface markers were measured using VFC with well-characterized
fluorescence-labelled antibodies and calibrated using fluorescence intensity and antibody
binding standards.
Results: Cell-derived EVs are stable for months at −80C and weeks at 4C, as assessed
by measurement of number, size distribution, and surface markers. RBC EVs had a median
diameter of 115 nm and expressed a median of ~2700 anti-CD235ab binding sites per
EV, while PLT EVs had a median diameter of 145 nm and expressed a median of ~1200
anti-CD41 binding sites per EV.
Summary/conclusion: EV standards that are well characterized at the single EV level
in terms of number, size, and molecular cargo can facilitate assay validation, sharing
of data and results between labs, and support the development of new analysis technologies
with improved sensitivity, resolution, and throughput.
Funding: Supported by the US National Institutes of Health.
LBT01.04
Cell-specific EV tetraspanin expression
John Nolan and Erika Duggan
Scintillon Institute, San Diego, USA
Introduction: Tetraspanins (TSs) are integral membrane proteins present on plasma
and internal membranes and are thought to affect membrane organization and function.
Tetraspanins can also be found in extracellular vesicles released from cells and have
been considered canonical EV markers. To gain insight into the significance of TS
expression on EVs, we used single vesicle flow cytometry (VFC) to measure the TS expression
on individual EVs from different cell sources.
Methods: EVs were prepared from 10 different cell lines cultured in seru-free media
and enriched by ultracentrifugation or ultrafiltration. EVs from washed red blood
cells (RBCs) and platelets (PLTs) by were isolated by centrifugation, and characterized
by nanoparticle tracking analysis (NTA), microfluidic resistive pulse spectroscopy
(MRPS), cryo-electron microscopy (cryo-EM), and vesicle flow cytometry (VFC). TS expression
was measured using a panel of phycoerythrin-conjugated monoclonal antibodies against
CD9, CD63, CD81, CD82, CD151, CD53 and CD231. The fluorescence scale was calibrated
using intensity standard meads and expressed as PE MESF (mean equivalent soluble fluorochromes).
Results: The “canonical” TS EV markers CD9, CD63, and CD81 were expressed on EVs from
all cells except RBCs, which expressed detectable amounts (LOD ~25 MESF) of no TS,
but the relative and absolute amounts varied drastically from cells which expressed
primarily CD9 molecules on EVs (PLT and A431), to those that expressed predominantly
CD63 (MCF7, U87) to those that expressed predominately CD81 (293T, iPSC-derived neurons).
Moreover, EVs from most cells expressed some level of CD151, while CD82 was detected
on EVs from A431 and U87MG cells.
Summary/conclusion: Tetraspanins appear to be involved in many different cellular
processes and their specific roles in EV-related physiology is not understood. Single
vesicle analysis of TS expression using VFC reveals the diversity in TS expression
and abundance on EVs from different cell types. Understanding the tetraspanin expression
on EVs may provide information about the cellular origin of EVs, their effects on
recipient cells, or both.
Funding: Supported by the US National Institutes of Health.
LBT01.05
Characterization of lipid profile of extracellular vesicles and lipoproteins in human
plasma and serum
Yuchen Sun
a, Kosuke Saitob and Yoshiro Saitob
aDivision of Medical Safety Science, National Institute of Health Sciences, Kanagawa,
Japan; bDivision of Medical Safety Science, National Institute of Health and Sciences,
Kawasaki, Japan
Introduction: Extracellular vesicles (EVs) are lipid bilayer nano-vesicles existing
in various biofluids, and regarded as valuable sources for biomarker. To data, the
main target field of previous biomarker studies on EVs are proteome and transcriptome.
Meanwhile, liquid chromatography coupled with high resolution mass spectrometry (LC-MS)
has recently been employed to study comprehensive lipid profiles of in vitro EVs and
their parental cells. However, lipid profile of EVs in biolfluids, especially blood
specimens such as plasma and serum, has not been well-characterized. To use control
data for EVs, we aimed to characterize lipid profile of EVs in human healthy plasma
and serum, and to compare their lipid profile with that of other lipid-containing
particles in blood, high density lipoproteins (HDL) and low/very low density lipoproteins
(LDL/VLDL).
Methods: EVs, HDL and LDL/VLDL fraction were collected from 12 plasma or serum samples
obtained from young healthy African Americans using commercially available isolation
kits. Written informed consents were obtained from all participating donors. Protein
marker expression of each fraction was analysed by Western blotting. Lipidomic analysis
was performed using LC-MS operating in negative ion mode.
Results: Successful EVs, HDL and LDL/VLDL isolations were validated by confirming
corresponding marker proteins (CD9; EVs, apoA-I; HDL, apoB; LDL/VLDL). As a result
of lipidomic analysis, we identified 264 lipids in plasma EVs, HDL and LDL/VLDL fractions.
We also found that EVs showed strikingly higher levels of lyso-glycerophospholipids
than HDL and LDL/VLDL. Additionally, compared with EVs, higher sphiongolipid species
levels were observed in LDL/VLDL, while polyunsaturated phosphatidylcholine were highly
detected in HDL. Similar profiles were also observed in each fraction derived from
human serum.
Summary/conclusion: Lipidomic profiling demonstrates that EVs has a unique lipid profile
compared with lipoprotein particles, although the biological meaning of these differences
should be further evaluated in future studies. Nevertheless, the method presented
in this study can be useful for lipid biomarker screening for EVs as well as lipoprotein
particles derived from both plasma and serum for human diseases.
Funding: Japan Agency for Medical Research and Development
LBT01.06
Enhancing extracellular vesicle isolation of human plasma verified by high resolution
lipidomics
Amani M. Batarseh
a, Alex Chenb, Kim Ekroosc, Susannah Hallald, Kimberley Kaufmane and Michael Marianif
aBCAL Dx, Eveleigh, NSW, Australia 2015, Eveleigh, Australia; bThermo Fisher Scientific,
Scoresby, VIC, Australia 3179, Scoresby, Australia; cLipidomics Consulting Ltd., Esbo,
Finland 02230, Esbo, Finland; dDiscipline of Pathology, Brain and Mind Centre, Sydney
Medical School, University of Sydney, Camperdown, NSW, Australia 2050, Camperdown,
Australia; e1-Department of Neurosurgery, Chris O’Brien Lifehouse, Camperdown, NSW,
Australia 2050, 2-Discipline of Pathology, Brain and Mind Centre, Sydney Medical School,
University of Sydney, Camperdown, NSW, Australia 2050, Camperdown, Australia; fThermo
Fisher Scientific, North Ryde, NSW, Australia 2113, North Ryde, Australia
Introduction: Extracellular vesicles (EVs) are secreted from many cell types and play
important roles in intercellular communication. EVs carry a range of biomolecules
that reflect the identity and molecular state of their parental cell and are found
in biological fluids. Omics studies have extensively focused on characterisation of
the protein and nucleic acid cargo of EVs while lipids are less studied. EVs are increasingly
being utilised in disease diagnosis as they are considered to carry valuable information
about the disease state. Thus, novel disease biomarkers might be identified EV lipidomes.
Methods: EVs were enriched from 1ml normal human plasma samples using ultracentrifugation
(UC), considered the gold standard approach for EV enrichment, and size exclusion
chromatography (SEC) using qEV original columns (Izon, NZ). Lipids extracted according
to Matyash et al. (2008) were loaded on a C30 Acclaim column (Thermo, AU) using a
Vanquish liquid chromatography (LC) system and analysed using a Fusion orbitrap mass
spectrometer (MS) using targeted and untargeted lipidomics approaches. LipidSearch
software was used to annotate and quantify lipid species.
Results: More than 250 lipid species were identified and quantified in the plasma
EVs following both enrichment methods. The two methods also generated highly similar
lipid profiles, indicating that SEC may be a viable alternative to the cumbersome
UC method. Interestingly, the SEC approach yielded less lysophosphatidylcholine (LPC)
lipids, which may be related to a more homogenous vesicle population captured by SEC.
Various literature reviews refer to glycerolipids, likely originating from co-isolating
vesicles such as low-density lipoproteins, as contaminants in the EV fractions. We
detected these lipids and propose that if they are differentially expressed in states
of disease, they can be used as biomarkers independent of their origin.
Summary/conclusion: This study presents a workflow for comprehensive lipidomics of
EVs using two isolation methods that are compatible with downstream state-of-the art
LCMS, improving our ability to study the lipid components of EVs and identifying new
disease biomarkers. As lipidome profiles were similar between the two isolation methods,
large scale diagnostic assays should consider employing the SEC, which is by far the
more efficient, scalable approach.
LBT01.07
Extracellular vesicle measurements with nanoparticle tracking analysis – An accuracy
and repeatability comparison between NanoSight NS300 and ZetaView
Daniel Bachurski
a, Maximiliane Schuldnerb, Phuong-Hien Nguyena, Alexandra Malzb, Katrin S. Reinersc,
Patricia C. Grenzid, Felix Babatze, Astrid C. Schausse, Hinrich P Hansena, Michael
Halleka and Elke Pogge von Strandmannb
aDepartment I of Internal Medicine, University Hospital of Cologne, University of
Cologne, Cologne, Germany; bExperimental Tumor Research, Center for Tumor Biology
and Immunology, Department of Hematology, Oncology and Immunology, Philipps University
Marburg, Marburg, Germany; cInstitute for Clinical Chemistry and Clinical Pharmacology,
University of Bonn, Bonn, Germany; dDepartment I of Internal Medicine, University
Hospital of Cologne, University of Cologne, Cologne, Germany, São Paulo, Brazil; eCECAD
Center of Excellence on ‘‘Cellular Stress Responses in Aging-Associated Diseases’’,
University of Cologne, Cologne, Germany
Introduction: The expanding field of extracellular vesicle (EV) research needs reproducible
and accurate methods to characterize single EVs. Nanoparticle Tracking Analysis (NTA)
is commonly used to determine EV concentration and diameter. As the EV field is lacking
methods to easily confirm and validate NTA data, questioning the reliability of measurements
remains highly important. In this regard, a comparison addressing measurement quality
between different NTA devices such as Malvern’s NanoSight NS300 or Particle Metrix’
ZetaView has not yet been conducted.
Methods: To evaluate the accuracy and repeatability of size and concentration determinations
of both devices, we employed comparative methods including transmission electron microscopy
(TEM) and single particle interferometric reflectance imaging sensing (SP-IRIS) by
ExoView. Multiple test measurements with nanospheres, liposomes and ultracentrifuged
EVs from human serum and cell culture supernatant were performed. Additionally, serial
dilutions and freeze-thaw cycle-dependent EV decrease were measured to determine the
robustness of each system.
Results: Strikingly, NanoSight NS300 exhibited a 2.0–2.1-fold overestimation of polystyrene
and silica nanosphere concentration. By measuring serial dilutions of EV samples,
we demonstrated higher accuracy in concentration determination by ZetaView (% BIAS
range: 2.7–8.5) in comparison to NanoSight NS300 (% BIAS range: 32.9–36.8). The concentration
measurements by ZetaView were also more precise (% CV range: 0.0–4.7) than measurements
by NanoSight NS300 (% CV range: 5.4–10.7). On the contrary, quantitative TEM imaging
indicated more accurate EV sizing by NanoSight NS300 (% DTEM range: 79.5–134.3) compared
to ZetaView (% DTEM range: 111.8–205.7), while being equally repeatable (NanoSight
NS300% CV range: 0.8–6.7; ZetaView: 1.4–7.8). However, both devices failed to report
a peak EV diameter below 60 nm compared to TEM and SP-IRIS.
Summary/conclusion: Taken together, NTA devices differ strongly in their hardware
and software affecting measuring results. ZetaView provided a more accurate and repeatable
depiction of EV concentration, whereas NanoSight NS300 supplied size measurements
of higher resolution.
LBT01.09
Exodisc for fast and robust isolation of extracellular vesicles from whole-blood
Vijaya Sunkaraa, Chi-Ju Kimb, Juhee Parkc, Hyun-Kyung Woo
d, Dongyoung Kima and Yoon-Kyoung Chod
aCenter for Soft and Living Matter, Institute for Basic Science (IBS), South Korea,
Ulsan, Republic of Korea; bUlsan National Institute of Science and Technology (UNIST),
South Korea, Ulsan, Republic of Korea; cCenter for soft and living matter, institute
for basic science (IBS), South Korea, Ulsan, Republic of Korea; dUlsan national institute
of science and technology (UNIST), South Korea, Ulsan, Republic of Korea
Introduction: The circulating nano-vesicles, known as extracellular vesicles, are
abundant in most of the body fluids and play vital roles in regulation of various
biological processes, including signalling in the tumour microenvironment. They possess
significant potential for disease diagnosis and treatment monitoring, however, their
use in clinical settings is limited due to lack of simple and robust isolation methods.
To address this, earlier we have developed Exodisc for isolation and analysis of the
EVs from urine. In this study, lab-on-a-disc for the isolation of EVs from whole blood,
Exodisc-B, is demonstrated.
Methods: Exodisc-B comprises of blood separation and filtration chambers connected
with individually addressable diaphragm valves for the automatic control of sequential
transfer of liquid samples. The device consists of two nano-porous membrane filters
with pore sizes of 600 nm (track-etched PC membrane) and 100 nm (AAO membrane). First,
the plasma was separated and passed through two filters sequentially to concentrate
the EVs on filter-II. Then the EVs were washed and transferred to a collection chamber
for retrieval. The performance of the device in comparison to ultracentrifugation
(UC) was evaluated by analysing yield, purity, RNA and protein content of the isolated
EVs.
Results: Compared with the UC technique, the Exodisc-B is capable of isolating at
least an order of magnitude higher number of EVs with about 30-fold higher mRNA count
within 40 min. Sandwich ELISA of EV-specific membrane proteins – CD9-CD81 – confirmed
that it can isolate EVs with a capture efficiency >75%. The device also facilitates
temporal monitoring of tumour progression within live mouse xenograft models over
a period of 13 weeks while using minimal volumes of weekly collected blood samples.
Further, in ELISA analyses of multiple cancer-related proteins extracted from EVs
isolated from human plasma, 43 patients were differentiated from 30 healthy donors.
Summary/conclusion: We have demonstrated the performance of Exodisc-B for label-free
and automatic isolation of EVs from whole-blood. The device offers a simple, fast
and efficient means of intact EV isolation in a reproducible manner, from small sample
volumes measuring as small as 30 µL of whole-blood.
Funding: This work was supported by grants A121994 and IBS-R020-D1 funded by the Korean
Government.
LBT01.10
Optimization and characterization of low vacuum filtration procedure – novel method
for the isolation of extracellular vesicles
Anna Elżbieta. Drożdż
a, Agnieszka Kamińskaa, Magdalena Surmanb, Agnieszka Gonet-Surówkac, Andrzej Wróbeld
and Ewa Łucja Stępieńd
aFaculty of Physics, Astronomy and Applied Computer Science of the Jagiellonian University,
Kraków, Poland; bInstitute of Zoology and Biomedical Research of the Jagiellonian
University, Kraków, Poland; cFaculty of Chemistry of the Jagiellonian University,
Kraków, Poland; dFaculty of Physics, Astronomy and Applied Computer Science of the
Jagiellonian University, Kraków, Poland
Introduction: Despite recent developments in the field of extracellular vesicles (EVs)
isolation methods, the process remains challenging, mainly due to the low isolation
yield, co-precipitation of proteins, changes in biophysical properties of EVs and
time consuming procedures. Answering these problems, we created and validated new
EVs isolation method – Low Vacuum Filtration (LVF) and compared it with two most commonly
applied procedures – differential centrifugation (DC) and ultracentrifugation (UC).
Methods: The main element of the isolation system is dialysis membrane (MWCO = 1,000
kDa) combined with the low vacuum pump, assuring the high yield of isolation and short
procedure time. EVs isolated from endothelial cells culture media have been characterized
by (a) transmission electron microscopy (TEM) (b) nanoparticle tracking analysis (NTA),
(c) western blot and (d) Fourier-Transform Infrared Spectroscopy (FTIR).
Results: TEM measurement visualized EVs with size of (a) LVF: 201 ± 136 nm, (b) DC:
256 ± 140 nm and (c) UC: 78 ± 25 nm. For LVF and DC EVs size was confirmed by NTA,
for UC estimated size was higher (224 ± 112 nm). NTA showed substantial increase in
EVs concentration, compared to the initial sample: (a) LVF: 22 fold, (b) DC: 13 fold,
(c) UC: 35 fold. Western blot analysis confirmed the presence of exosome’s (hsp70)
and ectosome’s (Arf6) markers in (a) LVF – CHsp70 = 0.48 ± 0.14 AU and CArf6 = 0.05 ± 0.02
AU, (b) DC – CHsp70 = 0.04 ± 0.01 AU and CArf6 = 0.07 ± 0.02 AU) and (c) UC (CHsp70 = 0.23 ± 0.12
AU and CArf6 = 0.07 ± 0.04 AU). We observed correlation between ATR-FTIR spectra quality
(amid I:lipids ratio) and the EVs and proteins concentration.
Summary/conclusion: LVF method is an easy and fast EVs isolation method which allows
for isolation of both ectosomes and exosomes from high volume sources and could be
an efficient alternative for commonly applied methods.
Funding: The authors acknowledge financial support from National Science Centre Poland
[grant no. 2017/25/N/ST5/00831].
LBT01.11
Heterogeneity of erythrocytes derived microvesicles: their size and concentration
Roberta Cordeiro Freezora and Sheelagh Heugh
b
aLondon Metropolitan University, London, United Kingdom; bline manager, London, United
Kingdom
Introduction: Extracellular Vesicles (EV) are heterogeneous populations of vesicles
with different compositions, physiochemical properties and sizes. Random sampling
is convenient when the population members are similar to one another on variables,
ensuring a high degree of representativeness because it can critically construct generalizability
of results. These key concepts can be misconstrued and blended, concealing the general
drawbacks of validity. Here, erythrocytes MV (eMV) samples were derived from the same
blood donor and are not to be presented as representative data of the general type
of MV population, but to compare their heterogeneity (induced and non-induced).
Methods: Blood cells were purified and isolated utilising the Ficoll-Paque PLUS method.
Erythrocytes concentrate pellets were used in 3 different ways (in triplicates): 1.
eMVc- erythrocyte pellet with 10 mL 200 nm filtered PBS pH 7.4; 2. eMV CaCl2- As in
1 plus 20 µL of 2 mM of CaCl2 and; 3. eMV NHS- as in 2 plus 1 mL 20 nm filtered normal
human serum (NHS). Samples were incubated for 45mins at 37°C and eMV were isolated
by ultracentrifugation and suspended in 200 nm filtered PBS then analysed using the
Guava flow cytometry (FC) EasyCyte HT system and qNano instrument.
Results: FC analyses showed similar characteristics in sizing and FC position (>800nm),
the majority of samples laying within the MV gate created (size beads used), but eMV
CaCl2 (3.4x10 6/mL) and eMV NHS (2.9x 10 7/mL) showed a significant increase in their
amount of release (P value/mL). qNano analyses showed an increase in concentration
distribution for induced samples (100nm to 800nm). eMVc peaks were concentrated between
170 nm to 220 nm (ranging 100 nm to 370 nm). eMV CaCl2 showed a greater concentration
between 150 nm to 250 nm (ranging 100 nm to 600 nm) and eMV NHS was between 120 nm
to 350 nm (ranging 100 nm to 750 nm).
Summary/conclusion: Here, the FC size beads proved to be useful not only for the measurement
of MV sizes, but also for the concentration as MV samples fitted with the created
gate. In relation to MV concentration distribution, the qNano proved to be a helpful
apparatus by accurately distributing the concentration of MV according to their size
spectrum. A combination of the different approaches may be able to provide useful
information on the amount of MV released from inducements.
LBT01.12
Pentapartite fractionation of particles in oral fluids by differential centrifugation
Chiho Hiraga
a, Tamiko Minamisawab, Sachiko Matsumurac and Kiyotaka Shibad
aDivision of protein Engineering, Japanease Foundation for Cancer Research, Koto-ku,
Japan; bJapanese Foundation for Cancer Research, Tokyo, Japan; cJapaese Foundation
for Cancer Research, Koto-ku, Japan; dJapaese Foundation for Cancer Research, Tokyo,
Japan
Introduction: Novel diagnostic methods are being developed for various oral maladies
by using extracellular vesicles (EVs) contained in oral fluids because EVs carry condensed
diagnostic information. However, our knowledge on the comprehensiveness of oral EVs
is still very limited. In particular, cross-contamination of desquamated epithelial
cells in oral fluids with EV fractions is our current interest because this contamination
could interfere with the diagnostic information. To understand the possible interference
of desquamated epithelial cells in oral EVs, we fractionated human oral fluids into
5 fractions by differential centrifugation and analysed the protein markers and nucleic
acids in the fractions.
Methods: We obtained oral fluids from three healthy volunteers with informed consent.
Each sample was separated into 5 fractions (0.3K, 2K, 10K, 160K and supernatant) by
differential centrifugation. The numbers and the sizes of the particles in the fractions
were analysed by nanoparticle tracking analysis (NTA). The expression levels of the
protein markers were estimated by western blotting (WB). The amounts of mitochondrial
and bacterial DNAs were quantified by PCR-based methods targeting the ND1 gene and
rRNA gene, respectively. The numbers of cells were estimated by Trypan blue and Papanicolaou
staining.
Results: Trypan blue staining showed that the 0.3K and 2K fractions contained 1.35 × 105
and 2.22 × 102 cells/mL of nucleated cells, respectively, while no intact cell was
observed in the 10K and 160K fractions by Papanicolaou staining. NTA showed that the
average diameters of the particles in the 10K, 160K, and the supernatant were 206.1 ± 17.0
nm, 122.1 ± 9.2 nm and 139.4 ± 29.4 nm, respectively. WB analyses showed that CD81,
CD9, Alix, and Aquaporin 5 were mostly enriched in the 160K fraction, whereas HSP70,
Ago2, and ATP5A were the most abundant in the 0.3K fraction. Mitochondrial DNA was
abundant in the 0.3K fraction, and bacterial ribosomal DNAs were present in the 0.3K
and 2K fractions.
Summary/conclusion: The WB suggested that HSP70, Ago2, and ATP5A can be used as markers
of whole cells (mostly desquamated cells). Because the expression levels of these
markers in 10K and 160K were very limited, we concluded that cross-contamination of
desquamated epithelial cell-derived particles in 10K and 160K would be very less,
if any.
LBT01.13
Heat shock protein-accessorized exosomes: presence in states of danger, disease, and
disruption
Xiaoli Yu
a, Mary Wanga, Anthony Fringuelloa, Steve Griffithsb and Michael Granera
aUniversity of Colorado Denver, Aurora, USA; bminervagen biotechnologies corporation,
tucson, USA
Introduction: Heat shock proteins (HSPs) function as chaperones under both normal
and pathologic conditions. As chaperones they assist in protein folding, in holding
protein complexes for current or future activation, and in the degradation of senescent
proteins for recycling of components and displaying for immune surveillance. During
stressful situations, HSP quantities and/or activities are increased as cells and
tissues seek protection from insults. On occasion, these insults can result in the
cell surface display of HSPs, which can then lead to the surface display of HSPs on
exosomes, membrane-enclosed vesicles released extracellularly after passage through
the endosomal system. HSPs present on the cell surface or in the extracellular space
are regarded as “danger signals” in an ancient biologic paradigm. HSP-accessorized
exosomes may act as “danger boli”, carrying not only the HSPs, but hundreds of components
of the stressed parental cell, capable of prompting immune responses, or possibly
immune suppression, depending on the status of the recipient cell.
Methods: Exosomes from the plasma of patients suffering from neurological maladies
(glioblastoma grade IV, traumatic brain injury, multiple sclerosis) are precipitated
by peptides designed to bind HSPs and analysed by metabolomics.
Results: The metabolome of exosomes purified by HSP peptides from plasma of patients
with various neurological disorders is distinct from that of blood exosomes from healthy
donors (>80 distinct compounds in GBM exosomes, and TBI exosomes; >30 compounds in
MS exosomes; all are unique to those groups). There are also numerous lipid and metabolic
pathways linked to those compounds.
Summary/conclusion: Such HSP-accessorized exosomes thus possess metabolites with possible
ties to the different CNS pathologies that may represent disease-specific biomarkers
in a “liquid biopsy” setting.
LBT02: Late Breaking- EV Biomarkers Chairs: Maja Mustapic; Dakota GustafsonLocation:
Level 3, Hall A 15:30–16:30
LBT02.01
Cancer stem cell-derived exosomes:potential for early detection in pancreatic cancer
Haobin Wang
a, Yingshu Luob, Margot Zoellerc and Shijing Yued
aThe third people‘s hospital of Chengdu/Affiliated hospital of Southwest Jiaotong
University, Chengdu, China (People‘s Republic); bUniversity of Electronic Science
and Technology of China, Chengdu, China (People‘s Republic); cHeidelberg University,
Heidelberg, Germany; dNankai University, Tianjin, China (People‘s Republic)
Introduction: Pancreatic cancer (PaCa) is the most deadly malignancy, due to late
diagnosis and early metastatic spread, which prohibits surgery. it is urgently for
reliable, early detection. Research shows that tumour-derived exosomes, which had
been present in the blood in the early stage of tumour formation and before metastasis,
is the vanguard forces of tumour formation and metastasis; Cancer stem cell-derived
exosomes (CSC-Exos) has stronger migration ability, so the detection of blood CSC-Exos
for early diagnosis and monitoring of progress for PaCa has great research potential
and the value of application.
Methods: Protein markers were selected according to expression in exosomes of PaCa
cell line culture supernatants, but not healthy donors’ serum- exosomes. According
to these preselections, serum-exosomes were tested by flow cytometry for the pancreatic
cancer stem cell marker Tspan8.
Results: The majority (95%) of patients with PaCa and patients with nonPa-malignancies
reacted with anti-Tspan8. Serum-exosomes of healthy donors’ and patients with nonmalignant
diseases were not reactive. Recovery was tumour grading and staging independent including
early stages.
Summary/conclusion: Thus, the evaluation of pancreatic CSC-derived exosomes awaits
retrospective analyses of larger cohorts, as it should allow for a highly sensi- tive,
minimally-invasive PaCa diagnostics.
Funding: Supported by the National Natural Science Foundation of China (No. 81702963)
LBT02.02=OWP3.01
Using plasma to identify neural biomarker for antidepressant response in a treatment
resistant cohort
Corina Nagy
a, Saumeh Saeedib, Jean-Francois Therouxc, Marina Wakidc, Naguib Mechawarc and Gustavo
Tureckib
aDHRC- McGill University, Verdun, Canada; bMcGill University, Verdun, Canada; cMcGill
University, verdun, Canada
Introduction: Small extracellular vesicles (SEV) have emerged as candidate biomarkers
in many complex diseases. An important characteristic of SEVs is their ability to
bidirectionally cross the blood-brain barrier. This is particularly important in the
context of major depressive disorder (MDD), where biomarkers are obtained from peripheral
tissue and have been hard to relate to changes in brain functioning. 60% of MDD patients
do not respond to their first antidepressant drug therapy (ADT) and treatment options
are entirely at the discretion of the physician. Findings that can predict ADT response
as well as provide insight into central mechanistic changes could revolutionize MDD
treatment. The aim of this study is to profile exosomal microRNA (miRNA) in the context
of ADT response in people with treatment-resistant depression. miRNA can act as biomarkers
and might influence recipient cells to provide insight on disease-relevant mechanistic
changes.
Methods: This pilot uses plasma from 10 controls and 10 patients with MDD (5 ADT responders
(RES), and 5 non-responders (NRES)) from baseline (T0, before treatment). SEVs were
isolated using a size exclusion column from Izon Science (Christchurch, New Zealand).
Each isolation was divided into a “whole exosome” fraction and an immunoprecipitated
“(NDE)” fraction using neural marker L1CAM. Quantitation and size determination was
done using Tunable Resistive Pulse Sensing (TRPS) on the qNano gold. RNA was also
extracted from SEVs from both fractions. The 4N-small RNA-Seq (Galas) protocol was
used for library preparation.
Results: We found that the range of SEVs in the NDE fraction was smaller than the
pool of all exosomes combined. Further SEVs from all depressed patients were significantly
smaller than controls irrespective of the fractions. Our sequencing results showed
an increase of miR-151a-3p and miR-3168 in NRES, and miR-22-3p in RES. These results
were specific to the NDE fraction.
Summary/conclusion: We have identified three potential biomarkers for ADT response
which are uniquely present in the neural-derived fraction of peripheral SEVs.
Funding: Canadian Institutes of Health Research
LBT02.03=OWP1.08
Isolation of neuron-specific extracellular vesicles
Dmitry Ter-Ovanesyan
a, Maia Kipmanb, Emma Kowalc, Ju Hyun Leeb, Wendy Trieub, Aviv Regevd, David Waltb
and George Churchb
aHarvard, Cambridge, USA; bWyss Institute, Boston, USA; cMIT, Cambridge, USA; dBroad
Institute, Cambridge, USA
Introduction: Human biological fluids contain extracellular vesicles (EVs) from different
cell types. It would be incredibly useful to be able to isolate EVs that originated
from specific cell types for diagnostic purposes as a way to gain molecular information
(RNA, protein) from inaccessible cell types non-invasively.
Methods: We have developed a general framework for identifying EV surface markers
that can be used for immuno-isolation of cell type specific EVs. As a proof of principle,
we have applied this framework to the isolation of neuron-derived EVs from human cerebrospinal
fluid or plasma. In addition to the computational analysis, we have developed an in-vitro
system of human neurons differentiated from human induced pluripotent (iPS) cells.
We performed mass spectrometry on EVs isolated from these neurons to identify neuron-specific
proteins. We also used this system to develop a robust immune-isolation method for
neuron EV markers.
Results: We have characterized the proteins present in neuron exosomes by mass spectrometry
and then used computational analysis of published gene expression and proteomics data
to come up with a list of candidate neuron-specific EV markers. After developing methods
for immuno-isolation of neuron EVs with these markers, we applied our methods to human
cerebrospinal fluid and plasma.
Summary/conclusion: We have developed a framework for the isolation of cell type specific
EVs through the combination of an experimental in vitro system and computational analysis
of gene expression and proteomics data. We have applied this framework to the isolation
of neuron-specific EVs in human biological fluids. We envision these methods being
broadly applicable to the development of novel diagnostic biomarkers for a variety
of diseases.
LBT02.04
Labelling and tracking extracellular vesicles using a RNA-targeting AIE fluorogen
Bo Situ, Xiaojing He and Lei Zheng
Nanfang hospital, southern medical university, guangzhou, china (people‘s republic)
Introduction: Extracellular vesicles (EVs) are considered as crucial carriers in cell-to-cell
communication, immune response, tumourigenesis and metastasis. To gain direct insights
into EVs functions, it is necessary to observe their intracellular localizations and
biodistribution. Given the fact that EVs carry various RNA species, fluorescence labelling
of RNA in EVs is one of the most high-profile strategies. However, ideal probes are
still lacking.
Methods: In this work, we report that a commercial cell-permeant dye HSP may serve
as a simple and facile probe for staining RNA within EVs. The good performance of
HSP allows EVs to be analysed and imaged by nano-flowcytometry and structured illumination
microscopy (SIM), respectively. Additionally, for the first time we uncover that HSP
exhibits typical AIE (aggregation-induced emission) property. The labelling procedure
can thus be performed in a wash-free manner due to the low fluorescent background
of HSP in water before binding to RNA, which greatly avoid EVs losing during the experiment.
Results: HSP shows advantages over traditional SytoRNASelect in labelling EVs RNA
in terms of its superior brightness, high specificity and excellent photostability.
Summary/conclusion: HSP may serve as a new probe for EVs labelling and shows great
potential in studying behaviours and bio-distributions of EVs in a wide range of research
fields.
LBT02.05
The identification of extracellular vesicles proteins in glioblastoma diagnosis
Szu-Yi Chou
a, Che-Chang Changb and Shun-Tai Yangc
aGraduate Institute of Neural Regenerative Medicine, Taipei Medical University, Taipei,
Taiwan (Republic of China); bGraduate Institute of Translational Medicine, Taipei
Medical University, Taipei, Taiwan (Republic of China); cDivision of Neurosurgery,
Shuang Ho Hospital, Taipei, Taiwan (Republic of China)
Introduction: Glioblastoma multiforme (GBM) is a highly malignant type of brain tumour
in humans. GBM cells reproduce quickly and the median survival time for patients is
about 1 ~ 2 years. Current diagnostics and treatments for GBM are limited. Recently,
many studies used proteomic analyses of GBM extracellular vesicles (EVs) or secretomes
have been helpful in identifying biomarkers and potential treatment strategies for
GBM.
Methods: Herein, our study used mass spectrometry (MS) to analysis the EV proteins
from GBM cell lines – U87 and A172, and normal human astrocyte – SVG-p12 cultures.
IPA analysis identified several proteins from GBM cell lines EVs are significantly
different from the normal astrocytes cultures. EVs from 30 patients plasma with different
grades of glioma were isolated and analysed to conform the findings from IPA analysis
Results: We identified several signalling pathways have been changed in different
GBM cultures. Further validation with 30 different grade of glioma patients, we identified
three proteins – chaperonin containing TCP1 subunit 8 (CCT8), Glypican (GPC1) and
Periostin (POSTN) which levels in plasma EVs are associated to GBM but not plasma
which also have been reported associated to GBM progression. Database analysis also
found the EVs level of CCT8, GPC1 and POSTN in different grade of glioma can represent
the RNA level in tumour from microarray. Additionally, we also found some specific
signalling pathways changes in different GBM lines such as transforming growth factor
beta induced (TGFB1) in U87 EVs and prosaposin (PSAP) in A172 EVs. The elevation of
different molecules in EVs provides specific characters to individual GBM.
Summary/conclusion: We found EV contents – CCT8, GPC1 and POSTN were associated in
GBM which could be used for clinical diagnosis; also some different GBM EV proteins
– TGB1 and prosaposin could be used in characterization and targeting therapy of GBM
in the further.
Funding: Ministry of Science Technology – MOST 105-2628-B-038-005-MY3
LBT02.06
Universal reference transcripts for miRNA normalization – a meta-analysis on human
blood extracellular vesicle RNA sequencing data sets
Alexander Hildebrandta, Benedikt Kirchner
a, Chenna R. Galivetib, Esther N. Nolte-‘t Hoenb and Michael Pfaffla
aAnimal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical
University of Munich, Freising, Germany, Freising, Germany; bDepartment of Biochemistry
and Cell Biology, Utrecht University, Utrecht, The Netherlands, Utrecht, Netherlands
Introduction: Due to their importance in intercellular communication, extracellular
vesicles (EV) have emerged as important sources of biomarkers for pro- and diagnostic
purposes. With the advent of RNA-seq as the tool of choice for unbiased biomarker
screening, a major focus has been laid on miRNAs, important regulators of post-transcriptional
gene expression. Feasibility of RNA biomarkers presently still relies on validation
and analysis by RT-qPCR which in turn is depending on stably expressed reference transcripts
for normalization. To assess whether a set of universal reference miRNA transcripts
for normalization exists, a meta-analysis on blood derived EV samples was conducted.
Methods: From eight different research studies, we analysed small RNA-seq reads of
531 EV samples that were isolated from various pathological conditions or healthy
controls and enriched by standardized methods (SEC, UC or precipitation). To account
for the variety of commonly utilized RNA-seq analysis methods, a standardized big-data
analysis pipeline was established, that combined robust filtering by six different
normalization methods and three algorithms to detect suitable reference transcripts.
Sets of stably expressed transcripts were finally compared across different studies,
isolation methods and data analysis combinations.
Results: Results of our pipeline showed substantial overlap for miRNAs ranked by stability
for different normalizations and algorithms over all samples albeit compromised by
high variances in general. Contrarily reference miRNAs determined within a single
research study showed much higher stability values and were consistent over multiple
analysis combinations.
Summary/conclusion: Although first results suggest the possibility that blood EVs
contain a common set of miRNAs that may be used as universal reference transcripts,
different EV isolation methods, pathophysiological conditions and sequencing methodology
have a major influence on expression profiles. With the availability of additional
small RNA-seq data sets in the future, robustness and validity of miRNA references
will continue to grow, but success will ultimately be depending on further standardization
of EV isolation and data analysis. Based on the current data, we recommend analysing
reference transcripts in each study individually.
LBT02.07
Small extracellular vesicle content in porcine blood plasma, cerebrospinal fluid and
seminal plasma for proteomic analyses in biomarker discovery
Helena Kupcova Skalnikova
a, Jakub Cervenkaa, Karolina Turnovcovab, Bozena Bohuslavovaa, Jana Juhasovaa, Stefan
Juhasa and Petr Vodickaa
aCzech Academy of Sciences, Institute of Animal Physiology and Genetics, Libechov,
Czech Republic, Libechov, Czech Republic; bCzech Academy of Sciences, Institute of
Experimental Medicine, Prague, Czech Republic, Prague, Czech Republic
Introduction: Extracellular vesicles (EVs) released to body fluids carry molecules
of the source cells and are subjects of intensive research of protein and nucleic
acid biomarkers of diseases. Pig represents a valuable experimental biomedical model
to study human diseases due to close anatomic and physiologic similarity to human.
The aim of this work was to compare suitability of porcine blood plasma, cerebrospinal
fluid and seminal plasma for EV isolation for proteomic analyses and optimize sample
preparation for mass spectrometry.
Methods: EVs were isolated from porcine body fluids by differential centrifugation
and ultracentrifugation and characterized by transmission electron microscopy, flow
cytometry and western blotting. Three different lysis buffers (RIPA, Triton X100 and
SDS) were compared in efficacy to extract EV proteins in combination with filter-aided
sample preparation (FASP) for LC-MS/MS analysis (triple TOF).
Results: Seminal plasma yielded largest amount of EVs, followed by blood plasma. In
cerebrospinal fluid, the EV content was very low. Proteomic analysis of seminal plasma-derived
EVs enabled identification of approximately 1200 proteins, including 76 of the top
100 mainly identified proteins in EVs (Exocarta). Approximately 550 proteins were
quantified by SWATH-MS. In contrast, only 200 proteins were identified in the crude
seminal plasma used for EV isolation.
Summary/conclusion: We have optimized techniques for the EV enrichment from porcine
body fluids and for characterization of their protein content by mass spectrometry.
Such techniques may be applied to biomarker discovery in porcine model of diseases
as well as adopted to other species, including human.
Funding: This study was supported by Czech Science Foundation (reg. No. 19-01747S),
Operational Programme Research, Development and Education (reg. No. CZ.02.1.01/0.0/0.0/16_019/0000785),
and National Sustainability Programme I. of the Czech Ministry of Education, Youth
and Sports (reg. No. LO1609).
LBT02.08
Quantitative proteomic profiling of tissue-exudative EVs identified a novel diagnostic
antigen for early detection of colorectal cancer
Makoto Konishi
a, Makoto Sumazakia, Satoshi Nagayamab and Koji Uedaa
aCancer Proteomics Group, Cancer Precision Medicine Center, Japanese Foundation for
Cancer Research, Tokyo, Japan; bDepartment of Gastroenterological Surgery, Cancer
Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
Introduction: Development of biomarkers for early detection of colorectal cancer (CRC)
is demanded as the number of CRC patients is increasing. Recent studies exhibit that
extracellular vesicles (EVs) are expected as biomarker carriers in any body fluids.
To explore CRC-specific antigens, we isolated EVs from viable CRC or adjacent normal
tissues (n = 17), followed by global quantitative proteome analysis.
Methods: Tissue-exudative EVs (Te-EVs) were purified from serum-free media of freshly
resected CRC and adjacent normal tissues, using the sequential ultracentrifugation
method (n = 17). Purified Te-EVs were analysed by Orbitrap Fusion Lumos LC/MS system
(Thermo Scientific). Protein identification, label-free quantification, and statistical
analysis were performed on MaxQuant and Proteome Discoverer softwares. A statistically
valid biomarker candidate protein (TMAM) was further evaluated by plasma exosome sandwich
ELISA (n = 357). Additional clinical and functional assessments were also performed
including IHC staining and cell growth assays.
Results: Among 6,149 identified Te-EV proteins, 393 proteins were significantly overexpressed
(p < .05 and fold change > 4.0) in EVs from CRC tissues compared to those from normal
mucosa. We especially focused on transmembrane protein TMAM (p = 3.62 E-5, fold change = 7.0)
which was known to be a key regulator of cell growth and also overexpressed in CRC
cells. Exosome sandwich ELISA confirmed significant elevation of TMAM level in plasma
EVs even in stage-I CRC patients (n = 72) compared to healthy donors (n = 72, p = .040).
IHC staining analysis also showed that TMAM was specifically overexpressed in CRC
tissues. Interestingly, TMAM-overexpressed EVs decoyed its inhibitory ligand away
from cancer cells, resulting in their outgrowth.
Summary/conclusion: These results indicate that TMAM on EVs should have great potential
as a novel target for CRC diagnosis and therapy.
LBT02.09
Single-molecule co-Immunoprecipitation reveals functional inheritance of epidermal
growth factor receptors in extracellular vesicles
Mi Sook Sung
a, Jik Han Jungb, Tae-Young Yoonc, Ji-Ho Parkb and Cherlhyun Jeonga
aCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, Republic
of Korea; bDepartment of Bio and Brain Bioengineering, Korea Advanced Institute of
Science and Technology (KAIST), Daejeon, Republic of Korea; cSchool of Biological
Sciences and Institute for Molecular Biology and Genetics, Seoul National University,
Seoul, Republic of Korea
Introduction: Cancer cells actively release extracellular vesicles (EVs) as important
carriers of cellular information to tumour microenvironments. Although the composition
and quantity of the proteins contained in EVs are characterized, it remains unknown
how these proteins in EVs are related to those in the original cells at the functional
level. Ultimately, the question should be resolved to ensure the use of EVs in diagnosing
the status of cancer patients by liquid biopsy.
Methods: Using the recently developed single-molecule immunolabelling and co-immunoprecipitation
schemes, the quantity and PPI strengths of EGFRs derived from EVs and the original
lung adenocarcinoma cells are determined.
Results: It is found that the microvesicles exhibit higher correlations with the original
cells than the exosomes in terms of the EGFR levels and their PPI patterns. In spite
of these detailed differences between the microvesicles and exosomes, the EGFR PPI
strengths measured for EVs generally show a tight correlation with those determined
for the original cells.
Summary/conclusion: With epidermal growth factor receptor (EGFR) in lung adenocarcinoma
cells as a model oncoprotein, it is studied how distinct types of EVs, microvesicles
and exosomes, represent their original cells at the protein and protein–protein interaction
(PPI) level. The results suggest that EGFRs contained in EVs closely reflect the cellular
EGFR in terms of their downstream signalling capacity. Moreover, it gives a possibility
that EGFRs derived from different types of EVs may work as a biomarker for the intensity
of the EGFR signalling pathway in the parental cancer tissue.
LBT03: Late Breaking- EVs and Stem Cells Chairs: Sicheng Wen; Hiroaki TatenoLocation:
Level 3, Hall A 15:30–16:30
LBT03.01
Regenerative potential of extracellular vesicles-derived from mesenchymal stem cells
on epithelial wound healing
Tatiana Lopatina
a, Chiara Gaib, Giovanni Camussic and Giuseppe Montrucchiod
aPostdoc, Turin, Italy; bDepartment of Medical Sciences, University of Turin, Turin,
Italy; cDepartment of Medical Sciences, University of Turin, Turin, Italy; dUniversity
of Turin, Turin, Italy
Introduction: Wound healing is a complex process involving cell death, migration,
proliferation, differentiation, inflammation, and extracellular matrix remodelling.
A key role in this context is played by resident stem cells. Mesenchymal stem cells
(MSCs) favour wound healing via extracellular vesicles (EVs), which transfer transcription
modulators and nucleic acid, including mRNA and micro-RNA.
Methods: We found that MSC-derived EVs favour epithelial wound healing in vitro, and
that EVs regulate the EGFR/PI3K/Akt/mTOR pathway, a key player in keratinocyte stem
cells biology, glucose homeostasis and aging. Moreover we have characterized the mRNA
and miRNA content of MSC-derived EVs and our analysis revealed several miRNA potentially
involved in wound healing. To identify potential miR candidates, we clustered miRNAs
expressed by EVs into families, according to their seed sequence and scanned the 3ʹ-UTR
of keratinocyte expressed genes for perfect seed-match occurrences. To account for
potential cooperative action of different miRNAs, we will restrict our research to
those genes targeted by at least 2 expressed miRNA families.
Results: We selected several miRNAs which target wound healing cellular pathways and
carried by MSC-EVs (miR-let-7a-5p, miR-10a-5p, miR-10b-5p, miR-21-5p, miR-22-3p, miR-100-5p,
miR-143-3p, miR-146a, miR-191-5p, miR-181a-5p, miR-27b-3p). We have found that miRNA146a
is a key activator of the Notch1/Akt pathway. Notably, Notch1 levels are elevated
in limbal-corneal epithelial stem cells relative to their migratory cell progenies,
and abnormally elevated miRNA146a levels are implicated in defective corneal wound
healing in diabetes. Thus, miRNA146a may regulate the balance between LESC self-renewal
versus migration/differentiation via Notch/Akt regulation.
Summary/conclusion: We have shown that transfection of MSC by siRNA anti miR-146a
decrease the biologic effect of MSC-EVs on migratory capacity of epithelial cells.
It could be a direct effect of the absence of miR-146a in MSC-EVs or consequence of
the miR-146a signalling pathway disruption.
Funding: CAMG_PRIN_2015_16_01
LBT03.02
Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC)
and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological
function in rat after acute ischemic stroke
Shun-Cheng Wu
a, Pei-Lin Shaob and Hon-Kan Yipc
aOrthopaedic Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung,
Taiwan (Republic of China); bDepartment of Nursing, Asia University, Kaohsiung, Taiwan
(Republic of China); cDivision of Cardiology, Department of Internal Medicine, Kaohsiung
Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung,
Taiwan (Republic of China)
Introduction: We tested the hypothesis that combined xenogenic (from mini-pig) adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy could reduce brain-infarct
zone (BIZ) and enhance neurological recovery in rat after acute ischemic stroke (AIS)
induced by 50-min left middle cerebral artery occlusion.
Methods: Adult-male Sprague-Dawley rats (
n
= 60) were divided equally into group 1 (sham-control), group 2 (AIS), group 3 [AIS-ADMSC
(1.2 × 106 cells)], group 4 [AIS-exosome (100 μg)], and group 5 (AIS-exosome-ADMSC).
All therapies were provided intravenously at 3h after AIS procedure.
Results: BIZ determined by histopathology (by day-60) and brain MRI (by day-28) were
highest in group 2, lowest in group 1, higher in groups 3 and 4 than in group 5, but
they showed no difference between groups 3 and 4 (all p < .0001). By day-28, sensorimotor
functional results exhibited an opposite pattern to BIZ among the five groups (p < .005).
Protein expressions of inflammatory (inducible nitric oxide synthase/tumour necrosis
factor-α/nuclear factor-κB/interleukin-1β/matrix metalloproteinase-9/plasminogen activator
inhibitor-1/RANTES), oxidative-stress (NOX-1/NOX-2/oxidized protein), apoptotic (caspase-3/Poly-ADP-ribose
polymerase), and fibrotic (Smad3/transforming growth factor-β) biomarkers, and cellular
expressions of brain-damaged (γ-H2AX+/XRCC1-CD90+/p53BP1-CD90+), inflammatory (CD11+/CD68+/glial
fibrillary acid protein+) and brain-oedema (aquaporin-4+) markers showed a similar
pattern of BIZ among the groups (all n < 0.0001).
Summary/conclusion: In conclusion, xenogenic ADMSC/ADMSC-derived exosome therapy was
safe and offered the additional benefit of reducing BIZ and improving neurological
function in rat AIS.
LBT03.03
Changes in amino acid concentration of umbilical cord mesenchymal stem cell culture
medium
Angliana Chouw, Geofanny Facicilia, Cynthia Retna Sartika, Emilia Rahmadania Utami,
Julia Riswandani, Yanni Dirgantara, Dwi Ajeng Permata Dewi and Endah Dianty Pratiwi
PT prodia stemcell Indonesia, Jakarta, Indonesia
Introduction: Mesenchymal Stem Cell is a multipotent cell that works in two ways,
replacing the injured cells and releasing active biomolecules that work as a paracrine
signal for cell migration and proliferation. Recent discoveries suggest that potential
cytokine, growth factors, and many different soluble factors are released by MSCs
during the culturing process into its environment. In this study, we aim to analyse
that changes of amino acid concentration from the fresh complete growth medium and
post-culture medium from umbilical cord mesenchymal stem cell (UC-MSC) cultured.
Methods: UC-MSC was cultured with the seeding density of 5000 cells/cm2 in tissue
culture plasticware. When the cells, reached 70–80% confluency, the culture medium
was collected and centrifuged to remove the unwanted debris. Collected medium was
stored in −80°C until the amino acid concentration was analysed using Mass Spectrophotometry.
Results: The fresh and post-culture media contains both essential and non-essential
amino acid. The post-culture culture media contains higher amino acid compared to
the fresh medium. In this study, there is an increasing concentration of glycine,
l-arginine, l-phenylalanine, l-histidine, l-leucine, l-lysine, l-serine, l-threonine,
l-tyrosine and l-valine concentration. The concentration of L-glutamine from post-cultures
is decreasing compared to fresh medium while the concentration of L-glutamic acid
(+959 mg/ml) is increasing. This due to the regulation of glutamate synthase which
changes the L-glutamine into L-glutamate (L-glutamic acid). The methionine and cysteine
cycle also show by comparing both media, where methionine and cysteine are decreasing
to produce cystine.
Summary/conclusion: Glutamate-Glutamine cycle and Methionine-Cysteine cycles were
shown in the metabolism of UC-MSC proliferation during cell culture. This cause changes
in amino acid concentration between fresh and post-culture media.
Funding: All the research were funded by PT. Prodia StemCell Indonesia
LBT03.04
Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes
for protecting kidney from acute ischemia-reperfusion injury
Shun-Cheng Wu
a, Pei-Lin Shaob and Hon-Kan Yipc
aOrthopaedic Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung,
Taiwan (Republic of China); bDepartment of Nursing, Asia University, Kaohsiung, Taiwan
(Republic of China); cDivision of Cardiology, Department of Internal Medicine, Kaohsiung
Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung,
Taiwan (Republic of China)
Introduction: In this study, we tested the hypothesis that a combined adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat kidney
from acute ischemia-reperfusion (IR) injury (i.e., ligation of both renal arteries
for 1h and reperfusion for 72h prior to euthanization).
Methods: Adult-male SD rats (n = 40) were equally categorized into group 1 (sham control),
group 2 (IR), group 3 [IR+exosome (100 μg)], group 4 [IR+ADMSC (1.2 × 10(6) cells)]
and group 5 (IR-exosome-ADMSC). All therapies were performed at 3 h after IR procedure
from venous administration.
Results: By 72h, the creatinine level and kidney injury score were the lowest in group
1 and the highest in group 2, significantly higher in group 3 than in groups 4 and
5, and significantly higher in group 4 than in group 5 (all P < .0001). The protein
expression of inflammatory (TNF-α/NF-κB/IL-1β/MIF/PAI-1/Cox-2), oxidative-stress (NOX-1/NOX-2/oxidized
protein), apoptotic (Bax/caspase-3/PARP) and fibrotic (Smad3/TGF-β) biomarkers showed
an identical pattern, whereas the anti-apoptotic (Smad1/5, BMP-2) and angiogenesis
(CD31/vWF/angiopoietin) biomarkers and mitochondrial cytochrome-C showed an opposite
pattern of creatinine level among the five groups (all P < .001). The microscopic
findings of glomerular-damage (WT-1), renal tubular-damage (KIM-1), DNA-damage (γ-H2AX),
inflammation (MPO/MIF/CD68) exhibited an identical pattern, whereas the podocyte components
(podocin/p-cadherin/synaptopodin) displayed a reversed pattern of creatinine level
(all P < .0001).
Summary/conclusion: Combined exosome-ADMSC therapy was superior to either one for
protecting kidney from acute IR injury.
LBT03.05
Adipose-derived mesenchymal stem cell-derived exosomes alleviate overwhelming systemic
inflammatory reaction and organ damage and improve outcome in rat sepsis syndrome
Pei-Lin Shao
a, Shun-Cheng Wub and Hon-Kan Yipc
aDepartment of Nursing, Asia University, Kaohsiung, Taiwan (Republic of China); bOrthopaedic
Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
(Republic of China); cDivision of Cardiology, Department of Internal Medicine, Kaohsiung
Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung,
Taiwan (Republic of China)
Introduction: This study tested the hypothesis that healthy adipose-derived mesenchymal
stem cell (ADMSC)-derived exosomes (HMSCEXO) and apoptotic (A) (induced by 12 h hypoxia/12 h
starvation)-ADMSC-derived exosomes (AMSCEXO) were comparably effective at alleviating
sepsis syndrome [SS; induced by cecal-ligation and puncture (CLP)]-induced systemic
inflammation and reduced organ damage and unfavourable outcomes in rats.
Methods: SD rats were divided into sham control (SC), SS only, SS + HMSCEXO (100 µg
intravenous administration 3 h after CLP), and AMSCEXO.
Results: By day 5 after CLP procedure, the mortality rate was significantly higher
in SS than in SC and HMSCEXO (all P < .01), but it showed no significant different
between SC and HMSCEXO, between AMSCEXO and HMSCEXO or between SS and AMSCEXO (P > .05).
The levels of inflammatory mediators in circulation (CD11b/c/Ly6G/MIF), bronchioalveolar
lavage (CD11b/c/Ly6G) and abdominal ascites (CD11b/c/CD14/Ly6G/MIF) were highest in
SS, lowest in SC and significantly higher in AMSCEXO than in HMSCEXO (all P < .001).
The circulating/splenic levels of immune cells (CD34+/CD4+/CD3+/CD8+) were expressed
in an identical pattern whereas the T-reg+ cells exhibited an opposite pattern of
inflammation among the groups (all P < .001). The protein expressions of inflammation
(MMP-9/MIF/TNF-α/NF-κB/IL-1β) and oxidative stress (NOX-1/NOX-2/oxidized protein),
and cellular expressions (CD14+/CD68+) in lung/kidney parenchyma exhibited an identical
pattern of inflammatory mediators (all P < .001). The kidney/lung injury scores displayed
an identical pattern of inflammatory mediators among the groups (all P < .001).
Summary/conclusion: In conclusion, HMSCEXO might be superior to AMSCEXO for improving
survival and suppressing the inflammatory reactions in rats after SS.
LBT03.06
Bile acids hybrid extracellular vesicles derived from mesenchymal stem cells for cartilage
tissue regeneration
Yoshie Arai
a, Hyoeun Parka, Sunghyun Parkb, Alvin Belloc, Jinsung Ahna, Dohyun Kima, Byoung Ju
Kima, Hansoo Parkd and Soo-Hong Leee
aDongguk University, Goyang-si, Republic of Korea; bCHA University, Goyang-si, Republic
of Korea; cChung-Ang University, Goyang-si, Republic of Korea; dChung-Ang University,
Seoul, Republic of Korea; eDongguk University, goyang, Republic of Korea
Introduction: Tauroursodeoxycholic acids (TUDCA) has been known as an amphiphilic
therapeutic drug for a variety of diseases such as cholestasis, amyotrophic lateral
sclerosis, type 1 diabetes and so on. Recently, we reported TUDCA has a role in bone
and cartilage regeneration through leading to osteogenic or chondrogenic differentiation
of mesenchymal stem cells (MSCs). In addition, TUDCA is also able to form a nano-sized
micelle, penetrate and incorporate into the membrane of cells depending on the concentration,
therefore, suggesting that TUDCA would be a useful drug to modify cell membrane and
extracellular vesicles (EVs).
Methods: In this study, we investigated whether the EVs derived from the amphiphilic
bile acids-treated cells could produce hybrid EVs composed with cell membrane and
bile acid and also they include mRNA, micro RNA and proteins at the core of EVs. To
aim this, we isolated EVs from TUDCA-treated mesenchymal stem cells (MSCs) and identified
their characteristics. In addition, the regenerative effect of EVs was also evaluated
using degenerated chodnrocytes (DC) derived from the knee cartilage of osteoarthritis
(OA) patients.
Results: It was found that TUDCA-hybrid EVs (TUDCA-EVs) was successfully isolated
and the total amount of EVs was increased with the treatment of TUDCA. We also tried
to characterize the size and zeta-potential of TUDCA-EVs as well as the expression
of genes which are contained in TUDCA-EVs compared to control EVs. Next, TUDCA-EVs
were treated to DC. TUDCA-EVs treatment on degenerated chondrocyte (DC) increased
IL-6 expression associated with the differentiation of M2 macrophage and anti-inflammatory
signalling. In addition, TUDCA-EVs increased COL2 expression while they decreased
RUNX2 and MMP13, as a hypertrophic marker gene, expression in DC.
Summary/conclusion: These indicated that TUDCA-EVs have the potential to restore the
chondrogenic properties of degenerated chondrocytes. Therefore, it is concluded that
TUDCA-EVs would be a useful systemic drug for OA therapy. In ongoing in vivo study,
we are confirming whether TUDCA-EVs indeed have an influence on cartilage tissue regeneration
and alleviate OA symptoms.
LBT03.07
Role of stem cell-derived extracellular vesicles and their enriched microRNAs during
alcoholic liver injury
Nan Wua, Heather Francisa, Gianfranco Alpinib and Fanyin Meng
a
aIndiana University School of Medicine, Indianapolis, USA; bIndiana University School
of Medicine, Pittsburgh, USA
Introduction: Senescence of activated stellate cells limits hepatic fibrogenesis.
Stem cell-derived extracellular vesicles (EVs) and their related microRNAs mediate
genetic changes that promote recovery of liver disorders. The present study was aimed
to characterize the functional role of liver stem cell-derived EVs and specific miRNAs
in the regulation of hepatic stellate cell senescence during alcohol induced liver
injury.
Methods: microRNA expression was assessed using microarray and real-time PCR assays
in isolated EVs from human mesenchymal stem cells (MSCs) and liver stem cells (LSCs).
HSCs were also isolated from lin28 knockout mice with or without ethanol feeding for
5 weeks by laser capture microdissection (LCM) and the senescence and fibrosis genes
are evaluated by Western blot and real-time PCR analysis.
Results: We found that expression of several miRNAs were consistently up-regulated
in both MSCs and LSC- derived EVs compared to normal hepatocyte-derived EV controls,
including let-7 family members. Treatment of human HSCs with TGF-β/LPS (20 ng/ml)
for 72 h induced a significant decrease of let-7a and let-7b in both activated and
control states. Transfection of let-7a and let-7b precursors in human HSCs markedly
induced the expression of cellular senescence markers p16 and CCl2, and blunted the
enhanced expression of α-SMA, collagen a1, MMP-2 and MMP-9 (key genes involved in
the activation of HHSCs) by TGF-β/LPS treatment. Treatment with MSC/LSC derived EVs
(30 μg/ml, 72 h) phenocopied the senescence/anti-fibrosis effects of let-7 overexpression
in activated HHSCs by TGF-β/LPS. A complementary mass spectrometry-based proteomics
approach with luciferase reporter assay identified TLR4, the key LPS receptor, as
putative let-7 cluster target. Furthermore, the expressions of senescent hepatic stellate
markers and verified let-7 target genes, including α-SMA, collagen a1, p16, CCl2,
TLR4, MMP-2, MMP-9 and TIMP-3, were significantly altered in liver specimens and LCM
isolated HSCs from lin28 knockout mice with ethanol feeding relative to WT ALD mice
controls.
Summary/conclusion: Our findings provide new insight into the function of specific
miRNAs in stem cell-derived EVs regulating HSC senescence, and their therapeutic potentials
in alcoholic liver injury and fibrosis.
LBT03.08
Interferon-gamma priming, but not hypoxia, modifies the miRNA landscape of human mesenchymal
stromal cells (MSC) extracellular vesicles (EV)
Juliette Peltzera, Kyle Lundb, Philippe Mauduitc, Jean-jacques Latailladeb and Sebastien
Banzet
d
aInstitut de Recherche Biomédicale des Armées, INSERM UMR-MD-1197, Clamart, USA; bInstitut
de Recherche Biomédicale des Armées, INSERM UMR-MD-1197, Clamart, France; cINSERM
UMR-MD-1197, Villejuif, France; dInstitut de Recherche Biomédicale des Armées, INSERM
UMR-MD-1197, CLAMART, France
Introduction: MSC-based cell therapy has received great interest in the past years,
especially in regenerative medicine and tissue repair. The concept of priming consists
in preconditioning the cells during the culture phase (often with cytokines or hypoxia)
to improve their effects. The literature shows that MSC EVs can recapitulate a substantial
part of the beneficial effects of the cells they originate from, and that miRNAs are
key players in EVs action. Therefore, in the present work, our aim was to determine
if IFN or hypoxia priming of MSC could modify their EVs miRNA content.
Methods: Human bone marrow MSC from five healthy donors were isolated and cultured
at 20% of O2 in MEM-alpha/FBS medium until 60–70% confluence, then with (IFN) or without
(CONT) interferon-gamma (25ng/ml, 48 h) or in hypoxia (3% O2 throughout the duration
of the culture process). Then the cells were rinced with PBS and placed in serum free
MEM for 48 h. The conditioned media was collected and EV were isolated by ultracentrifugation
(100 000g for 1h10). Total RNA was isolated and reverse transcribed. Pools of CONT,
IFN and HYP cDNA were prepared, miRNA profiling was performed using Exiqon miRnome
PCR panel I and II. Then, selected miRNAs were measured on each sample.
Results: A set of 89 miRNAs was detected (quantification cycle < 35) in at least one
of the pools of MSC EVs. They were measured on each individual sample. 41 miRNAs were
measured in all samples; results were normalized with 5 endogenous miRNAs. Hypoxia
induced no significant modification of EVs miRNA content. IFN priming induced a significant
increase in hsa-miR-106a-5p, 25-3p, 126-3p, 451a and 665. Their validated targets
were determined with miRTarBase and the proteins were analysed with Panther classification
system. Among the most cited pathways, we found p53, inflammation, Wnt signalling,
Apoptosis signalling and Angiogenesis.
Summary/conclusion: MSC priming can modify the miRNA landscape of their EVs. IFN priming
modifies MSCs EVs miRNA involved in biological pathways relevant to tissue repair.
Functional analysis of these EVs with selected miRNAs inhibition is needed to evaluate
the biological effects of such an approach.
Funding: This work has been funded by the french Direction Générale de l’Armement,
Biomedef PDH-1-SMO-1–218
Industry Poster Session Thursday 25 April 2019 Location: Level 3, Hall A
IP.01
Standardizing F-NTA measurements: evaluation of four-wavelengths nanoparticle tracking
analysis with cell-line derived EVs
Clemens Helmbrechta and Paolo Guazzib
aParticle Metrix GmbH; bHansaBioMed Life Sciences
Introduction: Nanoparticle tracking analysis (NTA) has emerged to a vital and fast
characterization technology for exosomes, microvesicles or viruses. In combination
with fluorescence detection (F-NTA), NTA enables the user to perform biomarkers detection
on the single particle level, thus enhancing real EV concentration measurement. Classic
NTA instruments are equipped with one laser, requiring phenotyping in sequence. Multi-fluorescence
detection of four biomarkers in one sample by NTA is shown for the first time.
Methods: A four-laser NTA instrument (ZetaView PMX-420) equipped with excitation wavelengths
of 405, 488, 520 and 640 nm and dedicated long-pass filters was evaluated. Concentration
and particle size measurements were performed with fluorescent standard beads and
proprietary labelled sub-micrometre sized vesicles. Phenotyping was performed on EVs
from HCT116 cell line (HansaBioMed Life Sciences).
Results: The efficiencies of the individual laser channels were determined by fluorescently
labelled vesicles. SOPs for conjugation of EVs were optimized regarding antibody to
vesicle ratio and incubation time. Phenotyping by single and multi-wavelength NTA
for wash and no-wash strategies were compared regarding background and efficiency.
Summary/conclusion: Standardization of SOPs is a key to improve repeatability for
concentration measurements. Using four wavelengths, phenotyping of EVs was performed
with four-fold reduction of sample amount in shorter time compared to sequential one
laser measurements. NTA delivers total particle count, biomarker count and/or vesicle
count on one sample including size distributions. Cross-validation with complementary
techniques such as ELISA and FC/IFC becomes imperative.
IP.03
Double tangential flow filtration and size exclusion chromatography for scalable and
reproducible EV isolation and size fractionation
Elina Aleksejevaa, Julia Gavrilovaa, Maija Puhkab, Karina A. Barreiroc, Clemens Helmbrechtd
and Paolo Guazzie
aHansaBioMed Life Sciences; bInstitute for Molecular Medicine Finland and EV Core,
University of Helsinki; cInstitute for Molecular Medicine Finland (FIMM), University
of Helsinki, Finland; dParticle Metrix; eHansaBioMed Life Sciences
Introduction: The purification of Extracellular Vesicles (EVs) for industrial processes
is still missing of reproducible, scalable and high throughput method, applicable
to multiple sources of material (cell conditioned media, biofluids, plant extracts).
HansaBioMed Life Sciences (HBM-LS) has developed a scalable EV purification process
combining two tangential flow filtration steps followed by size exclusion chromatography.
We set a standardized procedure which easily allows the isolation and the collection
of big EVs (>200 nm), the fluid concentration and the removal of small molecules (<
500 kDa) with minimal loss of EVs, finally purified by SEC. The quality of vesicles
has been assessed in terms of particle size distribution, morphology, concentration,
phenotyping and storage stability.
Methods: EVs were isolated from cell conditioned media combining 2 TFF steps (HBM-TFF:
HBM-TFF-MV) and SEC (maxiPURE-EVs HBM-LS). EV morphology and phenotype was analysed
by NTA Zetaview (Particle Metrix), ExoTEST ELISA (HBM-LS), and electron microscopy.
Results: Analysing different purifications performed combining the double TFF and
SEC we defined quality parameters for EVs in term of size distribution, concentration
and maker expression, showing high reproducibility and EV stability under defined
storage conditions.
Summary/conclusion: The combination of two TFF steps and SEC allows an efficient fractionation
of different EV sizes and works as a scalable and reproducible method for EV production
from large quantity of different fluids.
IP.04
Development of an automated, high-precision, standardizable extracellular vesicle
isolation platform for clinical studies
Anoop Pala, Shayne Harrela, Robert Vogelb and Murray Broomb
aIzon Science US Ltd; bIzon Science Ltd
Introduction: Extracellular Vesicles (EVs) derived from biological fluids possess
extensive heterogeneity with regards to size, number, membrane composition and cargo.
Tremendous research interest exists towards development and use of EV fraction of
bio-fluids as rich sources of diagnostic and prognostic biomarkers. High precision
fractionation of the nanobiological content of biofluids can dramatically reduce background,
increase purity and inform on the biology of the biomarkers and therapeutic biomolecules.
Methods: Size exclusion chromatography (SEC) is the most standardizable technique,
already widely used for the purification of EVs from biofluids. Significant improvement
to the use of SEC is possible through automation and precision. Here, we developed
a range of SEC columns of various sizes, with 2 resin types, separating down to 35 nm
or 70 nm. We also developed a low-cost prototype automatic fraction collector (AFC)
that adds high precision, improves repeatability, speeds up workflow. RFID tags are
proposed to ensure high quality of data capture and transfer. Moreover, Tunable Resistive
Pulse Sensing technology was used for accurate, high-resolution particle analysis
(size, size range, concentration, and electrophoretic mobility) and normalization.
Results: SEC columns provide a convenient, reproducible and highly effective means
of eliminating >99% of non-vesicular protein from biological fluid samples, and separating
exosomal and non-exosomal volumes for further downstream analysis. 35 nm pore sized
SEC gel leads to increased resolution, higher yield and one fraction earlier elution
of EVs from plasma compared to the 70 nm pore size. Use of AFC allowed precise mass-based
measurements and tunability within 30 ul of volume exiting the column.
Most importantly, due to the additional functionality provided by AFC, the EV field
needs to revisit the way fraction numbers, post-SEC are used. That will be replaced
with a more logical framework, wherein the void volume is measured and disposed of,
and precise volumes are used instead of the somewhat arbitrary fraction numbers.
Summary/conclusion: Thus, the qEV-AFC platform allows for QA, high-precision EV volume
collection and minimizes samples processing related reproducibility issues for clinical
studies.
IP.05
Faster, More Reproducible Exosomes Data – Hands Free!
Kohei Shiba, Pauline Carnell-Morris, Matthew McGann and Agnieszha Siupa
Malvern Panalytical
Introduction: In analytical data collection, the most common form of error is that
generated by human error. From simple pipetting to manually adjusting optical settings
on an instrument all these sources of error result in data sets that are less reproducible
and increasingly difficult to interpret. The introduction of the NanoSight Sample
Assistant for the NS300 brings about a new level of repeatability and reproducibility
in analysis of Extracellular Vesicle (EV) samples. This work will examine the benefits
of using the sample assistant for sample handling including time saving, and improved
data quality.
Methods: The particle size distribution and concentration of exosome samples isolated
from urine (20 x 1 mL) and SKOV3 cells (96 x 1 mL) was determined using the NanoSight
NS300 system (Malvern Panalytical, UK) integrated with the NanoSight Sample Assistant
(1mL). All samples were analysed under the same capture and process settings and the
total time of analysis recorded. A series of experiments were also completed using
SKOV3 samples, acquired manually on the NanoSight NS300 system to compare repeatability,
reproducibility of data to that acquired by the sample assistant.
Results: Analysis of the data shows that data acquisition of 96 EV samples can be
completed in approximately 15 h using the Sample Assistant, a 70% improvement compared
to an estimated 50 h of manual acquisition. Setup time of the instrument however was
approximately 30 min, reducing hands on instrument time by ~99%. An additional dataset
of EV samples was measured as a dilution series, both manually and using the Sample
Assistant. Data showed a measurable improvement in both repeatability of the concentration
as well as linearity of the series.
Summary/conclusion: The new NanoSight sample assistant accessory for NS300 provides
size and concentration data measurements of up to 96 samples in as little as 15 h,
including under 30 min of set-up time. Data quality is typically improved by the elimination
of user error and subjectivity. The Sample Assistant is compatible with many sample
types, and generates key exosome characterization data, whilst freeing up valuable
scientist time to work on other tasks.
Funding: This project received funding from the European Union’s Horizon 2020 research
and innovation programme under grant agreement No 646,002
IP.06
Identifying, characterizing and quantifying extracellular vesicles using multispectral
imaging flow cytometry
Haley R. Pugsley, Sherree Friend, Bryan Davidson and Phil Morrissey
Amnis part of Merck KGaA
Introduction: Extracellular vesicles (EV) are a heterogeneous group of membrane derived
structures that include exosomes, microvesicles and apoptotic bodies. Quantifying
and characterizing EVs in a reproducible and reliable manner has been difficult due
to their small size (down to 30 nm in diameter). Attempts to analyse EVs using traditional
PMT based flow cytometers has been hampered by the limit of detection of such small
particles, their low refractive index and the swarming effect. To overcome these limitations,
we have employed multispectral imaging flow cytometry that has the advantage of high
throughput flow cytometry with higher sensitivity to small particles due to the CCD
based, time-delay-integration image capturing system. Several recent publications
have reported using multispectral imaging flow cytometry to identify and characterize
EVs; however, the collection settings and gating strategies used to identify and characterize
EVs is not consistent between publications.
Methods: Here we demonstrate the optimal collection settings, parameters and gating
strategy to identify, characterize and quantify a variety of EVs using multispectral
imaging flow cytometry. EVs obtained from commercial sources are identified using
a combination of CD markers, membrane stain and 405 nm SSC. In each case, the membrane
stain and 405 nm SSC initially identify an EV and CD markers are used for characterization
and immunophenotyping the EV.
Results: Data will be presented using the ImageStream multispectral imaging flow cytometer
to identify, characterize and quantify a variety of EV samples. Strategies for optimal
collection and analysis of the multispectral imaging flow cytometry EV data will also
be discussed.
Summary/conclusion: Multispectral imaging flow cytometry is able to characterize and
quantify EVs with very high sensitivity due to the CCD based time-delay-integration
image capturing system.
IP.07
Microfluidic Resistive Pulse Sensing (MRPS) Measurements of EVs and EV Standards
Franklin Monzona, Jean-Luc Fraikinb, Ngoc Doa, Tom Maslanikc, Erika Duggand and John
Noland
aSpectradyne; bSpectradyne LLC; cCellarcus Biosciences Inc; dScintillon Institute
Introduction: As science-based on EVs advances, it is important to be able to compare
measurements of vesicles across different manufacturing sites and manufacturing methods.
To isolate differences or drifts in EV formulations, it is necessary to have stable
metrology so that these differences can be properly attributed to changes in the formulation
and not the metrology. Establishing stable metrology in turn relies on the development
of standards measured by multiple orthogonal methods. With this goal in mind, this
paper discusses measurements of EVs and EV standards using Microfluidic Resistive
Pulse Sensing (MRPS) and other measurement techniques.
Methods: The size distribution and concentration of EV standards and EVs derived from
various sources were characterized by MRPS, Nanoparticle Tracking Analysis (NTA),
cryo-Electron Microscopy (EM), and Vesicle Flow Cytometry (VFC). In some cases, EVs
were destroyed by lysing agents and measurements were repeated to demonstrate this
effect.
Results: MRPS measurements gave high resolution size and concentration information
down to ~ 50 nm diameter for all samples. Because MRPS is an electrical technology,
it did not suffer from sensitivity limitations related to the low index of refraction
contrast between the nanoparticles (be they EVs or standards) and the surrounding
liquid. MRPS could not distinguish particles based on type (in contrast to VFC), however
it was more sensitive to the presence of non-EV nanoparticles in the samples. Concentration
reproducibility was in the range of ± 20% and sizing reproducibility in the range
of ± 5% independent of particle material.
Summary/conclusion: Quantifying the purity of an EV population is important. Techniques
such as VFC do an excellent job in quantifying the EV population of interest but are
not necessarily sensitive to contamination or the presence of non-target EVs. MRPS,
on the other hand, gives high resolution information on all nanoparticles present
in a mixture. From a process development standpoint, this information is critical
to the improvement of a formulation. The orthogonal nature of MRPS measurements, compared
to optical methods, is therefore an important part of the development of robust EV
standards, and the associated measurement protocols, that will be required for the
successful wide deployment of EV-based diagnostics and therapeutics.
IP.08
Development of EV-targeting tools for novel liquid biopsy approaches in Lung Cancer
Diogo Fortunatoa, Laura Bianciardib, Gaia Papinic, Mattia Criscuolic, Davide Zoccod
and Nataša Zarovnib
aExosomics/University of Siena; bExosomics; cExosomics Siena, University of Siena;
dExosomics Siena
Introduction: Mounting clinical evidence suggests that liquid biopsy may revolutionize
the way cancer patients are currently managed. Within this context, our study aims
to assess and reinforce unique and complementary advantages of EV/exosome-based approaches,
through identification and quantitative detection of non-small cell lung cancer (NSCLC)
EV biomarkers. Current technology and methods for exosome isolation from complex biological
samples (i.e. plasma), have shown to be unreliable. There is a need to substantially
improve them to enable multiparameter EV analysis. Therefore, in addition to EV-biomarker
discovery, we are testing plasma processing and preanalytical tools, devices and optimized
immunoaffinity protocols that tackle fundamental obstacles, such as complex matrix
effects. Our goal is to provide an EV immunocapture approach with enough sensitivity,
specificity and robustness for clinical grade diagnostic applications.
Methods: Size-based vs. immunocapture methods for exosome isolation. Enzymatic and
immunological assays for plasma pre-clearing; Flow cytometry, ELISA, nanoparticle
tracking analysis, Western Blot, SPR and ddPCR for antibody and exosome characterization.
Results: Exosomes derived from NSCLC cell lines display distinct membrane markers
recognized by a panel of proprietary Abs, screened by flow cytometry, SPR, IP, ELISA
and PCR. We developed and tested a screening platform based on endogenously labelled
EVs to identify NSCLC EV antigens. Selected antibodies will be used to develop an
immune-isolation protocol, coupled to state-of-the-art analytics for a rapid and sensitive
readout, thus enabling a comparative evaluation of a repertoire of plasma pre-analytical
protocols.
Summary/conclusion: Different plasma pre-analytical protocols are ranked and orthogonally
combined to optimally counteract matrix effects, increment EV yield by immune-isolation
approaches and facilitate the analysis of enriched EV subpopulations.
Funding: The project is funded under the Marie Skłodowska-Curie grant agreement No.
765,492 “ELBA – European Liquid Biopsies Academy” and internal Exosomics R&D Funds.
IP.09
Side scatter module for enhanced detection of Extracellular Vesicles by flow cytometry.
Tina Van Den Broecka, Ludovic Monheimb, Ihor Berezhnyya, Oleg Guryeva, Tatyana Chernenkoa,
Marybeth Sharkeya and Geoffrey Osbornea
aBD Biosciences; bBD Life Sciences, Erembodegem, Belgium
Introduction: EVs are nanosized (20 ~ 5000 nm) membrane vesicles released from cells
that can transport cargo – including miRNA and proteins – between cells as a powerful
way of intercellular communication. Currently, flow cytometry is the only high throughput
technique capable of single particle cell surface phenotyping and sorting with the
possibility of concentration determination. Unfortunately, the drawback of standard
flow cytometry is lack of sensitivity to detect smallest particles, especially for
those with a size less than or equal to the dimensions of the excitation laser wavelength.
Methods: BD has developed an accessory side scatter (SSC) module for enhanced scatter
detection of small particles by flow cytometry: the SP SSC module. The SP SSC module
should be used in combination with a laser power of at least 100 mW. Small particle
detection enhancement is achieved by significantly increasing the signal-to-noise
ratio of the SSC.
Results: The SP SSC module can be installed on most commercially available BD flow
cytometers, which have sufficient laser power, as an additional option. The normal
SSC detector remains in place and the SP SSC module has minimal impact on regular
SSC and fluorescent performance therefore use of the system for cell analysis applications
is still possible. Initial results using the SP SSC module were obtained using a BD
FACSCelesta™ SORP and a BD FACSAria™ Fusion, respectively having a 100 and 200 mW
488 laser. Side-by-side comparison of the regular SSC detection vs. SP SSC detection
was done using polystyrene beads, silica beads, EV reference material and antibody-stained
EV material.
Summary/conclusion: Utilization of the SP SSC module for sorting of natural (plasma
EVs) and artificial (liposomes) membrane particles is currently being undertaken.
IP.10
Quantitative imaging and phenotyping of EVs with 20 nm resolution
Andras Miklosi, Zehra Nizami, Blanka Kellermayer and Mariya Georgieva
ONI (Oxford Nanoimaging ltd)
Introduction: Complex extracellular vesicle (EV) phenotyping is a major technical
challenge that hinders clinical translation. Single-molecule localization microscopy
(SMLM) is a Nobel-Prize winning technique that allows quantitative imaging below the
diffraction limit necessitating only simple and fast sample preparation. The data
presented here constitutes one of the first accounts of single-molecule imaging used
to successfully resolve the structure, protein (CD9, CD63, and CD81) and nucleic acid
content of EVs with 20 nm resolution.
Methods: EV isolation was performed from keratinocyte culture media. EV suspensions
were stained using fluorescently labelled primary antibodies raised against known
exosome markers, and commercially available membrane and nucleic acid labels. Characterization
of the molecular content and structural properties of surface-immobilized EVs was
performed using the SMLM mode of the ONI Nanoimager. Sizing of EVs in solution was
performed using the dual-colour single-particle tracking mode of the ONI Nanoimager.
Results: Multicolour super-resolution microscopy imaging of purified EVs revealed
the phenotypic and structural properties of hundreds of individual vesicles at a time.
The membrane staining allowed to visualize EVs with sizes ranging from ~20 nm to >250 nm,
and sizing by tracking confirmed this distribution and a mean size of 120 nm. For
EVs of >40 nm the membrane appeared as a ring and was a confirmation of their intact
structure. CD63, CD9 and CD81 co-localized with the membrane staining at the nm scale,
thus allowing to determine the molecular ID of EV subpopulations and correlate the
protein marker levels with the size of EVs.
Summary/conclusion: The quantitative nature of single-molecule imaging and tracking
significantly improves EV characterization. This work provides evidence of the use
of SMLM imaging as a novel and powerful tool for rapid and multiplexed EV characterization
with unique combination of structural and phenotypic insight.
IP.11
Benchmarking of established exosome isolation methods (density gradient centrifugation,
size-exclusion chromatography and immune-bead separation) with glycan recognizing
EXÖBead
Dapi Meng Lin. Chianga, Chin-Sheng Linb and Michael Pfafflc
aBiovesicle; bDivision of Cardiology, Tri-Service General Hospital, Taiwan & National
Defense Medical Center, Taiwan; cAnimal Physiology and Immunology, School of Life
Sciences Weihenstephan, Technical University of Munich, Freising, Germany
Introduction: Exosomes are small vesicles (30–150 nm) found in various human biofluids,
such as plasma. OptiPrep density gradient centrifugation (DGC) is widely accepted
as a pure exosome isolation method. Size-exclusion chromatography (SEC) is a fast
exosome isolation method, but exhibit contaminations such as lipoprotein or aggregated
proteins. Immuno-beads (HBM) are based on high specific recognition of exosome CDs,
but uses a harsh elution procedure to get intact exosome. EXÖBead (Biovesicle) are
glycan recognition magnetic beads and show high exosome specificity by FACS, NTA and
TEM analysis. In this study, we compared these four isolation methods based on FACS
established exosomal markers, intact exosome size/number and lipoprotein contamination.
Methods: Mix plasma samples were collected from healthy donors (n = 5) and patients
undergoing coronary angiography (n = 6). Exosomes were isolated from 250 μl plasma
by SEC and DGC, fractions were collect from SEC (7 ~ 10) or DGC (6 ~ 8), and then
covalent-coated on 1 μm magnetic beads (followed Chemicell). We also covalent-coated
1 ml 10% exosome free (EF) FBS in PBS as a negative control. We directly incubated
250 μl plasma with 1 μm glycan recognition magnetic beads EXÖBead (37°C, 1 h) or 1 μm
latex HBM immunobeads (4°C, 16h). As a negative control 1 ml (EF) FBS was incubated.
Universal antibody mix (PE-Cy7-CD63, FITC-CD81 and APC-CD9) was used for all isolation
methods. The negative control reduced fluorescence data are presented by median fluorescence
intensity (MFI). NTA data were collected only from intact exosomes.
Results: EXÖBead represents highest MFI of CD63 (247.9) compared to SEC (232.42),
DGC (25.72) and HBM (5.13). EXÖBead also showed highest MFI of CD9 (475.4) compared
to SEC (42.3), DGC (5.1) and HBM (0). Only SEC (88.9) and EXÖBead (41.1) could detect
CD81. Experiment processing time for EXÖBead is 2h, SEC is 4h, HBM is 19h, and DGC
even 22h. SEC represents highest intac
t exosomes/ml (4.9E+10), EXÖBead (1.7E+9), HBM (1.9E+8), and DGC (1.5E+8), measured
by NTA. Median exosome sizes are EXÖBead 72.0 nm, SEC 107.0 nm, DGC 89.6 nm and HBM
96.1 nm.
Summary/Conclusion: EXÖBead serves as a new time-saving plasma isolation method with
high exosome yield and specificity.
IP.12
Characterizing the cellular uptake of neural stem-cell derived exosomes using live-cell
imaging techniques
Samuel Jonesa, Thomas Cawsb, Anthony Hayesa, Victoria Marsh Durbanb, Randolph Cortelingb
and Peter Watsona
aSchool of Biosciences, Sir Martin Evans Building, Cardiff University, Museum Avenue,
Cardiff, Wales, UK; bReNeuron Limited, Pencoed Business Park, Pencoed, Bridgend, Wales,
UK
Introduction: Neural stem cell derived exosomes (“ExoPr0”); purified from the conditioned
medium of a GMP manufactured, conditionally-immortalized human neural stem cell line
(“CTX0E03”), demonstrates a unique biodistribution profile in mice compared to exosomes
derived from a control producer cell line. We have previously shown that ExoPr0 is
able to cross the blood brain barrier, and to further explicate these findings, we
investigated the uptake of ExoPr0 at the cellular level using live-cell imaging techniques.
Methods: We employed live-cell confocal microscopy to directly visualize uptake of
fluorescently labelled exosomes. A quantitative image analysis protocol was developed
and applied to assess the uptake of exosomes in a number of cell types.
Results: Time course incubations of cells treated with ExoPr0 produced data that revealed
heterogeneity in uptake between cell types. ExoPr0 was compared to exosomes derived
from a control producer cell line, highlighting source-specific differences in uptake
kinetics. Uptake was observed to occur through more than one pathway resulting in
trafficking through endo-lysosomal compartments. The effect of cell cycle on the uptake
of ExoPr0 was investigated, but was not observed as having a significant influence.
Summary/conclusion: Findings from this study have eluded to the specificity of ExoPr0
towards different cell types and work is ongoing to further elucidate the delivery
mechanism of ExoPr0 and understand the subcellular trafficking in recipient cells.
Symposium Session 7: Advances in EV Isolation in Cancer Chairs: Leonora Balaj; Johan
SkogLocation: Level B1, Hall A 17:00–18:00
OT07.01
Aggregation-induced emission probe/graphene oxide aptasensor for label-free and “turn-on”
fluorescent aptasensor for cancerous exosomes
Bo Li, Weilun Pan, Chunchen Liu and Lei Zheng
Clinical Laboratory Department, Nanfang Hospital, Southern Medical University, Guangzhou,
China (People’s Republic)
Introduction: Exosomes are the smallest subset (30–150 nm) of extracellular vesicles
(EVs), a heterogeneous population of vesicles originate from all types of tissue cells,
which can freely pass through the blood vessel wall and distribute in various body
fluids. Exosomes carry different macromolecules, such as nucleic acids, proteins and
lipids for intercellular communication. In the last decade, numerous researches demonstrated
that exosomes’ cargo is affected in the progression of malignant tumours, positioning
exosomes as potential sources for the discovery of novel biomarkers. For example,
it is confirmed that PSMA is enriched in the membrane of exosomes from prostate cancer
cells. So, PSMA positive exosomes subpopulation is regarded as the diagnostic biomarker
for prostate cancer. But conventional methods can hardly quantify low-concentration
PSMA positive exosomes subpopulation in small volumes of clinical samples rapidly.
Methods: In this work, we constructed the label-free and “turn-on” aptasensor for
the detection of the PSMA positive prostate cancer exosome based on PSMA aptamer as
the recognition element, Aggregation-Induced Emission (AIE) probes: TTAPE as fluorescent
indicators and Graphene Oxide (GO) as fluorescent quencher. In the absence of PSMA
positive exosomes, the fluorescence of TTAPE aggregated in the aptamer would be quenched
efficiently by GO. However, in the presence of PSMA positive exosomes, the specific
and stronger binding between aptamers and PSMA positive exosomes could weaken the
binding interaction between aptamer and GO. So the fluorescence of TTAPE aggregated
in the aptamer would recover, which could appear “turn-on” fluorescent property.
Results: Under optimal conditions (37°C, 15 min), the linear range of detection for
prostate cancer exosomes is estimated to be 4.07 × 105–1.83 × 107 exosomes/μL with
a detection of limit (LOD) of 3.43 × 105 exosomes/µL. We further successfully applied
it for exosomes quantification in plasma samples from prostate cancer patients.
Summary/Conclusion: This aptasensor is expected to become a powerful tool for rapid
and simple cancer liquid biopsy.
Funding: This study was financed by grants from the National Natural Science Foundation
of China (81371901, 81702100), the Science and Technology Planning Project of Guangdong
Province (2017A020215123).
OT07.02
Single extracellular vesicle (EV) profiling and EV subpopulation analysis of cancer
related EVs in human plasma
Yanling Cai
a, Zesong Lia and Di Wub
aShenzhen Second People’s Hospital, First affiliated hospital of Shenzhen University,
Shenzhen, China (People’s Republic); bDepartment of Biochemistry and Biophysics, Science
for Life Laboratory, Stockholm University, Solna, Sweden., Solna, Sweden
Introduction: Extracellular vesicles (EV) carry important information of their parental
cells, and are therefore promising biomarkers for liquid biopsy and early diagnosis
of multiple diseases including cancer. However, the detection of disease specific
EV among huge numbers of EVs in the clinical sample, e.g. plasma remains a challenge,
which makes single EV and EV subpopulation analysis preferable to bulk analysis.
Methods: In the presented work, in order to recognize the cancer cell line specific
EVs, we utilized a proximity barcoding assay (PBA) to analyse the surface protein
composition of single EVs and investigated the EV subpopulation. A pool of hundred-plex
oligonucleotide-conjugated antibodies against reported cancer biomarkers candidates
was employed to recognize the surface proteins of individual EVs. Then all the oligonucleotides
on the same EV obtained an unique EV tag in a PBA. The pool of extension products
can be amplified and sequenced by next generation sequencing. After sorting the reads,
we could reconstruct the surface protein composition of individual EVs.
Results: We applied PBA to analysed EVs purified from cancer cell lines and from human
plasma. We could identify different subpopulation EVs, that are specific for certain
cell lines and human plasma. We then spiked in different amount cancer cell-line derived
exosomes in the plasma derived EVs from healthy donors in different ratio. We could
observe en expected increase of certain population of exosomes in the human plasma.
Summary/Conclusion: In summary, PBA is a multiplexed and high throughput approach
to analyse surface proteins of individual EVs. The cancer cell line EVs mixed into
healthy control plasma were successfully detected, indicating this technique can be
applied to search for rare population of EVs in the plasma samples of patients.
Funding: National Natural Science Foundation of China, project 81802052
OT07.03
miRNA signature derived from GBM plasma exosomes as a diagnostic biomarker
Luz M. Cumba Garcia
a, Pritha Chananab and Ian Parneyc
aMayo Clinic Graduate School of Biomedical Sciences, Department of Immunology, Rochester,
USA; bMayo Clinic, Department of Health Sciences Research- Division of Biomedical
Statistics and Informatics, Rochester, USA; cMayo Clinic, Department of Neurologic
Surgery, Department of Immunology, Rochester, USA
Introduction: Gliomas including glioblastoma (GBM) are the most common malignant brain
tumours. Glioma extracellular vesicles (EVs), especially plasma exosomes, have biological
effects such as mediating immunosuppression and contain signature tumour-specific
cargo that could serve as liquid biopsies. Increasing interest in molecular biomarkers
to determine patient prognosis in GBM has suggested that EV miRNA-based signatures
may be able to predict progression-free and overall survival, differentiate normal
donors from GBM patients, and distinguish true progression from treatment-related
pseudo-progression.
Methods: We have established a simple technique, using density gradient ultracentrifugation,
to isolate plasma exosomes from glioma patients and normal donors. Purification of
total RNA, including miRNA, was performed on plasma exosomes from normal donors (n = 8)
and GBM patients (n = 7) using the miRNeasy kit (Qiagen). Next generation short non-coding
RNA sequencing was performed by Illumina HiSeq 4000.
Results: RNA sequencing revealed many differentially expressed miRNAs in GBM patients
with high fold change/low false discovery rates compared to normal donor plasma exosomes.
Ingenuity Pathway Analysis showed that these differentially expressed miRNAs target
mRNAs that are associated with distinctive GBM and cancer pathways. In order to test
the diagnostic accuracy of the proposed technique, ROC analysis was performed based
on the top 33 differentially expressed miRNA samples. The area under the ROC curve
(AUC; a figure of merit to determine the optimal miRNA signature) was 0.968. In addition,
multiple novel miRNAs and other short non-coding RNA species (Y-RNA, piRNA, snoRNA)
were found with some differential expression.
Summary/Conclusion: In conclusion, miRNA sequencing from plasma exosomes shows marked
differential miRNA expression between healthy donors and GBM patients. These findings
as well as additional differentially expressed short non-coding RNA species suggest
plasma EVs may serve as a robust platform to develop GBM liquid biopsies.
Funding: Mayo Clinic Center for Individualized Medicine (CIM) Brains Together For
a Cure
OT07.05
Isolation of extracellular vesicles by nanoDLD lab-on-a-chip technology for clinical
applications
Stacey M. Gifford
a, Joshua Smitha, Benjamin Wunscha, Navneet Dograa, Mehmet Ahsenb, Kamlesh Yadavc,
Ashutosh Tewarid, Carlos Cordon-Cardoe and Gustavo Stolovitzkya
aIBM T.J. Watson Researc Center, Yorktown Heights, NY, USA; bDepartment of Genetics
and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
cDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
dDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA;
eDepartment of Oncology Sciences and Pathology, Icahn School of Medicine at Mount
Sinai, New York, NY, USA
Introduction: There is great interest in exosome isolation and analysis to develop
non-invasive “liquid biopsies” for diagnosis, prognosis, and surveillance of diseases.
However, current exosome isolation methods lack purity, yield and reproducibility
and the inability to rapidly and reliably separate exosomes hinders clinical application.
Thus, there is an urgent need to develop novel tools to isolate exosomes as a promising
source of new biomarkers.
Methods: We have developed a lab-on-a-chip technology based on deterministic lateral
displacement at the nanoscale (nanoDLD) which separates and concentrates particles
in continuous flow and in specific size ranges, going to scales as small as 20 nm.
We used nanoDLD to isolate EVs from urine and serum and characterized these EVs by
NTA and RNA sequencing.
Results: Benchmarking studies of nanoDLD isolation of exosomes show comparable or
improved yield and concentration compared to standard techniques such as SEC and UC
at volumes suitable for clinical applications. We isolated EVs from the urine and
serum of prostate cancer (PCa) patients. Our preliminary data show PCa patient serum
exosomes are enriched in known PCa biomarkers. Screening for an EV RNA panel associated
with aggressiveness could aid detection of clinically significant PCa and reduce unnecessary
radical prostatectomies.
Summary/Conclusion: We have developed a chip-based tool for EV separation and demonstrated
improved yield, concentration and processing time compared to existing isolation methods.
This technology has enabled high-resolution temporal studies of urinary EVs to better
understand the impact of pre-analytical challenges on EV studies. Finally we used
nanoDLD to isolate EVs from prostate cancer patient samples and detect an enrichment
of known mRNA prostate cancer markers in serum EVs. Our nanoDLD technology enables
frequent, rapid isolation of EVs at improved yield and concentration enabling the
use of smaller sample volumes.
Funding: Work was funded by IBM Research and the Icahn School of Medicine at Mount
Sinai.
Symposium Session 8: Mechanisms of Delivery Chairs: Lorraine O’Driscoll; Carlos SalomonLocation:
Level 3, Hall B 17:00–18:00
OT08.01
Magnetically navigated intracellular delivery of extracellular vesicles using nanogels
Yoshihiro Sasaki, Ryosuke Mizuta and Kazunari Akiyoshi
Kyoto University, Kyoto, Japan
Introduction: Extracellular vesicles can control important biological phenomena such
as cell differentiation and cell death. In addition, extracellular vesicle is also
regarded as a promising material for biomedical application. However, due to their
low efficiency of intracellular uptake, development of effective intracellular delivery
method has been remained challenging issue. We report here the complexation of extracellular
vesicles and magneto-responsive nanogels, and efficient intracellular delivery of
extracellular vesicles into cells by magnetic guidance for induction of differentiation
of stem cells by delivered extracellular vesicles.
Methods: Magnetic nanogels were prepared by mixing oleic acid-coated iron oxide nanoparticles
dispersed in an organic solvent to nanogels composed of cholesteryl group-substituted
pullulan. Magnetic nanogel-exosome complexes were prepared by isolating exosomes from
culture supernatants of myoblasts and nerve cells by ultracentrifugation and mixing
this exosome with magnetic nanogels. The resulting magnetic nanogel-exosome complex
was delivered to the cells by magnetic induction and its intracellular dynamics were
investigated using a confocal laser microscope and flow cytometry.
Results: In 24 h, 90% of exosome could be complexed with magnetic nanogel. The obtained
magnetic nanogel-exosome complex was delivered to adipose-derived mesenchymal stem
cells (ADSC) by magnetic induction. As a result, the introduction of magnetic nanogel
and exosome into the cytoplasm was confirmed. From the results of immunostaining,
expression of the differentiation marker was confirmed in which the complex was introduced
to ADSC by magnetic induction for both myoblasts and nerve cells.
Summary/Conclusion: Differentiation was induced to ADSC by efficient magnetic delivery
of exosome. This magnetic nanogel introduction method is expected to be used as analysis
of exosomes whose function is unclear or as a novel cell function control technique
using exosome.
OT08.02
Tissue distribution of extracellular vesicle-binding proteins after in vivo gene transfer
into mice
Yoshihiko Shimazawa
a, Kosuke Kusamorib, Yuki Takahashic, Yoshinobu Takakurac and Makiya Nishikawab
aFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan; bTokyo
University of Science, Noda, Japan; cKyoto University, Kyoto, Japan
Introduction: Successful application of extracellular vesicles (EVs) as delivery systems
for bioactive molecules, including miRNAs and tumour antigens, requires the understanding
and control of their tissue distribution. Our previous studies demonstrated that the
exogenously administered EVs of about 100 nm in diameter quickly disappeared from
the systemic circulation after intravenous injection into mice. Despite these results,
endogenous EVs might have different tissue distribution properties from exogenously
administered ones. To test this hypothesis, it is important to develop a method to
analyse the properties of endogenous EVs. In this study, as a first step, we selected
Gaussia luciferase (gLuc) and lactadherin (LA) as a reporter protein and an EV-binding
protein, respectively, and examined whether the fusion of LA to gLuc could alter the
tissue distribution of gLuc after in vivo gene transfer into mice.
Methods: pcDNA3.1 plasmid vectors encoding gLuc, a fusion protein of gLuc and LA (gLuc-LA),
or a fusion protein of gLuc and a mutated LA which has low affinity to EVs (muLA)
were constructed (pCMV/gLuc, pCMV/gLuc-LA and pCMV/gLuc-muLA). Each plasmid was injected
into 4-week-old male ddY mice using the hydrodynamic injection method, and blood was
collected at several time points to obtain plasma. Then, EVs in plasma were separated
and collected by the ultracentrifugation method. The characteristics of the EVs were
evaluated by western blotting and dynamic light scattering. The luciferase activity
of the plasma and the EVs was measured in a luminometer.
Results: In all the cases examined, the luciferase activity in the plasma was very
high soon after hydrodynamic injection of the plasmid vectors, then it decreased with
time. No significant luciferase activity was detected in the EVs when pCMV/gLuc or
pCMV/gLuc-muLA was injected. By contrast, about 5% of luciferase activity of the plasma
was recovered in the EV fraction when mice received an injection of pCMV/gLuc-LA.
Summary/Conclusion: These results indicate that gLuc-LA binds to EVs in mouse blood
through LA after in vivo gene transfer, which suggests that gLuc-LA can be used to
analyse the tissue distribution of endogenous EVs.
OT08.03
Capabilities of HEK293T cell-exosomes as a non-invasive delivery tool for mammalian
sperm
Teresa Vilanova
a, Celine Jonesa, Rebecca Dragovica, Kevin Cowarda and Marc Yestea
aUniversity of Oxford, Oxford, UK; bUniversidad de Gerona, Girona, Spain
Introduction: Male infertility accounts for 35–50% of human infertility, and 2.5–12%
of men present some form of infertility. Several non-invasive approaches to treat
sperm-borne aberrations are being developed such as exosomes for compound delivery.
Human Embryonic Kidney (HEK)293T cell-exosomes appear to be safe and versatile in
terms of their targeting abilities. However, the safety aspects for gametes need to
be investigated. In this study we developed HEK293T cell-exosomes for in vitro co-incubation
with boar sperm. Exosome binding and exposure effects (for viability, mitochondrial
membrane potential (MMP) and membrane fluidity (MF)) were examined.
Methods: HEK293T-exosomes were characterised by Nanoparticle Tracking Analysis, Western
Blotting and Transmission Electron Microscopy. Boar sperm samples (n = 3) were in
vitro co-incubated at an exosome:sperm ratio of 10:1 (4h pH<7). Sperm aliquots at
0, 2 and 4h post-incubation were analysed for exosome binding. Moreover, boar sperm
(n = 5) was in vitro co-incubated at different ratios (1:1, 10:1 and 100:1) under
capacitating and progesterone-induced hyper-activating conditions. Analysis at 0h,
2h, 4h, 4h 10 min, 4h 30 min and 5h post-incubation by flow cytometry for viability,
MMP and MF of exosome-treated samples was performed by staining with SYBR-14/PI, JC-1
and YO-PRO-1/Merocyanine-540, respectively. Data were analysed with a mixed model
(between-subjects factor: treatment; within-subjects factor: incubation time) followed
by the post-HOC Sidak test.
Results: Data revealed an homogeneous exosome-enriched sample in terms of exosome-like
morphology and size. Exosome-sperm binding to the head, mid-piece and tail was confirmed
with up to two exosomes/sperm cell. No statistically significant differences were
found in terms of viability, MMP and MF for any of the tested ratios at each time
point, compared to controls.
Summary/Conclusion: HEK293T cell-derived exosomes bound to all sperm parts soon after
the incubation began. A high exosome concentration did not compromise the viability
nor the response of boar spermatozoa to induced capacitation and acrosome-exocytosis
in vitro. In conclusion, HEK293T cell-exosomes have shown to have potential as a future
clinical delivery system in the context of male infertility.
Funding: SRF and St. Peter’s College (University of Oxford).
OT08.04
Extracellular vesicles from de-differentiated human adipose tissue endothelial cells
have potential to disseminate angiostatic signals in human obesity
Anca D. Dobrian
a, Bronson Haynes, Ryan Huyck, Lifang Yang, Vanessa Correll, William McPheat and O.
John Semmesb
aEastern Virginia Medical School, Norfolk, USA; bLeroy T. Canoles Jr. Cancer Research
Center, Eastern Virginia Medical School, Norfolk, USA
Introduction: Endothelial-to-mesenchymal transition (EndoMT) characterized by endothelial
cell (EC) de-differentiation into a mesenchymal phenotype is a focal event present
in the vasculature of obese adipose tissue (AT) and has been shown to contribute to
various vascular pathologies. EC from human AT impacted by EndoMT are angiostatic
and have a quiescent metabolic phenotype. We hypothesize that extracellular vesicles
(EV) produced by such EC may lead to propagation of angiostatic signals which may
contribute to hypoxia and insulin resistance in obese AT.
Methods: We modelled EndoMT in vitro by treatment of human AT ECs with pro-inflammatory
cytokines and prepared EV from conditioned media by ultracentrifugation. Uptake of
EVs by naïve EC was measured by flow cytometry; angiogenesis by in vitro tube formation;
and mitochondrial energetics with Seahorse bioanalyzer. The miRNA cargo of the EVs
was analysed using the Nanostring platform and the proteome was determined using LC/MS/MS.
Results: EV from EndoMT cells produced a dramatic angiostatic effect on recipient
EC without affecting migration or proliferation. Recipient EC became quiescent and
had lower ATP production compared to controls. Pathway analysis of EV cargo showed
significant targeting of fatty acid synthesis and oxidation in recipient EC. We found
abundant miR-155-3p in EV and reduced expression of its metabolic enzyme targets CPT1a
and ACLY in recipient EC. Treatment of EC with the CPT1a inhibitor etomoxir recapitulated
the angiostatic effect of the EVs. The EV proteome was also enriched in peptide signatures
for VEGFR1, VEGFR2 and neuropilin.
Summary/Conclusion: We show that the metabolic shift produced by EV from EndoMT cells
may explain their angiostatic effect. miR-155 delivered via EV may be key for metabolic
quiescence via inhibition of CPT1 and ACLY. We report a novel mechanism by which EndoMT
in EC produces EVs that may propagate angiostatic effects throughout the AT vasculature
in obesity.
Funding: NIHR15NHLBI, American Heart Association-AIREA.
Symposium Session 9: EV Biogenesis II Chairs: Bong Hwan Sung; Graca RaposoLocation:
Level B1, Hall B 17:00–18:00
OT09.01
Different exosome subtypes have distinct ESCRT-associated biology and control tumour
cell adaptation in vivo
Shih-Jung Fana, Benjamin Kroegerb, Pauline Mariea, Esther Bridgesa, Kristie McCormicka,
John Masona, Helen Sheldona, Claudia Mendesa, Mark Wainwrighta, John Morrisa, Adrian
Harrisa, Clive Wilsona and Deborah C I. Goberdhan
a
aUniversity of Oxford, Oxford, UK; bPeter MacCallum Cancer Centre, Melbourne, Australia
Introduction: Determining the function of specific extracellular vesicle (EV) and
exosome subtypes has proved challenging, in part due to the difficulty in untangling
the mechanisms leading to their generation.
Methods: We investigated the cell biology behind exosome formation using the large
endosomal compartments offered by an in vivo fly model, and analysis in human HCT116
and other cancer cell lines. EV preparations were also tested in vivo following injection
in to human xenografts in mice. We analysed different EV preparations by mass spectrometry
using Tandem Mass Tag labelling to identify changes in protein cargo of EVs in response
to microenvironmental stress.
Results: Using these complementary approaches, we show that microenvironmental stress,
such as glutamine depletion, leads to a switch in membrane trafficking from the classic
late endosomal multivesicular endosomes to Rab11a-positive recycling endosomes and
the production of Rab11a-positive exosomes, which promote cell growth under stress
conditions. This activity is suppressed by blocking Rab11a-dependent trafficking and
ESCRT function. Our proteomics and fly data suggest that some ESCRTs are differentially
involved in these two exosome-generating processes. Furthermore, mouse xenografts
highlight roles for stress-induced EVs in increasing the turnover of tumour cells,
leading to an increase in hypoxic stress, associated with selection for aggressive
cells that can promote tumour progression. These stress-induced vesicles also have
a potent effect on blood vessel growth in vivo.
Summary/Conclusion: We conclude that stress-induced EVs and exosomes made in Rab11a-positive
recycling endosomes are involved in tumour adaptation.
Funding: This work was funded by Cancer Research UK [C19591/A19076], the CRUK Oxford
Centre Development Fund [C38302/A12278], BBSRC [BB/K017462/1, BB/N016300/1, BB/R004862/1],
John Fell Fund, Oxford, Wellcome Trust [MICRON; #091911, #107457], Royal College of
Surgeons.
OT09.02
Emerging role of L-type calcium channel-mediated calcium influx in regulating apoptotic
bodies formation
Thanh Kha Phan
a, Bo Shib, Niall Geogheganc, Kelly Rogersd and Ivan Poone
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science,
La Trobe University, Bundoora, Australia; bDepartment of Biochemistry and Genetics,
La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia;
cCentre for Dynamic Imaging, Walter and Eliza Hall Institute of Medical Research,
Melbourne, Australia; dCentre for Dynamic Imaging, Walter and Eliza Hall Institute
of Medical Research, Melbourne, Australia; eLa Trobe University, Bundoora, Australia
Introduction: Dying cells often break into smaller membrane-bound fragments, called
apoptotic bodies (ApoBD), via apoptotic cell disassembly (ACD), an essential physiological
or pathophysiological event downstream of apoptosis. Emerging evidence implies the
importance of ApoBD formation in mediating efficient phagocytic removal of apoptotic
debris and facilitating intercellular communication through trafficking of biomolecules
and pathogen-derived materials. In contrast to long-lasting belief, our recent findings
have demonstrated that apoptotic cell disassembly is a tightly regulated and temporally-controlled
three-step process: (i) membrane blebbing, (ii) formation of thin membrane protrusion
promoting bleb separation and (iii) protrusion fragmentation to form ApoBD. However,
detailed insights to the underlying mechanism, particularly ion channels and chemical
signalling, undoubtedly require further investigations.
Methods: To identify ion channel(s) involved in ACD process, cells were treated channel
blockers prior to UV irradiation. ApoBD formation was monitored using DIC microscopy
and quantified by our recently-developed multi-parametric flow cytometry analysis
using TOPRO-3 dye and Annexin V. Lattice light sheet microscopy allowed us to obtain
high-resolution imaging of calcium-mediated ACD in presence of various fluorescent
stains.
Results: Our data showed that calcium influx preceded disassembly step of apoptotic
cell, blockade of which, using calcium channel inhibitors, abolished ApoBD formation.
Strikingly, calcium channels contain a tentative caspase cleavage site, immediately
preceding calmodulin-binding IQ motif which mediates calcium-dependent feedback inactivation
of the channels. Thus, maximised calcium influx by caspase-cleaved calcium channels
could be a novel regulatory mechanism of ACD. Furthermore, we could monitor the detailed
progression of the process, from cytosolic calcium accumulation to form electrochemical
force, driving protrusion formation and ACD process.
Summary/Conclusion: Our findings therefore provide further molecular insights into
dying cell disassembly and calcium-induced ApoBD-associated pathogenesis, particularly
vascular calcification.
OT09.03
A novel UBL3 modification influences protein sorting to small extracellular vesicles
Hiroshi Ageta
a, Natsumi Ageta-Ishiharab, Keisuke Hitachia, Takanori Onouchia, Hisateru Yamaguchia,
Yusuke Yoshiokac, Nobuyoshi Kosakad, Tomihiko Idea, Makoto Kinoshitab, Takahiro Ochiyad,
Mitsutoshi Setoue and Kunihiro Tsuchidaa
aFujita Health University, Toyoake, Japan; bNagoya University, Nagoya, Japan; cTokyo
Medical University, Shinjyuku-ku, Japan; dDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku, Japan; eHamamatsu
University School of Medicine, Hamamatsu, Japan
Introduction: Small extracellular vesicles (sEVs) are nanometre-sized vesicles secreted
from various cell types. Exosomes, a type of sEVs, derived from multivesicular bodies
(MVBs), mediate cell-to-cell communication by transporting proteins, mRNAsand miRNAs.
The delivery of proteins between cells by sEVs, including exosomes, is related to
tumour progression and neurodegenerative diseases. However, the molecular mechanism
by which proteins are sorted to sEVs is not fully understood.
Methods: By using immunoprecipitation, immunocytochemical, electron microscopic and
proteomics analysis, we report that ubiquitin-like 3 (UBL3)/membrane-anchored Ub-fold
protein (MUB), an evolutionarily conserved protein, acts as a novel posttranslational
modification (PTM) factor that regulates protein sorting to sEVs.
Results: We find that UBL3 modification is through cysteine residues only under non-reducing
conditions and is indispensable for sorting of UBL3 to MVBs and sEVs. Furthermore,
we observe a 60% reduction of total protein, but not RNA, levels in serum sEVs purified
from UBL3-knockout (KO) mice compared with those from wild-type mice. To identify
the types of proteins that are modified by UBL3, we perform comprehensive proteomics
analysis and find 1,241 UBL3-interacting proteins depending on the two C-terminal
cysteine residues. Among these, 369 proteins are annotated as “extracellular vesicular
exosome” by Gene Ontology (GO) analysis, and there are at least 22 disease-related
molecules, including Ras. To investigate whether UBL3 modification affects protein
sorting to sEVs, we choose Ras as a model protein. We show that Ras and oncogenic
RasG12V mutant are post-translationally modified by UBL3, and that increased sorting
of RasG12V to sEVs by UBL3 modification enhances activation of Ras signalling in the
recipient cells.
Summary/Conclusion: Collectively, these results indicate that a novel PTM by UBL3
influences the sorting of proteins to sEVs. UBL3 modification could be a novel therapeutic
target for sEV-related disorders.
OT09.04
Stringent small extracellular vesicle purification and ligation-independent small
RNA-seq: new insights into released RNA populations
Kenneth W. Witwera, Tine Schøyena, Yiyao Huang
a, Andrey Turchinovichb, Senquan Liua, Linzhao Chenga and Vasiliki Machairakic
aJohns Hopkins University School of Medicine, Baltimore, USA; bSciBerg, Heidelberg,
Germany; cJohns Hopkins University, Baltimore, USA
Introduction: MicroRNAs are a major focus of exRNA and EV studies. Many publications
report miRNAs as the plurality or majority of released small RNAs. However, legacy
sRNA profiling methods are biased towards miRNAs. Abundant RNAs outside vesicles also
contaminate many EV preparations. We sequenced exRNA from induced pluripotent stem
cells (iPSCs) with a ligation-independent method: ultra-low-input capture and amplification
by tailing and sequencing (CATS).
Methods: Culture conditioned medium (CCM) was collected from 4 lines of count-normalized
iPSCs over 3 passages (> 200 mL/passage). Fractions were: cells (washed/lysed); “whole
releasate" = clarified CCM (300 x g, 2k x g); “large EVs (lEVs)" = pellet of 10k x
g spin; “small EVs (sEVs) = preparation by tangential flow filtration (100 kDa cutoff)
and size exclusion chromatography (Izon); and “soluble" = flow-through from sEV preparation.
Particles were counted by ParticleMetrix, visualized by TEM, and tested for up to
7 positive or negative markers per MISEV2014/18. lEVs and sEVs were treated with nucleases.
CATS sRNA libraries were analysed for contribution of RNA classes. Statistics were
corrected for multiple comparisons; significance = corrected p < 0.01.
Results: Using CATS, miRNAs mapped at only a small % of total sRNA reads; typically
less than 1%. Nuclease-treated sEVs had significantly lower relative miRNA levels
than cells or soluble releasate. tRNAs/fragments had highest relative abundance in
whole releasate and soluble fractions, albeit with substantial variability. Significantly
different in most releasate fractions vs cells were sno/scaRNA, mRNA, and lncRNA.
Cellular distribution differed only from lEV and sEV for RNU RNAs, and only from sEV
for Y RNAs. rRNAs/fragments did not differ significantly. Medium-only process controls
had only a small per cent of human mapping.
Summary/Conclusion: miRNAs are found at lower relative levels in cells and releasate
than indicated by legacy sequencing methods. miRNAs also tend to be excluded from
sEVs vs. cells or other releasate fractions. While this study uses iPSCs, similar
results would likely be obtained with other cells. We do not discount the role for
miRNAs in cell-cell communication but suggest that sEVs may not be a vastly superior
source of miRNAs.
Funding: This work was supported by the US NIH: NIA (AG057430), NIDA (DA040385 and
DA047807) and NIMH (MH118164).
Symposium Session 10: EVs in Blood and Blood Disorders Chairs: Ai Kotani; Rienk NieuwlandLocation:
Level B1, Lecture Room 17:00–18:00
OT10.01
Different ATT isoforms are associated to EVs from ATT type II deficient patients
Annalisa Radeghieri
a, Silvia Alacquab, Giuliana Martinic, Eugenio Montib and Paolo Bergesed
aDepatment of Molecular and Translational Medicine and CSGI, Università degli Studi
di Brescia, ITALY, Brescia, Italy; bDepartment of Molecular and Translational Medicine,
Università degli Studi di Brescia, Brescia, Italy; cSpedali Civili of Brescia, Clinical
Chemistry Laboratory, Brescia, Italy; dDepartment of Molecular and Translational Medicine
and CSGI, Università degli Studi di Brescia, Italy
Introduction: Antithrombin (AT) is a glycoprotein involved in the regulation of blood
coagulation. It belongs to the family of serine-protease inhibitors and acts as the
most important antagonist of different clotting factors. Two types of inherited AT
deficiency can be distinguished: Type I (quantitative deficit), and Type II (qualitative
deficit). The latter is characterized by an impaired inhibitory activity related to
dysfunctional domains of the protein. Three Type II subtypes can be defined: Type
IIa (reactive site defect), Type IIb (heparin binding site defect) and Type IIc (pleiotropic
defect). This classification has clinical importance since these subtypes have a different
thrombotic risk. No functional routine diagnostic assay, however, can be assumed to
detect all forms of Type II deficiencies since false-negative results may hamper the
diagnosis.
Methods: We analysed the biochemical/biophysical association of ATT to EVs. We separated
EVs from plasma of healthy or Type II affected patients or from cultured hepatocytes
through differential ultracentrifugation followed by sucrose density gradient and/or
immunoprecipitation. We next combined dot blot analysis, WB, 2D electrophoresis and
enzymatic assays to reveal the nature of ATT association to EVs.
Results: We evidenced that ATT is associated to the external leaflet of EVs. We also
found that specific ATT isoforms are enriched in EV preparations in respect to total
plasma and that those isoforms are selectively associated to EVs when comparing healthy
or ATT type II deficient patients.
Summary/Conclusion: ATT selective association pattern to EVs might be related either
to mutations in the primary sequence of the protein or alterations in the glycosylation
process, hence experiments are ongoing to reveal the nature of this phenomenon. Our
findings suggest that analysis of ATT enriched in EV preparations might be useful
to gain insights into the pathogenesis and be of support in the diagnostic algorithm
of ATT deficiency.
Funding: This work acknowledges FFABR (Fondo finanziamento attività Base di ricerca
from MIUR, Ministry of Education, Universities and Research, Italy) for financial
support.
OT10.02
Search for EV signature in sickle cell disease
Sisareuth Tana, Celine Gounoua, Marc Romanab, Stephane Mornetc, Alain R. Brisson
d
aUMR-CBMN, Pessac, France; bUMR-1134 INSERM-Université Antilles-Guyanne, Pointe à
Pitre, France; cUMR-5026-ICMCB, Pessac, USA; dUniversity of Bordeaux, Pessac, France
Introduction: Sickle cell disease (SCD) is a hereditary haemoglobinopathy characterized
by the production of sickled red blood cells (RBC), anaemia and vascular occlusion
crises. The presence of extracellular vesicles (EV) in blood from SCD patients has
long been recognized, yet with a large divergence of results (1). Our objective was
to characterize in details EV in plasma from SCD patients, by combining flow cytometry
and immuno-gold cryo-electron microscopy (2,3). We focused on two EV populations:
1) EV exposing phosphatidylserine (PS), because the increased exposure of PS at the
RBC surface is a hallmark of SCD (4), and 2) exosomes exposing CD71 (CD71-Exo), because
the reticulocyte count is a marker of anaemia and CD71-Exo are released during the
maturation of reticulocytes into erythrocytes (5).
Methods: Platelet-free plasma (PFP) was obtained from 11 SCD patients and 18 control
individuals. Annexin-5, anti-CD235a- and anti-CD71-IgGs, either fluorescently labelled
or conjugated to gold particles, were used to detect PS+ EV, RBC-derived EV and CD71-Exo,
respectively, by flow cytometry and immuno-cryo-EM (2,3).
Results: By flow cytometry, seven populations of RBC-derived EV were identified in
SCD plasma, based on the presence vs. absence of PS, EV size and morphology. The main
difference between SCD and control PFP was the presence in SCD PFP of large amounts
of PS+ EV of small size (100 to 200 nm, as determined by immuno-cryo-EM) (250,000 ± 20,000
/ µL for SCD PFP vs. 30,000 ± 10,000/µL for control PFP).
In addition, CD71-Exo were detected in SCD PFP by immuno-cryo-EM, while they are almost
absent in control PFP. As expected, CD71-Exo were highly homogeneous in size, ranging
from 50 to100 nm. Their concentration was determined by fluorescence-triggered flow
cytometry: 70,000 ± 40,000 / µL for SCD PFP vs. 7,000 ± 5,000 / µL for control PFP.
Summary/Conclusion: We have identified two EV populations present in large amounts
in SCD plasma, while they are almost absent in control plasma. Further study is needed
to evaluate the use of these EV as biomarkers of the coagulation or endothelium activation
states in SCD.
1. Hebbel & Key. Brit J. Haem 2016 174:16
2. Arraud et al., J. Thromb Haemost 2014 12:614
3. Arraud et al., Cytometry A. 2016 9:184
4. Chiu et al., Blood 1981 58:398
5. Harding et al., J. Cell Biol 1983 97:329
Funding: Labex GR-Ex
OT10.03
Surface protein cargo of extracellular vesicles in blood plasma; the effect of an
inflammatory disease on the vesicle surface protein interactome
Eszter Á. Tóth, Katalin É. Szabó-Taylor, Tamas Visnovitz, György Nagy and Edit I Buzás
Semmelweis University, Department of Genetics, Cell and Immunobiology, Budapest, Hungary
Introduction: Extracellular vesicles (EVs) are endogenous nanoparticles produced by
cells. Artificial nanoparticles used for targeted therapy have been found to develop
a protein corona altering their biodistribution and bioavailability in biological
media. Here we set the aim to study if a similar protein corona is formed at the surface
of EVs in biofluids and if inflammation had an effect on the protein corona formation.
Methods: Blood plasma depleted in both platelets and EVs was generated from blood
samples of healthy subjects (n = 12) and rheumatoid arthritis patients (n = 10). Nascent
EVs of THP1 cells and platelets were isolated and incubated in the plasma samples
for 30 minutes. EVs were then washed and were studied by mass spectrometry (MS/MS),
immune electron microscopy and flow cytometry. Controls included i) plasma without
the addition of EVs; ii) EVs incubated in buffer. The effect of different protein
coronas was also studied by phagocytosis and TaqMan® assays. Flow cytometry was also
performed after saline washing and protease digestions. All experiments were performed
in accordance with the Declaration of Helsinki. Infomed consent was obtained from
all participants.
Results: A significantly higher number of proteins was found in the plasma+EV samples
compared with the summed number of proteins found in the only plasma and the only
EV samples (p < 000.1). Subtracting the proteins that were found in pure EV samples
from the list of proteins of EV samples incubated in plasma for 30 min and washed
2 times, a high number of proteins were found, out of which several were more characteristic
of rheumatoid arthritis samples and only a few were more prevalent in healthy samples.
Interactions between fibrinogen, haptoglobin, complement protein C3. and EVs were
also confirmed by flow cytometry and immune electron microscopy.
Summary/Conclusion: Our data suggest the existence of a protein corona on EVs of blood
plasma. The differences in protein coronas found between healthy controls and patients
with rheumatoid arthritis suggest that EV surface-associated proteins may play a role
in disease pathology and may serve as biomarkers.
Funding: NKFIH-OTKA PD 104369; PD 112058; 111958; 120237, NVKP_16, MTA-SE Immun-Proteogenomikai
EV Kutatócsoport, VEKOP-2.3.2-16-2017–000002, VEKOP-2.3.3-15-2017-00016 H2020 MSCA
ITN TRAIN-EV, SE STIA-2017
OT10.04
Oxidized LDL stimulates production of inflammatory extracellular vesicles by platelets
Maarit Neuvonena, Katariina Öörnib, Erja Kerkeläc, Kati Hyvärinenc, Saara Laitinenc
and Pia Siljander
d
aEV-Group, Faculty of Bio- and Environmental Sciences and Faculty of Pharmacy, Helsinki,
Finland; bWihuri Research Institute, Helsinki, Finland; cFinnish Red Cross Blood Service,
Helsinki, Finland; dEV-group, Molecular and Integrative Biosciences Research Programme,
Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki,
Finland
Introduction: Platelets may become activated under hyperlipidemic conditions and are
thought to promote atherosclerotic plaque development. Platelets can generate a diverse
mixture of extracellular vesicles (EVs) when they are activated through different
signalling pathways. In this study, we investigated in detail the EV-generating capacity
of different lipoproteins and compared the cellular effects of the resulting EVs on
macrophage differentiation.
Methods: Platelets (isolated by gel-filtration from fresh concentrates) were stimulated
by LDL, oxidized LDL or HDL together with thrombin + collagen co-stimulus, a potent
EV-inducing signal. After careful platelet removal, EVs were isolated by serial ultracentrifugation.
Platelet activation was monitored by P-selectin exposure in flow cytometry. EVs were
analysed by an EV-dedicated high-resolution flow cytometer and Western blotting, and
quantified by protein concentration and particle number. Macrophage differentiation
was induced by GM-CSF in the presence or absence of the different EVs. After 6 days,
macrophages were activated by IFN-γ and LPS, and after a further 3 days, the macrophages
were profiled by flow cytometry and their secreted cytokines.
Results: Lipoproteins induced platelet EV production in a concentration- and time-dependent
manner at concentration levels relevant to hyperlipidemic conditions. Oxidized LDL
increased EV formation by platelets, whereas co-incubation with HDL inhibited this
effect. Platelet derived EVs modulated the macrophage differentiation as seen by the
changes in their pro-inflammatory cytokines and surface marker profiles.
Summary/conclusion: In conclusion, hyperlipidemic lipoprotein profiles in plasma can
manifest in (1) altered platelet EV generation which in turn (2) may program macrophage
differentiation in a manner relevant for atherosclerotic plaque development.
Funding: Academy of Finland grant 287089, Finnish Foundation for Cardiovascular Research
Symposium Session 11: EV Therapeutics I Friday 26 April 2019Chairs: Andre Gorgens;
Sai Kiang LimLocation: Level B1, Hall B 08:30–10:00
OF11.01
Exosomes from cerebral endothelial cells suppress chemotherapy-induced peripheral
neuropathy and sensitize anti-tumour effects of platinum drugs
Yi Zhanga, Zheng Gang Zhang
b, Michael Choppc and Chao Lid
aHenry Ford Health System, Detroit, USA; bDepartment of Neurology, Henry Ford Hospital,
Detroit, MI, USA, Troy, USA; cDepartment of Neurology, Henry Ford Health System, Detroit,
MI, Department of Physics, Oakland University, Rochester, MI, USA; dDepartment of
Neurology, Henry Ford Health System, Detroit, MI, USA
Introduction: Platinum-based drugs are commonly used to treat cancers. However, peripheral
neuropathy is a common adverse effect of platinum-based chemotherapy. Neurotoxicity
often requires platinum drug dose reduction thereby, compromising therapeutic efficacy
of platinum drugs to suppress tumour progression.
Methods: Using differential ultracentrifugation, we isolated exosomes from cultured
human primary cerebral endothelial cells (CEC-exos). Ovarian tumour was induced in
mice by implantation of human ovarian cancer cells. Platinum-induced CIPN start from
distal axons. Thus, we examined the direct effect of platinum drugs on distal axons
of dorsal root ganglia (DRG) neurons using a microfluidic device that separates distal
axons from their parent cell bodies.
Results: We found that addition of oxaliplatin or carboplatin into the axonal compartment
significantly suppressed axonal elongation, whereas application of CEC-exos into the
axonal compartment completely abolished oxaliplatin-inhibited axonal growth. In vivo,
treatment of tumour-bearing mice with platinum drugs (n = 7/group) induced CIPN characterized
by tactile and cold allodynia, reduction of sensory nerve conduction velocity, and
decreases of the number of epidermal nerve fibres compared to the control mice (n = 7/group).
However, tumour-bearing mice treated with platinum drugs along with CEC-exos (n = 7/group)
exhibited a significant reduction of platinum-drug induced peripheral neuropathy.
Moreover, CEC-exos in combination with platinum drugs significantly decreased tumour
size by 80–91% compared to platinum drugs alone which reduced tumour growth only by
50–72%. In sciatic nerve tissues, CEC-exos in combination with platinum drugs significantly
increased miR-15b, −26a, and −214, and substantially reduced axonal damage protein
levels of PTEN, SARM1, and TRPV1. In tumour tissues, the combination treatment significantly
increased miR-15b and −26a, and reduced their target chemoresistant protein levels
of P-gp and ABCC1.
Summary/Conclusion: Our data demonstrate that CEC-exos reduce CIPN by reversing the
platinum-inactivated neuroprotective network and that CEC-exos suppress a chemoresistant
network of miRNAs/protein-coding genes to enhance the anti-tumour effect of platinum
drugs.
Funding: NIH R01CA219829; NIH R01NS088656; AHA 16SDG29860003.
OF11.02
EV-mediated in vitro transcribed (IVT) mRNA-based gene delivery for specific pro-drug
activation in the tumour treats breast cancer in mice with no offsite toxicity
Alexis Forterrea, Jing-Hung Wanga, Alain Delcayreb, Kyuri Kimc, Carol Greenc, Mark
Pegramd, Stefanie Jeffreye and Ac Matin
f
aDepartment of Microbiology & Immunology, Stanford University School of Medicine,
Stanford, USA; bExoThera LLC, Menlo Park, USA; cSRI Biosciences, Menlo Park, USA;
dDepartments of Medicine and Oncology, Stanford University School of Medicine, Stanford,
USA; eDepartment of Surgery, Stanford University School of Medicine, Stanford, USA;
fDepartment of Microbiology & Immunology Stanford University School of Medicine, Stanford,
USA
Introduction: We previously reported EV-mediated specific delivery of a gene (as mRNA)
encoding the HChrR6 enzyme to orthotopically implanted HER2+ breast cancer tumours
in mice. HChrR6 activated the pro-drug CNOB and completely inhibited tumour growth.
EVs and CNOB were delivered systemically. A new plasmid loaded the EVs with the mRNA;
they displayed the EVHB protein containing anti-HER2 scFv (“PEVs”). However, no direct
evidence was presented that the treatment was free of off-target toxicity. Here, three
aspects, relevant to clinical transfer of the regimen, are explored: IVT- instead
of plasmid-based mRNA loading; use of the pro-drug CB1954 whose safe dose in humans
is known (HChrR6 also activates CB1954); haematological and histopathologic studies
to detect off-target toxicity.
Methods: Exogenous mRNA delivery using exosomes is difficult because of its fragmentation.
To ensure the mRNA integrity (at synthesis, loading, and delivery), we used the “MCHB”
test. MCHB is the product of CNOB activation and is strongly fluorescent, providing
a facile method to test this. The mRNA was transcribed in vitro from the HChrR6 gene
(standard kits) and was tested by translating it into the enzyme and ascertaining
the enzyme’s ability to produce fluorescence upon CNOB addition. mRNA copy number
in the EVs and the recipient cells was determined by qRT-PCR. The loaded EVs were
HER2 targeted as above, using EVHB (“IEVs”). HER2+ BT474 breast cancer tumours were
orthotopically implanted in mice.
Results: While 5,000 PEVs were needed to deliver one copy of the mRNA, <50 IEVs delivered
this. BT474 cells transfected in vitro with IEVs showed significantly higher mRNA
expression than those transfected with PEVs. Expression of the latter peaked at ca.
72 h; of the former continued throughout the length of the experiment (120 h). We
found that CB1954 (20 mg/kg) completely arrested tumour growth with 220-fold fewer
IEVs (3.4 x 10^8) than PEVs; experiments in progress suggest that even lower IEVs
may be sufficient. Extensive haematological and histopathologic studies showed no
significant toxicity.
Summary/Conclusion: IEV + CB1954 therapy completely arrests tumour growth at a much
lower IEV dose and without introducing potentially harmful plasmid DNA and off-target
toxicity. The findings move this approach closer to clinical transfer.
Funding: NIH NCATS UH3TR000902.
OF11.03
High yield hMSC derived mechanically induced xenografted extracellular vesicles are
well tolerated and induce potent regenerative effect in vivo in local or IV injection
in a model of chronic heart failure
Max Piffouxa, Iris Marangonb, Nathalie Mougenotc, Claire Wilhelmd, Florence Gazeaue,
Onnik Agbulutf and Amanda Brun-Silva
g
aLaboratoire Matière et Systèmes Complexes, CNRS UMR 7047 Université Paris Diderot,
Paris, France; bUniversité Sorbonne Paris Cité, Laboratoire Matière et Systèmes Complexes,
CNRS UMR 7047 Université Paris Diderot, France; cSorbonne Universités, Université
Pierre et Marie Curie Paris 6, Plateforme PECMV, UMS28, Paris, France; dlaboratoire
Matière et Systèmes Complexes, paris, France; eUniversité Sorbonne Paris Cité, Laboratoire
Matière et Systèmes Complexes, CNRS UMR 7047 Université Paris Diderot, Paris, France;
fUniversité Sorbonne Paris Cité, Laboratoire Matière et Systèmes Complexes, CNRS UMR
7047 Université Paris Diderot, Paris, France; 7Université Sorbonne Paris Cité, Laboratoire
Matière et Systèmes Complexes, CNRS UMR 7047 Université Paris Diderot, Paris, France
Introduction: On the road towards the use of extracellular vesicles (EVs) for regenerative
medicine, technological hurdles remain unsolved: high-yield, high purity and cost-effective
production of EVs.
Methods: Pursuing the analogy with shear-stress induced EV release in blood, we are
developing a mechanical-stress EV triggering cell culture approach in scalable and
GMP-compliant bioreactors for cost-effective and high yield EV production. The third
generation setup allows the production of up to 300,000 EVs per Mesenchymal Stem Cell,
a 100-fold increase compared to classical methods, i.e physiological spontaneous release
in depleted media (around 2000 EVs/cell), with a high purity ratio 1 × 10e10 p/µg
Results: We investigated in vitro the regenerative potential of high yield mechanically
induced MSC-EVs by demonstrating an equal or increased efficiency compared to classical
EVs with the same amount of EVs. The regenerative properties of mechanically induced
MSC-EVs was confirmed in vivo in a murine model of chronic heart failure demonstrating
that high, medium shear stress EVs and serum starvation EVs or mMSCs had the same
effect using local injection. We later on tested the effect of the injection route
and the use of xenogenic hMSC-EVs on their efficiency in the same model of murine
chronic heart failure. Heart functional parameters were analysed by ultrasound 2 months
(1 month post EV injection) post infarction. Interestingly, hMSC-EVs had the same
effect compared to mMSC-EVs in local injection, showing that xeno-EVs in immunocompetent
mices was well tolerated. Moreover, hMSC EV IV injection was as efficient as local
intra-myocardium muscle injection with an increase in the left ventricular ejection
fraction of 26% compared to pre-treatment values, whereas PBS injected controls lost
13%.
Summary/Conclusion: We demonstrated an equal or superior regenerative effect of high
yield mechanically produced EVs compared to spontaneously released EVs or parental
cells in vitro and in vivo, and good tolerance and efficacy of hMSC EV both with local
and IV injection. This unique technology for EV production combines decisive assets
for clinical translation of EV-based regenerative medicine : a GMP-compliant setup,
high density cell culture, high yield release of EVs per cell, high purity EVs.
OF11.04
Prolongation of allograft survival via donor MHC chimerism induced by extracellular
vesicles
Bruno Adonai Gonzalez Nolasco
a, Mengchuan Wanga, William Orenta, Aurore Prunevieillea, Jane Oa, Kaitlan Ahrensa,
Joren C Madsenb and Gilles Benichoua
aDepartment of Surgery, Center for Transplantation Sciences, Massachusetts General
Hospital and Harvard Medical School, Boston, USA; bDepartment of Surgery, Center for
Transplantation Sciences and Division of Cardiac Surgery, Massachusetts General Hospital
and Harvard Medical School, Boston, USA
Introduction: Achieving robust and durable host immune tolerance of allogeneic transplants
is the ultimate goal in clinical transplantation. Mixed chimerism induced via donor
bone marrow transplantation and host non-myeloablative conditioning has reliably achieved
tolerance of allogeneic organ transplants in mice and humans. Tolerance in this model
is believed to rely essentially on the presentation of donor MHC molecules in the
host’s thymus. In this study, we investigated whether donor MHC chimerism could be
achieved via donor extracellular vesicles (EVs) injections and subsequent cross-dressing
of recipient cells in the host’s thymus.
Methods: Conditioned SJL (CD45.1+, H2-Ks+) recipient mice received a single IV dose
of purified bone marrow derived exosome-enriched EVs (BM-EVs) isolated from C57BL/6
(CD45.2+, H2-Kb+) donors through sequential centrifugation or using a commercially
available exosome isolation kit. Nanoparticle tracking showed vesicles of approximately
100nm in size in the BM-EVs preparation and Western Blot showed the presence of MHCI.
Image flow cytometry was used to detect the presence of cross-dressed cells from day
10 through 100 after exosome injection. For NHP studies, MHC class I H38+ BM-EVs were
injected into a H38- conditioned cynomolgus macaque prior to a combined heart and
kidney transplant. PBMCs, thymus, spleen and mesenteric lymph nodes were collected
for image flow cytometry.
Results: Intravenous injection of BM-EVs into conditioned mice resulted in the presentation
of donor MHC and CD45.1 molecules by host’s thymic and splenic cells. Similarly, H38+cross-dressed
cells were detected at D33 after exosome injection in all of the NHP recipient tissues
collected. In mice, donor but not syngeneic or third-party BM-EVs significantly prolonged
skin allograft survival (median survival = 17 VS 11 days, p < 0.001).
Summary/Conclusion: These results show that delivery of donor-derived extracellular
vesicles can induce donor MHC chimerism via cross-dressing of recipient APCs with
allogeneic MHC molecules in the host’s thymus. This suggests that donor EVs could
be used in place of bone marrow cells to induce chimerism and allograft survival with
minimal conditioning and no risk of graft versus host disease (GVHD).
Funding: NIH R01DK115618.
OF11.05
Proteomic and transcriptomic characterization of exosomes-mimetic nanovesicles reveals
their relevance as a therapeutic delivery system
Amirmohammad Nasiri Kenari
a, Kenneth Kastaniegaardb, Mitch C. Shambrooka, David Greeninga, Allan Stensballeb,
Lesley Chenga and Andrew Hillc
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science,
La Trobe University, Melbourne, Australia; bDepartment of Health Science and Technology,
Faculty of Medicine, Aalborg University, Denmark, Aalborg, Denmark; cThe Department
of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University,
Bundoora, Australia
Introduction: The potential of utilizing exosomes (endosomal derived vesicles) as
a therapeutic delivery system of biological and chemical drugs are an active area
of clinical phase investigation. However, the field is currently facing challenges
such as the insufficient release of exosomes, their heterogeneity and reproducibility
of isolation. These issues may be overcome through the development of artificial extracellular
vesicles (EVs). Cell-derived mimetic nanovesicles (M-NVs) can be generated from numerous
cell lines with advantages such as, reproducibility, large scale production, uniformity,
cost effectiveness and a simple purification method. Although several studies have
shown that M-NVs have similar morphology, size and therapeutic potential to exosomes,
comprehensive characterization and to what extent these artificial EV components mimics
exosomes remain elusive.
Methods: In this study, M-NVs generated by subjecting cells to the extrusion, were
comprehensively characterized and compared to the exosomes by proteomic and transcriptomic
analysis.
Results: We analysed the proteome between M-NVs and exosomes to provide key insights
into key membrane surface features of exosomes for cargo sorting and therapeutics
delivery are preserved in M-NVs (158 proteins). Furthermore, our study highlighted
differences in protein post-translational modifications among M-NVs, as distinct from
exosomes, using a non-targeted informatic approach, specifically showing phosphorylation,
ubiquitination, and thiophosphorylation as enriched protein modifications in M-NVs.
Small RNA analysis reveals that unlike exosomes, the RNA cargo of M-NVs is similar
to that of the parental cells. In addition, we found that M-NVs could be useful for
packaging proteins or RNA which are globally enriched in cells. Indeed, this may overcome
the challenges involved in selective packaging of therapeutic proteins or RNAs into
exosomes.
Summary/Conclusion: In summary, results from this study provides key insights into
omics of M-NVs cargo in comparison to exosomes and ultimately its potential as therapeutic
delivery system.
Funding: Grants from the Australian Research Council, Lundbeck Foundation and the
Danish National Mass Spectrometry Platform for Functional Proteomics.
OF11.06
Exosomes from periodontal ligament-derived cells promote cutaneous wound healing and
topical application is superior to local injection
Sebastian Sjoqvist
a, Azela Gladyb, Ryo Okadac, Akiko Takahashid, Taichi Ishikawae, Satoru Onizukaf,
Nobuo Kanaif and Takanori Iwataf
aKarolinska Institutet/Tokyo Women’s Medical University, Tokyo, Sweden; bDepartment
of Pharmacology, Keio University School of Medicine, Tokyo, Japan; cProject for Cellular
Senescence, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan;
dProject for Cellular Senescence, Cancer Institute, Japanese Foundation for Cancer
Research, Koto-ku, Japan; eDivision of molecular microbiology, Iwate Medical University,
Iwate, Japan; fInstitute of Advanced Biomedical Engineering and Science, Tokyo Women’s
Medical University, Tokyo, Japan
Introduction: Periodontal ligament-derived mesenchymal stromal cells (PDL-MSCs) represent
an attractive source of cells for regenerative medicine due to four reasons; 1) similarly
to other MSCs, they exhibit pro-regenerative properties, 2) accessibility is great
due to abundance of extracted teeth, 3) they can easily be expanded and 4) they can
be used in an allogeneic fashion. We are currently investigating the use of sheets
produced from these cells to regenerate periodontal tissue. In this study we aimed
to investigate the potential of exosomes from human PDL-MSCs to stimulate wound healing.
Methods: We used ultrafiltration and size-exclusion chromatography to isolate vesicles
from serum-free conditioned media. BCA-assay and nanoparticle tracking analysis (NTA)
was used to determine yield. We performed Western Blot for positive and negative extracellular
vesicle-markers, and transmission electron microscopy was used to evaluate morphology.
We then performed wound healing assay in immunocompetent rats. Each rat received two
full-thickness wounds, treated with either topical application or perilesional injections,
and PBS was used in control rats. The animal weights were measured and wounds were
photographed every other day. The animals were sacrificed on day 7 and the tissue
was collected for histopathological analysis.
Results: Exosome yield was on average 0.83 µg proteins per million cells per 24 h.
The exosomes had a mean size of 130 nm, showed positivity for CD9 and Flotillin-1
and negativity for GRP94 and had a spherical morphology. The exosomes were applied
to wounds and rats receiving exosomes gained significantly more weight than controls.
Topical application proved to be superior to injections based on macroscopic wound
evaluation and histopathology.
Summary/Conclusion: PDL-MSC-derived exosomes stimulate wound healing in a xenogeneic
setting and topical application is superior to local injections.
Funding: This work was supported by The Swedish Society of Medicine, Erik och Edith
Fernströms stiftelse för medicinsk forskning, Misao-Yanagihara-Grant for regenerative
medicine research and JSPS KAKENHI Grant Number JP18H02985.
Symposium Session 12: Protein Biomarkers in Human Disease Chairs: Malene Møller Jørgensen;
Koji UedaLocation: Level B1, Lecture Room 08:30–10:00
OF12.01
Biomarkers of peritoneal membrane alteration in dialysis efflux-extracellular vesicles:
a longitudinal study in patients under peritoneal dialysis treatment
Laura Carreras-Planella
a, Jordi Soler-Majoralb, Cristina Rubio-Esteveb, Míriam Morón-Fontc, Marcella Franquesac,
Jordi Bonald, Maria-Isabel Troya-Saboridob and Francesc E. Borràsc
aReMAR-IVECAT group, Health Science Research Institute Germans Trias i Pujol (IGTP),
Badalona, Spain; bNephrology Department, Badalona, Spain; cREMAR-IVECAT Group, “Germans
Trias i Pujol” Health Science Research Institute, Can Ruti Campus, Badalona, Spain;
dNephrology Department, “Germans Trias i Pujol” University Hospital, Can Ruti Campus,
Badalona, Spain
Introduction: Peritoneal dialysis (PD) is considered the best renal replacement therapy
for patients waiting for a kidney transplant. Many patients eventually suffer ultrafiltration
failure of the peritoneal membrane (PM), leading to severe clinical complications
and the urgent need to change the dialysis technique. Currently, PM functionality
is monitored by the peritoneal equilibration test (PET), a tedious technique that
only shows changes when the PM damage is advanced. We hypothesized that peritoneal
dialysis efflux (PDE)-extracellular vesicles (EV) may contain biomarkers of PM state.
In a previous study (Carreras-Planella, et al., PLoS One 2017), we showed for the
first time that PDE-EVs could be isolated and their protein content showed differences
between newly enrolled and long term PD patients. Here, we present the results of
a longitudinal study in a new cohort of PD patients.
Methods: PDE was collected from 12 PD patients every 6 months (coincident with PET
controls) up to 24 months follow up. PDE-EV were isolated by size-exclusion chromatography
and characterized by expression of classical tetraspanin EV markers. EV proteome was
analysed by Mass Spectrometry (LC-MS/MS).
Results: In accordance with our previous study, PDE-EV proteome showed reduced expression
of several proteins at longer timer points (>12 months) of treatment. In addition,
statistical analysis revealed confidently identified proteins – potentially involved
in fibrotic processes – that are significantly deregulated in patients showing alterations
in PET monitoring at 12 months of treatment.
Summary/Conclusion: Our results confirm the potential of analysing PDE-EV as biomarkers
of PM alteration allowing improved monitoring of PD patients compared to PET.
Funding: The IGTP is member of the CERCA network of institutes. LCP is sponsored by
the FPU scholarship (FPU17/01444) from the Ministerio de Ciencia, Innovación y Universidades
of the Spanish Government. MF is sponsored by the PERIS contract SLT002/16/00069,
from the Generalitat de Catalunya. F.E.B. is a researcher from Fundació Institut de
Recerca en Ciències de la Salut Germans Trias i Pujol supported by the Health Department
of the Catalan Government (Generalitat de Catalunya).
OF12.02
Proteomics of urine-derived extracellular vesicles to identify biomarkers of prostate
cancer risk groups
Amanda Khoo
a, Meinusha Govindarajanb, Vladimir Ignatchenkoc, Vincent Huangd, Julius O. Nyalwidhee,
O. John Semmese, Paul Boutrosf, Stanley Liug and Thomas Kislingerc
aDepartment of Medical Biophysics, University of Toronto, Toronto, Burlington, Canada;
bDepartment of Medical Biophysics, University of Toronto, Toronto, Canada; cPrincess
Margaret Cancer Centre, University Health Network, Toronto, Canada; dOntario Institute
for Cancer Research, Toronto, Canada; eLeroy T. Canoles Jr. Cancer Research Center,
Eastern Virginia Medical School, Norfolk, USA; fUCLA, Jonsson Comprehensive Cancer
Center, Los Angeles, CA, USA; gOdette Cancer Research Program, Sunnybrook Research
Institute, Toronto, Canada
Introduction: Prostate cancer (PCa) is the most common cancer in men and can be detected
early through screening of asymptomatic men. Most prostate cancers are indolent at
time of diagnosis and current prognostic protocols do not accurately predict disease
aggression and clinical outcome, which limits optimal patient management. For example,
high serum prostate-specific antigen (PSA) levels could be indicative of metastatic
cancer or benign prostatic conditions, while needle biopsies are invasive and can
undersample the prostate, resulting in uncertainty of cancer grading. We hypothesize
that small extracellular vesicles (sEVs) isolated from post-digital rectal exam urine
(pDRE-urine) contain protein biomarkers will allow for non-invasive PCa risk stratification.
Methods: We have performed deep proteomics analysis on pDRE-urine-derived sEVs from
105 treatment-naïve, richly annotated patients (age, T-stage, Gleason score, PSA,
etc.). sEVs were isolated by differential ultracentrifugation and processed for proteomics
(LC-MS). Size and morphology of sEVs were verified by nanoparticle tracking analysis
and TEM.
Results: We detected 3,688 proteins in sEVs, 80% of which are shared with the prostate
cancer tissue proteome (unpublished). sEV proteins were enriched in cytoplasmic and
membrane proteins and depleted in nuclear proteins. Interestingly, sEVs were also
enriched for prostate-specific proteins compared to the proteome of urine that was
analysed in parallel, suggesting enrichment for low-abundance tissue-originating protein
cargo in sEVs. Samples clustered into three groups based on global protein expression,
suggesting that there may be subtypes of sEVs within pDRE-urine.
Summary/Conclusion: We are currently applying machine learning approaches to identify
biomarkers that could supplement current diagnostic tests and improve stratification
of patient risk groups. In the future, we will confirm differential protein expression
by targeted proteomics assays using an active surveillance cohort and perform parallel
profiling of sEV RNA cargo. Ethics approval at University Health Network.
Funding: National Cancer Institute-Early Detection Research Network.
OF12.03
Extracellular vesicle biomarkers predict Alzheimer’s disease in the baltimore longitudinal
study of ageing
Maja Mustapic
a, Michelle Shardella, Sean Berkowitzb, Thomas Diehlc, Ryan Spanglerd, Joyce Trane,
Michael Lazaropoulosc, Sahil Chawlaa, Seema Gulyania, Erez Eitand, Yang Ana, Chiung-Wei
Huanga, Susan Resnika, Edward Goetzlf, Luigi Ferruccia and Dimitrios Kapogiannisg
aNIH/National Institute on Aging (NIA), Baltimore, USA; bNIH/NIA, Nashville, USA;
cNIH/NIA, Philadelphia, USA; dNIH/NIA, Boston, USA; eNIH/NIA, San Diego, USA; fDepartment
of Medicine, University of California, San Francisco, CA; ‡Jewish Home of San Francisco,
San Francisco, San Francisco, USA; gNational Institute on Aging, Baltimore, USA
Introduction: It was recently reported that plasma neuronal-enriched extracellular
vesicles (EVs) of Alzheimer’s disease (AD) patients exhibit elevated levels of phosphorylated
tau, Aβ42, and phosphorylated insulin receptor substrate-1 (IRS1). To validate them
as AD predictors, we interrogated preclinical samples from Baltimore Longitudinal
Study of Ageing participants.
Methods: We blindly analysed 931 longitudinal plasma samples from 138 cognitively
normal participants who eventually developed AD (cases) and 233 age and sex-matched
Controls who remained cognitively normal. The earliest samples preceded AD symptom
onset by a median of 4.1 years. We precipitated total particles using Exoquick and
then immunoprecipitated neuronal-enriched EVs using antibody against neuronal cell
adhesion molecule L1CAM. We lysed isolated EVs and quantified proteins by immunoassays.
We adjusted values for EV concentration and diameter to normalize for EV yield. We
compared cross-sectional and longitudinal trajectories of EV biomarkers between future
AD and Control participants and performed stepwise logistic regression with internal
cross-validation and receiver operating characteristic analysis to assess the ability
of EV biomarkers to discriminate future AD cases from Controls.
Results: Future AD cases had cross-sectionally and longitudinally higher p181-Tau,
p231-Tau, pSer312-IRS1, pY-IRS1 and EV diameter than Controls but similar Aβ42, total
Tau, TSG101 and EV concentration. A model optimally combining longitudinal data for
multiple biomarkers achieved 90.2% sensitivity (95% confidence interval [CI], 81.2–95.4%),
83% specificity (95% CI, 76–88%) and 91.6% area under-curve (95% CI, 87.9–95.4%) for
predicting AD. Preclinical levels of several EV biomarkers were associated with cognitive
performance.
Summary/Conclusion: We validated several neuronal-enriched EV biomarker candidates
and further demonstrated that their preclinical longitudinal trajectories predict
AD diagnosis with high sensitivity. These
findings motivate further development of EV biomarkers towards a clinical blood test
for AD.
Funding: This research was supported entirely by the Intramural research Program of
the NIH, National institute on Aging
OF12.04
CD315 (PTGFRN) – a new biomarker for tumour-derived extracellular vesicles
Kathrin Gärtner
a, Corinna Hülsa, Gabor Gondia, Judith Dünzkoferb and Reinhard Zeidlerc
aHelmholtz Center Munich German Research Center for Environmental Health, Research
Unit Gene Vectors, Munich, Germany; bDepartment of Otorhinolaryngology, Klinikum der
Universität (KUM), Munich, Germany; cHelmholtz Center Munich German Research for Environmental
Health, Research Unit Gene Vectors, Munich, Germany, Munich, Germany
Introduction: Extracellular vesicles (EVs) represent important mediators of cell-cell
communication and are secreted by many types of cells, including tumour cells, into
the extracellular milieu. Tumour-derived EVs hold a lot of promise for non-invasive
diagnostic tests, also known as liquid biopsy, because they are present in all kind
of biological fluids and carry a large variety of proteomic and genetic information.
There is now an ever-growing need for new specific biomarkers, which allow for the
isolation of distinct EV subclasses in order to improve EV-based diagnostics. We show
for the first time that CD315 (also known as PTGFRN, EWI-F or CD9P-1) may represent
a new potential biomarker for tumour-derived EVs.
Methods: The expression of CD315 was studied in cell lines, primary tumour samples
and corresponding EVs. CRISPR/Cas9 CD315 knockout cells were used to investigate the
impact of CD315 on cell proliferation and EV secretion. Furthermore, we generated
a CD315-specific monoclonal antibody to elucidate the diagnostic potential of CD315+EVs
in blood samples of cancer patients.
Results: We demonstrated that CD315 is highly expressed on a large variety of tumour
cells and is present on the surface of tumour-derived EVs. In vitro knockout of CD315
hampered proliferation and migration of tumour cells and affected cellular EV production.
Moreover, our CD315-specific antibody was successfully used to capture and isolate
CD315+EVs by immunoaffinity.
Summary/Conclusion: We identified CD315 as a promising new biomarker with diagnostic
potential. Although its specific function still remains to be elucidated, we were
the first to show that CD315 is highly abundant in tumour-derived EVs. Additionally,
we generated a CD315-specific antibody as a valuable tool for immunoisolation of distinct
EV subclasses.
OF12.05
Analysis of urinary extracellular vesicles auto fluorescence in imaging flow cytometry
and spectral flow cytometry.
Luca Musantea, Sabrina La Salviaa, Joanne Lanniganb and Uta Erdbruegger
c
aDepartment of Medicine/Nephrology Division, University of Virginia, Charlottesville,
USA; bSchool of Medicine, Flow Cytometry Core, University of Virginia, Charlottesville,
USA; cUniversity of Virginia Health system, Charlottesville, USA
Introduction: Urinary extracellular vesicles (uEVs) provide a source of valuable biomarkers
for kidney and urogenital diseases. Analysis of uEVs in imaging flow cytometry is
challenging for its intrinsic natural auto fluorescence emission across the whole
electromagnetic spectrum. To date it is not known what the rate of the autofluorescence
interference is with respect to the detection of specific marker uEVs markers
Methods: First morning void urine and citrate blood from the same donor were centrifuged
at 4,600 g for 30 and 15 min, respectively. The supernatant was centrifuge at 20,000g
to collect urinary (uEVs) and plasma (pEVs) which were stained with the same commercial
clone antibody (3D3) anti podocalyxin (PODXL) conjugated with 3 different fluorescent
dyes: Alexa Fluor® 405 (AF405), Alexa Fluor® 488 (AF488) and Alexa Fluor® 647 (AF647).
Stained EVs were acquired with both imaging flow cytometry and spectral flow cytometry.
Gate strategy was based on the low scatter of the unstained uEVs and the negative
control was the fluorescent probe alone in buffer.
Results: Acquisition of uEVs alone showed auto-fluorescence emission in channel 2
(λex 488 nm; λem 480–560 nm) camera 1 and channel 11 (λex 658 nm; λem 660–740 nm)
but not channel 7 (λex 405 nm; λem 420–505 nm) for camera 2 for the imaging flow cytometry
meanwhile the spectral flow cytometry revealed a spectral fingerprint spanning from
the violet to the red emission. Autofluorescence was detected for uEVs but not pEVs.
Podocalyxin-AF405 conjugated stained both uEVs and pEVs with a double staining for
the autofluorescence and PODXL on the same uEV. While PODXL-AF488 and AF647 stained
pEVs both the antibody conjugated failed to detect the uEVs as per PODXL-AF405. Same
results were obtained for both flow cytometry instruments.
Summary/Conclusion: While imaging flow cytometry represent a major advancement in
the identification of uEVs, our results showed an unexpected additional complication
of the analysis originated from the auto-fluorescence of the uEVs fraction. In fact,
The autofluorescence quenched the emission of PODXL-AF488 and AF647 but not AF405.
uEVs auto-fluorescence needs to be taken into account especially when simultaneous
co-detection of uEVs markers of podocyte origin is planned with particular emphasis
on the critical selection of the antibody conjugated fluorescent dye.
OF12.06
Serum vs. plasma: a comparative study in EV composition
Razieh Dalir Fardoueia, Rossella Crescitellib, Aleksander Cvjetkovica, Jan Lötvallc
and Cecilia Lasser
d
aKrefting Research Centre/University of Gothenburg, Gothenburg, Sweden; bKrefting
Research Centre, Dept of Internal medicine and clinical nutrition, Institute of Medicine,
University of Gothenburg, Sweden, Gothenburg, Sweden; cKrefting Research Centre, Dept
of Internal medicine and clinical nutrition, Institute of Medicine, University of
Gothenburg, Sweden, Gothenburg, Sweden; 4Krefting Research Centre/University of Gothenburg1
Krefting Research Centre, Dept of Internal Medicine and Clinical Nutrition, Institute
of Medicine, University of Gothenburg, Sweden, Gothenburg, Sweden
Introduction: The ability to isolate extracellular vesicles (EVs) from blood is paramount
in the development of EVs as disease biomarkers. However, this is complicated by the
profuse presence of plasma proteins and lipoprotein particles, making blood one of
most difficult body fluids to isolate EVs from. We have previously developed a method
to isolate EVs from blood with minimal contamination of lipoprotein particles (Karimi
et al 2018). The aim of this study was to compare the amount of EVs and their protein
cargo isolated from plasma and serum.
Methods: Blood was collected from healthy subjects, from which plasma and serum were
isolated. EVs were isolated using a combination of density cushion and size exclusion
chromatography (SEC). Purity and yield of EVs were determined by nanoparticle tracking
analysis (NTA), Western blot, electron microscopy (EM), and mass spectrometry (LC-MS/MS).
Additionally, Cy7-labelled cell line-derived EVs were spiked in to blood prior to
isolation of plasma and serum to compare the recovery.
Results: As determined by NTA and protein measurement more EVs could be isolated from
plasma. This result was supported by experiments were labelled EVs were spiked in
to blood, which demonstrated that less labelled EVs could be retrieved from serum
compared to plasma. Enough plasma EVs could be isolated for proteomic analysis from
12 ml blood, which was not possible for serum-derived EVs from the same amount of
blood. When larger amount of serum and plasma was used as starting material 1789 proteins
could be identified in plasma-derived EVs, while only 628 proteins could be identified
in serum-derived EVs. Both proteomes were strongly associated with the GO term “Extracellular
exosome”, while the serum derived EVs were more associated with “Complement activation”.
Summary/Conclusion: This study shows that a larger amount of EVs could be isolated
from plasma compared to serum. We currently don’t have the explanation why this is
so, however it might be due to the fact that EVs get trapped in the clot during serum
formation. Future studies are needed to answer how this affects the use of blood-derived
EVs as biomarkers from serum and plasma.
Symposium Session 13: Stem Cell Derived EVs Chairs: Qingling Fu; Tatiana LopatinaLocation:
Level 3, Hall B 08:30–10:00
OF13.01
Extracellular vesicles confer DNA damage on residual long-term HSC in the AML niche
Sherif Abdelhameda, John Butlerb and Peter Kurre
c
aKnight Cancer Institute, Oregon Health & Science University, Portland, USA; bMedical
Scientist Training Program, Oregon Health & Science University, Portland, USA; cChildren’s
Hospital of Philadelphia, Philadelphia, USA
Introduction: Acute Myeloid Leukaemia (AML) is a hematopoietic cancer that arises
from mutations in hematopoietic stem cells (HSC). Genomewide sequencing has revealed
that patients harbour multiple leukaemic clones operating in dynamic succession. Molecular
abnormalities have also been uncovered in phenotypically normal residual HSC from
AML patients. Independently, several groups showed enforced quiescence in residual
long-term (LT-) HSC in the AML microenvironment. Neither observation is fully understood.
Methods: Our previous studies in AML xenografts showed that extracellular vesicles
(EV) contribute to the erosion of hematopoietic progenitor function. Here we hypothesized
that AML EV may similarly shape fate and function of residual HSC in the AML niche.
We used a combination of in vivo, ex vivo and in vitro approaches and utilizing both
AML cell lines and primary AML patient cells.
Results: We confirmed the relative enrichment of residual HSC in the BM due to gains
in quiescence even at low leukaemic burden, or following AML EV injections. We also
observed in vivo AML-EV trafficking to LT-HSC associated with p53 hyperphosphorylation,
but not apoptosis or senescence. Next, a proteomic screen of EV-exposed HSPC identified
the systematic suppression of ribosome biogenesis as the most highly enriched Gene
Ontology category. The mTOR pathway governs ribosome biogenesis and protein synthesis,
and we went on to show that AML-EV trafficking of micro RNA-1246 targets Raptor, a
pathway component. Translational suppression of Raptor In turn caused ribosomal protein
S6 hypo-phosphorylation and suppressed protein synthesis. Quiescent HSC are known
to rely on error prone mechanisms of DNA repair, and we demonstrate that residual
HSC accrue DNA damage, gain replating competency and show increased in vivo repopulation.
Summary/Conclusion: Altogether, our studies suggest that EV miRNA dysregulate proteostasis
and confer HSC quiescence in the AML BM. We uncover evidence of long-lasting DNA damage
in residual LT-HSC via AML EV.
Funding: Institutional,; Hyundai Hope on Wheels Foundation.
OF13.02
Extracellular vesicles contribute to the development of ionizing radiation-induced
late bone marrow pathologies
Dávid Kisa, Rita Hargitaib, Nikolett Sándora, Eszter Persaa, Tünde Szatmárib, Enikő
Kisa, Géza Sáfrányb and Katalin Lumniczky
b
aNational Public Health Center, Budapest, Hungary; bNational Public Health Center,
Division of Radiobiology and Radiohygiene, Department of Radiation Medicine, Budapest,
Hungary
Introduction: Bone marrow (BM) is a particularly radiosensitive organ; haematological
malignancies, myelodysplastic syndrome and chronic bone marrow insufficiency are considered
long-term consequences of bone marrow irradiation. Ionizing radiation (IR) damages
the stem and progenitor cells and alters signalling between the stem cell compartment
and the BM stroma. The major objective of our work was to investigate extracellular
vesicles (EVs) mediated IR effects in the BM and stroma at low and high irradiation
doses and to study possible underlying mechanisms using an in vivo murine model.
Methods: C57Bl/6 mice were irradiated with 0.1 Gy or 2 Gy and EVs isolated from the
BM supernatant were injected systemically into naive animals. EV-mediated phenotypical
changes were determined by flow cytometry in the stem and progenitor cell compartment
and in the BM stroma. Apoptosis in various cellular subpopulations was measured by
Tunnel assay, DNA damage by immunostaining using the γH2AX assay, senescence by β-gal
staining. Oxidative damage was evaluated in the BM cells by measuring protein oxidation
and lipid peroxidation and systemically by determining the level of 8-hydroxy-2’ -deoxyguanosine
in the urine.
Results: Treatment of naïve mice with BM-derived EVs from irradiated animals induced
apoptosis in certain cellular subpopulations, led to local and systemic oxidative
damage, decreased the number of haematopoietic and mesenchymal stem cells and of lymphoid
progenitors, changed the ratio between the long term and short term stem cells, increased
systemic release of immature progenitors into the circulation. Stroma was less affected;
endothelial cells were the most sensitive.
Summary/Conclusion: BM-derived EVs mediated IR-induced damage in the bone marrow and
stroma, which raise the role of BM-derived EVs in the development of IR-induced late
BM pathologies.
Funding: Euratom research and training programme 2014–2018 under grant agreement No
662287 (CONCERT)
OF13.03
Myeloid derived extracellular vesicular WNT induces rectal stem cell regeneration
Payel Bhanjaa, Felipe Rodrigueza, Giselle Sanchez Guerreroa and Subhrajit Saha
b
aKUMC, Kansas City, USA; bDepartment of Radiation Oncology, University of Kansas Medical
Center, Kansas City, USA
Introduction: Rectal epithelial injury is the major limiting factor for pelvic radiotherapy.
Activation of regenerative response of rectal stem cells (RSCs) is critical to mitigate
radiation injury. Wnt β catenin signalling plays a critical role in homeostasis and
regeneration of intestinal stem cell (ISC). Both epithelium and stroma are the major
source of WNT ligands. Intestinal stroma consists of several cell types including
mesenchymal cells and myeloid/macrophages (Mφ). Genetic or pharmacological inhibition
of WNT release from mesenchymal stromal cells did not affect the ISC homeostasis or
regeneration. In the present study we have examined the effect of Mφ derived extracellular
vesicle (EV) packaged WNT in homeostasis and repair of RSCs.
Methods: Csf1r.iCre;Porcnfl/fl mice deficient in Mφ derived WNT due to Mφ-restricted
ablation of Porcupine, a gene essential for WNT synthesis were used to determine effect
of Mφ derived in EV-WNT in RSC homeostasis and regeneration. Mice were exposed to
lethal dose of pelvic irradiation (PIR) (18Gy) to deplete RSCs and therefore evaluate
the regenerative response following treatment with Mφ derived EV packaged WNT. Effect
of Mφ-EV WNT on RSCs were also examined in ex-vivo rectal organoid system developed
from Lgr5/GFP-IRES-Cre-ERT2 knock-in for visualization and quantification of Lgr5+ve
RSCs.
Results: Histopathological analysis of Csf1r.iCre;Porcnfl/fl mice rectum demonstrated
no differences in epithelial morphology compared to wild type mice. However, exposure
to PIR which depletes all RSCs demonstrated higher radio-sensitivity and significant
damage in rectum epithelium in Csf1r.iCre;Porcnfl/fl mice compared to wild type mice.
EV purified from Mφ conditioned medium demonstrated presence of functionally active
WNT ligands and improve regenerative capacity of RSCs in both human and mice rectal
organoid model ex-vivo. Treatment with Mφ conditioned medium containing EV promote
regenerative capacity of Lgr5+ ve RSCs in Lgr5/GFP-IRES-Cre-ERT2 knock-in mice exposed
to PIR. However, treatment with EV depleted condition medium failed to rescue RSCs
against irradiation.
Summary/Conclusion: Homeostasis of rectal epithelium is not dependent on Mφ derived
EV packaged WNT. However, Mφ derived EV packaged WNT is critical for regenerative
response of RSCs against injury.
OF13.04
Glycome analysis of extracellular vesicles derived from stem cells using lectin microarray
Sayoko Saito, Keiko Hiemori, Kayo Kiyoi and Hiroaki Tateno
National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan
Introduction: In addition to proteins, nucleic acids and lipids, extracellular vesicles
(EVs) are also composed of glycans. EV glycome may provide vital clues for a better
understanding the biogenesis, release and transfer of vesicles. However, little is
known regarding glycans on EVs. Do glycans on EVs change depending on cell types and
cellular conditions? More specifically, do stem cell-derived EVs carry stem cell glycan
markers? Such basic questions remain unclear.
Methods: Here, we performed glycome analysis of EVs derived from stem cells including
human induced pluripotent stem cells (hiPSCs) and human messenchymal stem cells (hMSCs)
using high-density lectin microarray and flow cytometry.
Results: Detailed analysis of the results obtained by lectin microarray and flow cytometry
revealed that hiPSC-derived EVs carry characteristic features of cell surface glycans.
rBC2LCN, a specific lectin for hPSCs, bound to hiPSC-derived EVs, but not to non-hiPSC-derived
EVs. One of the glycoprotein ligands of rBC2LCN on EVs was identified as podocalyxin,
which is a cell surface glycoprotein ligand of rBC2LCN. Other hiPSC surface glycan
markers were also detected on the surface of EVs. Finally, we developed a sandwich
assay to specifically detect hiPSC-derived EVs using rBC2LCN and Tim4, which binds
to phosphatidylserine (PS). rBC2LCN is useful for the specific detection of hiPSC-derived
EVs.
Summary/Conclusion: The EV glycome reflects its cellular origin, which could be a
novel target for the development of the quality control system of stem cells used
for regenerative medicine.
Funding: JST CREST
OF13.05
Exosomes derived from human MSC mediate monocyte mobilization to orchestrate neovascularization
in radiation-induced skin injury
Alexandre Ribaulta, Bruno Lhommea, Celine Loinarda, Marc Benderittera, Stephane Flamanta,
Ruenn Chai Laib, Sai Kiang Limc and Radia Tamarat
a
aIRSN, Paris, France; bIMB ASTAR, Singapore, USA; cInstitute of Medical Biology, Agency
for Science, Technology and Research, Singapore, Singapore
Introduction: Emerging evidences indicate that extracellular membrane vesicles, such
as exosomes, could recapitulate the therapeutic effects of huMSC. Of note, exosomes
displayed marked pro-angiogenic activity, however a better understanding of their
underlying mechanisms of action remained to be defined. This study aims to investigate
the mechanisms governing the pro-angiogenic effects of huMSC derived exosomes (huMSC-Exo)
in a mouse model of radiation-induced musculo-cutaneous injury.
Methods: Mice lower limb was exposed to 80Gy X-ray irradiation to induce radiation
injury. After 14 days, mice received an intramuscular injection of 106 human MSCs,
400 µg MSC-EXO, or PBS. Angiogenesis was estimated by skin perfusion (laser Doppler
imaging), immunohistochemistry (CD 31 endothelial marker) and microangiography (barium
sulphate). Mice were sacrificed at several time points, and tissues of both irradiated
and contralateral limbs were harvested for histological and biochemical analyses.
Bone marrow, spleen and blood were collected for analysis of inflammatory cells and
circulating factors. In vitro assays were used to validate the pro angiogenic effet
of HuMSC- exo.
Results: The huMSC-Exo stimulated vascular growth as revealed by the increase in cutaneous
blood perfusion, capillary density and angiographic score with stimulation of pro-angiogenic
factor levels such as VEGF-A and eNOS. In vitro, huMSC-Exo fostered endothelial cells
and fibroblast migration in a PI3K/AKT and TGF-β/SMAD2 dependent pathways. Finally,
huMSC-Exo triggered the mobilization of both Ly6Chi and Ly6Clo monocytes from the
spleen and the bone marrow and their recruitment into the irradiated muscle. Additionally,
monocyte and macrophage depletion through clodronate treatment completely abrogated
the pro angiogenic effect of huMSC-Exo.
Summary/Conclusion: This study demonstrates, for the first time, that huMSC derived
exosomes enhance the angiogenic process in the radiation-induced ischemic tissue by
stimulating the mobilization and recruitment of innate cells to the lesion and nurturing
neovascularization. These results highlight the concept that huMSC-Exo administration
represents a suitable innovative approach for therapeutic angiogenesis in irradiated
tissue.
OF13.06
hucMSCs derived exosomes enhance lymphangiogenesis in experimental lymphedema via
exosomal transfer of Ang-2 and Tie2
Ting Zhao and Yongmin Yan
Jiangsu University, Zhenjiang, China (People’s Republic)
Introduction: Exosomes are small biological membrane vesicles secreted by cells, including
MSCs. Here, we evaluated lymphangiogenic potential and key exosomal prolymphangiogenic
factors of human umbilical cord MSC-derived exosomes (hucMSC-Ex) to providing a mechanistic
basis for optimizing future hucMSC-Ex-based lymphedema therapies.
Methods: hucMSC-Ex were extracted from condition medium of hucMSCs. Using a murine
lymphedema model, we evaluated oedema at various time points post hucMSC-Ex injection.
HE stain and Immunohistochemical stain were applied to analyse the lymphaniogenesis.
In vitro, human dermal lymphatic endothelial cells (HDLECs) were treated with hucMSC-Ex,
and cell proliferation, migration and tube formation were assayed using cell counting
Kit-8 (CCK-8), transwell chamber inserts, and matrigel-based tube formation assays,
respectively. Western blot and immunofluorescence stain were performed to test the
expression level of proteins which were associated with lymphaniogenesis after co-cultured
with hucMSC-Ex in HDLECs.
Results: Mice treated with hucMSC-Ex showed significantly decreased oedema formation
and restored drainage of intradermally injected methylene blue after 6 weekly injections.
HE stain showed subcutaneous oedema of tail faded obviously after hucMSC-Ex injection.
Immunohistochemical analysis revealed that mice tails receiving hucMSC-Ex injections
had enhanced lymphangiogenesis compared to the PBS-treated groups as determined by
staining of lymphatic marker LYVE-1. The proliferation, migration, and tube formation
of HDLECs were significantly increased by hucMSC-Ex. Also, the expression level of
Ang-2, Lyve1, Prox1, VEGFR3, p-Akt in HDLECs was up-regulated both in western blot
and Immunofluorescence stain. Mechanically, hucMSC-Ex derived Ang-2 and Tie2 proteins
were transferred to HDLECs. Ang-2 controlled the proliferation, migration and tube
formation of HDLECs. And hucMSC-Ex delivered Ang-2 and Tie2 activated the expression
of lymphangiogenic factors.
Summary/Conclusion: Ang-2 and Tie2 are essential for hucMSC-Ex effects on lymphangiogenesis
in vitro and in vivo.
Funding: Zhenjiang Key Laboratory of Exosomes Foundation and Transformation Application
High-tech Research,china: (ss2018003);National Natural Science Foundation of China:
(81670549)
Symposium Session 14: Parasite and Bacterial EVs Chairs: Yong Song Gho; Mariko IkuoLocation:
Level B1, Hall A 08:30–10:00
OF14.01
Macrophage-derived exosomes encapsulate Salmonella antigens and stimulate the activation
of Type 1 T-helper cells in vivo
Winnie W. Hui
a, Mark Oub, Beata Clappc, David Pascualc and Mariola Edelmanna
aUniversity of Florida Dept of Microbiology and Cell Science, Gainesville, USA; bUniversity
of Florida Dept of Microbiobiology and Cell Science, Gainesville, USA; cUniversity
of Florida Dept of Infectious Disease, Gainesville, USA
Introduction: Salmonella enterica serovar Typhimurium is a Gram-negative, intracellular
bacterium which invades macrophages and leads to the production of pro-inflammatory
exosomes. S. Typhimurium is the causative agent of salmonellosis affecting 1.2 million
people annually in the USA. There are no FDA approved vaccines against non-typhoidal
Salmonella infections for human thus showing a significant limitation in current prevention
methods. Exosomes are a subclass of extracellular vesicles characterized by their
size, morphology and biogenesis. The cargo, including protein, nucleic acids and metabolites,
carried by exosomes vary depending on the physiological conditions present and the
origin of the cell. We hypothesize that during Salmonella infections, exosomes transport
Salmonella antigen to alert neighbouring cells which can lead to the stimulation of
naïve T-lymphocytes.
Methods: We focus on the release of exosomes by S. Typhimurium-infected macrophages
and their function in stimulating an adaptive immune response in vivo. To determine
if exosomes have any effect on the adaptive immune response, mice were given doses
of exosomes derived from S. Typhimurium infected macrophage. Fluorescent activated
cell sorting was used to monitor T- lymphocyte response.
Results: Exosomes stimulate a distinct cytokine secretion pattern among CD4+T lymphocytes
in vivo. The cytokines milieu, including IFN-, TNF- and IL-2, expression by T-lymphocytes
suggest that the CD4 T-lymphocytes differentiated in to Type 1 T-helper set producing
pro-inflammatory cytokines. Additionally, mouse serum was taken to analyse for antibody
production against Salmonella in which we observe exosomes derived from Salmonella
infected cells provide a similar antibody production to the live vaccine. Based on
our -omics study, we identify Salmonella antigens and other pro-inflammatory molecules
in exosomes isolated from Salmonella infected-macrophages from 24 and 48 h infections.
Hence, the cargo plays a critical role in intercellular communication in response
to infection as naïve macrophages treated with these exosomes result in M1 polarization.
Summary/Conclusion: Our data support the hypothesis that exosomes isolated from Salmonella
infected macrophages carry Salmonella antigens as a cargo and stimulates the activation
of Type 1 effector T lymphocytes.
OF14.02
Extracellular vesicles from Leishmania donovani infected macrophages contain infection-specific
cargo that contribute to lesion development
Anna E. Gioseffi and Peter Kima
University of Florida, Gainesville, USA
Introduction: Extracellular vesicles (EVs) have emerged as important mediators of
cell-to-cell communication and have been shown to contribute to the pathogenesis of
infectious microorganisms. Leishmania is an intracellular eukaryotic parasite and
causative agent of leishmaniasis. This work aims to evaluate EVs in the context of
Leishmania donovani infection.
Methods: To better understand the properties and function of EVs produced by L. donovani
infected RAW264.7 macrophages (iEVs), we used a series of approaches, including comparative
proteomics of iEVs or EVs derived from uninfected RAW 264.7 macrophages, pathway analysis
to infer activity, and functional assays such as in vitro migration assays and flow
cytometry to evaluate endothelial cell activation after EV treatment.
Results: We obtained a profile of host and parasite proteins in iEVs, EVs from uninfected
macrophages, and EVs from macrophages infected with Centrin knockout (CenLd) parasites.
CenLd parasites are unable to mature into the amastigote form within macrophages.
In addition to host derived molecules previously identified by others in exosome preparations,
we identified host and parasite derived molecules, such as parasite PI3K, vasohibin,
and serine/threonine protein phosphatase, and mouse histone 2B, annexin A3, and galectin-3
within iEVs. Our results showed that EVs from macrophages infected with CenLd parasites
have a molecular composition that is qualitatively different from iEVs released by
macrophages infected with wild type parasites. Pathway analysis of the host-derived
proteins in iEVs suggested their involvement in cell migration and neovascularization.
In vitro cell migration assays validated the observation that intact iEVs enhance
cell migration, which is in contrast to EVs from Cen-/-Ld infected macrophage or disrupted
iEVs that do not induce cell migration. In addition, flow cytometry analysis of endothelial
cells treated with iEVs suggested that EVs from infected macrophages activate endothelial
cells. The latter observations were surrogate indicators of pathogenic neovascularization.
Summary/Conclusion: Taken together, we present a comprehensive molecular profile of
the molecules released in EVs from L. donovani-infected macrophages which includes
infection-specific molecules that contribute to lesion development.
Funding: NIH.
OF14.03
The role of extracellular vesicles in neurophysiological changes induced by chronic
Toxoplasma gondii infection
Ellie Tedford
a and Glenn McConkeyb
aUniversity of Cambridge, Cambridge, UK; bUniversity of Leeds, Leeds, USA
Introduction: During chronic Toxoplasma gondii infection, parasites become encysted
in neurons in the host brain. Infection is associated with a plethora of behavioural
and neurophysiological changes despite only a small number of neurons infected. Perturbations
in dopamine metabolism have been observed with infection. We have previously described
parasite induced down-regulation of dopamine β-hydroxylase. In this study, the role
of extracellular vesicles during chronic T. gondii infection was investigated.
Methods: Primarily transwell culturing and extracellular vesicle purification via
ultracentrifugation were used during this study. Extracellular vesicles were collected
from chronically infected human and rat catecholaminergic cells. Purification via
a 12 step sucrose gradient was performed prior to conditioning in vitro and in vivo.
Results: Altered DBH mRNA expression was identified during T. gondii infection in
rat catecholaminergic and human neuronal cells. This down-regulation of DBH was identified
in de novo RNA, suggesting that regulation occurs at the transcriptional level. Using
MSRE-qPCR, hypermethylation in the 5‘ upstream region of the DBH promoter was identified
in infected rat catecholaminergic cells and human neuronal cells. Surprisingly, DBH
mRNA down-regulation and methylation in the 5’ promoter were globally altered in vivo,
despite the fact that only a small number of cysts can be identified in the host brain.
DBH silencing was observed in cells only exposed to infected cells. Extracellular
vesicles purified from infected rat catecholaminergic cells induced transcriptional
silencing of DBH. This effect could also be generated in vivo when rats received intracererbral
injections with purified extracellular vesicles from infected cells. This represents
a new perspective of the host-pathogen interaction.
Summary/Conclusion: Through this mechanism T. gondii may be able to induce many of
neurophysiological changes associated with chronic infection. In addition, T. gondii
is a unique model to study mammalian neurological function, by examining the influence
the parasite is able to exert over cell-cell communication, we may be able to further
understand the mechanisms governing CNS function and dysfunction.
Funding: The University of Leeds.
OF14.04
Bacterial membrane vesicles as vaccines in aquaculture
Julia Tandberga, Leidy Lagosb, Alexander Kashulin-Bekkelundc, Petter Langletea and
Hanne C. Winther-Larsen
a
aUniversity of Oslo, Oslo, Norway; bNorwegian University of Life Sciences, Ås, Norway;
cNorwegian University of Life Sciences, Oslo, Norway
Introduction: Infections by two Gram-negative intracellular bacterial pathogens Piscirickettsia
salmonis and Francisella noatunensis, are causing major problems in aquaculture world-wide.
F. noatunensis sp hampers the development of fish farming based on cod in and is deleterious
to tilapia. P. salmonis infections have been devastating for salmon aquaculture. As
of today no effective treatments are available against the diseases. Both P. salmonis
and F. noatunensis secrete membrane vesicles (MV). Bacterial MV has been reported
as potential vaccine candidates for a range of host including humans, mice and fish
against infection caused by intracellular pathogenic bacteria as they induce both
a humoral and cellular immunity.
Methods: We have isolated MVs from both Francisella and Piscirickettsia by the ultracentrifugation
Method. The MVs were characterized by their size distribution, by transmission electron
microscopy (TEM) and proteomics. Their toxicity were tested by injecting MVs into
both our zebrafish vaccine and challenge model as well as in cod, tilapia and salmon.
A vaccine trail was performed first in our zebrafish model, and then in cod, tilapia
and salmon.
Results: The MV size analysis showed that the MVs size distribution ranged from 20–250 nm
in size with most ranging from 70–100 nm. Both single and double membrane MV were
found in the population as investigated by TEM. Further, immune-gold labelling revealed
the presence of DNA in both populations. Proteomics analysis revealed that the MV
content varied between bacterial strains. Immunization with MV gave protection against
disease caused by both P. salmonis and F. noatunensis in our zebrafish model, however,
did not protect cod, tilapia nor salmon.
Summary/Conclusion: The MVs from P. salmonis and F. noatunensis revealed a similar
size distribution and that the content contains various bacterial virulence factors
as well as DNA that can be transferred to the host. As for their immunogenic properties
this seems to vary between the vaccine and challenge model compared to the natural
hosts. The use of the MVs as vaccines in their natural hosts such as strain-specificity
and cross-immunity need further investigation.
Funding: Research Council of Norway (RCN) and University of Oslo.
OF14.05
Bacterial membrane vesicles enter polarised epithelial cells and deliver their protein
cargo to exosomes
Lorinda Turnera, Nestor Solisb, Georg Rammc, Viola Oorschotc, Amanda De Paolia, Hassan
Chaudhrya, Stuart Manneringd, Stuart Cordwellb, Maria Kaparakis-Liaskose and Richard
Ferrero
a
aHudson Institute of Medical Research, Melbourne, Australia; bThe University of Sydney,
Sydney, Australia; cMonash University, Melbourne, Australia; dSt. Vincent’s Institute
of Medical Research, Melbourne, Australia; 5Department of Physiology, Anatomy and
Microbiology, La Trobe University, Melbourne, Australia
Introduction: Gram-negative bacteria use outer membrane vesicles (OMVs) to deliver
a range of factors to host cells. Although OMVs are highly effective at entering simple
non-polarised cell monolayers, it is not known whether these nano-sized vesicles can
penetrate an intact epithelial barrier and, potentially, disseminate their protein
cargo to tissues.
Methods: We have addressed this question using a cell culture model that reproduces
the transepithelial resistance and apical-basolateral polarity of normal epithelium.
For this, colonic epithelial cells of the T84 line were grown on Transwell filters
to generate transepithelial electrical resistance (TEER), a measure of epithelial
monolayer integrity. The cells were then co-cultured with Alexa Fluor-labelled OMVs
from the gastric pathogen, Helicobacter pylori.
Results: We showed that H. pylori OMVs readily entered polarised epithelial cells,
but had no effect on the TEER nor permeability of these monolayers. OMVs induced the
basolateral secretion of the neutrophil chemoattractant, interleukin-8 (IL-8) and
expression of human leukocyte antigen class I and II molecules. In exosomes isolated
from the basolateral compartment of OMV-stimulated cells, we identified peptides derived
from eight H. pylori proteins, of which seven are surface- or membrane-associated
and are known to localise within OMVs.
Summary/Conclusion: Collectively, the data show that OMVs can enter polarised epithelial
cells and deliver their protein cargo to exosomes. We propose that these exosomes
may directly or indirectly present antigen to immune cells and even transport bacterial
proteins to other tissue sites.
Funding: This project was supported by funding from the National Health and Medical
Research Council (NHMRC), the Australian Research Council, The Juvenile Diabetes Research
Foundation and the Victorian Government’s Operational Infrastructure Support Program.
R.L.F. is supported by an NHMRC Senior Research Fellowship. N.S. is funded through
a Canadian MSFHR Research Trainee Fellowship and an NHMRC Early Career Fellowship.
L.T. was funded by an Australian Postgraduate Award and an Excellence Award from Monash
University FMNHS.
OF14.06
Bacterial Extracellular Vesicles: intercellular package or intracellular garbage?
The example of RNAs associated to Salmonella enterica EVs
Antoine Malabirade
a, Janine Habiera, Anna Heintz-Buschartb, Patrick Maya, Julien Godetc, Rashi Haldera,
Alton Etheridged, David Galasd, Joëlle V. Fritza and Paul Wilmesa
aLuxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette,
Luxembourg, Belval, Luxembourg; bDepartment of Soil Ecology, Helmholtz-Centre for
Environmental Research – UFZ, Halle, Germany, Belval, Luxembourg; cUMR CNRS 7021,
Laboratoire de BioImagerie et Pathologies, Université de Strasbourg, Strasbourg, France,
Strasbourg, France; dPacific Northwest Research Institute, Seattle, WA, United States,
Seattle, USA
Introduction: Bacteria have developed many ways of communicating with one another
and with other prokaryotic or eukaryotic species. The secretion of Extracellular Vesicles
(EVs) is one of them. Bacterial EVs are small spherical containers filled with a wide
range of biomolecules originating from the mother cell, including RNAs. The protection
conferred by the physical envelope of EVs to these delicate components is of prime
importance for message delivery to other cells. However, this idea of EVs being mail
carriers competes with the concept of a simple trash bin used by bacteria to get rid
of unnecessary components.
Methods: Taking Salmonella enterica as an example, we purified EVs and sequenced their
RNA content. The strain was cultivated in different conditions mimicking separate
stages of a gut infection. Growth until stationary phage in Lysogeny Broth (LB) medium
induces Salmonella pathogenicity island 1 (SPI-1), which is required for virulence
during the intestinal phase of infection. Growth in acidic and phosphate-depleted
medium triggers the expression of Salmonella pathogenicity island 2 (SPI-2) and is
comparable to the macrophage environment.
Results: Every type of RNA was exported, including ribosomal, messenger and non-coding
RNAs. By comparison with the intracellular RNA composition, our data demonstrate that
a proportion of RNAs exported through EV secretion were enriched. This export is depending
on the environmental conditions and reflects the adaptation to each infection step.
Some transcripts were confirmed to be in their native state and not degradation products,
opening the possibility for a functional RNA delivery to surrounding cells. Finally,
we show by a digestion protection assay that vesicles prevent enzymatic degradation
of given full-length transcripts (SsrS, CsrC, 10Sa and rnpB).
Summary/conclusion: These results reinforce the idea of a complex interaction network
existing in the gut microbiome and more generally in microbial ecosystems.
Funding: Luxembourg National Research Fund (FNR) (CORE Junior/14/BM/8066232, CORE/15/BM/10404093,
CORE/16/BM/11276306), NIH Common Fund Extracellular RNA Communication Consortium (1U01HL126496),
Baylor subaward (5U54DA036134).
Plenary Session 2: Therapeutics Chairs: Edit Buzás; Uta Erdbrügger Location: Level
3, Hall B 11:54–11:55
Self-assembled supramolecular nanosystems for Smart diagnosis and targeted therapy
of intractable diseases
Kazunori Kataoka
Innovation Center of NanoMedicine, Kawasaki Institute of Industrial Promotion, Kawasaki
210-0821, Japan; Institute for Future Initiatives, The University of Tokyo, Tokyo113-0033
kataoka@bmw.t.u-tokyo.ac.jp
Nanotechnology-based medicine (Nanomedicine) has received progressive interest for
the treatment of intractable diseases, such as cancer, as well as for the non-invasive
diagnosis through various imaging modalities. Engineered polymeric nanosystems with
smart functions play a key role in nanomedicine as drug carriers, gene vectors and
imaging probes. This presentation focuses present status and future trends of supramolecular
nanosystems self-assembled from designed block copolymers for therapy and non-invasive
diagnosis of intractable diseases. Nanosystems with 10 to 100 nm in size can be prepared
by programmed self-assembly of block copolymers in aqueous entity. Most typical example
is polymeric micelle (PM) with distinctive core-shell architecture. PMs have several
properties relevant for nanosystems, including controlled drug release, tissue penetrating
ability, and reduced toxicity1,2. Furthermore, smart functionalities, such as pH-
and/or redox potential responding properties, can be integrated into the PM structure3.
These smart PMs loaded with various chemotherapy reagents were evidenced to have a
significant utility in the treatment of intractable and metastatic cancers, including
pancreatic cancer4, glioblastoma5 and tumours harbouring recalcitrant cancer stem
cells (CSCs)6. Eventually, five different formulations of the PMs developed in our
group have already been in clinical trials world-wide, including Japan, Asia, USA
and European countries7.
Versatility in drug incorporation is another relevant feature of supramolecular nanosystems
for drug delivery. Nucleic acid-based medicine can be assembled into nanosytstems
through the electrostatic interaction with oppositely-charged polycationic block copolymers8.
In this way, siRNA- or antisense oligo (ASO)-loaded micellar or vesicular nanosystems
were prepared, and their utility in molecular therapy of cancer has been revealed9-11.
Recently, nanosystem-based imaging reagents were developed, opening a new avenue for
the novel type of theranostic nanomedicines12. Furthermore, nanosysems hold promise
for the treatment of intractable diseases other than cancer. Very recently, we developed
nanosystems decorated with glucose to crossing blood-brain barrier by recognizing
glucose-transporter overexpressing on brain endothelial cells, indicating a novel
route to deliver versatile drugs into brain for the treatment of neurodegenerative
diseases, including Alzheimer’s disease13.
[1] H. Cabral and K. Kataoka, J. Control. Rel. 190 (2014) 465–476; [2] Y. Matsumoto,
et al, Nature Nanotech. 11 (2016) 533–538; [3] H. Cabral, K. Miyata, K. Osada, and
K. Kataoka, Chem. Rev. 118 (2018) 6844–6892; [4] H. Cabral, et al, Nature Nanotech.
6 (2011) 815–823; [5] Y. Miura, et al, ACS Nano
7 (2013) 8583–8592; [6] H. Kinoh, et al, ACS Nano
10 (2016) 5643–5655; [7] N. Nishiyama, et al, Cancer Sci. 107 (2016) 867–874; [8]
K. Miyata, et al, Chem. Soc. Rev. 41 (2012) 2562–2574; [9] Y. Yi, et al, J. Control.
Rel. 295 (2019) 268–277; [10] K. Katsushima, et al, Nature Commun. 7 (2016) 13616;
[11] B.-S. Kim, et al, J. Amer. Chem. Soc. 141 (2019) 3699; [12] P. Mi, et al, Nature
Nanotech. 11 (2016) 724–730; [13] Y. Anraku et al, Nature Commun. 8 (2017) 1001.
MSC-sEV translation: back to basics
Sai Kiang Lim
Institute of Medical Biology (IMB)
Mesenchymal stromal cell (MSC) are presently the most used cell type in clinical testing
and are being tested against a wide spectrum of diseases. Their therapeutic efficacy
is increasingly shown to be mediated by their secretion and in particular, the secreted
extracellular vesicles (sEVs) of 50–200 nm. In this talk, I will elaborate on the
development of clinical applications for MSC sEVs and the associated challenges. A
major challenge is the complexity of a typical MSC-sEV preparation. As the size ranges
of many EV types such as exosomes, microvesicles, and ectosomes overlap significantly
and most EV types include EVs of 50–200 nm, the term “sEVs” essentially describes
a complex population of similarly sized EVs consisting of many known and possibly
unknown EV types. This complexity is further compounded by the heterogeneity in the
source and culture of MSCs, and in the downstream processing of MSC secretion. Together,
this poses a challenge to data sharing by the research community and to the regulation
of MSC sEVs as therapeutic products. Unfortunately, resolution of this conundrum through
process standardization or purification of specific EV type is presently not practical
and/or technically challenging. To circumvent this, about 20 members from the ISCT,
ISEV, ISBT and SOCRATES have recently proposed several metrics to quantify distinctive
features of a MSC-sEV preparation that will identify the cellular origin of the sEVs
in a preparation, presence of lipid-membrane vesicles, and the degree of physical
and biochemical integrity of the vesicles. Such metrics will facilitate comparison
among different MSC-sEV preparation as differences could then be mapped to quantified
differences in the features. The biological significance of such mapping would then
be testable.
Featured Abstracts- Session 1 Chairs: Edit Buzás; Uta ErdbrüggerLocation: Level 3,
Hall B 11:55–12:30
FA1.01
Molecular basis for contradictive roles of melanoma-derived EVs in metastasis
Maximiliane Schuldner
a and Elke Pogge von Strandmannb
aExperimental Tumor Research, Center for Tumor Biology and Immunology, Clinic for
Hematology, Oncology and Immunology, Philipps University of Marburg, Marburg, Cologne,
Germany, Germany; bExperimental Tumor Research, Center for Tumor Biology and Immunology,
Department of Hematology, Oncology and Immunology, Philipps University Marburg, Marburg,
Germany
Introduction: Recent studies have highlighted the role of melanoma cell-derived EVs
in the formation of pre-metastatic niches or, on the contrary, in tumour immune surveillance.
The molecular machinery and mechanisms directing distinct cargo loading, regulatory
release and function of stress-induced EVs remain unknown.
Methods: EV release was quantified by NTA. EVs were isolated by ultracentrifugation
and analysed by proteomics and transcriptomics. EV function was investigated in vivo
by intravenous injections followed by lung transcriptomics and by using an experimental
metastasis transplantation model. The mechanistic release of EVs was analysed using
diverse molecular, cell biological, spectroscopic and microscopic techniques.
Results: Our study reveals a crucial role of the chaperone and NK cell ligand BAG6
for the formation and reprogramming of pro- and anti-tumour EVs. Loss of BAG6 led
to an increase in EV production and a decrease in EV size. In contrast to the melanosome-like
protein signature observed for WT-EVs, BAG6KO-EVs showed an exosome-like profile and
induced a neutrophil gene signature in the lungs of mice. Education with B-16V WT-EVs,
but not BAG6KO-EVs, suppressed lung metastasis concomittant with the accumulation
of anti-tumour Ly6Clow patrolling monocytes. Mechanistically, the formation of anti-tumour
EVs was dependent on BAG6 mediating the nucleo-cytoplasmic shuttling of CBP/p300 acetyltransferases
to acetylate p53. We have identified a late endosomal P(S/T)AP motif in BAG6 which
mediated its direct recruitment to the ESCRT machinery, thereby providing a molecular
link between the regulatory role of BAG6 to EV cargo loading.
Summary/Conclusion: Our findings provide a conceptual advance in the understanding
of the biogenesis and function of EVs, identifying BAG6 as an ESCRT-associated protein
and a molecular switch for the formation of anti- versus pro-tumourigenic EVs in tumour
immune surveillance.
FA1.02
Development of a live-cell imaging technique for secretion activity of extracellular
vesicles of individual cells
Yoshitaka Shirasaki
a, Keisuke Tsukadab, Nobutake Suzukic, Tamiko Minamisawad, Mai Yamagishie, Nobuyoshi
Kosakaf, Takahiro Ochiyaf, Osamu Oharag, Kiyotaka Shibah and Sotaro Uemurai
aJST PRESTO, Tokyo, Japan; bThe University of Tokyo, bunkyo, Japan; cThe university
of Tokyo, Bunkyo-ku, Japan; dJapanese Foundation For Cancer Research, Koto-ku, Japan;
eDepartment of Biological Sciences, Graduate School of Science, The University of
Tokyo, Japan; fDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Shinjyuku-ku, Japan; gRIKEN Institute for Integrative
Medical Sciences, Yokohama, Japan; hJapaese Foundation for Cancer research, Tokyo,
Japan; iThe University of Tokyo, Tokyo, Japan
Introduction: The cells in our body exchange their information using various methods
to control the expression of functions, to form higher order systems and to maintain
homeostasis. Particularly in the communication between spatially separated cells,
mediation of humoral factors such as cytokines can be mentioned. Addition to this,
extracellular vesicles (EVs) have been reported to participate in intercellular communication.
The EVs classically include exosomes, microvesicles and apoptotic bodies. Also, vesicular
autophagosome and transport vesicles in the intercellular space might be released
during necrosis-like cell death (pyroptosis, necroptosis etc.). Although conventional
biochemical methods can classify these EVs by size, density or antigens on their membrane,
it is difficult to distinguish individual vesicles depending on their biogenesis.
Methods: We have developed LCI-S (Live Cell Imaging for Secretion activity), which
is a time-resolved microscopic observation technology of secreted humoral factors
from individual cells. LCI-S utilises sandwich fluoroimmunoassay and in situ detection
of the immunocomplex by total internal reflection microscopy. LCI-S reveals intercellular
variability of secretion activity and time-correlation with the cellular state such
as intracellular enzymatic activity, cell shape or viability. In this study, we focused
on the release of EVs having the same topology as cell membranes such as exosomes,
targeting membrane surface antigens such as CD63 and CD9.
Results: We have evaluated EVs secretion from kinds of cancer cell lines and succeeded
in detecting vesicle-like adherent plaque under the cells and also free-diffusion
type vesicles (free-EVs). We also found that the minor population showed higher secretion
activity of free-EVs in our experimental condition. Furthermore, free-EVs secretion
activity was not uniform nor constant. Some cells showed a burst secretion mode, and
some showed an accelerated secretion mode. The cells bursting free-EVs tended to be
associated with membrane blebbing, suggesting that they were in an excessive stress
state.
Summary/Conclusion: In this study, we demonstrated that LCI-S has the potential to
distinguish individual EVs depending on their biogenesis.
Funding: This research was supported by JST, PRESTO Grant Number JP17940748, Japan.
Symposium Session 15: EVs in Cancer Chairs: Takahiro Ochiya; Carolina SoekmadjiLocation:
Level 3, Hall B 13:30–15:00
OF15.01
Transfer of functional cargo in exomeres
Qin Zhang
a, James Higginbothamb, Dennis Jeppesena, Yu-Ping Yanga, Wei Lib, Ramona Graves-Deala,
Jie Pinga, Colleen Britainc, Kaitlyn Dorsettc, Celine Hartmand, David Fordd, Ryan
Allena, Kasey Vickersa, Qi Liua, Jeffrey Franklina, Susan Bellisc and Robert Coffeya
aVanderbilt University Medical Center, Nashville, USA; bVanderbilt University Medical
Center, Nashville, USA; cUniversity of Alabama at Birmingham, Birmingham, USA; dSaint
Louis University School of Medicine, Saint Louis, USA
Introduction: There is an increasing appreciation that secreted nanoparticles are
a heterogeneous mixture of distinct entities. One newly identified nanoparticle, exomeres
(< 50 nm), were recently identified by the Lyden lab using asymmetric flow field-flow
fractionation (AF4), a method that is not widely available. No known biological function
has been assigned to these nanoparticles. In this study, we employed a simplified
ultracentrifugation method to isolate and characterize subpopulations of exomeres
and distinguish them from exosomes.
Methods: A two-step ultracentrifugation method was used to separate exomeres from
exosomes. Purified exomeres were characterized by NTA, TEM, proteomics, lipidomics,
DNA and RNA analysis Cell surface target sialylation by exomeres was measured by flow
cytometry using fluorescence-labelled SNA lectin. Subpopulations of exosomes were
purified by fluorescence-activated vesicle sorting (FAVS) and analysed for distinguishing
cargos. Normal and neoplastic mouse colonic organoids were used for functional studies
comparing exosome and exomere activities.
Results: Our analysis of the content of exomeres largely confirms what has been reported
by Lyden and co-workers. We identify distinct functions of exomeres mediated by two
of their cargos, the β-galactoside α2, 6-sialyltransferase 1 (ST6Gal-I) that α2,6-
sialylates N-glycans, and the EGF Receptor (EGFR) ligand, amphiregulin (AREG). Functional
ST6Gal-I in exomeres can be transferred to recipient cells resulting in hypersialylation
of cell surface proteins, including β1-integrin. AREG-containing exomeres elicit prolonged
EGFR and downstream signalling in recipient cells, modulate EGFR trafficking in mouse-derived
colonic organoids, and dramatically enhance the growth of tumour colonoids.
Summary/Conclusion: This study describes a simplified method for exomere isolation
and provides the first demonstration of transfer of functional cargo by exomeres and
underscores the functional heterogeneity of secreted nanoparticles.
OF15.02
Exosomes secreted from senescent cells provoke chromosomal instability
Kenichi Miyataa, Kazuhiro Hitomia, Tomoka Misawaa, Ryo Okadaa and Akiko Takahashi
b
aProject for Cellular Senescence, Cancer Institute, Japanese Foundation for Cancer
Research, Tokyo, Japan; bProject for Cellular Senescence, Cancer Institute, Japanese
Foundation for Cancer Research, Koto-ku, Japan
Introduction: Cellular senescence is the state of irreversible cell cycle arrest that
can be induced by a variety of potentially oncogenic stimuli and is therefore considered
to act as an important tumour suppression mechanism in vivo. However, cellular senescence
is also associated with the increasing expression and secretion of inflammatory and
pro-proliferative factors. This phenotype, termed the senescence-associated secretory
phenotype (SASP), contributes to cancer development. In addition to inflammatory proteins,
we reported that exosome secretion has dramatically increased in senescent cells,
acting as harmful SASP factors. Recently, we found that senescence-associated non-coding
RNAs (SA-ncRNA) are enriched in exosomes and these exosomes provoke chromosomal instability
in normal cells.
Methods: Pre-senescent normal human diploid fibroblasts were rendered senescent by
either serial passage, ectopic expression of oncogene or X-ray irradiation. Then we
collected the exosomes secreted from young or senescent cells and checked the component
of exosomes. To analyse the biological function of these exosomes, colony formation
analysis and karyotype analysis were performed. Additionally, we manipulated SA-ncRNA
to load into exosome using Exotic devise, then investigated the biological roles of
them.
Results: We found that epigenetic de-regulation of genomic DNA induces the aberrant
expression of non-coding RNA in senescent cells and SA-ncRNAs are enriched in exosomes
secreted from senescent cells. Surprisingly, these exosomes cause anchorage-independent
growth of normal cells and change the number of chromosomes. It is therefore possible
that the overexpression of SA-ncRNA in old mice may eventually promotes tumorigenesis.
These results indicate that senescence-associated epigenetic dysregulation is likely
to contribute to tumour development not only through SASP but also exosomes during
aging process.
Summary/Conclusion: Here we show a novel function of exosomes secreted from senescent
cells on chromosomal instability. These data suggest that senescence-associated exosome
secretion may contribute to age-related increase of cancer incidence.
Funding: PRESTO, JST.
OF15.03
Orthotopic neuroblastoma tumour model generating GFP-labelled extracellular vesicles
(EV) reveals specific capture of GPF EV by monocytes/macrophages and mesenchymal cells
in liver and bone marrow
Yves A. DeClerck
a, Laurence Blavierb and Rie Nakatac
aUniversity of Southern California, Los Angeles, CA, USA; bChildren’s Hospital Los
Angeles, LosAngeles, CA, USA; cChildren’s Hospital Los Angeles, Los Angeles, CA, USA
Introduction: EV released by tumours reaches target cells at distant sites. The study
of their capture in vivo has been limited by methods relying on intravenous injection
(i.v.) of EV isolated in vitro. Using human tumour cells producing GFP-labelled EV,
we have examined the capture of tumour-derived EV in distant organs in vivo.
Methods: Luciferase expressing NB cell lines (SK-N-BE(2), CHLA-136, CHLA-255) were
transduced with a lentivector targeting the GFP protein to the exosomal membrane (CMV-XP-GFP-EF1
aka XPack). The analysis of EV produced by XPack NB cells by differential ultracentrifugation
followed by OPDG confirmed the presence of GFP in fractions containing exosomes. Mice
orthotopically implanted with XPack NB cells were sacrificed at week 2, 4, 6 and 8,
and the bone marrow (BM), liver, lung, kidney, and spleen were examined by FACS and
immunofluorescence imaging (BM and liver) for the presence of GFP+ cells. The presence
of the disialoganglioside 2 (GD2) was used to distinguish positive tumour cells from
host cells having captured EV.
Results: Preliminary experiments with PKH67-stained NB-derived EV injected i.v. showed
that after 24 h 0.9–1% of CD 45+cells in the BM, 6.7–20.3% of CD105+ cells in the
bone, and 0.2–8.2% of CD45+ in the liver and lung contained green vesicles. In mice
orthotopically implanted with NB cells producing GFP-labelled EV, we observed an increasing
amount of GD2- /GFP+ cells in the BM (0.2%) between week 2 and 6. The expression of
CD45, CD11b, and CD105 in these GD2- cells suggests their myeloid, monocytic, and
mesenchymal origin. In the liver, a similar capture by CD45+ and CD11b+ was observed
(up to 0.2%). We also observed an increasing amount of GD2- /GFP+ cells that were
negative for CD45, CD11b, and CD105 at week 6–8. No GFP+ cells were detected in the
lung, spleen and kidney.
Summary/Conclusion: Tumour-derived exosomes are specifically captured by a small percentage
(within the limits of FACS detection) of myeloid and stromal cells in the BM and the
liver in the early stages of tumour development before NB cells home to these organs.
The data which used an orthotopic model rather i.v. injection, support the concept
that exosomes contribute to the pre-metastatic niche.
Funding: RO1 CA 207983 from the National Institutes of Health, USA.
OF15.04
ExoBow – a transgenic strategy to study CD63+extracellular vesicles in vivo
Bárbara Adema, Nuno Bastosa, Carolina Ruivoa, Maxwell Goodrichb, Zhang Xiaojingc,
Barbara Seidlerd, David W Goodriche, Jose L Costaf, José Machadof, Dieter Saurg, Dawen
Caih and Sónia Melo
f
ai3S – Instituto de Investigação e Inovação em Saúde, Porto University, Portugal;
IPATIMUP – Instituto de Patologia e Imunologia Molecular da Universidade do Porto;
ICBAS – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto,
Portugal; bDepartment of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer
Center, New york, NY, USA; 34Department of Pharmacology & Therapeutics, Roswell Park
Comprehensive Cancer Center, New York, NY, USA; dGerman Cancer Research Center (DKFZ)
and German Cancer Consortium (DKTK), Heidelberg, Germany, heidelberg, Germany; eDepartment
of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, New York,
NY, USA; fi3S – Instituto de Investigação e Inovação em Saúde, Porto University, Portugal;
IPATIMUP – Instituto de Patologia e Imunologia Molecular da Universidade do Porto;
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal; gGerman Cancer
Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany, Heidelberg,
Germany; hUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Introduction: The whereabouts of extracellular vesicles (EVs) inside a multicellular
organism following their spontaneous natural flow and the identification of their
recipient cells is still elusive. A comprehensive map of the network of communication
established by EVs in vivo requires the development of new tools.
Methods: We have developed a CD63 multireporter transgenic mouse model to determine
the spatiotemporal biodistribution of tissue/cell specific derived CD63-enriched EVs,
exosomes, that we termed ExoBow. Using organ-specific promoters we have mapped the
network of communication mediated by pancreas and intestine derived exosomes within
the respective organ microenvironment, and also with neighbour and distant organs.
The ExoBow transgene allows a stochastic Cre recombination that determines the expression
of one of the fusion proteins CD63-mCherry, -phyYFP, -eGFP or -mTFP, and secrete colour-coded
CD63+ EVs. We have used genetically engineered mouse models of pancreatic cancer crossed
with our ExoBow to determine the flow of cancer exosomes during disease progression.
Results: We demonstrate that communication from the pancreas occurs more frequently
upon cancer-associated transformation when compared to a healthy setting.
Summary/Conclusion: Our work is the first attempt to dissect the spontaneous flow
of exosomes in a multicellular organism and to understand their involvement in several
processes that occur in non-pathological and in pathological conditions. The ability
of the ExoBow model to conditionally label any unique organ/tissue/cell within a mouse,
opens an unprecedented opportunity to determine the connectome established by the
flow of exosomes in vivo, unravelling their biological significance in health and
disease.
Funding: NORTE-01-0145-FEDER-000029. Fundacao Ciencia Tecnologia: IF/00543/2013/CP1184/CT0004,
PTDC/BIM-ONC/2754/201, POCI01-0145-FEDER-32189. FAZ Ciencia Astrazeneca
OF15.05
BMP2-dependent osteoblast differentiation is suppressed by multiple myeloma-derived
extracellular vesicles
Mariko Ikuo
a,b, Kei Sugisakib, Jumpei Teramachib, Ryou-u Takahashia, Masahiro Abeb, Kohji Itohb
and Hidetoshi Taharaa
aHiroshima University, Hiroshima, Japan; bTokushima University, Tokushima, Japan
Introduction: Multiple myeloma (MM) suppresses osteoblast differentiation and destroys
bones. Cancer-derived extracellular vesicles (EVs) such as exosomes control microenvironments,
but little is known about EVs and exosomes secreted from MM cells (MM-EV). We examined
whether and how MM-EV affects osteoblastic differentiation.
Methods: The mouse pre-osteoblast MC3T3-E1 cells and human osteosarcoma SaOS-2 cells
was stimulated with bone morphogenic protein-2 (BMP2) to activate BMP/Smad pathway
and induce osteoblastic differentiation. Alkaline phosphatase (ALP) induction and
calcium deposition were used as indicators of differentiation. The promoter activities
of Smad’s target genes were quantified by luciferase reporter assays.
Results: In BMP2-treated MC3T3-E1, MM-EV repressed ALP induction and calcium deposition.
MM-EV fractions were collected by Total Exosome Isolation Reagent (Invitrogen) or
ultracentrifugation. The ALP suppression activity of the MM-EV collected by the kit
and MM-EV collected by ultracentrifugation were correlated with the vesicle quantity
and exosomal marker protein quantity. The suppression of ALP induction by MM-EV was
inhibited by macropinocytosis inhibitor 5-(N-Ethyl-N-isopropyl) amiloride. In mouse
cell MC3T3-E1 and human cell SaOS-2, MM-EV did not suppress Smad signal transduction.
Contrary, these MM-EV inhibited promoter activation of genes targeted by Smad. This
suppression activity required Smad binding elements (SBEs) of the promoter sequence.
On Smad target promoters, a transcription factor X co-represses Smad’s activity and
inhibit osteoblast differentiation. The factor X was translocated in the nucleus and
its target genes’ expressions were changed in the cells treated with MM-EV.
Summary/Conclusion: MM-EV suppresses osteoblast differentiation by inhibiting promoter
activation of Smad. This finding will lead a novel drug development strategy for the
bone defects of MM.
Funding: Research Support Foundation of Tokushima University and TAIHO Pharmaceutical
Co., LTD, JSPS Grant-in-Aid for Young Scientists (B) (ID 26860037), and JSPS Grant-in-Aid
for Early-Career Scientists (ID 18K15213).
OF15.06
Tumour
-derived extracellular vesicles require β1 integrins to promote anchorage-independent
growth
Lucia R. Languino, Rachel DeRita, Aejaz Saeed, Vaughn Garcia, Shiv Ram Krishn, Christopher
Shields, Andrea Friedman and Srawasti Sarker
Thomas Jefferson University, Philadelphia, PA, USA
Introduction: While the significance of extracellular vesicles (EVs) in disease progression
is known, it is not clear whether “tumour-derived” EVs are detectable in vivo and
are active. EVs contain different integrins; the β1 integrins, which are expressed
in different cell types, contribute to cancer progression, and are known to signal
through endosomes. In this study, we investigated whether prostate cancer (PrCa) EVs
affect anchorage-independent growth and whether β1 integrins in EVs are required for
this effect.
Methods: We used EVs separated by ultracentrifugation and density–gradient from TRAMP
mice, which develop PrCa (TRAMP, transgenic adenocarcinoma of the mouse prostate).
We also used a cell line-based genetic rescue approach. For this study, we selected
EVs with 1.14g/ml density and 100nm mean size.
Results: We show that EVs from either cancer cells in vitro or from blood of tumour-bearing
TRAMP mice promote anchorage-independent growth of PrCa cells. In contrast, EVs from
cultured cells harbouring a shRNA to β1, from wild-type mice or from β1pc-/- /TRAMP
mice carrying a β1 conditional ablation in the prostatic epithelium, do not. Additionally,
we show that genetic rescue of β1 restores the stimulatory function of secreted EVs
on anchorage-independent growth. We demonstrate that EVs isolated through density–gradients
from cancer cells or TRAMP blood, are functional and co-express β1, src, as well as
CD9, CD63 and TSG101; in contrast, EVs from β1pc-/- /TRAMP or wild-type mice lack
β1 as well as the other markers listed above.
Summary/Conclusion: In this study, we demonstrate that tumour-derived epithelial EVs
require β1 integrins to stimulate anchorage-independent growth of recipient cells.
Overall, this study opens new perspectives in cancer treatment based on inhibition
of circulating β1 integrin- containing EVs shed by cancer cells.
Funding: This study was supported by NIH R01 CA-224769, P01 CA-140043; Thomas Jefferson
University Dean’s Transformational Science Award. This project is also funded, in
part, under a Commonwealth University Research Enhancement Program grant with the
Pennsylvania Department of Health (H.R.); the Department specifically disclaims responsibility
for any analyses, interpretations or conclusions.
Symposium Session 16: Central Nervous System EVs Chairs: Lesley Cheng; Dimitrios KapogiannisLocation:
Level B1, Hall A 13:30–15:00
OF16.01
Brain tissue-derived extracellular vesicles of Alzheimer’s disease patients with different
apolipoprotein E genotypes
Yiyao Huang
a, Vasiliki Machairakib, Lesley Chengc, Olga Pletnikováa, Juan Troncosoa, Andrew Hilld,
Lei Zhenge and Kenneth W. Witwera
aJohns Hopkins University School of Medicine, Baltimore, USA; bJohns Hopkins University,
Baltimore, USA; cDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular
Science, La Trobe University, Melbourne, Australia; dThe Department of Biochemistry
and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora,
Australia; eClinical Laboratory Department, Nanfang Hospital, Southern Medical University,
Guangzhou, China (People’s Republic)
Introduction: Sporadic Alzheimer’s disease (AD) associates with Apolipoprotein E (APOE)
genotype. The ε4 allele is associated with increased risk vs. the more common ε3,
while ε2 is protective. Recently, Vella, et al. (JEV, 2017) reported efficient enrichment
of EVs from brain by differential and gradient density ultracentrifugation. Importantly,
the method was carefully evaluated by levels of proteins presumed to be depleted in
EVs vs. artefacts of tissue processing, per MISEV. Using a modification of this rigorous
method, we extracted brain-derived EVs (bdEVs) of AD patients with different APOE
alleles and non-AD brain tissues for quantitive and qualitative evaluation of EVs
and their cargo.
Methods: Brain of AD patients with different APOE genotypes [ε2/ε3 (n = 5), ε3/ ε3
(5), ε3/ε4 (6), ε4/ε4 (6)] and non-AD controls (n = 7) was obtained from the Johns
Hopkins Alzheimer’s Disease Research Center. Tissue was processed per Vella et al.
(JEV, 2017) through 10k x g centrifugation. Subsequently, SEC was followed by UC to
concentrate bdEVs. Protein and particle concentration, morphology, and protein markers
were examined by BCA, nano-flow cytometry (NanoFCM), TEM, and Western blotting. RNA
and protein from brain homogenate (BH), 10k x g large EVs (lEVs) and small EVs (sEVs)
were extracted for proteomics and small RNA QC (Fragment Analyser) and sequencing.
Results: bdEVs of acceptable purity were obtained using the modified method. No remarkable
differences in bdEV morphology or size distribution were observed between AD and non-AD
material. Similarly, no significant differences in particle counts separated AD from
non-AD controls. Stratifying by APOE genotype several differences were observed. In
contrast with a recent report on APOE4, counts of ε4-associated bdEVs were not lower
than those of brains with other genotypes. Indeed, liberated particle counts were
highest for ε4/ε4. Fragment Analyser revealed abundant sRNAs in sEVs. Total RNA and
miRNA abundance from highest to lowest by source was: BH, lEVs, and sEVs.
Summary/Conclusion: Our results suggest ε4/ε4 genotype in AD associates with greater
bdEV recovery than for other genotypes or non-AD brain. Ongoing evaluation of protein
and RNA from these samples may reveal correlates or mechanisms of EV release.
Funding: US NIH: NIA (AG057430), NIMH (MH118164).
OF16.02
Murine CNS-Derived extracellular vesicles originate from astroctyes and neurons and
carry misfolded proteins
Judith Maxwell. Silverman, Sarah Fernando, Catherine Cowan, Luke McAlary, Leonard
Foster and Neil R. Cashman
University of British Columbia, Vancouver, Canada
Introduction: Extracellular vesicles (EVs) are secreted by myriad cells in culture
and unicellular organisms, and their identification in mammalian biofluids suggests
that vesicle release occurs at the organism level also. However, despite clear importance
to the understanding of EVs in organismal biology, EVs in solid tissues have received
little attention. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative
disease resulting in the progressive loss of motor neurons in the brain, brainstem
and spinal cord. The disease is characterized by progressive propagation of pathology
spreading from the CNS foci in which symptoms first appear.
Methods: To better understand to role of EVs in an ALS-affected central nervous system,
we employed a method of whole tissue vesicle isolation. We applied a protocol for
primary neural cell culture and modified it for the collection of EVs from frozen
whole murine and human neural tissues by serial centrifugation and purification on
a sucrose gradient.
Results: Quantitative proteomics found that brain-derived EVs contain canonical exosomal
markers, with enrichment in synaptic and RNA binding proteins. The brain EVs contained
numerous proteins implicated in ALS, and SOD1G93A transgenic EVs were significantly
depleted in myelin-oligodendrocyte glycoprotein compared to non-transgenic animals.
Brain and spinal cord EVs are positive for the astrocyte marker GLAST and the synaptic
marker SNAP25, while CD11b, a microglial marker, was largely absent, suggesting that
microglia do not contribute to the tissue EV population under these conditions. EVs
from SOD1G93A transgenic ALS mouse model brains and spinal cords, as well as human
SOD1 familial ALS patient spinal cord, possess abundant misfolded and non-native disulfide-crosslinked
aggregated SOD1.
Summary/Conclusion: We established a phenotypic profile of vesicles from whole mouse
brains and spinal cords, and investigated how model motor neuron disease modifies
this phenotype. The data demonstrates that intra-organ CNS-EVs from disease affected
animals and humans contain pathogenic disease-causing protein, and suggests that in
the brain and spinal cord, astrocytes and neurons, as opposed to microglia, are the
main source of EVs.
Funding: A Bernice Ramsay ALS Canada grant supported the work, along with funding
from the Paul Heller Memorial Fund for JMS.
OF16.03
Investigating microvesicle motion on neuron surface through optical tweezers
Giulia D’Arrigo
a, Martina Gabriellib, Dan Cojocc, Giuseppe Legnamed and Claudia Verderioe
aInternational School for Advanced Studies of Trieste, Varese, Italy; bCNR Institute
of Neuroscience, Milano, Italy; cCNR – Institute of Materials, Trieste, Italy; dInternational
School for Advanced Studies of Trieste, Trieste, Italy; eCNR Institute of Neuroscience,
Trieste, Italy
Introduction: Microvesicles (MVs) play an essential role in intercellular communication.
Exposing adhesion receptors, they can interact with target cells and deliver complex
signals. It has been shown that MVs also cover a crucial role in the spreading of
pathogens in neurodegenerative disorders, but almost nothing is known about how MVs
can transport messages moving in the extracellular microenvironment exploiting neuronal
connections.
Methods: In order to investigate the interaction of MVs with the plasma membrane of
neurons, MVs released from cultured astrocytes and isolated by differential centrifugation,
were added to the medium of cultured hippocampal neurons. Using optical manipulation,
single MVs in suspension were trapped by an infra-red laser collimated into the optical
path of the microscope, and delivered to neuron surface. The MV-neuron dynamics were
monitored by collecting bright-field images.
Results: Analysis of time-lapse recordings revealed that MVs efficiently adhered to
neurons and about 70% showed a displacement along the surface of neurites. Interestingly,
the MVs velocity (143 nm/sec) is in the same range of retrograde actin flow, which
regulates membrane diffusion of receptors linked to actin. Accordingly, we found that
MV movement is highly dependent on neuron energy metabolism. Indeed, only 33% of MVs
were able to move on energy depleted neurons treated with rotenone. Moreover, inhibiting
neuron actin cytoskeleton rearrangements (polymerization and depolymerization) with
cytochalasin D, which binds fast growing end of actin, the percentage of EVs able
to move on neuron surface was significantly reduced from 79% to 54%, revealing that
neuronal actin cytoskeleton is involved in EV-neuron dynamics.
Unexpectedly, we found by cryo-electron microscopy that a subpopulation of MVs contains
actin filaments, suggesting an intrinsic capacity of MVs to move. To address this
hypothesis, we inhibited actin rearrangements in EVs with Cytochalasin D and observed
a significant decrease, from 71% to 45%, of MVs able to drift on neuron surface.
Summary/Conclusion: Our data support two different way of MV motion. In the first
case, MV displacement could be driven by the binding with neuronal receptors linked
to the actin cytoskeleton. In the second, actin rearrangements inside MVs could drive
the motion along a gradient of molecules on neuron surface.
OF16.04
P2RX7 Inhibitor suppresses tau pathology and improves hippocampal memory function
in tauopathy mouse model
Seiko Ikezu, Zhi Ruan, Jean Christophe Delpech, Mina Botros, Alicia Van Enoo, Srinidhi
Venkatesan Kalavai, Katherine Wang, Lawrence Hu and Tsuneya Ikezu
Boston University School of Medicine, Boston, USA
Introduction: Microglia, the innate immune cells in the central nervous system, could
spread pathogenic tau protein via secretion of extracellular vesicles, such as exosome.
P2X7 receptor (P2RX7) is an ATP-gated cation channel and highly expressed in microglia
and triggers exosome secretion. We hypothesize that P2RX7 inhibitor could alleviate
tauopathy in PS19 tau transgenic mice by inhibiting the exosome secretion by microglia.
Methods: BV-2 murine microglial cell lines were treated with GSK1482160, a specific
inhibitor of P2RX7, prior to ATP stimulation. Exosomes were enriched from the conditioned
media and quantified using Nanoparticle Tracking Analysis and CD9 ELISA. Three-months
old P301S Tau (PS19) and control wild-type mice were treated with GSK1482160 (20 mg/kg)
or vehicle by oral gavage for 30 days. The animals were tested for hippocampal memory
function. The accumulation of pathogenic Tau was determined by immunohistochemistry
and ELISA.
Results: ATP stimulation of BV-2 cells significantly increased secretion of exosomes
(30–150 nm), which was significantly inhibited by GSK1482160 treatment in a dose-dependent
manner. Daily administration of GSK1482160 over 30 days had no effect on body weight
of PS19 mice. Interestingly, GSK1482160 treatment enhanced spontaneous alteration
in Y-maze and improved prepulse inhibition as compared to vehicle-treated group. In
addition, pTau level in the hippocampal tissue was significantly reduced in GSK1482160-treated
PS19 mice as compared to vehicle-treated group as determined by neuropathology and
ELISA.
Summary/Conclusion: GSK1482160 treatment suppresses ATP-induced exosome secretion
from BV-2 cells. Its oral administration to PS19 mice improved hippocampal memory
function and reduced the accumulation of pathogenic tau. These data demonstrate that
targeting P2RX7 is a novel target for suppressing the exosomal spread of pathogenic
tau protein by microglia, which may be applicable to Alzheimer’s disease.
Funding: Grant/Other Support: NIH 1RF1AG054199-01
Grant/Other Support: 1R01AG054672-01
Grant/Other Support: 1R56AG057469-01
Grant/Other Support: DVT-14–320835
Grant/Other Support: Cure Alzheimer’s Fund.
OF16.05
Astrocyte-derived extracellular vesicles shed in response to IL-1beta up-regulate
amyloidogenic processing in neurons
Zhigang Li
a, Raha Dastgheyba, Seung-Wan Yooa, Carlos Nogueras-Ortizb, Dimitrios Kapogiannisb
and Norman Haugheya
aJohns Hopkins University, Baltimore, MD, USA; bNational Institute on Aging, Baltimore,
MD, USA
Introduction: Chronic inflammation is thought to contribute to the pathogenesis of
Alzheimer’s disease by upregulating amyloidogenic processing of APP. Based on previous
findings that inflammatory stimuli modify the cargo of astrocyte derived extracellular
vesicles (ADEV), we sought to determine if ADEVs released in response to IL-1β (ADEV-IL-1β)
contain cargo that regulate APP processing in neurons.
Methods: Neurons were stimulated with constitutively released ADEV or ADEV-IL-1β.
APP, and BACE1 co-localization in membrane microdomains was measured by immunofluorescence
staining. APP and BACE1 protein and mRNA levels measured by western blot and RT-QPCR.
The binding of APP mRNA and heterogeneous nuclear ribonuclear protein C (hnRNP C)
was measured by immunoprecipitation. Casein kinase 1 (CK1) efficiency was blocked
using pharmacological inhibition and genetic knockdown. Isolation of human plasma
ADEV was achieved by GLAST-1 pull-down.
Results: Neurons exposed to ADEV-IL-1β promoted the co-localization of APP and BACE1
into membrane microdomains (p < 0.001), and increased production of Aβ1-42. Protein
expression of APP (p = 0.0051) but not BACE1 was also increased. APP mRNA was not
increased following exposure of neurons to ADEV-IL-1β, suggesting a post-translational
event. APP translation is regulated by a competitive interaction of the fragile X
mental retardation protein (FMRP), and hnRNP C with the APP coding region. hnRNP C
can displace FMRP and increase APP translation. The association of hnRNP C with APP
mRNA increased following exposure to ADEV-IL-1β. Compared with ADEV-CR, ADEV-IL-1β
selectively carried CK1. CK1 is known to activate hnRPC. Knockdown of CK1 in astrocytes
reduced CK1 in ADEV-IL-1β (p = 0.0061), prevented the upregulation of APP protein
expression (p = 0.007), and co-localization of APP with BACE1 (p < 0.001). Overexpression
of CK1 in astrocytes increased CK1 in ADEV-IL-1β, increased APP protein expression
(p = 0.0026), and co-localization of APP with BACE1 (p = 0.0015). We confirmed in
ADEVs isolated from human plasma that AD patients, but not healthy age-matched controls
contain CK1 (p = 0.0467).
Summary/Conclusion: These data suggest that neuroinflammatory stimuli modify ADEV
cargo to enhance amyloidogenic processing of APP by delivering CK1 to regulate the
association of hnRNPC with APP mRNA.
OF16.06
The role of human choroid plexus-derived extracellular vesicles in viral neuroinvasion
Bethany O’Hara, Jenna Morris-Love, Gretchen Gee, Walter Atwood and Sheila Haley
Brown University, Providence, RI, USA
Introduction: The human polyomavirus JCPyV causes the fatal disease progressive multifocal
leukoencephalopathy (PML) in immunocompromised individuals and patients undergoing
immunomodulatory therapy. A critical question in JCPyV pathogenesis is understanding
how the virus is transported from the periphery to the CNS to infect glial cells and
cause demyelination. An additional paradox is that the target glial cells do not express
known virus receptors. Previously, we analysed JCPyV infection of the choroid plexus
(CPE), a functional barrier to the CSF and showed CPE cells are permissive to JCPyV
infection and express viral attachment and entry receptors. Here, we investigate the
role of CPE-derived extracellular vesicles in receptor-independent infection of glial
cells by JCPyV.
Methods: In addition to analysing primary human CPE cells, we also developed an immortalized
human CPE line. CPE were transformed using hTERT lentiviral transduction and verified
by STR profiling. EV from both cell types were concentrated by differential centrifugation
and evaluated by transmission electron microscopy, Western blot, nanoparticle tracking
analysis, infection, and qPCR for protected viral genomes. Infection was evaluated
by immunofluorescence analysis with antibodies against the major viral capsid protein
VP1. Uptake was evaluated by flow cytometric analysis of PKH67 fluorescently labelled
particles and confocal imaging.
Results: EV from CPE cells display characteristic markers and morphology, contain
intact JCPyV virions, and are infectious to both CPE cells and human glial cells.
EV-mediated infection is receptor independent. Infection and uptake of EV cannot be
inhibited by neutralizing antisera and internalization is via endocytosis. EV from
CPE contains significantly more VP1 than other glial cell lines.
Summary/Conclusion: Primary and transformed CPE produce similar EVs that are able
to deliver significant amounts of JCPyV in a receptor independent manner to target
cells in the CNS. The choroid plexus may be an entry point by which JCPyV accesses
the brain leading to the development of PML.
Funding: NIH RO1NS043097.
Symposium Session 17: EVs in Tissue Injury and Repair Chairs: Benedetta Bussolati;
Dominique de KleijnLocation: Level B1, Hall B 13:30–15:00
OF17.01
Mesenchymal stem cell derived extracellular vesicles restore the engraftment capacity
of stem cells in radiation exposed mice
Sicheng Wen
a, Mark Doonerb, Laura Goldbergc, Elaine Papac, Michael Del Tattoc, Mandy Pereirac,
Yang Chenc, Theodor Borgovand and Peter Quesenberryb
aBrown University/Rhode Island Hospital, Providence, RI, USA; bBrown University Department
of Hematology Oncology; Rhode Island Hospital, Providence, RI, USA; cRhode Island
Hospital, Providence, RI, USA; dRhode Island Hospital/ Brown University, Providence,
RI, USA
Introduction: We have shown that pretreated irradiated murine bone marrow stem cells
(BMSCs) with mesenchymal stem cells-extracellular vesicles (MSC-EVs) in vitro, could
significantly improve the engraftment capacity of radiation damaged BMSCs with a predominant
reversal effect in later periods of post-transplant from 12 weeks up to 36 weeks.
This indicates a long-term effect of MSC-EVs on reversal of radiation damage of BMSCs.
Methods: In this study, we investigated the long-term effect of MSC-EVs on the restoration
of engraftment of BMSCs in radiation-exposed mice in vivo up to 53 weeks. Moreover,
the safety and toxicity of MSC-EVs treatment were also evaluated.
Results: 500cGy radiated mice were injected with human MSC-EVs by tail vein injection
at 24, 48 and 72h post-radiation. We followed the peripheral blood cell counts up
to 53 weeks post-EV injection. There was a significant RBC, HGB and platelet restoration
in EV treated radiated mice compared to untreated mice in the early period (before
day 35). For the evaluation of reversal effect on BMSCs, bone marrow, harvested at
6, 12, 26 and 53 weeks. post-EV injection, were transplanted into 950 cGy exposed
B6.SJL mice. The engraftment was evaluated at 4 and 12 weeks post-transplantation.
In those transplanted mice at 6 weeks post-EV injection, there was a slight increase
in the restoration of engraftment rate in EV treated mice (17.58 ± 2.32%) compared
to untreated mice (13.80 ± 1.41%) after 1 month post-transplantation. However, for
those mice transplanted at 12, 26, and 53 weeks post-EV injection, there were significantly
higher restorations of engraftment in EV treated mice (40.48 ± 6.03%, 33.93 ± 3.76%,
and 56.62 ± 3.63) compared to untreated mice (12.39 ± 1.30%, 15.14 ± 2.21%, 36.21 ± 3.63%)
after 4 weeks transplantation, respectively. The similar restorations of engraftment
were also seen in 12 weeks post-transplantation. These data suggested that EVs have
early and late mitigating effects on peripheral blood cytopenias and BMSCs. No toxic
effect was observed in bone marrow, kidney, liver, spleen, lung and heart up to 53
weeks post-EV injection.
Summary/Conclusion: Our data suggest that there is a long-term effect of MSC-EVs on
the restoration of engraftment of BMSCs in radiation-exposed mice, and MSC-EV treatment
is a safe therapeutic strategy.
Funding: NIH grants 5UH2TR000880 and 5T32HL116249.
OF17.02
Connexin43-positive exosomes released by osteoarthritic chondrocytes favours osteoarthritis
progression by spreading senescence and inflammatory mediators to nearby tissues
Marta Varela-Eirína, María D. Mayán Santos
b, Adrián Varela-Vázqueza, Amanda Guitián-Caamañoa, Susana B. Bravo-Lópezc, Carlos
Paínod, Raquel Largoe, Eduardo Fonsecaa, Mustapha Kandouzf, Trond Aaseng, Arantxa
Taberneroh, Alfonso Blancoi, José R. Caeiroj and María D. Mayána
aCellCOM research group. Instituto de Investigación Biomédica de A Coruña (INIBIC),
Servizo Galego de Saúde (SERGAS), A Coruña, Spain; bTranslational Research in Cell
Communication and Signalling (CellCOM), Instituto de Investigación Biomédica de A
Coruña (INIBIC), A Coruña, Spain; cProteomics laboratory. Instituto de Investigación
Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de
Santiago de Compostela (CHUS), A Coruña, Spain; dUnit of Experimental Neurology-Neurobiology.,
Madrid, Spain; eBone and Joint Research Unit, Rheumatology Department, IIS-Fundación
Jiménez Díaz UAM, Madrid, Spain; fDepartment of Pathology, School of Medicine, Wayne
State University, Detroit, MI, USA; gTranslational Molecular Pathology research group.
Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona,
Spain; hDepartamento de Bioquímica y Biología Molecular, Instituto de Neurociencias
de Castilla y León (INCYL), Universidad de Salamanca, Salamanca, Spain; iFlow Cytometry
Core Technologies, UCD Conway Institute, University College Dublin, Dublin, Ireland;
jDepartment of Orthopaedic Surgery and Traumatology, Complexo Hospitalario Universitario
de Santiago de Compostela (CHUS). Universidade de Santiago de Compostela (USC), Santiago
de Compostela, Spain
Introduction: Chondrocytes in articular cartilage undergo phenotypic changes and senescence,
restricting cartilage regeneration and favouring osteoarthritis (OA) progression.
Like other wound healing disorders, chondrocytes from OA patients show a chronic increase
in the transmembrane channel protein connexin43 (Cx43). Extracellular vesicles (EVs),
including exosomes, have been show to harbour connexin channels that allow the formation
of gap junctions between the exosome and the target cell. However, the role of these
vesicles and exosomal-Cx43 in OA progression has not been studied yet. The objective
of this study was to investigate the role of EVs released by osteoarthritic chondrocytes
(OACs) in cellular plasticity and senescence of surrounding tissues.
Methods: EVs were isolated from OA/healthy chondrocytes by ultracentrifugation and
their protein content was analysed by LC-MS/MS using 6600 triple TOF. RNA levels,
protein activity and cellular senescence were analysed by RT-qPCR, western blot, immunofluorescence
and flow cytometry.
Results: Our results indicate that OACs contain increased levels of Cx43 within their
EVs in comparison to the EVs isolated from healthy donors. Overexpression of Cx43
in chondrocytes increased senescence and the total content of Cx43 in the EVs. The
treatment of target cells with EVs containing Cx43 led to a significant increase in
Cx43 mRNA and protein levels. The increase of Cx43 lead to dedifferentiation in the
recipient cells via EMT by activation of Twist-1, with increased levels of the mesenchymal
markers CD105 and CD166. The phenotypic changes detected in OACs lead to a decrease
in the main cartilage markers Col2A1 and ACAN expression, and increased the levels
of cellular senescence and SASP in target cells via p53/p16 and NF-kß. These results
were corroborated by analysing the protein cargo of these Cx43 positive EVs, where
we found enrichment in proteins related with the catabolic, senescence and wound-healing
pathways
Summary/Conclusion: Together, these results suggest that Cx43-positive EVs released
by OACs may be involved in the spread of cellular senescence, inflammation and reprogramming
factors involved in wound healing failure to neighbouring tissues in the joint. Further
understanding of the role of exosomal Cx43 in OA will help to halt the disease spread
and progression.
OF17.03
Extracellular vesicles in ageing: from skin to bone
Lucia Terlecki-Zaniewicza, Madhusudan Reddy Bobbilia, Matthias Hacklb, Regina Grillaric,
Ingo Lämmermanna, Vera Pilsd, Florian Grubere and Johannes Grillari
f
aBOKU – University of Natural Resources and Life Sciences Vienna, Vienna, Austria;
bTAmiRNA GmbH, Vienna, USA; cEvercyte GmbH, Vienna, Austria; dBOKU – University of
Natural Resources and Life Sciences Vienna, Vienna, USA; eChristian Doppler Laboratory
on Biotechnology of Skin Aging; Medical University of Vienna, Vienna, USA; fChristian
Doppler Laboratory on Biotechnology of Skin Aging, University of Natural Resources
and Life Sciences, Vienna (BOKU), Vienna, Austria
Introduction: Cellular senescence has evolved from an in vitro model system to study
aging to a multifaceted phenomenon of in vivo importance since senescent cells in
vivo have been identified and their removal delays the onset of age-associated diseases
in a mouse model system. In order to understand how senescent cells that accumulate
within organisms with age negatively impact on organ and tissue function, we have
started to characterize secreted miRNAs within extracellular vesicles that are differentially
expressed in early passage versus senescent cells and their functional role in the
context of cellular and organismal aging.
Methods: We performed next generation sequencing as well as qPCR on extracellular
vesicles from senescent versus control cells, after characterizing the EVs in detail.
In addition, open flow microperfusion experiments were used to proof the presence
of EVs in the interstitial fluid of the skin.
Results: We identified extracellular vesicle contained miRNAs as bona fide members
of the senescence associated secretory phenotype (SASP) that are transferred from
senescent cells to their microenvironment or even the systemic environment. These
miRNAs, among them miR-23a-5p, are transported via extracellular vesicles also in
organotypic human skin equivalents and recipient cells taking them up are altered
in their cell fate, including altered wound healing and apoptototic behaviour. In
addition, miR-31 is transferred to mesenchymal stem cells, inhibiting osteogenic differentiation.
Summary/Conclusion: In summary, we present evidence of the importance of specific
miRNAs and highlight their potential use as biomarkers of aging and age-associated
diseases, or even as therapeutic tools and targets to prevent age-associated diseases.
Funding: This work was funded by the Christian Doppler Society. The financial support
by the Austrian Federal Ministry of Economy, Family and Youth; the National Foundation
for Research, Technology and Development is also gratefully acknowledged, as is funding
by the Austrian Science Fund (FWF: I2514 to JG) and the PhD Programme BioToP – “Biomolecular
technolgy of proteins”.
OF17.04
Human embryonic stem cells derived exosomes promote tissue regeneration in aged mice
by rejuvenating senescent endothelial cells
Bi Chen, Liangzhi Gong
a and Yang Wangb
aShanghai Jiaotong University Affiliated Sixth People’ Hospital, Shanghai, China (People’s
Republic); bShanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai,
China (People’s Republic)
Introduction: Angiogenesis plays a crucial role in tissue repair. This process is
significantly impaired by age-related dysfunction of vascular endothelial cells in
aged bodies. Exosomes from embryonic stem cells (ESCs) contain primitive molecules
(proteins, miRNA, etc.) from their parent cells. Therefore, our hypothesis is that
ESCs derived exosomes (ES-Exos) would influence and rejuvenate aging endothelial cells
and lead to enhanced tissue repair in aged bodies.
Methods: Six- to eight-week-old C57BL/6 mice were daily subcutaneous injection of
D-gal (1000 mg/kg) to establish aged mice model. Pressure ulcers were created on the
back of each mouse, followed by pipetting ES-Exos (1*1011/mL) suspension or PBS one
time per day. Mice were sacrificed at 3, 7, 14, and 21 days after intervention. In
addition, a group of young mice with pressure ulcer was also set. Samples from each
mouse were evaluated in the aspect of vascular formation and aging condition. Furthermore,
we induced HUVEC senescence in vitro by D-gal treatment and investigate the function
and mechanism of ES-Exos in restoring function and rejuvenation of senescent endothelial
cells by qRT-PCR, WB, and immunofluorescent staining.
Results: Our results showed that ES-Exos treated aged mice exhibit faster repairing
than PBS treated group. The angiogenesis condition of ES-Exos treated group was similar
as that of young mice and was better than PBS treated senescent mice. The number of
SA-β-gal-positive cells and the expression level of P16 and P21 in ES-Exos treated
group were significantly lower than that in PBS treated group. In vtiro experiments
showed that ES-Exos could also downregulate senescent related protein expressions
and enhance tube formation of senescent endothelial cells. In addition, our results
also showed that ES-Exos could greatly decreased the expression level of MDA and increase
the activity of SAD, CAD, and GSH, molecules tightly related with endogenous anti-oxidative
condition. Further investigation demonstrated that ES-Exos could activate NRf2 pathway
by inhibiting Keap1, leading to rejuvenative function on senescent endothelial cells.
Summary/Conclusion: We demonstrate that ES-Exos can accelerate wound healing and promote
angiogenesis in aged mice by rejuvenating endothelial senescence.
Funding: NSFC Project No. 81871833 and 81672254.
OF17.05
Schwann cell derived exosomes regulate Schwann cell activation and neuropathic pain
related behaviours
Naoya Hirosawaa, HyoJun Kwonb, Haylie Romerob, John Kimb, Coralie Brifaultc, Seiji
Ohtorid and Wendy Campana
e
aAnesthesiology and Program in Neuroscience, University of California, San Diego,
CA, USA; bDepartment of Anesthesiology, School of Medicine, University of California,
San Diego, CA, USA; cUniversity of California, San Diego, San Diego, CA, USA; dDepartment
of Orthopaedic Surgery, Chiba University, Chiba, Japan; eDepartment of Anesthesiology
and Program in Neuroscience, School of Medicine, University of California, San Diego,
CA, USA
Introduction: Exosomes (Exs) are small extracellular vesicles originally known to
be secreted from multivesicular endosomes in dendritic cells. We now know that Exs
are secreted from many cell types and are essential for autocrine/paracrine communication.
In the peripheral nervous system (PNS), Exs derived from primary Schwann cells (SC)
appear to facilitate axon growth after injury, however their effects on SC physiology
and pain outcomes are unknown.
Methods: Exs were purified from primary SC conditioned media by ultracentrifugation
(SC-Ex) and characterized by immunoblotting and NanoSight In cultures of SC, TNFa
robustly activated proinflammatory cell signalling and migration. SC-Ex (50–500 ng/mL)
were added to TNFa treated SC, and phosphorylation of p38MAPK and JNK1/2 were measured.
Transwells were used to evaluate SC migration. To determine if SC-Ex regulate neuropathic
pain, we performed intraneural injections of SC-Ex (500–1500 ng) or vehicle into sciatic
nerves during partial nerve ligation (PNL) surgeries in adult male rats (n = 12).
Tactile allodynia was assessed using von Frey filaments.
Results: Nanoparticle tracking of SC-Ex showed the expected size distribution with
a mean peak diameter of 121 nm. Immunoblotting of SC-Ex revealed that exosome markers,
TSG101 and flotillin-1, and SC marker, P0 protein, were expressed. The golgi marker,
GM130, and GFAP were not. In cultured SC, the SC-Ex signalling response was distinguished
from the cell signalling signature elicited by TNF alone, which robustly activated
p38MAPK and JNK1/2 by > 6 and 4-fold (p < 0.01), respectively. When SC-Ex were added,
p38MAPK and JNK1/2 activation were dose dependently and significantly inhibited (p < 0.05).
TNF increased SC migration 3-fold after 4 h that was blocked by SC-Ex at low doses.
Local injections of SC-Ex modified tactile allodynia associated with PNL compared
to saline injected controls.
Summary/Conclusion: We demonstrated that SC utilizes autocrine secretion of Exs for
regulating SC signalling and migration. SC-Ex act as cell independent entities, carrying
bioactive substances capable of inhibiting pro-inflammatory signalling in SCs that
may contribute to the extent and magnitude of chronic pain. Future studies will elucidate
SC-Ex cargo driving autocrine/paracrine activities after PNS injury.
Funding: VA.
OF17.06
Urinary extracellular vesicles improve the recovery of renal function in an Acute
Tubular Injury model restoring Klotho levels
Elli Papadimitrioua, Benedetta Bussolati
b, Cristina Grangec, Veronica Dimuccioc and Giovanni Camussid
aDepartment of Molecular Biotechnology and Health Sciences; University of Turin, Turin,
Italy; bDepartment of Molecular Biotechnology and Health Sciences, University of Turin,
Turin, Italy; cUniversity of Turin, Turin, Italy; dDepartment of Medical Sciences,
University of Turin, Turin, Italy
Introduction: Extracellular vesicles present in urine (uEVs), are considered a non-invasive
source of information regarding the pathophysiology of the whole kidney. Mainly secreted
by renal cells lining the nephron, uEVs have been studied as biomarkers for diagnosis
of renal diseases. However, their possible therapeutic use has not been addressed
yet. In the current study, we investigated the potential therapeutic effect of uEVs,
in a murine model of acute kidney injury (AKI). While the beneficial effect of mesenchymal
stromal cell-derived EVs (MSC EVs) for AKI treatment has been extensively described,
we here tested the possible therapeutic use of uEVs as more “renal committed” source.
Methods: uEVs were isolated by ultracentrifugation of human urine provided by healthy
subjects. AKI was performed by intramuscular injection of 8 ml/kg hypertonic glycerol.
Next day, 2 × 108 uEVs /mouse were intravenously injected and 48 h later mice were
sacrificed.
Results: Our data showed that administration of uEVs in AKI mice resulted in the acceleration
of renal recovery in a MSC EV-treatment comparable manner. Functional and histological
abnormalities, observed upon AKI, were alleviated, cell proliferation was stimulated,
while the expression of renal tissue injury and inflammation markers was reduced.
The analysis of uEV miRNA cargo showed the presence of several miRNAs possibly involved
in tissue repair. miR-30 and miR-151, previously described present in MSC EVs, were
further found transferred in renal tissue of uEV-injected mice. In addition, the reno-protective
factor Klotho, was found present in uEVs at both protein and mRNA level. The administration
of uEVs in AKI mice resulted in the restoration of Klotho protein levels in renal
tissue, significantly lowered upon damage. Of interest, ineffective fibroblast-derived
EVs loaded with recombinant Klotho exhibited a reno-protective effect, suggesting
a possible Klotho-mediated mechanism in the amelioration of AKI.
Summary/Conclusion: Overall, our results reveal a novel potential therapeutic approach
for AKI treatment, using renal cell-derived EVs present in urine and indicate common,
as well as unique, uEV and MSC EV mechanisms of action.
Funding: FP7 NephroToolsproject and by Miur ex60%
Symposium Session 18: EV Function in Health and DiseaseChairs: David Carter; Jacky
GoetzLocation: Level B1, Lecture Room13:30–15:00
OF18.01
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients
with intestinal barrier dysfunction
Joeri Tulkens
a, Glenn Vergauwena, Jan Van Deuna, Edward Geeurickxa, Bert Dhondta, Lien Lippensa,
Marie-Angélique De Scheerderb, Ilkka Miinalainenc, Pekka Rappud, Bruno G De Geeste,
Katrien Vandecasteelef, Debby Laukensg, Linos Vandekerckhoveb, Hannelore Denysh, Jo
Vandesompelei, Olivier De Wevera and An Hendrixa
aLaboratory of Experimental Cancer Research, Department of Human Structure and Repair,
Ghent University, Ghent, Belgium; bDepartment of Internal Medicine, Ghent University
Hospital, Ghent, Belgium; cBiocenter Oulu, University of Oulu, Oulu, Finland; dDepartment
of Biomolecular medicine, University of Turku, Turku, Finland; eDepartment of Pharmaceutics,
Ghent University, Ghent, Belgium; fDepartment of Radiation Oncology, Ghent University
Hospital, Ghent, Belgium; gDepartment of Gastroenterology, Ghent University Hospital,
Ghent, Belgium; hDepartment of Medical Oncology, Ghent University Hospital, Ghent,
Belgium; iCenter for Medical Genetics, Ghent University, Ghent, Belgium
Introduction: Bacterial extracellular vesicles (EV) are secreted by gut bacteria and
contain nucleic acids, proteins, metabolites and endotoxins. Consequently, bacterial
EV that enters the systemic circulation may deliver and elicit a variety of immunological
and metabolic responses in different organs. However, the systemic presence and activity
of bacterial EV in patients with intestinal barrier dysfunction have not been investigated.
Methods: Size exclusion chromatography and density gradient centrifugation were combined
to fractionate faeces and plasma in two dimensions separating bacterial EV-associated
LPS from other LPS products and eukaryotic EV. Bacterial EV-associated LPS levels
of 49 subjects with a compromised or intact intestinal barrier were measured by Limulus
Amebocyte Lysate and Toll-like receptor four reporter assays and confirmed by immunoelectron
microscopy. Plasma zonulin was measured to assess intestinal barrier integrity and
Caco-2 transwell systems were used for in vitro validation experiments.
Results: We calculate that the human gut harbours approximately 100 trillion bacterial
EV which may serve as a substantial source of systemic pathogen-associated molecular
patterns (PAMP), evidenced by proteomic analysis of faeces-derived bacterial EV. We
demonstrate that bacterial EV can translocate the intestinal epithelial layer in a
paracellular way. LPS-positive bacterial EV levels are significantly increased in
plasma of patients diagnosed with HIV, inflammatory bowel disease and cancer therapy-induced
intestinal mucositis compared to respective controls (Mann-Whitney U test, p < 0.01).
These bacterial EV are able to induce immune activation and significantly correlate
with impaired barrier integrity of the patient (Spearman’s ρ = 0.4241, p = 0.0245).
Summary/Conclusion: Pathologies with an intestinal barrier dysfunction open the door
for bacterial EV to enter the circulation and to induce immune activation. Their systemic
presence correlates with impaired gut barrier integrity. These data deliver novel
opportunities to advance our knowledge of PAMP-induced systemic reactions and biomarker
development.
Funding: This work was supported by concerted research action from Ghent University
and Krediet aan Navorsers from the Research Foundation Flanders (FWO). JVD, EG, LV
and AH are supported by fellowships from FWO.
OF18.02
Milk exosomes accumulate in the intestinal mucosa and peripheral tissues in wild-type
pups nursed by exosome and cargo tracking dams
Janos Zempleni
a, Bijaya Upadhyayaa, Mengna Xiaa, Hideaki Moriyamaa and Masato Ohtsukab
aUniversity of Nebraska-Lincoln, Lincoln, USA; bTokai University, Kanagawa, USA
Introduction: Exosomes and their cargos may be obtained from dietary sources such
as milk. Hypothesis: Milk exosomes accumulate in the intestinal mucosa and peripheral
tissues in suckling mice. Aims: 1) Develop an Exosome and Cargo Tracking (ECT) mouse
to assess the origin, destination and cargo of exosomes. 2) Assess the bioavailability
and distribution of milk CD63-positive EVs (“exosomes”) labelled with fluorescent
proteins in suckling pups.
Methods: ECT mice were developed by random integration of an ECT plasmid. The plasmid
encodes a fusion protein of CD63 and green fluorescent protein (eGFP) plus stop codon,
flanked by two loxP sites (ORF-1). A second ORF, coding for a CD63/near-infrared protein
(iRFP) fusion protein, follows downstream of ORF-1. A transmembrane domain is fused
to the C-terminus of the iRFP to create an extra-exosomal C-terminus, followed by
a second iRFP and a stop codon. In the presence of Cre, the CD63/eGFP/Stop insert
is removed and the mice switch from expressing eGFP-labeled exosomes to iRFP-labeled
exosomes, including an extra-exosomal iRFP for collection with anti-iRFP and magnetic
beads. Wild-type (WT) pups were fostered to ECT dams to assess the bioavailability
of milk exosomes.
Results: ECT mice showed no disease phenotypes. In the absence of Cre, the mice expressed
eGFP-labeled exosomes, whereas the offspring of mice mated with Cre mice expressed
iRFP-labelled exosomes. The same patterns were obtained when HEK-293 cells were transfected
with the ECT plasmid in the absence of presence of Cre plasmid. Fluorescent proteins
localized to exosomes but not to other complexes secreted by HEK-293 cells. The particles
had the size expected for exosomes (131 ± 49 nm), stained positive for CD9, Alix and
TSG101, stained negative for histone H3, and were captured by anti-CD63. When WT pups
were nursed by ECT dams for three weeks, exosomes accumulated primarily in the intestinal
mucosa, brain and kidneys.
Summary/Conclusion: We have developed a mouse that permits tracking CD63-positive
exosomes and their cargos. CD63-positive exosomes are bioavailable in suckling mice.
Funding: NIFA, NIH, Gates Foundation, Gerber Foundation, USDA. JZ serves as consultant
for PureTech Health, Inc.
OF18.03
Deciphering extracellular vesicle mediated host-pathogen interaction in streptococcus
pneumoniae
Saigopalakrishna Yerneni
a, Rory Eutseyb, Sarah Wernerb, Surya Aggarwalb, Changjin Huangc, K. Jimmy Hsiac,
Luisa Hillerb and Phil Campbelld
aDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA,
USA; bDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA,
USA; cSchool of Mechanical and Aerospace Engineering, College of Engineering, Nanyang
Technological University, Singapore, Singapore; dDepartment of Biomedical Engineering
and Engineering Research Accelerator, Carnegie Mellon University, Pittsburgh, PA,
USA
Introduction: Extracellular vesicles (EVs) represent a highly sophisticated cell-to-cell
mailing system. Both eukaryotic and prokaryotic cells selectively pack signalling
cargo into and onto EVs and deliver them to the extracellular milieu. However, it
was not until recently, that Gram-positive bacteria including the major respiratory
pathogen Streptococcus pneumoniae (pneumococcus), were shown to produce EVs, likely
originating from the plasma membrane to be released into the extracellular milieu.
The role of Gram-positive EVs in cell-to-cell communication, and their interactions
with the host immune system remain poorly understood. Similarly, the interaction of
eukaryotic immune EVs with pneumococcus remains unexplored. In this study, EVs from
pneumococci and pneumococci-conditioned macrophages were isolated and reciprocal interaction
between the host and the microbe was explored.
Methods: EVs from pneumococci and pneumococci-conditioned macrophages were isolated
using size exclusion chromatography and characterized by transmission electron microscopy,
dynamic light scattering, tunable resistive pulse sensing and western blotting. Effects
of pneumococcal EVs on different immune cell subsets were assessed using flow cytometry,
western blotting and immunostaining. Effects of EVs on S. pneumoniae were assessed
by evaluating their growth kinetics and biofilm development.
Results: Pneumococcal EVs were internalized by various immune cells and conversely,
eukaryotic EVs from J774A.1 cells were taken up by both Gram-positive and Gram-negative
bacteria. In a reporter murine macrophage cell line (RAW 264.7), pneumococcal EVs
induced NF-kB expression in a dosage-dependent manner and induced p65 nuclear translocation
in human primary macrophages. Pneumococcal EVs also activated primary human CD4+ and
CD8 + T cells as evidenced by their CD69 upregulation in a dose and time-dependent
manner. Moreover, EVs secreted by S. pneumoniae promoted their own planktonic growth
and biofilm development in a dose-dependent manner.
Summary/Conclusion: For the first time, we show that eukaryotic EVs are taken up by
Gram-positive bacteria. Our data also indicate that pneumococcal EVs have immunomodulatory
effects on the host immune cells and represents a sophisticated communication system
that needs further investigation.
OF18.04
Calpain carried by platelet-derived microparticles mediates protease-activated receptor
1-dependent vascular inflammation in diabetes.
Anastasia Kyselova, Amro Elgheznawy, Ingrid Fleming and Voahanginirina Randriamboavonjy
Goethe University, Frankfurt, Germany
Introduction: Diabetes mellitus is a major risk factor for cardiovascular diseases
and platelet hyperactivation in diabetes is linked to the release of platelet-derived
microparticles (PMPs) that carry the Cab+-activated protease calpain 1 (CAPN1). Here
we determined whether CAPN1 could target proteins on the vascular wall that could
precipitate the development of vascular disease.
Methods: Mass spectrometry and ELISA were used to analyse proteins in the culture
medium. Protein levels on the surface of endothelial cells were measured by FACs and
en-face immunostaining was used to assess protein levels on intact aorta. Diabetes
was induced with streptozotocin.
Results: In vitro treatment of human endothelial cells with PMPs or recombinant calpain
1(CAPN1) led to a decrease in endothelial protein C receptor (EPCR) levels on the
cell surface and an increase in its levels in the culture medium. In agreement, EPCR
levels were increased in plasma from diabetic patients. Also, diabetes induction in
mice led to a similar increase in plasma EPCR levels, an effect prevented by treatment
with the calpain inhibitor. At the molecular level, CAPN1 did not directly target
the EPCR but rather cleaved the protease-activated receptor 1 (PAR-1), inducing an
intracellular signalling cascade i.e the phosphorylation of protein kinase C (PKC)
and the extracellular regulated kinase (ERK) as well as the activation of the tumour
necrosis factor (TNF)- converting enzyme (TACE). The latter was responsible of EPCR
shedding as well as of the increased local TNF- levels. TNF- triggered the phosphorylation
of the p65 subunit of NFκB, increased ICAM-1 expression and enhanced monocyte adhesion.
The same phenomenon was evident in vivo as en-face preparations of aortae from diabetic
mice revealed a loss of PAR-1 but induction of ICAM-1 which could be prevented by
CAPN inhibitor or by specific knocking out of CAPN1 in platelets (PF4-Capn1-/-). All
of the effects of PMPs or CAPN1 were abolished in PAR-1-deficient endothelial cells.
Summary/Conclusion: These data demonstrate that platelet-derived calpains contribute
to diabetes-associated vascular inflammation by targeting the PAR-1 receptor.
Funding: Deutsche Forschungsgemeinschaft RA 2435/3-1.
OF18.05
Plasma-derived extracellular vesicles from P. vivax patients increase ICAM-1 expression
of human spleen fibroblasts facilitating adherence of infected reticulocytes
Haruka Toda
a, Wanlapa Roobsoongb, Miriam Díaz-Varela1a, Barbara Baroc, Marcus VG Lacerdad, Pilar
Armengole, Jetsumon Sattabongkotb, Carmen Fernandez-Becerraf and Hernando A del Portillog
aISGlobal Institute for Global Health, Hospital Clínic – Universitat de Barcelona,
Barcelona, Spain; bMahidol Vivax Research Unit, Fac. of Tropical Medicine, Mahidol
University, Bangkok, Thailand; cFundaçao de Medicina Tropical Dr. Heitor Vieira Dourado
(FMT-HVD), Manaus, Brazil; dFundaçao de Medicina Tropical Dr. Heitor Vieira Dourado
(FMT-HVD), Manaus, Brazil, and Instituto Leônidas & Maria Deane (ILMD), Fiocruz, Manaus,
Amazonas, Brazil., Manaus, Brazil; eInstitut d’Investigació Germans Trias i Pujol
(IGTP), Badalona/Barcelona, Spain; 6ISGlobal Institute for Global Health, Hospital
Clínic – Universitat de Barcelona, Barcelona, and Institut d’Investigació Germans
Trias i Pujol (IGTP), Badalona/Barcelona, Spain; 7ISGlobal Institute for Global Health,
Hospital Clínic – Universitat de Barcelona, Barcelona, and Institut d’Investigació
Germans Trias i Pujol (IGTP), Badalona/Barcelona, Spain, and Institució Catalana de
Recerca i Estudis Avançats (ICREA), Barcelo, Barcelona, Spain
Introduction: Using a reticulocyte-prone rodent malaria model, resembling P. vivax,
our group demonstrated cytoadherence of infected reticulocytes to spleen blood barrier
cells of fibroblastic origin (Martin-Jaular et al., 2011). Here, as extracellular
vesicles (EVs) play a role in intercellular communication, we hypothesized that plasma-derived
EVs from natural vivax infections (PvEVs) signal human spleen fibroblasts facilitating
adherence of P. vivax, a reticulocyte-prone human malaria parasite.
Methods: Upregulation of ICAM1 and other targeted genes upon uptake of PvEVs in human
spleen fibroblasts (hSF) was determined by qRT-PCR. Expression of ICAM1 was validated
by FACS. NF-kB nuclear translocation analysis was determined by confocal microscopy.
The binding capacity of P. vivax-infected reticulocytes from infections upon uptake
of PvEVs was tested after maturation and purification of frozen estabilates of isolates
from Mae Sot (Thailand). P. vivax-infected reticulocytes were incubated with hSF previously
stimulated with PvEVs, hEVs or PBS, and the number of binding parasites determined
by microscopy.
Results: ICAM-1, a known receptor for binding of malaria, was specifically upregulated
by EVs from infections in a dose-dependent manner at mRNA and protein levels. NF-κ
B was observed both in the cytoplasm and the nucleus on non-stimulated and hEVs-stimulated
hSF, whereas PvEVs stimulation induced nuclear translocation of NF-κ B on hSF. By
comparing the binding of iRBCs to hSF, we last demonstrated significant higher binding
to the cells after uptaken of exosomes from infections.
Summary/Conclusion: These results suggest that circulating exosomes from vivax malaria
infections have spleen-tropism signalling spleen fibroblasts to induce ICAM-1 through
NF-kB and facilitate adherence of infected reticulocytes. Thus, unveiling molecular
insights of cytoadherence in P. vivax infections.
Funding: Funded by Generalitat de Catalunya, Ministerio Español de Economía y Competitividad,
REDiEX, and Fundación Ramón Areces. HT is recipient of an AGAUR PhD fellowship
OF18.06
Oxidative stress alert by extracellular vesicles, in vitro study in ocular drainage
system
Natalie Lernera, Sofia Schreiber-Avissara and Elie Beit-Yannai
b
aClinical biochemistry and Pharmacology department, Ben-Gurion University, Beer-Sheva,
Israel; bBen-Gurion University, Beer-sheva, Israel
Introduction: The ocular drainage system is chronically exposed to oxidative stress
(OS) contributing to cataract and primary open angle glaucoma (POAG) development.
Classical markers of OS were found in patients ocular drainage tissues. The ability
of EVs to deliver OS alert messages between the aqueous humor producing cells named
non pigmented ciliary epithelium (NPCE) end the Trabecular Meshwork (TM) cells draining
the aqueous humor was studied.
Methods: NPCE cells were exposed to OS and their released EVs were collected (Ox-EV).
Non-stressed NPCE derived EVs (N-EV) were used as control. TM cells exposed to the
same OS were treated with Ox-EV or N-EV and non-stressed TM cells were use as control.
The EV treatment effect was measured by Nrf2-Keap1 signaling pathway changes including
Nrf2 expression, related antioxidant gene expression, SOD and Catalase activity and
TM cell antioxidant capacity.
Results: TM cells exposed to OS caused a significant 25% reduction in viability. When
treated with Ox-EV the viability decrease was abolished. This cell rescue effect was
not shown with N-EV treatment. Increase in Nrf2 cytosolic and nucleic expression was
found following TM oxidative stress. Some nucleic but not cytosolic increase was found
when N-EV treatment was done. The most pronounced significant increase cytosolic and
nucleic expression was found following Ox-EV treatment. Antioxidant gene expression
showed a significant increase following Ox-EV treatment in SOD2, GPx, HOX1 and NRF2
an effect that was not archived following N-EV treatment. SOD1 gene expression decreased
following N-EV treatment but did not change when Ox-EV were used. Using the DCF-DA
analytical method for total antioxidant capacity of TM cells we found that OX-EV treatment
resulted in significantly higher antioxidant capacity vs N-EV or untreated TM cells.
The two major antioxidant enzymes, SOD and Catalase activity was significantly higher
following OX-EV treatment.
Summary/Conclusion: EVs are capable of OS alert to other cell resulting in a better
antioxidant capacity. This phenomenon is relevant probably for all cells, can be the
result of EVs cargo modification under OS including proteins and miRNAs or/and oxidized
proteins, lipid and nucleic acids carried by the EVs as cargo or on their surface.
Funding: ISRAEL SCIENCE FOUNDATION (grant No. 1315/ 14).
PF01: EVs Immune System Friday Poster Session Chairs: Wilfrid Boireau; Saara LaitinenLocation:
Level 3, Hall A15:30–16:30
PF01.01
From adults to centenarians: characterization of T cell immunosenescence markers on
plasma extracellular vesicles and their influence on T cell activation, viability
and interleukin secretion
Ainhoa Alberro
a, Iñaki Osorio-Querejetaa, Leire Iparraguirrea, Susana Carregalb, Natalia Elguezabalc,
Itziar Vergaraa, Adolfo López de Munaind, Matías Sáenz-Cuestaa and David Otaeguia
aBiodonostia Health Research Institute, Donostia – San Sebastián, Spain; bCIC biomaGUNE,
Donostia – San Sebastián, Spain; cNeiker Tecnalia, Derio, Spain; dDonostia University
Hospital and Biodonostia Health Research Institute, Donostia – San Sebastián, Spain
Introduction: Aging is a universal, complex and heterogeneous process that leads to
reduced adaptation capacity and increased vulnerability. Two of the hallmarks of aging
are cellular senescence and altered intercellular communication. Specifically, the
dysfunction and accumulation of senescent cells of the immune system is called immunosenescence.
Regarding intercellular communication, the term senescence-associated secretory phenotype
(SASP) is used and while inflammaging has been broadly studied, the role of extracellular
vesicles (EVs) remains unclear. In the present work, we investigated the senescent
features of plasma EVs and their role in T cell activation, viability and interleukin
(IL) secretion.
Methods: All participants (24–104 years) gave informed consent and the study was approved
by the Donostia University Hospital Ethics Committee. PBMCs were isolated with Ficoll-Hypaque
method and EVs by differential centrifugation as described before by our group (Saenz-Cuesta
et al., 2015). T cells were characterized by flow cytometry (FC) (FACSCanto II). Isolated
EVs were detected by cryoEM, NTA and FC. The immunosenescence markers of EVs were
also assessed by FC (CytoFLEX). Coculture experiments of PBMCs and EVs were performed
and activation of T cells was induced by PHA. Cultured cells were evaluated by FC
and the supernatants by Luminex for IL measurement.
Results: Senescent T cells accumulate with age, and CD8 cells are more affected than
CD4 cells. Most of isolated EVs are 100–200 nm. They carry characteristic EV markers
(CD63, CD81, CD9) as well as T cell markers, but no accumulation of EVs with senescent
features was found with age. The co-culture of plasma EVs with PBMCs influences diverse
aspects of T cells. They enhance cell viability. Besides, under PHA stimulation, EVs
influence T cell activation and interleukin secretion. Interestingly, the effect of
plasma EVs is distinct depending on the age of the donor.
Summary/Conclusion: Plasma EVs bear characteristic tetraspanins and T cell markers
and can be detected by FC. However, EVs with senescent features do not accumulate
with age. Moreover, EVs can influence T cell viability activation and IL secretion
in vitro.
Funding: AA, IOQ and LI are supported by a fellowship from the Dept. of Education
of the Basque Government
PF01.02
Profiling tetraspanin expression patterns on the surface of retroviruses and extracellular
vesicles by nanoscale flow cytometry
Vera Tang, Tyler Renner; Anna Fritzsche; Mariam Maltseva and Marc-André Langlois
University of Ottawa, Ottawa, Canada
Introduction: Tetraspanins are membrane-associated proteins with variable functions.
Given that extracellular vesicles (EVs) bud from the membranous structures of the
cell, whether it be at the cell surface or through the endosome, they serendipitously
uptake these membrane-spanning proteins, most notably CD9, CD63 and CD81. Retroviruses
share numerous biophysical and biochemical features with EVs, and especially small
EVs in the 80 – 150nm size range. They also have a membrane-derived envelope that
captures tetraspanins, as they too can egress from the cell surface and from the endosomal
pathway. Here we attempt to distinguish EVs from retroviruses according to their surface
tetraspanin expression profiles.
Methods: Using nanoscale flow cytometry (NFC), we assessed the expression of tetraspanins
CD9, CD63 and CD81 by optimized antibody labelling on different fluorescent retroviruses
including murine leukemia virus (MLV), avian leukosis virus (ALV), and the human immunodeficiency
virus-1 (HIV-1). These retroviruses were engineered to express either eGFP or superfolder
GFP (sfGFP) on their surface as a fusion protein with the viral envelope glycoprotein.
We also analysed endogenous retroviruses released from murine T cell lines EL-4 and
BW5147, and from primary splenocytes from various mouse strains.
Results: Differential levels of CD9, CD63 and CD81 expression was observed among the
retrovirus strains. Also, the type of fluorescent reporter present influenced tetraspanin
capture on the surface of these viruses. Overall, these expression patterns appear
dissimilar to those present on EVs released from uninfected cells. Analysis of murine
T cells lines and primary splenocytes also exhibit release of endogenous retroviruses,
which was confirmed by Western Blot analysis of the p30 capsid protein.
Summary/Conclusion: Taken together, these findings suggest that caution must be exercised
in the use of tetraspanins as identifying markers for EVs as they are also highly
expressed on retroviruses, which are known to be prevalent in most animal species
including birds, mice and humans. Furthermore, mouse studies should control for the
presence of endogenous retroviruses, which may contaminate EV sample preparations.
Funding: Natural Sciences and Engineering Research Council of Canada (NSERC)
PF01.03
Isolation of EVs derived from human oral keratinocytes
Younggap Lim and Bong-Kyu Choi
Department of Oral Microbiology and Immunology, School of Dentistry, Seoul National
University, Jongno-gu, Seoul, Republic of Korea, Seoul, Republic of Korea
Introduction: Oral keratinocytes are the first defense line against external environments
such as chemical agents, microbes and physical factors. Stimulated oral keratinocytes
produce cytokines/chemokines to modulate local inflammatory status. Based on recent
researches, not only cytokines/chemokines but extracellular vesicles (EVs) also regulate
immune response. Therefore, we hypothesized that oral keratinocytes release EVs and
those EVs could modulate immune response in the gingival tissue.
Methods: EVs were isolated from human oral keratinocytes (HOK-16B) by ultracentrifugation
(UC) and commercial EVs isolation kit and analysed by western blotting and Nanoparticle
Tracking Analysis (NTA).
Results: To exclude EVs originated from cell culture medium, we compared three different
keratinocyte culture media, then we chose medium that contained the smallest number
of particles. Two million HOK-16B cells released 10 billion EVs for 24 h. The EVs
expressed general EV markers such as CD9, CD63, Flotillin-1 and Alix. According to
the NTA the EVs were heterogeneous in size.
Summary/Conclusion: HOK-16B cells released EVs that have general EV markers. The EVs
derived from HOK-16B infected with periodontopathogen need to analyse and confirm
the biological function to other cells.
Funding: This work was supported by National Research Foundation of Korea grants (No.
NRF-2018R1A5A2024418 and NRF-2018R1A2A2A05018558).
PF01.04
Air pollution effects on the clinical course of autoimmune diseases: the role of extracellular
vesicles
Mirjam Hoxhaa, Tommaso Schioppob, Simona Iodicea, Laura Pergolia, Nicola Ughib, Luca
Ferraria, Francesca Ingegnolib and Valentina Bollati
a
aUniversity of Milan, Department of Clinical Sciences and Community Health, Milan,
Italy; bDivision of Clinical Rheumatology, G. Pini Hospital, Milano, Italy
Introduction: Autoimmune diseases (ADs) are characterized by the body’s intolerance
to self-antigens. The cause of autoimmunity is still unknown. However, it is generally
accepted that ADs might be triggered by environmental factors able to increase inflammation.
In recent years, extracellular vescicles (EVs) have been described to play an important
role both in ADs pathogenesis and environmental toxicants, such as particulate matter
(PM). The aim of our study is to evaluate PM effects on EV release in ADs.
Methods: We recruited 24 patients with ADs (12 Rheumathoid Arthritis, RA and 12 Systemic
Sclerosis, SSc) and 12 patients with Osteoarthritis (OA), a non-autoimmune inflammatory
disease taken as control. Plasma EVs were analysed by Nanosight and flow cytometry
after labelling with the following markers: CD14+ (monocyte), CD61+ (platelet), CD25+
(T-reg), ERVWE1+ (human endogenous retrovirus W), HLAG+ (human leukocyte antigen G).
PM10 and PM2.5 concentrations at the residency of each subject were obtained from
the regional air quality monitoring network.
Results: The increase of PM2.5 led to a decrease of MVs CD14+ (β = −0.13; p < 0.01)
and CD61+ (β = −0.08; p = 0.05) in RA, of ERVWE1+ in both SSc (β = −0.10; p = 0.01)
and OA (β = −0.09; p = 0.01), and of HLA+ (β = −0.12; p < 0.01) only in SSc. Similar
results were observed analyzing PM10 exposure. Analysis of EVs concentration according
to their dimensions showed a negative association in the size range of exosomes (63–92 nm)
in RA and SSc compared to OA (p < 0.05). Finally, we observed a negative association
between exosomes and C-reactive protein (β = −1.99; p = 0,03), and a positive association
between ERVWE1+ and Erythrocyte Sedimentation Rate (ESR) (β = 0.53; p = 0,06) and
HLA+ and ESR (β = 0.29; p = 0,01).
Summary/Conclusion: Our findings showed that PM exposure could be a further risk factor
of autoimmunity through a modulation of EV release.
PF01.05
The immunomodulatory effects of human umbilical cord perivascular cell-derived extracellular
vesicles on T lymphocyte differentiation
Ching-Po Huang
a, Lianet Lopezb, Daniel Ngb, Ansar Khanb, Peter Szarazc, Denis Gallagherb, Andrée
Gauthier-Fisherb and Clifford Librachd
aCReATe Fertility Centre, Toronto, Ontario, Canada, National Yang Ming University,
Taiwan., Hsinchu City, Taiwan (Republic of China); bCReATe Fertility Centre, Toronto,
ON, Canada; cCReATe Fertility Centre, Toronto, ON, Canada; dCReATe Fertility Centre,
Toronto, ON, Canada. Department of Obstetrics & Gynecology, University of Toronto,
Toronto, Canada. Institute of Medical Sciences, University of Toronto, Toronto, Canada
Introduction: We have characterized human umbilical cord perivascular cells (HUCPVC)
as a promising source of mesenchymal stromal cells (MSC). Our previous data from in
vitro and in vivo models of myocardial infarction and neurovascular injury support
that HUCPVCs have potent immunomodulatory property, and in many cases, are superior
to bone marrow MSCs. The immunomodulatory effects of HUCPVCs are thought to be contributed
by paracrine factors. However, the role of HUCPVCs in immunomodulation is still unknown.
Here, we reveal the immunomodulatory effects of HUCPVC-derived extracellular vesicles
(EV) on T cell differentiation in vitro.
Methods: Conditioned medium (CM) was obtained from sub-confluent first trimester (FTM)
and term HUCPVCs cultured for 48 hrs in serum-free RPMI medium with or without cytokines
(10 ng/mL of IFN-γ, 15 ng/mL of TNF-α). HUCPVC-derived EVs were enriched from CM using
the Qiagen exoEasy Maxi kit, followed by a Vivaspin 100k MWCO buffer exchange. Human
peripheral blood mononuclear cells (PBMC) were isolated by Ficoll gradient with written
informed consent from healthy donors. PBMCs stimulated with anti-CD3/CD28 beads were
co-culture with HUCPVCs or their EVs for five days. T cell differentiation and proliferation
were analyzed by flow cytometry.
Results: HUCPVCs elicited an immunomodulatory effect by increasing the T regulatory
cells/T effector cell (Treg/Teff) ratio in a paracrine manner, which could be partially
impaired by the endosomal pathway inhibitor, GW4869. In the CD4+ population, HUCPVC-derived
EVs promoted both the proliferation of Treg and Teff. Notably, the ratio of proliferating
Treg/proliferating Teff is increased by HUCPVC-derived EVs treatment when compared
to no cell-CM control isolation, which eventually resulted in an increase of Treg/Teff
ratio. In the CD8+ population, administration of HUCPVC-derived EVs significantly
shifted the CD8+ population towards a CD8low population. We found no significant difference
in the effect of EVs derived from inflammatory primed and unprimed HUCPVCs.
Summary/Conclusion: HUCPVC-derived EVs demonstrated immunomodulatory effects by increasing
Treg/Teff ratio in the CD4 T helper cells and shifting the cytotoxic T cell phenotype
towards CD8low. We suggest that HUCPVC-derived EVs represent a promising cell-free
immunomodulatory therapy.
PF01.06
Cytokine and miRNA profiling of plasma extracellular vesicles in individuals with
myalgic encephalomyelitis/chronic fatigue syndrome
Ludovic Giloteaux
a, Adam O’Neala, Jesus Castro-Marrerob, Jennifer Grenierc, Maureen Hansona
aDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, USA; bCFS/ME
Unit, Vall d’Hebron University Hospital Research Institute (VHIR), Universitat Autònoma
de Barcelona, Barcelona, Spain, Barcelona, Spain; cRNA Sequencing Core, Department
of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca,
USA
Introduction: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating
disease of unknown aetiology lasting for 6 months or more, with features including
fatigue, cognitive impairment, myalgias, postexertional malaise, and immune system
dysfunction. Given the possibility that abnormal protein signaling could be altering
cellular function in ME/CFS, we aimed to characterize the cytokine/chemokine profile
and miRNA content of blood-derived Extracellular Vesicles (EVs) in ME/CFS individuals
and healthy controls.
Methods: We included 35 ME/CFS patients and 35 sedentary controls matched for age,
sex and BMI. EVs were enriched from plasma by precipitation and characterized by NTA,
TEM and western blotting. A 43-plex immunoassay was used to determine cytokine/chemokine
concentrations in both plasma and isolated EVs. Total RNA was isolated from EVs and
small RNA libraries were prepared and sequenced for miRNA profiling.
Results: ME/CFS patients had significantly higher levels of EVs than controls and
morphological analysis showed a homogeneous population of vesicles in both groups.
Comparison of cytokine concentrations in plasma and isolated EV for cases and controls
yielded few significant results. Cases had higher plasma levels of MCP-1 and IP-10
and lower levels of RANTES, EGF and GROβ. In isolated EVs, EGF and GROβ were also
significantly lower in patients while concentrations of IL-12p70, IL-2 and GM-CSF
were higher. Correlations analysis revealed that CD40L was a negative driver of TRAIL
and IP-10 in patients but had no inverse associations with other cytokines within
the control group. We also generated on average over 800,000 miRNA-mapped reads per
EV sample. A total of 316 mature miRNAs sequences were detected and no significant
differences between groups after multiple corrections were found. PCA analysis of
all ME/CFS and control miRNAs revealed a separation of the groups based on PC4.
Summary/Conclusion: Higher levels of pro-inflammatory cytokines were found in plasma
and EVs from ME/CFS patients and inter-cytokine correlations revealed unusual regulatory
relationships among cytokines in the ME/CFS group that were not apparent in the control
group. Studies with expanded cohorts are needed to increase power of analysis.
Funding: This project was funded by NIH NIAID R01 AI107762.
PF01.08
Immunomodulatory exosomal signalling mediated by porous templated scaffolds
Thomas Hady, Billanna Hwang and James Bryers
University of Washington, Seattle, USA
Introduction: Porous templated scaffolds (PTS) with pores 40 µm in diameter drive
healing upon implantation by reducing inflammation and foreign body rejection while
increasing local angiogenesis. Macrophage recruitment and polarization are known to
play roles in this phenomenon, but the mechanism driving this healing response is
poorly understood. We believe 40 µm PTS resident immune cells are releasing exosomes
containing unique cargo that modulates healing by influencing CD4+ T cell subsets.
Methods: We quantified the cellular origin and internal composition of exosomes isolated
from explanted 40 µm and 100 µm PTS using a Cre-Lox double transgenic mouse model
and qPCR, respectively. We then quantified the cellular response to these exosomes
in vitro using qPCR, ELISA and cell proliferation assays.
Results: Our evidence shows that immortalized T cells treated with exosomes isolated
from explanted 40 µm PTS significantly down regulate TNF-α expression without other
transcriptomic effects. Moreover, primary co-stimulated (CD3/CD28) T cells treated
with exosomes from macrophages (MØ) resident to 100 µm PTS exhibited broad transcriptional
upregulation and significantly upregulated proportional expression of several pro-inflammatory
genes: TNFα, TBX21, GATA3 and TGF-β1. When treated with exosomes from MØ in 40 µm
PTS, these T cells exhibited no broad transcriptional upregulation but proportionally
upregulated immunomodulatory T cell phenotypic markers FoxP3 and IL-10.
Summary/Conclusion: These data show that exosomal signalling of PTS resident cells
is controlled by pore size, thus influencing T cell differentiation and host response.
Particularly, exosomes from cells in 100 µm PTS proportionally upregulate T cell markers
associated with Th1, Th2 and Th3 T cell subpopulations and transcriptomic stimulation,
whereas exosomes from 40 µm PTS induce a proportional upregulation of T cell markers
associated with immunomodulatory Tregs, without broad transcriptomic stimulation.
Our next experiments will examine the ability of exosomes generated in 40 µm PTS to
recapitulate a healing response in implants known to otherwise promote the foreign
body response.
PF01.09
Extracellular vesicles in systemic sclerosis as potential mediator for pulmonary vascular
disease
Federica Rotaa, Alessandro Albinib, Marco Vicenzib, Rosa Casellab, Santaniello Alessandrob,
Lorenzo Berettab, Jacopo Marianic, Laura Cantonea, Laura Dionia, Valentina Bollatic
and Federico Lombardib
aEPIGET LAB, Department of Clinical Sciences and Community Health, Università degli
Studi di Milano, Milan, Italy; bFondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,
Milan, Italy; cUniversity of Milan, Department of Clinical Sciences and Community
Health, Milan, Italy
Introduction: Pulmonary vascular disease (PVD) is characterized by media muscular
hypertrophy/hyperplasia. Recently, the deregulation of EVs in some forms of pulmonary
hypertension studies has been reported, but data on pulmonary vascular disease are
still lacking. We investigated whether EVs from SSc patients with or without established
PVD can induce hypertrophy and/or hyperplasia in in vitro smooth muscle cells and
to study vesicular miRNAs expression.
Methods: We isolated plasma EVs from: 3 SSc-PAH patients with established PVD under
target therapy [PH+]; 3 SSc patients with high clinical risk without PVD [PH−]; 3
early SSc patients with low clinical risk [Ea]; and 3 healthy control subjects. Smooth
muscle cells were cultured in RPMI complete medium enriched with EVs purified from
each study subject. Real-time cell growth was analysed with xCELLigence RTCA. miRNAs
from both plasma and medium cell EVs were characterized and target prediction was
performed via Diana Tools mirPath 2.0.
Results: Real-time analysis of cellular growth showed a brisker growth in every aliquot
exposed to EVs with respect to the control. The intergroup comparison showed that
EVs from controls induced an inferior growth in terms of cell index and doubling time.
PH− showed the greatest effect on cell growth with respect to Ea and PH+ treated subjects.
The most deregulated miRNA was miR-324-3p which was strongly downregulated in PH−,
weakly downregulated in PH+ and upregulated in Ea. Bioinformatics prediction for 324-3p
showed it to target lipids synthesis and metabolism pathways.
Summary/Conclusion: These results provide evidence that EV content may predispose
to PVD. The observed miRNA is potentially linked with the effect on cellular growth,
suggestive of a role in subjects with high risk to develop PVD. The potential implication
of deregulated miRNAs, especially 324-3p, on lipids metabolism indicates that this
pathway could be involved in the pathogenesis of SSc-PVD.
PF01.10
Extracellular vesicles-associated cytokines in human pathologies
Leonid Margolis
Section of Intercellular Interactions, Eunice Kennedy Shriver National Institute of
Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA
Introduction: Many human diseases progress due to low-level chronic immune activation
associated with the release of cytokines. Recently, we found that many cytokines are
released in association with extracellular vesicles (EVs) rather than in the soluble
form. Here, we investigated these EV-associated cytokines in three human diseases
that are known to be facilitated by improper immune activation.
Methods: Multiplexed bead-based assays of 33 free and EV-associated cytokines in culture
supernatants, platelet poor plasma and amniotic fluid.
Results: HIV disease: Infection of human lymphoid tissue by HIV-1LAI.04 resulted in
the increased release of cytokines of which IL-7, IL-21, IFN-, MIP-1 and RANTES were
selectively increased in EV-associated form. After 13 days of tissue treatment with
combined anti-retroviral therapy (ART) cytokines, in particular, those that were associated
with EVs, remain upregulated in spite of complete suppression of HIV replication.
Cardiovascular disease: Myocardial infarction (STEMI) is associated with increased
production of various cytokines of which IL-2, IL-6, IL-18, Gro-α and MIG were selectively
increased in EV-associated form. Logistic regression analysis of a cohort of 110 individuals
demonstrated that healthy controls and STEMI patients can be discriminated solely
based on the analysis of EV-associated cytokines with 82.3% sensitivity and 85.4%
specificity. Pregnancy complications: Amniotic fluid from pregnancies with intra-amniotic
infection (IAI) demonstrated significantly increased concentrations of almost all
cytokines in EV-associated form, as well as an increase of cytokine fraction released
in EV-associated form.
Summary/Conclusion: The increase of EV-associated cytokines is a common denominator
for diverse human diseases associated with chronic immune activation. For three diverse
human pathologies, we observed increased cytokines packaging in EVs. In HIV infection
EV-associated cytokines failed to return to baseline with ART, increases in STEMI
allow for discrimination from controls, and IAI increases EV-associated cytokines.
EV-associated cytokines may contribute to various disease progressions and can be
developed into diagnostic tools.
Funding: NIH/NICHD Intramural Program.
PF01.11
Isolation and characterization of serum exosomes from Cystic Fibrosis patients receiving
lung transplant
Ruying Chen, Billanna Hwang, Erika D. Lease, Ryan V. Abbaszadeh, James Bryers, Michael
S. Mulligan
University of Washington, Seattle, USA
Introduction: Lung transplantation is an important therapeutic option for Cystic fibrosis
(CF) patients with end-stage lung diseases. Long-term survival has been impaired by
various post-transplant complications. There is a critical need for development of
methods to noninvasively monitor and evaluate patient recovery. Exosomes are the key
mediator of intercellular communication, regulator of immune system and have been
considered a promising candidate for liquid biopsy. Here, we developed imaging flow
cytometry method that enables easy quantification and characterization of the exosomes
surface markers in clinical samples. We profiled circulating exosome in serum isolated
from a cohort of CF lung transplant patients with two macrophage and T cell-associated
panels.
Methods: Serum samples were acquired from 30 CF patients 0, 1, 3, 6 and 12 months
following lung transplantation. Upon isolation, exosomes were labelled with CFSE and
a macrophage (CD68, CD86, CD163) or T cell panel (CD3, CD4, CD8, CD45RO). Flow cytometry
analysis was carried out with Amnis Imagestream X Mark II. Results were analysed with
patients’ clinical indicators including pulmonary function tests (PFTs) and chronic
lung allograft dysfunction (CLAD) diagnosis.
Results: Using optimized staining protocol, exosomes isolated from a wide range of
patient samples were labelled consistently. All seven selected surface markers were
detected on circulating exosomes. Results indicate that markers were selectively expressed
on exosomes and do not follow the classic immune cell subsets. Results indicated that
pan markers (CD68, CD3) expressions were lower than some subset markers, especially
pro-inflammatory CD86. Patients diagnosed with CLAD showed higher percentage of macrophage
surface markers consistently than the ones without CLAD. Additionally, patients not
diagnosed with CLAD demonstrated a higher percentage of CD45RO expressing exosomes
than those with CLAD at 6 months.
Summary/Conclusion: Detection and profiling of macrophage and T cell associated surface
markers on circulating exosomes provide additional insights into patients’ recovery
and immune processes. Imaging flow cytometry-based exosome profiling represents a
novel and promising strategy in CF patients post-transplant follow-up.
Funding: 265-2368 LTR Training Funds Mulligan (PI) 09/01/2010-12/1/2025.
PF01.12
Loss of TP53 modifies the quantity and protein load of extracellular vesicles in leukemic
B-cells
Elena Izquierdo
a, Daniela Vorholtb, Janica Wiedersteinc, Liudmila Lobastovab, Stuart Blakemoreb,
Marcus Krügerc, Hinrich Peter Hasenb, Michael Hallekd and Christian Pallaschb
aDepartment I for Internal Medicine and CECAD, University Hospital of Cologne, Bonn,
Germany; bDepartment I for Internal Medicine and CECAD, University Hospital of Cologne,
Köln, Germany; cGermany Institute for Genetics and CECAD, Köln, Germany; dDepartment
I of Internal Medicine, University Hospital of Cologne, Center for Integrated Oncology
Cologne-Bonn, CECAD Center of Excellence on “Cellular Stress Responses in Aging-Associated
Diseases”,Center for Molecular Medicine Cologne, University, Köln, Germany
Introduction: Macrophages are key effector cells of the chemo-immunotherapy (CIT)
response in B-cell malignances. We have previously shown that loss of TP53 in leukemic
B-cells diminishes the anti-tumour capacity of macrophages upon CIT. Here, we investigated
the potential p53-dependent mechanisms in leukemic B-cells that could alter the phagocytic
capacity of macrophages upon CIT.
Methods: The proteomic profile of control and TP53-deficient leukemic B-cells, untreated
or treated with mafosfamide, was analysed by mass spectrometry. EVs were isolated
from control and TP53-deficient leukemic B cells by differential ultracentrifugation
and their proteomic content was evaluated by mass spectrometry. Validation of protein
expression was performed by Western Blot and flow cytometry. The measurements of exosomes
concentration and size distribution were performed by NanoSight NS300 and ZetaView.
Results: 244 of 5785 proteins were observed to be significantly different between
TP53-deficient and control leukemic B-cells, with 159 independent of mafosfamide treatment,
147 associated to mafosfamide and 86 modifications shared between DMSO and mafosfamide
treatment. Enrichment analysis for GO terms showed that TP53-deficient leukemic B-cells
exhibited mainly altered expression of proteins associated with EVs. We confirmed
that TP53-deficient leukemic B-cells produced higher concentration of EVs and that
the EV-protein content differed from control leukemic B-cells. Notably, 1239 of 2663
proteins were significantly different between TP53-deficient and control leukemic
B-cells, 68 were exclusively detected in the control-derived EVs and 128 proteins
were only found in the TP53-deficient-related EVs
Summary/Conclusion: The loss of TP53 drastically modifies the proteomic profile of
leukemic B-cells and influences the protein expression of leukemic B-cells upon mafosfamide
treatment. Especially, the loss of TP53 regulates the EV-related protein expression
and EV production in leukemic B-cells
PF02: EVS in the Central and Peripheral Nervous System Chairs: Sowmya Yelamanchili;
Elena BatrakovaLocation: Level 3, Hall A15:30–16:30
PF02.01
The effect of exosome purification method on the detection of amyloid β in exosomes
with Photooxidation-Induced Fluorescence Amplification (PIFA)
Youhee Heo
a, Min Cheol Parkb, SangYun Kimc, Kwanwoo Shind and Ji Yoon Kange
aKorea Institute of Sceince and Technology, Seoul, Republic of Korea; bIntekBio, seoul,
Republic of Korea; cSeoul national university bundang hospital, seoul, Republic of
Korea; dsogang university, soeul, Republic of Korea; eKorea Institute of Science and
Technology, Seoul, Republic of Korea
Introduction: Blood-based diagnosis of disease using exosomes sometimes demands a
highly sensitive bioassay to detect rare protein biomarkers. New assay methods were
suggested to overcome the limitations of a conventional ELISA system such as digital
ELISA or plasmonic ELISA. However, these methods need a special expensive equipment
with the long process. We have developed a photo-oxidation-induced fluorescence amplification
(PIFA) that can measure less than 1 pg/mL by continuous irradiation on resorufin for
the photooxidation of chemi-fluorescent substrate amplex red. This paper demonstrated
it can identify Alzheimer’s disease (AD) patient from normal control (NC) by measuring
a low level of amyloid beta(Aβ) in the neuronal exosome from plasma samples.
Methods: The level of resorufin was measured by PIFA to compare with conventional
ELISA. The oligomer Aβ was detected by same antibody system whose capture antibody
is same as detection antibody to exclude the signals from monomer Aβ. We isolated
exosomes from plasma samples (AD:4, NC:4) by three methods: ultracentrifuge(UC), CD9
antibody-coated magnetic beads (MB) and ExoQuick with agarose precipitation (EQ).
Exosomes were lysed with RIPA buffer and Aβ as a cargo protein in exosomes were measured
by PIFA. ELISA was performed by an automated machine using polypropylene tip. After
removing the tip with HRP-tagged detection antibody, the fluorescence was measured
continuously to amplify the fluorescence.
Results: The LOD of PIFA in measuring oligomer Aβ was less than 100 fg/mL that was
lower than 2 orders of magnitude than commercialized ELISA kit. The dynamic range
of PIFA assay is more than 5 decades. The volume of plasma sample was 150 uL and the
final volume of exosome was almost the same. The concentrations of UC and EQ are 8.16 × 10^10
and 5.77 × 10^10 particles/mL. The AUC (area under curve) in identifying AD was 1.0,
1.0, and 0.875 by UC, MB and EQ, respectively. The result showed it could clearly
identify AD from NC.
Summary/Conclusion: Exosome isolations using the magnetic beads, the exosomes can
be extracted even in a small amount of less than 50 μl. Therefore, it is advantageous
that the sample is used less and the exosome can be isolated quickly. We believe that
the reliability of human samples will be improved by an additional number of testing
samples and optimization of PIFA assay.
PF02.02
Bioinformatic and biochemical evidence for extracellular vesicle remodelling in Huntington’s
disease
Francesca Farinaa, françois-Xavier Lejeuneb, Satish Sasidharan Nairb, Frédéric Parmentierb,
Jessica Voisinb, Lorena Martin-Jaularc, Clotilde Theryc and Christian Neri
b
aSorbonnes Université, Centre National de la Recherche Scientifique, Research Unit
Biology of Adaptation and Aging, Team Brain-C, Paris, France; bSorbonnes Université,
Centre National de la Recherche Scientifique, Research Unit Biology of Adaptation
and Aging, Team Brain-C, Paris, France; cInstitue Curie, Paris, France
Introduction: Intercellular communication mediated by extracellular vesicles (EV)
is emerging as a mechanism that is important to neuronal development and survival.
Here, we investigated the features of EV signalling in response to Huntington’s disease
(HD), a neurodegenerative disease that is caused by CAG expansion in the Huntingtin
gene and that shows a significant degree of clinical heterogeneity.
Methods: We applied an integrated approach in which we combined bioinformatic analysis
of public HD datasets and biological analysis in cellular models of HD pathogenesis.
Results: Using network methods to integrate high-dimensional HD transcriptomic data,
we built a computational model of the transition between different phases of the HD
process: from cell differentiation (early phase) to dysfunctional striatum (intermediate
phase) and finally advanced neurodegeneration (late phase). This model evidenced the
deregulation of a set of genes associated with the biology of EVs from the earliest
to latest phases of the disease. To test this hypothesis experimentally, we analysed
EVs in mouse and human neuronal cell models of HD pathogenesis. To this end, we analysed
different EV subtypes, testing for changes in secreted level and protein cargo composition.
The results suggest that EV subtypes, especially small EVs, possibly including exosomes,
may be altered in these cells.
Summary/Conclusion: Collectively, these data point to EV remodelling in the course
of HD. Biological and clinical implications will be discussed.
Funding: ANR, France
PF02.03
HIV-1 Tat-induced astrocytic extracellular vesicle miR-7 impairs synaptic architecture
Guoku Hu, Fang Niu, Ke Liao and Shilpa Buch
University of Nebraska Medical Center, Omaha, USA
Introduction: Although combination antiretroviral therapy (cART) has improved the
health of millions of those living with HIV, the penetration into the CNS of many
such therapies is limited, thereby resulting in residual neurocognitive impairment,
commonly referred to as NeuroHIV. Additionally, although cART can successfully suppress
peripheral viremia, there is a continuous persistence of the cytotoxic viral Transactivator
of transcription (Tat) protein in tissues such as the brain, thereby contributing
to neuronal injury.
Methods: Transmission electron microscopy, NanoSight and western blot analyses were
used to characterize astrocyte-derived EVs (ADEVs). Among the various dysregulated
miRs in the ADEV cargo, miR-7 levels were found to be upregulated by real-time PCR.
Uptake of ADEVs by neurons was assessed by confocal microscopy. Rodent hippocampal
neurons were exposed to Tat-ADEVs and assessed for inhibitory (GAD65 and gephyrin)
and excitatory (vGlut1 and PSD95) synapses by immunostaining and confocal microscopy.
Results: Expression level of miR-7 was upregulated in the astrocytes from SIV+/HIV+
brains. In addition, Tat-stimulated astrocytes also demonstrated upregulated expression
and release of miR-7 in the EVs, that were taken up by neurons, resulting in synaptic
injury. Furthermore, our results also demonstrated that exposure of hippocampal neurons
to Tat-ADEVs resulted in decreased expression of neuronal NLGN2, which in turn, led
to loss of both excitatory and inhibitory synaptic densities. Moreover, we also demonstrated
a neuroprotective role of PDGF-CC in rescuing Tat-ADEV-mediated synaptic loss.
Summary/Conclusion: We demonstrate that exposure of astrocytes to HIV protein Tat
mediates the induction and release of EV-miR-7 that is taken up by neurons, leading
in turn, to downregulation of neuronal NLGN2 and ensuing synaptic alterations. Importantly,
synaptic impairment could be reversed by pretreatment of neurons with a neurotropic
factor PDGF-CC.
Funding: This work was supported by grants DA040397, MH112848 (S.B.) and DA042704,
DA046831 (G.H.) from the National Institutes of Health. The support by Nebraska Center
for Substance Abuse Research is acknowledged.
PF02.04
The pericytes-derived extracellular vesicle-mimetic nanovesicles rescues erectile
function by enchancing penile neurovascular regeneration in a mouse model of cavernous
nerve injury.
Jiyeon Ocka, Guonan Yin
b, Mi-Hye Kwona, Kang-Moon Songa, Kalyan Ghataka, Nguyen Nhat Minha, Min-Ji Choic,
Yong Song Ghod, Ji-Kan Ryua and Jun-Kyu Suha
aNational Research Center for Sexual Medicine and Department of Urology, Inha University
School of Medicine, incheon, Republic of Korea; bNational Research Center for Sexual
Medicine and Department of Urology, Inha University School of Medicine, Incheon, Republic
of Korea; cinha university urology, incheon, Republic of Korea; dDepartment of Life
Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea
Introduction: Extracellular vesicles (EVs) contains various proteins, mRNA and miRNA,
that have many regulatory effects on recipient cells. However, most mammalian cells
release low quantities of EVs, therefore, we use bioengineered method and extract
extracellular vesicle-mimetic nanovesicles from mouse cavernous pericyte. The aim
of this study was to investigate effectiveness of pericytes-derived extracellular
vesicle-mimetic nanovesicles (PC-NVs) in restoring erectile function in cavernous
nerve injury (CNI) mice.
Methods: Twelve-week-old C57BL/6J mice were used and divided into into groups (N = 5
per group): sham operation group and bilateral cavernous nerve crushing group receiving
a single intracavernous injection of PBS (20 µl) or PC-NVs (0.1 µg, 1 µg, 5 µg/20 µl,
respectively). One week later, erectile function was measured by electrical stimulation
of the cavernous nerve (N = 5 per group). The penis was then harvested and stained
with antibodies to CD31, NG2 and βIII tubulin. We also determined the neurotrophic
and angiogenic potential of PC-NVs in an ex vivo major pelvic ganglion (MPG) culture
experiment.
Results: The PC-NVs was extract and characterized by several EVs markers, such as
CD63, CD81 and TSG101. Intracavernous injections of PC-NVs significantly improved
erectile function in CNI mice, which reached up to 84% of control values. PC-NVs induced
significant restoration of cavernous contents of endothelial cells, pericytes, and
neuronal cells in CNI condition. Moreover, PC-NVs promoted major pelvic ganglion neurite
sprouting in ex vivo culture experiment.
Summary/Conclusion: In light of critical role of neuropathy in the pathogenesis of
radical prostatectomy-induced ED, pericytes-derived extracellular vesicle-mimetic
nanovesicles successfully restored erectile function in cavernous nerve injury mice.
Further studies are needed to clarify mechanism by which PC-NVs induces neuropathy
repair.
Funding: This work was supported by the National Research Foundation of Korea (NRF)
grant funded by the Korea government (MSIP) (Guo Nan Yin, 2018R1C1B6003829).
PF02.05
Neuronal EVs and microglial activation in hypoxia
Yvonne Couch and Kate Lambertsen
University of Oxford, Oxford, UK
Introduction: There is significant data suggesting that EVs play a key role in CNS
injuries such as stroke. During these types of injury the penumbral tissue around
the core of the injured area is hypoxic and inflammatory. Here, we aimed to test the
hypothesis that hypoxia affects EV production in cells of the neurovascular unit.
Methods: Using endothelial cells, microglia and neurons, we subjected cells to short
periods of oxygen and glucose deprivation (OGD) measuring both the EVs released into
the medium, and the downstream effects of these EVs on cells.
Results: Brain-derived endothelial cells (b.END3) and microglia (BV-2) do not produce
significant numbers of EVs in response to hypoxia. However, N2A neuronal cells do,
both under normal and differentiated conditions. These EVs appear to be pro-inflammatory
when applied to microglia in culture.
Summary/Conclusion: Together, these data suggest that EVs produce pro-inflammatory
EVs during periods of hypoxia, capable of activating microglia. Characterizing these
neuronal EVs more fully may enable us to determine whether they are also able to escape
the CNS during brain injury and activate peripheral macrophage populations.
Funding: MRF University of Oxford, Rose Trees Trust
PF02.06
Comprehensive study of vesicular and non-vesicular-associated miRNAs from a volume
of cerebrospinal fluid compatible with the clinical practice
Endika Prieto Fernándeza, Ana Maria Aransayb, Felix Royoc, Esperanza Gonzalezc, Juan
Jose Lozanod, Borja Santos-Zorrozuae, Nuria Macias-Camarab, Monika Gonzalezb, Raquel
Perez Garayf, Javier Benitog, Africa Garcia-Orada and Juan Manuel Falcon-Perez
c
aDepartment of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine
and Nursery, University of The Basque Country (UPV/EHU), Leioa, Spain; bGenome Analysis
Platform, CIC bioGUNE, Derio, Spain; cExosomes Lab, CIC bioGUNE, CIBERehd, Derio,
Spain; dBioinformatics Unit, Centre Esther Koplovitz (CEK), CIBERehd, Barcelona, Spain;
eDepartment of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine
and Nursery, University of The Basque Country (UPV/EHU), Leioa, Spain; fBiochemistry
service, Cruces University Hospital, Barakaldo, Spain; gDepartment of Pediatric Emergency,
Cruces University Hospital, Barakaldo, Spain
Introduction: Cerebrospinal fluid (CSF) miRNAs have emerged as a potential low invasive
diagnostic tool for central nervous system malignancies. However, they have not yet
been implemented in the clinic since there is no a reliable and simple method established
to analyse the limited amount of CSF obtained from patients, especially from infants.
Methods: We have compared six existing protocols for characterizing miRNAs from a
clinically rational volume (i.e. 200 µl) of CSF. Four of the methods incorporated
an extracellular vesicles (EVs) enrichment step and the other two aimed to extract
miRNAs directly from cleared CSF. The efficiency of each method was assessed by real-time
PCR (qPCR) and smallRNA sequencing (smallRNAseq). Additionally, by size-exclusion
chromatography, we determined the distribution of miRNAs among different CSF components.
Results: We found that NOR and INV protocols were the most efficient. According to
our results, NOR was very reproducible by qPCR, showed a good miRNA levels correlation
between techniques, and presented a user-friendly protocol starting from low volumes
of CSF. In addition, we identified a set of microRNAs enriched in CSF exosomes that
are involved in neurodevelopmental pathways.
Summary/Conclusion: We found that different protocols purify specific miRNAs subpopulations
and CSF exosomes isolated by size-exclusion chromatography contain miRNAs involved
in neurodevelopment.
Funding: This work was supported by the Basque Government [IT989-16]; the Spanish
Ministry of Economy and Competitiveness MINECO (SAF2015-66312), and the Ramon Areces
Foundation (FRA-17-JMF). We also thank MINECO for the REDIEX (Spanish Excellence Network
in Exosomes) and the Severo Ochoa Excellence Accreditation (SEV-2016-0644).
PF02.07
Identifying plasma-derived extracellular vesicle (EV) contained biomarkers in the
development of chronic neuropathic pain
Natasha Sosanya
a, Raina Kumarb, John Cliffordc, Roger Chavezd, George Dimitrove, Seshamalini Srinivasanf,
Aarti Gautamg, Alex Trevinoa, Rasha Hammamiehh, Bopaiah Cheppudirai, Robert Christya,
Stephen Crimminsj
aUSAISR, San Antonio, USA; bUSACEHR/FNLCR, Fort Detrick, USA; cUS Army Center for
Environmental Health Research, Frederick, USA; dCo-Author, Floresville, USA; eUSCEHR;
FNLCR, Fort Detrick, USA; fUS Army Medical Research and Materiel Command, USACEHR,
Frederick, USA; gUS Army Center For Environmental Health Research, Frederick, USA;
hUSACEHR, Frederick, USA; iUS Army Institute of Surgical Research, San Antonio, USA;
jUS Army Institute of Surgical Research, San Antonio, USA
Introduction: Over 100 million Americans suffer from chronic pain. However, research
into potentially novel biomarkers and therapeutics for chronic pain is lacking. microRNAs
(miRNAs) are attractive candidates as biomarkers due to their conservation across
species, stability in liquid biopsies, and variation that corresponds to a pathologic
state. miRNAs can be sorted into extracellular vesicles (EVs) within the cell and
released from the site of injury. EVs transfer cargo molecules between cells thus
affecting key intercellular signalling pathways. The focus of this study was to determine
the plasma-derived EV miRNA content in a chronic neuropathic pain model.
Methods: Male Sprague-Dawley rats underwent either spinal nerve ligation (SNL; n = 6)
or sham (n = 6) surgery, while under anaesthesia. Mechanical allodynia (MA) was assessed
and plasma-derived EV RNA was isolated at baseline and days 3 and 15 post-injury followed
by small RNA sequencing. Differentially expressed (DE) miRNAs and gene target enrichment/signalling
pathways analysis was performed using R packages and TargetScan/IPA, respectively.
Results: SNL rats displayed a time-dependent increase in MA from day 3 to day 15 post-injury.
Our results indicate that 22 miRNAs at day 3, 74 miRNAs on day 15, and 33 miRNAs at
both day 3 and 15 were uniquely differentially expressed between the SNL and sham
groups. The plasma-derived DE EV miRNAs were also found to regulate processes important
in the development and maintenance of neuropathic pain states.
Summary/Conclusion: The key findings from this proposal include (1) the majority of
the DE EV miRNAs, which normally function to suppress inflammation, were downregulated,
and (2) twenty-one of the plasma-derived DE EV miRNAs reflect previously observed
changes in the injured L5 nerve. This suggests that the plasma-derived EVs can potentially
serve as key regulators, biomarkers and targets in the progression and treatment of
neuropathic pain.
Funding: This research was supported by Congressionally Directed Medical Research
Programs-Applied Pain Research (MR157005C). Research was conducted in compliance with
the Animal Welfare Act, and all other Federal requirements. The views expressed are
those of the authors and do not constitute endorsement by the U.S. Army.
PF02.08
A pilot study to evaluate serum miRNA from extracellular vesicles of neural origin
for insight into neurological disorders
Michelle M. Barnett
a, Michael Geaghana, Ebrahim Mahmoudia, Judith Weidenhoferb and Murray Cairnsc
aUniversity of Newcastle, Australia, Callaghan, Australia; bUniversity of Newcastle,
Australia, Ourimbah, Australia; cUniversity of Newcastle, Callaghan, Australia
Introduction: miRNA are important regulators of gene expression and can be informative
biomarkers of disease state. Alteration of miRNA expression in the brain has been
observed in several neurological and psychiatric disorders postmortem, but they are
almost impossible to non-invasively biopsy. These molecules, however, have been observed
in serum and serum vesicles and have application as trait biomarkers. While it is
possible that brain disorders also have systemic changes that contribute to the serum
profile it is reasonable to suspect that extracellular vesicles (EV) that originated
in the brain would have more specificity and relevance to the neuropathology. In this
pilot study we investigated strategies for capturing and profiling the miRNA content
from extracellular vesicles derived from the brain using an immunoaffinity approach.
Methods: Whole blood from a healthy male volunteer was collected in serum separator
tubes, immediately processed and stored at −80°C. Antibody-coupled magnetic beads
were incubated with serum and cell culture EV. Enriched and non-enriched fractions
were recovered using a commercial spin column kit for EV purification and RNA extraction.
Small RNA libraries were prepared for 75 cycles of single end multiplex sequencing.
Raw reads were converted to fastq, adaptors trimmed, reads mapped, aligned and counted.
Results: miRNA were identified in both total human serum and the neural fractions.
Functional annotation of the 37 miRNA present in the neural EV revealed that neuron
projection was the most enriched cellular component in predicted targets, suggesting
that they may serve to augment the synaptic regulatory environment. In support of
this hypothesis, we found over representation of all four cytoplasmic polyadenylation
element binding proteins (CPEB1-4) among targets predicted to be regulated by the
most abundant miRNA. CPEB proteins affect translation of mRNA bearing polyadenylation
element sequences and alterations in the expression of these proteins have been associated
with synaptic plasticity, intellectual disability and autism spectrum disorder.
Summary/Conclusion: Serum EV can be enriched for those of neuronal origin and this
strategy may provide insight into the brain’s regulatory environment and ultimately
more sensitive biomarkers of neurological and psychiatric disorders.
PF03: EVs Cancer Metastasis Chairs: Ryou-u Takahashi; Irina NazarenkoLocation: Level
3, Hall A15:30–16:30
PF03.01
Promotion of metastasis via alteration of vascular endothelium by tumour exosome miRNA
Masahiro Morimoto
a, Nako Maishia, Aya Matsudaa, Tetsuya Kitamuraa, Fumihiro Higashinoa, Yoshimasa Kitagawab,
Yasuhiro Hidac and Kyoko Hidaa
aVascular Biology and Molecular Pathology, Hokkaido University Graduate School of
Dental Medicine, Sapporo, Japan; bOral Diagnosis and Medicine, Hokkaido University
Graduate School of Dental Medicine, Sapporo, Japan; cCardiovascular and Thoracic Surgery,
Hokkaido University Graduate School of Medicine, Sapporo, Japan
Introduction: We have reported that tumour endothelial cells acquire diversity by
cancer secreting factors. Cancer cells secrete exosomes to create a suitable environment
for themselves. miRNA (miR) is transported by exosome from cell to cell. We have identified
miR-1246 that is more abundant in high metastatic melanoma (A375SM) exosomes compared
with in low metastatic melanoma (A375) exosomes by miRNA array analysis. In this study,
we investigated the role of miR-1246 in alteration of the character of endothelial
cells (ECs). In addition, we addressed the mechanism of cancer metastasis induced
by miR-1246.
Methods: We focused on the adhesion between ECs and between cancer cells and ECs.
Changes in adhesion molecule expression and endothelial permeability were examined.
We analysed the effect of the administration of A375SM exosome and miR-1246 knockdown
on lung metastasis in vivo. In addition, exosome miR-1246 levels in blood of melanoma
and oral cancer patients were compared with healthy subjects.
Results: miR-1246 transfection in ECs increased the expression of adhesion molecule,
ICAM-1 via activation of STAT3, and increased the number of adherent cancer cells
to ECs. Furthremore, A375SM exosome treatment enhanced endothelial permeability. Also,
the expression of VE-Cadherin, which is intracellular adhesion molecule of EC and
function as EC barrier, was downregulated by miR-1246 transfection. The target gene
prediction database and reporter assay showed that VE-Cadherin is the target gene
of miR-1246. Intravenous administration of A375SM exosome-induced cancer cell colonization
in the lung, resulting in establish of lung metastasis. In contrast, miR-1246 knockdown
in A375SM caused in decrease of lung metastasis in vivo model. Exosome miR-1246 levels
in blood of melanoma and oral cancer patients were significantly higher than those
in healthy subjects.
Summary/Conclusion: Thus, it was suggested that miR-1246 in tumour-derived exosomes
promotes lung metastasis by inducing the adhesion of cancer cells to ECs and destroying
the EC barrier.
PF03.02
Patient-derived circulating exosomes enhance cancer and stemness properties through
polymeric immunoglobulin receptor in liver cancer
Sze Keong Tey and Judy Yam
The University of Hong Kong, Hong Kong, Hong Kong
Introduction: Hepatocellular carcinoma (HCC) is a primary malignancy of liver which
often diagnosed at an advanced stage accompanied by extrahepatic metastasis. Emerging
evidences have demonstrated cancer cells derived exosomes play an important role in
intercellular communication in tumour microenvironment during metastasis. Thus, exosome
research may solve the mystery of metastatic organotropism in HCC.
Methods: Exosomes were isolated from HCC patients. The biological effects of exosomes
were studied using transwell and matrigel invasion assays. The in vivo effect of exosomes
were analysed in mice by intravenous injection of exosomes together with hepatoma
cells. The in vivo lung pulmonary vasculature and vascular leakiness were revealed
by FITC-lectin stain and presence of Texas Red-dextran, respectively. Stem-like properties
were examined by spheroid assay and flow cytometry. Proteomic profiling and expression
level of exosomal proteins were analysed by mass spectrometry and enzyme-linked immunosorbent
assay (ELISA), respectively.
Results: We recruited representative individuals of different stages of HCC development
for the collection of circulating exosomes, namely, exosomes of healthy individual
(Normal-Exo), patient with cirrhosis (Cirrhosis-Exo), HCC patients at early stage
(E-HCC-Exo) and late stage with distant metastasis to lungs (L-HCC-Exo). Among these
exosomes, L-HCC-Exo exhibited the highest effect in promoting HCC cell migration and
invasion in vitro and colonization of hepatoma cells in lungs. L-HCC-Exo also modulated
tumour microenvironment by enhancing pulmonary vascular permeability. Along with cancerous
behaviours, L-HCC-Exo induced stem-like properties such as increased self-renewal,
expressions of hepatic CSC markers and drug resistance. Elevated level and activity
of β-catenin were also detected in cells stimulated by L-HCC-Exo. Proteomic profiling
of exosomal proteins identified polymeric immunoglobulin receptor (pIgR) to be markedly
upregulated in L-HCC-Exo when compared with exosomes of other subjects.
Summary/Conclusion: HCC patient-derived circulating exosomes augment cancer and stemness
properties through the activation of β-catenin signalling by exo-pIgR, leading to
a more aggressive phenotype in HCC tumourigenesis and metastasis.
PF03.03
Ectopic ATP synthase induces extracellular vesicle release for cell-to-cell communications
Yi-Chun Kaoa, Nai-Wen Changb, Yi-Wen Changa, Charles P. Laic, Hsuan-Cheng Huangd and
Hsueh-Fen Juan
e
aDepartment of Life Science, National Taiwan University, Taipei, Taiwan (Republic
of China); bInstitute of Molecular and Cellular Biology, National Taiwan University,
Taipei, Taiwan (Republic of China); cInstitute of Atomic and Molecular Sciences, Academia
Sinica, Taipei, Taiwan (Republic of China); dInstitute of Biomedical Informatics,
National Yang-Ming University, Taipei, Taiwan (Republic of China); eNational Taiwan
University, Taipei, Taiwan (Republic of China)
Introduction: Ectopic Adenosine triphosphate synthase (eATP synthase) is defined as
ATP synthase located on cell surface instead of inner membrane of mitochondria. Our
previous studies showed eATP synthase located on lung cancer cell surface and generated
ATP to extracellular space. Recently, several reports indicated that the subunits
of ATP synthase were identified in extracellular vesicles (EVs) using proteomics approach.
However, where does ATP synthase in EVs come from and what are the functions of it
are still unclear. We proposed the hypothesis: ATP synthase in EVs may be conveyed
from cell surface for cell-to-cell communications.
Methods: Here we used immunochemistry to detect eATP synthases and serial high-speed
centrifugation to isolate EVs including apoptotic bodies, microvesicles and exosomes
which were further confirmed by transmission electron microscopy (TEM) and nano tracking
analysis (NTA). Furthermore, we used quantitative proteomics by dimethyl labelling
to profile the proteomes in extracellular vesicles, and dot blot analysis to elucidate
whether ATP synthase was localized on the EV membrane.
Results: We identified 892, 311 and 331 proteins including ATP synthase subunits in
apoptotic bodies, microvesicles and exosomes, respectively. We further confirmed that
ATP synthase was indeed localized on EV membrane. Additionally, we observed the release
of these three subtypes of EVs was decreased after starvation stress and an eATP synthase
inhibitor citreoviridin treatment. However, we did not measure the significantly different
ATP production between control and citreoviridin treatment in apoptotic bodies, microvesicles
and exosomes, indicating that ATP synthase on the EVs may not be for ATP synthesis.
We observed that eATP synthase was transferred from cancer cells to normal cells via
EVs, indicating eATP synthase plays an important role for cell-to-cell communications
and eventually promotes cancer metastasis.
Summary/Conclusion: Our findings suggest that ATP synthase indeed exists on the membrane
of EVs and enhances cancer cells to release EVs for cell-to-cell communications.
Funding: Ministry of Science and Technology (MOST 106-2320-B-002-053-MY3) and National
Health Research Institutes. (NHRI-EX107-10709BI) in Taiwan.
PF03.04
Anesthesia-dependent changes in vesicular miRNA profiles during colorectal cancer
surgery
Dominik Buschmann
a, Anja Lindemannb, Florian Brandesc, Gustav Schellingc, Michael Pfaffld and Marlene
Reithmaire
aTUM School of Life Sciences Weihenstephan, Division of Animal Physiology and Immunology,
Freising, Germany; bInstitute of Human Genetics, University Hospital, LMU Munich,
Germany, Munich, Germany; cDepartment of Anesthesiology, University Hospital, Ludwig-Maximilians-University
Munich, Germany, München, Germany; dAnimal Physiology and Immunology, School of Life
Sciences Weihenstephan, Technical University of Munich, Freising, Germany, Freising,
Germany; eInstitute of Human Genetics, University Hospital, Ludwig-Maximilians-University
Munich, Germany, München, Germany
Introduction: Colorectal cancer (CRC) is one of the most common and most deadly cancer
types worldwide, leading to 50,000 annual deaths in the US alone. Even though surgical
resection presents the best chance of survival for CRC patients, accumulating evidence
demonstrates that removal of primary tumours can foster disease progression and metastasis.
Recent outcome-based studies described differential effects of the type of anaesthesia
used during CRC surgery on metastasis as well as overall and recurrence-free survival.
As mechanistic data on how anaesthesia impacts cancer progression are sparse, we assessed
the potential involvement of extracellular vesicles (EVs) in the process.
Methods: Serum was sampled from 18 CRC resection patients before induction of anaesthesia
(pre) using propofol (n = 8) or sevoflurane (n = 10) and after surgery (post). EVs
were precipitated from 1 ml serum, and associated microRNAs (miRNAs) were profiled
by Next-Generation Sequencing. The anaesthesia-dependent impact on miRNA profiles
in paired EV samples was assessed using DESeq2. Next, we performed pathway analyses
based on differentially regulated miRNAs. Additionally, deregulated candidates selected
from NGS data were validated by RT-qPCR.
Results: NGS-based profiling of EVs resulted in 3.79E6 ± 1.58E6 (propofol pre), 3.09E6 ± 1.81E6
(propofol post), 3.40E6 ± 1.65E6 (sevoflurane pre) and 3.34E6 ± 1.32E6 (sevoflurane
post) mean miRNA reads per sample. As evidenced by Principal Component Analysis, samples
from pre- and post-operative sera clustered into distinct groups for both types of
anaesthesia. Differential expression analysis revealed 64 and 44 miRNAs significantly
regulated by propofol and sevoflurane, respectively. Despite substantial overlap in
the intraoperative miRNA changes, a set of 31 (propofol) and 11 (sevoflurane) miRNAs
specifically responsive to either drug was also identified. In silico analyses indicated
a differential effect of anaesthesia-responsive miRNAs on cancer-relevant pathways
such as proliferation, apoptosis and migration.
Summary/Conclusion: Previous studies have demonstrated distinctive effects of propofol
and sevoflurane on tumour cells, host immunity and survival in CRC. Anaesthesia-induced
changes in circulating miRNAs might mediate disease progression and impact post-surgical
outcome.
PF03.05
The role of hypoxia-derived exosomes in determining Neuroblastoma dissemination and
aggressiveness
Pina Fusco
a, Maria Rosaria Espositob, Giulia Borilec, Marcello Manfredid, Emilio Marengod and
Elisa Cimettaa
aDepartment of Industrial Engineering (DII), Padova University – Fondazione Istituto
di Ricerca Pediatrica Città della Speranza (IRP), Padova, Italy; bDepartment of Industrial
Engineering (DII), Padova University – Fondazione Istituto di Ricerca Pediatrica Città
della Speranza (IRP), Padova, Italy; cUniversity of Padova, Department of Physics
and Astronomy, Padova, Italy; dUniversity of Piemonte Orientale, Department of Science
and Technological Innovation, Alessandria, Italy
Introduction: Neuroblastoma (NB) is a heterogeneous paediatric malignancy of the sympathetic
nervous system accounting for up to 10% of childhood cancers with a strong tendency
to metastasize. Hypoxia is a key feature of solid tumours and is specifically known
to (i) favour NB metastasis and dedifferentiation towards immature stem cell-like
phenotypes and to (ii) stimulate release of exosomes (EXO), facilitating intercellular
communication at distant sites. In this study, we characterized the proteomic and
miRNAs cargo of EXO isolated from NB cell lines cultured at different oxygen concentrations
to identify an exosomal signature associated with NB metastatic dissemination.
Methods: SKNAS and SKNDZ NB cell lines were cultured for 48 h in standard (20% O2)
and hypoxic (1.5% O2) conditions. EXO were purified from the media using Ultra spin
tubes 100K MWCO and characterized by scanning electron microscopy (SEM) and qNANO.
Proteome and miRNA cargo profiles were analysed by quantitative mass spectrometry
and FirePlex Discovery Panel (on 405 miRNAs), respectively, and surface markers were
evaluated using MACSplex technology.
Results: SEM and qNANO size distribution analysis gave populations of round particles
within the expected diameters (50–120 nm). Surface markers analysis revealed that
NB hypoxia-derived EXO express an increase of proteins associated with angiogenesis,
adhesion, stemness and immune function such as CD105, CD29, CD49e, SSEA4, HLA-DR and
HLA-ABC. We characterized the proteomic cargo of EXO isolated from cultures in normal
and hypoxic conditions revealing differential expression of about 90 proteins. These
preliminary results highlight relevant changes in the expression of several markers
of EXO derived from cultures exposed to different oxygen concentrations.
Summary/Conclusion: We successfully isolated and purified exosomes from NB cell lines
and assessed their protein composition. These promising results are the starting point
for the identification of predictive biomarkers to be used to detect and monitor metastatic
spread in NB.
Funding: ERC Starting Grant 2017 to Elisa Cimetta.
PF03.06
HNSCC exosomes drive tumour angiogenesis via ephrin reverse signalling
Shinya Sato and Alissa Weaver
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine,
Nashville, USA
Introduction: Exosomes are small extracellular vesicles (EVs) that are secreted upon
fusion of multivesicular endosomes (MVE) with the plasma membrane and carry bioactive
protein and RNA cargoes. A number of studies have identified key roles for exosomes
in promoting tumour angiogenesis; however, the mechanisms are unclear. Our goal is
to identify the role of head and neck squamous cell carcinoma (HNSCC) exosomes in
tumour angiogenesis.
Methods: EVs were collected from the conditioned media of HNSCCs and purified through
cushioned density gradient ultracentrifugation. An orthotopic mouse model was used
for the assessment of tumour angiogenesis. Angiogenic potential of EVs was assessed
by tube formation assays with Human Umbilical Vein Endothelial Cells (HUVECs).
Results: In HNSCC tumours, the microvessel density correlated with exosome secretion
rates of original HNSCC lines. In vitro, CM and purified exosomes but not exosome-depleted
CM from HNSCC cells drove tube formation of HUVECs and human lymphatic endothelial
cells. Proteomics analysis of HNSCC exosomes revealed multiple potential angiogenic
proteins, including EphB2 and EphB4. The addition of purified HNSCC exosomes to HUVECs-induced
reverse ephrin-B signalling in endothelial cells, as assessed by Western blot analysis.
To test whether reverse ephrin-B signalling might account for exosome-induced angiogenesis,
we pre-incubated purified exosomes with Fc-ephrin-B2 to block the interaction between
exosomal EphB2 and ephrin-B2 on endothelial cells. We found that low concentrations
of this reagent had little effect on endothelial tube formation in the absence of
exosomes but blocked the pro-angiogenic effect of the exosomes. In addition, EphB2-KD
HNSCC derived exosomes significantly reduced endothelial tube formation compared to
parental HNSCC derived exosomes.
Summary/Conclusion: We find that HNSCC-derived exosomes can induce reverse ephrin-B
signalling and angiogenesis. This mechanism may be important in the HNSCC microenvironment.
Funding: This work was funded by the National Institutes of Health grant R01CA163592.
PF03.07
Nanoparticle mediated inhibition of intercellular communication between enzalutamide
resistant prostate cancer cells and myeloid cells
Stephen Henrich
a, Kaylin McMahona, Michael Plebanekb and C. Shad Thaxtona
aNorthwestern University, Chicago, USA; bDuke University, Durham, USA
Introduction: Crosstalk between neoplastic cells and myeloid cells has emerged as
an axis of communication which drives tumour progression and metastasis. Recently,
our group and others have shown that cancer exosome-mediated intercellular signalling
is dependent, in part, upon target cell cholesterol homeostasis. In this study, we
investigated whether exosome signalling between enzalutamide resistant (EnzR) prostate
cancer cells and myeloid cells could be effectively inhibited by targeted reduction
of myeloid cell cholesterol using high density lipoprotein mimetic nanoparticles (HDL
NPs).
Methods: Exosomes were isolated via ultracentrifugation of conditioned media from
EnzR CWR-R1 prostate cancer cells. Murine bone marrow macrophages were obtained by
culturing total bone marrow in M-CSF for 7 days. For in vitro experiments, cells were
treated with exosomes derived from EnzR CWR-R1 cells (1–10 ug/mL exosomal protein)
with or without HDL NPs (50–150 nM). For in vivo experiments, 10 ug exosomal protein
were injected via tail vein with or without HDL NPs (1 uM, 100 ul). Confocal microscopy
and flow cytometry were used for uptake experiments. Osteoclast differentiation assays
were performed using a commercially available TRAP staining kit (Sigma Aldrich). NF-kB
activation assays were performed using the human monocyte reporter cell line, THP-1
Dual. HDL NPs were synthesized using 5 nm gold nanoparticle templates, phospholipids,
and apolipoprotein A-1. Mechanistic studies were performed using transgenic, SR-B1
knockout mice.
Results: Results showed that myeloid cell uptake of EnzR CWR-R1 exosomes was inhibited
in vitro and in vivo upon treatment with HDL NPs. Furthermore, functional inhibition
was observed via reduced osteoclast differentiation and reduced stimulation of NF-kB
signalling. Finally, experiments conducted using SR-B1 knockout mice revealed that
nanoparticle inhibition is dependent upon the scavenger receptor, SR-B1.
Summary/Conclusion: Our findings demonstrate that exosome-mediated signalling between
prostate cancer cells and myeloid cells can be inhibited using HDL NPs. Furthermore,
our results strongly suggest that exosome-mediated crosstalk between prostate cancer
cells and myeloid cells are dependent upon cholesterol homeostasis.
Funding: This work was supported by the National Institutes of Health and the Prostate
Cancer Foundation.
PF03.08
High-grade bladder cancer cells secrete extracellular vesicles containing MiRNA-146a-5p
and promotes angiogenesis
Marta Prieto Vila
a, Wataru Usubab, Nobuyoshi Kosakac, Fumitaka Takeshitad, Hideo Sasakib, Tatsuya Chikaraishib
and Takahiro Ochiyac
aDivision of Mollecular and Cellular Medicine, National Cancer Center Research Institute,
Japan, Tokyo, Japan; bSt. Marianna University, School of medicine., Tokyo, Japan;
cDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Shinjyuku-ku, Japan; dDivision of functional analysis, National
Cancer Center Research Institute, Tokyo, Japan
Introduction: High recurrence is one of the major issues in bladder cancer (BCa).
The classical method for detecting recurrence is cystoscopy, a highly invasive technique.
Thus, novel methodologies with high reliability and low-invasiveness are needed. To
overcome this problem, biomarkers in the urine such as microRNA (miRNA) in extracellular
vesicles (EVs) are been proposed. We previously detected high urinary levels of miR-146a-5p
in patients with BCa related to tumour grade. However, the function of this miRNA
in EVs from BCa had not been elucidated yet. Here, we show that miRNA-146a-5p in EVs
promoted angiogenesis in BCa.
Methods: High-grade BCa cell line, UMUC-3, with miR-146a overexpression, was established
and orthotopically transplanted in SCID mice. Immunohistochemical analysis was performed
to evaluate angiogenesis. Cellular proliferation, migration, and invasion were assessed
in human umbilical vein cell (HUVEC) after the addition of EVs from BCa. The target
gene of miR146-5p was identified by microarray and in silico analyses, and downregulation
was further confirmed by qPCR and western blot.
Results: Urinary miR-146a-5p level was higher in patients with high-grade BCa and
the tumours presented high levels of angiogenesis. Similarly, miR-146a overexpressed
BCa cells orthotopically injected into mice generated tumours with high levels of
angiogenesis. HUVEC cell proliferation was significantly increased, both under transfection
of miR-146a mimic and treatment with miR-146a-enriched EVs. Moreover, the target of
miR-146a was found to be TET2, which has been reported to regulate cell growth in
other malignancies. Consequently, TET2 was downregulated, both at RNA and protein
level, under miRNA-146a-enriched EVs treatment.
Summary/Conclusion: Our findings indicate that EVs containing miR-146a-5p from BCa,
previously described as BCa biomarker, promoted the proliferation of endothelial cells
that supported tumour growth. These results demonstrate that miRNAs in EVs may become
not only a diagnosis tool but also a target molecule for cancer therapy.
PF03.09
Activated glial cells stimulated by breast cancer-derived exosomes enhance proliferation
of brain metastatic breast cancer cells
Dayi Jeonga, Oh Jinhye
a, Dowon Hwangb and Dongsoo Leeb
aSeoul National University, Seoul, Republic of Korea; bSeoul National University Hospital,
Seoul, Republic of Korea
Introduction: Brain metastatic breast cancer cells have been known to stimulate glial
cells in the brain to facilitate their brain metastasis. Long distance of primary
breast cancer site to the brain may require the communication mediator to deliver
cancer favourable information to the brain. However, the exact role of breast cancer-derived
exosome during brain metastasis is not well understood. In this study, we observed
the phenomenon that breast cancer-derived exosomes directly activate primary astrocytes
and the co-culture condition of these activated astrocytes with microglia cells enhances
cancer cell proliferation and invasion.
Methods: To trace the extracellular vesicle (EV) including exosome movement, Palm-tandem
dimer tdTomato (Palm-tdTomato) lentiviral vector was transduced into MDA-MB-luc-D3H2LN
(D3H2LN) breast cancer cells. EVs isolated from D3H2LN-Palm-tdTomato cell lines showed
the increased Palm-tdTomato fluorescence intensity and were stably internalized into
astrocytes. After astrocytes were treated by the EVs, we checked the level of Glial
Fibrillar Acidic Protein (GFAP), vimentin, MCP-1/CCL2 and IL-6 expression. Astrocytes
and microglia are co-cultured under the EVs containing media.
Results: We found that astrocytes taken up by cancer-derived exosomes were activated,
showing the increase in GFAP, vimentin, MCP-1/CCL2 and IL-6 expression. Also, we found
that co-culture glial cells of astrocytes and microglia significantly increased cytokine
IL-6 production. The co-cultured medium from cancer exosomes-stimulated astrocytes
and microglia increases invasion and proliferation of cancer cells and inhibits tumour
suppressor gene in breast cancer cells.
Summary/Conclusion: These results indicate that breast cancer-derived exosomes participate
in activating astrocytes and the activated astrocytes and microglia induce breast
cancer proliferation and invasion during brain metastasis.
PF03.10
The glycosylation status affects the biodistribution of cancer extracellular vesicles
Akiko Kogure
a, Nao Nishida-Aokib, Naoomi Tominagac, Nobuyoshi Kosakad and Takahiro Ochiyad
aDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute,
Tokyo, Japan; bHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle,
USA; cDepartment of Biology, Massachusetts Institute of Technology, Massachusetts,
USA; dDepartment of Molecular and Cellular Medicine, Institute of Medical Science,
Tokyo Medical University, Shinjyuku-ku, Japan
Introduction: It has been shown that extracellular vesicles (EVs) from cancer cells
delivered to the metastatic site, and promoted metastasis by communicating with microenvironmental
cells, although molecules, which are indispensable for cancer progression, has been
investigating yet. It is well known that aberrant glycosylation is a hallmark of cancer,
and is related to the cancer malignancy; however, the role of the glycosylation of
EV surface proteins in cancer progression has not been clarified yet. In this study,
we investigated the role of glycosylation of the EVs from metastatic cancer cells
in the biodistribution.
Methods: We performed lectin blot analysis in order to compare the glycan level of
the EVs among metastatic cancer cell lines and non-metastatic cancer cell lines. Then,
we investigated whether glycosylation of EVs affects their incorporation rate to endothelial
cells by enzymatic deglycosylation in vitro. DiR-labelled EVs were employed to analyse
the location of EVs in vivo by intravenous injection. After 24 h of injection, the
fluorescence intensities of each organ were measured in order to determine the amount
of the EVs remained at the organs.
Results: We found that the glycosylation level of EVs from metastatic cancer cells
was higher than that from non-metastatic cancer cells. Moreover, enzymatic digestion
of N- and O-linked glycans on EVs increased their incorporation to the endothelial
cells in vitro. Furthermore, we found that the glycosylation status of EVs from cancer
cells influenced their direction to the organs in mice.
Summary/Conclusion: These findings suggest that the glycosylation of EVs from cancer
cells involved in the biodistribution of EVs.
PF04: EV-mediated inter-organism communication Chairs: Chitose Oneyama; Kyoko Hida
Location: Level 3, Hall A15:30–16:30
PF04.01
Preferential packaging of tRNA fragments into extracellular vesicles released by protozoan
parasite Trichomonas vaginalis
Anastasiia Artuyants
a, Anthony Phillipsb and Augusto Simoes-Barbosaa
aSchool of Biological Science, The University of Auckland, Auckland, New Zealand;
bDepartment of Surgery, Faculty of Medical and Health Sciences, The University of
Auckland, Auckland, New Zealand
Introduction: Extracellular vesicles (EVs) are important mediators of cell-to-cell
communication. Delivery of EVs is known to modulate the response of the recipient
cells. EVs are produced by most if not all organisms and are involved in communication
between host and pathogen. Trichomonas vaginalis is a unicellular eukaryotic pathogen,
known to produce EVs with proteins and RNA cargo. This parasite colonizes the mucosal
surface of the human genitourinary track extracellularly. In this study, we hypothesised
that the RNA cargo of parasite EVs is an important element of this host-pathogen communication.
Methods: As the first step of this investigation, we isolated and characterised EVs
from T. vaginalis strain B7RC2. Small RNAs present in these vesicles were identified
by deep-sequencing and specificity of these molecules as EVs cargo was evaluated.
Results: Our results show that T. vaginalis releases membrane-bound vesicles with
an average size of ~100 nm that are taken up by host cells. These vesicles are depleted
of DNA but enriched with RNAs of small size. These RNAs are physically protected from
exogenous RNases. The population of small RNAs was consistent among libraries, with
tRNA being the most abundant RNA biotype in all samples. We identified individual
sequences from the top 30 transcript clusters as being mostly tRNA fragments, particularly
5’-tRNA halves. The presence of the identified fragments was validated and compared
with total cells by digital droplet PCR, showing the preferential packaging for these
tRNAs into EVs.
Summary/Conclusion: Our study indicates that tRNA fragments from T. vaginalis EVs
(particularly tRNA halves) might play a role in communication with host cells. Work
to confirm their bioactivity continues.
PF04.02
The endothelial PlGF is upregulated by exosomes from activated kidney fibroblast
Noritoshi Kato
a, Fumitoshi Nishiob, Yoshio Funahashic, Hiroki Kitaic, Shintaro Komatsuc and Shoichi
Maruyamac
aNagoya University Graduate School of Medicine, Nagoya, Japan; bTushima City Hospital,
Tushima, Japan; cNagoya University Graduate School of Medicine, Nagoya, USA
Introduction: It is well known that patients with chronic kidney disease (CKD) are
at risk of cardiovascular diseases, but the mechanism of this distant organ crosstalk
is not fully understood. Recently, placental growth factor (PlGF) received attention
in pathogenesis of cardio-renal syndrome (CRS). Under the hypothesis that exosomes
are involved in pathophysiology of CRS, the aim of this study is to explore the role
of exosomes from kidney fibroblasts, which actively proliferate in diseased kidney,
on vascular endothelial cells.
Methods: Clinical samples; HUVECs were stimulated by serum exosomes from stage G5
CKD patients and healthy donor. Exosomes tracking; Primary culture of activated kidney
fibroblasts were obtained from experimental renal fibrosis model mice. These exosomes
were labelled by microRNA of C. elegance (Cel-miR-39) then labelled exosomes were
injected to the mice through tail vein. Effects of exosomes on endothelial cells;
We purified exosomes from culture media of TGF-b stimulated kidney fibroblasts cell
line (NRK-49f), and then primary culture of vascular endothelial cells (RAOEC) was
stimulated using these exosomes. By qPCR, we evaluated the expression of PlGF genes.
Results: (1) Not only the serum but also exosomes from CKD stage G5 patients stimulated
PlGF expression on HUVECs. (2) Injected labelled exosomes from activated kidney fibroblast
distributed mainly in lung, liver and aorta. (3) RAOEC stimulated with exosomes form
TGF-b activated rat kidney fibroblast showed higher expression of PlGF than control.
Summary/Conclusion: So far, CRS is considered to be caused by uremic factor, RAS system,
chronic inflammation and so on. From this study, both serum and exosomes from CKD
patients stimulated PlGF transcription on endothelial cells. Exosomes from activated
kidney fibroblast had same tendency. We speculated that exosomes from diseased kidney
have some roles in atherosclerotic change by modulating the expression of PlGF on
endothelial cells. Farther studies are needed to elucidate the degree of contribution
to CRS.
Funding: N/A.
PF04.03
The effect of in vivo irradiation on the extracellular vesicle’s cargo and uptake
Tünde Szatmári
a, Dávid Kisa, Nikolett Sándora, Eszter Persab, Rita Hargitaia, Enikő Kisa, Katalin
Balázsa, Géza Sáfránya and Katalin Lumniczkya
aNational Public Health Center, Division of Radiobiology and Radiohygiene, Department
of Radiation Medicine, Budapest, Hungary; bNational Public Health Center, Budapest,
Hungary
Introduction: Recent studies suggest that ionizing radiation (IR), as a stress agent,
induces changes in the release, uptake and composition of extracellular vesicles (EVs).
EVs were shown to play a role in radiation-related signalling and radiation induced
bystander effects (RIBE). We have recently shown that EVs released by bone marrow
(BM) cells of mice irradiated with X-rays mediate RIBE, such as DNA damages, chromosomal
aberrations or phenotypical changes in certain cellular subpopulations of the BM.
The aim of this study is to investigate the mechanism of these functional changes.
Methods: In order to follow the uptake of irradiated EVs, we isolated EVs from BM
of total-body irradiated (TBI) mice, labelled them with a selective RNA stain and
co-incubated them in vitro for 3 h with BM cells extracted from nonirradiated mice.
We quantified the uptake of EVs in different BM subpopulations by flow cytometry and
fluorescence microscopy. To test whether in vivo irradiation affects the miRNA cargo
of EVs, total RNA was isolated from the same EVs, subjected to miRNA profiling and
assessed by bioinformatical tools. Significantly altered miRNAs were validated by
qRT-PCR in EVs, BM cells of EV donor and recipient mice.
Results: There were differences in EV uptake capacity of different BM cell subpopulations
but irradiation did not change the extent of EV uptake. We identified a panel of miRNAs
differentially expressed in the EVs following TBI of mice with involvement in DNA
damage repair, immune system regulation and acute leukaemia.
Summary/Conclusion: We proved that EVs transmit certain radiation related signals;
IR alters the miRNA cargo of EVs, but does not affect their uptake. Our study helps
to disclose the radiation-related mechanisms involved in EV signalling and the role
of EV signalling in systemic response of organisms to IR.
Funding: The Euratom research and training programme 2014–2018 (CONCERT, grant agreement
number 662287) and a Hungarian Scientific Research Fund–OTKA (124879).
PF04.04
UVB induced-release of bioactive microvesicle particles in keratinocytes carry platelet-activating
factor
Ji Bihl, Langni Liu, Christine Rapp and Jeffrey Travers
Wright State University, Dayton, USA
Introduction: Ultraviolet B radiation (290–320 nm; UVB) has profound effects upon
skin and generates systemic consequences. As UVB only penetrates the epidermis, a
major question in photobiology is how UVB-treated skin sends systemic signals. Recent
studies have indicated that small membrane-bound vesicles known as microvesicle particles
(MVP) released from cells in response to various stressors can act as potent signalling
agents due to their ability to carry nuclear and cytoplasmic components. Our lab has
previously determined that UVB induces the production of the lipid mediator, platelet-activating
factor (PAF), which is involved in mediating both acute pro-inflammatory and immunosuppressive
UVB responses. More recently, we discovered that UVB generates MVP release (UVB-MVP)
from epithelial cells and skin in a PAF-PAFR dependent way. However, the contents
of UVB-MVP have not identified and whether UVB-MVP carry PAF is not known.
Methods: In this study, we determined the kinetics of PAF production in cell- vs.
MVP over time. IL-8 release assay was further used to confirm the PAF-R-agonist activity
in KBP cells using PAF as positive control. Moreover, we verified the PAF-R-agonist
activity in UVB-MVP in animal models.
Results: The kinetics of PAF agonist production following UVB suggest that PAF-R agonists
generated in response to UVB were cell-associated early, then, were found predominantly
in MVP. The PAF-R-agonist activity found in MVP of HaCaT cells 2 h post UVB. UVB-MVP
contain approximately 20 ng of PAF activity per 1E+10 MVP. However, PAF agonistic
activity was not found in control MVP, and UVB-MVP did not generate IL-8 release in
PAFR- negative KBM cells. Topical application of lipid extracts from UVB-MVP derived
from HaCaT cells onto ears of WT mice resulted in an increase in ear thickness at
2 h, however, there was no effect on PAF-R Knock-out (KO) mice
Summary/Conclusion: This study suggests that UVB-MVP contain bioactive PAF agonists
involved in acute UVB-induced inflammation. This is the first study demonstrating
that UVB-MVP carry PAF.
Funding: National Institutes of Health (NIH): R21 AR071110.
PF04.05
A mathematical model for extracellular vesicles, as a communication tool between cells.
Anna Concetta Berardi
a and Andrea Collevecchiob
aospedale Santo Spirito Pescara, Pescara, Italy; bMonash University, Melbourne, Australia
Introduction: The main goal of the present work is to introduce a mathematical model
for extracellular vesicles (EV), as a communication tool between cells.
Methods: Our basic model has a graph theoretical representation in terms of weighted
graphs and stochastic processes that take values on the vertices of the graph, which
play the role of cells. More specifically consider a complete graph, where each vertex
communicates with any other vertex. To each edge of the graph associate a positive
number, which might be interpreted as the euclidean distance between cells. In order
to understand the main features of the model, it is enough to isolate one designated
cell, called the root, and understand how effective is its communication with the
other cells.
Results: We regard the EV as signals sent to other cells. At each stage the root sends
a signal to another cell chosen with probability proportional to the weight associated
to the connecting it to the root. Each time an edge is traversed, its weight is updated.
This allows learning during the communication. In other words, the root has preference
in communicating with cells that has been already contacted before. Each signal contains
a task. Once a cell receives a task, it will activate in order to complete it. On
the other hand, the completion of the task has a random duration. If during this time
the cell is contacted too frequently by the root cell (that is above a certain threshold),
it will abort the task.
Summary/Conclusion: Our goal is to understand what are the phases transitions of this
model with respect to its parameters as the number of vertices grow to infinity. In
other words, if the threshold associated to the abortion is large enough, we expect
to have a positive proportion of the cells to accomplish the task.
PF05: EVs in Infectious Diseases and Vaccines Chairs: Tsuneya Ikezu; Maja MustapicLocation:
Level 3, Hall A15:30–16:30
PF05.01
Extracellular vesicles from KSHV-infected cells stimulate antiviral immune response
through mitochondrial DNA
Hyungtaek Jeon, Jisu Lee, Suhyuk Lee, Su-Kyung Kang, Sang June Park, Seung-Min Yoo
and Myung-Shin Lee
Eulji University School of Medicine, Daejeon, Republic of Korea
Introduction: Interferon-stimulated genes (ISGs) are vital in controlling viral infections.
As many antiviral ISGs continue to be identified, their roles in viral pathogenesis
are also being explored in more detail. Kaposi’s Sarcoma-associated herpesvirus (KSHV)
is the etiologic agent of Kaposi’s sarcoma, which is the most common cancer in acquired
immune deficiency syndrome patients. Because KSHV contains numerous viral proteins
that modulate antiviral response, type 1 Interferon response is strongly suppressed
in KSHV-infected cells. However, the antiviral effects of extracellular vesicles (EVs)
during de novo KSHV infection have not been investigated to our best knowledge.
Methods: EVs were isolated from KSHV-infected cells at 24 h of postinfection and characterized.
The expression of ISGs in these EVs-treated human endothelial cells was investigated
and underlying mechanisms were analysed.
Results: In this study, we showed that KSHV-infected cells induce ISG response in
uninfected bystander cells using EVs. mRNA microarray analysis indicated that ISGs
and IRF-activating genes were prominently activated in EVs from KSHV-infected cells
(KSHV EV)-treated human endothelial cells, which were validated by RT-qPCR. Mechanistically,
mitochondrial DNA on the surface of KSHV EVs was presumed to be associated with ISG
response via the cGAS-STING pathway. In addition, KSHV EV-treated cells showed lower
infectivity for KSHV and viral replication activity than mock EV-treated cells.
Summary/Conclusion: Our results indicated that EVs from KSHV-infected cells would
be an initiating factor for the innate immune response against viral infection, which
would be helpful to expand our understanding of the microenvironment of virus-infected
cells.
Funding: This work was supported by the Basic Science Research Program through the
National Research Foundation of Korea (NRF-2017R1A2B1006373, NRF-2017R1A2B4002405).
PF05.02
Exosomes secreted by platelets infected with Hepatitis E virus can mediate transmission
of HEV
Lishan Chenga, Yu Liu
b, Ping Fuc, Bingting Wuc and Ling Kec
aChinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China
(People’s Republic); bChinese Academy of Medical Sciences and Peking Union Medical
College, 石家庄市, USA; cChinese Academy of Medical Sciences and Peking Union Medical
College, chengdu, China (People’s Republic)
Introduction: Evidences suggested that exosomes can transfer genetic material between
cells, including viral nucleic acids, proteins or miRNAs which can mediate transmission
of viruses such as HBV or HCV. It is known that platelet-derived exosomes constitute
the major fraction in the circulating plasma which can participate in haemostasis,
immunity and development. Whether the virus infected platelet-derived exosomes can
also promote the transmission of virus has not been reported. The hepatitis E virus
(HEV) is one of the most common causes of acute hepatitis worldwide. Recent studies
have shown that the exosomes secreted by HEV-infected cells were infectious. Our studies
have confirmed that HEV can infect platelets, thus we conducted this study to prove
if exosomes secreted by platelets infected with HEV are also infectious, thereby further
promoting the transmission of HEV.
Methods: An in vitro model of HEV-infected platelets were established by HEV-G3 virus
strain and washed human platelets and the exosomes were isolated from HEV-infected
and uninfected platelet by differential centrifugation and magnetic bead separation.
Exosomes were characterized by Western Blot and TEM, and quantitated by NTA. qRT-PCR
and ELISA were used to detect HEV RNA and proteins in exosomes. Positive exosomes
were used to infect PLC/PRF/5 cells, observing the changes of HEV RNA and proteins
within one month.
Results: The in vitro model of HEV-infected platelets was successfully established.
The concentration of exosomes secreted by HEV-infected platelets was higher than uninfected
platelets. Exosomes isolated from HEV-infected platelets contained HEV RNA and proteins.
HEV RNA and proteins were detected in cells and supernatant of PLC/PRF/5 cells infected
with positive exosomes, and the concentration of which increased after the culture
of one month.
Summary/Conclusion: Our study showed that HEV can promote the secretion of platelet
exosomes and these vesicles can establish a productive infection which suggested that
the exosomes secreted by platelets not only play a role in haemostasis, immunity and
development, but also play a non-negligible role in the transmission of the virus.
Funding: 1.CAMS Innovation Fund for Medical Sciences (CIFMS2016-I2M-1-018)
2. Supported by the Fundamental Research Funds for the Central Universities(Item No:3332018125)
PF05.03
Multi organ association mediated by extracellular vesicles secreted from HBV positive
hepatocyte
Ai Kotani
a and Masatoshi Kakizakib
aTokai University, Isehara, Japan; bTokai University, School of Medicine, Department
of Gastroenterology, Iisehara, Japan
Introduction: Hepatitis B virus (HBV) infected hepatocytes secreted extracellular
vesicles such as virion, exosome and incomplete virions such as hallow particles which
have only HBs viral antigens but neither capsid and HBV genome. We found that the
EVs are taken by monocyte/macrophage which upregulates PD-L1, immune checkpoint molecule.
(Kakizaki et al PLOS one in press). It suggests that the EVs play critical roles in
viral immunology.
Methods: PKH labelled EVs are injected into mice then those biodistribution are analysed
by tissue sections and confocal microscopy and flow cytometry then multiorgan association
are analysed by use of bone marrow transplantation. The HBV hepatitis model mice was
established to analyse the significance of the EVs on HBV hepatitis.
Results: In almost all the organs we analysed the PKH signal were detected which suggest
the biodistribution of the EVs are systemic. Especially in the bone marrow monocytes,
PKH positive cells are abundant. Then the bone marrow cells which were treated by
PKH labelled the EVs secreted from HBV infected hepatocytes were transplanted. The
organ where the most PKH positive cells were detected was gut. These cells showed
CD103 positive which suggest these cells are regulatory DCs. The HBV hepatitis model
mice treated by the EVs showed persistent HBV infection.
Summary/Conclusion: Based on the results, the EVs secreted from HBV infected hepatocytes
have significant roles in HBV hepatitis through the multiorgan association of liver,
bone marrow and gut.
Funding: AMED hepatitis grant.
PF05.04
HIV-1 Nef mediated Hck kinase activation triggers loading of TACE into EVs in a ceramide-dependent
manner
Zhe Zhao, Riku Fagerlund and Kalle Saksela
University of Helsinki, Helsinki, Finland
Introduction: TNF-α converting enzyme (TACE) exists in circulating EVs collected from
HIV-infected individuals. In addition to its role in TNF-α shedding, TACE is responsible
for the proteolytic maturation of numerous cytokines, cytokine receptors and extracellular
matrix components involved in inflammation. Thus, EV-associated TACE could be a key
player in the chronic immune activation that drives AIDS pathogenesis and persistent
viral replication. Although uploading of TACE into EVs is promoted by the HIV-1 pathogenicity
factor Nef, the mechanism of TACE secretion remains incompletely understood.
Methods: EVs were isolated by ultracentrifugation and analysed by western blotting.
Gene knock-out by CRISPR was used to study TACE loading into exosomes.
Results: We have previously shown that uploading of TACE into EVs is promoted by HIV-1
pathogenicity factor Nef via its interaction with cellular protein kinases. Herein,
we have studied the molecular mechanisms of TACE loading into EVs in more depth and
show that active Src family tyrosine kinases (SFKs) Lck, Hck, Lyn, Fyn and Fgr can
trigger TACE secretion. Among the SFKs Hck is unique by displaying two isoforms p59
and p61. We found that only activated p59, but not p61, could trigger TACE secretion.
In contrast to the myristoylated and palmitoylated SFKs and p59Hck the p61 isoform
lacks the palmitoylation signal and these differing signals have been shown to direct
p59 and p61 to the plasma membrane and lysosomes, respectively. Our observations show
that catalytic activity and proper membrane association domain of Hck is required
for TACE secretion into EVs. We characterized the origin of the EVs in Hck-activated
TACE secretion by nSmase2 knock-out, and found that Hck-mediates the loading of TACE
into vesicles that similar to classical exosomes are generated in a manner requiring
nSmase2-mediated ceramide synthesis.
Summary/Conclusion: We conclude that HIV-1 Nef mediated Hck p59 kinase activation
triggers the loading of TACE into exosome-like vesicles in a ceramide dependent manner.
Funding: Jane and Aatos Erkko Foundation
PF05.05
Role of Extracellular Vesicles in HIV and Methamphetamine induced neurotoxicity
Sowmya V. Yelamanchili
a, Dalia Moorea, Catherine DeMarinob, Farah Shahjinc and Fatah Kashanchib
aDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska
Medical Center, Omaha, USA; bGeorge Mason University, Manassas, USA; cDepartment of
Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center,
OMAHA, USA
Introduction: The advent of combined antiretroviral treatments (cART) has markedly
decreased the prevalence of HIV-associated dementia. However, there remains a high
prevalence rate of the milder forms of HIV-associated neurocognitive disorders (HAND).
Although many contributing factors have been studied, the role of drugs of abuse has
remained elusive. Methamphetamine (Meth) and related amphetamine compounds, which
are potent psychostimulants, are among the most commonly used illicit drugs. Long-term
Meth abuse is associated with a host of systemic and neurological maladies. Neurologically,
Meth abusers exhibit cognitive and psychomotor impairment, and have shown increased
risk for HIV infection. However, the mechanisms underlying Meth and HIV neurotoxicity
are still not known. This study focuses extracellular vesicles (EVs) and their role
in HIV infection and chronic Meth abuse. Our results presented here, indicate that
Meth can not only increase EV biogenesis and release but also change the composition
of EV cargo.
Methods: EV isolations, EV quantification by Nanoparticle tracking analysis, Immunoflurescence
and structural illumination microscopy, transmission electron microscopy, Taqman RT-PCR,
In situ hybridization, in vitro primary macrophage cultures.
Results: Nanoparticle tracking analysis and transmission electron microscopy revealed
that Meth changed EV dynamics in uninfected and HIV infected macrophage cultures.
Our investigation revealed that the genes involved in the endosomal sorting complexes
required for transport (ESCRT) are responsible are significantly increased upon Meth
treatment. Further, our data reveals that Meth increases the release of HIV accessory
protein, myristoylated Nef (Myr-Nef), that plays a critical role in HIV/AIDS progression.
Myr-Nef is N-terminally myristoylated, which acts as a membrane anchor. Furthermore,
we also reveal that gp120 is released in the EVs along with Myr-Nef. We show that
the release of gp120 is followed by the increase in syncytia formation in the macrophage
cultures.
Summary/Conclusion: We conclude that chronic Meth abuse interferes with EV biogenesis
and cargo release in HIV infected cells. These results can uncover the role of chronic
Meth abuse in progression of HIV pathogenesis.
Funding: NIH/NIMH/NIDA
PF05.06
Extracellular vesicle-associated cytokines in HIV infected human lymphoid tissue ex
vivo
Vincenzo Mercurio
a, Wendy Fitzgeraldb and Leonid Margolisc
aDepartment of Biomedical and Clinical Sciences ‘L. Sacco’, University of Milan, Milan.,
Bethesda, USA; bSection of Intercellular Interactions, Eunice Kennedy Shriver National
Institute of Child Health and Human Development, National Institutes of Health, Bethesda,
MD, USA; cSection of Intercellular Interactions, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, National Institutes of Health, Bethesda, MD,
USA
Introduction: Cytokines play an important role in HIV infection. Some of these cytokines
are present on the surface or encapsulated in extracellular vesicles (EVs). We investigated
the modulation of EV-associated cytokines during HIV infection and antiretroviral
therapy (ART) in human ex vivo tonsils.
Methods: Ex vivo tonsils were infected with HIV-1 strains, X4-LAI04 or R5-SF162. HIV
was either allowed to replicate for 15 days, or tissues were treated with ART (3TC
and AZT) at day 2 post-infection. 33 cytokines in soluble or EV-associated forms were
evaluated with multiplexed bead-based assays.
Results: Infection with HIV-1 led to increases in many soluble cytokines, with the
highest increases in IL-2, IL-12, IL-15, IFN-γ, MIP-1α, MIP-1β and RANTES by both
viruses. These same, and additional, cytokines, were elevated in EV-associated form,
often increasing in both EV surface and internal compartments. Likewise, soluble cytokines
unaffected by HIV infection tended to also be unchanged in EVs.
ART treatment halted HIV-1 replication, but cytokines increased by HIV infection remained
elevated. After 13 days of ART, five of the above seven soluble cytokines remained
high for X4, and 4 for R5. EV-associated cytokines were less likely to be restored:
13 days after ART, for X4 all 10 of the most upregulated cytokines remained high,
and for R5 7 of 10.
Summary/Conclusion: Cytokine levels increased during HIV infection in both soluble
and EV-associated forms; the same cytokine is often upregulated in both forms. Many
soluble cytokines upregulated by HIV did not decrease even after 13 days of ART, and
EV-associated cytokines were even less likely to decrease. X4 induced increases were
less likely to return to control levels. ART-treated infected human tissues provide
a new model to study tissue activation after HIV replication is suppressed, in particular,
the role of EVs in this phenomenon. These studies will assist in deciphering mechanisms
of pathologies that develop in ART-treated patients.
PF05.07
Circulating MiR-122 and let-7a may predict progression to hepatocellular carcinoma
in patients with chronic hepatitis C virus infection
Yuki Ichikawa
a, Masashi Sakakib and Hitoshi Yoshidac
aShowa University, Ito, Japan; bShowa University, Tokyo, Japan; cShowa University,
Tokyo, Japan
Introduction: At the bedside, circulating microRNAs in human body liquids are noted
as `liquid biopsy’ to evaluate the disease stages, especially in Liver diseases, `actual
biopsy’ is used in patients because of its invasiveness. In chronic liver disease,
many circulating miRNAs are recently reported such as miR-122, miR-192, miR-223 to
diagnose HCC patients and HCV- or HBV-infected patients, in this study. To identify
the miRNAs which can predict HCC (hepatocellular cell carcinoma) development, we first
focused on the microRNAs associated with the liver fibrosis, because liver fibrosis
stages are one of the most important factors to predict Hepatocellular cell carcinoma
(HCC) development and evaluated those predictable ability among other noninvasive
fibrosis markers to clarify our hypothesis that those miRNAs are pathologically related
to carcinogenesis development.
Methods: Serum circulating miR-122 and let-7a were retrospectively evaluated using
RT-PCR in 35 patients with HCV-related chronic hepatitis and cirrhosis who undergone
DAA treatment. HCC had developed in 8 patients afterwards in the observation period.
Informed consent was obtained and the study was approved by a recognized medical ethics
committee in our hospital.
Results: Serum miRNA miR122and let-7a levels were significantly higher in liver chirrosis
than chronic hepatitispatients. (miR122, p = 0.00836 let-7a p = 0.01595). For the
predictable ability of HCC, AUROC of miR122 was 0.85606 and le1-7a was 0.76667,which
showed highest ability compared with other non-invasive fibrosis markers, such as
APRI, FIB-4. (AUROC = 0.5023, 0.66697, respectively) Based on our ROC results to predict
complicating HCC, COF of miR122 was 0.04175 (sensitivity and specificity of 86% and
75%, respectively) and COI of let-7a was 0.0166 (sensitivity and specificity of 71%
and 87%). The cumulative incidence rate of HCC was significantly different miR-122 ≥ 0.04175
and > 0,04175 groups or let-7a ≥ 0.01666 (p = 0.050 and 0.00054)
Summary/Conclusion: Serum miR-122 and let-7a values appear to have superior ability
to predict HCC development in patients with chronic HCV infection, which implies the
possibility that they have crucial role in HCC development.
PF05.08=OWP2.07
Biogenesis of JC polyomavirus associated extracellular vesicles depends on neutral
sphingomyelinase 2
Jenna Morris-Love
a, Bethany O‘Haraa, Gretchen Geea, Aisling Duganb, Benedetta Assettac, Sheila Haleya
and Walter Atwooda
aBrown University, Providence, USA; bAssumption College, Worcester, USA; cBrown Univerisity,
Providence, USA
Introduction: JC polyomavirus is a non-enveloped virus that causes progressive multifocal
leukoencephalopathy (PML) in immunocompromised patients. JCPyV infects cells by first
binding to the major attachment receptor lactoseries tetrasaccharide C (LSTc), followed
by the serotonin receptor 5-hydroxytryptamine type 2 required for entry. In PML, JCPyV
undergoes lytic infection in oligodendrocytes and astrocytes, both of which have been
shown to lack LSTc. Further, deep sequencing has shown that viral quasispecies existing
in PML patients contain mutations in the sialic acid binding pocket of the major viral
capsid protein, rendering these virions incapable of binding LSTc. We have recently
demonstrated that JCPyV is packaged into extracellular vesicles (EV) that can spread
the virus, potentially overcoming this paradox. Here, we begin to characterize the
biogenesis of this EV-virus association by examining endosomal sorting complexes required
for transport (ESCRT) proteins and neutral sphingomyelinase 2 (nSMase2).
Methods: Cambinol was used to specifically target nSMase2 activity. Knockdown cell
lines were created with shRNA targeted against ALIX, TSG101, or SMPD3. SMPD3 was also
targeted using CRISPR/Cas9 genetic knockout in separate cell lines. Knockdown was
confirmed by qPCR and/or Western blot, and knockout by next generation sequencing.
EV were concentrated by differential centrifugation and evaluated by transmission
electron microscopy, Western blot, nanoparticle tracking analysis, infection, and
qPCR for protected viral genomes. Infection was scored by immunofluorescence analysis
with antibodies against the major viral capsid protein VP1.
Results: We found that depletion of nSMase2 by cambinol, genetic knockdown or knockout
caused a reduction in spread of JCPyV over time. Knockdown and knockout SMPD3 cell
lines produced less infectious EV. In the absence of nSMase2, cells produced more
EV but there were fewer protected genomes associated with the EV. Knockdown of Alix
or TSG101 had no effect on the infectivity of EV or the production of EV.
Summary/conclusion: Overall, our studies found that biogenesis of JCPyV associated
extracellular vesicles depends upon the enzymatic activity of nSMase2 and not the
ESCRT-related proteins Alix or TSG101.
Funding: NIH R01NS043097
PF05.09=OWP2.08
Exosomes mediate the anti-viral activity of interferon-β against zika virus infection
Shuang Li, Shilin Li and Limin Chen
Provincial Key Laboratory for Transfusion-Transmitted Infectious Diseases, Institute
of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical
College, Chengdu, Sichuan, 610052, China, Chengdu, China (People‘s Republic)
Introduction: IFNβ-induced exosomes (Exo-IFNβ) may impact on viral dissemination or
antiviral immunity and therefore involve in the pathogenesis of many infectious pathogens.
However, little is known about its underlying mechanisms. To better understand how
Exo-IFNβ performs its anti-viral effect, we employed RNA sequencing analysis to explore
the exosomal expression profiles of lncRNA and mRNA related to viral infections. We
hypothesized that exosomes can regulate viral infection through transmitting enclosed
specific lncRNAs into neighbouring cells to inhibit viral replication.
Methods: Exosomes were purified from A549 with/without IFNβ treatment by serial centrifugation
followed by sucrose density gradient purification, and characterized by TEM and Western
Blot. ELISA assay were performed on purified exosome fractions to demonstrate that
they are free of IFNβ. ZIKV replication was assayed by real-time PCR.
Results: ZIKV replication was significantly suppressed in A549 cells pre-treated with
Exo-IFNβ followed by ZIKV infection. Moreover, we found that anti-ZIKV effect of Exo-IFNβ
is IFN-independent because ZIKV replication was also decreased in U5A cells (IFN-α/β
receptor IFNAR deficient) pre-treated with Exo-IFNβ . Similar results were observed
in Dengue virus and HCV infections. RNA sequencing analysis found several lncRNAs
and mRNAs were differentially expressed and function annotation and pathway analysis
demonstrated that the differentially expressed genes were involved in many functions
and pathways, including anti-viral infection. To validate the RNA sequencing analysis
results, some lncRNAs were selected to test their expression levels by qPCR. We are
in the process of deciphering the mechanism employed by these exosomal lncRNAs in
anti-viral activty independent of inteferon.
Summary/conclusion: We believe that understanding the anti-viral functional molecules
wrapped in exosomes may help design exosomes as efficient vehicles for antiviral therapy.
Funding: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
(2016-12M-3–025)
PF06: Advances in EV Quantification and Characterization Chairs: Estefanía Lozano-Andrés;
Kenneth WitwerLocation: Level 3, Hall A15:30–16:30
PF06.01
Exosome quantification by ELISA and Flowcytometry using anti-CD9 antibody
Naoki Hata
a, Hiroyuki Kogurea, Hikaru Sonodab and Chihiro Okadab
aLuminex corporation, Tokyo, Japan; bHakarel Inc, Osaka, Japan
Introduction: Quantifying and characterizing exosomes in a reproducible and reliable
manner has been challenging due to their small sizes, of which the ranges are from
30 to 150 nm in diameter. The analysis used to be mainly performed with either the
electric microscopy or the nanoparticle tracking analysis; however, these techniques
are low throughput and not enough for the quantification especially in the large and
heterogeneous populations. Also, attempts to analyse exosomes using traditional PMT-based
flow cytometers has been hampered by the limit of detection of such small particles
and low refractive index. Here, to overcome these limitations, we used the highly
qualified and validated monoclonal antibodies for CD9 on the surface of exosome to
employ ELISA and the high sensitive flow cytometry. In this study, we would like to
show and discuss more reliable and robust platforms for the quantification of exosomes
with use of ELISA and flow cytometry.
Methods: Malignant cell line-derived exosome was prepared by the ultracentrifugation
↓
Diluted the samples in PBS at 1:60, 1:120, 1:240, 1:480 and 1:960
↓
Measured the samples either by CD9-based ELISA (Hakarel Inc) or Flow cytometer (CellStream,
Luminex Corporation)
Results: The quantifications of exosomes were performed by ELISA and CellStream flow
cytometer with use of anti-CD9 monoclonal antibody
Summary/Conclusion: In this study, the quantifications of exosomes were performed
by ELISA and CellStream flow cytometer with use of anti-CD9 antibody. Tumour cell-derived
exosomes were labelled with CD9-PE. The average concentration of the exosomes was
measured by CD9 ELISA whereas the mean fluorescence intensity and the objects per
microlitre for the exosomes and control samples were shown by CellStream flow cytometer.
The robust sensitivity of ELISA and CellStream flow cytometer with use of the validated
CD9 antibody would provide an informative platform for measuring exosomes.
Funding: No fundings.
PF06.02
Characterizing the light-scatter sensitivity of the CytoFLEX flow Cytometer
George Brittain, Sergei Gulnik and Yong Chen
Beckman Coulter Life Sciences, Miami, USA
Introduction: Extracellular vesicles (EVs) and other biological nanoparticles (NPs)
generally fall within the optical noise of light-scatter-based detection methods,
and most flow cytometers are not sensitive enough to effectively detect NPs less than
300 nm in diameter. The CytoFLEX is a notable exception to this: it is so sensitive
that the SSC detector actually has an attenuation filter to reduce 95% of the scatter
signal, adjusting it to a range useful for cells. As an alternative, the Violet SSC
(VSSC) signal is unfiltered and can be used to bring the CytoFLEX sensitivity well
into the nanoparticle range. However, the added VSSC layer can confuse individuals,
and a few instrument comparisons have even been published by users unfamiliar with
the use of VSSC on the CytoFLEX.
Methods: In order to better characterize the biological threshold sensitivity of the
CytoFLEX using VSSC, we analysed a variety of NPs of different compositions, including
viruses and purified plasma EVs. The plasma EVs were prepared from fresh human blood
using centrifugation, size filtration, and column chromatography, followed by size
characterization using DLS. After acquisition on the CytoFLEX, we converted the median
scatter intensity for each sample to either their size or refractive index (RI) using
Mie theory approximations.
Results: We found that the CytoFLEX could fully resolve 70 nm polystyrene and 100 nm
silica (Si) NPs, including Si with a RI of 1.43 at 405 nm. We could fully resolve
both 110 nm MLV viruses and 90 nm Adenoviruses with RIs of 1.47–1.50. And, we were
able to detect plasma EVs at least as small as 80 nm in diameter using only a VSSC
trigger, though immunofluorescence was necessary to fully resolve the smallest of
these EVs from noise.
Summary/Conclusion: Ultimately, the CytoFLEX is highly sensitive for NP detection.
Moreover, unlike dedicated microparticle analysers, the CytoFLEX is a full-fledged
flow cytometer with a biological dynamic range extending from approximately 80 nm–50 µm.
The CytoFLEX is for research use only. Individual results may vary. The Beckman Coulter
product and service marks mentioned herein are trademarks or registered trademarks
of Beckman Coulter, Inc. in the USA and other countries.
PF06.03
Preparing a CytoFLEX for Nanoscale flow Cytometry
George Brittain, Sergei Gulnik and Yong Chen
Beckman Coulter Life Sciences, Miami, USA
Introduction: Built around semiconductor technology, with a number of innovations
to enhance light capture, reduce noise and prevent signal losses, the CytoFLEX is
capable of detecting biological nanoparticles (NPs) as small as 80 nm by light scatter,
and has a linear fluorescence range that extends down into the single digits for fluorophores
like FITC. However, in order to properly setup the CytoFLEX for NP analyses, a variety
of considerations need to be taken into account, some of which are extraordinary to
conventional flow cytometry.
Methods: In this poster, we will demonstrate how to properly setup and clean a CytoFLEX
flow cytometer for NP analyses. First, we will explore the different threshold options
and sensitivity ranges. Next, we will show how to clean the instrument and reduce
noise. And finally, we will discuss several important issues that affect proper sample
analyses.
Results: The three primary detection methods on the CytoFLEX are FSC, SSC and Violet-SSC
(VSSC). FSC on the CytoFLEX utilizes comparative signal analyses rather than traditional
small-angle scatter, and is accurate for sizing events from 500 nm to 50 µm, independent
of the refractive index or membrane integrity. The biological threshold sensitivities
for SSC and VSSC on the CytoFLEX range roughly between 250 nm–20 µm and 80 nm–2 µm,
respectively. In order to take full advantage of the lower end of these scatter ranges,
cleaning the instrument and thoughtful sample preparation are very important.
Summary/Conclusion: Ultimately, the CytoFLEX is one of the most sensitive flow cytometers
on the market. However, with such great power comes great responsibility to properly
prepare the instrument and samples for effective nanoscale flow cytometry experiments.
The CytoFLEX is for Research Use Only. Individual results may vary. The Beckman Coulter
product and service marks mentioned herein are trademarks or registered trademarks
of Beckman Coulter, Inc. in the USA and other countries.
PF06.04
Improved scatter sensitivity of a flow cytometer for detection of extracellular vesicles
Leonie de Ronda, Edwin van der Pol
b, Ludovic Monheimc, Ton van Leeuwend and Frank Coumanse
aAmsterdam University Medical Centers, Amsterdam, USA; bAmsterdam UMC, University
of Amsterdam, Department of Biomedical Engineering and Physics, Amsterdam, Netherlands;
cBD Life Sciences, Erembodegem, Belgium; ddAmsterdam UMC, University of Amsterdam,
Department of Biomedical Engineering and Physics, Amsterdam, Netherlands, ; eAmsterdam
UMC, University of Amsterdam, Laboratory of Experimental Clinical Chemistry, Amsterdam,
Netherlands,
Introduction: To investigate the biomarker potential of extracellular vesicles (EVs),
EV subtypes are studied by flow cytometry. A flow cytometer detects fluorescence,
forward (FSC) and side scattered (SSC) light of single EVs. However, the scatter intensities
of the majority of EVs are below the detection limit of common flow cytometers because
EVs are small and have a low refractive index. We aim to improve the scatter sensitivity
of a common flow cytometer 450-fold for SSC and 107-fold for FSC, which will allow
detection of 100 nm EVs. Improved scatter sensitivity enables us to derive the size
of EVs from the scatter signal and to increase the fraction of EVs that can be characterized
using immunofluorescence as well as scatter-based sizing.
Methods: A FACSCanto (Becton Dickinson) was adapted by replacing the 20 mW laser with
a 20–200 mW adjustable power laser (both 488 nm Sapphire, Coherent). Confocal detection
was achieved by replacing the standard 1000 µm pinhole on SSC by a 200 µm pinhole,
and the standard photodiode on FSC by a 350 µm pinhole and PMT. The improvements in
scatter sensitivity were quantified by calculating the scatter stain index (SI) (median
intensity of a bead minus median intensity of the noise divided by two times the standard
deviation of the noise) of a 500 nm polystyrene bead and the robust coefficient of
variation (rCV) of a 100 nm polystyrene bead (both BioCytex). Ideally the SI is as
high as possible and rCV as low as possible.
Results: A 10-fold increase in laser power increased the SI on SSC 2.9-fold and on
FSC 20-fold, whereas the rCV improved (reduced 0.67-fold and 0.97-fold, respectively).
The improved confocal detection increased the SI on SSC 6.4-fold and on FSC 550-fold,
while the rCV slightly worsened (increased 1.1-fold and 1.02-fold, respectively).
Combining both increased laser power and confocal detection resulted in a 20-fold
increase in SI for SSC and 2 · 10^4-fold for FSC, and improved the rCV (reduced 0.39-fold
and 0.24-fold, respectively).
Summary/Conclusion: Adaption of the optical configuration of the FACSCanto by increasing
the laser power and confocal detection improved the scatter sensitivity 20-fold for
SSC and 2 · 10^4-fold for FSC. Next, we will evaluate the influence of increased measurement
time and reduction of the number of particles in the sheath on the scatter sensitivity.
Funding: NWO-TTW Perspectief CANCER-ID 14195
PF06.05
Lipoprotein particles can be detected by high-resolution flow cytometry and potentially
interfere with EV characterisation
Rikke Wehner Rasmussen, Jaco Botha, Mathilde Sanden and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark,
Aalborg, Denmark
Introduction: Lipoproteins co-isolate with EVs and are potential confounders in EV
characterisation. CD36 is a membrane-bound scavenger receptor located on cells and
EVs capable of interacting with VLDL and LDL, which could interfere with antibody-based
phenotyping. Freezing and thawing samples was shown to increase phosphatidylserine-positive
(PS+) EVs while other common phenotype markers were unchanged. This could provide
a method for disrupting lipoproteins and EVs. Thus, we aimed to investigate the impact
of lipoproteins on EV characterisation and freezing/thawing samples on their dissociation
from EVs on a high-resolution flow cytometer (hFCM).
Methods: Plasma from 6 healthy individuals was subjected to either 0, 2, 4 or 6 freeze-thaw
(FT) cycles and stained with a cocktail of lactadherin-FITC, anti-CD41-BV510, anti-CD36-PE
and anti-ApoB-APC or lactadherin-FITC and matched isotype controls. Samples were analysed
on an Apogee A60 Micro-PLUS hFCM. Gating was performed as follows: size gates established
on silica reference beads; phenotype gates set on 99th percentile of isotype control
channel fluorescence.
Results: hFCM was able to detect both free apolipoprotein B (ApoB) particles and ApoB
bound to PS+CD41+, PS+CD36+ and PS+CD41+ CD36+ EV phenotypes. From 0–2 FT cycles,
ApoB bound to PS+CD41+ and PS+CD41+ CD36+ phenotypes tended to decrease (p > 0.05).
Moreover, ApoB bound to PS+CD36+ increased 4.9-fold from 0–2 FT cycles for (p < 0.05).
Interestingly, this progression mirrored that of PS+CD36+ (2.0–2.5-fold, p < 0.05),
bulk CD36+ (1.8–2.4-fold, p < 0.05) and ApoB+ (4.1–5.0-fold, p < 0.01). Finally, in
line with previous reports, PS+ tended to increase following FT (1.5-2.1-fold, p > 0.05).
Contrary to previous reports, certain EV phenotypes decreased from 0–2 FT cycles (PS+CD41+ and
PS+CD41+ CD36+, both 2.6-fold, p < 0.05) suggesting that EV phenotypes might perish
following FT further confirmed on bi-variable plots of data.
Summary/Conclusion: This study demonstrates that ApoB can be detected on hFCM and
thereby interfere with EV characterisation. What further complicates matters is that
lipoproteins could carry markers traditionally associated with EVs including PS and
CD36. FT cycles did not consistently dissociate EVs and lipoproteins; however, FT
affected certain EV populations. Further studies are required to elucidate these findings.
PF06.06
Analysis of fluorescent labelling efficiency of extracellular vesicles derived from
different kingdoms of life with lipid-binding dyes via nano-flow cytometry
Ye Tian
a, Chen Chenb, Qian Niua, Shaobin Zhuc and Xiaomei Yand
aDepartment of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen
University, Xiamen, China, Xiamen, China (People’s Republic); bInstitute for Chemical
Research, Kyoto University, Uji, Japan; cNanoFCM Inc., Xiamen, China (People’s Republic);
dDepartment of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen
University, Xiamen, China, Xiamen, China (People’s Republic)
Introduction: In all domains of life – archaea, bacteria and eukarya, cells produce
and release extracellular vesicles (EVs). The double-layered lipid membrane is the
most prominent feature of EVs, and fluorescent labelling with lipid-binding dyes has
been frequently used to visualize and detect single EVs. For example, most conventional
flow cytometers rely on fluorescence threshold triggering for single EV detection
upon membrane labelling with lipophilic dyes. However, the labelling efficiency of
EVs with these lipid-binding dyes remains unknown. Here, we reported an approach to
quantitatively analyse the labelling efficiency of lipid-binding dyes toward EVs by
using a laboratory-built nano-flow cytometer (nFCM) that enables light scattering
detection of individual EVs as small as 40 nm.
Methods: EVs were extracted from cultured medium of HCT15 cells (colorectal cancer
cell line), E. coli O157:H7 (gram-negative), S. aureus (gram-positive) and Prochlorococcus
(Pro., marine cyanobacteria) by differential ultracentrifugation. EVs isolated from
E. coli O157:H7 and S. aureus were further purified by floatation in iodixanol density
gradient. The purity of these EV isolates was assessed by enumerating the particles
before and after the treatment with Triton X-100. Subsequently, the labelling efficiency
of several lipophilic fluorescent dyes, such as PKH26, PKH67, DiI and Di-8-Ane for
EVs were evaluated by comparing with their light scattering signals.
Results: The purity of EVs isolated from HCT15 cells, E. coli O157:H7, S. aureus and
Pro. were around 80% to 90%. Compared with side scattering signals, we found that
almost all the EVs derived from E. coli O157:H7, S. aureus and Pro. could be lightened
up by PKH26, PKH67, DiI and Di-8-Anepps. However, only around 40% of EVs isolated
from HCT15 cells could be labelled by these dyes. Morphological study by cryo-TEM
indicates that some vesicles secreted by HCT15 cells had surface protrusions (electron-dense
spikes protruding from the membrane). We suspect this structure may prevent these
lipophilic dyes from intercalating with EV membrane.
Summary/Conclusion: The nFCM provides a straightforward platform to analyse the labelling
efficiency of EVs with different lipid-binding dyes, which will be very helpful in
guiding the development of efficient vesicle-labelling strategies.
PF06.07
Evaluating the surface charge of yeast extracellular vesicles as a function of environmental
parameters
Nicholas M. Rogers, Meta Kuehn, Claudia Gunsch and Mark Wiesner
Duke University, Durham, USA
Introduction: Understanding the mechanisms of extracellular vesicle (EV) fate and
transport is critical to predicting their targeting capabilities and delivery efficiencies.
Surface chemistry has been shown to be an effective predictor of the fate of nanomaterials
(which include EVs) in complex environments. In particular, ascertaining how surface
charge changes based on surrounding conditions provides a foundation for the prediction
of nanomaterial behaviour. Hence, the goal of this study is to evaluate EV surface
charge as a function of environmental parameters to predict their ultimate environmental
fate.
Methods: EVs were isolated from yeast (S. cerevisiae) cell culture via the ultracentrifugation/density
gradient purification method. Nanoparticle Tracking Analysis (NTA), transmission electron
microscopy (TEM) and the Coomassie protein assay data collectively confirm the presence
of EVs. To evaluate the surface charge of EVs, electrophoretic mobility was measured
(Malvern Zetasizer Nano ZS) at varied pHs, ionic strengths and organic contents to
simulate environmental solution chemistry; values were then converted to zeta potential
estimates via the Smoluchowski approximation.
Results: Initial tests reveal EVs to have a predominantly negative charge, with a
zeta potential of −5.4 mV in phosphate buffer. Higher ionic strengths destabilize
vesicles, causing aggregation by neutralizing the surface charge.
Summary/Conclusion: We demonstrate an initial understanding of the behaviour of how
EV surface charge is influenced by various environmental parameters; the effects of
these changes are variable. This implies that studying these trends mechanistically
in complex systems may be challenging. Changes to the EV surface chemistry induced
by alterations in the surrounding environment often also causes aggregation, which
has implications for fate and transport. Further, work will be performed to probe
the aggregation tendencies of EVs. The quantification of physico-chemical parameters
is a first step in parameterizing future fate and transport models.
Funding: Funded by the National Science Foundation (NSF) and the Environmental Protection
Agency (EPA) under NSF Cooperative Agreement EF-0830093 and DBI-1266252, Center for
the Environmental Implications of NanoTechnology.
PF06.08
Isolation and characterization of bovine milk-derived EVs.
Saori Fukunagaa, Yuki Yamamoto
b and Hidetoshi Taharaa
aHiroshima University, Hiroshima, Japan; bHiroshima university, Hiroshima, Japan
Introduction: Extracellular vesicles (EVs) are secreted from various cells and known
to contain DNA, RNA and protein. Such inclusion is taken in other cells and plays
functionally. Since recent studies reported that EVs are detected in food, such as
fruits, vegetables and bovine milk, we hypothesized that functional EVs in food could
contribute to human health. In the study, we investigated whether the growth environment
for dairy cattle affected the contents and functions of EVs from bovine milk.
Methods: Milk was warmed at 37ºC water bath for 10 min, then mixed with 1/100 volume
of acetic acid at room temperature for 5 min and centrifuged at 10,000 x g at 4ºC
for 10 min to remove milk fat and debris. The supernatant was filtered with a 0.22
um membrane and defined as whey. The whey was ultracentrifuged at 200,000 x g for
70 min at 4ºC. After PBS wash was performed twice, the pellet of EVs was resuspended
in PBS, and centrifuged at 10,000 x g for 5 min at 4ºC. The supernatant was used as
EV solution. Particle size and concentration of EVs were measured by qNano. Total
RNA of EVs was isolated by miRNeasy Mimi kitand the RNA concentration was measured
by Agilent 2100 Bioanalyzer. RNA sequence was performed by Ion S5. The sequences data
was analysed by CLC Genomics.
Results: We compared two bovine milks, which were collected from different farm. Milk
A and milk B were both from healthy cattle who grew up with nutrient-filled pasture
without giving stress, however, B was raised under better conditions. Between milk
A and B, bovine milk-derived EVs were almost same particle size and concentration.
Then, amount of RNA containing EVs were same between milk A and B. However, NGS data
was revealed that EVs from milk B contained more immune-related microRNAs than milk
A.
Summary/Conclusion: This study revealed that the better growth environment of dairy
cattle increased immune-related microRNAs in bovine milk-derived EVs and so might
be better for health.
PF06.09
Regulatory effect of apple-derived nanoparticle on intestinal organic anion transporting
polypeptide (OATP) 2B1
Daichi Fujita
a, Hisakazu Komoria, Yuma Shirasakia, Toshiki Araia, Yui Iwamotoa, Tomohiko Wakayamab,
Takeo Nakanishia and Ikumi Tamaia
aFaculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health
Sciences, Kanazawa University, Kanazawa, Japan; bFaculty of Life sciences, Kumamoto
University., kumamoto, Japan
Introduction: Several studies have shown that plant-derived nanoparticles (NPs) taken
up by the intestinal cells affect intestinal function. Food-derived NP is known to
facilitate delivery of proteins, nucleic acids including microRNA (miRNA) and other
large molecules to intestinal tissues. Therefore, such large molecules may affect
gastrointestinal functions through NPs. Accordingly, we investigated the effect of
apple-derived NP to intestinal transporters through containing cargos.
Methods: NP was prepared by ultracentrifugation. Lipid membrane of NP and apple-derived
nucleic acid were labelled by fluorescents to examine uptake in Caco-2 cells using
microscope. Expressions of mRNA and protein of transporters in Caco-2 cells were evaluated
by qRT-PCR and Western blotting. Transport activity of OATP2B1 was evaluated by uptake
of oestrone sulphate. Apple miRNA targeting OATP2B1 predicted by in silico analysis
were detected by RT-PCR. microRNA target sites for OATP2B1 were evaluated by deletion
assay and luciferase assay.
Results: Fluorescent labelled NP and nucleic acids were observed in Caco-2 cells after
6 h exposure. NP significantly decreased expression and transport activity of OATP2B1
in Caco-2 cells. When NP were heat-denatured or broken by sonication, their decreasing
effects were attenuated. In deletion assay, decrease of OATP2B1 mRNA expression was
observed in only plasmid construct containing 3’ untranslated region (3’UTR). Luciferase
activity of pGL-OATP2B1-3’UTR was reduced by NP exposure. Seven miRNAs which predicted
to bind to this region were detected in NP. Moreover, decreased luciferase activity
was inhibited by some miRNA inhibitors for predicted miRNAs.
Summary/Conclusion: Apple NP reduced mRNA and protein expressions and activity of
OATP2B1, suggesting that apple miRNA in NP is involved in drug food interaction. Moreover,
it was suggested that apple miRNA contributes to drug disposition by regulation of
drug absorption mediated by OATP2B1 through NPs,
PF06.10
Fluorescent retroviruses as reference particles for Nanoscale flow cytometry
Vera Tang
a, Tyler Rennera, Anna Fritzschea, Dylan Burgera, Edwin van der Polb and Marc-André
Langloisa
aUniversity of Ottawa, Ottawa, Canada; bAmsterdam UMC, University of Amsterdam, Department
of Biomedical Engineering and Physics, Amsterdam, Netherlands
Introduction: Nanoscale flow cytometry (NFC) is a promising tool for phenotypic analysis
of individual small particles such as extracellular vesicles (EVs) and viruses that
are smaller than 500 nm in diameter. However, since many small EVs are currently at
the limit of detection for commercial flow cytometers, successful detection of EVs
requires optimization of both sample preparation and instrument settings. These optimizations
require reference particles reflecting size, refractive index (RI), and fluorescence
emission intensity of the labelled EVs of interest. Murine leukaemia virus (MLV) is
a retrovirus ~114 nm in diameter as measured by cryo-EM, with an estimated RI of 1.5.
Here we showcase the monodispersed nature of these viruses and demonstrate their use
as fluorescence reference particles for NFC.
Methods: We engineered MLVs to express its envelope glycoprotein fused to green fluorescent
proteins (eGFP and sfGFP) on the viral surface. MLVs were characterized by NFC and
by nanoparticle tracking analysis. Because MLVs are monodispersed, we combined scatter
intensities and hydrodynamic diameter to obtain the effective RI by solving the inverse
light scattering problem using Mie theory.
Results: We measured an antigen density of ~300 MESF of GFP per virion. In addition,
we found that antibody labelling of this virus-associated antigen with different fluorophore
conjugates (PE, BV421 and AF647) modulates both scatter intensities and hydrodynamic
diameter of the labelled virus. With regard to the hydrodynamic diameter, we show
that the effective RI of the viruses could be tuned by using different fluorophores.
Summary/Conclusion: MLVs are similar to small EVs in size with equivalent surface
area and comparable capacity for antigen expression. Unlike synthetic beads, MLVs
can be genetically engineered to express protein antigens of choice in biologically
relevant and consistent levels to act as internal positive controls for phenotypic
studies of EV surface marker expression. Moreover, MLVs are monodisperse and have
tuneable RI. Collectively, these properties support that MLVs are strong candidates
as fluorescence reference particles for NFC.
Funding: Natural Sciences and Engineering Research Council of Canada (NSERC)
PF07: Biogenesis II Chairs: Mathilde Mathieu; Hang Hubert YinLocation: Level 3, Hall
A15:30–16:30
PF07.01
Proteomic profiling of outer membrane vesicles derived from MicA, a small RNA from
Escherichia coli
So Hee Lee
a, Yeong-Jun Parkb and Kwang-sun Kima
aPusan National University, Busan, Republic of Korea; bPusan National University,
Pusan, Republic of Korea
Introduction: Outer membrane vesicles (OMVs) produced by Gram-negative bacteria are
utilized as vaccine or drug delivery platforms in terms of their efficient immune
responses to host cells. In a previous report, we identified that ectopic expression
of MicA, a small noncoding RNA from E. coli, produced a high production of OMVs as
a conserved manner in both E. coli and Salmonella through both up- or down-regulation
of OmpC or OmpA level, respectively, in OMV fractions. Moreover, MicA-derived OMVs
showed the protective role against Salmonella challenge, suggesting that OmpC-enrichment
in OMVs is important for the production and function of OMVs. However, MicA overexpression
in the knockout strain of ompA, a target of MicA, still strongly induced the production
of OMVs, indicating that another underlying mechanism of high production of OMV is
presented.
Methods: Analysis of total and surface proteins from control- and MicA-derived OMVs
from E. coli was performed using high-resolution mass spectrometry. The OMVs were
isolated from culture supernatants, followed by characterization using Nanosight.
We then analysed proteins of OMVs by in-gel digestion from SDS-PAGE, followed by nano
LC-MS/MS analysis. The functional analysis of candidate proteins on the biogenesis
of OMVs was performed by OMV preparation, BCA quantification, and protein analysis
from knockout strains of specific genes.
Results: We found that spherical OMVs were an average diameter of 84.7 ± 1.3 nm and
88.2 ± 2.4 nm for MicA- or control-derived OMVs, respectively. Further, we identified
1,102 (38) or 656 (40) proteins for MicA- or control-derived OMVs in total (or surface)
fractions are presented. Among them the level of 84 or 15 proteins from total or surface
fractions, respectively, was decreased or absent compared to control sample. Total
99 proteins were categorized into 19 functional groups and found that 60 proteins
are associated with flagella, ribosome, and modification. Moreover, the role of individual
proteins on the biogenesis of OMVs using knockout strains expressing proteins was
evaluated.
Summary/Conclusion: All our results enabled us to elucidate the underlying mechanism
of high production of OMVs by MicA and the information will be utilized as a vaccine
platform for infectious diseases.
PF07.02
Dysfunction in an autophagy-lysosome degradation pathway promotes secretion of ubiquitinated
proteins via extracellular vesicles
Toshihide Takeuchi, Satoko Sakai, Harue Ando and Yoshitaka Nagai
Osaka University, Suita, Japan
Introduction: Autophagy-lysosome degradation is a cellular protective mechanism that
prevents aberrant accumulation of cellular proteins, and thus, maintains protein homeostasis.
Recent studies have suggested that autophagy impairment leads to an increase in secretion
of aggregation-prone proteins, such as proteins that are associated with the neurodegenerative
diseases, although molecular mechanisms underlying such secretion and its biological
significance still remain elucidated.
Methods: The extracellular vesicle (EV) fractions were collected from the cell culture
media by ultracentrifugation, and analysed by Western blotting, electron microscopy
and nanoparticle tracking analysis.
Results: Here we show that perturbation of the autophagy/lysosome pathway activates
secretion of ubiquitinated proteins via EVs. We found that treatment of cells with
autophagy inhibitors leads to an increase in the amounts of ubiquitinated proteins,
as well as autophagy-related proteins including LC3 and p62, in the EV fraction of
the culture media. We also found that inhibitor treatment facilitates secretion of
EVs distinct from exosomes in size, and that these EVs are involved in secretion of
ubiquitinated proteins. Interestingly, analysis of knockout cells deficient for autophagy-related
proteins revealed that the factors in the initiation step of autophagy are needed
for EV-mediated secretion of ubiquitinated proteins.
Summary/Conclusion: These results indicate that autophagy impairment promotes secretion
of ubiquitinated proteins via EVs. Our data provide the mechanistic link between the
autophagy/lysosome pathway and vesicle secretion. We propose that cells may use the
EV-mediated secretion as an alternative pathway to maintain protein homeostasis when
cellular proteostasis machinery is functionally impaired.
Funding: This work was supported by JST; by KAKENHI (18H02585); by The Asahi Grass
Foundation and The Tokyo Biochemical Research Foundation.
PF07.03
Identifying the miRNAs associated with EV Secretion from cancer cell lines
Tomofumi Yamamoto
a, Nobuyoshi Kosakab, Fumihiko Urabea, Yutaka Hattoric and Takahiro Ochiyab
aDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute,
Tokyo, Japan; bDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Shinjyuku-ku, Japan; cClinical Physiology and Therapeutics,
Keio University Faculty of Pharmacy, Tokyo, Japan
Introduction: Extracellular vesicles (EVs) derived from cancer cells contribute to
their surrounding microenvironmental cells for their benefit. Our group has previously
shown that inhibiting the EVs production attenuated the angiogenesis in the tumour,
resulting in the suppression of metastasis. Thus, understanding the mechanisms of
EV secretion might contribute to the regulation of EV-mediated cancer progression.
However, the precise mechanism of EV secretion in cancer cells remains unclear. The
purpose of this study is to elucidate the unknown mechanisms of EV secretion in cancer
cells. To reveal this, microRNAs (miRNAs), which regulate multiple genes, are employed.
Methods: To identify the EV secretion associated miRNAs, miRNA-based screening method
was established. Combined with ExoScreen, which is ultra-sensitive detection method
of EV by measuring surface protein of EVs, such as CD9 and CD63, miRNA-based screening
was performed in colorectal cancer cell line, HCT116, and lung cancer cell line, A549.
The results of the screening were confirmed by the nanoparticle tracking analysis.
Candidate genes of these miRNAs were chosen by in silico analysis.
Results: From the initial 1728 miRNAs, we identified 13 miRNAs which are associated
with EV secretion in each cell lines. Then, the target genes of these miRNAs were
identified and confirmed that EV secretion was attenuated by siRNAs against candidate
genes. From 6 miRNAs, 27 genes, which were associated with EV secretion, were identified.
Interestingly, among six miRNAs, four miRNAs altered the EV secretion in both cell
lines, HCT116 and A549.
Summary/Conclusion: Some of these target genes have reported as endosomal pathway
associated protein and shown the up-regulation in cancer cells. These findings suggest
that the identification of target genes of these miRNAs provides the new insight into
the cancer cell communication with the microenvironmental cells, which leads to a
promising therapeutic approach against cancer progression.
PF07.04
Ras Tumour microvesicles biogenesis and signalling in drosophila
Vakil Ahmad, Carson Broeker, Kayla Calandro and Yves Chiswili. Chabu
University of Missouri, Columbia, USA
Introduction: Tumour-derived exosomes and microvesicles are increasingly implicated
in cancers. Their respective functional contributions to cancer progression and the
related mechanisms remain poorly defined. This is partly because current techniques,
centered on differential centrifugation, do not permit adequate and specific isolation
of pure exosomes or MV for targeted functional studies. More importantly, the paucity
of animal models to address mechanistic and functional questions in tissues has further
limited our knowledge on the role of extracellular vesicles in cancer biology
Methods: Using a Drosophila Ras tumour model, we have identified a strategy to specifically
label and genetically manipulate tumour microvesicles in tissues for mechanistic studies.
Results: We will discuss some of our preliminary results on the dynamic of microvesicle
biogenesis and their role in Ras tumour-macrophage signalling interaction.
Summary/Conclusion: Together with the power of Drosophila genetics, this in vivo system
will enable novel insights into microvesicle biogenesis and function during tumour
progression.
PF07.05
Src in endosomal membranes promotes exosome secretion and cancer progression
Chitose Oneyama
Cancer Cell Regulation, Aichi Cancer Center Research Institute, Nagoya, Japan
Introduction: c-Src is a membrane-associated tyrosine kinase that has key roles in
the signalling transduction that controls cell growth, adhesion and migration. In
the early stage of carcinogenesis, c-Src is activated under the plasma membrane and
transduces oncogenic signals. Previous reports demonstrate that c-Src is localized
to intracellular membranes, such as those of endosomes. However, the functional significance
of endosomal c-Src in cancer is not well understood.
Methods: We examined intracellular localization of active c-Src, and in intermediate
sections we found c-Src localized in perinuclear regions. In co-localization experiments
with organelle markers in Src-transformed cells, active c-Src was present with the
late endosome markers, including CD9 and CD63, which are also known as canonical exosome
markers. We examined exosome secretion in c-Src-transformed cells.
Results: Our results indicate that activated c-Src in the endosomal membrane promoted
the secretion of exosomes, in which c-Src was encapsulated. In addition, the ESCRT-interacting
molecule, Alix was identified as a c-Src–interacting protein in exosomes. We revealed
that the interaction between the SH3 domain of c-Src and the proline-rich region of
Alix activates ESCRT-mediated intra-luminal vesicle (ILV) formation, resulting in
the upregulation of exosome secretion in c-Src–transformed cells. We observed also
a correlation between malignant phenotypes and Alix–dependent aberrant exosome secretion
in c-Src–upregulated cancer cells.
Summary/Conclusion: Our findings indicate that c-Src-mediated activation of Alix promotes
ILV formation in MVB, resulting in increased exosome secretion from various human
cancer cells with activated c-Src. These data suggest that dysfunctions of exosome
secretion suppress cell transformation, offering a novel signalling target and strategy
for cancer therapeutics.
Funding: JST, PRESTO Grant Number JP1005457, Japan.
PF07.06
Modulation of Sphingosine-1-phosphate lyase and its implication in release of apoptotic
exosome-like vesicle
Jihyo Kim, Jaehark Hur and Yong Joon Chwae
Introduction: Biogenesis of apoptotic exosome-like vesicles (AEVs), which can function
as damage-associated molecular patterns, is reported to be regulated by sphingosine-1-phosphate
(S1P)/S1P receptor 1/3 signalling. Thus, cellular S1P levels could be key factors
in the biogenesis of AEVs. As is well-known, S1P is synthesized from sphingosine by
sphingosine kinase 1/2-mediated phosphorylation and irreversibly degraded into fatty
aldehydes and phosphoethanolamine by the enzyme, S1P lyase. In the present work, we
investigated the role of S1P lyase in biogenesis of the AEVs and its molecular modulation
in the apoptotic processes.
Methods: Preparation of AEVs: The conditioned medium was centrifuged for 10 min at
200 × g and twice for 20 min at 2,000 × g to remove cellular debris and apoptotic
bodies. The pellets were collected by overnight incubation in 8% PEG6000 and 0.5 M
NaCl, and washed by ultracentrifugation at 100,000 × g for 70 min.
Results: S1P lyase was degraded caspases-dependently in HeLa cells by apoptotic stimuli.
Over-expression of N-terminal 3X flag- and C-terminal HA-tagged S1P lyase turned out
that C-terminal region of S1P lyase was degraded. However, S1P lyase was not a direct
target of caspases because mutations of Asp residues at C-terminal regions did not
block its degradation. Possibly, S1P lyase might be a substrate of calpain in that
co-treatment of a calpain inhibitor, PD150606 with staurosporine inhibited the degradation
of S1P lyase. In consistent with this, knock-down of an endogenous inhibitor of calpain,
calpastatin increased the degradation of S1P lyase while knock-down of calpain small
subunit, CAPNS1 decreased the degradation of S1P lyase. Functionally, mutant form
of S1P lyase deleted in C-terminal 21 amino acids showed decreased enzyme activities
as well as less inhibitory effect on release of the AEVs when compared with wild type.
Summary/Conclusion: C-terminal degradation of S1P lyase during apoptotic processes
contribute to enhancement of biogenesis of the AEVs, possibly through decreasing enzymatic
activities of S1P lyase and subsequent increment of S1P in ER region. Although degradation
of S1P lyase is caspases-dependent, S1P is not a direct substrate of caspases. It
would be probable that S1P lyase was degraded by calpain, activated caspase-dependently.
PF07.07
Super-repressor-IκB-loaded exosome improves survival in a mouse model of sepsis and
attenuates sepsis-induced inflammation
Youngeun Kim
a, Hojun Choib, Amin Mirzaaghasib, Eunsoo Kimc, Kyungsun Choic and Chulhee Choic
aCellex LIfe Sciences Incorporated, Daejeon, Republic of Korea; bKorea Advanced Institute
of Science and Technology (KAIST), Daejeon, Republic of Korea; cCellex Life Sciences
Incorporated, Daejeon, Republic of Korea
Introduction: The nanoparticles referred as exosomes play an active role in intercellular
communication. The ability of exosomes to travel between cells and deliver their cargo,
which includes proteins and nucleic acids, makes them an appealing cell-free therapy
option to treat multiple diseases. Super-repressor IκB (srIkB) which is S32A and S36A
mutant form of IκB can continuously inhibit NF-κB because it is not phosphorylated
by IκB Kinase and degraded by proteasome. Therefore, it has the great potential as
a treatment for various inflammatory diseases. We have previously developed an opto-genetically
engineered exosome system named exosomes for protein loading via optically reversible
protein–protein interaction (EXPLOR) that can deliver soluble proteins via reversible
protein–protein interactions. Here, we generated opto-genetically engineered exosome
system to load srIkB into newly generated exosomes. Treatment with srIkB-loaded exosomes
significantly reduced tumour necrosis factor-α-induced translocation and DNA binding
of the p65, a subunit of NF-κB, in HeLa cells. Furthermore, srIkB-loaded exosomes
administration improved survival in the cecal ligation and puncture (CLP)-induced
sepsis mouse model and attenuated lipopolysaccharide (LPS)-induced systemic inflammation.
In addition, in sepsis-induced mice, exosomes accumulated in the spleen and liver
after intraperitoneal injection. This finding may be helpful for understanding the
mechanism about how the administration of srIkB-loaded exosomes facilitates the recovery
from sepsis. Taken together, these results show that srIkB-loaded exosomes could potentially
be a novel anti-inflammatory and immunosuppressive cure in the treatment of sepsis
and septic shock.
Methods: ABC
Results: ABC
Summary/Conclusion: ABC
PF07.08
Efficient delivery of Glucocerebrosidase Lysosomal Enzyme via EXPLOR technology for
treatment of Gaucher’s disease
Yonghee Song
a, Hojun Choib, Youngeun Kimc, Kyungsun Choia and Chulhee Choia
aCellex Life Sciences Incorporated, Daejeon, Republic of Korea; bKorea Advanced Institute
of Science and Technology (KAIST), Daejeon, Republic of Korea; cCellex LIfe Sciences
Incorporated, Daejeon, Republic of Korea
Introduction: Many intracellular proteins with great potential as biopharmaceutical
drugs have been identified. However, numerous challenges associated with intracellular
protein delivery have yet to be solved. Over the past years, extracellular vesicles
including exosome have been regarded as a new paradigm for soluble protein delivery
into cells or tissues. Because of their biological functions and features, exosomes
are expected to be a novel treatment for diverse diseases, such as cancer and rare
genetic disorder diseases. We have previously developed an opto-genetically engineered
exosome system named exosomes for protein loading via optically reversible protein–protein
interaction (EXPLOR) that can deliver soluble proteins via reversible protein–protein
interactions. Here, we demonstrate the intracellular delivery of β -glucocerebrosidase
(GBA) as functional proteins from the exosomes to the target cells. We generated opto-genetically
engineered exosome system to load GBA, which is an enzyme deficient in Gaucher disease
patients, into newly generated exosomes. Treatment with GBA-loaded exosomes showed
the significant increase of intracellular levels of cargo proteins and their function
in recipient cells in both time- and dose-dependent manner. In the present study,
we tested lysosomal localization of GBA-loaded exosome in the target cells and compared
the the efficacy with an analogue of the human GBA, VPRIV, to suggest it as a potential
drug candidate in Gaucher disease.
Methods: ABC
Results: ABC
Summary/Conclusion: ABC
PF07.09
Sequence-specific release of EV-associated RNAs
Christian Preußer, Marie Mosbach, Lee-Hsueh Hungand Albrecht Bindereif
Institute of Biochemistry, Justus Liebig University of Giessen, Giessen, Germany
Introduction: Extracellular vesicles (EVs) contain different classes of RNAs, such
as mRNA, miRNAs and circRNAs. As shown for miRNA and circular RNAs, RNAs are selectively
exported into vesicles [1–2]. However, the factors or mechanisms that contribute to
this specificity remain elusive. Thus, for example, a so-called Exo-motif has been
described for miRNAs, which, however, cannot be transferred to all miRNAs classes,
and for circRNAs a possible size-dependent export was suggested. In addition, only
a few putative protein factors involved in packaging have been described [2].
Methods: To determine the export signals for the selective release of certain RNA
species into EVs, we designed a modified in vivo SELEX approach (Systematic Evolution
of Ligands by Exponential Enrichment) for identifying putative RNA sequence elements.
We generated a random sequence pool (N40), which was transfected and expressed into
HEK293 and HeLa cells. Moreover, several expression constructs were used, which consist
of either an RNA Pol II or a Pol III promoter to analyze possible modification effects
on the 5’-end of the RNA. Similarly, we introduced transcription terminators at the
3’-end to prevent possible polyadenylation. EVs were isolated, followed by RNA isolation,
library preparation, RNA-seq analysis and bioinformatic identification of enriched
RNA motifs.
Results: We developed a new SELEX-based approach to identify enriched sequence motifs
within EV-RNAs. For this, we have generated constructs that express long degenerate
sequences but are still relatively small in total (85 nts). In a first attempt, we
analysed the expression of the degenerated sequences and were able to recover these
sequences from EV-RNAs. Detailed sequence and motif enrichment analyses are now in
progress.
Summary/Conclusion: Here we described a novel approach to determine specific sequence
motifs required for selective loading of RNA into EVs. This unbiased method should
contribute to our understanding of how RNAs are specifically packaged into EVs.
References: [1] Preußer et al. 2018, J Extracell Vesicles.; [2] Villarroya-Beltri
et al. 2013, Nat Commun.
PF07.10=OWP2.14
Isolation of extracellular vesicles from extracellular matrix based hydrogel 3D cell
cultures
Jens Luoto
a, Lea Sistonenb and Eva Henrikssona
a1Cell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University,
FI-20520, Turku, Finland; 2Turku Centre for Biotechnology, University of Turku and
Åbo Akademi University, FI-20521, Turku, Finland;, Turku, Finland; b1Cell Biology,
Biosciences, Faculty of Science and Engineering, Åbo Akademi University, FI-20520,
Turku, Finland; 2 Turku Centre for Biotechnology, University of Turku and Åbo Akademi
University, FI-20521, Turku, Finland;, Turku, Finland
Introduction: Cancer-derived extracellular vesicles (EVs) are commonly studied and
isolated from two-dimensional (2D) cell cultures. Nevertheless, three-dimensional
(3D) culture systems with extracellular matrix (ECM) provide physiologically more
relevant system to mimic in vivo tumour growth and progression of invasion. However,
there are currently no methods to efficiently isolate EVs from ECM-based 3D cultures.
For that purpose, we established a protocol for isolating EVs from cancer cells growing
in a 3D ECM-based hydrogel.
Methods: Human prostate cancer PC3 cells were grown in 3D to form spheroids in a commercially
available ECM-based hydrogel and the growth media was collected every two days for
a period of 14 days, during which the spheroids grew invasive. The respective media
were differentially centrifuged at 2K, 10K and 100K g and the pellets were resuspended
in PBS. The EVs were analysed by western blotting (WB) against the common EV markers
CD81, CD63 and CD9.
Results: Our preliminary data shows a step-wise increase of the EV markers in the
media as the PC3 spheroids formed, expanded and invaded to the surrounding 3D ECM.
The EVs produced by non-invasive or invasive spheroids are currently being characterized
with nano tracking analysis, electron microscopy and WB.
Summary/conclusion: This study demonstrates that EVs can be isolated from 3D ECM-based
hydrogel cell cultures, which recapitulate the tissue architecture of solid tumours.
Our results suggest that 3D cancer cell cultures have dynamic EV secretion determined
by the phenotype of the spheroids. Taken together, we present a novel protocol for
EV isolation from a 3D culture system and provide a platform to investigate EVs from
in vivo mimicking conditions.
Funding: This project is funded by Magnus Ehrnrooth Foundation, K. Albin Johansson
Foundation and Åbo Akademi University.
PF08: EVs in Tissue Injury and Repair Chairs: Johannes Grillari; Bas van BalkomLocation:
Level 3, Hall A15:30–16:30
PF08.01
The role of adipocyte-derived extracellular vesicles in vimentin mediated fibrosis
Sepideh Parvaniana,b, Fang Cheng
c,d,e, John Erikssonf,g, Jens Luotoh,i and Peiru Yangf,g
aCell Biology, Biosciences, Faculty of Science and Engineering, Åbo Akademi University,
Turku, Finland; bTurku Centre for Biotechnology, University of Turku and Åbo Akademi
University, Turku, Finland; Turku, Finland; cCell Biology, Biosciences, Faculty of
Science and Engineering, Åbo Akademi University, Turku, Finland; dTurku Centre for
Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland; eSchool
of Pharmaceuticals, Turku, Finland; fCell Biology, Biosciences, Faculty of Science
and Engineering, Åbo Akademi University, Turku, Finland; gTurku Centre for Biotechnology,
University of Turku and Åbo Akademi University, Turku, Finland; hCell Biology, Biosciences,
Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland; iTurku
Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland
Introduction: Vimentin is involved in wound healing by mediating fibroblast proliferation,
epithelial-mesenchymal transition processing, and collagen accumulation, but its functional
contribution to this process is not clear. Adipocyte-derived extracellular vesicles
(EVs) have the potential to promote wound healing by controlling molecular processes
on recipient cells.
Methods: Differential centrifugation was used for the isolation of EVs from wilde-type
(WT) and vimentin knockout 3T3lt1 (VIM-/-) cells. Electron microscopy and Western
blot were used to characterize EVs from the cell culture media. In vitro analysis
of cell migration and proliferation were performed using wound scratch assay and cell-derived
matrices (CDM) in response to WT and VIM-/- EVs.
Results: Our preliminary data shows that Human Dermal Fibroblasts (HDF) show different
significant migration responses in the presence of Adipose-derived Stem Cells (ASCs)
EVs. Especially, exosomes treatment induced more migration compared to other EVs.
Also, vimentin affected the results of the exosome treatment in fibroblast proliferation
and migration assays.
Summary/Conclusion: This study is expected to reveal novel mechanisms of ASCs-derived
exosomes regulating fibroblast activities in physiological wound healing and fibrosis.
Funding: This project was funded by Sigrid Juselius Stiftelse and Åbo Akademi University.
PF08.02
Effect of exosomes from human adipose-derived stem cells on hair growth
Hye-In Choi
a, Eun Wook Choib, Sang Won Yoonb and Byung-Soon Parkb
aR&D Center, PROSTEMICS, Seoul, Republic of Korea; bR&D Center, PROSTEMICS, seoul,
Republic of Korea
Introduction: Hair loss (alopecia) is a common medical problem affecting both men
and women, and is caused by genetics, hormonal changes, medical condition or medications.
Adipose-derived stem cells (ASCs) have been reported as an important component of
regenerative medicine and cell therapy for hair loss. Recent studies have demonstrated
that exosomes from mesenchymal stem cells and DPCs may regulate the hair follicle
development and hair growth. In this study, we investigated the function of ASC secreted
exosomes (ASC-exos) on hair growth.
Methods: Exosomes were isolated from the conditioned medium of human ASCs. The effects
of ASC-exos on hDPC proliferation were evaluated using CCK-8 assays. The mRNA expression
of growth factors was investigated using real-time PCR. Additionally, anagen induction
was evaluated using an in vivo mice model. Furthermore, we analyzed the profile of
exosomal microRNAs (exo-miRNAs) by microarray analysis, which was isolated from ASC-exos.
Results: We found that the ASC‐exo enhanced the cell proliferation of DPCs. Also,
quantitative real-time PCR showed that the expression of genes related with hair growth,
such as transforming growth factor β-2, noggin, was increased after being treated
with ASC‐exos. Additionally, ASC‐exos treatment accelerated the anagen hair induction
when topically applied to C57BL/6 mice. Based on this finding, we conducted microRNA
analysis and selected 12 miRNAs that contribute to regulation of hair growth.
Summary/Conclusion: Our results show that the exosomes from ASCs have a potential
to activate DPCs and promotes hair growth in vivo and may use in treatment of hair
loss.
PF08.03
Paracrine regenerative function of mesenchymal stem cells is not affected by chronic
kidney disease
Bas WM. van Balkom
a, Femke van Rhijn-Brouwerb, Diana Papazovab, Dienty Hazenbrinkb, Anke Meijerb, Arjan
van Zuilena, Raechel Tooropa, Joost Fledderusa, Hendrik Gremmelsa and Marianne Verhaara
aUMC Utrecht, Utrecht, Netherlands; bUMC Utrecht, Utrecht, USA
Introduction: Cell-based therapies have been developed to meet the need for curative
therapy in chronic kidney disease (CKD). Mesenchymal stromal cells (MSCs) enhance
tissue repair and induce neoangiogenesis through paracrine action of secreted proteins
and extracellular vesicles (EVs). Administration of allogeneic MSCs is less desirable
in a patient population likely to require a kidney transplant, but potency of autologous
MSCs should be confirmed, given previous indications that CKD-included dysfunction
is present. While the immunomodulatory capacity of CKD MSCs has been established,
it is unknown whether CKD affects wound healing and angiogenic potential of MSC-derived
CM and EVs.
Methods: MSCs were cultured from BM obtained from kidney transplant recipients (N = 15)
or kidney donors (N = 17). Passage 3 MSCs were used for experiments and collection
of conditioned medium (CM). EVs were isolated from passage 8 MSCs from 13 male participants.
In vitro pro-migratory and pro-angiogenic capacity of bone marrow (BM) MSC-derived
CM and EVs was assessed using an in vitro scratch wound assay and Matrigel angiogenesis
assay. Our methods are in agreement with the declaration of Helsinki and we obtained
written consent from bone marrow donors.
Results: Healthy and CKD MSCs exhibited similar differentiation capacity, proliferation
and senescence-associated β-galactosidase activity. Scratch wound migration was not
significantly different between healthy and CKD MSCs (p = 0.18). Healthy and CKD CM
induced similar tubule formation (p = 0.21). There was also no difference in paracrine
regenerative function of EVs (tubulogenesis: P = 0.46; scratch wound: P = 0.6).
Summary/Conclusion: Our results indicate that CKD does not affect the regenerative
potential of CM and EVs derived from CKD BM MSCs. This suggests that autologous MSC-based
therapy is a viable option in CKD.
Funding: Netherlands Organisation for Scientific Research (NWO)
PF08.04
Cell to cell interactions orchestrated by exosomal MiRNAs between pathogenic- and
Non-pathogenic corneal endothelial cells
Kazuko Asadaa, Junji Hamuro
a, Morio Uenoa, Atsushi Mukaia, Munetoyo Todab, Shigeru Kinoshitab and Chie Sotozonoa
aDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan;
bDepartment of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural
University of Medicine, Kyoto, Japan
Introduction: Corneal endothelial dysfunction such as bullous keratopathy (BK), Fuchs’
endothelial corneal dystrophy (FECD) can be restored only with corneal transplantation.
We have recently developed a cell-injection therapy using cultured human corneal endothelial
cells (cHCECs) (New Eng J Med.2018). Cultured HCECs have an inclination towards cell-state
transition (CST). The expression of miRNAs is essential in the regulation of many
cellular processes closely linked to CST in cHCECs. Here, we studied the role of exosomal
miRs in pathogenesis of BK and FECD.
Methods: The composition of heterogeneous cHCEC subpopulations (SPs) were verified
in regard to their surface cluster determinant (CD) markers. The profiles of miRs
in cells, culture supernatants (CS) and in fresh corneal tissues were detected by
3D-Gene® Human miRNA Oligo chip (Toray). Exosome surface markers were measured either
directly by Exo Screen or by WB after ultracentrifugation. PKH-labelled exosome was
applied for the evaluation of the incorporated exosomes in cHCECs with distinct CD44
expression levels.
Results: MiR34a-5p and miR-378 family were detected only intracellularly and were
strikingly lowered in pathogenic corneal endothelium. Candidate miRs in CS to discriminate
CD44- SPs from those with CD44++~+++ phenotypes were miRs 23a-3p, 24-3p, 184, 1246,
1273 and 1285-3p. Among these miRs 23a-3p, 24-3p and 184 have a tendency to decrease
in senescence-disposed cHCECs, the inversely correlated decrease with upregulated
CD44. It is of note that lowered expression of cellular miR-378 induced the elevated
gene expression of IL-8, MCP-1 and VEGF, and the increased secretion of exosomal miRs
23a-3p / 24-3p / 184 / 1273e / 1285-3p. CD9+ exosomes were more elevated in cHCEC
CS with senescence-like CST than those without CST, indicating the possible import
of these extracellular vesicles into cHCECs without CST. Compared with non-CST, CST
cHCECs have a tendency to incorporate more exosomes.
Summary/Conclusion: MiRNAs in exosomes serve as an alternative tool to qualify cHCEC
SPs. In this current study, we present the first finding that the lowered miRs in
pathogenic tissues may induce the groups of exosomal miRs reliant on the depolarized
CD44++~+++ HCECs.
PF08.05
Urinary CRK1 positive vesicles yield novel insight into microvesicular signaling of
the kidney
Fabian Braun
a, Inka Homeyera, Valerie Oberübera, Victor Puelles Rodriguezb, Sasha Shafikhanic
and Tobias B. Hubera
aIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg,
Germany; bIII. Department of Medicine, University Medical Center Hamburg-Eppendorf,
Hamburg, Germany, Hamburg, USA; cDepartment of Medicine, Division of Hematology/Oncology,
Department of Immunology and Microbiology, Rush University Medical Center, Chicago,
USA
Introduction: While specific functions of microvesicles have been uncovered in many
fields of biology and medicine, very little is known about their role in kidney health
and disease. Recently, a new subgroup of microvesicles was discovered in human and
murine cell culture as well as a model of glomerulonephritis. These vesicles are shed
upon apoptosis and trigger proliferation in neighbouring cells, hence named apoptotic
compensatory proliferative signalling vesicles – ACPSVs. As these vesicles could be
isolated from kidney tissue, we hypothesized that a fraction is shed into the urine
and can be isolated for further analyses.
Methods: We established a protocol of differential centrifugation and filtration to
isolate ACPSVs from urine samples of healthy control subjects and patients suffering
from different nephropathies. With western blot analysis and immunofluorescence microscopy,
we validated the presence of ACPSVs and investigated the cellular origin of the vesicles.
Whole lipid quantification was used to determine vesicle amount and to normalize the
protein content. To identify the potential of initiating proliferation, HeLa cells
were counted 24 h after treatment with freshly isolated urinary vesicles.
Results: The employed protocol lead to a robust isolation of spherical vesicles ranging
between 0.6–1.8 µm containing the ACPSV marker protein CRK1. Further protein analysis
revealed the presence of Podocin and Nephrin, pointing to a clear podocyte origin
of a fraction of these vesicles. Similar results could be obtained for vesicles originating
from the proximal tubulus and the collecting duct.
Summary/Conclusion: Our study represents the first analysis of urinary CRK1 containing
vesicles. Taken into account the presence of podocyte marker proteins in the vesicle
fraction isolated, we hypothesize, that these are not only shed upon apoptosis, hence
would not call the isolated fraction urinary ACPSVs. Ongoing studies aim to validate
the potential to initiate proliferation on different renal cell types, to further
identify the cellular origin as well as to determine differences in their function
and content in the state of renal diseases. As these vesicles can be easily isolated
in a high purity, they also represent a valuable source for biomarker research in
various nephropathies.
PF08.06
Human adipose stem cells-derived vesicles improve pain and reduce cartilage destruction
in an osteoarthritis rat model
Sehee Kim
a, Jihye Leeb, Jinhee Parkb, Jieun Leeb, Soyeon Kimb, Hanlim Moonb and Shingyu Baec
aMDimune, Seoul, Republic of Korea; bStem cell team, Seoul, Republic of Korea; cMdimune
corp., Seoul, Republic of Korea
Introduction: Human mesenchymal stem cells (hMSC) release extracellular vesicles (EV)
containing various proteins and RNAs, which can act as regulatory signals between
cells. hMSC-EVs also have provided significant beneficial effects in various disease
models. However, most mammalian cells secret small amount of EV, which is a limitation
for development of therapeutics. Therefore, the next generation of EV-mimetic vesicles
produced by serial extrusion of cells produces higher number of vesicles, and may
be easier to scale up for therapeutic developments. In this study we aimed to test
the efficacy of EV-mimetic vesicles derived from human adipose-derived stem cells
(hASCs) on rat osteoarthritis (OA) model.
Methods: hASC-derived EV-mimetic vesicles (CDV) were produced by serial extrusions
of cells through filters. The CDVs were characterized by transmission electron microscopy
(TEM), nanoparticle analysis system (NTA), and western blot and flow cytometry. CDVs
were injected into the joints in a MIA-induced osteoarthritis (OA) rat model. Improvement
of pain after CDV injections was assessed by paw withdrawal threshold and weight bearing,
whereas the joint destruction was evaluated by histology. We also estimated the effects
of CDV on proliferation and migration of human chondrocytes in vitro by cell-counting
and scratch assays.
Results: The CDV were 50–150 nm in diameter and carried multiple EV-associated tetraspanins
(CD63, CD9, CD81). CDV-treated OA mice had reduced paw withdrawal and was more weight
bearing 17 days after treatment than PBS-treated. Further, histology showed reduced
joint defects at 24 days. CDV-treated OA models displayed significant improvement
in paw withdrawal behaviour and weight bearing analysis. Similarly, chondrocyte migration
and proliferation were enhanced by CDV in a dose-dependent manner.
Summary/Conclusion: This study demonstrates for the first time the efficacy of hASC
EV-mimetic vesicles in OA model. Most interestingly we have confirmed that hASC EV-mimetic
vesicles can improve pain and regenerate defected cartilage. These results support
the concept that a potential application of hASC EV-mimetic is osteoarthritis, by
giving CDV locally into affected joints.
PF08.07
Natural and synthetic biomaterial mediated delivery of Mesenchymal Stem Cell derived
exosomes
Chun-Chieh Huang
a, Miya Kanazawab, Praveen Gajendrareddyc and Sriram Ravindrana
aUniversity of Illinois at Chicago, Chicago, IL, USA; bUIC College of Dentistry, Oral
Biology, Chicago, IL, USA; cUniversity of Illinois, Chicago, Chicago, IL, USA
Introduction: Mesenchymal stem cell (MSC) derived exosomes are versatile agents that
possess immunomodulatory and regenerative properties. However, systemic delivery of
natural or engineered MSC exosomes lacks site-specificity and can trigger ectopic
effects. Therefore, biomaterial-mediated site-specific delivery of exosomes is important.
As exosomal membranes are subsets of the plasma membrane. We hypothesized that MSC
exosomes can bound to extracellular matrix proteins and the property can be used as
a delivery technique.
Methods: To test this hypothesis, we evaluated the binding and delivery kinetics of
MSC exosomes to and from fibronectin, type I collagen and their derivative peptides
followed by in vitro and in vivo evaluation of their efficiency when delivered using
this approach.
Results: Results indicated that MSC exosomes bound dose-dependently and saturably
to fibronectin, type I collagen and their derivative peptides in an integrin mediated
fashion. The presence of integrins on the exosomal membrane was verified by immuno
electron microscopy and immunoblotting. Finally, exosomes bound to 3D hydrogels containing
these motifs were able to promote differentiation of naive MSC in vitro and bone regeneration
in a valvaria defect model in vivo.
Summary/Conclusion: Overall, this study shows that MSC exosomes can be tethered to
natural and synthetic biomaterials for site-specific delivery to aid repair and regeneration
of tissues.
Funding: This project is sponsored by NIH grant R01DE027404 and The Osteology Foundation
Advanced Researcher award.
PF08.08
Exosomes secreted during chondrogenic differentiation of human adipose-derived stem
cells for osteoarthritis treatment
Ye eun Yun
a, Woo Sung Kima, Hyun-A Parkb, Su Yeon Kimb and Yong Woo Choc
aDepartment of Chemical Engineering, Hanyang University, Ansan, Republic of Korea;
bExostemtech,Inc., Ansan, Republic of Korea; cHanyang University, Ansan, Republic
of Korea
Introduction: Osteoarthritis (OA) is a chronic degenerative joint disease and the
most common form of arthritis. Most of the current treatments focus on pain management
and treatment options for repair and regeneration of damaged articular cartilage are
limited. In recent years, stem cell-derived exosomes have been the spotlight as a
therapeutic candidate due to their regenerative and immunomodulatory capabilities.
In this study, we hypothesized that exosomes (Chondro-EXOs) secreted during chondrogenic
differentiation of human adipose-derived stem cells (hASCs) may contain specific biochemical
cues that promote the regeneration of damaged cartilage in OA animal model.
Methods: Chondro-EXOs were isolated from conditioned media during chondrogenic differentiation
by pre-filtration in 0.2 μm, followed by tangential flow filtration (TFF) system (300
kDa MWCO). The isolated Chondro-EXOs were characterized using transmission electron
microscopy (TEM), nanoparticle tracking analysis (NTA), flow cytometry, western blot,
and cytokine arrays. To evaluate the therapeutic efficacy of Chon-EXO, we injected
a mixture of Chondro-EXOs (1×108 particles) and hyaluronic acid hydrogel (1%) once
a week for 3 weeks at intra-articular site of MIA-induced subacute OA models. Knee
joints were harvested at four weeks after MIA injection and analysed histologically
by safranin O-fast green and haematoxylin and eosin (H&E).
Results: Chondro-EXOs were approximately 50-120 nm in diameter and expressed exosomal
markers such as CD9, CD63, and CD81. Various soluble factors related to anti-inflammatory
and cartilage regeneration were contained in Chondro-EXOs. In vivo studies demonstrated
that Chondro-EXOs significant prevented proteoglycan degradation and attenuated the
cartilage destruction in the damaged articular cartilage.
Summary/Conclusion: Our findings suggest that Chondro-EXOs act as a biological cue
for cartilage repair and provide a new therapeutic approach for osteoarthritis treatment.
PF08.09
hucMSC exosomes delayed diabetic kidney diseases by transported kinase ubiquitin system
promoted YAP ubiquitination degradation
Si Qi Yina, Cheng Ji
b, Hui Qianc and Jia Hui Zhangd
aJiangsu university, Zhen jiang, China (People’s Republic); bZhengjiang, China (People’s
Republic); czhen jiang, China (People’s Republic); 4Zhen jiang, China (People’s Republic)
Introduction: Diabetes mellitus (DM) is a type of metabolic disease. Diabetic kidney
disease (DKD) is the important microvascular complications of DM, the leading cause
of end-stage renal disease (ESRD). Human umbilical cord mesenchymal stem cell exosomes
(hucMSC-Exosomes) can participated in a variety of tissue damage repair. In this study,
we demonstrated that the mechanism which hucMSC-Exosomes delayed the progression of
DKD.
Methods: The DKD rat model established by 45% high-fat diet combined with streptozotocin
(STZ, 35 mg/kg,iv). DKD group (n = 12) and hucMSC-exosomes group (n = 12), control
group (n = 6). Blood glucose, body weight and 24 h urinary albumin clearance were
measured at 16 and 24 weeks. HE, PAS staining used to observed pathological of renal
tissue, Sirius red staining to detected renal interstitial fibrosis. YAP protein in
renal tissues with time. Confocal microscopy observed YAP in cytoplasm and nucleus
location. The CO-IP showed that the ubiquitin bound by YAP protein was significantly
increased. LC-MS/MS and west bolt confirmed CK1δ/β-TRCP existed in the exospores.
Used the adenovirus shRNA experiment knockdown CK1δ/β-TRCP.
Results: hucMSC-exosomes can migrated to renal injury site and regulated blood glucose
in tissues. hucMSC-exosomes intervention delayed the progression of DKD. Maintained
rat weight, reduced serum urea nitrogen, the degree of interstitial fibrosis significantly
weakened. Sustained high glucose stimulated activation of YAP. The YAP increased significantly
with time which increased degree of interstitial fibrosis. hucMSC-exosomes transported
CK1δ/β-TRCP repaired kinase ubiquitin system imbalance inhibited YAP activity that
attenuated interstitial fibrosis of DKD. Our experiments confirmed that hucMSC-exosomes
carried CK1δ/β-TRCP promoted YAP ubiquitination degradation.
Summary/Conclusion: hucMSC exosomes delayed diabetic kidney diseases by transported
CK1δ/β-TRCP promoted YAP ubiquitination degradation reduced renal interstitial fibrosis.
Funding: National Natural Science Foundation of China: (81871496)
Zhenjiang Key Laboratory of Exosomes Foundation and Transformation Application High-tech
Research, China: (ss2018003)
PF08.11
Neutrophil extracellular vesicles protect from joint breakdown in inflammatory arthritis
Bethan Lynne. Thomas
a, Lucy Norlingb, Francesco Dell’Acciob and Mauro Perrettib
aWilliam Harvey Research Institute, Queen Mary University London, London, UK; bWilliam
Harvey Research institute, Queen Mary University of London, London, UK
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune, inflammatory disease.
Recently our understanding of the inflammatory component has progressed tremendously,
however, even after the control of inflammation, joint damage, in particular cartilage
breakdown, continues to progress leading to secondary osteoarthritis and patient disability.
Extracellular vesicles (EVs), with their roles in cell-to-cell communication, present
a novel opportunity for treatment within difficult to target joint tissues like cartilage.
Neutrophil EVs are remarkable in their bio-actions and are abundant within the joints
of RA patients. Here we report the role of Neutrophil EVs in RA and their effect on
cartilage breakdown.
Methods: EVs were generated from human neutrophils stimulated with TNF (20 ng/ml;
20 min), and tested in the K/BxN murine model of inflammatory arthritis.
Results: In murine inflammatory arthritis, intra-articular injection of neutrophil
EVs (30–300x103 per joint), reduced knee swelling and displayed cartilage protective
effects, measured as reduced loss of proteoglycans and improved structural integrity
in the treated joints. Cartilage in EV-treated joints also maintained a higher content
of Collagen type2, an important component of healthy cartilage, and contained fewer
hypertrophic chondrocytes, abundant in diseased cartilage. Of great translational
importance, this effect lasted at least 28 days, suggesting that administration of
these EVs enacted positive circuits of protection characterized by a phenotypic change
within the tissue, resulting in long lasting protective effects even after the EVs
themselves have been cleared. In vitro, neutrophil EVs inhibited IL-1-induced cartilage
breakdown and restored basal expression of cartilage specific genes.
Summary/Conclusion: Neutrophil EVs exert powerful and long lasting protective bioactions
in inflammatory arthritis, modulating the ongoing joint inflammation while also protecting
from cartilage breakdown.
Funding: Medical Research Council (MRC) Regenerative medicine research grant
PF08.12
Role of small extracellular vesicles in ageing
Juan Antonio Fafian Labora, Ana O’Loghlen, Paula Carpintero-Fernandez and Olga Eleftheriadou
Epigenetics & Cellular Senescence Group, Blizard Institute, Barts and The London School
of Medicine and Dentistry, Queen Mary University of London, London, UK
Introduction: Ageing is a major risk factor for many human diseases. It is a complex
process that progressively compromises most of the biological functions of the organisms,
resulting in an increased susceptibility to disease and death. Hutchinson-Gilford
progeria syndrome (HGPS) and normal aging share many cellular phenotypes: abnormal
nuclear shape, dysregulated of epigenetic markers, increased DNA damage. Remarkably,
partial reprogramming extended the lifespan of the progeric mice with remodelling
of the epigenetic markers. The alteration in intercellular communication with age
has been demonstrated to be due to senescent cells developing a senescence-associated
secretory phenotype (SASP).
Methods: In this study, we have a characterization of small extracellular vesicles
(sEVs) using in vitro normal and premature ageing models and the rejuvenation capacity
of sEVs from young donors and iPSCs in old and progeria recipients.
Results: Firstly, we performed the evaluation of production of sEVs using Nanoparticle
Tracking Analysis (NTA) and characterization of positive CD63/CD81 sEVs by flow cytometry.
Then, we evaluated the rejuvenation potential of sEVs from young and iPSCs donors
on old and progeria fibroblasts. We found an increment of sEVs production with the
age and the capacity of sEVs from young and iPSCs donors to recover the proliferation
capacity (BrdU) and epigenetic marker (H3K9me3) in fibroblasts from progeria and old
donors.
Summary/Conclusion: These findings are important to the understanding about influence
of the ageing on sEVs and the development sEV-based therapies in age-related diseases.
Funding: BBSRC (BB/P000223/1) and The Royal Society (RG170399) awarded to AOL. JFL
and PCF are funded by the Xunta de Galicia Fellowships (Spain).
PF08.13
Rab27a dependent exosome secretion from tubular epithelial cell promotes albumin-induced
tubulointerstitial inflammation
Ye Feng
a, Linli Lvb and Bi-Cheng Liua
aInstitute of Nephrology, Southeast University, Nanjing, China (People’s Republic);
bInstitute of Nephrology, Zhongda Hospital, Southeast University, Nanjing, China (People’s
Republic)
Introduction: Tubular epithelial cells (TECs) secrete increasing exosomes under with
proteinuric toxicity. However, the mechanism through which exosomes are produced and
the effect on tubular cell haemostasis and tubulointerstitial inflammation are unknown.
Methods: Proteinuric renal disease model was induced by adriamycin (ADR) administration
through tail vein. Urinary albumin was determined at 0, 7, 14, 21 and 23 days after
ADR injection. For in vitro studies, TECs were treated with albumin. Exosomes were
purified from isolated tubules of kidney and cell culture supernatant for characterization
and functional study.
Results: Urinary albumin was significantly increased in ADR-treated mice 2 weeks after
injection compared with controls. Exosome production was increased significantly in
kidneys and tubules of ADR mice and in TECs with albumin exposure, confirmed by electron
microscopy, western blotting analysis of exosome markers and EXOCET. Interestingly,
we showed increasing levels of Rab27a mRNA and protein both in the tubules of ADR-injected
mice and in BSA-treated TECs in a dose dependent manner. Furthermore, the increased
exosome production was dependent on Rab27a up-regulation since silencing of Rab27a
reversed the exosomes secretion. Importantly, albumin was present in TEC-derived exosomes
after BSA exposure. Impressively, lysosomal degradation of albumin was increased while
the mRNA expression of inflammatory cytokines was reduced after inhibition of exosome
secretion by Rab27a silencing in TECs treated with BSA. To explore the effect of TEC
exosome production under albumin exposure, TEC-exosomes were purified and added to
naïve TEC. Up-regulation of inflammatory cytokines were found in receipt TECs. Lentivirus
Rab27a-inhibitor intrarenal injection reversed tubulointerstitial inflammation and
increased survival of ADR-induced mice through stably inhibiting Rab27a expression.
Clinically, high levels of Rab27a were found in tubules and correlated with the magnitude
of urinary exosomes in patients with chronic kidney disease.
Summary/Conclusion: These results suggest that Rab27a-dependent exosomes secretion
drive albumin escaping degradation and secreting into extracellular fluid may exacerbate
TECs injury by enhancing inflammatory response and consequently leading to tubulointerstitial
inflammation.
PF09: Detection of EV-based Biomarkers Chairs: Fabia Fricke; Shinichi KanoLocation:
Level 3, Hall A15:30–16:30
PF09.01
Extracellular vesicle (EV) extraction and characterisation in amniotic fluid (AF)
Natalia Gebara
a, Corinne Lampietrob, Benedetta Bussolatic, Chiara Benedettod and Luca Marozioe
aUniversity of Torino, Torino, Italy; bDepartment of Molecular Biotechnology and Health
Sciences, University of Torino, Torino, Italy; cDepartment of Molecular Biotechnology
and Health Sciences, University of Turin, Turin, Italy, Turin, Italy; dDepartment
of Surgical Sciences, Obstetrics and Gynecology, Torino, IL, USA; eDepartment of Surgical
Sciences, Obstetrics and Gynecology, Torino, Italy
Introduction: During pregnancy, placental-derived EVs have been identified in maternal
blood and AF thus are implicated in cell-to-cell communication. We hypothesize that
placental-derived EVs released in amniotic fluid may possess angio-modulating properties
that could be relevant in placental angiogenesis and that these characteristics may
be altered in pre-eclampsia (PE), a pregnancy complication characterised by hypertension
and proteinuria causing neonatal morbidity and perinatal mortality.
Methods: The amniotic fluid was obtained from normal pregnancies during caesarean
sections. The physio-chemical characteristics were tested by Nanosight technology
(NTA) and characterization of exosomal markers was carried through FACS using microspheres
and MASPlex exosome kit. MASPlex kit simultaneously detects 37 exosome surface epitopes.
Results: We set up a method for EV isolation from AF based on subsequent dilution
with PBS; first centrifugation at 10,000 g for 30 min at 4°C, filtration through a
0.45 µM filter and ultracentrifugation at 100,000 g for 2 h in 4°C. The averages EV
concentration was 4.34×1011 particles/ml with a mean peak of 240.45 nm, measured by
NTA. FACS analysis showed presence of angiogenic markers VEGFR 1,2,3 and CD105, immunological
markers HLA ABC, HLA DR, exosome specific markers CD81 and CD63 also CD133, which
indicates kidney origin. By using the MASPlex kit, we set up a semiquantitative method
for detection of 37 different potential AF-EV surface markers in one sample simultaneously.
We confirmed the heterogenic characteristics of AF-EVs, including expression of immune
system markers CD209, CD62P, CD11c, CD20 and endothelial markers CD146 and CD41b.
Summary/Conclusion: The characterisation of the AF-EVs with NTA and FACS demonstrates
the composition and size as well as presence of markers of different origin including
kidney, immune system and endothelium. The investigation of EV properties in healthy
and diseased placenta could prove useful in the future as a diagnostic tool to understand
and diagnose pregnancy-associated diseases.
Funding: This work was supported by the iPlacenta project founded by the European
Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie
grant agreement No. 765274
PF09.02
Evaluation of non-invasive biomarkers for monitoring functional status of endometrium
Mattia Criscuoli
a, Gaia Papinia, Davide Zoccob, Alice Luddic, Valentina Pavonec, Paola Piombonic and
Nataša Zarovnid
aExosomics Siena – University of Siena, Siena, Italy; bExosomics Siena, Siena, USA;
cUniversity of Siena, Siena, Italy; dExosomics, Siena, Italy
Introduction: Endometrium is a complex tissue with self-renewing properties, normally
undergoing cyclic modifications regulated by ovarian steroids divided into proliferative
and secretory phase. The transcriptomic profile of the endometrium is influenced by
other endometrial cell types (glandular epithelial and stromal) in both physiological
and pathological conditions. These cells have mutual paracrine effects partially mediated
by EVs, and they grow in a cycle-dependent manner. To assess the endometrium status,
several invasive or expensive techniques are currently employed, including immunohistochemistry
(IHC) on tissue biopsy, cytology and imaging. Development of protocols for the isolation
of EVs from novel biological sources is an extremely attractive means to surrogate
endometrial biopsies. These novel protocols may enable the identification and sensitive
detection of specific endometrial EV biomarkers for diagnostic solutions in reproductive
medicine, endometriosis or cancer.
Methods: Samples: primary endometrial cultures, urine from healthy donors in secretory
phase; Differential centrifugation, size exclusion chromatography (SEC), immunobeads
for EV isolation; Nanoparticle Tracking Analysis (NTA), BCA assay, ELISA, HS Qubit,
ddPCR, SPR, FACS for EVs and EV markers quantification and characterization.
Results: We provide new evidence that urine is a surrogate biofluid suitable for the
detection of endometrial EV biomarkers. Using pre-selected antibody panels, we identify
specific endometrium EV binding antibodies in relevant in vitro models. Coupling immune-isolation
to pre-analytical protocols for urine processing and sample quality testing enables
detection of a panel of endometrial genes in urine-recovered EVs.
Summary/Conclusion: Overall, the study provides a tool for non-invasive monitoring
of the functional status of the endometrium, supporting biomedical niches such as
assisted fertilization and diagnosis of endometriosis.
Funding: ENDEvor POR Region Tuscany (identification of the project) and Exosomics
R&D Programme
PF09.03
Unveiling autologous blood doping: comparative analysis of different purification
strategies for urinary extracellular vesicles pioneering miRNA biomarker research
Veronika Mussack
a, Georg Wittmannb and Michael Pfafflc
aTUM School of Life Sciences Weihenstephan, Division of Animal Physiology and Immunology,
Freising, Germany, Freising, Germany; bDepartment for Transfusion Medicine, Cell therapeutics
and Haemostaseology, University Hospital LMU, Munich, Germany, München, Germany; cAnimal
Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University
of Munich, Freising, Germany, Freising, Germany
Introduction: Autologous blood doping (ABD) increases the oxygen capacity via re-infusion
of a person’s autologous red blood cells. It is therefore used by endurance athletes
with a high level of unreported cases, especially since reliable methods for unequivocal
detection are still lacking. To support the Worldwide Anti-Doping Agency (WADA) in
protecting the athletes’ healthiness and ensuring harmonization, hereinafter extracellular
vesicles (EVs) and their conveyed cargo were used as potential biomarkers. Since degraded
red blood cells and their content are eliminated via the kidney and urine, the urinary
EV population and their microRNA (miRNA) profile were particularly focused.
Methods: After study approval by the local ethics committee, written informed consent
was obtained of 30 healthy men undergoing different ABD intensities and several sampling
time points. Consistent compliance with the “Declaration of Helsinki” was assured.
Due to a lack of standardization in urinary EV purification, five different isolation
strategies were evaluated: ultracentrifugation, membrane affinity, spin column chromatography,
immunoaffinity and precipitation. After EV characterization by nanoparticle tracking
analysis, western blotting, and transmission electron microscopy, total RNA was isolated
and a library for small RNA sequencing was prepared. The resultant successful strategy
was then applied to all the collected samples which were equally analysed regarding
their EV distribution and miRNA content.
Results: The comparative analysis disclosed huge discrepancies with respect to EV
yield, population, and purity, as well as RNA yield and detected miRNAs. By applying
the best performing strategy, which was based on immunoaffinity, significantly higher
amounts of urinary EVs and several significantly differentially regulated miRNAs were
observed after ABD.
Summary/Conclusion: Urinary EVs and their miRNA profile hold indeed promising attempts
for the clear separation of ABD and non-doped athletes. Moreover, the included complex
comparative methodological analysis contributes enormously to future standardization
and comparability of urinary EV research.
Funding: The current project has been financially supported by the WADA.
PF09.04
Extracellular vesicles as graft biomarkers to address lung transplantation outcome
Mario Barilani
a, Ilaria Righib, Giuseppe Buonoc, Lorenzo Rossod, Mario Nosottie and Lorenza Lazzaric
aUnit of Regenerative Medicine – Cell Factory, Department of Transfusional Medicine
and Hematology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano
(MI), Italy; Università degli Studi di Milano, Milan, Italy; bThoracic Surgery and
Lung Transplant Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano
(MI), Italy, Milano, Italy; cUnit of Regenerative Medicine – Cell Factory, Department
of Transfusional Medicine and Hematology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore
Policlinico, Milano (MI), Italy, Milano, Italy; dUniversità degli Studi di Milano,
Milano (MI), Italy, Milano, Italy
Introduction: In the medical practice, lung transplantation is the last therapeutic
option for end-stage pulmonary failure, when other treatments are no longer effective.
Yet, only 15-20% of the multi-organ donors have suitable lungs. Furthermore, clinical
complications may rise after organ retrieval following ischemia–reperfusion lung injury,
such as primary grafts dysfunction or chronic lung allograft dysfunction. Currently,
clinical parameters implemented to assess the quality of the graft have failed to
evaluate tissue damage at the cellular level and to predict transplantation outcome.
Therefore, we focused our attention on extracellular vesicles (EV) as innovative,
non-invasive biomarkers urgently needed to assess lung quality and monitor organ engraftment.
Methods: Research activities involving human subjects complied the Declaration of
Helsinki. Informed consent and local ethics committee approval were obtained. Size
and concentration analysis were performed by nanoparticle tracking analysis (Nanosight
NS300, Malvern).
Results: Preliminary results showed the presence of EV of different sizes in bronchoalveolar
lavage (BAL) and plasma of both donors and recipients. EV presented highly polydispersed
size distributions in a 50–1000 nm range. Different EV production kinetics were observed
in the recipients (10E08-10E10 particles/mL range): BAL samples showed concentration
peaks within 72 h post-transplant and a subsequent decreasing trend, whereas plasma
samples showed a slightly increasing trend. EV samples will be analysed for RNA content
and antigen expression, and correlation with lung transplantation outcome will be
evaluated at the conclusion of the follow-up.
Summary/Conclusion: The identification of specific EV kinetics patterns and RNA signatures
represents a promising approach to define biomarkers useful for thoracic surgeons
who want to manage in advance complications associated with lung transplantation.
PF09.05
Expression profile analysis of miRNAs in serumal exosomes as sensitive biomarkers
before and after hematopoietic stem cell transplantation
Daming Wang
a, Lei Zhengb and Taixue Anc
aShenzhen, China (People’s Republic); bClinical Laboratory Department, Nanfang Hospital,
Southern Medical University, Guangzhou, China (People’s Republic); cNan Fang Hospital,
Southern Medical University, Guangzhou, China (People’s Republic)
Introduction: To investigate the differential expression of miRNAs of candidate genes
in peripheral blood serum of patients with acute graft-versus-host disease (aGVHD)
after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Methods: There were a total of 30 patients with aGVHD and without aGVHD within 100 days
after allogeneic hematopoietic stem cell transplantation in leukaemia; serumal exosome
and RNA were extracted before and after the transplantation; image acquisition and
data analysis were performed after hybridization of gene chips; candidate genes associated
with the occurrence of aGVHD were screened out based on the differential expression
of miRNAs.
Results: The expression profile of miRNAs after hybridization of gene chips showed
increasing or decreasing tendency of miRNAs before and after the transplantation.
Compared with the control group, for the miRNAs whose signal fold multiples greater
than 10 folds, there were 11 miRNAs increased and 26 decreased in the aGVHD group.
The expression of hsa-miR-3976, hsa-miR-122-5p, hsa-miR-3125 were significantly up-regulated
and the expression of hsa-miR-4687-5p, hsa-miR-941, hsa-miR-4769-5p were down-regulated;
these six miRNAs were listed as candidate miRNA gene sensitive biomarkers in peripheral
serum.
Summary/Conclusion: Through Go, pathway and target gene analysis, candidate genes
participate in regulating water-soluble vitamin metabolism, mitochondrial apoptosis
and other biological processes, regulating cell membrane and organelle synthesis.
The specific mechanism will be further studied.
Funding: Natural Science Foundation of Guangdong Province (2015–2018)
Free application project of Shenzhen Science and Technology Innovation Committee (2017–2020)
PF09.07
Circulating cancer-associated extracellular vesicles as early detection and recurrence
biomarkers for pancreatic ductal adenocarcinoma
Yusuke Yoshioka
a, Tetsuya Nakatsurab and Takahiro Ochiyac
aTokyo Medical University, Shinjyuku-ku, Japan; bDivision of Cancer Immunotherapy,
Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa,
Japan; cDepartment of Molecular and Cellular Medicine, Institute of Medical Science,
Tokyo Medical University, Shinjyuku-ku, Japan
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is usually found at an advanced
stage, although diagnosis at an early stage is unequivocally associated with better
long-term survival. Therefore, there is an urgent need to develop early detection
methods to improve these outcomes. Extracellular vesicles (EVs) attract much attention
as potential biomarker because tumour cells have been shown to release EVs into circulation
which mirror their cellular origin. Detection of cancer-associated EVs in body fluids
from patients could serve as a non-invasive liquid biopsy for diagnosis and monitoring
of cancer. The main objective of this study is the identification and detection of
PDAC-specific EVs in patient-derived serum.
Methods: Total EV proteins were purified from three different stages of PDAC (stage
II, III and IV, each group: six patient sera pooled) and healthy donors. Mass spectrometry
was performed with purified EV proteins, and biomarker candidates were validated by
immunoblotting in PDAC patient blood samples.
Results: Proteomics analysis identified over 500 proteins in each pooled samples,
and we identified nine membrane proteins, which were detected in only PDAC patients,
not in healthy donors. We focused on two proteins and performed immunoblotting for
the validation of potential biomarkers in three stages of PDAC blood samples. As a
result, these proteins were detected exclusively in EVs of PDAC patient sera including
stage II. Moreover, we analysed a total of 33 samples from 11 PDAC patients who performed
surgery at three time points; before surgery, after surgery and recurrence as an early
stage model. As a result, these proteins were detected in EVs derived from preoperative
samples and recurrence samples.
Summary/Conclusion: This study using unique recurrence samples as an early stage model
shows that the identified EV-associated proteins have potential as early detection
makers and warrant further investigation.
Funding: This work was supported in part by a Grant-in-Aid from the Japan Science
and Technology Agency (JST) through the Center of Open Innovation Network for Smart
Health (COINS) and a Grant-in-Aid from the Japan Agency for Medical Research and Development
(AMED) through Project for Cancer Research and Therapeutic Evolution (P-CREATE: JP18cm0106402).
PF09.08
Exosome-encapsulated miRNA in urine as a non-invasive biomarker for prostate cancer
Zhuo Li, La-Xiu Li, Yanjun Diao, Yue-yan Ma and Xiaoke Hao
Department of Clinical Laboratory Medicine, Xijing Hospital, Air Force Medical University,
Xi’an, China (People’s Republic)
Introduction: Prostate cancer (PCa) is the most common malignant tumours in male urinary
system. Novel and non-invasive biomarker with higher sensitivity and specificity for
the diagnosis of PCa are urgently needed. Exosomal microRNAs in circulating fluids
have recently been reported to augment diagnosis and management of certain diseases,
including cancer. The purpose of this study is to explore the diagnostic value of
urinary exosomal miRNAs for PCa.
Methods: A urinary exosomal microRNA expression profiling was performed by next-generation
sequencing using urine samples. Then, candidate miRNAs were selected and validated
by qRT-PCR in 3 cohorts consisting of PCa patients, healthy controls and patients
with benign prostatic hyperplasia (BPH). Receiver operator characteristic (ROC) analysis
was used to evaluate the diagnostic and prognostic value of urinary exosomal miRNA
in PCa.
Results: Five candidate miRNAs were found by NGS. Significant downregulation of urinary
exosomal miR-375 was observed in PCa patients comparing with healthy controls, while
miR-451a, miR-486-3p and miR-486-5p were found significantly upregulated. However,
no significant difference was found for miR-16-2-3p. The expression level of urinary
exosomal miR-375 showed significant correlation with clinical stage and bone metastasis
of the patients with PCa (p < 0.05). ROC analysis demonstrated that the urinary exosomal
miR-375, miR-451a, miR-486-3p and miR-486-5p are able to differentiate PCa patients
from healthy controls, with the AUC of 0.788, 0.757, 0.704 and 0.796, respectively.
The urinary exosomal miR-375 was found superior in discriminating localized PCa from
metastatic PCa, with an AUC of 0.806. Additionally, PCa patients can be distinguished
from BPH patients by using a panel combining urinary exosomal miR-375 and miR-451a,
with an AUC of 0.726.
Summary/Conclusion: These findings demonstrate that the urinary exosomal miRNA can
serve as a novel and non-invasive biomarker for diagnosing and predicting the progression
of PCa.
Funding: Shaanxi Health and Family Planning Commission Foundation Project (2016D020),
Xi’an Science and Technology Bureau Foundation Project (2017121SF/YX015) and Shaanxi
Natural Science Foundation Project (2018JQ8010).
PF09.09
Unlocking the secret of salivary exosomes derived from HPV-driven oropharyngeal cancer
Kai D Tang
a, Yunxia Wana, Natalie Bozyka, Xi Zhanga, Liz Kennyb and Chamindie Punyadeeraa
aThe School of Biomedical Sciences, Institute of Health and Biomedical Innovation,
Queensland University of Technology and The Translational Research Institute, Queensland,
Australia., Brisbane, Australia; bSchool of Medicine, University of Queensland; Royal
Brisbane and Women’s Hospital, Brisbane; Central Integrated Regional Cancer Service,
Queensland Health, Queensland, Australia., Brisbane, Australia
Introduction: There has been a significant rise in the incidence of oropharyngeal
cancer (OPC) associated with high-risk human papillomavirus (HPV), predominantly HPV-16
infections in high-income countries, especially when compared to HPV-negative head
and neck cancer (HNC). Growing evidence supports the concept that exosomes (30–150 nm)
loaded with unique bio-components (DNA, RNA and protein) play a salient role in cancer
development and progression. However, the role of exosomes in saliva obtained from
HPV-driven OPC is still far from clear.
Methods: Morphology and molecular features of exosomes derived from three different
saliva sampling methods: unstimulated saliva, acid-stimulated saliva and salivary
oral rinses were examined using transmission electron microscopy (TEM), nanoparticle
tracking (NTA) and western blot analysis. HPV-16 DNA detection in salivary exosome
was determined using qPCR method. Proteome profile of salivary exosomes derived from
both cancer-free controls and HPV-driven OPC patients was characterized using mass
spectrometry analysis.
Results: Here, we showed that unstimulated saliva had the greater abundance of exosomes
when compared to the other saliva sampling methods. In fact, the three common exosome
markers (CD9, CD63 and CD81) were higher in unstimulated saliva method. Nevertheless,
no appreciable difference in exosome morphology was found among the three different
sampling methods. Furthermore, only salivary exosome derived from HPV-driven OPC had
a detectable level of HPV-16 DNA. Intriguingly, the proteomic signature of salivary
exosome was significantly different between cancer-free controls and HPV-driven OPC.
Summary/Conclusion: Taken together, our results showed that unstimulated saliva is
an optimum sampling method for exosome characterization. More importantly, the development
of a low cost non-invasive saliva-based test (salivary exosomal DNA and protein) will
offer an opportunity to detect HPV-driven OPC, thereby opening new avenues in the
future for clinical and commercial translation.
Funding: N/A
PF09.12
Determination of the protein cargo of colon cancer tissue-derived extracellular vesicles
Aleksander Cvjetkovic
a, Rossella Crescitellib, Helena Taflinc, Cecilia Lassera and Jan Lötvalld
aKrefting Research Centre/University of Gothenburg1 Krefting Research Centre, Department
of Internal medicine and clinical nutrition, Institute of Medicine, University of
Gothenburg, Gothenburg, Sweden; bKrefting Research Centre, Department of Internal
medicine and clinical nutrition, Institute of Medicine, University of Gothenburg,
Gothenburg, Sweden; cDepartment of Surgery, Institute of Clinical Sciences, Sahlgrenska
Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg,
Sweden; d1 Krefting Research Centre, Dept of Internal medicine and clinical nutrition,
Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Introduction: Colorectal cancer (CC) is the third most common cancer to affect both
men and women, and the third-leading cause of cancer-related mortality. In order to
be curable, CC has to be diagnosed and treated by surgery before the tumour cells
have started to metastasize. In order to find CC at an early stage, more sensitive
biomarkers need to be developed. Extracellular vesicles (EVs) have in the last decade
been recognized as major players in cancer biology but it’s only in recent years that
isolation protocols have reached enough sophistication for a truly meaningful proteomic
analysis.
Methods: Tumour and non-tumour tissue (approx. 10 cm from tumour) were excised from
10 CC patients. The tissue was sliced into approximately 1 mm 3 pieces and partially
digested with DNase and Collagenase in cell culture medium for 30 min at 37°C. Digested
tissue was filtered through a 70 µm filter to remove tissue pieces and large fragments.
Vesicles were isolated from the media with an isolation process consisting of differential
ultracentrifugation and density gradient floatation aimed at isolating EVs. Isolates
were then lysed, tryptically digested and Tandem Mass Tag labelled before analysis
by mass spectrometry. The samples, 20 in total, were analysed in two rounds as “Set
1” and “Set 2”, with each set containing EVs derived from five tumour tissues and
five non-tumour tissues.
Results: In total, approximately 4000 proteins were identified and quantified, with
2567 and 3742 proteins identified in Set 1 and Set 2 respectively with an overlap
of 2271 proteins between the sets. Proteins which after a t-test had a p-value lower
than 0.05 and a fold change of at least two were considered as being differently expressed
in tumour tissue EVs as compared to normal tissue EVs. 299 and 592 such proteins were
identified in Set 1 and Set 2 respectively, with 125 meeting these requirements in
both Sets.
Summary/Conclusion: EVs isolated directly from the tumour tissue microenvironment
differ in their protein cargo from that of EVs resident in equivalent non-tumour tissue.
Proteins carried by tumour derived EVs could potentially play a role in tumour biology
by mediating signalling to neighbouring cells. Furthermore, these differentially expressed
proteins could potentially function as biomarker candidates.
PF09.13
Characterization of small extracellular vesicles secreted by dermal fibroblasts
Marijana Jevtić
a and Sarah Hetrichb
aMaster of Pharmacy – Medical Biochemist, Berlin, Germany; bProf. Dr, Berlin, Germany
Introduction: Dermal fibroblasts play a key role in epidermal proliferation and differentiation.
They communicate with other cell types, playing a crucial role in the regulation of
the skin (patho)physiology. Extracellular vesicles (EVs) are small membrane-enclosed
vesicles (30-150 nm) that are released from all cell types into the extracellular
space and represent an important mode of cell-to-cell communication. Emerging data
indicate that they play key roles in many (patho)physiological processes. However,
there is currently very little information about the content and the function of EVs
from dermal fibroblasts. Therefore, we aimed to isolate and characterize EVs secreted
by dermal fibroblasts.
Methods: Dermal fibroblasts were isolated from juvenile foreskin and cultivated in
DMEM supplemented with 7.5% FBS and 2 mM L-glutamine. On day 5 of cultivation, dermal
fibroblasts were washed with PBS and further cultured in EV-depleted medium for 24h
before collecting the medium. To elucidate the characteristics of EVs, EVs were isolated
from conditioned medium by several ultracentrifugation and filtration steps. To verify
the presence of EVs, nanoparticle tracking analysis (NTA), transmission electron microscopy
(TEM) and flow cytometry (FACS) were performed on the dermal fibroblasts-derived EVs.
Results: With FACS analysis of dermal fibroblasts, we proved that more than 95% of
the cells were alive in the culture, what provide that we isolated pure EVs released
by live cells. NTA and TEM analyses proved the presence of EVs, cup-shaped structure
and size smaller than 150 nm. With FACS analysis of EVs, we proved that EVs are enriched
with cytosolic protein present in EVs, Tsg101.
Summary/Conclusion: Here we present characterization of EVs secreted by dermal fibroblasts
in terms of size, shape and cytosolic proteins present in EVs. In next steps, we plan
mass spectrometry of the proteome of dermal fibroblasts and EVs secreted by dermal
fibroblasts. EVs are able to interact with cells located nearby or distantly and EVs
can be a way for carrying information from cell to cell. These findings may lead to
identification of new signalling pathways in between dermal fibroblasts and other
cells present in the skin, what could help us to understand the regulation of the
skin physiology.
Funding: S.H. acknowledges financial support by the German Research Foundation (DFG
HE 7440/4–1).
PF10: Advances in EV separation and concentration Chairs: Stacey Gifford; Fuquan YangLocation:
Level 3, Hall A15:30–16:30
PF10.01
Efficient clearance of lipoproteins from anti-coagulated and native blood-derived
products to yield pure extracellular vesicle preparations
Alexander Otahala
, Olga Kutenb, Andrea De Lunab, Zsombor Laczac and Stefan Nehrerb
aDanube University Krems, Krems An Der Donau, Austria; bDanube University Krems, Vienna,
Austria; cOrthosera, Vienna, Austria
Introduction: Extracellular vesicles (EVs) increasingly gain focus in regenerative
medicine for promoting tissue repair and alleviating inflammation. However, there
are no standards for EV isolation from patient blood nor for quality assessment owing
to lack of knowledge about active components or mechanisms of action. It is known
that high, low and very low density lipoproteins (HDL, LDL, VLDL) as well as chylomicrons
copurify with EVs during isolation from various body fluids including blood via ultracentrifugation
(UC) or size exclusion chromatography (SEC). The aim of our study was to develop an
isolation strategy to purify EVs from blood derived products which are already in
clinical use. Therefore, we analysed EV preparations from citrate-anticoagulated platelet-rich
plasma (CPRP) and hypACT™ serum.
Methods: Particle concentrations after UC, SEC or a combination of both were assessed
via nanoparticle tracking analysis (NTA). EVs were labelled with annexin V (AnnV),
CD63 as well as CD41 and analysed by flow cytometry (FC). LDL and HDL content was
determined in EV preparations by labelling of Apolipoprotein A1 (ApoA1) and Apolipoprotein
B100/48 (ApoB-100) by FC as well as detection via Western Blot. Presence of EVs was
confirmed by cryo electron microscopy.
Results: NTA revealed 100-fold higher particle concentrations after SEC than after
UC or UC+SEC in both, CPRP and hypACT(TM) serum. AnnV, CD63 as well as CD41 were detected
on EVs via FC. It also revealed efficient clearance of ApoB-100 bearing particles
by UC, while ApoA1-positive particles persisted. SEC alone removed ApoA1-positive
particles, but failed to remove ApoB-100 bearing particles. The combination of enrichment
via UC and purification via SEC enabled efficient clearance of both lipoprotein species
(ApoA1 as well as ApoB-100). These findings are also supported by Western Blot analysis.
Summary/Conclusion: EV preparations are commonly contaminated with lipoproteins due
to their similar size and density. The coupling of UC to separate EVs from lipoproteins
by density and SEC to yield separation by size enabled efficient clearance of lipoproteins
from CPRP or hypACT(TM) serum and obtaining pure EV preparations.
Funding: The work was funded by the Wissenschaftsfonds of Lower Austria (NÖ) together
with the European Fund for Regional Development (EFRE).
PF10.02
Proteomic and Lipidomic Analysis of Extracellular Vesicles from Human Plasma and Urine
Purified by Asymmetrical Flow Field-Flow Fractionation
Fuquan Yang
Institute of Biophysics, Chinese Academy of Sciences, Beijing, China (People’s Republic)
Introduction: Extracellular vesicles (EVs) are composed of lipid bilayer membranes
and they are a group of heterogeneous, nano-sized structures vesicles enriched with
nucleic acids, proteins and lipids. EVs can be released by normal and cancer cells
to their surrounding environments and they are also found in diverse body fluids,
including blood, urine, saliva, cerebrospinal fluid, breast milk, seminal fluid. EVs
play many important roles in numerous physiological and pathological processes.
In recent years, various studies on EVs have been conducted in the clinical research.
EVs are rich in disease related biomarkers, and can protect the wrapped parent cells
derived materials due to their double layer membrane structures and target the specific
cells or tissues. EVs have promising potential for diagnostic and therapeutic applications,
and can serve as biomarkers and targeting drug delivery systems.
Omics studies of EVs have been used for the discovery of biomarkers. The isolation
of EVs are the key step for the omics studies on EVs.
Methods: Field-flow fractionation (FFF) technique was first invented in 1966 by J.
Calvin Giddings. FFF has unique properties enabling separation and characterization
of macromolecules, polymers, proteins, colloids, cells and vesicles from 1 nm to 100 m
at high resolution. AF4 has been reported to purify EVs from the supernatant of cell
culture. In this study, we have developed AF4 based mothed for isolation of EVs from
human plasma and urine. The proteomic and lipidomic analysis was performed using LC-MS/MS.
Results: EVs in human plasma were isolated from HDL and LDL with good resolution by
an optimized AF4 conditions. EVs in human urine were also isolated from the high abundant
protein uromodulin by optimized AF4 conditions after treatment with DTT reduction.
Transmission electron microscopy (TEM), SDS-PAGE, Western Blot, proteomics and lipidomics
are further applied for the studies on purified EVs from human plasma and urine.
Summary/Conclusion: The results reveal that AF4-based separation method for EVs is
of high reproducibility, purity, recovery and continuous preparation and separation
ability. The specific proteins and lipids have been identified from human plasma and
urine EVs compared with the whole components in human plasma and urine
PF10.03
A centrifugation model to predict the behaviour of tumour biomarkers in liquid biopsies
Linda Rikkert
a, Edwin van der Polb, Ton van Leeuwenc, Rienk Nieuwlandd, Leon Terstappene and Frank
Coumansd
aAmsterdam UMC, location AMC, Amsterdam, Netherlands; bAmsterdam UMC, University of
Amsterdam, Department of Biomedical Engineering and Physics, Amsterdam, Netherlands,
Amsterdam, Netherlands; cdAmsterdam UMC, University of Amsterdam, Department of Biomedical
Engineering and Physics, Amsterdam, Netherlands, Amsterdam, Netherlands; dAmsterdam
UMC, University of Amsterdam, Laboratory of Experimental Clinical Chemistry, Amsterdam,
Netherlands, Amsterdam, Netherlands; eMedical Cell Biophysics, University of Twente,
Enschede, Netherlands
Introduction: Biomarkers in blood of cancer patients include circulating tumour cells
(CTCs), tumour-educated platelets (TEPs), tumour-derived extracellular vesicles (tdEVs),
EV-associated miRNA (EV-miRNA), and circulating cell-free DNA (ccfDNA). Because the
size and density of biomarkers differ, blood is centrifuged to isolate or concentrate
the biomarker of interest. Here, we applied a model to predict the effect of centrifugation
on the purity of a biomarker according to published protocols.
Methods: The model is based on the Stokes equation and was validated using polystyrene
beads in buffer and plasma. Next, the model was applied to predict the biomarker behaviour
during centrifugation. The result was expressed as recovery of CTCs, TEPs, tdEVs in
three size ranges (1–8 µm, 0.2-1 µm, and 0.05–0.2 µm), EV-miRNA and ccfDNA.
Results: Bead recovery was predicted with errors <18%. Most notable cofounders are
the 22% contamination of 1–8 µm tdEVs for TEPs, and 50–82% of tdEVs <200 nm for ccfDNA.
Based on our model, none of the evaluated protocols produces a pure biomarker. Thus,
care should be taken in interpretation of obtained results, as, for example, results
from TEPs may originate from co-isolated large tdEVs, and ccfDNA may originate from
DNA enclosed in tdEVs <1 µm.
Summary/Conclusion: The Stokes model can be applied to predict the behaviour of biomarkers
– including EVs- during isolation or concentration to other body fluids, which may
facilitate the comparison of such protocols in e.g. EV-TRACK, further standardization
of protocols, and develop optimal biorepository conditions.
Funding: This work is supported by the Netherlands Organisation for Scientific Research
– Domain Applied and Engineering Sciences (NOW-TTW), research programs VENI 13681
(Frank Coumans), Perspectief CANCER-ID 14198 (Linda Rikkert), and VENI 15924 (Edwin
van der Pol).
PF10.04
Effects of lipoprotein destabilization on isolation and analysis of plasma-derived
extracellular vesicles
Danilo Mladenovića
, Paolo Guazzib, Elina Aleksejevab, Antonio Chiesib, Kairi Koorta, Davide Zoccoc,
Triin Ojab and Nataša Zarovnid
aTallinn University, School of Natural Sciences and Health, Tallinn, Estonia; bHansaBioMed
Life Sciences, Tallinn, Estonia; cExosomics Siena, Siena, USA; dExosomics, Siena,
Italy
Introduction: Plasma is one of the most commonly used sources of EVs since it is easy
to access and is extensively used in clinical research and diagnostics. Isolation
of pure EVs from such a complex biofluid is hard to accomplish due to presence of
many contaminants (lipoproteins, soluble proteins and protein aggregates) that affect
downstream application. Here, we are exploring effects of plasma acidification on
isolation, purification and detection of EVs, as stand-alone or combined with other
pre-analytical steps: lipoprotein lipase (LPL) and low-density lipoprotein receptor
(LDLR) treatment, in line with further purification and analytical methods.
Methods: Plasma preclearing and EV isolation: differential centrifugation, tangential
flow filtration (TFF), size exclusion chromatography (SEC), enzyme-coupled and affinity
magnetic beads.
Quantification and characterization of EVs: ELISA, NTA (Nanoparticle Tracking Analysis),
BCA assay, Western Blot, total RNA extraction and quantification.
Results: Preliminary results reveal 3–5 fold increase of EV protein signal in EV-enriched
SEC fractions after plasma acidification, although lipoprotein profile in same fractions,
as well as NTA counts and protein content, stay mostly unchanged compared to normal
pH (control) samples. Additional steps aimed at separation of lipoproteins from vesicles,
after lipoprotein destabilization through combination of size focusing, enzymatic
digestion and ligand specific-depletion/selection, are described.
Summary/Conclusion: Our experiments are addressing the issue of plasma EV purification
in attempt to deplete lipoprotein particles using different preanalytical approaches.
Acidification, along with LPL and LDLR incubation, hold potential for lipoprotein
removal.
Funding: This research is part of TRAIN-EV project, funded by EU grant under the Horizon2020
Marie Sklodowska Curie Innovative Training Network (MSCA-ITN) programme.
PF10.05
The stability of placental extracellular vesicles in different short-term storage
conditions
Qi Chena
, Yunhui Tangb
, Chunlin Sub, Michelle Wisea and Larry Chamleya
aThe University of Auckland, Auckland, New Zealand; bFudan University of China, Shanghai,
China (People’s Republic)
Introduction: Extracellular vesicles (EVs) are attracting considerable attention from
a wide range of researchers because of their signalling capacity of relevance to health
and many diseases. EVs are classified to macro-, micro-, and nano-EVs based on their
size and carry complex cargos of RNAs, protein, DNA and lipids that can change the
behaviour of target cells. Given the unique characteristics of EVs and that they are
challenging to isolate in large quantities for use in experiments especially in vivo
experiments it is important to be able to store EVs and maintain their quality. In
this study we began to investigate the stability of human placental EVs which were
extruded from first trimester placentae.
Methods: EVs were isolated from first trimester placental explants (range from 8 to
12 weeks of gestation, n = 8) and separated into micro- and nano-EVs by differential
centrifugation. EVs were then individually stored in PBS at room temperature, 4°C
or −20oC for up to 2 weeks. The concentration and the size of each type of EVs were
measured by Nanoparticle Tracking Analysis at day 0, day 3, day 7 and day 14.
Results: The concentration of micro-EVs or nano-EVs which were stored at 4oC or room
temperature was not significantly different between days 0, 3, 7 or 14. In contrast,
the concentration of micro-EVs which were stored at −20°C was significantly reduced
at both days 7 (p = 0.001) and 14, compared with the concentration of micro-EVs at
day 0. The concentration of nano-EVs stored at −20°C was significantly reduced at
day 14 (p = 0.04), compared with the concentration of nano-EVs at day 0. In addition,
there was no difference in the modal (or mean) size of either micro- or nano-EVs regardless
of the storage conditions at any time point.
Summary/Conclusion: we found that, at least in terms of concentration and size, short/medium-term
storage of placental EVs at 4°C or room temperature was preferable to freezing. Further
work is required to determine optimal storage conditions to maintain EV function.
PF10.06
Only a portion of the T cell-released exosomes has a capacity to destruct mesenchymal
tumour stroma
Naohiro Seo
a, Tsuguhiro Kanedaa, Junko Nakamuraa, Fumiyasu Momosea, Kazunari Akiyoshib and Hiroshi
Shikua
aMie University Graduate School of Medicine, Mie, Japan; bKyoto University, Kyoto,
Japan
Introduction: Exosomes (Exo) released from single cells have been thought to be diverse
populations in membrane structures, membrane charges and bioactive substances. We
have reported that CD8 + T cell Exo can deplete mesenchymal tumour stromal cells and
suppress tumour invasion and metastasis (Nat. Commun. 9: 435, 2018). In this study,
we examined the diversity of CD8 + T cell Exo and destruction of mesenchymal tumour
stroma.
Methods: H-2Kd-restricted and mutated (m) ERK2 136–144 peptide-specific TCR gene-transfected
DUC18 mice were used in this study. DUC18 splenocytes were cultured for 7 days with
mERK2 peptide, and obtained culture supernatant (sup) was used as a source of CD8 + T
cell (CTL) Exo. Ultrafiltration (UF) of DUC18 culture sup was performed by tangential
flow filtration system (KrosFlo TIFF system) using mPES MidiKros Filter Modules (MWCO
500 kDa or 750 kDa: Spectrum) at the entrance flow rate of approximately 50 mL/min.
DEAE-sepharose Fast Flow (GE) was used as a carrier of cationic ion-exchange chromatography.
DEAE-sepharose column (bed volume 8 cm3) was equilibrated with 10 mM Tris-HCl (pH7.5)
containing 0.15 M NaCl. DUC18 Exo concentrated with UF was loaded on the column, and
washed with TBS at over three column volumes. Exo bound with DEAE-sepharose were eluted
by linear gradient of NaCl.
Results: By UF with 750 kDa MWCO mPES filter, CD8 + T cell Exo can be effectively
concentrated more than 20 times without leaking. The concentrated CD8 + T cell Exo
was adsorbed on a DEAE column and eluted with NaCl gradient of 0.15 M to 0.8 M. As
a result, the various Exo fractions could be obtained from the difference of the levels
of CD9 expression, CD90 expression, Granzyme B content, the Tsg101 content, and engulfment
by mesenchymal stem cells. Interestingly, capacity of destruction of mesenchymal stroma
was found only in Exo fraction eluted about 0.25 M NaCl, indicating that a part of
CD8 + T cell Exo exerts a biological function.
Summary/Conclusion: We establish a novel method for Exo preparation according to the
negative charge. Exo released from single cells are diverse populations with different
physical properties, some of which exhibit biological significance.
Funding: This work was supported by a grant from the JST CREST (JPMJCR17H2).
PF10.07
Evaluation of the effects of acidification on isolation of extracellular vesicles
from bovine milk
Md. Matiur Rahman
a, Kaori Shimizub, Marika Yamauchic, Ayaka Okadab and Yasuo Inoshimab
aThe United Graduate School of Veterinary Sciences, Gifu University, Gifu, Japan;
bGifu University, Gifu, Japan; cGifu University, Gifu, USA
Introduction: Acidification has shown potential for separating casein from raw bovine
milk to facilitate isolation and purification of extracellular vesicles (EVs). The
purpose of this study was to evaluate the effects of different acidification treatments
on the yield and surface marker proteins of EVs from raw bovine milk.
Methods: Fresh raw bulk milk was collected from healthy dairy cows. Casein was separated
from the raw milk by ultracentrifugation (UC), treatment with hydrochloric acid, or
treatment with acetic acid, followed by filtration and preparation of the whey. The
protein concentration of the whey was determined by spectrophotometry, and the size
and concentration of EVs were measured by tunable resistive pulse sensing analysis.
Surface marker proteins of EVs were detected by western blot (WB) analysis using the
primary antibodies anti-CD9, anti-CD63, anti-CD81 and anti-MFG-E8.
Results: The UC method yielded a higher concentration of proteins in the whey than
did acidification. However, both acidification treatments yielded higher amounts of
EVs than UC. WB analysis revealed that acidification had partially degraded the surface
marker proteins CD9 and CD81 but not CD63 or MFG-E8.
Summary/Conclusion: Acidification was likely favourable to the removal of casein and
the rapid, efficient isolation of milk EVs. A higher amount of EVs were purified by
acidification, but this treatment degraded partially some of the surface marker proteins
of the EVs. Our results suggest that appropriate surface marker antigens should be
used for evaluation of EVs from bovine milk after acidification in the following EVs
experiments.
Funding: This study was partly supported by a research project for Improving Animal
Disease Prevention Technologies to Combat Antimicrobial Resistance 2017–2021 FY of
the Ministry of Agriculture, Forestry and Fisheries of Japan. This study was also
supported in part by the OGAWA Science and Technology Foundation and the Morinaga
Foundation for Health and Nutrition.
PF10.08
Comparison of isolating method for obtaining extracellular vesicles from cow’s milk
Mai Morozumi
a, Hirohisa Izumib, Muneya Tsudac, Takashi Shimizua and Yasuhiro Takedaa
aMorinaga Milk Industry Co., Ltd., Zama-City, Japan; bMorinaga Milk Industry Co.,
Ltd., Zama-city, Japan; cMorinaga Milk Industry Co., Ltd., Zama, Japan
Introduction: MicroRNAs (miRNAs) are present in many foods including milk, which could
be involved in various bioactivities when taken orally. Milk consists mainly of two
fractions, i.e. casein and whey, and most of the milk miRNAs are thought to be included
in extracellular vesicles (EVs) in whey fraction. Biological roles of milk miRNAs
are not fully elucidated and thus require further investigation. However, procedures
for isolating milk-derived EVs (M-EVs) have not fully established. The aim of this
study was to compare methods for isolating M-EVs.
Methods: Aiming to minimize the contamination of casein in whey fraction, which is
the great obstacle to determining M-EVs purity, whey fraction was separated from milk
(defatted) by centrifugation only, acetic acid precipitation, or EDTA precipitation
(n = 3). M-EVs were then isolated from each whey fraction by ultracentrifugation,
an exoEasy Maxi kit (Qiagen), a qEV kit (Izon Science) or an EVSecondL70 kit (GL Sciences).
The number of M-EVs particles was measured using NanoSight (Malvern Instruments).
Results: Acetic acid precipitation prevented casein contamination to greater extents.
Three combinations, such as “acetic acid precipitation and qEV”, “acetic acid precipitation
and EVSeocondL70” and “EDTA precipitation and qEV” were able to collect larger numbers
of total M-EVs particles than the other combinations. Among the three combinations,
“EDTA precipitation and qEV” achieved collecting the largest number of M-EVs but “acetic
acid precipitation and EVSeocondL70” was able to obtain M-EVs fractions with high
concentration.
Summary/Conclusion: The combination of “EDTA precipitation and qEV” is suited to collect
the largest amount of M-EVs. The combination of “acetic acid precipitation and EVSeocondL70”
is capable of obtaining M-EVs fractions with high concentration.
PF10.09
Generating, characterizing and testing recombinant extracellular vesicles as biological
reference material
An Hendrix; Edward Geeurickx; Olivier De Wever
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair,
Ghent University, Ghent, Belgium
Introduction: Recent years have seen a tremendous increase in the study of extracellular
vesicles (EV) geared towards biological understanding, diagnostics and therapy. Concurrently
EV data interpretation remains challenging owing to the complexity of biofluids and
the technical variation introduced during EV sample preparation and analysis.
Methods: To understand and mitigate these limitations we have developed a standard
operating procedure to generate trackable recombinant EV (rEV).
Results: Employing complementary characterization methods we demonstrate that rEV
are stable, commutable and share both physical and biochemical characteristics with
sample EV. rEV can be accurately measured using fluorescence-, RNA and protein-based
technologies. Implementation of rEV reduces intra-method and inter-user variability
of EV sample preparation and analysis, and improves the sensitivity of EV enumeration
in biofluids.
Summary/Conclusion: The informed use of rEV will aid method development, instrument
calibration, data normalization and routine evaluation of EV sample preparation and
analysis in various research and biomedical applications.
PF10.10
ExtraSome: method for exosome isolation based on polyethylene glycol
Jihye Kim
a and Jihye Choib
aYonsei University, Seoul, Republic of Korea; bYonsei University College of Medicine,
Seoul, Republic of Korea
Introduction: Exosome sized 30-120 nm secreted from cells and present in blood, urine
and cell media. It contains biomarkers that play important roles cell–cell communication.
Therefore, it is important to isolate exosome in stable and effectively eliminate
these contaminants. Extant method to isolate exosome include ultracentrifugation,
immunoisolation and precipitation in polymeric solution. Ultracentrifugation is the
most conventional method due to its reliability but it has the demerits of lengthy
and laborious centrifugation, requirement for expensive equipment and low yield. Immunoisolation
which uses beads conjugated with an antibody to isolate EVs; this method has high
specificity but the EVs are hard to detach from beads, and detachment methods may
reduce the functionality of the surface protein.
Methods: Exosomes were isolate from Fetal Bovine serum (FBS): After centrifugation
at 2000g for 30 min, 5 mL of FBS were combined with PEG buffer solution, resulting
in 2–30% final PEG concentration. The sample were carefully mixed and incubated at
4 C overnight. Then the samples were pun down at 11,000 rpm for 1 h. The supernatant
was discarded, and the exosome pellet was resuspended in PBS and the number of exosomes
was quantified on a Nanosight LM10 instrument.
Results: We isolate exosome from FBS using PEG buffer solution varied molecular weight
(1000, 6000, 8000, 10,000, 20,000) at various concentration (2–30 w%). We confirm
the size, morphology, chemical structure and biological marker (CD63, CD81) of the
exosome. As a result, we verify the optimal isolation condition of exosome for efficient
system.
Summary/Conclusion: In summary, we have developed a new method for the determination
of the critical PEG value of exosome, which was proven to be very convenient and reliable.
We believe that this method is highly effective and economical and has great potential
to be further used for the selective separation of exosome.
Funding: This work was supported by a National Research Foundation (NRF) grant funded
by the Korean government, Ministry of Education and Science Technology (NRF-2017M2A2A6A01071157,
NRF-2018R1C1B6008799).
PF10.11=OWP3.05
Aqueous two-phase system to isolate extracellular vesicles for prostate cancer diagnosis
Hyunwoo Shin
a, Jiyoon Kima, Mee Young Kimb, Yong Hyun Parkb, Yong Goo Kimc, Ji Youl Leeb and Jaesung
Parkd
aPOSTECH, Pohang, Republic of Korea; bDepartment of Urology, Seoul St. Mary’s Hospital,
The Catholic University of Korea, Seoul, Republic of Korea, Seoul, Republic of Korea;
cDepartment of Laboratory Medicine, Mary’s Hospital, The Catholic University of Korea,
Seoul, Republic of Korea, Seoul, Republic of Korea; dDepartment of Mechanical Engineering,
POSTECH, Pohang, Republic of Korea, Pohang, Republic of Korea
Introduction: Analyzing extracellular vesicles (EVs) is an attractive means in prostate
cancer diagnosis. However, existing methods of EVs isolation have low efficiency,
purity and long process time, which induce low diagnostic ability. To approach the
problems, we adapt a two-phase system to diagnose prostate cancer by isolating EVs
from patients’ urine. Using the two-phase system, prostate hyperplasia (BPH) patients
and prostate cancer (PCA) patients were diagnosed, and the diagnostic ability was
compared with conventional diagnostic methods.
Methods: Forty-two prostate cancer (PCA) patients and 20 benign prostate hyperplasia
(BPH) patients’ urine, plasma, saliva was collected and used for identifying EVs isolation
ability of aqueous two-phase system (ATPS) and for comparing diagnostic ability of
ATPS with conventional diagnosis.
Results: With an optimized ATPS, EVs were isolated with an efficiency of approximately
90%. In addition, the EV-isolation time was within approximately 30 min, and the purity
of EVs in ATPS was approximately two times better than achieved with a conventional
methods, ultracentrifugation and polymeric precipitation. After the ATPS isolated
EVs from patients’ body fluid, PCR and ELISA were utilized to detect EVs derived from
prostate cancer cells. The expression levels of RNA and protein markers of prostate
cancer were compared, and the relationship between expression levels and clinical
data was analysed. The results demonstrated that diagnostic ability based on ATPS
was better than other conventional methods (serum PSA and sediments). Moreover, sensitivity
increased by at least 10%, and specificity was improved by at least 20% compared to
conventional methods.
Summary/conclusion: High quality and quantity of EVs can be obtained from patients’
body fluid using ATPS. Using the abundant sources, which contain cancer-related proteins
and genes, we can perform a diagnosis with high specificity and sensitivity. Therefore,
ATPS offers a powerful tool for more specific and sensitive diagnosis.
PF11: EV-Based Therapeutics IIChairs: Yasnouri Fujita; Xue ZouLocation: Level 3, Hall
A15:30–16:30
PF11.01
Therapeutic effect of plant sap-derived nanovesicles on cancer cells
Kim Kimin
a, Yeon Ju Hun
b, Yoo Hye Jua and Ruri Leea
aUniversity of brain education, Cheon-an, Republic of Korea; bUniversity of British
Columbia, cheonan, Republic of Korea
Introduction: Most of the chemical agents are toxic to both malignant and normal cells.
The new anticancer agents with debilitating side effects are highly demand. Various
plant sap have known to possess therapeutic effects like anticancer traditionally.
Plant-derived nanovesicles play critical roles in intercellular and inter-species
communications to transfer plant components to mammalian cells. Plant sap-derived
nanovesicles successfully delivered contained components into cells with high efficiency.
Methods: We extracted plant sap-derived nanovesicles from four endemic plants: Dendropanax
morbifera (DM), Pinus densiflora (PD), Chamaecyparis obtusa (CO) and Thuja occidentalis
(TO), and investigated endocytosis pathway of nanovesicles to malignant and benign
cells. We assessed their anti-cancer effects on breast, skin, colon and melanoma cancer
cells of normal, benign and malignant origins.
Results: We found that different endocytosis pathway between malignant and benign
cells, DM-derived exosome-like nanovesicles (DM-ENVs) showed anticancer effect especially
on malignant breast cancer cells, while no cytotoxic effects were exhibited against
benign cells. PD-ENVs showed the cytotoxic effect on malignant skin cancer cells but
not on Fibroblasts. TO-ENVs and CO-ENVs showed no cytotoxic effect on most malignant
cancer cells. We also found the synergistic effect of the DMNVs and PDNVs on malignant
breast and skin cancer cells. We identified that combination of DM-ENVs and PD-ENVs
make enhancement in the cytotoxicity against malignant cells than normal and benign
cells.
Summary/Conclusion: We confirm that DM-ENVs have anticancer effects against malignant
breast and skin cancer cells than benign breast and skin cancer cells. We also found
synergistic effects according to the combination of DM-ENVs and PD-ENVs on malignant
cells. These results provide that plant sap-derived ENVs can be a new source for specific
cancer therapeutics.
Funding: This work was supported by the Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by the ministry of Education, Science
and Technology (NRF-2016R1C1B2013345) and Samsung Research Funding Center of Samsung
Electronics under Project Number SRFC-IT1701-00
PF11.02
Amniotic fluid stem cell extracellular vesicles derived from different species contain
evolutionarily conserved microRNAs: valuable resources for regenerative medicine.
Lina Antounians and Augusto Zani
The Hospital for Sick Children, Toronto, Canada
Introduction: Amniotic fluid stem cells (AFSCs) are a population of multipotent cells
that have been reported to hold broad regenerative potential. This regenerative capacity
has been linked to a paracrine mechanism mediated by microRNAs (miRNAs) contained
in AFSC extracellular vesicles (EVs). Herein, we investigated the miRNA content of
AFSC-EVs from multiple species to identify commonly shared and evolutionarily conserved
miRNAs that may be responsible for AFSC beneficial effects.
Methods: In this study, we combined data from the literature and from our laboratory.
Literature review: Using a defined strategy, we conducted a systematic review searching
for studies reporting on AFSC-EVs and we extracted available miRNA sequencing data.
Our study: Rat AFSCs were subjected to exosome-depleted FBS in minimal essential media
for 18 h. Conditioned medium was collected, cleared of cells and debris, filtered
through a 0.22 µm syringe filter, and ultracentrifuged for 14 h at 100,000g. EVs were
assessed for size (nanoparticle tracking analysis), morphology (transmission electron
microscopy) and expression of canonical protein markers CD63, Hsp70, Flo-1 and TSG101
(Western). AFSC-EV RNA was isolated using SeraMir, constructed into libraries (CleanTag
Small RNA) and sequenced on NextSeq High Output single-end sequencing run. TargetScan
was used to identify species-specific and evolutionarily conserved miRNA using seed
sequences across all three species. Pathway enrichment analysis was conducted using
miR-path.
Results: Overall, data on AFSC-EVs from three species (n = 2 human, n = 2 mouse, n = 1
rat) were included. Four miRNAs (miR-21, miR-24, miR-100 and miR-145) were found in
AFSC-EVs from all three species and were reported to exert beneficial effects on lung,
muscle and kidney regeneration. These miRNAs were enriched in signalling pathways
that involve TGF-β (p = 0.004) and TNF-α (p = 0.03) and the maintenance of stem cell
pluripotency (p = 0.0001). We also observed species-specific miRNAs (n = 15 human,
n = 6 mouse, n = 6 rat) contained in AFSC-EVs.
Summary/Conclusion: AFSC-EVs isolated from different species have some miRNAs that
are shared and evolutionarily conserved. These miRNAs may have a specific role in
the regenerative effects that AFSC-EVs exert in different diseases.
Funding: CIHR-SickKids Foundation
PF11.03
Extra-cellular vesicles in human platelet lysates for clinical use and human cell
in vitro propagation
Liling Delila
a, Yu-Wen Wua, Ming-Li Choub, David Devosc and Thierry Burnoufd
aCollege of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan (Republic
of China); bCentre de Recherche Saint-Antoine (CRSA) – INSERM UMRS 938, Taoyuan, Taiwan
(Republic of China); cPharmacologie Médicale & Neurologie, University of Lille, University
hospital center, INSERM U-1171, Lille, France; dCollege of Biomedical Engineering,
Taipei Medical University, Taipei City, Taiwan (Republic of China)
Introduction: Human platelet lysates (HPLs) are increasingly used in regenerative
medicine and cell therapy. The functional activity of HPLs to regenerate tissues in
vivo and to expand cells in vitro is believed to be due to their richness in a plethora
of growth factors. However, little is known about the presence and content of extracellular
vesicles (EVs) in HPLs, as well as their potential functional activity, biological
impact and involvement in tissue repair. We aim to characterize the number, the size
and the biological functions of EVs present in HPLs in order to develop dedicated
preparations best suitable for specific clinical applications
Methods: Clinical grade of platelet concentrates were processed into different fractions
of HPLs: platelet pellet lysate (PPL); heat-treated PPL ; serum-converted platelet
lysate (SCPL) using calcium chloride/glass bead treatment; and heat-treated SCPL (HSCPL).
EVs in HPLs were isolated using size exclusion chromatography column. The number and
the size distribution were determined by dynamic light scattering (DLS), nanoparticle
tracking analysis (NTA) and transmission electron microscopy (TEM). EVs functional
activity was assessed for the expression of tissue factor and phosphatidylserine (PS)
activity. In addition, the HPLs were tested for their thrombin and plasmin activity,
anti-oxidative property and thrombin generation capacity
Results: Abundant number of EVs (1010 ~ 1012/mL) was found in all HPLs fractions.
DLS analysis showed that isolated EVs in PPL, HPPL, SCPL and HSCPL have size distribution
approximately ranging as follows: 100 ~ 250 nm; 45 ~ 210 nm; 145 ~ 230 nm and 55 ~ 180 nm,
respectively, these data being confirmed by NTA and TEM. None of the HPLs were found
to have detectable TF-expressing EVs but some significant differences in PS-expressing
EVs, as well as thrombin, plasmin and anti-oxidative activity were found, possibly
linked to their EVs composition
Summary/Conclusion: This study establishes that all HPLs evaluated have a high content
of EVs. Differences in functional activity were also unveiled supporting the need
for further studies of the physiological functions of HPL-derived EVs in cell-based
and preclinical animal models
PF11.04
EV-mediated delivery of enzymatically fabricated size-controllable functional DNA/RNA
microstructures for therapeutic applications
Hyejin Kim, Dajeong Kim and Jong Bum Lee
Department of Chemical Engineering, University of Seoul, Seoul, Republic of Korea
Introduction: Nucleic acids have been widely investigated as a generic material with
the advantage of their wide range of biological functions, predictable molecular structure,
programmability and reversibility of base-paring. Here, the following enzymatically
fabricated multiscale functional nucleic acid-based structures are introduced: bubbled
RNA-based cargoes (BRCs), messenger RNA nanoparticles (mRNA-NPs) and CpG incorporated
DNA microparticles (CpG DNA-MPs).
Methods: Primer DNA and long linear DNA bearing complementary sequences to functional
DNA or RNA were prepared for the synthesis of circular DNA for the BRCs and CpG DNA-MPs.
For mRNA-NPs, plasmid DNA bearing T7 promoter region, ribosome binding site and ORF
was prepared. T7 RNA polymerase or Phi29 DNA polymerase were used to induce self-assembly
of DNA or RNA-based structures, respectively.
Results: Adaptation and modification of rolling circle replication (RCR) approach
has enabled generating these functional structures with desired sizes for demonstration
of regulation of biological processes. The BRCs were designed to down-regulate the
target gene upon introducing to cells by bearing specific cleavage sites for Dicer
to generate functional siRNAs. Furthermore, manipulating template DNA to polymerase
ratio in the modified RCR reaction enabled size-modulable synthesis of BRCs. We also
adapted plasmid DNA as template DNA in RCR to fabricate mRNA-NPs for up-regulation
of target gene expression. While the two studies were geared towards regulation of
gene expression, we also demonstrated the fabrication of CpG DMA-MPs for boosting
immune response by improving efficiency of antigen presentation in macrophages.
Summary/Conclusion: Since the pre-assembled structures have high cargo capacity without
any condensation, loading extracellular vesicles (EVs) with the DNA/RNA-based nanostructures
would greatly enhance therapeutic potential of nucleic acid-based therapeutics. Together
with the nature of EVs being safe and effective delivery agent, we envision that the
exploitation of EVs in the field of nucleic acid engineering would provide a way of
next-generation gene therapy.
Funding: This research was supported by the Bio & Medical Technology Development Program
of the National Research Foundation of Korea (NRF) funded by the Korean Government
(NRF‐2016M3A9C6917402).
PF11.05
VES4US: Extracellular vesicles from a natural source for tailor-made nanomaterials
Daniele Romancinoa, Mauro Mannob, Antonella Cusimano
a, Sabrina Picciottoa, Samuele Raccostab, Vincenzo Martoranab, Rosina Notob, Rita
Carrottab, Elia Di Schiavic, Giovanna L. Liguorid, Annamaria Kisslingere, Katharina
Landfesterf, Blanca Rodriguezg, Svenja Morsbachh, Ales Iglici, Veronika Iglici, Laura
Corcuerah, Paolo Arosioj, Gabriella Pocsfalvik, Nicolas Touzetl and Antonella Bongiovannia
aNational Research Council (CNR), Institute of Biomedicine and Molecular Immunology
(IBIM), Palermo, Italy; bInstitute of Biophysics, Palermo, Italy; cNational Research
Council of Italy (CNR) – Institute of Biosciences and BioResources, IBBR, Napoli,
Italy; dNational Research Council of Italy (CNR) – Institute of Genetics and Biophysics,
Palermo, Italy; eNational Research Council – Institute of Experimental Endocrinology
and Oncology (IEOS), Napoli, Italy; fMax-Planck Institute for Polymer Research, Mainz,
Germany; gZabala Innovation Consulting, Navarra, Spain; hFaculty of Health Sciences,
University of Ljubljana, Ljubljana, Slovenia; iETH Zurich Institute for Chemical and
Bioengineering, Zurich, Switzerland; jExtracellular Vesicles and Mass Spetrometry
Group, Institute of Bioscience and BioResosrces (IBBR) – CNR, Naples, Italy; kInstitute
of Technology Sligo – ITSligo, Sligo, Ireland
Introduction: VES4US is a new European project funded by the Horizon 2020-Future and
Emerging Technology Open programme, which aims to develop an innovative platform for
the efficient production of extracellular vesicles (EVs) from a renewable biosource,
enabling their exploitation as tailor-made products in the fields of nanomedicine,
cosmetics and nutraceutics (https://ves4us.eu). A core aspect of the project is to
focus on an identified natural source to constitute a cost-effective and sustainable
source of EVs. The project will run for the next three years with six organizations
from six European countries.
Methods: In the first phase, the focus will be the selection of the natural source
and the optimization of culture condition at pre-industrial scale. Then, the isolation
and physiochemical characterization of the EVs will be realized. In the second phase,
the functionalization and load of the EVs will be approached. Finally, the biological
activity of the EVs will be explored both in vitro and in vivo.
Results: The selection of the best EV-producing natural source strain/s is ongoing
and it will get to the production of the EVs needed to develop the natural nanocarriers.
Before that happens, it exists the need of applying good research practices that include
personnel training on Standard Operating Procedures to control major experimental
activities for harvesting, manipulating, storing, characterizing and treating EVs,
as well as for key related activities.
Summary/Conclusion: Safe, efficient and specific nano-delivery systems are essential
to current therapeutic medicine, cosmetic and nutraceutics sectors. The ability to
optimize the bioavailability, stability and targeted cellular uptake of a bioactive
molecule while mitigating toxicity, immunogenicity and off-target/side effects is
of the utmost priority. VES4US aims at creating a fundamentally new bioprocessing
approach to generate and functionalize EVs from a renewable biological source.
Funding: This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 801338.
PF11.07
Therapeutic effects of mesenchymal stem cell exosomes in myocardial ischemia/reperfusion
injury in a porcine model
Max Silvis
a, Vince de Hoogb, Sai Kiang Limc, Dominique de Kleijnd and Leo Timmerse
aUMC Utrecht, Cardiology, Nijmegen, Netherlands; bUMC Utrecht, Utrecht, USA; cInstitute
of Medical Biology, Agency for Science, Technology and Research, Singapore, Singapore,
Singapore; dUMCU, Utrecht, Netherlands; eSt. Antonius Nieuwegein, Utrecht, USA
Introduction: After an acute myocardial infarction, restoration of the blood flow
to the ischemic myocardium (reperfusion) is the standard and most effective treatment
for reducing the infarct size and improving clinical outcome. The process of reperfusion,
however, can induce injury as well. Studies in animal models suggest that this “reperfusion
injury” accounts for up to 50% of the final size of a myocardial infarct and in these
models a number of strategies have been shown to ameliorate lethal reperfusion injury.
Our laboratory previously showed that human ESC-derived mesenchymal stem cell-derived
exosomes mediate cardio protection during myocardial ischemia/reperfusion injury in
a mouse model.
However, the therapeutic efficacy of these exosomes in a large-animal model remain
to be addressed.
In the current study, we therefore hypothesized that infusion of MSC exosomes reduces
infarct size and preserves cardiac function in a large-animal model.
Methods: Thirty female landrace pigs were subjected to 60 min transluminal balloon
occlusion and treated with a combination of intravenous (1 mg) and intracoronary (1 mg)
MSC exosomes (n = 15) or placebo (n = 15) in a randomized, blinded fashion. At baseline
and prior to termination 3D transesophageal echocardiography was performed to assess
cardiac function. Infarct size will be calculated as the percentage of the area at
risk using Evans blue/TTC double staining.
Results: This is an ongoing study and no major results are available yet. However,
pilot studies in an open chest LCx ligation model revealed that 1 mg of MSC exosomes
(200 μg i.v. 5 min before reperfusion and 800 μg intracoronary immediately after reperfusion)
resulted in a significant reduction of infarct size compared to saline injection (infarct
size as a percentage of the area at risk 22% vs 46%, p = 0.01).
Summary/Conclusion: In this study, we will investigate whether MSC exosomes are capable
of reducing infarct size and preserving cardiac function in a highly translational
large-animal model.
The main goal is to establish a clinically applicable protocol for MSC exosomes to
be used as a therapeutic tool for the treatment of acute MI.
Funding: Dutch Heart Foundation
PF11.08
The therapeutic potential of MSC-derived extracellular vesicles for stroke
Ji Hee Sung
a, Eun Kyoung Shinb, Jeong Pyo Sonc, Yeon Hee Choa, Dong Hee Kimd, Mi Jeong Ohb, Eun
Hee Kimb, Jae Min Chae, Oh Young Bangf
aSamsung medical center, seoul, Republic of Korea; bSamsung medical center, Seoul,
Republic of Korea; cSungkyunkwan University, Seoul, Republic of Korea; dSungkyunkwan
University, seoul, Republic of Korea; eDepartment of Mechatronics, College of Engineering,
Incheon National University, Incheon, Republic of Korea; fSamsung medical center,
Seoul, Republic of Korea
Introduction: Adult stem cell therapy is an excellent treatment for a variety of ischemic
diseases including ischemic heart disease, limb ischemia and stroke. Mesenchymal stem
cells (MSCs) exert their therapeutic capability via extracellular vesicles (EVs) in
infarcted tissue. Therefore, we hypothesized that MSC-derived EVs (MSC-EVs) possess
the equivalent sets of therapeutic molecules to MSCs.
Methods: EVs were isolated from 3D cultures of Wharton’s Jelly MSC (WJ-MSC) using
tangential flow filtration system and characterized by nanoparticle tracking analysis.
We investigated the therapeutic efficacy of WJ-MSC derived EVs (does tested: 0.3 × 1010,
1.5 × 1010, 3 × 1010 EVs/rat) in a rat stroke model.
Results: The infarct size did not decrease, but the ladder walking test showed a greater
improvement in behaviour in all EV groups than in the control group. Immunohistochemical
analysis was performed using ki-67 (proliferating cells), DCX (immature progenitor
neurons) and collagen IV (angiogenesis) of ipsilateral. EVs groups showed significantly
increased co-expression of ki-67 and DCX in the subventricular zone. Enhanced expression
of collagen IV in the ischemic boarder zone was more found in the EV groups than in
the control group. Diffusion tensor imaging was used to examine the regeneration of
nerve fibre bundles, and nerve fibre bundles were also increased in the EV groups.
Summary/Conclusion: Our study shows that WJ-MSC derived EVs from 3D culture system
promotes the neurogenesis, angiogenesis and recovery of nerve fibre bundles in rat
stroke models. These results suggest that an effective MSC-derived EV can be used
ideally for the treatment of stroke.
Funding: This study was supported by a grant from the Korean Healthcare Technology
R&D Project, Ministry of Health & Welfare (HI17C1256) and Basic Science Research Program,
the Ministry of Science, ICT and Future Planning (2018M3A9H1023675).
PF11.10
Exosomes from human urine-derived stem cells promote neurogenesis via histone deacetylase6
regulation in ischemic stroke
Xiaozheng Linga, Zhang Guoweia, Qingwei Zhua, Hu Guowena, Yang Wang
b and Zhifeng Denga
aShanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai, China
(People’s Republic); bShanghai Jiao Tong University Affiliated Sixth People’s Hospital,
Shanghai, China (People’s Republic)
Introduction: Human urine-derived stem cells (USCs) are receiving much more attention
in tissue regeneration and injury repair. Exosomes derived from USCs (USCs-Exo) have
recently been suggested to mediate the restorative effects of USCs. However, whether
USCs-Exo play a protective role in stroke remains unknown.
Methods: Therapeutic effect of USCs-Exo in vivo was evaluated by cerebral infarction
and neurological behaviour. The proliferation and differentiation of neural stem cells
(NSCs) was determined by double immunofluorescent staining. The viability, apoptosis,
proliferation, and differentiation of NSCs subjected to oxygen glucose deprivation/reoxygenation
(OGD/R) were assessed, respectively. The protein expression and activity of HDAC6,
and the expression levels of miRNAs both in vivo and in vitro were assessed to detect
the possible mechanism.
Results: We found that intravenous injection of USCs-Exo reduced brain infarct volume
and improved functional recovery by enhancing the proliferation and differentiation
of NSCs in ischemic rats. The in vitro results suggested that USCs-Exo increase viability,
reduce apoptosis, and promote the proliferation and neuronal differentiation of NSCs
after OGD/R. We further found that miR-206 contained in USCs-Exo is associated with
the therapeutic efficacy for neurogenesis through the inhibition of histone deacetylase6
(HDAC6).
Summary/Conclusion: Our study demonstrates that USCs-Exo can improve neurological
function recovery by promoting neurogenesis, which is attributed to miR-206-mediated
HDAC6 inhibition. Our research suggests that the use of USCs-Exo represents a novel
therapeutic strategy for stroke recovery.
Funding: This work was funded by National Natural Science Foundation of China (Numbers
81671209, 81471243 and 81472152).
PF11.11
Protective effect of extracellular vesicles released from the neural stem cells on
6-hydroxydopamine induced pathological condition of Parkinson’s disease
Eun Ji Leea, Dowon Hwang
b and Dong Soo Leea
aDepartment of Nuclear Medicine, Seoul National University Hospital, Seoul, Republic
of Korea; bSeoul National University Hospital, Seoul, Republic of Korea
Introduction: Parkinson’s disease (PD) is a neurodegenerative disease characterized
by bradykinesia, resting tremors and postural instability. A key symptom of PD is
the loss of the nigral dopaminergic neurons and subsequent dopamine deficit in the
brain. However, the precise mechanism is still unknown. While neural stem cells (NSCs)
are potential therapeutic resources for PD, NSC-secreted extracellular vesicles (EVs)
including exosomes are key mediators of positive paracrine effects. Direct evidence
for neuronal protective effects of EVs is essential for developing new PD therapeutics.
Methods: To trace EV movement, a lentivirus containing Palm-tandem dimer tdTomato
(Palm-td) was transduced into F3 NSCs. EVs isolated from Palm-td-infected F3 cells
showed high tdTomato fluorescence intensity enough to visualize their functional actions
such as secretion, migration and engulfment between cells. We found that pretreatment
with EVs dramatically prevented 6-OHDA-induced toxicity by reducing intracellular
reactive oxygen species (ROS), percentage of apoptotic cells and caspase-3/7 activity.
Results: These results indicate that NSC-derived EVs have neuroprotective effects
against the cell damage, possibly through antioxidant and anti-apoptotic action. Specifically,
F3-derived EVs effectively prevents 6-OHDA-induced the production of ROS, NSC-EVs
that inhibit ROS production might be applied as an important therapeutic agent for
neuroprotection. EV-mediated neuroprotection likely acts by inhibiting the generation
of caspase-3/7, leading to reduce apoptosis induction caused by 6-OHDA neurotoxicity.
Summary/Conclusion: In summary, this study demonstrates that NSC-derived EVs protected
dopaminergic cells from oxidative insults. While 6-OHDA-induced cell death in SH-SY5Y
cells occurs by the generation of ROS, the neurotoxin-mediated cell death was suppressed
by F3-derived EVs via their protective effects on ROS-induced cell damage. We therefore
expect that further investigations into the therapeutic applications of NSC-derived
EVs will reveal additional advantages for EV-based PD therapies in comparison to cell
transplantation.
PF11.12
The function of extracellular vesicles secreted by human-induced pluripotent stem
cell-derived mesenchymal stem cells on a cellular ischemic stroke model
Gang Lu, Man Sze Wong, Xian Wei Su, Rui Can Cao, Hoi Hung Cheung and Wai Yee Chan
CUHK-SDU joint laboratory on reproductive genetics, School of Biomedical Sciences,
The Chinese University of Hong Kong, Hong Kong, Hong Kong
Introduction: Stroke is the second leading cause of death and the primary cause of
long-term disability, but yet lack of effective treatment. Studies suggested the transplantation
of mesenchymal stem cells (MSCs) improved recovery from stroke in animal models, similar
therapeutic effect was found with the injection of MSCs medium. MSCs medium was found
enriched with extracellular vesicles, hence leads to the focus on utilizing extracellular
vesicles to treat neurological diseases, due to the evidence that extracellular vesicles
are able to penetrate the blood–brain barrier. This project aims to develop a product
with enriched extracellular vesicles and to evaluate its therapeutic efficacy in ischemic
stroke.
Methods: MSCs, with same passage number, were derived from human-induced pluripotent
stem cells-MSCs for the isolation of extracellular vesicles. The derived MSCs were
then confirmed by the adherence to plastic, multipotent differentiation potential
and surface antigen expressions. Three methods (ultracentrifugation, ultrafiltration
and polyethylene glycol) were used to extract extracellular vesicles, which were further
analysed by the expression of surface proteins, electron microscopy, ribosomal RNA
detection and oxygen–glucose deprivation (OGD) in vitro stroke model.
Results: Differentiated MSCs exhibited adherence to plastic, ability to differentiate
into osteoblasts, adipocytes and chondroblasts, and ≥95% population expressed CD105,
CD73 and CD90, and lack of CD45, CD34 and HLA class II. The isolated extracellular
vesicles expressed CD9, CD63 and CD81, with the size between 30 and 200 nm and contained
RNA with a peak between 25 and 200 nucleotides. Products from ultrafiltration were
found to increase cell viability in vitro stroke model most significantly.
Summary/Conclusion: Extracellular vesicles were able to increase the viability of
neuronal cell (HT22) in oxygen–glucose deprivation in vitro stroke model, indicating
the potential use of extracellular vesicles injection as an alternative therapy for
ischemic stroke.
Funding: Innovation and Technology Fund ITS-053–17FX, the Government of the Hong Kong
Special Administrative Region.
PF11.13
Endosomal escape enhancing compounds facilitate functional delivery of EV cargo
Nikki Heatha, Xabier Osteikoetxea
b, Taiana Mia de Oliveirac, Elisa Lázaro-Ibáñezd, Olga Shatnyevae, Christina Schindlerf,
Natalie Tiguef, Lorenz Mayrg, Niek Dekkerh, Ross Overmanb and Rick Daviesb
aAstraZeneca, Vancouver, Canada; bAstraZeneca, Macclesfield, UK; cAstraZeneca, Cambridge,
UK; dAstraZeneca, Molndal, Sweden; eAstraZeneca, Molndal, Sweden; fMedImmune, Cambridge,
UK; gAstraZeneca, Cambridge, USA; hAstraZeneca, Mölndal, Sweden
Introduction: Extracellular vesicles (EVs) are desirable carriers and delivery vehicles
for therapeutic cargoes. We aimed to load EVs with Cre recombinase (Cre) as a model
protein cargo and determine whether functional delivery to cells could be improved
by using uptake-enhancing compounds.
Methods: Expi293F cell line was used for isolating Cre loaded EVs by differential
centrifugation after transfecting releasing cells with constructs for protein expression.
EVs were then analysed by nanoparticle tracking analysis, western blotting, RT-qPCR
and cryo-electron microscopy including detergent and nuclease digestion controls.
Uptake of Cre loaded EVs was assessed using modified Hek293T cells expressing a fluorescent
reporter cassette consisting of LoxP – GFP – LoxP – RFP.
Results: Endosomal escape enhancers chloroquine and Unc10217939 increased TATcre functional
delivery by ≥50%. CreFRB protein was loaded into EVs by rapalog-induced dimerisation
to CD81FKBP. Cells treated with 20 µg/mL CreFRB loaded EVs showed functional Cre activity
only in the presence of 25 µM chloroquine or 2 µM unc10217939.
Summary/Conclusion: Passively loaded protein and mRNA was effectively delivered to
recipient Hek293T fluorescent Cre reporter cells in the presence of endosomal escape
enhancing compounds. This finding shows that endosomal escape enhancing compounds
may have a place in the clinic to improve delivery efficiency of nanoparticle-based
therapies.
PF11.14=OWP1.02
MSC exosome works through a multifaceted mechanism of action in joint repair
Shipin Zhang
a, Yedan Wangb, Francis Keng Lin Wongc, Ming Wangb, Ruenn Chai Laid, James Hoi Po
Huib, Sai Kiang Limd and Wei Seong Toha
aFaculty of Dentistry, National University of Singapore, Singapore, Singapore, Singapore;
bDepartment of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University
of Singapore, Singapore, Singapore; cDepartment of Orthopaedic Surgery, Sengkang General
Hospital, Singhealth, Singapore, Singapore, Singapore; dInstitute of Medical Biology,
Agency for Science, Technology and Research, Singapore, Singapore, Singapore
Introduction: Mesenchymal stem cell (MSC) exosome is increasingly accepted as the
principal agent that underpins the therapeutic efficacy of MSC in tissue repair. Here,
we aim to elucidate the mechanism of action of MSC exosome in immunocompetent rat
models of osteochondral defect and osteoarthritis (OA).
Methods: Exosomes were purified from conditioned medium of human MSCs by size fractionation.
Osteochondral defect creation or anterior cruciate ligament transection to induce
OA were performed in 72 adult rats. Thereafter, weekly 100 µl intra-articular injections
of 100 µg exosome or PBS vehicle were given. Analysis included weight distribution,
histology, immunohistochemistry and cytokine assay. Cellular assays using chondrocytes
were performed to determine the exosome-activated cellular processes and signalling
pathways.
Results: We observed that exosome-mediated repair of osteochondral defects was characterized
by increased cellular infiltration and proliferation, enhanced matrix synthesis, together
with a regenerative M2 macrophage phenotype and a reduction in pro-inflammatory cytokines
IL-1β and TNF-α. In OA joints, MSC exosome mediated an early suppression of pain and
degeneration with reduced inflammation, followed by sustained proliferation and matrix
restoration that led to cartilage and subchondral bone regeneration. Using chondrocyte
cultures, we could attribute some of these cellular activities during exosome-mediated
joint repair to exosomal CD73-mediated adenosine activation of AKT and ERK signalling.
These effects were partially abrogated by wortmannin or U0126, which inhibited AKT
and ERK phosphorylation, respectively. The role of exosomal CD73 was confirmed using
CD73 inhibitor and theophylline that showed inhibition of exosome-induced AKT and
ERK phosphorylation.
Summary/conclusion: Our observations suggest that MSC exosome works through a multifaceted
MoA that involved multiple cellular processes to restore joint homeostasis and promote
regeneration.
Funding: National Medical Research Council Singapore (NMRC/CNIG/1168/2017 and NMRC/CIRG/1480/2017).
PF11.15=OWP1.04
Exosome-mediated enhancement of cellular therapy in acute myelogenous leukemia (AML)
Theo Borgovan
a, Peter Quesenberryb, Mike Deltatto; Sicheng Wenb, Mark Doonerb
aBrown University Department of Hematology Oncology; Rhode Island Hospital, Pawtucket,
USA; bBrown University Department of Hematology Oncology; Rhode Island Hospital, Providence,
USA
Introduction: Of the acute myelogenous leukemia (AML) patients able to tolerate curative
therapy with chemotherapy and stem cell transplant, many are challenged by treatment
related toxicities as well as graft versus host disease. There is novel work exploring
the utility of haploidentical cellular therapy infusion in order to incite purposeful
recipient immune response and subsequent cytokine storm to treat refractory AML. Our
group has demonstrated the healing potential of bone marrow-derived mesenchymal stem
cell extracellular vesicles (MSC-EVs) across multiple disease states, most recently
demonstrating the pro-apoptoic signalling imparted by these nanoparticles on nascent
leukemic cells in vivo; as well as the potentiating effects of MSC-EVs when used as
an adjunct to standard cytarabine chemotherapy. We have also shown the protective
role of HMSC EV on radiated BM and stem cell recovery.
Methods: Kasumi AML cells lines were seeded with MSC-derived EVs. Vesicles were isolated
using an established differential centrifugation technique, and were co-cultured with
Kasumi cells for various time points. To study cellular viability, we used a fluorescence-based
method for quantifying viable cells.
We also explored various modes of death EVs may illicit via a tri-dye Abcam assay
designed to simultaneously monitor apoptotic, necrotic and healthy cells. Both assays
were used to measure viability and apoptosis in similar experiments employing cytarabine
Results: AML cell proliferation decreased after 1−6 days of co-culture with hMSC-derived
EVs.
Apoptosis is the primary mode of death induced.
AML cell Proliferation Decreased synergistic after 1–6 days of co-culture with hMSC-derived
EVs ± Cytarabine.
Summary/conclusion: MSCs inhibits the proliferation of the AML cell line in vitro
and work synergistically with cytarabine chemotherapy to promote apoptotic death in
AML cell lines. Our prior work has shown that MSC-EVs can abate the effects of toxic
chemo/radiation and serve to protect stem cell allowing for quicker recover in cell
blood counts.
Based on the innate ability of MSC-EV to directly alter the cellular machinery of
abnormal leukemic cell and of nascent immune cells our corollary hypothesis is that
BM-derived MSC-EVs may serve as suitable alternative to conditioning chemo/radiation
in the AML setting and will enhance the effects seen by cellular therapy infusion.
Funding: t32
PF12: Advances in EV Cargo ProfilingChairs: Leonid Margolis; Yutaka NaitoLocation:
Level 3, Hall A15:30–16:30
PF12.01
Tumor driver TGFBR2-dependent microRNA profiles in colorectal cancer cells and their
EVs
Fabia Fricke
a, Veronika Mussackb, Dominik Buschmannb, Michael Pfafflc, Jürgen Kopitzd and Johannes
Gebertd
aDepartment Applied Tumor Biology, University Hospital Heidelberg, German Cancer Research
Center (DKFZ), Heidelberg, Germany; bTUM School of Life Sciences Weihenstephan, Division
of Animal Physiology and Immunology, Freising, Germany; cAnimal Physiology and Immunology,
School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany;
dApplied Tumor Biology, University Hospital Heidelberg, Heidelberg, Germany
Introduction: Microsatellite unstable (MSI) colorectal cancers accumulate frameshift
mutations at short repetitive DNA sequences (microsatellites). MSI-specific mutation
patterns in tumour driver genes such as Transforming Beta Receptor Type 2 (TGFBR2)
were found to be reflected in the cargo of MSI cell line-derived extracellular vesicles
(EVs). In previous work, we have shown that TGFBR2 reprograms the protein content
of MSI tumour cells and small EVs derived thereof. Here, we report on TGFBR2-dependent
alterations of miRNA expression in small EVs and their corresponding parental MSI
tumour cells.
Methods: To identify TGFBR2-regulated miRNAs in an isogenic background, the established
doxycycline (dox)-inducible MSI model HCT116-TGFBR2 was used. RNA was isolated from
four biological replicates of TGFBR2-proficient (+dox) and TGFBR2-deficient (-dox)
cells and their EVs. EVs were isolated by differential centrifugation, ultrafiltration,
and precipitation and characterized by electron microscopy, Western blot, and nanoparticle
tracking. RNA quality and concentration were determined by capillary electrophoresis.
cDNA libraries for small RNA fractions were generated and RNA sequencing was performed.
TGFBR2-regulated miRNA expression was assessed by DESeq2 and validated by RT-qPCR.
Results: From 471 identified miRNAs, the majority (n = 263) was unaffected by TGFBR2
expression and shared by small EVs and parental MSI cells. In addition, we detected
specific miRNAs exclusively present in EVs from TGFBR2-deficient (n = 4) or TGFBR2-proficient
(n = 14) MSI cells. Differential expression analysis revealed TGFBR2-regulated miRNAs
in EVs (n = 10) and MSI donor cells (n = 15). Three candidates (miR-381-3p, −889-3p,
−323a-3p) were found to be upregulated in both TGFBR2-proficient EVs and parental
cells.
Summary/Conclusion: Our results emphasize a broad overlap of miRNAs between EVs and
their parental cells but also highlight the impact of the recurrent MSI tumour driver
TGFBR2 on aberrant miRNA signatures in MSI cancer cells and their small EVs.
Funding: This work was supported by intramural funding from the Technical University
Munich (MP) and the University Hospital Heidelberg (JG, JK).
PF12.02
Orthologous grouping and comparison of prokaryotic and eukaryotic EV proteomes
Tae-Young Roh
a, Seokjin Hamb, Dae-Kyum Kimc, Jaewook Leec and Yong Song Ghod
aDiv. of IBB, Department of Life Sciences, Pohang University of Science and Technology
(POSTECH), Pohang, Republic of Korea; bDepartment of Life Sciences, Pohang University
of Science and Technology (POSTECH), Pohang, Republic of Korea; cDepartment of Life
Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Republic
of Korea; dDepartment of Life Sciences, Pohang University of Science and Technology,
Pohang, Republic of Korea
Introduction: Most prokaryotic and eukaryotic cells secrete extracellular vesicles
(EVs) with bioactive molecules, including proteins and nucleic acid. Protein cargos
important for EV biogenesis and/or biological functions can be found using proteomic
analyses.
Methods: To analyse the similarity and difference between prokaryotic and eukaryotic
EVs, EV protein databases was obtained from EVPedia (http://evpedia.info), regardless
of EV sources and analysing platforms. EV proteins were catalogued into orthologous
groups and annotated these groups using eggNOG database. Gene set enrichment analysis
(GSEA) was employed to determine how much the orthologous groups are enriched in EVs
of prokaryotic or eukaryotic species. The core network of prokaryotic and eukaryotic
EV orthologous groups were explored by Generalized HotNet analysis. Only hot clusters
with more than four orthologous groups were visualized by Cytoscape.
Results: A total of 6634 proteomic orthologous groups were identified from 33 prokaryotes
and 22 and separated into two distinct groups. Each orthologous group was annotated
with gene symbols, GO terms, as well as functional interactions. Frequently detected
orthologous groups were related with mainly membrane-associated compartments. The
GSEA analysis showed some common and specific proteins to prokaryote or eukaryote
in the categories of biological process and cellular component. The correlation network
analysis clearly provided a domain-specific terms such as intracellular organelle
cilium, cytoplasm ribosome, and ribosome proteasome complex for eukaryotes, and cytoplasm
envelope, extracellular exosome and cell outer membrane for prokayrotes.
Summary/Conclusion: Our comprehensive EV proteome analysis could provide a functional
modules related with characteristic biological mechanisms in prokayrotes and eukaryotes.
This analytical strategy will also provide a new integrative method to investigate
EV proteins and propose an evolutionary protein repertoire of EV.
PF12.03
Quantitative proteomic analysis of trypsin-treated extracellular vesicles to evaluate
the real-vesicular proteins
Gyeongyun Go
a, Dong-Sic Choia, Dae-Kyum Kima, Jaewook Leea and Yong Song Ghob
aDepartment of Life Sciences, Pohang University of Science and Technology (POSTECH),
Pohang, Republic of Korea; bDepartment of Life Sciences, Pohang University of Science
and Technology, Pohang, Republic of Korea
Introduction: Extracellular vesicles (EVs) are nanosized vesicles surrounded by a
lipid bilayer and released into the extracellular milieu by most of cells. Up to date,
various isolation methods of EVs have been established. However, most of the current
methods isolate EVs with the contaminated extravesicular proteins, which are co-isolated
proteins or non-specifically bound proteins. Since it is difficult to isolate EVs
without any contaminations, the evaluation of the real-vesicular proteins could be
valuable for the quality control of EVs.
Methods: SW480 EVs were isolated from the conditioned medium by sucrose cushion and
iodixanol buoyant density gradient ultracentrifugation. The isolated EVs were treated
with trypsin or control for 6 h and then pelleted by ultracentrifugation, before undergoing
LC-MS/MS.
Results: Trypsin treatment could digest the contaminated extravesicular proteins without
influencing the intravesicular (luminal) proteins, as well as size and morphology
of EVs. By the quantitative proteomic analyses between vesicular proteins with and
without trypsin treatment, we classified the vesicular proteins into 363 candidate
real-vesicular proteins and 151 contaminated extravesicular proteins. Protein interaction
network analyses showed that candidate real-vesicular proteome is composed of proteins
derived from plasma membrane (46.8%), cytosol (36.6%), cytoskeleton (8.0%) and extracellular
region (2.5%). On the other hand, most of the identified proteins derived from other
cellular organelles including nucleus, Golgi apparatus, endoplasmic reticulum and
mitochondria were considered as the contaminated extravesicular proteins. In addition,
protein complexes, including ribosome and T-complex proteins, were classified as the
contaminated extravesicular proteins.
Summary/Conclusion: Taken together, this trypsin treatment to EVs with large-scale
quantitative proteomics allows the evaluation of the real-vesicular proteins in isolated
EVs as well as the sub-vesicular localization of identified proteins. Therefore, our
results provide the applicable approach to identify the reliable diagnostic markers
of EVs.
PF12.04
Characterization of sweat extracellular vesicles
Genevieve Bart
a, Anatoliy Samoylenkoa, Daniel Fischerb, Anna Kaisanlahtic, Artem Zhyvolozhnyia,
Marko Suokasd, Prateek Singha, Justus Reunanenc and Seppo Vainiod
aUniversity of Oulu, Biocenter Oulu, Laboratory of developmental Biology, Oulu, Finland;
bNatural Resources Institute Finland (Luke), Animal Genomics, Jokioinen, Finland;
cUniversity of Oulu, Biocenter Oulu, Cancer and Translational Medicine Research Unit,
Oulu, Finland; dUniversity of Oulu, Biocenter Oulu, Department of Biology, Oulu, Finland;
eUniversity of Oulu, Biocenter Oulu, Laboratory of Developmental Biology, Oulu, Finland
Introduction: The view that human beings are more complex than originally thought
and could be described as a mixture of human and microorganism is gaining momentum
and even biofluids which had always been considered sterile have now been shown to
contain bacteria originating molecules and, in some cases, bacteria. Healthy human
skin is populated by many species of unicellular organisms, a number of which are
known to secrete extracellular vesicles (EVs). Our study of sweat EV cargo using omics
is aiming to shed some light on these complex interactions.
Methods: We have collected sweat from the upper body of exercising individuals (men
and women) and isolated EVs and EV RNA using concentration and filtration. EVs were
checked by TEM and NTA then subjected to proteomics analysis. For RNA extraction EVs
were directly lyzed on filter. 1–10 ng of RNA was used to make libraries for sequencing.
Filtered and trimmed reads were aligned to human genome using Bowtie. Unmapped reads
were blasted against the EMBL database to identify and classify metagenomics reads.
Results: A few hundred human proteins were identified but also a number of bacterial
proteins. In the case of RNA the number of unmapped reads was larger than is usually
observed with extracellular small RNA sequencing. Metagenomic analysis provided information
about species but only a certain number of reads could be assigned, probably due to
the lack of available genome data. There is also an uncertainty about the precise
species as we can only identify with any precision taxonomy at the level of order.
Summary/Conclusion: Sweat EVs are a mixture of human and microbe-derived EVs and their
complete characterization will depend on the availability of genomic information including
for difficult to cultivate strains.
Funding: Academy of Finland Biofuture2025
PF12.05
Proteomic signature of mesenchymal stromal cell-derived small extracellular vesicles.
Bas WM. van Balkom
a, Hendrik Gremmelsa, Bernd Giebelb and Sai Kiang Limc
aUMC Utrecht, Utrecht, Netherlands; bUniversitatsklinikum Essen, Essen, Germany; cInstitute
of Medical Biology, Agency for Science, Technology and Research, Singapore, Singapore,
Singapore
Introduction: Small extracellular vesicles (EVs) are 50–200 nm vesicles secreted by
most cells. They are considered as mediators of intercellular communication, and EVs
from specific cell types, in particular mesenchymal stem/stromal cells (MSCs), offer
powerful therapeutic potential, and could provide a novel therapeutic strategy. They
appear promising and safe (as EVs are non-self-replicating), and eventually MSC-derived
EVs (MSC-EVs) may be developed to standardized, off-the-shelf allogeneic regenerative
and immunomodulatory therapeutics. Promising preclinical data have been achieved using
MSCs from different sources as EV-producing cells. Similarly, a variety EV isolation
and characterization methods have been applied. Interestingly, MSC-EVs obtained from
different sources and prepared with different methods show in vitro and in vivo therapeutic
effects, indicating that isolated EVs share a common potential.
Methods: We analysed published MSC-EV proteomics datasets to identify a unique and
robust proteomics signature.
Results: Here, we compare well-characterized and controlled publicly available proteome
profiles of MSC-EVs to identify a common MSC-EV protein signature that might be coupled
to the MSC-EVs’ common therapeutic potential.
Summary/Conclusion: This protein signature may be helpful in developing MSC-EV quality
control platforms required to confirm the identity and test for the purity of potential
therapeutic MSC-EVs.
PF12.06
Comparative analysis of stool extracellular vesicles between germ-free, bifidobacteria-di-associated
and SPF mice
Hirohisa Izumi
a, Tatsuya Eharab, Mai Morozumib, Fuuka Tabatab, Yosuke Komatsub, Takashi Shimizub
and Yasuhiro Takedab
aMorinaga Milk Industry Co., Ltd., Zama-city, Japan; bMorinaga Milk Industry Co.,
Ltd., Zama-City, Japan
Introduction: Gut microbiota is closely related to host immune and metabolic functions.
Recently, microRNA (miRNA) in extracellular vesicles (EVs) produced by host intestinal
epithelial cells participate in shaping the gut microbiota. However, effects of microbiota
on host gut EVs and miRNAs are not fully elucidated. In this study, we investigated
the effects of microbiota on host stool EVs and miRNAs using germ-free (GF), bifidobacteria-di-associated,
and specific pathogen free (SPF) mice.
Methods: GF mice and SPF mice (11 week, male) were obtained. At 12-week-old age, part
of GF mice were inoculated with Bifidobacterium longum BB536 and B. breve M-16V (1109
each) once, and maintained with 5% fructooligosaccharides (bifidobacteria-di-associated
mice). Mice were sacrificed at 15-week-old age by deep anaesthesia with sevoflurane,
and tissue samples and stool samples were harvested. Stool EVs were purified using
exoEasy Maxi Kit, and were analysed by NanoSight LM10. Total RNAs were purified from
stool EVs using miRNeasy, and were analysed by microarray.
Results: NanoSight analyses revealed that mean EV size of GF stool was significantly
smaller than that of SPF stool, and EV quanity of bifidobacteria-di-associated stool
was tend to be increased than that of GF stool. Moreover, microarray analysis revealed
that microbiota could change miRNA expression profiles of stool EVs.
Summary/Conclusion: Microbiota might affect host gut function via alterations of EVs’
characteristics.
PF12.07=OWP3.07
Shed microvesicles released from human primary and metastatic colorectal cancer cell
lines contain key cancer progression proteins and RNA species
Wittaya Suwakulsiri
a, Alin Raia, Rong Xua, Maoshan Chena, David Greeningb and Richard Simpsona
aDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science,
La Trobe University, Melbourne, Victoria 3086, Australia, Melbourne, Australia; bDepartment
of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University,
VIC, Australia, Melbourne, Australia
Introduction: Extracellular vesicles (EVs) function in bidirectional cell–cell communication
and contribute to the sustained growth, invasion, and metastasis of cancer cells within
the tumour microenvironment (TME). EVs comprise two main classes – exosomes and shed
microvesicles (sMVs, also termed microparticles and ectosomes) – with distinct modes
of biogenesis. Within each EV class, subtypes exist that can be distinguished by their
distinct protein/RNA signatures. Whilst much is known about exosome cargo content
and functionality, sMVs are poorly understood.
Methods: Here, we compare protein/RNA profiles and functionality of sMVs and exosomes
secreted from human primary (SW480) and metastatic (SW620) colorectal cancer cell
lines. Milligram amounts of EVs were purified from cell culture media using a combination
of differential ultracentrifugation/isopycnic iodixanol density centrifugation. Label-free
quantitative mass spectrometry was performed to obtain protein profiles for SW480-derived
and SW620-derived sMVs.
Results: We show that sMVs, unlike exosomes, are ALIX-, TSG101-, CD63- and CD9- and
contain a different suite of key cancer progression modulators. Protein/RNA signatures
for SW480-derived sMVs and exosomes differ from each other and also from their SW620-derived
counterparts. SW480-derived sMVs are enriched in ITGA/B, ANXA1, CLDN7, CD44 and EGFR/NOTCH
signalling networks, while SW620-derived sMVs are enriched in PRKCA, MACC1, FGFR4
and MTOR/MARCKS signalling networks. Fibroblast invasion capabilities of SW480-derived
and SW620-derived sMVs are comparable.
Summary/conclusion: Furthermore, we report for the first time a comprehensive biochemical/functional
analysis of a hitherto undescribed subpopulation of sMVs. We anticipate our in-vitro
findings will be a starting point for more sophisticated studies aimed at elucidating
the biochemical and functional properties of EV subtypes in vivo. The emerging roles
of specific EV subtypes in the TME we believe will alter our view of cancer biology
and might present new targets for therapeutic intervention.
Funding: Funding support from La Trobe University, Melbourne, Australia.
PF12.08=OWP3.08
Mass spectrometry analysis of small extracellular vesicles isolated from ovarian cancer
ascites
Anna Kotrbová
a, Kristina Gomoryovaa, David Potesilb, Vit Weinbergerc, Igor Crhac, Eva Jandakovad,
Lubos Minarc, Zbynek Zdrahalb, Vítězslav Bryjaa and Vendula Pospíchalovaa
aDepartment of Experimental Biology, Faculty of Science, Masaryk University, Brno,
Czech Republic; bCore Facility Proteomics, Central European Institute of Technology,
Masaryk University, Brno, Czech Republic; cDepartment of Obstetrics and Gynecology,
Faculty Hospital Brno, Brno, Czech Republic; dDepartment of Pathology, University
Hospital Brno, Brno, Czech Republic
Introduction: High-grade serous carcinoma (HGSC) of the ovaries, fallopian tube and
peritoneum is the deadliest gynaecological malignancy with 5-year survival rate below
30%. HGSC is frequently accompanied by ascites, a pathological accumulation of fluid
in the peritoneum, which can be exploited as a liquid biopsy containing not only cancer
cells but also the tumour microenvironment including extracellular vesicles (EVs).
Tumour cells produce substantially more EVs than healthy cells, thus malignant ascites
is the source of enriched pool of EVs of HGSC origin.
Methods: Ascitic fluids depleted of cells were fractioned using size-exclusion chromatography
and two fractions – containing and not containing EVs – were further analysed. In
parallel, small EVs were also isolated from ascitic fluids using differential ultracentrifugation
followed by purification step in sucrose/D2O cushion. In total, 24 malignant ascites
and 5 non-malignant ascites were used for EV isolation and further analysed using
high resolution hybrid mass spectrometer Orbitrap Fusion Lumos Tribrid. The subsequent
data visualization and statistical analyses were performed using in-house developed
pipelines in KNIME environment.
Results: We identified 2441 proteins in total in the EVs from the ascites among which
21 were present in all 29 EV samples and not in non-vesicular fractions. Several of
these proteins were specifically enriched in small EVs in malignant ascites in comparison
with non-malignant ascites. These proteins are now being evaluated as biomarkers.
Summary/conclusion: Using advanced mass spectrometry, we identified candidate proteins
which are specifically enriched in small EVs of HGSC. These proteins warrant further
investigation as they may act as important players in HGSC progression as well as
serve as potential prognostic/diagnostic/screening biomarkers of HGSC.
Funding: Czech Science Foundation, Grant No. GJ17-11776Y
PF12.09=OWP1.05
Extracellular vesicles derived from amniotic fluid stem cells rescue impaired foetal
lung development via the release of microRNAs
Lina Antounians, Vincenzo Catania, Benjamin Liu, Areti Tzanetakis, Louise Montalva
and Augusto Zani
The Hospital for Sick Children, Toronto, Canada
Introduction: Incomplete lung development, also known as pulmonary hypoplasia (PH),
is a recognized cause of neonatal death. To date, there is no effective treatment
that promotes foetal lung growth and maturation. Herein, we describe a stem cell based
approach that enhances foetal lung development via the administration of extracellular
vesicles (EVs) derived from amniotic fluid stem cells (AFSCs) in rat models of PH.
Moreover, we report the microRNAs present in AFSC-EVs that are responsible for these
beneficial effects.
Methods: AFSC-EVs were isolated by ultracentrifugation from conditioned medium (CM)
of c-Kit+ rat AFSC that were grown in exosome-depleted FBS for 18 h. AFSC-EVs were
assessed for size (nanoparticle tracking analysis), morphology (TEM), and expression
of CD63, Hsp70, Flo-1 and TSG101 (Western).
Ex vivo: Pregnant dams were gavaged nitrogen at E9.5 to induce foetal PH. At E14.5,
foetal lungs were harvested, and incubated with culture medium alone, AFSC-CM, or
AFSC-EVs. Foetal lungs from untreated dams served as control. Lungs were compared
for terminal bud density and surface area at 72 h, by two independent investigators.
In vitro: Foetal rat lung organoids were generated with epithelial cells from normal
and hypoplastic lungs. Organoids were cultured for 10 days in either medium alone
or medium supplemented with AFSC-EVs. Lung organoids from untreated normal pups served
as control. Organoids were assessed for proliferation (Ki67) and markers of epithelial
cell differentiation via immunofluorescence.
RNA-sequencing: RNA was isolated using SeraMir, constructed into libraries (CleanTag
Small RNA), and sequenced on NextSeq High Output single-end sequencing run.
Results: Administration of AFSC-EVs increased terminal bud density and surface area
of lung explants back to control levels and promoted lung epithelial cell differentiation
in lung organoids (increased SPC and CC10 expression). AFSC-EVs contain 901 microRNAs,
some of which are crucial for foetal lung development, such as miR17 ~ 92 cluster.
Summary/conclusion: Administration of AFSC-EVs rescues impaired foetal lung development
in experimental models of PH. AFSC-EV regenerative ability is exerted via the release
of miRNAs some of which regulate genes involved in foetal lung development. AFSC-EVs
represent a promising therapeutic strategy for PH in foetuses.
Funding: CIHR-SickKids Foundation
PF12.10=OWP2.10
HIV-specific antibody-mediated targeting of ENV+ tissues by exosomes
Zou Xue, Yuan M’eng, Zheng Nan and Wu Zhiwei
Nanjing University, Nanjing, China (People’s Republic)
Introduction: ART (Antiretroviral Therapy) can effectively suppress HIV replication
in the peripheral blood to an undetectable level. However, efforts to eradicate the
latent virus in reservoirs remain a challenge and are a major obstacle in the treatment
of HIV patients. Exosomes exhibit huge promise as an endogenous drug delivery nanosystem
for delivering drugs to reservoir tissues given their unique properties, including
low immunogenicity, innate stability, high delivery efficiency and mostly importantly
the ability to penetrate solid tissues due to their lipophilic properties.
Methods: In this study, we engineered and expressed the ScFv of a high affinity HIV-specific
monoclonal antibody, 10E8, on exosome surface. Exosomes from 293T cells were loaded
with curcumin via saponin, with efficient up to 34%. 10E8ScFv-expressing exosomes
(10E8-Exo) showed highly efficient targeting of and curcumin delivery to CHO cell
that expresses a trimeric gp140 on its surface (ENV+ cells) in vitro as demonstrated
by confocal imaging and flow cytometry. We showed that 10E8-Exo could effectively
bind to CHO cell that expresses a trimeric gp140 on its surface. The exosomes loaded
with curcumin, a chemical that was shown to kill HIV-infected cells, showed specific
killing of the trimeric gp140-expressing CHO cells. In an NCG mouse model that was
grafted with the tumourigenic gp140-CHO cells and developed solid tissue tumours intravenously
injected 10E8-Exo targeted the ENV-expressing tissues and delivered curcumin to induce
a strong suppression of the ENV+ tumour growth with a low toxicity.
Results: Our results demonstrated that engineered exosomes can deliver anti-HIV agents
to solid tissues by specifically targeting cells expressing viral ENV and induce cell
killings.
Summary/conclusion: It suggesting that such an approach can be developed for eradicating
virus-infected cells in tissue reservoir
Funding: This study was supported by The National Key Research and Development Program
of China (2016YFC1201000), Nature Science Foundation of Jiangsu Province (BY2015069-02)
and National Nature Science Foundation of China (81672020). The funders had no role
in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Late breaking- EVs and cancerChairs: Sonia Melo; Golnaz MoradLocation: Level 3, Hall
A15:30–16:30
LBF01.01
Exosomes from LNCaP cells promote the activity of osteoblasts through the transfer
of mir-375
Yun Ye
a and Su-liang Lib
aProstate Cancer, Xi’an, China (People’s Republic); bCancer, Xi’an, China (People’s
Republic)
Introduction: Studies have shown that exosomes influence tumour metastasis, diagnosis
and treatment. It has been found that exosomal miRNAs are closely linked to the metastatic
microenvironment. However, the regulatory role of exosomes from prostate cancer (PCa)
cells in bone metastasis remains poorly understood.
Methods: We isolated and purified exosomes by ultracentrifugation, isolated total
RNA from cells and total miRNA from exosomes, and analysed the level of miR-375 by
RT-PCR. Exosome libraries from LNCaP cells and RWPE-1 cells were sequenced and filtered
with an Illumina HiSeqTM 2500 system. The activity of alkaline phosphatase, the extent
of extracellular matrix mineralization and the expression of osteoblast activity-related
marker genes were measured to evaluate osteoblast activity.
Results: Morphological observation, particle size analysis and molecular phenotyping
confirmed that the isolated extracts contained exosomes. Differential expression analysis
confirmed the high expression of miR-375 in LNCaP cell-derived exosomes. We further
determined which exosomes could enter osteoblasts and increase their miR-375 level.
In addition, exosomal miR-375 could significantly promote the activity of osteoblasts.
Summary/conclusion: This study lays the foundation for further investigations on the
function of exosomal miR-375 in the activation and differentiation of osteoblasts
and the mechanism of bone metastasis in PCa.
Funding: none
LBF01.02=OWP1.13
Colorectal cancer cell-derived exosome enhances microenvironmental angiogenesis through
modulation of intracellular metabolism
Atsushi Ikeda
a, Satoshi Nagayamab and Koji Uedac
aCancer proteomics group, Cancer Precision Medicine Center, Japanese Foundation for
Cancer Research, Tokyo, Japan; bDepartment of Gastroenterological Surgery, Cancer
Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; cCancer
Proteomics Group, Cancer Precision Medicine Center, Japanese Foundation for Cancer
Research, Tokyo, Japan
Introduction: For improvement of prognosis of colorectal cancer (CRC), detection at
an earlier stage of CRC is essential. Exosomes are nanovesicles secreted from plasma
membrane, and have potential to be served as biomarker carriers. In this study, we
performed proteomic profiling of exosomes secreted from viable CRC tissues.
Methods: To identify early detection biomarkers for CRC, we performed comprehensive
proteome analysis of tissue-exudative extracellular vesicles (Te-EVs), which were
obtained from culture media of freshly resected viable CRC tissue or adjacent normal
mucosa (n = 17). Among the identified Te-EV proteins, we narrowed down the biomarker
candidate by selecting proteins which are statistically upregulated (p < .05, fold
change > 5.0) in Te-EVs from CRC tissues than those from adjacent normal tissues.
Then we performed functional analysis of the biomarker candidate specifically.
Results: Comprehensive LC/MS analysis identified 6149 Te-EV proteins, in which 641
proteins showed significant upregulation in Te-EVs from CRC tissues (p < . 05, fold
change > 5. 0) compared to those from adjacent normal mucosa. We focused especially
on GAM (p = 7.0 × 10–5, fold change = 7.4) as a novel biomarker candidate. GAM protein
was significantly overexpressed in CRC tissues compared with adjacent normal mucosa.
In EV-sandwich ELISA assay, the expression level of GAM on plasma EVs from CRC patients
was significantly higher than that from healthy donors in EV-sandwich ELISA assay
(n = 133, p = 4.0 × 10–7). In addition, the uptake of GAM-overexpressing EVs enhanced
vascular endothelial cell growth and angiogenesis through modulation of nitric oxide
metabolism.
Summary/conclusion: EV-GAM might have great potential as a target for both CRC diagnosis
and therapy. Our strategy for identification of exosomal biomarker by proteomic profiling
of Te-EV proteins can be applied to other cancers.
LBF01.03
Augmentation of Exosome secretion in Ha-RasV12-induced cell softening and multilayer
cellular aggregates in Madin-Darby canine kidney cells
Ming Jer Tang and Hsi Hui Lin
Deaprtment of Physiology, National Cheng Kung University Medical College, Tainan,
Taiwan (Republic of China)
Introduction: Ha-RasV12 overexpression-induced cell softening and multilayer cellular
aggregates (cell clumping) during confluence in MK4 cells (inducible Ras harbouring
MDCK cells). We have demonstrated that Ha-RasV12-induced cell softening and transformation
required Cav-1 downregulation and augmented secretion of Wnt-5a containing exosome.
Here, we explored the role of exosome secretion and cell softening in Ha-RasV12-induced
cell clumping.
Methods: We employed MK4 cells (inducible Ha-Ras-harbouring MDCK cells). Cell stiffness
was measured by atomic force microscope (Biowizard II, JPK) and cell aggregates were
examined under confocal microscope. Quantitation of exosome secretion in culture media
was assessed by Nanoparticle analysis.
Results: We found that Induction of Ha-RasV12-triggered YAP nuclear translocation
and subsequently YAP-targeted gene expression. However, verteporfin, a YAP/TEAD binding
inhibitor, failed to prevent Ha-RasV12-induced multilayer cellular aggregates. Overexpression
of Cav1 inhibited Ha-RasV12-induced YAP activation and multicellular cell aggregates,
whereas knockdown of Cav1 in MDCK cells resulted in activation of YAP, but not cellular
aggregates and cellular transformation. Activities of Rac and RhoA, both associated
with cell extrusion, were increased in Ha-RasV12-overexpressed MK4 cells. EHT1864
(Rac inhibitor) abolished multilayer cellular aggregates in Ha-RasV12-overexpressed
MK4 cells, whereas Y27632 (ROCK inhibitor) induced multilayer cellular aggregates
in MK4 cells. However, neither EHT1864 nor Y27632 inhibited Ha-RasV12-induced YAP
nuclear localization. Finally, Ha-RasV12-overexpression induced a marked increase
in exosome secretion and cell softening, which preceded cell clumping.
Summary/conclusion: Taken these data together, our results indicate that Cav-1 downregulation
is required for Ha-RasV12-induced YAP activation and cellular transformation. However,
only Cav1 downregulation and Rac activation, but not YAP activation, are required
for Ha-RasV12-induced multilayer cellular aggregate.
Funding: This work was partially funded by MOST 107-3017-F-006-002 to MJ Tang.
LBF01.04
Longitudinal analysis of serum-derived extracellular RNA for monitoring of treatment
response to targeted therapy in glioblastomas
Leonora Balaj
a, Rob Kitchenb, Bob Carterc, Xandra Breakefieldc and Johan Skogd
aMassachusetts General Hospital, Boston, USA; bExosome Diagnostics, Waltham, USA;
cMGH, Boston, USA; dExosome Diagnostics, Inc., Waltham, Massachusetts, USA, Waltham,
USA
Introduction: We performed longitudinal whole-transcriptome profiling of serum exosomes
from patients suffering from recurrent glioblastoma (GBM) enrolled in a clinical trial
to assess response to Dacomitinib, a second-generation irreversible EGFR tyrosine
kinase inhibitor. All patients had failed standard of care therapy and had tumours
amplified for EGFR. They underwent daily oral administration of Dacomitinib and blood
serum samples were collected immediately prior to first treatment and monthly thereafter.
Methods: Deep sequencing of exosomal RNA (exRNA), derived from just 2 ml of patient
serum, revealed robust signatures of treatment response, as defined by >6-month progression-free
survival.
Results: Non-responders were found to have significantly elevated levels of a number
of transcripts including colony stimulating factor 1, which regulates the proliferation,
differentiation, and survival of macrophages and microglia. We further identified
robust signatures of treatment response in post-treatment serum samples, including
the suppression of DNA methyltransferase 3 alpha, an important player in DNA methyl
transfer for de-novo methylation, as well as Adenosine A2B receptor, a member of the
G protein-coupled receptor superfamily which is overexpressed in a variety of cancers
and has been shown to play a role in tumour progression via increased angiogenesis
and metastasis. Furthermore, we identified general decreases in oncogene abundance
following Dacomitinib treatment, including tumour protein p53 and Ovo-like transcriptional
repressor 1, a zinc finger-containing transcription factor, shown to be a critical
inducer of epithelial-to-mesenchymal transition in cancer. Finally, in comparison
to healthy control serum, we find hundreds of transcripts exhibiting differential
abundance in pretreatment GBM patients that may serve as general non-invasive biomarkers
for this devastating disease.
Summary/conclusion: This study is unique because it represents the first longitudinal
profiling of the exosomal transcriptome in a cohort of genomically selected GBM patients.
These findings are a tantalizing step towards exosome-based biomarkers for the detection
of GBM, as well as patient stratification and monitoring.
Funding: CA069246 CA230697 TR000931
LBF01.05
Lung cancer exosome specific protein 1 (LESP-1) is increased in the plasma of non-small
cell lung cancer patients
Byeonghyeon Choi
a, Yu Hua Quanb, Jiyun Rhob, Hyesun Jeongc, Jik Han Jungd, Sunghoi Hongc, Ji-Ho Parkd,
Yeonho Choie, Yong Parkf, Kook Nam Hang, Young Ho Choig and Hyun Koo Kimg
aKorea university, Seoul, Republic of Korea; bDepartment of Biomedical Sciences, College
of Medicine, Korea University, Gurogu, Republic of Korea; cSchool of Biosystem and
Biomedical Science, Korea University, seongbuk-gu, Republic of Korea; dDepartment
of Bio and Brain Bioengineering, Korea Advanced Institute of Science and Technology
(KAIST), Daejeon, Republic of Korea; eDepartment of Bioconvergence Engineering, Korea
University, seongbuk-gu, Republic of Korea; fDivision of Hematology-Oncology, Department
of Internal medicine, Korea University Anam Hospital, seongbuk-gu, Republic of Korea;
gDepartment of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital,
Korea University College of Medicine, Gurogu, Republic of Korea
Introduction: Lung cancer remains to be the leading cause of cancer-related mortality
worldwide. Finding new non-invasive biomarkers for lung cancer is still a significant
challenge. Exosomes are endosome-derived, nano-sized (30–150 nm), extracellular microvesicles
released from many cell types, and that play a key role for in cell-to-cell communication.
Use of exosomes as biomarkers in of lung cancer, in a liquid biopsy, is a rising emerging
field in nanotechnology in a liquid biopsy. This research work focused on identifying
exosome-specific proteins (LESP) of in non-small cell lung cancer (NSCLC) by using
proteomics and assessed their concentration efficacy within exosomes derived from
the plasma of normal and NSCLC patients.
Methods: Proteomics analysis was performed to investigate lung cancer-specific proteins
within exosomes isolated from five NSCLC (H522, A549, H1299, H1650, PC9) and one normal
lung alveolar cell lines (Human pulmonary alveolar epithelial cell), using size exclusion
chromatography. We then isolated plasma exosomes from healthy controls and NSCLC patients
(17 controls and 54 patients) using dual size exclusion chromatography. ELISA and
Western blot were utilized to validate the proteomic results in NSCLC patients and
compare with healthy controls.
Results: Using proteomics analysis, we identified LESP-1 in the exosomes from NSCLC
cells, but not in those from normal cells. LESP-1 concentration was higher in lung
cancer patients compared to the healthy controls (p < .01), and increased according
to the grade of lung cancer, in peripheral blood (p < .01). Moreover, Western blot
results confirmed the increase in LESP-1 in NSCLC patients, with band intensity increasing
with the grade of lung cancer, compared to healthy controls.
Summary/conclusion: LESP-1 in exosomes was highly expressed in the blood plasma of
lung cancer patients, which suggests that LESP-1 could serve as a potential biomarker
for diagnosis of NSCLC.
Funding: This research was supported by the Korea Health Technology R&D Project (No.
HR14C0007) funded by the Ministry of Health & Welfare, Republic of Korea.
LBF01.06
Chloride intracellular channel protein 4 (CLIC4) is a serological cancer biomarker
released from tumour epithelial cells via extracellular vesicles and required for
metastasis
Vanesa C. Sanchez, Alayna Craig-Lucas, Ji Lou; Kent Hunter and Stuart Yuspa
National Institutes of Health (NIH), Bethesda, USA
Introduction: Chloride intracellular channel protein 4 (CLIC4) is a highly conserved
metamorphic protein originally described as an ion channel. It translocates to the
nucleus serving as an integral component of TGF-β signalling. In multiple cancers,
CLIC4 is a tumour suppressor, excluded from the nucleus and lost from the cytoplasm
of progressing cancer cells. In contrast, CLIC4 is upregulated in the tumour stroma
acting as a tumour promoter. Recent reports indicate that CLIC4 is detected in the
circulation of cancer patients serving as possible biomarker and has been detected
in extracellular vesicles (EVs).
Methods: EVs from multiple sources were isolated by differential centrifugation, following
ultracentrifugation and Optiprep density gradients. EV size distribution and concentration
were analysed by NTA and TEM. The presence of prototypical markers and CLIC4 were
analysed by immunoblot and by tissue staining.
Results: CLIC4 was present in EVs released from primary normal and multiple breast
tumour cell lines and increased in EVs from TGF-β-induced myofibroblasts. In vivo,
in two different orthotopic syngeneic mouse breast cancer models, CLIC4 levels in
EVs isolated from plasma increased with tumour burden and lung metastatic load. Moreover,
CLIC4 levels in EVs isolated from plasma of breast cancer patient was elevated when
compared to healthy age and race matched controls. To dissect the contribution of
stromal vs tumour epithelial compartments as the source of the CLIC4-high EVs, CLIC4
was either deleted in tumour cells lines by CRISPR/Cas9 or CLIC4 KO females were implanted
CLIC4 WT tumour cells. CLIC4 is reduced in circulating EVs from CLIC4 KO tumour bearing
mice when compared to WT and it is present in circulating EVs from CLIC4 KO females
bearing WT tumours, indicating that the major contribution of CLIC4 into circulation
is from tumour epithelium. Additionally, CLIC4 KO females display no difference in
primary tumour size and a significant reduction in both size and number of lung metastases.
Summary/conclusion: CLIC4 levels in EVs from biological fluids may have value as a
cancer biomarker, in conjunction with other markers, to detect or analyse tumour progression
or recurrence. The low lung metastasis frequency in CLIC4 KO females may due to a
defect in lung tissue to recruit neutrophils and to induce neovasculature.
Funding: National Institutes of Health
LBF01.07
Comparative proteomic analysis of exosomes and whole cells from NSCLC cell lines:
focus on gefitinib resistance
Mi young Lee, Ye-Eun Jeong and A-Reum Ryu
Soonchunhyang University, Asan, Republic of Korea
Introduction: Overexpression of epidermal growth factor receptor (EGFR) is a typical
feature of approximately 90% of NSCLC patients. EGFR mutations induce excessive activation
of tyrosine kinase domain of EGFR, eventually inducing oncogenic alterations. Thus,
EGFR has become a therapeutic target for NSCLC patients harbouring activating EGFR
mutations with tyrosine kinase inhibitor (TKI) such as gefitinib. However, more than
50% of patients with NSCLC receiving gefitinib showed resistance to gefitinib. Thus,
acquired resistance to EGFR TKI is a major challenge in the lung cancer treatment.
Although several mechanisms have been attributable to acquired resistance, the information
on exosomal studies on EGFR-TKIs resistance of NSCLC is limited.
Methods: In this study, comparative proteomic analysis of exosomes and whole cells
from EGFR mutant gefitinib-sensitive NSCLC cell lines (PC9) and gefitinib-resistant
cell line (PC9/GR) were conducted by quantitative proteomics. The significant protein
expression changes observed in each analysis, and the differences of gefitinib resistance-related
proteins from exosomes and whole cells were examined.
Results: Biological processes, molecular functions and cellular components associated
with gefitinib resistance and key pathways related with gefitinib resistance have
been identified in exosomes and whole cell lysates from PC9 and PC9/GR cells. The
results also revealed the similarities and differences between gefitinib-resistance
of exosomes and whole cells, through pathway analysis of the core functional proteins.
Summary/conclusion: The results might suggest that functional exosomal proteins secreted
from gefitinib resistant lung cancer cells contain specific signatures via horizontal
transfer from whole cells of NSCLC
Funding: This work was supported by the Industrial Strategic Technology Development
Program (10077559) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea).
LBF01.08
Extracellular vesicles derived from bone marrow stromal cells promote evasion of multiple
myeloma cells from natural killer cell antitumour activity
Tomohiro Umezua, Chiaki Kawanaa, Satoshi Imanishib, Junko Ohyashikia and Kazuma Ohyashikia
aTokyo Medical University, Tokyo, Japan; bTokyo University of Science, Tokyo, Japan
Introduction: Natural killer (NK) cells are a major component of the antitumour immune
response. NK cell dysfunctions have been reported in various haematologic malignancies,
including multiple myeloma (MM). In the bone marrow of MM patients, bone marrow stromal
cells (BMSCs) interact with MM cells, and also create a permissive microenvironment
for MM cell survival and immunosuppression. In this study, we investigated the biological
property of the extracellular vesicles (EVs) and EV-miRNAs of BMSCs derived from MM
patients (MM-BMSCs), aiming to clarify the involvement of EVs derived from MM-BMSCs
in tumour immune microenvironment.
Methods: BM samples were obtained from MM patients (age 68–79, n = 6) in accordance
with the Declaration of Helsinki and using protocols approved by the research Ethics
Committee of Tokyo Medical University (IRB No. 2648), and BMSCs derived from MM patients
(MM-BMSCs) were isolated by the classical adhesion method. BMSCs from healthy donors
(Normal-BMSCs) were purchased from Lonza Inc. The EVs were isolated from conditioned
medium of BMSCs using Exoquick-TC Reagent (System Biosciences). EV-miRNA profiling
was done using a TaqMan low-density array (Applied Biosystems). A rapid flow cytometry
assay for quantifying target cell killing after CellVue (Sigma)-labelled MM cell lines
(RPMI8226, U266) prior to co-incubation with NK cells (Biotherapy Institute of Japan,
Inc.).
Results: There were no significant differences in size and amount of EVs among Normal-BMSCs
and MM-BMSCs. We found that the expression of some miRNAs, including miR-146a, in
the EVs derived from MM-BMSCs were higher than that of Normal-BMSCs. Furthermore,
miR-146a in MM-BMSC-EVs was significantly up-regulated by co-culturing with MM cell
lines (RPMI8226, U266). Functionally, when the miR-146a-enriched MM-BMSC-EVs was added
to the NK cell-MM cell co-culture system, RPMI8226 become less sensitive to NK cell
killing compared with adding the Normal-BMSC-EVs.
Summary/conclusion: These results indicated that MM-BMSC-EVs, including miR-146a,
may function as immune regulator to inhibit NK cell function against tumours, therefore
providing a new therapeutic target for tumour treatment.
LBF01.09
Exosomal long noncoding RNA NBR2 facilitates the immunosuppression of MDSCs by enhancing
the phosphorylation of signal transducers and activators of transcription 3
Xinyu Tiana and lI Zhiyangb
aNanjing Drum Tower Hospital & the affiliated Hospital of Nanjing University Medical
School, Nanjing, China (People’s Republic); bNanjing Drum Tower Hospital Clinical
College, Nanjing, China (People’s Republic)
Introduction: The immunosuppression induced by myeloid-derived suppressor cells (MDSCs)
plays a crucial role in tumour escape. And long noncoding RNA (lncRNA) has been indicated
as a core regulator of tumour immunity. However, the effect and regulatory mechanism
of lncRNA on the immunosuppressive function of MDSCs remain unclear. Exosomes are
cell-derived vesicles which are present in high abundance in the tumour microenvironment
where they transfer information between cells.
Methods: Ultracentrifugation was used to isolate exosomes from cancer cells. MDSCs
and T cells were sorted from the spleen of tumour-bearing mice and wild type mice,
respectively, with immunomagnetic beads. CFSE was performed to estimate the influence
of MDSCs on the proliferation of T cells. And real-time fluorescence quantification
PCR (qRT-PCR) was used to detect the expression of lncRNA NBR2, while western-blot
was used to confirm the phosphorylation of signal transducers and activators of transcription
3 (STAT3).
Results: Herein, we found that tumour-derived exosomes (TEXs) could enhance the development
and immunosuppression of MDSCs. Furthermore, it was indicated that the regulation
of TEXs to the development and immunosuppression of MDSCs depending on the transportation
of lncRNA NBR2 from cancer cells to MDSCs. Besides that, lncRNA NBR2 conveyed by TEXs
induced the development and suppressive function of MDSCs by interacting with STAT3
and enhancing its phosphorylation.
Summary/conclusion: Thus, this present study indicates that exosomal lncRNA NBR2 can
increase the immunosuppression of MDSCs by regulating the phosphorylation of STAT3,
which will provide sufficient scientific basis for the immunotherapy of cancer.
LBF01.10
In vivo imaging of natural killer cells labelled with fluorophore-loaded extracellular
vesicle mimetics
Hye Sun Parka, Gyeongyun Gob, Yong Song Ghob and Kwan Soo Hongc
aKorea Basic Science Institute, Cheongju-si, Republic of Korea; bDepartment of Life
Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea;
cBioimaging Research Team, Korea Basic Science Institute, Cheongju, Republic of Korea
Introduction: In the field of cancer immunotherapy, in-vivo biodistribution of immunotherapeutic
moiety has emerged as important issue as well as its therapeutic efficacy. This is
because it plays an important role in assessing the pharmacokinetic aspects associated
with the bio-toxicity of the immunotherapeutic moieties injected in vivo and evaluating
the therapeutic effects associated with homing to lesion sites. Natural killer (NK)
cells have non-specific antitumour activity, and have been employed to treat tumours.
Unlike other immune cells, NK cells cannot perform phagocytosis sufficiently, so it
is difficult to label NK cells with imaging materials such as nanoparticles. Difficulty
in labelling NK cells makes it difficult to validate the distribution and antitumour
activity of NK cells in vivo.
Methods: In this study, we tried to develop NK cell labelling technology using exosome
mimetics, based on the fact that exosome mimetics can deliver their cargos to target
cells via receptor-mediated endocytosis. We analysed cell adhesion molecules that
were overexpressed in NK cells and produced the cell line that overexpress them using
cell transformation techniques. We also labelled NK cells with exosome-mimetic nanovesicles
loaded with magnetic nanoparticles and fluorophores, and evaluated biomedical imaging
and therapeutic effects of the NK cells using mouse tumour models.
Results: We analysed cell adhesion molecules expressed in NK cells and constructed
cell lines that overexpress counter receptors. We succeeded in labelling NK cells
with a fluorophore-loaded exosome mimetics and also quantitatively evaluated the biomedical
imaging and therapeutic effects of the labelled NK cells.
Summary/conclusion: We produced and characterized NK cell-targeting exosome-mimetic
nanovesicles. Exosome mimetics-based cell labelling technology developed in this study
will overcome the limitations of current technology and can be widely applied to in
vivo image-tracking of immune cells in cancer immunotherapy.
LBF01.11
Comparison of MMP-13-containing extracellular vesicles with metastatic ability in
human osteosarcoma cells
Ryo Sasakia, Mitsuhiko Osaki
b and Futoshi Okadab
aDivision of Pathological Biochemistry, Department of Biomedical Sciences, Faculty
of Medicine, Tottori University, Yonago, Japan; bDivision of Pathological Biochemistry,
Department of Biomedical Sciences, Faculty of Medicine, Tottori University, Yonago,
Japan
Introduction: Osteosarcoma commonly develops from bone and mainly affects children
and adolescents. Although therapy for primary osteosarcoma, such as adjuvant chemotherapy
combined with surgical wide resection, is being improved, 30–40% of osteosarcoma patients
die of lung metastasis. Therefore, it is important to elucidate the mechanism of lung
metastasis to establish specific new therapies based on the mechanism. We previously
reported that the down-regulation of miR-143 promotes cellular invasion of 143B cells,
a human osteosarcoma cell line, and that intravenous injection of miR-143 significantly
suppresses lung metastasis of osteosarcoma cells in mice. In addition, matrix metalloproteinase-13
(MMP-13) was identified as one of the miR-143 target genes, and knockdown of MMP-13
was able to suppress the invasion of 143B (metastatic osteosarcoma cell line) cells
in vitro.
Methods: These data motivated us to examine whether MMP-13 concentration in extracellular
vesicles (EVs) secreted by 143B was higher than in that secreted by HOS (non-metastatic
cell line). In this study, we examined the number of secreted EVs and MMP-13 concentration
in the EVs of two human osteosarcoma cell lines-143B and HOS.
Results: The number of EVs secreted by 143B was four times higher than those secreted
by HOS. Moreover, Western blot analysis revealed that MMP-13 concentration per 3 µg
of EVs was increased 2.5 times in EVs derived from 143B in comparison to those derived
from HOS.
Summary/conclusion: These data suggest that the number of secreted EVs and/or the
concentration of MMP-13 in EVs play an important role in the metastatic ability of
human osteosarcoma cells.
LBF01.13
Exosomal long noncoding RNA NBR2 induces the autophagy of lung cancer cells by interacting
with high-mobility group box 1
Ting Wang
a and Xinyu Tianb
aJiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer
Hospital of Nanjing Medical University, Nanjing, China (People’s Republic); bNanjing
Drum Tower Hospital, Nanjing, China (People’s Republic)
Introduction: Lung cancer has become the leading cause of disease-related death worldwide.
It has been confirmed that high-mobility group box 1 (HMGB1) is closely correlated
with the progression of lung cancer. However, it still remains unclear about the accurate
mechanisms of regulating the expression and secretion of HMGB1 in lung cancer cells.
Exosomes are cell-derived vesicles which are present in high abundance in the tumour
microenvironment where they transfer information between cells.
Methods: Exosomes from cultivate supernatant of lung cancer cells were isolated with
ultracentrifugation. Western-blot and immunofluorescence were performed to confirm
the expression of HMGB1 in lung cancer cells, and ELISA was used to detect the secreted
HMGB1. The expression of long noncoding RNA (lncRNA) NBR2 was detected with real-time
fluorescence quantitative fluorescence (qRT-PCR). Western-blot and transmission electron
microscope were used to make sure the autophagy of lung cancer cells.
Results: Herein, we demonstrated that exosomes from lung cancer cells could promote
the both the expression and secretion of HMGB1, and therefore induce the autophagy
of lung cancer cells. Besides that, it was also demonstrated that exosomes from lung
cancer cells promoted the expression and release of HMGB1 by conveying lncRNA NBR2
which could interact with HMGB1 protein and enhance its stability. Moreover, high
level of HMGB1 facilitated the autophagy of lung cancer cells via activating RAGE-Erk1/2
pathway, and accelerated the progression of lung cancer.
Summary/conclusion: Taken together, our study indicates that exosomal lncRNA NBR2
induces the autophagy of lung cancer cells and accelerates the tumour progression
by interacting with HMGB1.
LBF01.14
Morphology of tissue disruption at the sites of high-grade tumour
Mousumi Chaudhury
GIM foundation, Little Rock, USA
Introduction: Invasive cancers originating from diverse organs like breast, ovary
and lung metastasize to distant sites. However, the structural changes at the primary
site of these high-grade tumours have not been well characterized. In this observational
study using images of hematoxylin-eosin stained human tumour tissues, it is reported
that intriguingly, the morphology of the tissues at the metastatic front or at the
primary site appears similar, irrespective of the organ of origin of the primary tumour.
These structures appear as a bulb-like projection, emanating from the tumour cell
membrane. Mostly, they appear similar as a ball and stick bulge. Although structures
are not exactly similar in their dimension, there is a conserved bulb like morphological
protrusion in all tumours. Earlier studies have described in in vitro or mouse models
of similar structures as invadopodia, invadosome or podosome, but their morphology
has not been well characterized and examined in detail.
Methods: Web pathology website of H&E-stained human tumour slides were used. Cases
have been studied based on the H&E-stained slides and on their diagnosis available
for each case. Each organ and tissue specific tumours were selected after systematically
browsing all seminars. Control cases were chosen based on their diagnosis notes as
non-invasive benign tumour condition. In this study, image J was used for its different
potentials. It was used to prepare the figures to show boundary, measure the perimeter,
making efficient colour contrast figures.
Results: The preliminary observations reported in this study suggest that there may
be excessive force acting in the periphery of the cell, which likely leads to this
cytosol enclosed membrane protrusions, likely to contain the nuclei. Some of these
protrusions have nuclei and others do not. Also, there is clear evidence of enhanced
membrane synthesis in high-grade tumour tissues.
Summary/conclusion: This study suggests that there is a possible final common pathway
of mechanical force generation, likely via cytoskeleton remodelling, which may arise
irrespective of organ-specific genomic modulation related to the primary disease process.
These observations provide visual evidence of epithelial-mesenchymal transition during
tumour metastasis.
Funding: none
Late breaking- EVs and physiologyChairs: Elie Beit-Yannai; Benedikt KirchnerLocation:
Level 3, Hall A15:30–16:30
LBF02.01=OWP1.10
Type-2 transglutaminase affects calcium homeostasis in neurons and is released in
association with astrocytes-derived exosomes
Elisa Tonoli
a, Ilaria Pradab, Claudia Verderioc and Elisabetta Verderioa
aNottingham Trent University, Nottingham, United Kingdom; bCNR Institute of Neuroscience,
Milan, Italy., Milan, Italy; cCNR Institute of Neuroscience, Milan, Italy, Milan,
Italy
Introduction: Type-2 transglutaminase (TG2) has been linked to calcium (Ca2+) dysregulation
in conditions such as neurodegeneration. Recent evidences suggest that extracellular
vesicles (EVs) contribute to the onset and progression of neurological diseases, and
we have recently shown that TG2 is a cargo of EVs in biological fluids. Here, we hypothesise
that TG2 could be released by EVs, interact with neurons and affect neuronal Ca2+
homeostasis.
Methods: Primary hippocampal neurons were established from E18 rat embryos. Extracellular
TG2 was modulated in neurons either by lipofectamine transfection of a TG2-EGFP construct
or by addition of purified TG2. Intracellular Ca2+ concentration ([Ca2+]i) was assessed
by live imaging in fura-2/AM-loaded neurons. EVs were isolated from primary astrocytes
(60 DIV) by serial centrifugation, characterized by Western blotting (flotillin-2
and alix) and nanoparticle tracking analysis (ZetaView). Experiments to assess TG2
influence on exosomes-to-neural cells interactions, using a Renilla sensor based on
miR-146a-5p-transfer, are still ongoing.
Results: Increase of extracellular TG2 levels in neurons induced an influx of extracellular
Ca2+ ions, leading to a significant raise in basal [Ca2+]i both in normal conditions
(ΔF340/380 = 0.126 ± 0.014; N = 23; p < 10–5) and with inhibited synaptic transmission
(tetrodotoxin) (ΔF340/380 = 0.058 ± 0.005; N = 33; p < 10–5). Nifedipine, a blocker
of L-type voltage-operated Ca2+ channels (VOCCs), partially prevented TG2-dependent
Ca2+ response (average inhibition 36%; N = 21; p < 10–5), suggesting that Ca2+ influx
may occur through L-type VOCCs. To identify the source of extracellular TG2, we analysed
EVs isolated from rat primary astrocytes, previously reported to release TG2 into
the matrix especially in inflammatory conditions. TG2 was detected in astrocytic exosomes
(but not in ectosomes) only upon LPS stimulus, and not in the EVs-free medium, suggesting
that TG2 is a cargo of exosomes during neuroinflammation.
Summary/conclusion: TG2 is externalized through astrocyte-derived exosomes upon neuroinflammatory
stimuli. Extracellular TG2 mediates the opening of L-type VOCCs in neurons and sets
basal [Ca2+]i at higher levels, which could have a significant impact on neuronal
activity in neuroinflammation.
Funding: John Turland PhD bursary (NTU) and IBRO travel fund.
LBF02.02=OWP1.12
Plasma exosomes regulate proliferation and migration of vascular smooth muscle cells
Kosuke Otani
a, Mai Yokoyab, Muneyoshi Okadac and Hideyuki Yamawakib
aLaboratory of Veterinary Pharmacology, School of Veterinary Medicine, Kitasato University,
Towada, Japan; bKitasato University, Towada, Japan; cKitasato University, School of
Veterinary Medicine, Laboratory of Veterinary Pharmacology, Towada, Japan
Introduction: We previously reported that systolic blood pressure in spontaneously
hypertensive rats, an animal model of essential hypertension, was partly modulated
by circulating exosomes (BBRC 2018). Vascular wall remodelling regulated by proliferation
and migration of vascular smooth muscle cells (VSMCs) mediates development of hypertension.
We aimed to clarify the effects of plasma exosomes derived from SHR and control Wistar
Kyoto Rats (WKY) on proliferation and migration of VSMCs.
Methods: Exosomes were isolated from rat plasma by an ultracentrifuge method, and
identified through measurement of particle size distribution by a tunable resistance
pulse sensing. For exploring exosome internalization in VSMCs, the isolated exosomes
were labelled with PKH67 dye and observed by a fluorescence microscopy. Proliferation
and migration of SMCs were determined by a bromodeoxyuridine incorporation and Boyden
chamber assay, respectively. Actin cytoskeleton was visualized by a rhodamine-phalloidin
staining. Expression of protein and microRNA in exosomes was determined by Western
blotting and microarray, respectively.
Results: There was no difference in size and concentration of plasma exosomes between
WKY and SHR. Exosomes were incorporated into VSMCs, while the internalization of SHR
exosomes was significantly lower than WKY exosomes. Both WKY and SHR exosomes similarly
stimulated proliferation, migration and cytoskeletal changes such as formation of
filopodia and lamellipodia in VSMCs. Heparin, an inhibitor of exosome internalization,
completely blocked the migration and proliferation. Protein expression of CD9 and
CD63, an exosomal marker, was significantly higher in exosomes from WKY than SHR.
The expression of several microRNAs in SHR exosomes changed compared with WKY exosomes.
Summary/conclusion: These results suggest that plasma exosomes play physiological,
but not pathological, role on VSMCs irrespective of their origin (normotensive or
hypertensive rats). Further research is required for determining whether the changes
in molecular profiles of circulating exosomes mediate the development of high blood
pressure in SHR.
LBF02.03
Exosomes containing HIV protein Nef reorganize lipid rafts inducing inflammatory responses
of immune cells and increasing their susceptibility to HIV infection
Dmitri Sviridova and Michael Bukrinsky
b
aBaker Heart and Diabetes Institute, Melbourne, Australia; bGeorge Washington University
School of Medicine, Washington, USA
Introduction: HIV disease is associated with co-morbidities, which persist even after
successful application of antiretroviral therapy. One important factor responsible
for these effects is exosomes containing the main HIV pathogenic factor, Nef, which
can be found in blood of HIV subjects with undetectable HIV load. In this study, we
investigated the effect of Nef-containing exosomes on uninfected macrophages and T
cells.
Methods: Exosomes were purified by differential centrifugation from HEK293 cells transfected
with Nef-expressing or empty vector, monocyte-derived human macrophages infected with
Nef-positive or Nef-deficient HIV-1, or plasma of uninfected subjects or patients
infected with wild-type or Nef-deficient HIV-1. Exosomes were adjusted by protein
content and added to cells at 0.2 ng/ml of Nef protein. Mice were injected with Nef
exosomes IP (2 μg per injection) 3 times a week for 2 weeks.
Results: Exosomes containing HIV protein Nef (exNef) are internalized by macrophages
altering cholesterol metabolism and causing sharp increase in the abundance of lipid
rafts through reduced activation of small GTPase Cdc42 and decreased actin polymerization.
ExNef increased susceptibility of MDM to fusion with HIV. These changes resulted in
activation of NLRP3 inflammasome and increased secretion of pro-inflammatory cytokines.
The effects of exNef were reversed by overexpression of a constitutively active mutant
of Cdc42. The findings were validated with exosomes produced by HIV-infected cells
and with exosomes isolated from plasma of HIV-infected subjects, but not from ΔNef-HIV-infected
subjects. Mice injected with exNef displayed altered cholesterol metabolism, monocytosis,
increased raft abundance and augmented inflammation.
Summary/Conclusion: Nef containing exosomes potentiate pro-inflammatory responses
by impairing cholesterol metabolism and reorganizing lipid rafts, increasing cell
susceptibility to HIV infection and contributing to co-morbidities of HIV disease.
Funding: Grants from NIH (HL131473, AI055019), American Heart Association (17GRNT33630163),
and NHMRC (GNT1036352).
LBF02.04
Exosomes derived from human mesenchymal stem cells ameliorates autistic-like behaviours
in BTBR and Shank3 mice models of autism
Nisim Peretsa, Ehud Maromb, Yona Geffenc, Uri Danond, Oded Orone, Evan Eliote and
Daniel Offen
f
aSagol School of neuroscience, Tel Aviv University, Israel, Tel aviv, Israel; bStem
Cell Medicine LTD, Jerusalem, Israel., Jerusalem, Israel; cStem Cell- Medicine LTD,
Jerusalem, Israel., Jerusalem, USA; dStem Cell Medicine LTD, Jerusalem, Israel, Jerusalem,
Israel; eFaculty medicine, Bar-Ilan University, Israel, Ramat Gan, Israel; fSagol
School of neuroscience, Tel Aviv University, Israel, Sacklar school of medicine, department
of human genetics and biochemistry Tel Aviv University, Israel., Tel Aviv, USA
Introduction: Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized
by three core symptoms that include severe impairment of social interaction and communication
skills, increased repetitive behaviours and cognitive inflexibility. Rate of ASD is
steadily increasing in children over the past several years, with no effective treatment.
Methods: BTBR and Shank3 are accepted mouse models used for evaluating autistic-like
behaviours as it presents all core symptoms and genetic human mutation of ASD. We
have previously shown that transplantation of human bone marrow mesenchymal stem cells
(MSCs) to the lateral ventricles of BTBR mice results in long lasting improvement
in their autistic behavioural phenotypes. Recent studies point of exosomes as the
main mediators of the therapeutic effect of MSCs.
Results: Here we show that intranasal administration of exosomes derived from bone
marrow or adipose tissue MSCs, ameliorate autistic-like behaviour in BTBR and Shank3
mice. Including significant increase of social interaction and ultrasonic vocalizations,
reduced repetitive behaviours and improve maternal behaviours of pup retrieval. No
negative safety symptoms were detected following exosomes intranasal treatments in
mice.
Summary/conclusion: The beneficial effects of the exosomes treatment in mice models
may be translated to a novel, easy to administer, therapeutic strategy to reduce the
symptoms of ASD.
Funding: Partially by Stem Cell Medicine LTD and Kamin
LBF02.05
The use of artificially produced bacterial vesicles as an immunotherapeutic vaccine
against Pseudomonas aeruginosa pneumonia
Kyong-su Park
a and Jan Lötvallb
aKrefting Research Centre, University of Gothenburg, Gothenburg, Sweden; bKrefting
Research Centre, Institute of Medicine at the Sahlgrenska Academy, University of Gothenburg,
Göteborg, Sweden, Gothenburg, Sweden
Introduction: Pseudomonas aeruginosa is an opportunistic pathogen which is involved
in pneumonia and cystic fibrosis. Immunization with outer membrane vesicles (OMVs),
which has naturally budded off from bacteria, is an evolving field in infectious diseases
due to their highly immunogenic properties. However, OMVs are difficult to produce
naturally in large quantities with high purity. This study aims to develop an artificial
OMVs (aOMVs) isolation method, and to investigate the protective effects of aOMVs
against P. aeruginosa-induced pneumonia.
Methods: Outer membranes were obtained from P. aeruginosa by lysozyme and detergent
treatment, followed by ionic stress and applied mild energy to generate aOMVs. The
yield and purity of aOMVs were analysed by nanoparticle tracking analysis and transmission
electron microscopy. The protein and RNA contents were examined by label-free quantitative
mass spectrometry and bioanalyzer. Inflammation was evaluated in lung macrophages
by measuring cytokine release. Naturally produced OMVs or aOMVs were weekly injected
in mice for 3 weeks, and then blood and spleen were obtained for antibody titer and
splenocyte cytokine study. Lung inflammation by P. aeruginosa challenge was assessed
in H&E stained lungs.
Results: The aOMVs were isolated in higher yield (fivefold) compared to OMVs. They
had similar spherical shape and size as OMVs, but had better purity. Outer membrane
components were more enriched in aOMVs, and cytosolic protein and RNA contents were
almost completely removed. Especially, aOMVs were observed to induce less inflammation
in macrophages compared to OMVs. In addition, immunization with aOMVs induced strong
IgG antibody response to the bacterial proteins, and a greater increase in IFN-gamma
from CD4+ T cells compared to OMVs. Moreover, aOMV-immunized mice showed dramatically
reduced lung inflammation caused by bacterial challenge.
Summary/conclusion: This study shows that aOMVs can be produced in a large amount
with high purity, and have protective effect against P. aeruginosa-induced pneumonia
through a balanced humoral and cellular immune response, suggesting that aOMVs may
be novel bacterial vesicle-mimetics to clinically applicable to infectious diseases.
Funding: This work was supported by Swedish Heart-Lung Foundation (20150588).
LBF02.06
Herpesvirus infection of infant tonsil mucosal epithelia containing intravesicular
Human Immunodeficiency Virus induces release of HIV from epithelial cells
Rossana Herrera, Kristina Rose and Sharof M. Tugizov
University of California San Francisco, San Francisco, USA
Introduction: Mother-to-child transmission (MTCT) of HIV is an important pathway for
the spread of the virus from mother to child; however, the molecular mechanisms of
HIV MTCT are poorly understood. Our recent work showed that >90% of virions internalized
into polarized infant tonsil epithelium were sequestered, that is, trapped in the
endosomes, including multivesicular bodies (MVBs) and vacuoles of epithelial cells,
for up to 9 days. The primary goal of this work was to investigate the role of common
oral viral pathogens herpes simplex virus-1 (HSV-1), human cytomegalovirus (HCMV),
and Epstein-Barr virus (EBV) in the release of endosomal HIV, which may play a role
in HIV MTCT.
Methods: Polarized tonsil epithelial cells were incubated with HIV-1. After 4 h, the
extracellular virus was removed, and cells were maintained for 3 days. Cells were
then infected with HSV-1, HCMV, and EBV. AP and BL medium was independently collected
after herpesvirus infection and HIV release was examined by p24 ELISA assay.
Results: Our data showed that the infection of HSV-1, HCMV and EBV in tonsil epithelial
cells containing intravesicular HIV-1 led to the release of HIV virions, which were
infectious for peripheral blood mononuclear cells. HIV release was correlated with
the reduction of TER in HSV-1-, HCMV- and EBV-infected polarized epithelial cells;
that is, herpesvirus-induced depolarization of epithelial cells was critical for HIV
release. HSV-1 and HCMV infection in tonsil epithelial cells substantially increased
the expression of GTPases Rab27a and Rab27b, which may regulate the movement of MVBs
and vacuoles to the plasma membrane and their fusion with the epithelial cell membrane.
Summary/conclusion: HSV-1- and HCMV-induced activation of Rab27a and Rab27b in epithelial
cells containing intravesicular HIV may promote virus release, that is, exocytosis
of virions. HSV-1-, HCMV- and EBV-induced depolarization of tonsil epithelial cells
also may play critical in the release of endosomal HIV. Herpesvirus interaction with
infant tonsil epithelial cells containing HIV may lead to the release and spread of
HIV into CD4+T lymphocytes, macrophages and Langerhans/dendritic cells, leading to
HIV MTCT.
Funding: R01DE028129, NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
LBF02.07
Syntenin regulates Hepatitis C virus sensitivity to neutralizing antibody by promoting
E2 secretion through exosomes
Libin Deng and Gang Long
Institut Pasteur of Shanghai, Shanghai, China (People’s Republic)
Introduction: Hepatitis C virus (HCV) is a major cause of chronic liver disease, infecting
approximately 71 million people worldwide. Assembly of infectious HCV particles involves
host lipoproteins, giving rise to unique lipo-viro-particles (LVPs), but proteome
studies suggest that additional cellular proteins are associated with HCV virions
or other particles containing the viral envelope glycoprotein E2. Many of these host
cell proteins are common markers of exosomes, most notably the intracellular adaptor
protein syntenin required exosome biogenesis. These observations suggest that E2 might
be a component of both LVPs and exosomes produced from HCV infected cells.
Methods: Using HCVcc in both hepatoma cells and primary human hepatocytes (PHHs),
we studied biogenesis and function of E2-coated exosomes.
Results: Knockout of syntenin had negligible impact on HCV replication and virus production
whereas ectopic expression of syntenin at physiological level reduced intracellular
E2 abundance concomitant with increased secretion of E2-coated exosomes. Importantly,
cells expressing syntenin and HCV structural proteins efficiently released exosomes
containing E2 but lacking the core protein. Furthermore, infectivity of HCV released
from syntenin expressing hepatoma cell and PHHs was more resistant to neutralization
by E2-specific antibodies and chronic-phase patient serum. Last, high E2/syntenin
levels in sera correlates to lower serum neutralization capability.
Summary/conclusion: E2- and syntenin-containing exosomes is a major type of particles
released from cells high expressing syntenin. Efficient production of E2-coated exosomes
in hepatoma cells and PHHs renders HCV infectivity less susceptible to antibody neutralization.
Funding: This work was supported by from the strategic priority research program of
the Chinese Academy of Sciences (XDB29010000), the National Science and Technology
Major Project of the Ministry of Science and Technology of China (2015CB554300 and
2016YFC1200400) and the National Nature Science Foundation of China (81761138046).
Work by R.B. was supported by the Deutsche Forschungsgemeinschaft, collaborative research
center (TRR) 179, TP9.
LBF02.08
Lipidomics profiles of plasma microvesicles differ in experimental cerebral malaria,
compared to malaria without neurological complications
Amani M. Batarseh
a, Elham Hosseini-Beheshtib, Alex Chenc, Amy Cohenb, Annette Juillardd, Michael Marianie
and Georges Graub
aBCAL Dx, Eveleigh, NSW, Australia 2015, Eveleigh, Australia; bVascular Immunology
Unit, Faculty of Medicine & Health, University of Sydney, Camperdown, NSW, Australia
2050, Camperdown, Australia; cThermo Fisher Scientific, Scoresby, VIC, Australia 3179,
Scoresby, Australia; dVascular Immunology Unit, Faculty of Medicine & Health, University
of Sydney, Camperdown, NSW, Australia 2050, Sydney, Australia; eThermo Fisher Scientific,
North Ryde, NSW, Australia 2113, North Ryde, Australia
Introduction: Cerebral malaria (CM), a fatal complication of Plasmodium infection
affecting children in sub-Saharan Africa and adults in South-East Asia, results from
incompletely understood pathogenetic mechanisms, which include sequestration of infected
erythrocytes, cytokine overproduction, accumulation of inflammatory cells, and excessive
release of microvesicles (MV). Plasma MV levels are elevated in CM patients and in
the experimental mouse model. Here, MV lipidomics profile was studied in relation
to the development of cerebral complications.
Methods: Plasma MV was enriched using differential centrifugation (El-Assaad 2014).
Lipids were extracted according to Matyash et al. (2008), loaded on a C30 Acclaim
column using a Vanquish liquid chromatography (LC) system and analysed using a Fusion
mass spectrometer (MS). LipidSearch software was used for lipid species annotation
and quantification.
Results: We compared lipid profiles in circulating MV purified from CBA mice with
P. berghei ANKA (PbA), which causes CM, to those from P. yoelii (Py), which does not.
Plasma MV produced at the time of CM dramatically differed from those from non-CM
mice, in spite of identical levels of parasitaemia: using high-resolution LCMS, we
identified over 200 lipid species within 12 lipid classes. Total phosphatidylethanolamine
(PE) levels were significantly higher in MV from PbA mice compared to those from uninfected
control and Py. Using fragmentation MS, we identified that this PE increase is due
at least in part to PE (16:0_22:6), PE (18:0_22:6) and PE (18:1_22:6) species identified
in PbA vs Py and uninfected control. Total phosphatidylserine (PS) was significantly
higher in both PbA and Py compared to uninfected control. Conversely total lysophosphatidylcholine
(LPC) and lysophosphatidylethanolamine (LPE) were significantly lower in PbA compared
to uninfected mice, while they were unchanged in Py MV.
Summary/conclusion: These results suggest, for the time, that experimental CM is characterized
by specific changes in lipid composition of circulating MV, pointing towards PE subsets,
LPC and LPE as potential important players in CM pathogenesis.
Funding: NHMRC Project grant APP1099920 to GG.
LBF02.09
Compound extracted from cinnamomum osmophloeum leaves reduced exosomes release from
hepG2 cells
Wei-chi Kua, Shu-yu Yangb, Jen Ying Lib and Meng-Jen Lee
c
aFu Jen Catholic University, New Taipei, USA; bTsu-chi Hospital, Taichung, Taiwan
(Republic of China); cDepartment of applied chemistry, Taichung, USA
Introduction: Cinnamomum osmophloeum belongs to the genus of Cinnamon, the same genus
as the species used for commercially sold cinnamon. Compounds of the extracted Cinnamomum
osmophloeum leaves have good potential to be developed into new drugs. Further, usage
of the leaves of the tree is much more sustainable and cost effective than the bark.
ABL006 is a major compound isolated from Cinnamomum osmophloeum that previously known
for insulin mimetick effect. For fear of side effect of pro-inflammatory effect to
the central nervous system, we tested using proteomic approach to study differential
protein expression after ABL006 treatment in astrocytic cells.
Methods: We used dimethyl labelling on the peptide level and LC-MS/MS to select differentially
expressed proteins. The selection criterion was based on significant up- or down-regulation
in both biological samples.
Results: We were able to quantitate 13,013 peptides, which corresponds to 1264 proteins
from two biological replicates. Thirty-two differentially expressed proteins were
shortlisted, among them some are nuclear protein and protein relevant to lipid metabolism.
Further pursuing this, we treat hepG2 with ABL006, and study the differential protein
expression in the conditioned medium, hoping to understand further the lipid regulating
action of ABL006. The differentially expressed proteins between treated and non-treated
were short-listed to 33 proteins. These proteins were checked against the 100 top
expressing proteins secreted by the exosomes (Exocarta, http://exocarta.org/index.html).
Out of 33 most significantly regulated proteins, 8 were exosomal markers, and almost
all were down-regulated upon ABL006 treatment.
Summary/conclusion: This suggested that exosomes release from hepG2 is reduced upon
ABL006 treatment.
Funding: MOST 107-2632-B-324-001.
LBF02.10
Placental cells function as environmental sensors that respond to changes in the extracellular
milieu via extracellular vesicles
Carlos Palma
a and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland
Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University
of Queensland, Brisbane QLD 4029, Australia, Brisbane, Australia; bExosome Biology
Laboratory, Centre for Clinical Diagnostics, University of Queensland Centre for Clinical
Research, Royal Brisbane and Women’s Hospital, The University of Queensland, Brisbane
QLD 4029, Australia., Brisbane, Australia
Introduction: Placenta-derived extracellular vesicles (PdEVs) are present in maternal
circulation as early as 6 weeks of gestation. Changes in the concentration of PdEVs
are found in gestational diabetes, preeclampsia and preterm birth. The aim of this
study was to characterize the release and biogenesis of EVs from placental cells in
response to extracellular glucose, insulin, lipopolysaccharide (LPS) and tumour necrosis
factor a (TNF-a) in vitro.
Methods: Bewo cells were used as a placental model. Cells were incubated with forskolin
for 24 h to stimulate syncytium formation in vitro. After syncytialization, cells
were incubated in the presence of forskolin with D-glucose (5 mM or 25 mM), insulin
(1 nM), LPS (0–10 μg/ml) and TNF-a (0–20 ng/ml) for 48 h. EVs were isolated from cell-conditioned
media by differential centrifugation and characterized by their size distribution,
protein abundance and morphology using nanoparticle tracking analysis, Western blot
and electron microscopy, respectively. The effect of the extracellular milieu on the
release of PdEVs was evaluated in four different subpopulations according to size;
<50, 50–150, 150–200 and >200 nm.
Results: Differential changes in the release of PdEVs subpopulations in response to
glucose, insulin, LPS and TNF-a were observed. High glucose induced the release of
EVs <50 nm, and >200 nm although this effect was abolished by insulin. High glucose
and insulin decreased the release of EVs 150–200 nm and EVs 50–150 nm, respectively.
The effect of LPS on the release of PdEVs was size-dependent with the greatest effect
on EVs of >200 nm. Finally, TNF-a increased the release of EVs in size and concentration-dependent
manner with a maximum effect on EVs >200 nm and 2 ng/ml. Changes in the release of
exosomes were associated with a differential abundance of proteins associated with
ESCRT machinery.
Summary/conclusion: The effect of the extracellular milieu on PdEVs release may be
recapitulated and is of clinical relevance in vivo in association with hyperglycaemia
(glucose and insulin), infection (LPS) and inflammatory (TNF-a) conditions.
Funding: Lions Medical Research Foundation, National Health and Medical Research Council
(NHMRC; 1114013), Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT
1170809), and CONICYT PFCHA/DOCTORADO BECAS CHILE/2018-72190513
LBF02.11
Association of cytokines with circulating populations of extracellular vesicles at
early gestation
Katherin Scholz-Romero
a, Andrew Laia, Carlos Palmaa, Gregory Duncombea, Gregory Ricea and Carlos Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland
Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University
of Queensland, Brisbane QLD 4029, Australia, Brisbane, Australia; bExosome Biology
Laboratory, Centre for Clinical Diagnostics, University of Queensland Centre for Clinical
Research, Royal Brisbane and Women’s Hospital, The University of Queensland, Brisbane
QLD 4029, Australia., Brisbane, Australia
Introduction: Cytokines have several roles across gestation, including implantation,
placentation and immune response, which are all essential for the continuation of
pregnancy. The aim of this study was to isolate and characterize different populations
of extracellular vesicles (EVs) from maternal plasma at the first trimester of pregnancy,
and quantify the levels of interleukin 10 (IL-10), 6 (IL-6), Interferon gamma (IFN-γ),
and tumour necrosis factor a (TNF-a), associated with EVs.
Methods: Plasma samples were collected from pregnant women during the first trimester
of pregnancy (n = 10). EVs were isolated through differential centrifugation, at 2000g
for 30 min (pellet 1); 12,000g for 45 min (pellet 2) and at 100,000g for 120 min (pellet
3). The supernatant after the last centrifugation was termed “soluble fractions”.
EVs were characterized by size distribution, abundance of proteins associated with
EVs (i.e. CD63, Flotilin-1 and TSG101), negative control for Grp94, and morphology,
according to the recommendations of the International Society of Extracellular Vesicles,
using Nanoparticle Tracking Analysis (NTA), Western blot analysis and electron microscopy,
respectively. The concentration of IL-10, IL-6, IFN-γ and TNF-a in the EVs and the
soluble fractions were established by cytokine array analysis (Bioplex-200).
Results: Specific changes in the levels of cytokines, in the different population
of vesicles, and in the soluble fractions were identified. The levels of IL-10, IL-6,
IFN-γ and TNF-a were significantly higher (p < .05) in the exosome fraction (pellet
3) compared to the values observed in pellet 1 and pellet 2 (macro and microvesicles
fractions). The levels of IL-10, IFN-γ and TNF-a were significantly higher (p < .05)
in the soluble fractions compared with the exosomal fraction. No significant difference
in the level of IL-6 in the exosomal and soluble fraction was observed.
Summary/conclusion: This study established that cytokines are packaged within EVs
(in which these molecules are protected), suggesting a novel mechanism of action through
which cytokines via EVs can lead to distal interactions.
Funding: Lions Medical Research Foundation, National Health and Medical Research Council
(NHMRC; 1114013), and Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT
1170809).
LBF02.12
Mesenchymal stem cell-derived exosomes attenuate inflammation and protect ischemic
neuronal damage
May-Jywan Tsai
a, Dann-Ying Lioub and Henrich Chengb
aNeurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan (Republic
of China); bNeurological Institute, Taipei Veterans General Hospital, Taiwan, Taipei,
Taiwan (Republic of China)
Introduction: Bone marrow mesenchymal stem cells (BM-MSC) are the most extensively
used stem cells in tissue engineering due to their easy access, rapid ex vivo expansion
and poor immunogenicity. MSCs secrete various factors that can modulate a hostile
environment, which is called the paracrine effect. MSCs have a strong capacity for
secretion of exosomes which are suspected to participate in paracrine cellular communication.
Methods: We compare the effects of BM-MSC conditioned medium (MSCcm) and MSC-derived
exosomes (MSCexo) in neuron-glial cultures as well as in spinal cord injured (SCI)
rat model.
Results: We found that both MSCcm and MSCexo were effective in reducing LPS stimulation
and oxygen glucose deprivation, an in vitro stroke model, damage in neuron-glial cultures.
Further comparison of the beneficial effects of MSCcm and MSCexo will be conducted
in in vivo SCI rats via vascular administration.
Summary/conclusion: This cell-free therapy, avoiding the risks associated with direct
MSC transplantation, may improve nerve regrowth and functional recovery after SCI.
Funding: Research grant (V107C-087) from the Taipei Veterans General Hospital in Taiwan,
and grants (106-2314-B-075-023 & 107-2314-B-075-021) from the Ministry of Science
and Technology in Taiwan.
Symposium Session 19: EV Cargo Profiling Chairs: Tang-Long Shen, Lei ZhengLocation:
Level B1, Lecture Room 16:30–18:00
OF19.01
Distinct extracellular RNA cargo types associate with specific vesicular and non-vesicular
RNA carriers across human biofluids
Aleksandar Milosavljevic
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA
Introduction: The Extracellular RNA Communication Consortium (ERCC) has developed
the ExRNA Atlas, a reference catalogue of exRNAs present in human biofluids. A computational
deconvolution analysis identified six RNA cargo types (CT1, CT2, CT3A, CT3B, CT3C,
CT4) present across human biofluids represented within the Atlas. Extensive experimental
analyses by the ERCC show association of these cargo types with specific vesicular
and non-vesicular (lipoprotein, RNP particle) carriers.
Methods: To identify carriers for the six CTs, we performed: cushioned density gradient
ultracentrifugation of serum and plasma using the OptiPrep density gradient, RNA-seq,
western blot and mass spectrometry analysis of the density fractions; RNA-seq profiling
of ultracentrifugation products, of size fractionation using nanoscale deterministic
lateral displacement (nano-DLD) arrays; of lipoprotein fractions; and of AGO-1 immuno-pulldowns.
We also carried out RNA-seq of a shared pool of human plasma and serum samples processed
using 10 widely used RNA isolation methods.
Results: CT1 correlates with RNA-seq profiles of carriers of exosomal size and density
(OptiPrep fractions 4–7 that are CD9 and Flotillin positive). CT2 correlates with
the exRNA profiles of lipoprotein carriers (HDL, LDL, VLDL, Chylomicron); the carrier
shows HDL density (OptiPrep fractions 9–12) and is APOA1 positive. CT3A and B show
high miRNA content and correlate with RNA-seq profiles of AGO2 immuno-pulldowns. CT4
correlates with the RNA-seq profiles of both low-density vesicles (OptiPrep fractions
1-3) and HMC-1 cell-line derived vesicles of higher-density. The 10 widely used commercial
RNA isolation kits show distinct preferences for specific CT subsets. On average,
across all kits, CT4 was captured at highest and CT3B at second-highest relative abundance.
Summary/Conclusion: The heterogeneity of exRNA cargo types exceeds the capabilities
of current experimental methods to reproducibly isolate defined carrier subpopulations
from human biofluids. While this problem calls for the development of new carrier
isolation methods, we have now demonstrated the power of computational deconvolution
to complement and enhance current isolation methods and have created the first comprehensive
survey of exRNA cargo types and their carriers in human biofluids.
Funding: Common Fund of the NIH (5U54 DA036134).
OF19.02
Heparan sulphate glycosaminoglycans on the extracellular vesicle surface bind a variety
of proteins
Sara Veiga
a, Alex Shepharda, Alex Cocksa, Aled Claytona and Jason Webberb
aTissue Microenvironment Group, Division of Cancer and Genetics, School of Medicine,
Cardiff University, Cardiff, UK; bCardiff University, Cardiff, UK
Introduction: Cancers develop in complex tissue environments, comprising multiple
cell types that contribute to tumour growth, invasion and metastasis. Our group has
previously demonstrated that prostate cancer derived EVs mediate the delivery of TGFβ,
via heparan sulphate (HS) glycosaminoglycans on the EV surface and stimulate fibroblast
to myofibroblast differentiation. Given the potential capacity for HS to bind other
“soluble” factors we have herein explored the repertoire of proteins associated vesicular
HS.
Methods: EVs were isolated from DU145 prostate cancer cells by differential centrifugation
followed by ultra-centrifugation on a sucrose cushion and washed with PBS. Specific
removal of Heparan sulphate side chains from the vesicle was performed by enzymatic
digestion using heparinase III (HEPIII). Differences in proteins with vs. without
digestion were identified by a sensitive multiplex proximity extension assay and select
targets validated by ELISA.
Results: Protein profiles identified approximately 60 factors that were significantly
differentially expressed on control versus HS-deficient EV’s. Some but not all of
these have been previously identified as HS-associated factors. Gene ontology analysis
points to functional relationships with angiogenesis, invasion and immune regulation.
Using ELISA, we have been able to quantify six selected candidates on wild type vesicles,
some of these are lost following HS-digestion. We went on to examine functional consequences
of HS-deficiency in relation to cell-uptake, and angiogenic responses.
Summary/Conclusion: These data demonstrate a diverse repertoire of proteins that are
bound to the surface of exosomes via HS glycosaminoglycans. We anticipate that removal
of EV-associated HS will result in attenuated delivery of multiple factors to recipient
cells, and this will have major implications on EV functions and their ability to
modulate tissue environments.
Funding: Cancer Research Wales.
OF19.03
Membrane lipid saturation modifies the lipid signature of extracellular vesicles released
by HuH7 hepatocarcinoma cells
Eva Costanzi
a, Yuta Shimanakab, Lorena Urbanellic, Krizia Saginic, Stefano Giovagnolid, Hiroyuki
Araie, Carla Emilianic and Sandra Burattac
aDepartment of Chemistry, Biology and Biotechnology (University of Perugia), Foligno,
Italy; bGraduate School of Pharmaceutical Sciences (University of Tokyo), Tokyo, Japan;
cDepartment of Chemistry, Biology and Biotechnology (University of Perugia), Perugia,
Italy; dDepartment of Pharmaceutical Sciences (University of Perugia), Perugia, Italy;
eGraduate School of Pharmaceutical Sciences (University of Tokyo), Perugia, Italy
Introduction: Extracellular vesicles (EVs) are membrane-limited particles released
by cells during physiological and pathological conditions involved in cell communication.
An increased ceramide-enriched pro-inflammatory EV release has been demonstrated in
in vitro lipotoxic conditions and in non-alcoholic steatohepatitis mouse models and
patients. So far, lipid profile changes in EVs released under lipotoxic conditions
have not been investigated, despite the evidence that EVs shuttle many membrane-derived
bioactive lipids playing crucial role in several processes, including inflammation.
In this study, we carried out a comprehensive lipidomic analysis of EVs released by
HuH7 cells under membrane lipid saturation conditions induced by lipotoxic palmitate
(PA) or Δ9 desaturase inhibition (SCD1i). Since membrane lipid saturation induces
ER stress, HuH7 cells were also treated with Thapsigargin (Tg), a conventional ER
stress inducer, and with oleate (OA), a nontoxic monounsaturated fatty acid.
Methods: EVs were isolated from culture media of HuH7 cells treated for 16 h with
fatty acids (400 μM), or Tg (2.5 nM), or SCD1i (CAY 10566, 5 μM). All treatments were
performed in serum-free medium containing 0.1% free fatty acids-BSA. EVs were recovered
by differential centrifugation and characterized by SEM and immunoblotting. Total
lipids from EVs and their parental cells were analysed by LC/MS-MS.
Results: EVs released by HuH7 cells expressed positive markers (Alix and CD63), whose
levels were higher in PA-EVs. SEM images showed vesicles with the typical cup-shaped
morphology and size, not altered by the various treatments. Lipid composition comparison
of EVs released by treated- and control cells showed a higher content of all phospholipid
subclasses, in PA-EVs, except for phosphatidic acid and phosphatidylinositol, whereas
no differences were observed in EVs released by OA-, Tg- or SCD1i-treated cells. Specific
differences have been observed in the levels of numerous phospholipid molecular species
in PA-EVs as compared to other treatments.
Summary/Conclusion: In HuH7 cells, the most relevant changes in lipid composition
were observed in PA-EVs, even if all treatments, except OA, induced ER stress. These
results suggest that the increase of membrane phospholipid saturation is crucial to
determine which lipids discarded via EVs.
OF19.04
Deconvolution analysis of small RNAseq data from exRNAs isolated using different methods
reveals multiple carrier subclasses and identifies optimal methods for isolation of
total and EV-specific exRNA
Srimeenakshi Srinivasan
a, Ashish Yerib, Pike See Cheahc, Kirsty M. Danielsond, Peter DeHoffa, Justyna Filante,
Anu Paulf, Ravi Shahb, Bridget Simonsonb, Irene Yang, Cuong Trana, Xuan Zhangc, Leonora
Balajh, Xandra Breakefieldi, Roopali Gandhif, Jodi Lapidusj, Eric Londink, Tushar
Patelg, Robert Raffail, Anil Soode, Saumya Dasb and Louise Laurentm
aUCSD, San Diego, USA; bCardiovascular Research Center, Massachusetts General Hospital,
Harvard Medical School, Boston, USA; cNeuology and Radiology Services and program
in Neuroscience, Harvard Medical School, Massachusetts General Hospital, Boston, USA;
dUniversity of Otago, Wellington, Wellington, New Zealand; eThe University of Texas
MD Anderson Cancer Center (MDACC), Houston, USA; fCenter for Neurologic Diseases,
Brigham and Women’s Hospital, Harvard Medical School, Boston, USA; gMayo Clinic Florida,
Jacksonville, USA; hMassachusetts General Hospital, Boston, USA; iNeurology and Radiology
Services and program in Neuroscience, Harvard Medical School, Massachusetts General
Hospital, Charlestown, USA; jBiostatistics & Design Program, Oregon Health and Science
University, Oregon Health & Science University – Portland State University School
of Public Health, Portland, USA; kSidney Kimmel College of Medicine, Thomas Jefferson
University, Philadelphia, USA; lUniversity of California & VA Medical Center, San
Francisco, San Fransisco, USA; mUCSD, La Jolla, USA
Introduction: Reproducibility has been a major challenge in extracellular RNA (exRNA)
research both due to low concentration and heterogeneity of exRNA carriers in biofluids,
such as EVs, RNPs and LPPs. Lack of knowledge regarding the efficiency/reproducibility
of different isolation methods in accessing the exRNAs in different carriers has hindered
rational selection of standardized methods.
Methods: Using small RNAseq, we compared the performance of 10 exRNA isolation methods
on standardized samples of five biofluids across multiple laboratories. We found that
the read depth required to maximize miRNA complexity in each biofluid was different:
1 million in Bile (~200 detected miRNAs), 0.5 million in Cell culture supernatant
(~300), 2 million in Plasma/Serum (~450), and 50,000 in Urine (~100). While the miRNA
profiles varied greatly among exRNA isolation methods in Plasma, Serum, and Bile,
Cell culture supernatant and Urine showed similar profiles for all tested methods.
Results: We performed small RNAseq on purified exRNA carriers from Plasma and Serum;
and used the resulting carrier-specific miRNA signatures to computationally deconvolute
the miRNA profiles from each of the isolation methods. We found that ExoRNeasy, ME,
and Ultracentrifugation purified miRNAs that were predominantly carried in EVs, while
Exiqon, ExoQuick, and Norgen isolated both EV- and AGO2+ RNP-associated miRNAs.
Summary/Conclusion: Our studies identified several factors that contribute to difficulties
with reproducibility in exRNA studies, like inefficient and variable exRNA isolation
for many of the available methods, differences in accessibility of miRNA cargo associated
with different carriers among methods, and insufficient sequencing depth. To help
investigators select an optimal method, we developed an interactive web-based application,
miRDaR, that will provide a ranked list of tested exRNA isolation methods by complexity/expression
level and reproducibility, specific to their biofluid and miRNA of interest.
Funding: This study was supported by the Extracellular RNA Communication Consortium
funded by the NIH Common Fund.
OF19.05
Novel angiogenic extracellular vesicles induced by StemRegenin1
Yen-Michael Sheng Hsu
a, Jae-Hung Shiehb, Taojunfeng Suc, Zhen Zhaoa
aDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York,
USA; bDepartment of Medicine, Weill Cornell Medicine, New York, NY, USA; cProteomics&Metabolomics
Core Facility, Weill Cornell Medicine, New York, NY, USA
Introduction: Aryl hydrocarbon receptor antagonists, such as StemRegenin1 (SR1), have
been recently shown to enhance expansion of hematopoietic stem progenitor cells (HSPCs).
Our preliminary data showed that SR1 enhances endothelial cells (EC) to promote HSPC
expansion possibly via direct and indirect intercellular interactions, including extracellular
vesicle (EV) production. However, the direct effect of SR1 on EC biology and EV production
is largely unknown.
Methods: Human umbilical vein EC (HUVEC) and HSPC were obtained per approved IRB protocol.
EC culture and EC-HSPC in vitro co-culture was performed as described previously.
EC-EV harvest was collected in serum free medium. The effect of SR1 on HUVEC growth
was evaluated by EC-colony-forming cell (EC-CFC) assay. HSPC population analysis was
done by FACS. EV was purified by ultracentrifugation. EV proteins were identified
by LC-MS/MS. Student t-test was performed with p < 0.05 for statistically significance.
Results: HSPC co-cultured with HUVEC in the presence of SR1 results in a ~ 2-fold
increase of more primitive HSPC subpopulation compared to the control group. SR1 treated
HUVEC leads to a significant >2-fold increase in EC-CFC numbers and >67% increases
in the colony diameter. A total of 327 proteins were detected in ECs derived from
HUVEC. As a quality control, many commonly reported “EV-enriched” proteins per “ISEV
position statement” were identified. A small fraction of proteins recovered from the
EV fraction (<2%) is found on EC membrane. Among the 327 proteins, 46 of them showed
a significant change with SR1 treatment. Functional annotation by DAVID bioinformatics
enrichment tools classified three EV proteins associated with enhanced angiogenesis
signalling pathways.
Summary/Conclusion: SR1 differentially regulates angiogenic EV production that associates
with increased robustness in endothelial growth and enhanced haematopoiesis. Future
investigations on the biological effects of HUVEC EV differentially produced by SR1
are in progress and needed.
OF19.06
Evaluation of circulating extracellular vesicles derived miRNAs as biomarkers of early
colon cancer: a comparison with plasma total miRNAs
Li Min
a, Shengtao Zhua, Lei Chena, Xiang Liub, Rui Weia, Libo Zhaob, Yuqing Yangb, Guanyi
Kongb, Peng Lic and Shutian Zhangc
aDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical University,
Beijing, China (People’s Republic); bEcho Biotech Co., Ltd, Beijing, China (People’s
Republic); cDepartment of Gastroenterology, Beijing Friendship Hospital, Capital Medical
University, Beijing, P. R. China
Introduction: Early diagnosis of colon cancer (CC) is clinically important, as it
can significantly improve patients’ survival rate and quality of life. Although the
potential role for small extracellular vesicles (sEVs) in early detection of many
diseases has been repeatedly mentioned, systematic screening of plasma sEVs derived
early CC biomarkers has not yet been reported.
Methods: Plasma sEVs were derived from 15 early stage CC patients and 10 normal controls
(NC) and characterized according to MISV2014 standard. The total circulating sEVs
derived microRNA (miRNA) expression profile of all participants was investigated by
next-generation sequencing (NGS). Selected miRNA candidates were further verified
in both plasma-derived sEV miRNA and plasma total miRNA of an independent cohort consisting
of 134 participants.
Results: RNA sequencing identified a total number of 95 sEVs miRNA with differential
expression between CC and NC, most of which (60/95) was in well accordance with tissue
results in the Cancer Genome Atlas (TCGA) dataset. Among those miRNAs, we selected
let-7b-3p, miR-139-3p, miR-145-3p, and miR-150-3p for further validation in an independent
cohort consisting of 134 participants (58 CC and 76 NC). In the validation cohort,
the AUC of 4 individual miRNAs ranged from 0.680 to 0.792. A logistic model combining
two miRNA (i.e. let-7b-3p and miR-145-3p) achieved an AUC of 0.901. Adding the 3rd
miRNA (miR-139-3p) into this model can further increase the AUC to 0.927. Side by
side comparison revealed that sEVs miRNA profile outperformed cell-free plasma miRNA
in the diagnosis of early CC.
Summary/Conclusion: Circulating sEVs have a distinct miRNA profile in CC patients,
and sEVs derived miRNA could be used as a promising biomarker to detect CC at an early
stage.
Funding: This work was supported by grants from the National Natural Science Foundation
of China (81702314).
Symposium Session 20: EV Therapeutics II Chairs: Minh Le; Lucia LanguinoLocation:
Level B1, Hall B 16:30–18:00
OF20.01
Nano-Ghosts: mesenchymal stem cells derived nanoparticles as a novel approach for
cartilage regeneration.
Domenico D’Atri
a, Joao Garciab, Laura Creemersc and Marcelle Machlufd
aTechnion Israel Institute of Technology, Haifa, Israel; bUMC Utrecht, Utrecht, Netherlands;
cDept Orthopaedics, University Medical Centre Utrecht, Utrecht, Netherlands; dTechnion
– Israel Institute of Technology, Haifa, Israel
Introduction: Osteoarthritis is the most common inflammatory disease of the joints
which is characterized by cartilage degeneration and bony overgrowth. Mesenchymal
stem cells (MSCs) play an essential role in inflammation, due to their aptitude to
home to inflamed tissues and modulate the process. We designed a new kind of particles
termed Nano-Ghosts (NGs), derived from the cytoplasmic membrane of the MSCs. Retaining
MSCs’ surface properties, NGs are expected to target inflamed tissue and modulate
inflammation. In this study, we demonstrate NGs’ ability to target human articular
chondrocytes (hACs) and cartilage explants while reducing inflammation.
Methods: Targeting was evaluated by flow cytometry and confocal microscopy. NGs’ anti-inflammatory
properties were studied in vitro on TNF-stimulated and non-stimulated hACs and, ex
vivo, on cartilage explants. qPCR and ELISA of various markers assessed anti-inflammatory
effect. Smooth muscle cell (SMC)-NGs were used as a non-MSC control.
Results: Flow cytometry showed that NGs can target hACs’ 2 times more efficiently
compared to SMC-NGs. Moreover, NGs showed 4 times higher targeting to TNF-stimulated
hACs. Targeting was confirmed by confocal microscopy and imaging flow cytometry which
showed that NGs bound the membrane and were taken up by the cells. Similar results
were achieved in human explants where the particles showed 4 times higher binding
to TNF-stimulated explants. To test the anti-inflammatory effect, different markers
such as NO2, IL6, PGE2 and MMP13 were analysed. Our data showed that NGs reduce inflammation
by more than 50% both at the protein and RNA level.
Summary/Conclusion: Here we provide a proof-of-concept for the utility of NGs with
intrinsic capabilities for targeted cartilage regeneration, either as a standalone
biological or as a carrier for the targeted delivery of therapeutics, such as anti-inflammatory
agents and growth factors. Ongoing in vivo studies are focusing on confirming the
NGs’ targeting and anti-inflammatory capacity.
Funding: This project has received funding from the European Union’s Horizon 2020
research and innovation programme under Marie Sklodowska-Curie grant agreement No
642414
OF20.02
Combining virus-based therapeutics and EV therapy for the treatment of pancreatic
cancer
Marie-Ève Wedge and Carolina Ilkow
Ottawa Hospital Research Institute, Ottawa, Canada
Introduction: Pancreatic cancer (PC) is a highly aggressive disease with unmet therapeutic
needs. Recent advances in the use of cancer killing oncolytic viruses (OVs) as cancer
therapeutic agents bring new hope to fight the notorious disease that is PC. Although
OVs have shown promising results in certain cancers, some tumours remain resistant
to OV therapy due to their inherent residual antiviral mechanisms. We hypothesized
that the use of OV-encoded artificial microRNAs (amiRs) could help target the cellular
antiviral components associated with the observed OV resistance and could also sensitize
neighbouring tumour cells to OV therapy and small molecule inhibitors through the
secretion of amiR-containing extracellular vesicles (EVs) from infected cells.
Methods: To find such amiRs, we passaged a viral library encoding ~16,000 unique amiRs
in several PC cell lines and patient-derived xenograft samples to enrich for sequences
that could enhance OV replication.
Results: We identified an amiR that improves PC cell killing (amiR-PC) when expressed
from an OV. Target identification of amiR-PC revealed ARID1A as a key player in resistance
to OV therapy in PCs. This target is of particular interest since its downregulation
acts in a synthetic lethal fashion with inhibition of the EZH2 methyltransferase.
Combining an amiR-PC-expressing OV with a small molecule inhibitor of EZH2 enhances
PC cell death. Moreover, we have shown that amiR-PC is packaged in cancer cell-secreted
EVs which have the ability to reach neighbouring naïve cells to sensitize them to
EZH2 inhibition-mediated cell death and to spread the OV-mediated tumour killing effect
throughout the tumour. These results translate into an impressive improvement in tumour
debulking and survival in animal models of highly aggressive PC.
Summary/Conclusion: This work not only broadens our knowledge on the resistance of
select tumours to oncolytic virotherapy and the EV-mediated bystander killing effect
in OV-infected tumours, but it also provides new hope for a cure to the grim disease
that is PC.
OF20.03
CD47, a “don’t eat me signal” expression in ovarian cancer cells were regulated by
circulating exosomes – the therapeutic potential of targeting exosomes by inhibiting
immune evasion
Aasa Shimizu
a, Kenjiro Sawadab, Masaki Kobayashib, Mayuko Miyamotob and Tadashi Kimurab
aOsaka University, Sjuita, Japan; bOsaka University, Suita, Japan
Introduction: CD47, a “don’t eat me” signal, is over-expressed on the surface of various
tumours to allows tumour immune evasion. However, the role and regulation of CD47
in high grade serous ovarian carcinoma (HGSOC) remains undetermined. CD47 is known
to be present on exosomes. Herein, we tested the following hypothesis that CD47 present
on exosomes mediates immune evasion of cancer cells from macrophages.
Methods: Prognostic significances of CD47 expression in HGSOCs were examined using
a public database including 1656 HGSOC patients (Kaplan-Meier Plotter; http://kmplot.com/analysis)
and validated with 80 HGSCOs treated at Osaka University Hospital between 2013 and
2017. CD47 expression in exosomes derived from several HGSOC cell lines were examined
by western blot. The effect of exosomal CD47 in HGSOCs was examined by inhibiting
exosome secretion with GW4869, or by inhibiting exosome uptake with E1PA. Further,
the co-culture experiments of HGSOCs with THP-1-derived macrophage were performed
and the effect of exosomal CD47 on phagocytosis was analysed.
Results: High CD-47 expression was correlated with poor prognoses of HGSOC patients
compared with low CD-47 expression (19.0 months vs. 23.6 months in overall survival
(OS)). Exosomes derived from SKOV3ip1, OVCAR3 and A2780 cell lines showed strong CD47
expression. The inhibition of exosome secretion and uptake by GW4869 and E1PA inhibited
CD47 expression in ovarian cancer cells, suggesting that CD47 is released from cells
via exosomes and thereafter recycled via pinocytosis. The co-culture assay revealed
that the inhibition of exosomal CD47 enhanced the phagocytosis of macrophage-like
cells against cancer cells, which may lead to cancer cell survival in vivo.
Summary/Conclusion: CD47 expression was correlated with poor OS in HGSOC patients,
suggesting the importance of immune evasion. CD47 was expressed on exosomes and the
inhibition of exosome recycling enhanced the phagocytosis of macrophage-like cells
against cancer cell through the down-regulation of CD47 expression in cancer cells.
Our data indicates that cancer derived exosomes can be considered as a therapeutic
target of HGSOCs.
OF20.04
The impact of in vitro ageing on the release of extracellular vesicles from human
mesenchymal stem cells
Xiaoqin Wang
a, Jincy Philipa, Forugh Vazirisanib, Chrysoula Tsirigotia, Peter Thomsenb and Karin
Ekströma
aDepartment of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy,
University of Gothenburg, Gothenburg, USA; bDepartment of Biomaterials, Institute
of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Introduction: Ageing increases the risk of bone degenerative diseases, which are partially
caused by ageing-related changes in mesenchymal stem cells (MSCs). Both in vitro ageing
(reflected by the passage number in culture) and ageing (donor age) reflect a loss
of regenerative capacity in terms of the proliferation and osteogenic differentiation
of MSCs. Extracellular vesicles (EVs) secreted from MSCs have been shown to exert
therapeutic effects that contribute to the regeneration of various tissues, but there
is scarce information on whether ageing, particularly in vitro ageing, influences
the release of EVs by MSCs.
Methods: An in vitro ageing model in which low- and high-passage cells (LP and HP
MSCs, respectively) represent “young” and “aged” cells, respectively, was utilized.
Both LP and HP EVs were characterized by NTA and WB. The EV protein contents were
further explored and the functions of LP and HP EVs on the survival and proliferation
of MSCs were investigated.
Results: The results showed that in vitro ageing retained the phenotypic signature
of MSCs but resulted in morphological changes and decreases in the proliferation and
osteogenic differentiation capacity of the cells. Both LP and HP MSCs secreted EVs
with similar characteristics in terms of size and typical exosomal protein markers,
but HP MSCs secreted more EVs than LP MSCs. The global proteome of the LP and HP EVs
revealed that the vast majority of the identified proteins were in fact associated
with EVs. The most abundant proteins in LP and HP EVs shared similar but not identical
functional characteristics, and the proteins showing significant differential expression
between HP and LP EVs were predicted to be enriched in Gene Ontology biological process
terms mainly related to transport and secretion and to pathways regulating cellular
morphology, growth/proliferation and development. Both LP and HP EVs promoted MSC
survival and proliferation in autocrine and paracrine manners, and the degree of proliferation
was dependent on the applied EV dose and associated with the characteristics of the
recipient cells.
Summary/conclusion: The above-described results demonstrate that in vitro ageing influences
the secretion of EVs by MSCs, particularly the number and protein cargoes of the EVs.
OF20.05
Novel role of BCR-ABL-containing leukemic extracellular vesicles in controlling the
function of regulatory T cells
Julian Swatler
a, Wioleta Dudka-Ruszkowskaa, Lukasz Bugajskib, Ewa Kozlowskac and Katarzyna Piwockaa
aLaboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy
of Sciences, Warsaw, Poland; bLaboratory of Cytometry, Nencki Institute of Experimental
Biology, Polish Academy of Science, Warsaw, Poland; cDepartment of Immunology, Faculty
of Biology, University of Warsaw, Warsaw, Poland
Introduction: BCR-ABL-positive chronic myeloid leukemia (CML) has only recently been
recognized as a malignancy associated with an immunosuppressive microenvironment,
which includes increased amount of Foxp3+ regulatory T cells (Treg). However, mechanisms
driving Treg differentiation and function in CML are mostly unknown. We hypothesize
that extracellular vesicles (EVs) released by leukemic cells may be engaged in this
phenomenon and mediate immunosuppression both inside and outside the CML bone marrow
niche.
Methods: We isolated EVs from murine BCR-ABL-expressing progenitor cells, using differential
centrifugation. EVs were characterized using TEM, Western blotting, Nanosight analysis
and uptake of EVs by lymphocytes was analysed by flow cytometry. Influence of CML-derived
EVs on Treg was analysed in different ex vivo settings, such as an in vitro suppression
assay and differentiation of Treg on dendritic cells. To precisely analyse Foxp3 expression
in Treg, we have used cells from B6.Cg-Foxp3tm2Tch mice that co-express Foxp3 and
EGFP. Treg in blood of CML patients were analysed using 13-colour flow cytometry.
Results: Leukemic EVs potentiate suppressive function of regulatory T cells. This
effect is driven by EV-mediated upregulation of Foxp3 – a transcription factor responsible
for Treg suppressive phenotype. Proteomic analyses revealed that CML-derived EVs contain
BCR-ABL oncoprotein. Interestingly, further functional studies revealed that inhibition
of kinase activity of BCR-ABL in EVs has abolished the increase in Foxp3 level in
EVs-treated Treg. Similarly to our in vitro findings, also Treg in CML patients seem
to have more suppressive phenotype, as demonstrated by e.g. larger amount of highly
suppressive CD39+ Tregs.
Summary/conclusion: CML-derived EVs seem to modulate immunosuppression in leukemia,
by increasing suppressive activity of regulatory T cells. This effect is largely driven
by BCR-ABL contained in leukemic EVs. However, precise mechanism of this regulatory
pathway is yet to be dissected.
Funding: Grants from National Science Centre: 2013/10/E/NZ3/00673 to KP, 2018/29/N/NZ3/01754
to JS and Foundation for Polish Science grant TEAM TECH Core Facility Plus/2017-2/2
to KP.
OF20.06
Immunomodulatory function of human mesenchymal stromal cells (MSC)-derived extracellular
vesicles (EVs) on type-i interferon response in human plasmacytoid dendritic cells
(pDCs) and its therapeutic effect on murine lupus model
Lin Kui
a, Godfrey Chanb and Pamela PW Leea
aDepartment of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University
of Hong Kong, Hong Kong, Hong Kong; bThe University of Hong Kong, Hong Kong, Hong
Kong
Introduction: Immunoregulatory effect of mesenchymal stem cell (MSC) is attributed
to extracellular vesicles (EVs) secretion. Given its effectiveness in preclinical
studies of autoimmune disease, no one has examined its effect on SLE pathogenesis,
signify by excessive type-I IFN production by plasmacytoid dendritic cells (pDCs)
and animal models.
Objective: To investigate the effect of MSC and MSC-EVs on regulating cytokines production
in pDCs, and the immunomodulatory role of MSC-EV in NZB/W F1.
Methods: htMSC (immortalized human MSCs), was cultured in CDPF medium for 48 h. EV
were isolated by ultracentrifugation at 100,000g, 3 h, 4°C and characterized. Comparison
of immunosuppressive function between htMSC-EV and TSG-6 knockdown htMSC on TLR9-mediated
cytokine production in pDC was determined with GEN2.2, a human pDC cell-line, following
activation by CpG-A, and analysis by qPCR and ELISA. Finally, we compared the survival,
pDC IFN-α intracellular expression and serum IgG autoantibodies expression of htMSC-EV-treated
NZB W/F1 mice with those that received htMSC cellular treatment, and PBS control-group.
Results: Upon activation of TLR9 by CpG-A, IL-1ß, TNF-α and IFN-α transcription was
upregulated in GEN2.2. Such response was reduced when CpG-A-primed GEN2.2 were co-cultured
with htMSC. Knockdown of TSG-6 in htMSC dampened its capacity to suppress IL-1ß, TNF-α,
IFN-α and IRF7 transcription in GEN2.2. To find out whether MSC exert its immunosuppressive
effect by means of EV, we isolated EVs from hTERT MSCs and found htMSC-EV contained
TSG-6 protein. Co-culture of htMSC-EV with CpG-A-primed GEN2.2 resulted in downregulation
of IFN-α transcription and protein expression, mediated via reduction in total and
phospho-IRF7. NZB/W F1 mice treated with htMSC-EV resulted in improved survival, followed
by reduction in splenic pDC IFN-α expression, and IgG autoantibodies in serum.
Summary/conclusion: We showed that MSC downregulated TLR9 activation in human pDCs,
in a TSG-6 dependent manner. Furthermore, htMSC-EV contains TSG-6 and suppress IFN-α
response in CpG-A-activated pDCs through reducing total and phospho-IRF7. Finally,
htMSC-EV treatment improved survival, and modulated pDCs and serum IgG autoantibodies
expression in NZB/W F1 mice.
Symposium Session 21: EVs in Migration and Cancer Chairs: Akiko Takahashi; Yoshinobu
TakakuraLocation: Level 3, Hall B16:30–18:00
OF21.01
Targeting Rab27a in pancreatic cancer
Nuno Bastos
a, Carolina Ruivoa, Bárbara Adema, Christoph Kahlertb, Bruno Gonçalvesc, Nuno Diasc,
Raghu Kallurid, Fátima Carneiroe, José Machadof and Sónia Melof
ai3S – Instituto de Investigação e Inovação em Saúde, Porto University, Portugal;
IPATIMUP – Instituto de Patologia e Imunologia Molecular da Universidade do Porto;
ICBAS – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto,
Portugal; bUniversitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany, Dresden,
Germany; cHospital de Viseu, Viseu, Portugal, Viseu, Portugal; dMD Anderson Cancer
Center, University of Texas, Texas, USA, Texas, USA; ei3S – Instituto de Investigação
e Inovação em Saúde, Porto University, Portugal; IPATIMUP – Instituto de Patologia
e Imunologia Molecular da Universidade do Porto; Department of Pathology, Centro Hospitalar
São João, Porto, Portugal, Porto, Portugal; 6i3S – Instituto de Investigação e Inovação
em Saúde, Porto University, Portugal; IPATIMUP – Instituto de Patologia e Imunologia
Molecular da Universidade do Porto; FMUP – Faculdade de Medicina da Universidade do
Porto, Porto, Portugal, Porto, Portugal
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers
with very limited therapeutic options. PDAC lesions are unique due to their extensive
desmoplastic reaction and sparse cancer cells, highlighting the potential role of
cell communication in PDAC progression. Despite cell communication being intrinsically
involved in tumour progression, this process of tumorigenesis is still off the cancer
therapy landscape. Exosomes have emerged as crucial mediators of intercellular communication
in cancer. Rab27a and −27b have been described as key players in cancer exosomes release.
Methods: Therefore we decided to evaluate if inhibition of cancer exosomes communication
could represent a novel therapeutic strategy in PDAC.
Results: We demonstrate that Rab27a, but not Rab27b, expression correlates with poor
survival in patients with metastatic PDAC, but the same is not true for early stage
PDAC. We further demonstrate that Rab27a knockout in pancreatic cancer cells is lethal,
further stressing the crucial role of Rab27a for cancer cells survival. When using
an inducible TetON knockdown system for Rab27a, downregulation of this protein impairs
tumour growth in orthotopic models and, most strikingly, inhibits liver metastatic
colonization. Next we evaluated Rab27a, −27b, −5 and −7 expression during disease
progression in a genetically engineered mouse model (GEMM) that spontaneously develops
PDAC (KPC) and reflects the human disease. Rabs expression is dynamic during the different
stages of disease progression, but only Rab27a shows an increased expression in metastatic
lesions. Using a Rab27a small molecule inhibitor in KPC mice we see a decrease in
the number of liver macro-metastasis and increase in overall survival. In addition,
we developed a conditional and inducible Rab27aKO mouse and show that pancreas conditional
KO of Rab27a does not affect the normal development and physiology of the pancreas.
Summary/Conclusion: We are currently assessing the effects of Rab27a conditional KO
in PDAC GEMMs.
Funding: Project NORTE-01–0145-FEDER-000029 from NORTE 2020. IF/00543/2013/CP1184/CT0004,
PTDC/BIM-ONC/2754/201 and, POCI01-0145-FEDER-32189 from FCT – Foundation for Science
and Technology. FAZ Ciencia Award from Astrazeneca Foundation.
OF21.02
Roles of lysyl oxidase like 2 (LOXL2) in exosomal fraction on lymph node metastasis
of head and neck squamous cell carcinoma
Hajime Yano, Afsana Islam, Teppei Kaminota, Reina Tanimoto, Naohito Hato and Junya
Tanaka
Graduate School of Ehime University Medical School, To-on, Japan
Introduction: The secretory enzyme lysyl oxidase like 2 (LOXL2) is assumed to contribute
to tumour progression through participation in cellular events including remodelling
extracellular matrix and epithelial-mesenchymal transition. In a previous study, we
identified elevated expression of LOXL2 in human head and neck squamous cell carcinoma
(HNSCC) lymph node metastases, and localization of LOXL2 in exosomal fraction of a
metastatic HNSCC cell. Here we assessed the significance of LOXL2 in the metastasis
and of liquid biopsies for detecting HNSCCs and their risk of the metastasis.
Methods: A mouse model of lymph node metastasis of HNSCC was established to assess
metastatic activity and responsible factors for the metastasis. LOXL2 protein expression
as well as lysyl oxidase enzyme activity were assessed in exosomal fraction of human
metastatic HNSCC cell. Effects of LOXL2 knockdown on the metastasis was assessed in
the mouse model. LOXL2 levels were assessed in immunohistochemistry and immunoblotting
in HNSCC tissues as well as serum from patients. Exosomal LOXL2 levels from further
38 serum samples from HNSCC patients were subjected to statistical analysis.
Results: LOXL2 localization was identified in exosome from metastatic HNSCC cell but
not in non-metastatic cancer cell. Knockdown of LOXL2 attenuated the lymph node metastasis.
Immunoblot analyses revealed that LOXL2 was present in human serum exosomal fractions,
and the mean LOXL2 level was approximately three-fold higher in patients than healthy
volunteers. Immunohistochemical LOXL2 staining was detected in HNSCC cells in a human
tongue HNSCC sample. Further measurements of exosomal LOXL2 showed higher LOXL2 levels
in patients.
Summary/Conclusion: Elevated serum exosomal LOXL2 levels can be an indicator of HNSCC.
A follow-up clinical study will be required to determine the clinical utility of using
LOXL2 to diagnose HNSCC and/or determine the risk of metastasis.
Funding: This study was supported in part by grants from Ehime University (#0101010010,
#0101050003, and #0101390003), Daiwa Securities Health Care Foundation (#14–23), and
the Ministry of Education, Culture, Sports, Science, and Technology of Japan (15K10809
and 18K09379).
OF21.03
Growing old disgracefully – a novel role of extracellular vesicles in bone invasion
Areeg A. Elmusrati, Daniel Lambert and Syed Ali Khurram
The University of Sheffield, Sheffield, UK
Introduction: Bone invasion is a common feature of oral squamous cell carcinoma (OSCC)
and is associated with poor prognosis. The mechanism of OSCC bone invasion remains
unclear, but our recent work indicated a key role for cancer-associated fibroblasts
(CAF)
Methods: In this study we sought to investigate whether senescent fibroblasts and
derived extracellular vesicles (EV) play a role in bone invasion in OSCC. Immunohistochemistry
(IHC) for senescence markers p16INK4a and dipeptidyl peptidase 4 (DPP4) was carried
out on bone resection cases with cortical and medullary OSCC invasion. Senescence
in normal oral fibroblasts (NOF) was experimentally induced through replicative mitotic
exhaustion, as well as exposure of NOF at low passage to hydrogen peroxide, and the
chemotherapeutic drug cisplatin. Senescence-associated beta-galactosidase (SA-βgal)
activity was monitored to confirm senescence induction. Receptor activator of nuclear
factor kappa-Β ligand (RANKL), a key pro-osteoclastogenic factor, and p16INK4a transcript
abundance was assessed by qPCR. Conditioned media was collected and an enzyme-linked
immunosorbent assay used to detect soluble RANKL protein secretion. Furthermore, osteoclastogenesis
and pit formation on a synthetic bone substrate was assessed in response to proliferating
and senescent NOF-derived EV conditioned media.
Results: Readily detectable p16INK4a and DPP4 expression was observed in fibroblastic
stroma adjacent to bone, indicative of the presence of senescent fibroblasts. A significant
increase in RANKL and p16INK4a expression was observed following 15 days of senescence
induction. RANKL secretion by NOFs was significantly upregulated following in vitro
induction of senescence. Conditioned media from senescent oral fibroblasts provoked
a marked increase in osteoclastogenesis, shown by an increase in tartrate resistant
acid phosphatase activity, multinucleation and osteoclastic resorption/pit formation.
Summary/Conclusion: Here we provide novel evidence that senescent oral fibroblasts
and derived EVs play an active role in OSCC bone invasion. The ability of senescent
fibroblast-derived factors to promote osteoclastogenesis may have implications more
broadly for age-related bone pathologies, and this is the focus of our ongoing investigations.
OF21.04
The multifaceted role of breast cancer-derived extracellular vesicles in brain metastasis
Golnaz Morad
a, Christopher Carmanb and Marsha Mosesc
aHarvard Graduate School of Arts and Sciences, Boston Children’s Hospital, Boston,
USA; bMolecular and Integrative Physiological Sciences Program, Harvard T.H. Chan
School of Public Health, Boston, USA; cVascular Biology Program, Boston Children’s
Hospital; Department of Surgery, Harvard Medical School and Boston Children’s Hospital,
Boston, USA
Introduction: Breast cancer brain metastasis is often associated with a dismal prognosis.
Elucidation of the early events that lead to brain metastasis will pave the way to
identifying potential diagnostic and therapeutic targets for early intervention. We
have previously shown that extracellular vesicles (EVs) derived from the brain-seeking
MDA-MB-231 breast cancer cell line can increase brain metastasis growth. To investigate
the mechanisms underlying the EV-induced facilitation of brain metastasis, we studied
the mechanisms with which EVs interact with and modulate the blood brain barrier (BBB),
as an initial niche for tumour cell growth.
Methods: EVs were isolated from the parental MDA-MB-231 breast cancer cell line (P-EVs)
and its brain-seeking variant (Br-EVs). Through retro-orbital and intracardiac injection
of EVs in mouse and zebrafish models, we studied the distribution of EVs to the brain.
A combination of in vitro and in vivo BBB models was used to study the mechanisms
with which EVs interact with an intact BBB. We next conducted continuous in vitro
and in vivo treatment with EVs to elucidate the effects of EVs on the behaviour of
the luminal and abluminal components of the BBB.
Results: Our distribution studies demonstrated that breast cancer-derived EVs could
enter the brain parenchyma via an intact BBB. Using state-of-the-art models of the
BBB and high-resolution microscopy, we have identified, for the first time, the mechanisms
with which Br-Ex interact with the endocytic pathway in brain endothelial cells to
cross the endothelium. Interestingly, our mechanistic studies showed that through
transferring miRNAs, Br-EVs could modulate the endothelial endocytic pathway to decrease
EV degradation. Moreover, we have shown that following their transport across the
brain endothelium, Br-EVs can exclusively alter the expression profile of astrocytes
to provide a suitable environment for metastatic growth.
Summary/Conclusion: These findings indicate that EVs derived from a brain-seeking
subpopulation of breast cancer cells can exclusively modify the physiological regulation
of the BBB at multiple levels to accelerate metastatic growth in the brain microenvironment.
Funding: This work was supported by the Breast Cancer Research Foundation and NIH
R01CA185530.
OF21.05
Exposed aminophospholipids enriched in a subtype of small extracellular vesicles from
tumour cell lines
Sachiko Matsumuraa, Tamiko Minamisawab, Kanako Sugac and Kiyotaka Shibad
aJapaese Foundation for Cancer Research, Koto-ku, Japan; bJapanese Foundation for
Cancer Research, Tokyo, Japan; cJapanese Foundation for Cancer Research, Tokyo, Japan;
dJapaese Foundation for Cancer Research, Tokyo, Japan
Abstract: Aminophospholipids such as phosphatidylserine (PS) and phosphatidylethanolamine
(PE) normally exist in the inner leaflet of the plasma membrane. Tumour cells, however,
expose PS on their surfaces and release the extracellular vesicles (EVs) enriched
with the exposed PS, which have been proposed to play an important role in communication
between tumour cells and other surrounding or distal cells. We have recently identified
a subtype of small EVs (sEVs) from tumour cell lines that were enriched with exposed
PS; this subtype has lower density, larger size, more negative zeta potentials and
lower abundance of exosomal proteins. Because PS and PE have often been reported to
change their membrane localization in a closely associated manner, in this study,
we aimed to examine if PE is also present in this subtype of sEVs.
Methods: An sEV fraction was prepared from a conditioned medium of tumour cell lines
(HT-29 and HT-1080) that were propagated in a serum-free medium for approximately
68 h. After differential centrifugations (10,000g for 30 min and 160,000g for 70 min)
and filtration with a 0.22-µm pore filter, the sEVs were further differentiated by
continuous density-gradient centrifugation (8–40% iodixanol, 100,000g, 17 h) into
10 fractions. Thereafter, the fractions were washed with phosphate-buffered saline
and analysed by Western blotting, silver staining, nanoparticle tracking and atomic
force microscopy (AFM). To detect PS or PE on the surfaces of the vesicles, sEVs were
labelled with gold nanoparticles (GNPs) using MFG-E8 or duramycin, respectively, followed
by AFM observation.
Results: Continuous density-gradient centrifugation showed two subtypes of sEVs. One
subtype was enriched with canonical exosome markers, including CD63, CD81, Alix and
Tsg101, and had a density of 1.10 g/ml. The other subtype, however, was scarce for
these markers and had a lower density of 1.04 g/ml. The estimation of the amounts
of exposed PS and PE by GNP in AFM showed that the second subtype of sEVs had exposed
PE as well as PS.
Summary/conclusion: The subtype of sEVs with lower density and fewer canonical exosome
markers in density-gradient centrifugation contained not only exposed PS but also
PE, which defined a new subtype of sEVs from tumour cells.
Funding: This work was supported by JSPS KAKENHI Grant Numbers 16K07152 to SM and
17H06255 to KS.
OF21.06
Mesenchymal stem cells-derived exosomes present natural migration and homing abilities
to specific neuropathological areas
Nisim Perets
a, Oshra Betzerb, Ronit Shapirac, Shmuel Berensteind, Areil Angele, Tamar Sadanb,Uri
Asheryf, Rachela Popovtzerb and Daniel Offeng
aSagol School of neuroscience, Tel Aviv University, Israel, Tel Aviv, Israel; bFaculty
of Engineering and the Institute of Nanotechnology & Advanced Materials, Bar-Ilan
University, Israel, Ramat Gan, USA; cSchool of Neurobiology, Biochemistry and Biophysics,
Life sciences faculty, Tel Aviv University, Israel, Tel Aviv, Israel; dSacklar School
of medicine, department of human genetics and biochemistry Tel Aviv University, Israel,
Petah Tikva, Israel; eSacklar School of Medicine, Department of Human Genetics and
Biochemistry Tel Aviv University, Israel, Petah Tikva, USA; fSagol School of neuroscience,
Tel Aviv University, Israel. School of Neurobiology, Biochemistry and Biophysics,
Life Sciences Faculty, Tel Aviv University, Israel, Tel Aviv, Israel; gSagol School
of Neuroscience, Tel Aviv University, Israel, Sacklar School of Medicine, Department
of Human Genetics and Biochemistry Tel Aviv University, Israel, Tel Aviv, USA
Introduction: Though exosoemes have been found to cross the blood–brain barrier, their
migration and homing abilities within the brain remain unstudied. We have recently
developed a method for longitudinal and quantitative in vivo neuroimaging of exosomes,
based on the superior visualization abilities of CT, combined with gold nanoparticles
as labelling agents. Here, we used this technique to track the migration and homing
patterns of intranasally administrated exosomes derived from bone marrow mesenchymal
stem cells (MSC-exo) in different brain pathologies, including stroke, autism, Parkinson’s
disease and Alzheimer’s disease. We found that MSC-exo specifically targeted and accumulated
in pathologically-relevant murine models brains regions up to 96 h post administration,
while in healthy controls they evacuated. The neuro-inflammatory signal in pathological
brains was highly correlated with MSC-exo accumulation. In addition, MSC-exo were
selectively uptaken by neuronal cells in the pathological regions.
Methods: Exosomes were extracted from human bone marrow mesenchymal stem cells. They
were loaded with glucose-conjugated gold nanoparticles and were given via intranasal
administration to mice with different pathologies. All mice were scanned with CT 1,
24 and 96 h post administration. Moreover, using PKH26 MSC-exo were labelled and were
visualized with whole brain florescence.
Results: Altogether, our DATA suggests that MSC-exo present distinct neurodistribution
which is pathology-specific in each of the mice models visualized both in vivo and
ex-vivo.
In both the induced stroke and Parkinson’s models, the MSC-exo were visualized mainly
in the damaged tissue (Striatum). In Alzheimer’s model, they were visualized mainly
in the hippocampus, and in the Autism mice model, they were visualized both in the
prefrontal cortex and the cerebellum. Interestingly, in healthy mice the exosomes
did not home to any specific location and the signal was lost 24 h post administration
both in vivo and ex vivo. In the damaged tissue, the MSC-exo were found mainly in
the neurons and not in other cells.
Summary/conclusion: Taken together, these findings can significantly promote the application
of exosomes for therapy and targeted drug delivery in various brain pathologies via
intranasal administration.
Symposium Session 22: Novel Methods of EV Analysis Chairs: An Hendrix; John NolanLocation:
Level B1, Hall A16:30–18:00
OF22.01
Biolayer interferometry – extracellular vesicles (BLIEV) platform for liquid biopsy
of ovarian cancer
Tatu Rojalina, Randy Carney
a and Kit Lamb
aUC Davis, Davis, USA; bUniversity of California, Davis, Sacramento, USA
Introduction: Rigorous efforts are being addressed to tackle the hurdles in extracellular
vesicle (EV)-based cancer diagnostics – in particular liquid biopsies. We introduce
a promising optical platform, biolayer interferometry – EV (BLIEV) for EV-based liquid
biopsies. BLIEV utilizes “dip-and-read” optical fibre biosensors without any microfluidics
that can be clogged by crude and complex sample matrices.
Methods: A ForteBio Octet RED384 System and SSA Streptavidin sensor tips were used
for the BLI. EVs were collected from the serum of 16 ovarian cancer (OvCan) patients
and 16 healthy (H) individuals. A group of 16 test samples was also prepared by spiking-in
several concentrations of OvCan EVs into healthy human plasma. The sensor tips were
functionalized with biotinylated CD9 or CD63. Bulk EVs from OvCan and H preparations
were captured by the BLIEV-CD9 or BLIEV-CD63 biosensors. The same procedure was repeated
for the spiked-in clinical test samples. Cancer-specific signals were acquired by
dipping the EV-containing BLIEV biosensors to the solution of an in-house cyclic reporter
peptide, LXY30, which has been demonstrated to bind the α3β1 integrin overexpressed
on OvCan cells and EVs.
Results: The EV capturing efficiency of BLIEV-CD9 and BLIEV-CD63 sensors was very
high, enabling the subsequent detection with LXY30. Regardless the used biosensor
type, high signals were recorded in the bulk-capturing phase for OvCan EV preparations
while the healthy EV samples gave negligible signals. Titration of the prepared spiked-in
clinical test samples yielded remarkably high OvCan detection specificity (>90%),
and the sensitivity reaching as low as < 1500 EVs/µL. Our integrin-binding reporter
peptide LXY30 enabled significant detection specificity towards the OvCan EVs.
Summary/Conclusion: We have developed a robust, sensitive, label-free, cost-effective,
and high-throughput BLIEV platform for EV-based liquid biopsies. Up to 16 clinical
EV samples can be analysed in parallel and total 384 samples in one run. Processing
16 EV samples required less than 2 min. To our knowledge, this is the first time BLI
has been used as a diagnostic tool. We strongly believe that the remarkable sensitivity
and specificity of our BLIEV platform exhibit clinical significance for the next-generation
cancer diagnostics.
Funding: Sigrid Juselius Foundation, Finland.
OF22.02
Enhanced detection and visualization of exosomes with interferometric reflectance
imaging
M. Selim Ünlü
a, Ayca Yalcin Ozkumura, Celalettin Yurdakula, Marcella Chiarib, Lei Tiana, Fulya
Ekiz Kanika, Nese Lortlar Unlua and Elisa Chiodic
aBoston University, Boston, USA; bConsiglio Nazionale delle Ricerche (CNR), Istituto
di Chimica del Riconoscimento Molecolare (ICRM), Milano, Italy; cCNR, Milano, Milano,
Italy
Introduction: Biological sensors that detect whole viruses and exosomes with high
specificity, yet without chemical labelling, are promising because they generally
reduce the amount and complexity of sample preparation required by molecular amplification
methods and may improve measurement quality by retaining information about nanoscale
biological structure. We developed an optical sensing technology, Interferometric
Reflectance Imaging Sensor (IRIS), a multifunctional platform for quantitative, label-free
and dynamic detection. In high-magnification modality, Single-Particle Interferometric
Reflactance Imaging (SPIRI) has the ability to detect and characterize individual
biological nanoparticles. We have recently improved the contrast and spatial resolution
of SPIRI by pupil function engineering and computational imaging.
Methods: In SPIRI, the interference of light reflected from the sensor surface is
modified by the presence of particles producing a distinct signal that reveals the
size of the particle that is not otherwise visible under a conventional microscope.
Using this instrument platform, we have demonstrated label-free identification and
visualization of various viruses in multiplexed format in complex samples in a disposable
cartridge. Recently, our technology was applied to detection of exosomes and commercialized
by Nanoview Biosciences for quantified measurement of exosomes on dry sensor chips.
We are currently focusing on various in-liquid detection as well as further improvement
of the technique using pupil function engineering.
Results: By acquiring multiple images with a partitioned pupil (resulting in structured
illumination) and computational imaging, we have demonstrated significant improvement
in visibility of low-index nanoparticles in liquid. Furthermore, spatial resolution
has been improved beyond the diffraction limit approaching 100 nm in the visible microscopy.
We have developed compact and inexpensive sensor chips and microfluidic cartridges
allowing for study of biological particles (exosomes and other extracellular vesicles)
directly in the bodily fluids without labels.
Summary/Conclusion: In summary, we have demonstrated improved visibility of exosomes
in SPIRI using pupil function engineering.
Funding: EU-INDEX
OF22.03
Proximity assays for detection and characterization of exosomes
Masood Kamali-Moghaddam, Ehsan Manouchehri, Alireza Azimi, Qiujin Shen, Radiosa Gallini
and Claudia Fredolini
Uppsala University, Uppsala, Sweden
Introduction: Exosomes receive an increased attention in basic biology as well as
in medicine. They are shown to be involved in many biological processes, and are proven
to hold great potentials as diagnostic and therapeutic tools. However, there is an
unmet need for new and improved technologies for quantitative and qualitative characterization
of exosomes to meet challenges related to these vesicles, such as low concentrations
in body fluids, the small size of the exosomes or the low copy numbers of antigens
present on the surface of the exosomes.
Methods: We have developed a large number of affinity-based proximity assays for single-
and multiplex detection of proteins and large complexes with high specificity and
sensitivity. Several of these technologies, such as proximity ligation assay combined
with flow cytometry readout, multiplex proximity extension assays and proximity barcoding
assays, are used for sensitive detection and characterization of individual exosomes.
Results: Commonly, in these assays the exosomes are recognized by several affinity
binders, each equipped with a DNA oligonucleotide. Upon binding of the target exosomes
by the affinity probes, the DNA oligonucleotides are brought in proximity, subjected
to enzymatic ligation or polymerization, which results in formation of an amplifiable
reporting molecule. The use of multiple recognition events in combination with signal
amplification allows detection of exosomes with high specificity and sensitivity.
Summary/Conclusion: Here, we discuss the application of proximity assays for sensitive
detection of exosomes in body fluids, to visualize the uptake of exosomes by cells,
and the potential of such approach to be used to better understand the biology of
the exosomes and to identify exosomes as disease biomarkers.
OF22.04
A 96 well plate format lipid quantification assay with improved sensitivity for standardization
of experiments with extracellular vesicles
Tamas Visnovitz
a, Xabier Osteikoetxeab, Barbara W. Sódarc, Judith Mihalyd, Péter Lőrincze, Krisztina
V. Vukmana, Eszter Ágnes Tótha, Anna Koncza, Inna Székácsf, Robert Horváthf, Zoltan
Vargag and Edit I Buzásc
aSemmelweis University, Dept. of Genetics, Cell- and Immunobiology, Budapest, Hungary;
bAstraZeneca, Macclesfield, UK; cSemmelweis University, Budapest, Hungary; dRCNS HAS,
Budapest, Hungary; eDepartment of Anatomy, Cell and Developmental Biology, Eötvös
Loránd University, Budapest, Hungary; fNanobiosensorics Laboratory MTA-EK-MFA, Budapest,
Hungary; gResearch Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest,
Hungary
Introduction: Current EV studies usually standardize EV samples on the basis of their
protein content, particle number or both. Even with this latter approach may lead
to inaccuracy and overestimation of the EV concentration. Lipid bilayers are defining
components of EVs. Therefore, a lipid-based quantification, especially in combination
with protein content and/or particle count determination, appears to be a straightforward
approach for quantification of EVs. Here we set the goal to improve the sensitivity
of the previously reported sulfo-phospho-vanillin (SPV) lipid assay.
Methods: We to replace the traditional purified lipid standards (diluted in organic
solvents) with an aqueous phase liposome standard (DOPC), and we optimized the concentration
of the vanillin reagent of the assay. Results of the lipid assay were compared with
the previously described ATR-FTIR spectroscopy-based lipid quantification approach.
The assay was validated with EPIC biosensor system, qNano, commercially available
lipid assay and commercial LDL. Using the optimized lipid assay, we tested liposomes
of known composition as well as EVs secreted by four different cell lines. EV markers
were documented by immune electron microscopy.
Results: Elimination of organic solvents from the reaction mixture abolished the background
colour that previously interfered with the assay. Comparison of the optimized assay
with a commercial lipid kit (also based on the original SPV lipid assay) showed an
increase of sensitivity by approximately one order of magnitude, and the lipid-based
quantification of EV samples have clearly increased the reliability of the experiments.
Summary/Conclusion: The optimized lipid assay with improved sensitivity provides a
fast, reliable and sensitive test that addresses an existing need in EV standardization.
This optimized lipid assay for EV lipid measurements can be as easy as a simple BCA
test for protein determination.
Funding: NVKP_16-1-2016-0017, OTKA11958, OTKA120237, OTKA PD112085, VEKOP-2.3.2-16-2016-00002
and VEKOP-2.3.3-15-2016-00016, KH_17 grant, ERC hu and Lendület, Institutional Higher
Education Excellence Program of the Ministry of Human Resources in the theme “Therapeutic
development”. János Bolyai Research Fellowship of HAS.
OF22.05
Characterization of exosomes-based on their unique dielectric properties by a novel
electrical impedance measurement system
Yuqian Zhanga, Esam Salemb, Takahisa Nakamurac and Leyla Esfandiar
d
aUniversity of Cincinnati, Non-hispanic or Latino, USA; bCincinnati Children’s Hospital
Medical Center, Cincinnati, USA; cCincinnati Children’s Hospiltal Medical Center,
Cincinnati, USA; dUniversity of Cincinnati, Cincinnati, USA
Introduction: Exosomes are composed of a lipid bilayer membrane containing nucleic
acids, proteins and lipids in the lumen and their compositions reflect their cell
of origin. Thus, when the secreting cells are in abnormal microenvironments, the exosomes
undergo the compositional changes. We have developed a new class of electrical impedance
measurement system to non-invasively characterize exosomes based on their unique dielectric
properties. Although, the biophysical properties of exosomes such as size, density
and shape have been characterized before, their dielectric properties have not been
investigated.
Methods: An electrokinetic-based system has been developed to characterize the dielectric
properties of exosomes extracted from human hepatocellular carcinoma (HuH-7) cells
under different culture conditions. Extracted exosomes were initially trapped with
dielectrophoresis and further characterized by their dielectric properties as 0.2Vpp
was swept from 1 kHz to 50 MHz.
Results: The principle of the impedance measurement was adapted from the Maxwell’s
mixing theory applied to analyse the dielectric behaviour of cells. Opacity was defined
as the ratio of impedance magnitude at high frequency (>1 MHz) to the low frequency
(e.g. 500 kHz), which provided a parameter independent of the number of vesicles,
reflecting the changes in dielectric properties including their membrane capacitance
and cytosolic conductance. Extracted exosomes from different cell of origins were
measured five times and the result showed the changes in opacity measurements at the
intermediate and high frequency ranges which represents the difference between the
membrane composition and cytosolic conductance of the exosomes.
Summary/Conclusion: A new class of electrical impedance measurement system was developed
with the capability to characterize and distinguish exosomes based on their unique
dielectric properties as their biogenesis was subjected to systematic changes under
different culture conditions. This technique can be further utilized for classification
of exosomes based on their cell of origin and can be evolved as a diagnostic tool
for characterizing the pathogenic exosomes.
Funding: UC Faculty Development Fund.
OF22.06
A snorkel-tag based method for in vivo isolation of recombinant extracellular vesicles
Madhusudhan Reddy Bobbili
a, Stefan Vogtb, Severin Muehlederc, Carolina Patriolid, Samir Barbariab, Markus Schossererb,
Wolfgang Holnthonee, Heinz Redle, André Görgensf, Samir El Andaloussig and Johannes
Grillarih
aUniversity of Natural Resources and Life Sciences Vienna (BOKU), Vienna, Austria;
bUniversity of Natural Resources and Life Sciences, Vienna (BOKU), Vienna, Austria;
cLudwig Boltzmann Institute for Experimental and Clinical Traumatology, vienna, Austria;
dUniversity of Natural Resources and Life Sciences, Vienna (BOKU), vienna, Austria;
eLudwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria;
fKarolinska Institutet, Department of Laboratory Medicine, Stockholm, Sweden; gDepartment
of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Sweden.,
Stockholm, Sweden; hChristian Doppler Laboratory on Biotechnology of Skin Aging, University
of Natural Resources and Life Sciences, Vienna (BOKU), Vienna, Austria
Introduction: Extracellular vesicles (EVs) emerged as an important mode of cell-to-cell
communication in both normal and pathological conditions by transferring the cargo
from donor cell to recipient cell. It is their apparent natural ability to transfer
cargo from donor cell to recipient cell and thus regulating via paracrine or endocrine
mode. Over a decade, lot of research has been done to understand the omics, mode of
secretion and uptake mechanisms. However, trafficking of EVs in vivo is still poorly
understood.
Methods: We used recombinant tetraspanin (tetraspanin with C-terminus snorkel tag
(1)) as a tool to understand trafficking of EVs in vivo. As a first step we established
a method for isolating functional EVs carrying recombinant tetraspanins from stably
expressing cells in vitro. The presence of snorkel-tagged tetraspanins on EVs are
not affecting the surface protein signature (2). This method uses a combination of
anti-HA (hemagglutinin) affinity matrix and Prescission protease to isolate EVs from
cell culture supernatants without damaging the integrity of the EV membrane.
Results: EVs isolated by this method are further characterized by using multiplex
bead-based flow cytometry assay and electron microscopy. The multiplex bead-based
assay results showed us that we are able to pull out EVs carrying only snorkel tag
from a mixture of different EVs from different sources. Furthermore, we plan to spike
in human recombinant EVs into mouse plasma and isolate recombinant EVs from this complex
matrix using this method and confirm by multiplex bead-based assay. In addition, to
determine the functionality of recombinant EVs, we used CRE-LoxP method (3) to confirm
the recombinant EV uptake in recipient cells.
Summary/Conclusion: Ultimately, we are comparing the RNA content of recombinant EVs
isolated by snorkel-tag to CD81+ affinity purified EVs with the total EV population
in order to investigate the specific RNA loading by RNA seq.
Funding: This work supported by the FWF Doctoral Program BioToP [W1224]
Plenary Session 3: RNA Saturday 27 April Chairs: Jan Lötvall; Marca WaubenLocation:
Level 3, Hall B 10:00–11:20
piRNA biogenesis and functions in drosophila
Mikiko C. SIOMI
University of Tokyo, Tokyo, Japan
PIWI-interacting RNAs (piRNAs) are small non-coding RNAs enriched in animal gonads
where they arm race with transposons to maintain germline genome integrity. Although
transposons are powerful agents contributing to evolution, they are also regarded
as selfish DNA parasites. Indeed, loss of piRNAs causes derepression of transposons,
leading to DNA damage and failure in gonadal development and fertility. Thus, piRNA-mediated
transposon silencing is indispensable for animals that undergo obligate sexual production,
including humans. Since the discovery of piRNAs, studies have intensively been conducted
worldwide and fundamental features of the pathway have emerged. We now know that piRNAs
are primarily produced from piRNA clusters, discrete intergenic elements composed
of transposon remnants, and loaded onto PIWI proteins to form piRISCs. Cytoplasmic
piRISCs silence transposons post-transcriptionally while piRISCs in the nucleus repress
target genes co-transcriptionally. However, the molecular mechanism is not yet fully
understood. To solve the problem, we have use Drosophila and Bombyx as model systems,
particularly their cultured cell lines where piRNAs are fully functional in repressing
transposons. The details of our new findings will be presented at the meeting.
EV as a novel therapeutic target for cancer metastasis
Takahiro Ochiya, Ph.D., Chief and professor
National Cancer Center, Tokyo and Tokyo Medical University
Extracellular vesicles, known as exosomes and microvesicles, serve as versatile intercellular
communication tools. Increasing evidence has suggested that cancer cell-derived exosomes
carry pathogenic components. Exosomal transfer of cancer pathogenic components enable
long-distance-crosstalk between cancer cells and target organs and tissues, resulting
in the promotion of the initial steps for pre-metastatic niche formation. Furthermore,
the circulating exosome have also been of interest as a source for liquid biopsies.
Circulating exosome in body fluids provides a reliable source of miRNAs, mRNAs, DNAs,
proteins and oncometabolites for cancer biomarkers. We also suggest our current knowledge
on the tumour-specific DNA methylome in exosomes effectively provide various messages
on the physiological and pathological status of cancer patients. In this talk, we
provide an overview of current research on exosomes in cancer. We also propose new
therapeutic strategies by targeting cancer-specific exosomes to inhibit tumour metastasis.
Featured Abstracts- Session 2 Chairs: Location: Level 3, Hall B 11:20–12:00
FA2.01
A novel CRISPR/Cas9-based reporter system enables detection of EV-mediated functional
transfer of RNAs on a single-cell level
Olivier G. de Jong
a, Dan E. Murphyb, Imre Mägerc, Eduard Willmsc, Sander A.A. Kooijmansb, Raymond Schiffelersb,
Samir El Andaloussid, Matthew J. A. Woodc and Pieter Vaderb
aDepartment of Physiology, Anatomy and Genetics, University of Oxford, UK, Utrecht,
Netherlands; bLaboratory of Clinical Chemistry and Hematology, University Medical
Center Utrecht, The Netherlands, Utrecht, Netherlands; cDepartment of Physiology,
Anatomy and Genetics, University of Oxford, UK, Oxford, UK; dDepartment of Laboratory
Medicine, Clinical Research Center, Karolinska Institutet, Sweden., Stockholm, Sweden
Introduction: In recent years, multiple studies have shown that extracellular vesicles
(EVs) play a role in intercellular communication through transfer of RNAs. Unfortunately,
our understanding of the mechanisms regulating EV-mediated RNA delivery and processing
is lacking, due to the absence of suitable readout systems for functional RNA transfer.
Here, we describe a novel highly-sensitive CRISPR/Cas9-based reporter system that,
for the first time, allows direct functional study of EV-mediated transfer of small
non-coding RNA molecules on a single-cell level.
Methods: We generated a CRISPR/Cas9-based stoplight reporter system, in which eGFP
expression is activated upon functional delivery of targeting single-guide RNAs (T-sgRNAs).
Donor cell lines were generated stably expressing either T-sgRNAs or non-targeting
sgRNAs (NT-sgRNAs). Intercellular functional RNA transfer was assessed by measuring
eGFP expression in reporter cells after direct co-culture, transwell co-culture, and
upon addition of isolated EVs, using fluorescence microscopy and flow cytometry. The
role of potential regulators of EV-mediated RNA transfer was assessed after RNAi-mediated
target knockdown in reporter cells, prior to co-culture experiments.
Results: Expression of sgRNAs in donor cells and EVs was confirmed by RT-PCR. A significant
activation of eGFP expression was observed in reporter cells after direct co-culture
and transwell co-culture with donor cells expressing T-sgRNAs, but not NT-sgRNAs.
Addition of EVs from cells expressing T-sgRNAs, and not NT-sgRNAs, also resulted in
significant reporter activation. Reporter activation was substantially decreased after
blocking EV production through addition of GW4869 or Rab27A knockdown in donor cells.
Knockdown of multiple targets in endocytosis and/or intracellular membrane trafficking
in reporter cells significantly decreased reporter activation, suggesting vital roles
for these processes in EV-mediated RNA transfer.
Summary/Conclusion: Here we demonstrate a CRISPR/Cas9-based reporter system that for
the first time allows the study of functional delivery of small non-coding RNAs with
single-cell resolution. This novel approach allows the study of EV cargo processing
in the context of functional RNA delivery, and may help to increase our understanding
of the regulatory pathways that dictate the underlying processes.
FA2.02
From nanoscale to organisms: a multi-resolution imaging system of endogenously released
extracellular vesicles with bioluminescence resonance energy transfer
Anthony Yan-Tang Wu
a, Yun-Chieh Sungb, John Jun-Sheng Koc, Alan Ling Yangd, Vanessa Guoe, Yunching Chenf
and Charles P. Laie
aDepartment and Graduate Institute of Pharmacology, National Taiwan University, Taipei,
Taiwan (Republic of China); bDepartment of Chemical Engineering, National Tsing Hua
University, Hsinchu, Taiwan (Republic of China); cInstitute of Biomedical Engineering,
National Tsing Hua University, Zuoying, Taiwan (Republic of China); dInstitute of
Atomic and Molecular Sciences, Taoyuan, Taiwan (Republic of China); eInstitute of
Atomic and Molecular Sciences, Academia Sinica, Taipei, Taiwan (Republic of China);
fNational Tsing-Hua University, Hsinchu, Taiwan (Republic of China)
Introduction: Accurate visualization and monitoring of EVs is paramount to the understanding
of its biological mechanism. However, EV labelling with organic dyes such as DiI and
PKH have an extended half-life (e.g. PKH26: >100 days) and self-assemble into micelles,
which may lead to inaccurate interpretation of EV spatiotemporal properties. Furthermore,
reporters which fuse EV and fluorescent proteins (e.g. CD63-GFP) may only detect specific
EV subpopulations.
Methods: To overcome these limitations, here we developed a next-generation reporter
to enable EV imaging from organismal to super-resolutions by engineering enhanced
green fluorescent protein fused to a palmitoylation signal and nanoluciferase, termed
PalmGp. HEK293T and HCA-1 cells were lentivirally transduced to stably expressed PalmGp
as EV donor cells. In vivo EV and nanoscopic imaging were achieved by in vivo imaging
system (IVIS) and super-resolution radial fluctuations nanoscopy, respectively.
Results: PalmGp predominantly labels EV inner membrane, and exhibited a robust bioluminescent
and BRET-GFP signals for EV imaging upon addition of its substrate, furimazine. IVIS
imaging of liver cancer HCA1-PalmGp bearing mice showed sustained bioluminescent and
fluorescent signals at the primary and metastatic sites, indicating the high sensitivity
of PalmGp to enable biodistribution and clearance of endogenously released EVs. PalmGp-EVs
could further be visualized at super-resolution (50–150 nm) to monitor EV subcellular
trafficking.
Summary/Conclusion: To our knowledge, this is the first report of a multi-resolution
reporter strategy that enables EV imaging. Efforts are currently underway in employing
the PalmGp EV reporter to elucidate the spatiotemporal property and mechanism(s) of
cancer EVs during disease progression.
Funding: Ministry of Science and Technology (MOST) grants104-2320-B-007–005-MY2 (C.P.L.),
106–2320-B-007–004-MY3 (C.P.L.), and Academia Sinica Innovative Materials and Analysis
Technology Exploration (i-MATE) Program AS-iMATE-107–33 (C.P.L.)
Symposium Session 23: EV Engineering II Chairs: Cherie Blenkiron; Thomas KislingerLocation:
Level 3, Hall B 13:00–14:00
OS23.01
exoTOPE: loading bioactive molecules into exosomes using a short-peptide fusion
Russell McConnell, Madeleine Youniss, Ke Xu, Kevin Dooley, Bryan Choi, Rane Harrison,
Sonya Haupt, Damian Houde, Nuruddeen Lewis, Shelly Martin, Chang Ling Sia and Sriram
Sathyanarayanan
Codiak BioSciences, Cambridge, USA
Introduction: Exosomes represent a promising therapeutic platform for the selective
delivery of diverse classes of payloads; however, loading exosomes with non-native
cargo molecules has historically been a significant barrier to unlocking this potential.
We reasoned that it would be possible to load therapeutically relevant proteins into
exosomes by identifying and co-opting peptide sequences that natively enrich proteins
in exosomes.
Methods: Differential and density gradient ultracentrifugation were used to purify
exosomes from cell culture supernatant. LC-MS/MS was used to identify proteins present
in purified exosomes, the amino acid sequences of highly abundant proteins were analysed
for common sequence features, and plasmids encoding candidate peptide sequences fused
to cargo proteins were expressed in stably selected cells. The enrichment of fusion
proteins in purified exosomes was assessed using biochemical, flow cytometric and
functional analyses.
Results: Among the most abundant native exosomal proteins identified by LC/MS-MS were
three members of the MARCKS family. All three MARCKS family members were found to
strongly localize to purified exosomes when overexpressed as GFP fusions. Using truncated
and point mutant versions of sequences derived from these proteins, we identified
a seven amino acid consensus peptide sequence that is able to load non-native cargo
proteins into the exosome lumen at extremely high levels, comprising up to ~10% of
the total exosomal protein. Sequences containing this seven amino acid “exoTOPE” tag
were used to load exosomes with cytosolic cargos such as fluorescent proteins, RNA-binding
proteins and mRNA, Cas9, antigenic peptides and proteins, and the type 2 transmembrane
protein CD40 ligand (CD40L). Exosomes carrying exoTOPE-CD40L activated antigen presenting
cells in PBMC assays with similar EC50 values as free recombinant CD40L.
Summary/Conclusion: We have identified and refined a short peptide, exoTOPE, that
can be used to load exosomes with diverse classes of cargos, including proteins and
nucleic acids. The small size of this peptide tag makes this system readily adaptable
to a wide variety of applications and represents a significant advance in our ability
to engineer exosomes with biologically active cargos.
Funding: Funded by Codiak Biosciences.
OS23.02
Retrograde dicer-independent AGO-loading of extracellular single stranded miRNA in
recipient human cells
Bartika Ghoshala and Suvendra N. Bhattacharyyab
aCSIR_Indian Institute of Chemical Biology, Kolkata, India, Kolkata, India; bMolecular
Genetics Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India
Introduction: microRNAs are tiny regulator of gene expression that can be transferred
between neighbouring cells in mammalian tissue to control the expression of genes
in both donor and recipient cells. How the extracellular vesicle (EV)-derived miRNAs
are getting internalized and become functional in target cells is an unresolved question.
Methods: We used mammalian cells in culture to study the EV-mediated miRNA delivery
to target cells. Using miR-122 negative HeLa cells as recipient cells and miR-122
containing exososmes isolated from miR-122 positive cells, we have delineated the
mechanistic detail of the import process.
Results: We have identified that, through a unique mechanism, the EV-associated miRNAs
that are primarily single stranded can get loaded with the Ago proteins present in
the target cells to become functional there. The loading of EV-derived miRNAs to host
cells Ago proteins is not dependent on the Dicer1 that otherwise required for the
loading of the Ago proteins with double stranded miRNAs before one strand get cleaved
and dislodged from Ago2. The EV-derived miRNA loading of Ago2 happens on the endosomal
membrane where the pH dependent fusion of the internalized EV membrane with endosomal
membrane releases the miRNAs that get loaded with unloaded Ago2 present on the endosomal
membrane. This process is depenent on memebrane dynamics and restriction of memebrane
dynamics either due to mitochondrial depolarization or other ways affects the loading
of EV-derived miRNAs with Ago2. Leishmania donovani, a protozoan parasite affect membrane
dynamics in infected macrophage cells and thus it restrict the internalization of
miR-122 containing EVs that otherwise cause an inflammatory response in mammalian
macrophage-a process detrimental for the pathogen.
Summary/Conclusion: therefore we conclude that Leishmania donovani Restricts Retrograde
Dicer-Independent Loading of Extracellular Single Stranded miR-122 in Host Cell Agos
to Prevent Inflammatory Response.
Funding: SERB, Dept of Science and Technology, Govt. of India and Swarnajayanti Fellowship
Fund, Dept of Science and Technology, Govt. of India.
OS23.03
Engineering of extracellular vesicles for surface display of targeting ligands
Elisa Lázaro-Ibáñez
a, Anders Gunnarssonb, Gwen O´Driscollb, Olga Shatnyevac, Xabier Osteikoetxead and
Niek Dekkerb
aAstraZeneca, molndal, Sweden; bAstraZeneca, Mölndal, Sweden; cAstraZeneca, Molndal,
Sweden; dAstraZeneca, Macclesfield, UK
Introduction: Cell engineering is one of the most common strategies to modify extracellular
vesicles (EVs) for therapeutic drug delivery. Engineering can be applied to optimize
cell tropism, targeting, and cargo loading. In this study, we screened several EV
proteins fused with EGFP to evaluate the surface display of the EV-associated cargo.
In addition, we screened for EV proteins that could efficiently traffic cargo proteins
into the lumen of EVs. We also developed a novel technology to quantify the number
of EGFP molecules per vesicle using total internal reflection (TIRF) microscopy for
single-molecule investigation.
Methods: Human Expi293F cells were transiently transfected with DNA constructs coding
for EGFP fused to the N- or C-terminal of EV proteins (e.g., CD63, CD47, Syntenin-1,
Lamp2b, Tspan14). 48 h after transfection, cells were analysed by flow cytometry and
confocal microscopy for EGFP expression and EVs were isolated by differential centrifugation
followed by separation using iodixanol density gradients. EVs were characterized by
nanoparticle tracking analysis, western blotting, and transmission electron microscopy.
Single-molecule TIRF microscopy was used to determine the protein number per vesicle
at a single particle level, using monomeric EGFP as a reference.
Results: The screening of EGFP fused to the N- or C-terminal of EV proteins served
as a quantitative method to identify protein candidates for the surface display of
EV-associated cargo. Fusions to CD47 and luminal EV proteins with a snorkel domain
allowed the display of EGFP at the surface of EVs, with CD47 as good candidate for
surface display. Alternatively, fusions of EGFP to EV proteins with either C- or N-in
topology like Tspan14 and CD63 allowed for loading of EGFP within the EV lumen. Single
EV analysis using TIRF microscopy enabled the quantification of the average number
of EGFP molecules per single engineered vesicle, which was between 15 and 136 EGFP/EV
depending on the fusion protein.
Summary/Conclusion: The screening of EGFP-fusions to EV proteins revealed several
protein candidates for both surface display and intra-luminal cargo loading in EVs.
These results contribute to the understanding of EV biogenesis and are relevant for
exploiting the potential of engineered EVs as drug delivery systems.
OS23.04
Endogenous drug loading of extracellular vesicles using microbubble-assisted ultrasound
Yuana Yuana
a, Kim van der Wurff-Jacobsa, Banuja Balachandrana, Linglei Jiangb and Raymond Schiffelersc
aDivision Imaging, UMC Utrecht, The Netherlands, Utrecht, Netherlands; bDepartment
of Clinical Chemistry and Haematology, UMC Utrecht, The Netherlands; cLaboratory of
Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands
Introduction: Development of extracellular vesicles (EVs) as nanocarriers for drug
delivery relies on loading a substantial amount of drug into EVs. Loading has been
done from the simplest way by co-incubating the drug with EVs or producer cells until
using physical/chemical methods (e.g. electroporation, extrusion, and EV surface functionalization).
We use physical method combining gas-filled microbubbles with ultrasound known as
sonoporation (USMB) to pre-load drug in the producer cells, which are eventually loaded
into EVs.
Methods: Cells were grown overnight in 0.01% poly-L-lysine coated cell culture cassette.
Prior to USMB, cells were starved for 4 h. Treatment medium containing microbubbles
and 250 µg BSA-Alexa Fluor 488 as a model drug was added to the cells grown in the
cassette. Cells were exposed directly to pulsed ultrasound (10% duty cycle, 1 kHz
pulse repetition frequency, and 100 μs pulse duration) with up to 845 kPa acoustic
pressure. After USMB, cells were incubated for 30 min and then treatment medium was
removed. Cells were washed and incubated in the culture medium for 2 h. Afterward,
EVs in the conditioned medium were collected and measured.
Results: Cells took up BSA-Alexa Fluor 488 after USMB treatment as measured by flow
cytometry. These cells released EVs in the conditioned medium which were captured
by anti-CD9 magnetic beads. About 5% of the CD9-positive EVs contained BSA-Alexa Fluor
488. The presence of CD9-positive EVs containing BSA also were confirmed by immunogold
electron microscopy.
Summary/Conclusion: USMB serves as a tool to pre-load the model drug, BSA-Alexa Fluor
488, endogenously and to produce EVs loaded with this model drug. USMB setup, incubation
time, and type of drugs will be investigated to further optimize the production of
drug-loaded EVs and to explore possible application for in situ drug delivery system.
Funding: This research is funded by Focused Ultrasound Foundation.
OS23.05
Extracellular Vesicles for new Molecular Insight to Biomolecular Interactions
Tamas Beke-Somfai
a, Priyanka Singhv, Imola Szigyarto and Zoltan Vargac
aPI, Budapest, Hungary; bMs, Budapest, Hungary; cResearch Centre for Natural Sciences,
Hungarian Academy of Sciences, Budapest, Hungary
Introduction: The potential of extracellular vesicles (EVs) to revolutionize the diagnosis
and therapy of various diseases has been realized and thus it is an extensively studied
direction. However, EVs are also in the size range suitable for membrane biophysics,
while they preserve the complex composition of a biological bilayer. Consequently,
they are optimal for monitoring the structure, orientation and function of biomolecules
associated to EVs.
Methods: The investigated red blood cell-derived vesicles (REVs) were isolated from
blood using a standard protocol and purified using size-exclusion chromatography.
REVs were subjected to IR, CD and flow-Linear Dichroism spectroscopy, freeze-fracture
Transmission Electron Microscopy as well as Dynamic Light Scattering.
Results: Here we demonstrate that polarized light spectroscopy techniques can provide
important information on REVs and molecules inserting into their bilayer. Flow-linear
dichroism (flow-LD) measurements show that EVs can be oriented by shear force, insight
into properties of oriented macromolecules in the vesicles. The Soret-band of the
LD spectra demonstrates that hemoglobin molecules are oriented and associated to the
lipid bilayer in freshly released REVs [1].
Further on, we selected three different antimicrobial peptides (AMPs), CM15, melittin
and gramicidin and investigated their interactions with REVs using a diverse set of
techniques. The peptide-membrane interactions reveal several novel function of AMPs,
including their ability to remove associated proteins from the surface of REVs (Figure
1).
[1] I. Cs. Szigyártó, R. Deák, J. Mihály, S. Rocha, F. Zsila, Z. Varga, T. Beke-Somfai.
Flow-alignment of extracellular vesicles: structure and orientation of membrane associated
biomacromolecules studied with polarized light. ChemBioChem. 2018;19:545–551
Summary/Conclusion: In conclusion, EVs provide excellent opportunities to better understand
the function and mechanism of natural membrane active biomolecues.
Funding: This work was funded by the Momentum programme (LP2016-2), by the National
Competitiveness and Excellence Program (NVKP_16-1-2016-0007) and BIONANO_GINOP-2.3.2-15-2016-00017.
The János Bolyai Research Scholarship (Z.V.) is greatly acknowledged.
Symposium Session 24: Mechanisms of EV Delivery Chairs: Pieter Vader; Hang Hubert
YinLocation: Level B1, Hall B 13:00–14:30
OS24.01
State of the art microscopy for live cell study of the extracellular vesicle-mediated
drug delivery
Ekaterina Lisitsyna
a, Kaisa Rautaniemia, Heikki Saarib, Timo Laaksonena, Marjo Yliperttulab and Elina
Vuorimaa-Laukkanena
aLaboratory of Chemistry and Bioengineering, Tampere University of Technology, Tampere,
Finland; bDivision of Pharmaceutical Biosciences and Drug Research Program, Faculty
of Pharmacy, University of Helsinki, Helsinki, Finland
Introduction: Extracellular vesicles (EVs) provide a compelling alternative for targeted
drug delivery due to the unique set of their properties: (1) natural protection of
EV content from degradation in the circulation; (2) EVs’ intrinsic cell targeting
properties and (3) innate biocompatibility. However, their mechanisms of interacting
with living cells are poorly understood.
Methods: Microvesicles (MVs) and exosomes (EXOs) derived from prostate cancer cells
were studied. The EVs were passively loaded with the conjugate of cancer drug Paclitaxel
(Ptx) and fluorescent probe Oregon Green (OG). Ptx-OG EVs were applied to the cells
autologously and imaged by fluorescence lifetime microscopy (FLIM). Simultaneous labelling
of cell organelles with the FRET pairs to OG was done to utilize FLIM in combination
with Foerster resonance energy transfer (FLIM-FRET). Time-resolved fluorescence anisotropy
imaging (TR-FAIM) was applied for the first time to study the EV-based drug delivery.
Confocal microscopy was used as a standard method of live cell imaging.
Results: By FLIM, we show distinct cellular uptake mechanisms for EXOs and MVs loaded
with the drug-dye conjugate Ptx-OG. We demonstrate differences in intracellular behaviour
and drug release profiles of Ptx-containing EVs in correlation with the intracellular
position. Based on FLIM and confocal data we suggest that EXOs deliver the drug mostly
by endocytosis while MVs enter the cells by both endocytosis and fusion with the cell
membrane. TR-FAIM shows that Ptx-OG binds some intracellular target inside the cell
that is in accordance with the known fact that Ptx interacts with microtubules network.
Summary/Conclusion: This research offers new real-time methods to investigate EV kinetics
with living cells and complements the existing techniques. The findings of the study
improve the current knowledge in exploiting EVs as drug delivery systems.
Funding: The research is funded by Academy of Finland projects 311362 and 258114.
OS24.02
Fusion of extracellular vesicles (EVs) and delivery of internal EV cargos to host
cells is dependent upon circulating or endogenous viral envelope proteins
Zach A. Troyer
a, Aiman Haqqanib and John Tiltonb
aCase Western Reserve University, Shaker Heights, USA; bCase Western Reserve University,
Cleveland, USA
Introduction: Extracellular vesicles (EVs) contain proteins and small RNAs that are
posited to mediate cell-to-cell communication; however, the precise molecular mechanisms
of EV fusion to host cells and delivery of internal cargos remains poorly defined.
Delivery of internal EV cargos to target cells requires fusion between the EV and
cell membranes; otherwise, the EV and its contents are degraded by lysosomal enzymes.
In this study, we probed the molecular mechanisms of EV fusion by adapting and employing
a validated and powerful viral fusion assay.
Methods: EVs were produced in HEK 293T cells and labelled with beta-lactamase (BlaM)
by overexpression or with BlaM-CD9/CD63/CD81 chimeric proteins. In some conditions,
the HEK 293T cells were also transfected with plasmids encoding viral envelope glycoprotein
(Env) proteins. EVs were isolated by ultracentrifugation and size exclusion chromatography,
characterized by TEM imaging, and titered with microBCA assay. To test EV fusion,
EVs were added to target cells containing CCF2-AM FRET dye. Fusion was measured by
flow-cytometric evaluation of CCF2-AM dye cleavage by BlaM.
Results: EVs produced in the absence of viral Env showed no evidence of fusion with
target cells. In contrast, EVs produced in cells co-transfected with vesicular stomatitis
virus Env (VSV-G) were highly fusogenic even at low doses. EV fusion was dependent
on the presence of functional viral Env machinery, either from actively circulating
viruses – including VSV-G, rabies, influenza, and mokola viruses – or from human endogenous
retroviruses (HERVs) Env proteins – such as syncytin-1.
Summary/Conclusion: EVs produced in the absence of viral Env machinery are poorly
fusogenic and are unlikely to be efficient mediators of cell-to-cell communication
via the delivery of EV contents to the cytoplasm. In contrast, viral Env proteins
significantly enhance EV fusogenicity, suggesting that EV fusion and communication
may occur and play a significant role during viral infections. Furthermore, cells
expressing the HERV Env syncytin-1 – including many human cancers – also give rise
to fusogenic EVs that may contribute to tumour establishment, growth, and metastasis.
These findings suggest that blocking syncytin-mediated EV fusion may be an effective
strategy to block EV communication in human cancers.
OS24.03
Preferential accumulation of copper-free click chemistry-modified exosomes to own
pancreatic xenograft in vivo
Lizhou Xu
a, Revadee Liam-Orb, Farid N. Faruqub, Omar Abedc, Danyang Lib, Julie Wangb and Khuloud
Al-Jamalb
aSchool of Cancer and Pharmaceutical Sciences, King’s College London, London, UK;
bKing’s College London, London, UK; cKing’s College London, London, UK
Introduction: Pancreatic cancer (PC) is one of the deadliest malignancy with few effective
approaches available for early diagnosis or therapy. Exosomes (Exo) as one type of
extracellular vesicles are currently being investigated as potential theragnostic
tools in cancer. However, it is not yet well-understood how Exo are taken up by PC
cells. This work aims to study the Exo dosimetry and preferential Exo-cell affinity
in PC cells in vitro and in vivo for exploitation of Exo-based delivery of therapeutics.
Methods: Exo are isolated by sucrose cushion ultracentrifugation and characterized
for exosomal marker expression, number, purity and shape. Exo were fluorescently labelled
by copper-free click chemistry to enable uptake quantification in cells using the
Design of Experiments (DoE) approach. Cellular uptake of Exo was investigated using
flow cytometry and confocal microscopy. Factors studied are donor Exo source, dose,
receipt cell type, and incubation time. Responses identified are Exo “Taken up numbers”
and “Percentage uptake” per cell. Candidate PC Exo uptake was then assessed in vivo
and compared between PC and melanoma xenograft models in NSG mice following intravenous
administration.
Results: Cellular uptake of Exo was time- and dose- dependent profiles. PC derived
PANC-1 Exo showed significantly higher and not saturable uptake in PANC-1 cells compared
to B16-F10 Exo (cancer-derived) and HEK-293 Exo (non-cancer derived) which showed
lower and saturable uptake profile at 24 h. In vivo biodistribution studies of PANC-1
Exo in subcutaneous PC xenograft further confirmed that PANC-1 Exo favoured accumulation
in PC tumours over melanoma (B16-F10) tumours.
Summary/Conclusion: A simple and highly efficient surface modification approach via
click chemistry was developed enabling both in vitro and in vivo tracking of Exo.
DoE modelling predicted PC cells’ preference to PC-derived Exo which was confirmed
also in vivo. This Exo dosimetry study could facilitate a rationalized approach in
Exo-based therapeutics for treatment of cancer in pre-clinical studies.
Funding: The K. C. Wong Education Foundation and The Marie Skłodowska-Curie actions,
European Commission “Horizon 2020”, EU (H2020-MSCA-IF-2016)
OS24.04
Specific transfer of hollow gold nanoparticles within exosomes is determined by the
exosome origin
Maria Sancho-Alberoa, Nuria Navascuésb, Gracia Mendozab, Victor Sebastiana, Manuel
Arrueboa, Pilar Martin-Duquec
and Jesus Santamariaa
aDepartment of Chemical Engineering, Aragon Institute of Nanoscience (INA), University
of Zaragoza, Campus Río Ebro- Edificio I+D, C/ Mariano Esquillor S/N, 5018- Zaragoza,
Spain.///Networking Research Center on Bioengineering, biomaterials and Nano, Zaragoza,
Spain; bDepartment of Chemical Engineering, Aragon Institute of Nanoscience (INA),
University of Zaragoza, Campus Río Ebro- Edificio I+D, C/ Mariano Esquillor S/N, 5018-
Zaragoza, Spain, Zaragoza, Spain; cInstituto Aragonés de Ciencias de la Salud/ IIS
Aragón// Fundación Araid, Zaragoza, Spain
Introduction: Exosomes are considered key elements for communication between cells
but very little is known about the mechanisms and selectivity of the transference
processes involving exosomes released from different cells.
Methods: In this study we have investigated the transfer of hollow gold nanoparticles
(HGNs) between different cells when these HGNs were loaded within exosomes secreted
by human placental mesenchymal stem cells (MSCs). These HGNs were successfully incorporated
in the MSCs exosome biogenesis pathway and released as HGNs-loaded exosomes, by using
time-lapse microscopy and atomic emission spectroscopy
Results: Those studies allowed us to demonstrate the selective transfer of the secreted
exosomes only to the cell type of origin when studying different cell types including
cancer, metastatic, stem or immunological cells.
Summary/Conclusion: In this study we demonstrate the selectivity of in vitro exosomal
transfer between certain cell types and how this phenomenon can be exploited to develop
new specific vectors for advanced therapies. We show how this preferential uptake
can be leveraged to selectively induce cell death by light-induced hyperthermia only
in cells of the same type as those producing the corresponding loaded exosomes. We
describe how the exosomes are preferentially transferred to some cell types but not
to others, thus providing a better understanding to design selective therapies for
different diseases.
Funding: We thank the ERC Consolidator Grant program (ERC-2013- CoG-614715, NANOHEDONISM)
for the financial support, and CIBER-BBN, financed by the Instituto de Salud Carlos
III.
OS24.05
A high-throughput screen for functional extracellular vesicles
Shu Liu
a, André Hossingera, Philip Dennera and Ina Vorbergb
aGerman Center for Neurodegenerative Diseases Bonn (DZNE e.V.), Bonn, Germany, Bonn,
Germany; bGerman Center for Neurodegenerative Diseases Bonn (DZNE e.V.), Bonn, Germany
/ Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany, Bonn, Germany
Introduction: Prions are infectious protein aggregates that self-propagate and infect
naïve cells by direct cell contact or via secreted vesicles. Several lines of evidence
argue that also protein aggregates associated with common neurodegenerative diseases
can intercellularly propagate their aggregated states in a prion-like manner. Thus,
targeting extracellular vesicles (EVs) has potential clinical implications for neurodegenerative
diseases. We have developed a mouse neuroblastoma cell-based assay to identify compounds
that modulate exosome uptake and subsequent protein aggregate formation in recipient
cells. In this novel cell-based assay, we take advantage of the non-toxic Saccharomyces
cerevisiae prion domain Sup35NM that forms self-templating protein aggregates in mammalian
cells capable of spreading through cell cultures. The addition of fibrils produced
from bacterially expressed Sup35NM to cells expressing soluble NM efficiently induces
appearance of NM aggregates which are faithfully inherited by daughter cells. Importantly,
EVs released from donor cells containing NM aggregates are infectious and induce the
aggregation of soluble NM-GFP in recipient cells after 12 h incubation time. We here
introduce a high throughput assay to screen for functional EVs that trigger NM reporter
protein aggregation in target cells.
Methods: We have developed a quantitative high-throughput screen assay to identify
modulators (inhibitors and activators) on exosome uptake. The read-out of this functional
EV assay is the percentage of recipient cells with induced NM-GFP aggregates.
Results: A total of 4135 small molecules were screened from three well-defined compound
libraries (LOPAC, TOCRIS and SELLECKCHEM). Thirty-three inhibitors and 35 activators
were found to decrease or increase the EV-mediated aggregate induction in recipient
cells, respectively. Lead compounds identified in this screen affect active and selective
EV uptake in recipient cells.
Summary/Conclusion: We successively developed a cell-based assay for functional extracellular
vesicles and performed high-throughput screening to identify the mechanisms of active
extracellular vesicle uptake. I will present some interesting findings out of the
screen.
Symposium Session 25: EVs in Neurological Diseases Chairs: Andrew Hill; Yiyao HuangLocation:
Level B1, Hall A 13:00–14:30
OS25.01
Circulating extracellular vesicles of astrocytic origin carry neurotoxic complement
in Alzheimer’s disease
Carlos Nogueras-Ortiza, Francheska Delgrado-Perezab, Vasiliki Machairakib and Dimitrios
Kapogiannis
a
aNational Institute on Aging, Baltimore, USA; bJohns Hopkins University, Baltimore,
USA
Introduction: Recent research has documented the role of reactive astrocytes in neuroinflammation
in Alzheimer’s disease (AD), and of Extracellular vesicles (EVs) in the transneuronal
propagation and seeding of Aβ, tau and other pathogenic protein mediators. However,
the mechanisms underlying the initial induction and propagation of neurodegeneration
in AD remain elusive. In our Lab, we have pioneered the isolation of neuronal- and
astrocytic-derived EVs (NDEVs, ADEVs) from peripheral blood and have found that, in
AD patients, NDEVs contain pathogenic Aβ and tau, whereas ADEVs contain high levels
of potentially toxic complement. Based on these observations we hypothesized that
ADEVs and/or NDEVs circulating in the plasma of AD patients are neurotoxic.
Methods: We isolated plasma ADEVs, NDEVs and CD81+ EVs from patients with sporadic
AD and age-matched controls. To assess their ability to induce neurotoxicity, we used
them to incubate cultures of rat cortical neurons and human iPSC-derived neurons.
We studied neuronal viability using the MTT assay and neurite density quantification;
necrosis using fluorescent detection of EthD-1; and apoptosis using caspase 3/7 assays
in vitro. We used the physiologic inhibitor of the terminal complement pathway CD59
in rescue experiments. In evolving vivo experiments, we perform hippocampal injections
in rats and study neurodegeneration and induction of Aβ and tau pathology.
Results: Neurons incubated with NDEVs and ADEVs from AD patients exhibited significantly
decreased neurite density, cell viability, and increased necrotic and apoptotic cell
death, compared to neurons treated with control EV subpopulations (CD81+, total EVs)
from patients or ADEVs or NDEVs from control participants. Blocking the formation
of the complement Membrane Attack complex with CD59 rescues the toxicity.
Summary/Conclusion: This is the first demonstration that blood-borne EVs from AD patients
are neurotoxic through a complement-mediated mechanism. These findings indicate a
novel mechanism for induction and perhaps propagation of neurodegeneration in AD through
circulating EVs with important therapeutic implications.
Funding: This research was supported entirely by the Intramural Research Program of
the National Institute on Aging, NIH.
OS25.02
Platelet extracellular vesicles as first liquid biopsy biomarkers to diagnose acute
ischaemic stroke
Aleksandra Gasecka
a, Ceren Eyiletenb, Edwin van der Polc, Rienk Nieuwlandd, Krzysztof J. Filipiake and
Marek Postulab
a1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland;
bDepartment of Experimental and Clinical Pharmacology, Centre for Preclinical Research
and Technology, Warsaw Poland, Warsaw, USA; cAmsterdam UMC, University of Amsterdam,
Department of Biomedical Engineering and Physics, Amsterdam, Netherlands, Amsterdam,
Netherlands; dAmsterdam UMC, University of Amsterdam, Laboratory of Experimental Clinical
Chemistry, Amsterdam, Netherlands, Amsterdam, Netherlands; e1st Chair and Department
of Cardiology, Medical University of Warsaw, Poland, Warsaw, USA
Introduction: Acute ischemic stroke is the second most common cause of death in Europe,
accounting for almost 1.1 million deaths annually. Diagnosis of stroke relies on neurologic
deficits and brain imaging. Because time is brain, stroke is preferably already diagnosed
in the ambulance, which requires a liquid biopsy biomarker. Our aim is to determine
whether EVs from platelets, leukocytes and endothelial cells can be used as biomarker
to diagnose stroke.
Methods: The study was approved by the medical ethics committee. Venous blood was
collected at days 1 (acute phase) and 7 (late phase) after the onset of stroke from
fasting patients (n = 19, mean age 53.8 ± 5.4 years, 55% male) and controls (patients
with Parkinson or Alzheimer disease, n = 9, mean age 57.1 ± 3.2 years, 53% male).
Flow cytometry (Apogee A60 Micro) was used to determine plasma concentrations of EVs
labelled with antibodies for activated platelets (CD61, CD62p; PEVs), leukocytes (CD45;
LEVs) and endothelial cells (CD146; EEVs). Flow cytometry data files were processed
using in-house developed, automated software (MATLAB R2018a), enabling flow rate stabilization,
diameter and refractive index determination, MESF calibration, fluorescent gate determination
and application, and statistics reporting. To standardize and differentiate EVs from
small platelets and lipoproteins, only events between 200 and 700 nm and with a refractive
index <1.42 were included.
Results: Concentrations of PEV were elevated in stroke patients compared to controls,
both at day 1 and day 7 (p = 0.035, p = 0.059, respectively). Concentrations of LEVs
were comparable at day 1 (p = 0.83) and decreased at day 7 (p = 0.059), whereas concentrations
of EEVs decreased at day 1 (p = 0.048) and normalized to control levels at day 7 (p = 0.91).
Summary/Conclusion: Concentrations of platelet EVs are elevated in patients with stroke
both at day 1 and day 7, compared to controls. In follow-up studies, we are going
to validate platelet EVs as the first liquid biopsy biomarker to diagnose ischemic
stroke. Concentrations of LEVs and EEVs fluctuate between day 1 and day 7 after stroke,
likely reflecting activation of immune system and endothelium following brain damage.
Funding: Polish National Science Centre (2017/25/N/NZ5/00545)
OS25.03
Circulating extracellular vesicles as a novel source of biomarkers for diagnosis and
monitoring of neurological diseases
Silvia Picciolini
a, Alice Gualerzia, Cristiano Carlomagnoa, Andrea Sguasseroa, Massimo Masserinib and
Marzia Bedonia
aIRCCS Fondazione Don Carlo Gnocchi, Milan, Italy; bNanomedicine Center NANOMIB, Monza,
Italy
Introduction: One of the main hurdle in clinical approach to neurological diseases
is the lack of easily accessible and sensitive biomarkers. Brain-derived extracellular
vesicles (EVs) circulate in blood, cross the blood–brain barrier and are involved
in the onset and progression of neurological disorders, but reliable, sensitive and
reproducible methods that can cope with their nanoscale dimensions are still lacking.
We propose to validate brain-derived EVs as new biomarkers of Stroke, Alzheimer’s
disease (AD) and Parkinson’s disease (PD) by using biophotonics-based techniques as
Surface Plasmon Resonance imaging (SPRi) and Raman Spectroscopy (RS).
Methods: EVs were isolated by size exclusion chromatography and ultracentrifugation
from plasma and serum of Stroke, AD and PD patients and healthy controls recruited
according to a protocol approved by the medical Ethics Committee. We developed an
SPRi antibody array to separate and characterize plasma EVs of different neural origins.
In parallel, RS was applied to serum EVs in order to obtain a snapshot of their biochemical
profiling. Statistical analysis was applied for the comparison of SPRi and Raman data
from healthy subjects and neurological patients.
Results: After the successful SPRi detection of EVs from neurons, oligodendrocytes,
astrocytes and microglia, the quantification of specific surface molecules related
to pathological or recovery processes has revealed variations of EVs specific content
during a disease. Moreover, the bulk characterization of EVs by RS demonstrated the
presence of EVs loaded with atypical cargoes when compared to healthy controls.
Summary/Conclusion: Our results provide support for using EVs as biomarkers for monitoring
the progression of Stroke, AD and PD, suggesting the possibility to use the SPRi-biosensor
and Raman fingerprint to identify and verify the neuro-pathological or recovery processes
ongoing in neurological patients.
Funding: This study was supported by the Italian Ministry of Health.
OS25.04
Extracellular vesicles of Alzheimer’s disease patients as a biomarker for disease
progression
Anat Aharon
a, Polina Spectorb, Rwan Sayed Ahmedc, Nizar Horranyd, Anni Sabache, Benjamin Brennerf
and Judith Aharon-Peretzg
aTel Aviv Sourasky Medical Center, Tel Aviv, Israel; bCognitive Neurology Unit, Rambam
Health Care Campus, Haifa, Israel; cDepartment of Hematology, Tel Aviv Sourasky Medical
Center, Tel-Aviv, Israel; dCognitive Neurology Unit, Rambam Health Care Campus, Haifa,
Israel; eDepartment of Hematology and Bone Marrow Transplantation, Rambam Health Care
Campus, Haifa, Israel; fBruce Rappaport Faculty of Medicine, Technion-Israel Institute
of Technology, Haifa, Israel; gBruce Rappaport Faculty of Medicine, Technion-Israel
Institute of Technology, Haifa, Israel
Introduction: Introduction: Alzheimer’s disease (AD) is progressive irreversible neurodegenerative
pathology and the most common cause of degenerative dementia. AD becomes symptomatic
only after brain changes occur over years.Accumulating evidence suggests that extracellular
vesicles (EVs) that contain cytokines and microRNA are involved in the regulation
of inflammation. The current study aimed to characterize the EVs of AD patients as
a biomarker for disease progression.
Methods: Blood samples were collected after obtaining signed informed consent (No.
0462-14-RMB) from 39 AD patients at three stages of disease severity and from 14 healthy
controls (HC). Cerebrospinal fluid was collected from five patients and three HC.
EV size and concentration were studied by Nano-tracking analysis. Membrane antigens
were characterized by their cell origin as defined by flow cytometry. EV protein contents
were screened by protein array, and miRNA content was screened by Nano-string technology
and validated by RT-PCR.
Results: The AD patients’ EVs were significantly smaller and the levels of neural
cell markers were higher than EVs obtained from HC. Moderate or severe AD patients’
EVs had a significantly higher level of the Myelin oligodendrocyte glycoprotein (MOG),
compared to the EVs obtained from patients with mild AD (P = 0.0002 and P = 0.036).
Levels of the EVs that expressed the axonal glycoprotein CD171 were significantly
higher in the patients with severe AD compared to HC (P = 0.0066), possibly indicating
injured apoptotic neural cells. There was also a significant increase in EVs originating
from endothelial cells (labelled with CD31+ CD41-, P = 0.0115 and with CD144, P = 0.0276)
in patients with moderate AD compared EVs obtained from the HC. A >2-fold increase
was measured in the content of inflammatory cytokines (TNFα, IL8, IL-2, IFNγ) as was
a >50% reduction in growth factors (FGF, EGF VEGF) and their receptors in the EVs
of moderate AD patients. miR-146a-5p and several other miRNAs obtained from the EVs
of severe AD patients had significantly low levels compared to HC.
Summary/Conclusion: The neural and endothelial damage severity as reflected by AD
patients’ EVs (antigen profiles cytokine and miRNA) may serve as a biomarker for disease
dynamics.
OS25.05
Novel Blood-derived Extracellular Vesicle-based Biomarkers in Alzheimer’s Disease
by the Proximity Extension Assay
Jonas E. Nielsen
a, Kamilla Pedersenb, Karsten Vestergårdc, Søren Kristensena and Shona Pedersena
aDepartment of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark;
bBioXpedia A/S, Aarhus, Denmark; cDepartment of Neurology, Aalborg University Hospital,
Aalborg, Denmark
Introduction: Biomarkers capable of identifying complex pathways contributing to neuropathological
development, especially in the early stages of Alzheimer’s disease (AD), are lacking.
Such biomarkers could be present in easily available fluids, such as blood, due to
the breakdown of the blood–brain barrier (BBB) early in AD. However, the identification
of specific and sensitive blood-based biomarkers is a challenging task. Therefore,
extracellular vesicles (EVs) may provide a window into AD etiology and therapeutic
targets, as brain-derived EVs have been shown to cross the BBB and are present in
blood. As biomarkers, proteins are a potential source of relevant information relating
to biological function. Thus, we investigated a subset of proteins hypothesized to
be involved in neurological processes in plasma and EV samples using the Proximity
Extension Assay (PEA).
Methods: EVs were isolated from platelet poor plasma from 10 healthy controls (HC),
10 patients with Mild Cognitive Impairment (MCI) and 10 patients with mild/moderate
AD. Isolation was performed using centrifugation at 20.000 xg, 1 h, 4°C with a subsequent
washing of the pellet at the same g-force. For the characterization of the EV isolates,
Nanosight and western blotting (CD9) are performed. A neurology panel of 92 biomarkers
were assessed in plasma and EVs using the PEA. Written informed consent was obtained
from all study participants and the study was approved by The North Denmark Region
Committee on Health Research Ethics (N-20150010).
Results: PEA showed no significant difference of protein levels comparing the three
groups for the plasma samples. Interestingly, EV samples showed four statistically
significant proteins; Siglec-9, CLM-1, CLM-6 and CD38, which were less expressed in
the MCI and AD groups compared with the HC group with a false discovery rate adjusted
p-values of 0.014, 0.024, 0.035 and 0.031, respectively. These proteins have been
documented to be involved in neurotoxicity protection and inflammatory regulation.
Summary/Conclusion: Our preliminary results demonstrate that EVs, compared to plasma,
hold potential as candidate diagnostic biomarkers in AD.
OS25.06
Proteomic and transcriptomic profiting of extracellular vesicles isolated from immune-stimulated
human primary astrocytes
Tsuneya Ikezu
a, Yang Youa, Kathleen Borgmannb, Satomi Stacyb and Anuja Ghorpadeb
aBoston University School of Medicine, Boston, USA; bUniversity of North Texas Health
Science Center, Fortworth, USA
Introduction: Astrocytes are abundant glial cells in the central nervous system that
provide supportive neuronal functions. They have critical roles in regulating neuronal
activities in response to pro-inflammatory factors in neurodegenerative diseases.
Exosomes, typically 50–150 nm in size extracellular microvesicles, are known to carry
a large diversity of molecules such as proteins and RNA species that can modify the
physiology of recipient cells. Here, we hypothesized that astrocyte-derived exosomal
proteins are regulated when exposure to pro-inflammatory factors, thus transported
to control neuronal function and plasticity.
Methods: We performed a quantitative proteomic and transcriptomic analysis of exosomes
purified from human primary astrocytes with or without interleukin 1-β (IL1-β) stimulation
in vitro. Exosome-enriched fractions were purified by size-exclusion columns. The
total proteins isolated from the EVs were run on 1D SDS-PAGE and mass spectrometry.
miRNA was isolated from EVs and subjected to Affymetrix miRNA 4.0 Array. The data
are subjected to bioinformatic analysis and validation for select molecules.
Results: A total of 539 common proteins were identified. IL1-β-stimulated astrocytes
enhanced the cargo load of proteins in the EVs. IL-1b stimulation induced activation
of immune response and modulation of cell adhesions. The EVs from resting astrocytes
play a role in protein metabolism, cell growth and maintenance. Finally, similar proteomic
results were also obtained from exosomes derived from astrocytes cultured in serum-free
media with IL1-β stimulation, further validating the alteration of exosomal proteins
in activated astrocytes which can be transferred to control neuronal function and
plasticity.
Summary/Conclusion: Our finding will be helpful to elucidate the pathophysiological
functions of astrocyte-derived exosomes in regulating neuronal networks and provide
new insights into the diagnostics and therapeutics of inflammatory diseases.
Funding: NIH 1R01AG054672, 1R56AG057469 and 1RF1AG054199 (TI), 5R24HD0008836
Saturday Poster SessionPS01: Engineering and Loading EVsChairs: Hang Hubert Yin; Antonella
BongiovanniLocation: Level 3, Hall A15:00–16:00
PS01.01
Targeting prostate cancer via PSMA-peptide decorated exosome-mimetics
Maja Severic, Guanglong Ma, Hatem Hassan, Sara Pereira, Calvin Cheung and Wafa AL-Jamal
Queen’s University Belfast, Belfast, UK
Introduction: Prostate cancer (PC) is the most common type of cancer and the second
cause of death in men worldwide. A range of effective anticancer drugs have been used
to treat advanced PC, however, their systemic toxicity has limited their clinical
use. Therefore, there is an unmet need to develop novel strategies to deliver cancer
therapeutics to PC tissues. Exosomes are nanosized, cell-derived vesicles that carry
proteins and RNAs for intercellular communication. They could also deliver their cargo
across the plasma membrane and delay premature drug transformation and elimination.
Exosomes have shown an intrinsic homing ability to a wide range of cells. Furthermore,
a new approach has been proposed to combine the intrinsic homing ability of exosomes
with active targeting to enhance their tumour accumulation. In the present work, we
report the development of novel prostate-specific membrane antigen (PSMA)-targeted
exosome-mimetics (EMs) for advanced PC.
Methods: Stably transfected PSMA-peptide expressing monocytes U937 cell line was established.
PSMA-targeted EMs were prepared by serial extrusion of the transfected U937 monocytes.
The PSMA-targeted EMs were characterized by dynamic light scattering, nanoparticle
tracking analysis, transmission electron microscopy, bicinchoninic acid assay and
western blotting. Furthermore, the binding of the PSMA-targeted EMs to the recombinant
human PSMA protein was confirmed by ELISA. Their drug loading capability was assessed
by loading doxorubicin and its derivatives. Next, in vivo biodistribution and safety
studies of targeted EMs were carried out in C4-2B and PC3- tumour-bearing mice.
Results: The engineered EMs exhibited high protein yield, good drug loading and exosome
markers expression. The expression of PSMA targeting peptide and its binding to PSMA
receptors was confirmed in vitro. Finally, successful tumour accumulation of PSMA-targeted
EMs was achieved in vivo with the absence of in vivo toxicity.
Summary/Conclusion: Our engineered PSMA-targeted EMs, could offer a promising drug
delivery system for PC, based on its drug loading capacity, tumour targeting and safety
in vivo.
Funding: Rosetrees Trust studentship (A1108), PCUK (CDF-12-002 Fellowship) and EPSRC
(EP/M008657/1).
PS01.02
Improved loading of plasma-derived extracellular vesicles to encapsulate antitumour
miRNAs
Margherita A. C. Pomattoa
, Benedetta Bussolatib, Sergio D’Anticoc, Sara Ghiottoc, Ciro Tettad, Maria Felice
Brizzia and Giovanni Camussia
aDepartment of Medical Sciences, University of Turin, Turin, Italy; bDepartment of
Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy; cBlood
Bank, A.O.U. Città della Salute e della Scienza, Turin, Italy; dUnicyte srl, Turin,
Italy
Introduction: Extracellular vesicles (EVs) are particles released by cells that carry
a complex cargo of molecules and mediate intercellular communication. Recently, they
have raised great interest as drug delivery systems and several engineering methods
are currently under investigation. Numerous factors, however, influence the transfection
yield, including protocol variability and EV damage.
Methods: The electroporation was investigated as method to directly load miRNAs in
plasma-derived EVs. Different parameters (voltage and number of pulses) were compared
for their effect on EV morphology and loading capacity of a synthetic miRNA, cel-39,
including miRNA enrichment in EVs and its transfer to target cells. Next, analyses
were performed to evaluated the transfection effect on EV endogenous cargo and the
exogenous miRNA protection from RNAse degradation. Then, EVs were loaded with antitumour
miRNAs and their pro-apoptotic effect was evaluated on a cell line of hepatocellular
carcinoma, HepG2 cells.
Results: The comparison of different electroporation settings demonstrated the importance
of choosing the more appropriate protocol parameters to obtain an efficient EV transfection
yield, understood as both molecules loading and EV damage. In particular, we observed
the superiority of one electroporation protocol (using 750 Volt and 10 pulses) that
allowed the most efficient miRNA packaging and transfer to target cells, without structurally
damaging EVs. The most efficient electroporation protocol was also proven to allow
a more efficient miRNA loading in respect to incubation, better protecting miRNA from
enzymatic digestion. In addition, our findings suggested that electroporation preserved
the naïve EV cargo, including RNAs and proteins, and did not alter their uptake in
cells. EVs engineered with antitumor miRNAs (miR-31 and miR-451a) successfully promoted
the apoptosis of HepG2 cells, downregulating their target genes related to apoptotic
pathways.
Summary/Conclusion: In conclusion, our findings indicate an efficient and functional
miRNA encapsulation in plasma-derived EVs following an electroporation protocol that
preserves EV integrity.
Funding: Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.), Unicyte AG (Switzerland)
PS01.04
Development of a platform for exosome engineering using a novel and selective scaffold
protein for surface display
Kevin Dooley, Ke Xu, Sonya Haupt, Shelly Martin, Russell McConnell, Nuruddeen Lewis,
Christine McCoy, Chang Ling Sia, Jorge Sanchez-Salazar, Nikki Ross, Rane Harrison,
Bryan Choi, Damian Houde, John Kulman and Sriram Sathyanarayanan
Codiak BioSciences, Cambridge, USA
Introduction: Membrane proteins preferentially partitioned into exosomes can be co-opted
to display pharmacologically active molecules on the exosome surface, which is an
important strategy for maximizing the potential of therapeutic exosomes. Previously
published approaches have relied on “canonical” scaffolds including multi-pass transmembrane
tetraspanins (CD9/CD63/CD81), LAMP2B, or non-exosomal domains such as pDisplay or
GPI anchors. We sought to identify novel scaffolds that enable more uniform, higher
density surface display of structurally and biologically diverse molecules.
Methods: Proteomic analysis of stringently purified exosomes led to the identification
of highly abundant and unique exosomal proteins, including a single-pass transmembrane
glycoprotein (Protein X, PrX) belonging to the immunoglobulin superfamily. Protein
X and fragments thereof were expressed in a cell line and the minimum PrX domain requirements
for exosomal enrichment were determined. Leveraging PrX as a scaffold for exosome
surface display, we developed our engEx platform to generate engineered exosomes functionalized
with a variety of pharmacologic payloads including enzymes, antibodies, type I cytokines
and TNF superfamily members. Biological activity of these engineered exosomes was
assessed in an array of in vitro assays and compared to previously described scaffolds.
Results: Stable expression of PrX in an exosome producing cell line resulted in 200-fold
enrichment of PrX on secreted exosomes. Interestingly, overexpression of PrX structural
paralogs did not result in similar levels of enrichment, suggesting PrX is unique.
Exosomes expressing PrX-GFP exhibited 100-fold increase in relative fluorescence compared
to LAMP2B and pDisplay GFP fusions. Similar levels of high-density expression were
achieved with a variety of topologically diverse therapeutic proteins fused to full-length
or truncated forms of PrX. Exosomes engineered to display IL7, CD40 ligand, IL12 and
antibody fragments via PrX fusion exhibited up to 1500-fold improvement in potency
compared to previously described scaffolds.
Summary/Conclusion: This work demonstrates the potential of our engEx platform to
generate novel exosome therapeutics, specifically through high density surface display
mediated by PrX.
PS01.05
Leptin-loaded macrophage-derived exosome: high-efficiency loading method and its properties
Ryo Kojima, Elena Batrakova and Alexander Kabanov
University of North Carolina at Chapel Hill, Chapel Hill, USA
Introduction: Exosome, one of extracellular vesicles, is considered to be an important
player in intercellular communication. Application of exosome to drug delivery system
is expected to target specific cells. Especially macrophage-derived exosome is known
to cross blood–brain barrier (BBB) and deliver its cargo after intravenous administration.
Leptin is hormone to regulate energy balance by inhibiting hunger, and leptin receptor
is located on neurons of hypothalamus. Drug delivery system of leptin to brain is
anticipated because leptin transporter at BBB is known to be impaired in obesity models.
However, it has been challenging to load enough amount of protein drugs into exosome
without changing its original properties.
Purposes of this research are to develop leptin-loading method into exosome with high
efficiency and to evaluate its physicochemical and biological characteristics.
Methods: Exosome was isolated from IC-21 (mouse macrophage) cells by an ultracentrifuge
method. Particle-size distribution of the exosome was measured by Nanoparticle Tracking
Analysis. Expression of exosome-marker protein was confirmed by Simple Western. Leptin
was loaded into the exosome by using a probe sonicator, and free leptin was removed
by gel filtration chromatography. Loaded amount of leptin was measured by ELISA. Release
profile of leptin from the exosome was evaluated in mouse serum at 37°C. In order
to evaluate protection ability of exosome formulation against protease, the leptin-loaded
exosome was treated with pronase and remained leptin was quantified. Stability of
the exosome was also investigated.
Results: IC-21 derived exosome had 100–110 nm of mean size and contained exosomal
markers, such as Alix and Rab11A. Size distribution and exosomal marker level of the
leptin-loaded exosome prepared under optimized condition were similar to those of
bare exosome. Drug-loading efficiency was 7% in this condition. Although ~50% of leptin
burst from the exosome after release study and ~70% of leptin was degraded by protease
challenge test, the other leptin was considered to be retained in the exosome. Particle-size
distribution and leptin concentration of the exosome were stable at 4°C for 1 month.
Summary/Conclusion: This methodology to load protein drugs into exosome is promising
strategy for its drug delivery application.
PS01.06
Characterization and in vivo imaging of mesenchymal stem cells derived extracellular
vesicle
Cheng-Hsiu Lu, Yi-An Chen, Chien-Chih Ke and Ren-Shyan Liu
National Yang-Ming university, Taipei, Taiwan (Republic of China)
Introduction: Mesenchymal stem cells (MSCs) are multipotent stromal cells which show
the great potential in tissue engineering, regenerative medicine and the treatment
of various diseases. Deep into mechanisms, paracrine effect has been reported to be
the major role in MSC therapy. Further, extracellular vesicles (EVs) are reportedly
the major player mediating the therapeutic and paracrine effects of MSCs. With the
rapid increase of attention and being of great potential as a future medical regimen
for human disease, the information of fate and behaviour of EVs in the living subject
should be urgently gathered. However, investigators still have not developed an effective
method to monitor the in vivo behaviour of EVs. Therefore, here in our study, EVs
derived from Wharton’s jelly MSCs were isolated, characterized and radiolabeled with
111In-oxine followed by biodistribution study and in vivo SPECT/CT imaging.
Methods: Conditioned medium was collected followed by exosome isolation using Exo-Prep
kit (Hansa BioMed) followed by purification with PD-10 columns and 100 kDa concentration.
Expression of EVs specific proteins CD63 and HSP70 was verified by western blot. Morphology
and size were characterized by transmission electron microscopy nanoparticle tracking
analysis (NTA). For radiolabeling, EVs were incubated with 111In-oxine in PBS at 37oc
for 1 h followed by purification and further characterization. Biodistribution and
in vivo SPECT/CT imaging of 111In-oxine- labelled EVs were performed at 1, 3, 6 and
24 h after intravenous injection into C57BL/6 mice.
Results: CD63 and HSP70 expression were observed on EVs as well as 111In-oxine-EVs.
Radiochemical purity of 111In-oxine-EVs as higher than 90% and remained stable for
at least 48 h. Result of biodistribution showed that 111In-oxine-labelled EVs accumulated
in liver, spleen, bone marrow and cleared rapidly from the circulation. In vivo SPECT/CT
imaging of 111In-oxine-labelled EVs showed high accumulation in liver, bone, spleen
and liver, but not in brain and circulation.
Summary/Conclusion: In this study, we have preliminarily demonstrated the feasibility
of in vivo tracking of MSC- derived EVs labelled with 111In-oxine. Further investigation
is still needed and underway to monitor the in vivo fate and behaviour of EVs.
PS01.07
EVs as siRNA delivery vehicles for functional knockdown in cells
Senny Nordmeier, Victoria Portnoy and Frank Hsiung
System Biosciences, Palo Alto, USA
Introduction: Extracellular vesicles (EVs) mediate cell-to-cell communication by delivering
cargo, composed of nucleic acids, proteins and various other molecules, from secreting
cells to specific tissues and recipient cells. This method of cellular delivery has
generated great interest in targeted delivery of therapeutics, such as chemical probes,
proteins and RNA. In particular, EV RNA has gained increasing attention not only in
biomarker development but also in the regulation of gene expression in cells. The
delivery of siRNA by EVs is one method to induce gene silencing. Here we developed
and optimized a method of loading EVs with siRNA using a chemical transfection reagent.
Methods: Isolated EVs from tissue culture media were loaded with siRNA using a chemical
transfection reagent. Various compositions of the chemical, as well as molar ratio
between the chemical and siRNA, temperatures and EV concentrations were examined to
determine optimal conditions. The transfected EVs were added onto cells and incubated
for 24–48 hrs. After the incubation period, the cells were imaged for fluorescence
and cell morphology changes. Then, the cells were harvested, lysed and analysed by
Western blot (protein level). Additionally, cell lysates RNA was isolated and analysed
by RT-qPCR.
Results: Fluorescent imaging showed a dose-dependent incorporation of control Cy3-labelled
siRNA into cells. The cell nuclear morphology was examined after delivery of ECT2
and TOR1AIP1 siRNA. In addition, RT-qPCR and Western blotting analyses were used to
measure the level of knockdown of the housekeeping gene, HPRT. CCK8 assay was used
to determine cell viability after delivery of EVs loaded with control siRNA and other
siRNAs.
Summary/Conclusion: Our results provide a specific and efficient approach for loading
siRNA directly into EVs for the implementation of targeted gene silencing.
PS01.08
Development of an in vivo extracellular vesicle-based peptide library screening tool
Masako Harada
Institute for Quantitative Health Science and Engineering (IQ), Michigan State University,
East Lansing, USA
Introduction: Extracellular vesicles (EVs) including exosomes and microvesicles are
heterogenous population of membrane-bound vesicles with cargos including protein,
lipids and nucleic acids of DNA and RNA species. Recently, EVs have gained attention
as a delivery vehicle for targeted delivery of oligo nucleotide drugs. Previous reports
suggest that particles coated with targeting peptide can be delivered to selected
cells and tissues. However, the biocompatible system for screening combinational libraries
have not been described. The goal of this project is to develop a biocompatible system
for peptide screening using EV-peptide display library.
Methods: Homologous recombination cloning using regenerative oligos are used to create
peptide library plasmids where peptide sequences are fused to the phosphatidylserine
binding domain (C1C2) of human lactadherin for peptide display to the vesicle surface.
Fluorescent reporter gene was cloned with C1C2 domain for imaging purposes. Plasmid
DNA was transfected to HEK293FT cells and EVs were harvested by ultracentrifugation
followed by differential centrifugation. DNA sequence was recovered from EV by direct
PCR amplification.
Results: Homologous recombination cloning was successfully used for EV library construction.
Chimeric protein expression on EVs was determined by Western blot analysis and that
of reporters was verified fluorescent microscopy. Direct detection of plasmid DNA
was verified from isolated EVs and the targeting with known targeting peptide is in
progress.
Summary/Conclusion: In this study, our current progress on developing in vivo peptide
screening strategy using degenerative oligonucleotide library EVs will be discussed.
The success of this approach may provide a novel biocompatible system for peptide
screening both in vitro and in vivo.
Funding: Michigan State University Startup funding
PS01.09
The construction of nanogel/exosome hybrid by exosome surface polymer engineering
Shin-ichi Sawada
a, Yuko T. Satob, Riku Kawasakib, Yoshihiro Sasakia and Kazunari Akiyoshia
aKyoto University, Kyoto, Japan; bKyoto University, Kyoto-shi, Japan
Introduction: Extracellular vesicles secreted by various cells have attracted attention
as a new system in cell-to-cell communication. We focus on the utilization of exosomes
as biological molecule delivery systems. However, it is not always easy to control
the delivery and internalization of exosomes to various cells. We propose here a new
strategy for the effective delivery of exosomes into cells using functional macromolecular
carriers such as amphiphilic nanogels. Surface polymer engineering was applied with
a carrier of exosomes, namely, amphiphilic cationic CHP (cCHP) nanogel, to improve
the delivery of exosome content by forming complexes with the exosomes. In this study,
we developed the preparation method of exosome hybrids with nanogel, and the hybrids
were evaluated the characteristics and the biological functions.
Methods: Mouse macrophage cells were used to produce the exosomes, which were then
mixed with cCHP nanogel to form a hybrid. Various characteristics of these hybrid
particles were examined by TEM observation, nanoparticle tracking analysis to determine
their size, measurements of their ζ-potential. The interactions between the hybrids
and cells were evaluated by confocal scanning laser microscopy and flow cytometry.
Results: TEM revealed that the surface of each exosome was coated by cCHP nanogel
particles. Flow cytometry also showed significant uptake of this exosome/nanogel hybrid
by cells, with the main mechanism behind this internalization being endocytosis. A
range of different molecules that inhibit different types of endocytosis were also
applied to determine the particular pathway involved, with a caveola-mediated endocytosis
inhibitor being revealed to markedly affect hybrid uptake. Next, we evaluated revealing
the functional efficacy of this approach, we showed that the nanogel system could
successfully deliver functional exosome into cells as indicated by its ability to
induce neuron-like cell differentiation in the recipient cells.
Summary/Conclusion: These results indicate that the newly developed cationic nanogel
systems for exosome delivery are powerful tools to investigate the biological functions
of exosomes.
PS01.10
Human telomerized cells for production of extracellular vesicles
Regina Grillaria
, Susanne Neubertb, Matthias Wiesera and Johannes Grillarib
aEvercyte GmbH, Vienna, Austria; bChristian Doppler Laboratory on Biotechnology of
Skin Aging, University of Natural Resources and Life Sciences, Vienna (BOKU), Vienna,
Austria
Introduction: Human cells are of ever increasing importance as in vitro test system
to represent the in vivo situation. Additionally, highly differentiated cells are
also essential production systems for complex biopharmaceuticals. However, the use
of such cell systems are limited due to the fact that the cells enter replicative
life span and therefore can only be propagated for a limited number of population
doublings in vitro, which limited standardization of experiments as well as production
processes. Moreover, reports have shown that the number of secreted vesicles significantly
reduced with increasing age of normal cells.
Methods: Human telomerase overexpression immortalizes cells while keeping primary
like characteristics intact. Ectopic overexpression and charcterization of mesenchymal
stem cells was used to establish production cell lines.
Results: Here we describe the development of human continuously growing cell lines
from various tissues that show a high potential as innovative production systems for
extracellular vesicles with use for clinical applications.
Summary/Conclusion: These cell lines will be used for the production of standardized
EV preparation.
PS01.11=OWP1.06
Extracellular vesicles from Fat-laden hypoxic hepatocytes activates pro-fibrogenic
signals in Hepatic Stellate Cells
Alejandra Hernandez
a, Yana Gengb, Daniel Cabrerac, Nancy Solisd, Han Moshagee and Marco Arresed
aPontificia Universidad Católica de Chile; University Medical Center of Groningen,
Groningen, Netherlands; bUMCG, Groningen, Netherlands; cPontificia Universidad Católica
de Chile/Universidad Bernardo O´Higgins, SANTIAGO, Chile; dPontificia Universidad
Católica de Chile, Santiago, Chile; eUniversity Medical Center Groningen, Groningen,
Netherlands
Introduction: Background: Transition from isolated steatosis (IS) to non-alcoholic
steatohepatitis (NASH) is a key issue in non-alcoholic fatty liver disease (NAFLD).
Recent observations in patients with obstructive sleep apnea syndrome (OSAS), suggest
that hypoxia may contribute to disease progression mainly through activation of hypoxia
inducible factor 1α (HIF-1α)-related pathways. Release of extracellular vesicles (EV)
by injured hepatocytes may be involved in NAFLD progression.
Aim: To explore whether hypoxia modulates the release of EV from free fatty acid (FFA)-exposed
hepatocytes and assess cellular crosstalk between hepatocytes and LX-2 cells (human
hepatic stellate cell line).
Methods: HepG2 cells were treated with FFAs (250 μM palmitic acid + 500 μM oleic acid)
and chemical hypoxia (CH) was induced with Cobalt (II) Chloride, which is an inducer
of HIF-1α. Induction of CH was confirmed by Western blot (WB) of HIF-1α. EV isolation
and quantification was performed by ultracentrifugation and nanoparticle tracking
analysis respectively. EV characterization was performed by electron microscopy and
WB of CD-81 marker. LX-2 cells were treated with 15 μg/ml of EV from hepatocytes obtained
from different groups and markers of pro-fibrogenic signalling were determined by
quantitative PCR (qPCR), WB and immunofluorescence (IF).
Results: FFA and CH-treatment of HepG2 cells increased gene expression of IL-1β and
TGF-β1 in HepG2 cells and increased the release of EV compared to non-treated HepG2
cells. Treatment of LX-2 cells with EV from FFA-treated hypoxic HepG2 cells increased
gene expression of TGF-β1, CTGF, α-SMA and Collagen1A1 compared to LX-2 cells treated
with EV from non-treated hepatocytes or LX-2 cells exposed to EV-free supernatant
from FFA-treated hypoxic HepG2 cells. Moreover, EV from FFA-treated hypoxic HepG2
cells increased Collagen1A1 and α-SMA protein levels.
Summary/conclusion: CH promotes EV release from HepG2 cells. EV from hypoxic FFA-treated
HepG2 cells evoke pro-fibrotic responses in LX-2 cells. Further genomic and proteomic
characterization of EV released by steatotic cells under hypoxia are necessary to
further delineate their role in the crosstalk between hepatocytes and stellate cells
in the setting of NAFLD and OSAS.
Funding: FONDECYT 1150327-1150311.
PS02: EVs in Infectious Diseases and Vaccines IIChairs: Norman Haughey; Ryosuke KojimaLocation:
Level 3, Hall A15:00–16:00
PS02.01
Host:pathogen interactions and host cell internalization of Trichomonas vaginalis
exosomes
Patricia J. Johnsona
and Anand Raib
aUniversity of California, Los Angeles, Los Angeles, USA; bUCLA, Los Angeles, USA
Introduction: The parasite Trichomonas vaginalis is the causative pathogen of the
sexually transmitted infection trichomoniasis. Depending on the parasite strain and
host, infections can vary from asymptomatic to highly inflammatory. We previously
reported that T. vaginalis generates and secretes vesicles with physical and biochemical
properties similar to mammalian exosomes that deliver their contents to human host
cells. T. vaginalis exosomes modulate host cell immune responses and likely assist
in parasite colonization of the host.
Methods: In our current study, we are optimizing methods to study the uptake of T.
vaginalis exosomes into the host cells.
Results: The data obtained from our studies show that exosome uptake is a time-dependent
process, regulated by many factors such as temperature, etc. Our findings also suggest
that exosome uptake is mediated by endocytosis, with specific host cell lipids playing
a critical role in this process. We have also identified target molecules present
on the surface of T. vaginalis exosomes that induce exosome uptake into the host cell.
Summary/Conclusion: This work expands our general knowledge of exosome uptake by target
cells and our understanding of the mechanisms used by exosomes to mediate T. vaginalis
host-pathogen interactions.
Funding: National Institutes of Health
PS02.02
Coating filter membranes with bacterial derived vesicles to study the permeation of
anti-infectives across the Gram-negative cell envelope
Robert Richtera
, Adriely Goesb, Marcus Kochc, Gregor Fuhrmannd, Nicole Schneider-Daume and Claus-Michael
Lehre
aDepartment of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research
Saarland, Saarbrücken, Germany; bBiogenic Nanotherapeutics (BION), Helmholtz Institute
for Pharmaceutical Research Saarland, Saarbrücken, Germany; cLeibniz Institute for
New Materials (INM), Saarbrücken, Germany; dHelmholtz-Institut for Pharmaceutical
Research Saarland (HIPS), Saarbrücken, Germany; eDepartment of Drug Delivery (DDEL),
Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany
Introduction: Less and less novel anti-infectives against diseases caused by Gram-negative
bacteria reach the market while bacterial resistance is steadily increasing. Among
the many hurdles of an antibiotic on its way from development to clinical use, the
Gram-negative cell envelope is one crucial factor strongly delimiting access to inner
bacterial targets and thus decreasing efficacy. As a model to study and optimize the
permeation of anti-infectives, outer membrane vesicles (OMV) were selected to create
an in vitro membrane model on a 96-well filter plate.
Methods: E. coli BL21 were cultured in Luria-Bertani medium until stationary phase.
Bacteria were separated by centrifugation (15 min, 9500g) and filtration (0.2 or 0.45 µm
membrane pore size). OMV’s were isolated by adding 33% (w/w) PEG 8000 solution to
the filtrate (ratio 4:1), shaking and overnight incubation at 4°C. The precipitate
was centrifuged (30 min, 16,233g) and the pellet resuspended in 100 µl filtered PBS.
This suspension was characterized by nanoparticle tracking analysis and coated onto
96-well filter plates using a vacuum oven (15 min, 37°C, 100 mbar). Coating morphology
was imaged by scanning electron microscopy and confocal laser scanning microscopy.
For permeation studies the OMV coating was covered with 0.5% (w/v) agarose gel before
adding solutions of different antibiotics to the donor compartment and determining
the concentration time course in the acceptor compartment using UV-spectroscopy.
Results: The filtration through 0.2 and 0.45 µm pores led in both cases to sterile
filtrates, whereas 0.45 µm pores led to larger vesicles and higher yield.
The applied microscopy methods indicated that a complete and homogenuous OMV coating
was achieved. Preliminary permeation studies revealed kinetic differences between
antibiotics.
Summary/Conclusion: The OMV isolation and purification protocol allowed for a yield
sufficient to coat 96-well filter supports. The measured permeated amounts allow to
distinguish the permeability of different antibiotics. Compared to artificial phospholipid
membrane models, fluxes across OMV derived membranes were significantly higher, facilitating
faster analytics. An involvement of outer membrane proteins in this model is subject
of ongoing investigations.
PS02.03
Quality markers for microbial EVs
Simon Swift
a, Jiwon Honga, Zachary Devereuxa, Priscila Dauros Singorenkoa, Cherie Blenkironb
and Anthony Phillipsc
aUniversity of Auckland, Auckland, New Zealand; bThe University of Auckland, Auckland,
New Zealand; cDepartment of Surgery, Faculty of Medical and Health Sciences, The University
of Auckland, Auckland, New Zealand
Introduction: Microbial EVs have potentially important roles in interactions with
cells in populations of the same species, with other microbial species and with eukaryotic
cells. To investigate the effect of these interactions in target cells it is important
to define the EVs under test.
Methods: Pathogenic Escherichia coli 536 and 2348/69 and probiotic Nissle 1917 were
cultured in RPMI 1640 ± FeCl3. Candida albicans and C. auris were cultured in YPD
broth. Microbial EVs were separated from cells by centrifugation, filtration (0.2
μm for bacteria or 0.45 μm for yeast) followed by concentration (100,000 kDa cut-off
filter) and ultracentrifugation. EVs were further enriched by either density gradient
centrifugation (DGC, bacterial samples) or size exclusion chromatography (SEC, bacterial
and yeast samples). An iTRAQ proteomic approach was used to identify proteins from
bacterial cells, crude EV pellets and DGC and SEC fractions. Yeast proteins were fractionated
by SDS/PAGE and proteins in EV-enriched and non-EV fractions were identified using
mass spectrometry techniques.
Results: A number of outer membrane proteins were identified in E. coli EVs, but with
some variation between strains and media used. Cytoplasmic protein GroEL was also
common. There were no obvious proteins removed by the purification of EVs and the
major differences in proteome were due to changes in environmental growth conditions.
For Candida, a clear set of EV-associated envelope proteins were identified. In addition,
a series of proteins removed from the crude EV prepartion by further enrichment were
identified for Candida species that may represent non-EV contaminants.
Summary/Conclusion: A number of possible markers for E. coli and Candida species have
been identified, which now need verification by alternative techniques and the screening
of a range of pathogenic and non-pathogenic isolates grown in different conditions.
These findings offer promising new markers for isolation of microbial EVs from both
laboratory cultures and from clinical samples.
Funding: School of Medicine Performance-Based Research Fund; Maurice and Phyllis Paykel
Trust Project Grant [8.1.17]; Lottery Health Research Grant [326702]; Health Research
Council, Explorer Grant [14/805]; Ministry of Business, Innovation and Enterprise,
Smart Ideas Grant [UOAX1507].
PS02.04
Akt and CD9 in urine exosomes as potential markers for urinary tract infection
Kosuke Mizutani
a, Kyojiro Kawakamib, Kengo Horiea, Yasunori Fujitab, Koji Kameyamac, Taku Katoa,
Keita Nakanec, Tomohiro Tuchiyad, Mitsuru Yasudac, Koichi Masunagae, Yutaka Kasuyae,
Yoshishige Masudae, Takashi Deguchif, Takuya Koiec, Masafumi Itob
aDepartment of Urology, Gifu University Graduate School of Medicine, Gifu, Japan;
bResearch Team for Mechanism of Aging, Tokyo Metropolitan Institute of Gerontology,
Itabashi-ku, Japan; cGifu University Graduate School of Medicine, Gifu, Japan; dGifu
University Graduate School of Medicine, Gifu, Japan; eDepartment of Urology, Tokyo
Metropolitan Geriatric Hospital, Tokyo, Japan; fTokyo Metropolitan Geriatric Hospital,
Tokyo, Japan; gDepartment of Urology, Kizawa Memorial Hospital, Minokamo, Japan
Introduction: Urinary tract infections (UTI) is one of the most common bacterial infections.
UTI is treated with antibacterial agents, but asymptomatic bacteriuria (ABU) that
is diagnosed by bacteriuria without any urinary tract symptoms should not be treated
except pregnant women and patients who will undergo traumatic urologic interventions.
However, there has been no clinically available biomarker to distinguish UTI from
ABU. Exosomes are 40–150 nm sized membrane vesicles containing proteins and nucleic
acids that are present within cells from which they are released and thus have the
potential as biomarkers for various diseases. It is likely that urine may contain
exosomes released from uroepithelial cells and white blood cells. In the present study,
we aimed to identify urinary exosomal markers that are useful to discriminate between
UTI and ABU.
Methods: Exosomes were collected by ultracentrifugation from the culture medium of
SV-HUC-1 (immortalized uroepithelial cell line) and THP-1 (acute monocytic leukaemia
cell line) co-cultured with or without Escherichia coli or treated with or without
LPS. The protein expression was examined by western blot analysis. Urinary exosomes
were isolated from urine by Tim4-conjugated magnetic beads. Expression of Akt and
CD9 in isolated exosomes was analysed by ELISA and CLEIA, respectively.
Results: Expression of Akt, ERK and NF-κB was increased in exosomes isolated from
SV-HUC-1 and THP-1 cells co-cultured with E. coli or treated with LPS compared to
without co-culture or treatment. The levels of Akt and CD9 in urinary exosomes from
patients with UTI were higher than those from ABU patients.
Summary/Conclusion: Our results suggest that intracellular signalling molecule Akt
and cell surface-resident exosomal marker CD9 in urinary exosomes have the potential
to discriminate UTI from ABU, thus providing novel objective markers for their differential
diagnosis, which will allow better diagnosis and treatment of UTI and ABU patients.
Funding: JSPS KAKENHI Grant Number JP18K09190, GSK Japan Research Grant 2015
PS02.05
Different protein profile and host immune response induced by extracellular vesicles
from Enterococcus faecium cultured with or without antibiotics
Mi Hyun Kim
a, Se Yeon Kima, Seung Il Kimb, Joo Hee Sona and Je chul Lee
c
aDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu,
Republic of Korea; bDrug & Disease Target Team, Korea Basic Science Institute, Ochang,
Republic of Korea; cDepartment of Microbiology, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea
Introduction: Vancomycin-resistant Enterococcus faecium is of medical importance associated
with multidrug resistance and opportunistic infection. E. faecium produces extracellular
vesicles (EVs), but EV production in E. faecium under antibiotic stress condition
and their pathogenic roles have not been determined yet. This study investigated the
production of EVs in vancomycin-resistant E. faecium strain cultured with or without
the sub-minimum inhibitory concentrations (MICs) of vancomycin and linezolid, and
determined the pathogenic roles of EVs in colon epithelial Caco-2 cells.
Methods: The EVs were purified from vancomycin-resistant E. faecium ATCC 700221 cultured
with or without the 1/2 sub-MICs of vancomycin and linezolid. Caco-2 cells were incubated
with E. faecium EVs and then analysed for cytotoxicity and pro-inflammatory cytokine
gene expression.
Results: E. faecium ATCC 700221 produced EVs during in vitro culture. E. faecium cultured
with 1/2 sub-MIC of vancomycin and linezolid produced 4.5 and 2 times more EV proteins
than bacteria cultured without antibiotics, respectively. A total of 438, 461 and
513 proteins were identified in the EVs isolated from E. faecium cultured in brain
heart infusion (BHI) broth (EVs/BHI), EVs from E. faecium in BHI broth with 1/2 sub-MIC
of vancomycin (EVs/VAN) and EVs from E. faecium in BHI broth with 1/2 sub-MIC of linezolid
(EVs/LIN), respectively. EVs/BHI induced cytotoxicity and stimulated the expression
of pro-inflammatory cytokine and chemokine genes in Caco-2 cells in a dose-dependent
manner. Moreover, EVs/LIN were more cytotoxic towards Caco-2 cells than EVs/BHI and
EVs/VAN, whereas EVs/VAN induced more pro-inflammatory cytokine and chemokine gene
expression in Caco-2 cells than EVs/BHI and EVs/LIN.
Summary/Conclusion: The sublethal dose of antibiotics modulates the EV biogenesis
in E. faecium. EVs produced by E. faecium under different antibiotic stress condition
show different host cell responses, which plays a role in bacterial pathogenesis.
Funding: This work was supported by the National Research Foundation of Korea (NRF)
grant funded by the Korea government (NRF-2017R1A2A2A05001014).
PS02.06
The RNA profile of extracellular vesicles released from Trypanosoma brucei
Christian Preußer
a, Lee-Hsueh Hungb and Albrecht Bindereifb
aJustus Liebig University of Giessen, Institute of Biochemistry, Giessen, Germany;
bJustus Liebig University of Giessen, Institute of Biochemistry, Giessen, Germany
Introduction: Trypanosomes are unicellular eukaryotes, which are vector-borne ubiquitous
parasites of vertebrates and have a high impact on global health. The well-known Trypanosoma
brucei for instance is the causative agent of the human African trypanosomiasis, a
lethal tropical disease, and the nagana-cattle disease in domestic livestocks in sub-Saharan
Africa. Besides this, trypanosomes have become an important model organism, because
of various biochemical and cellular characteristics such as trans spliced mRNAs. As
other parasites, trypanosomes produce extracellular vesicles (EVs), which contribute
to parasite-host interactions. Here we analysed for the first time the RNA profile
from EVs produced by parasitic T. brucei.
Methods: We isolated EVs released from two different life cycle stages (procylic and
bloodstream) of T. brucei, using a combination of differential centrifugation, size
exclusion chromatography and ultracentrifugation. Subsequently we performed RNA-seq
analysis of long RNAs (>200 nts) and small RNAs (<200 nts), followed by bioinformatic
identification; validation of trypanosome and EV-associated RNAs was based on quantitative
RT-PCR.
Results: Our analysis of RNAs revealed different RNA species in trypanosome-derived
vesicles. Interestingly, we observed specific release of fragments from certain mRNAs
into the vesicles, whereas metabolically important mRNAs were retained in the parasite,
suggesting a role in RNA disposal. We are currently comparing the mammalian- and insect-specific
life cycle stages of the parasites, which should further clarify a potential functional
role of vesicle-mediated host-parasite interactions.
Summary/Conclusion: Trypanosome-derived extracellular vesicles contain several RNA
species, which are selectively released, representing a class of diagnostic biomarkers
for diseases caused by these parasites.
Funding: LOEWE Center DRUID (Novel Drug Targets against Poverty-Related and Neglected
Tropical Infectious Diseases).
PS02.07
Host immune response induced by outer membrane vesicles derived from Burkholderia
cepacia cultured with different antibiotics
Se Yeon Kim
a, Mi Hyun Kima, Joo Hee Sona, Seung Il Kimb and Je chul Leec
aDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu,
Republic of Korea; bDrug & Disease Target Team, Korea Basic Science Institute, Ochang,
Republic of Korea; cDepartment of Microbiology, School of Medicine, Kyungpook National
University, Daegu, Republic of Korea
Introduction: Burkholderia cepacia is an opportunistic pathogen that usually infects
the patients with cystic fibrosis or indwelling hardware. This study investigated
the production of outer membrane vesicles (OMVs) in B. cepacia strain cultured with
the sub-minimal inhibitory concentrations (MICs) of antibiotics and their pathogenic
roles in vitro and in vivo.
Methods: OMVs were purified from the culture supernatants of B. cepacia ATCC 25416
cultured with the 1/4 sub-MICs of ceftazidime (CAZ), trimethoprim/sulfamethoxazole
(SXT) or meropenem (MEM). A549 cells were incubated with B. cepacia OMVs and then
analysed for cytotoxicity and pro-inflammatory cytokine gene expression. Mice were
treated with B. cepacia OMVs intratracheally, and lung pathology was evaluated.
Results: B. cepacia produced OMVs during in vitro culture. A total of 265 proteins
were identified in OMVs isolated from B. cepacia cultured in Luria-Bertani broth (OMVs/LB)
using proteomic analysis. OMVs/LB induced cytotoxicity and stimulated the expression
of pro-inflammatory cytokine genes in lung epithelial A549 cells in a dose-dependent
manner. B. cepacia produced more OMVs under antibiotic stress condition than under
no antibiotic condition. Host cell cytotoxicity and pro-inflammatory response were
significantly higher in A549 cells treated with OMVs from B. cepacia cultured with
1/4 sub-MIC of CAZ (OMVs/CAZ) than in the cells treated with OMVs/LB, OMVs from B.
cepacia cultured with 1/4 sub-MIC of SXT (OMVs/SXT) or OMVs from B. cepacia cultured
with 1/4 sub-MIC of MEM (OMVs/MEM). Intratracheal injection of OMVs/LB, OMVs/MEM,
and OMVs/CAZ induced histopathology and pro-inflammatory responses in the mouse lung,
but OMVs/SXT did not induce pro-inflammatory responses in the mouse lung. The expression
of the interleukin-1β and GRO-α genes was significantly higher in the mice treated
with OMVs/CAZ than the mice treated with other OMVs.
Summary/Conclusion: OMVs produced by B. cepacia exposed to different antibiotics represent
different host cell responses, which may modulate influence on the bacterial pathogenesis.
Funding: This work was supported by the National Research Foundation of Korea (NRF)
grant funded by the Korea government (NRF-2017R1A2A2A05001014).
PS02.08
Thymol suppresses the inflammatory responses induced by Staphylococcus aureus-derived
extracellular vesicles in cultured keratinocytes
Joo Hee Son
a, Se Yeon Kima, Mi Hyun Kima, Sang Hyun Kimb and Je chul Leec
aDepartment of Microbiology, School of Medicine, Kyungpook National University, Daegu,
Republic of Korea; bDepartment of Pharmacology, Kyungpook National University, School
of Medicine, Daegu, Republic of Korea; cDepartment of Microbiology, School of Medicine,
Kyungpook National University, Daegu, Republic of Korea
Introduction: Staphylococcus aureus-derived extracellular vesicles (EVs) deliver effector
molecules to host cells and induce host cell pathology. This study investigated whether
thymol could disrupt S. aureus EVs and suppress the pathology of the keratinocytes
induced by S. aureus EVs.
Methods: Membrane disruption of the S. aureus EVs treated with thymol was determined
using transmission electron microscopy. Human keratinocyte HaCaT cells were incubated
with either intact or thymol-treated S. aureus EVs and then analysed for cytotoxicity
and pro-inflammatory cytokine gene expression.
Results: Thymol inhibited the growth of S. aureus strains and disrupted the membranes
of the S. aureus EVs. Thymol-treated S. aureus EVs inhibited the cytotoxicity of HaCaT
cells when compared to intact S. aureus EVs; however, the cytoprotective activity
differed between the EVs derived from S. aureus strains. Intact S. aureus EVs stimulated
the expression of the pro-inflammatory cytokine and chemokine genes in keratinocytes.
The expression levels of the cytokine genes differed between thymol-treated EVs from
different S. aureus strains, but thymol-treated S. aureus EVs suppressed the expression
of these genes. Thymol-treated S. aureus EVs delivered lesser amounts of the EV component
to host cells than intact EVs.
Summary/Conclusion: Our results suggest that the thymol-induced disruption of the
S. aureus EVs inhibits the delivery of effector molecules to host cells, resulting
in the suppression of cytotoxicity and inflammatory responses in keratinocytes. Thymol
may attenuate the host cell pathology induced by an S. aureus infection via both the
antimicrobial activity against the bacteria and the disruption of the secreted EVs.
Funding: This work was supported by the National Research Foundation of Korea (NRF)
grant funded by the Korea government (NRF-2017R1A2A2A05001014).
PS02.09= OWP2.09
Deciphering the role of extracellular vesicles on the blood–brain barrier during Zika
virus infection
Antonios Fikatas, Sam Noppen, Peter Vervaeke, Jordi Doijen, Mohammed Benkheil, Christophe
Pannecouque and Dominique Schols
Laboratory of Virology and Chemotherapy, Rega Institute, KU Leuven, Belgium, Leuven,
Belgium
Introduction: The association of Zika virus (ZIKV) with severe neurological disorders
has gained increased interest over the last decade. However, the mechanism by which
ZIKV crosses the blood–brain barrier (BBB) and reaches the brain remains to be elucidated.
It is known that viruses incorporate viral material in extracellular vesicles (EVs)
as a spreading strategy. These membrane-enclosed vesicles play a vital role in intercellular
communication. Currently, there is a lack of knowledge on the possible involvement
of EVs in ZIKV pathogenesis. Our study aims to unravel the role of EVs in ZIKV RNA
transmission to the brain, via the BBB.
Methods: Human brain microvascular endothelial cells (HBMEC/D3) were used in our study
since they represent the BBB in vitro. Three different EV isolation methods (precipitation
kit, density gradient and size exclusion chromatography combined with the density
gradient) were performed. Western blot, Transmission electron microscopy and Nanosight
tracking analysis confirmed the presence of EVs in the supernatant of HBMEC/D3 cells.
The presence of ZIKV RNA in infected-EVs (IEVs) was evaluated by immunofluorescence
and qPCR. In addition, the effect of IEVs on the BBB was assessed using a label-free
impedance-based biosensor (ECIS, Applied BioPhysics).
Results: We confirmed the presence of viral components in our IEVs, including the
NS1 and E proteins of ZIKV. The obtained IEVs were able to re-infect susceptible cells,
even after being pretreated with RNase A. This indicates that the viral RNA resides
inside the IEVs. Using impedance measurements on HBMEC/D3 cell monolayers, we observed
that IEVs, as well as virus control caused similar and temporal disturbances on the
monolayer’s integrity within 30 min post infection. No disturbances were seen upon
addition of non-infected EVs.
Summary/conclusion: Our study demonstrates that EVs-derived from ZIKV-infected cells
are able to transfer proteins and viral RNA to recipient cells. Since both IEVs and
viral particles can induce similar changes on barrier’s integrity it is possible that
IEVs are involved in an alternative mechanism of ZIKV transmission.
PS02.10=OWP2.11
In vivo testing of OMV-based vaccine prototypes against Gallibacterium anatis
Fabio Antenucci
a, Homa Arakb, Jianyang Gaob, Toloe Allahghadryb, Ida Thøfnerb and Anders Miki Bojesenc
aUniversity of Copenhagen, København S, Denmark; bUniversity of Copenhagen, Copenhagen,
Denmark; cUniversity of Copenhagen, Copenhagen, USA
Introduction: Outer membrane vesicles (OMVs) are produced by the majority of Gram-negative
bacteria. Thanks to the antigenic similarity between OMVs and the bacterial outer
membrane, OMVs have proven to be promising for the development of novel vaccines against
bacterial pathogens. In this work, we describe the testing of OMV-based vaccine prototypes
against Gallibacterium anatis, a Gram-negative pathogen of great veterinary interest.
Methods: OMVs were isolated from a G. anatis hypervesiculating mutant using a modified
version of the Hydrostatic Filtration protocol described by Musante et al. (2014).
120 16-week-old Lohmann-Brown chickens were divided in six groups and immunized twice
intramuscularly with different combinations of buffer (controls), OMVs and selected
recombinant immunogens. Two weeks after second immunization, the effectiveness of
the immunization regimes adopted was tested by challenging the animals intraperitoneally
with live CFUs from a heterologous G. anatis strain. One week post-challenge, the
animals were sacrificed and an established lesion score model was used during necropsy
to evaluate the clinical outcome of infection.
Results: Statistical analysis of the recorded lesion scores showed that the group
immunized with G. anatis OMVs presented an average total score of 2.95, as opposed
to an average total score of 8.77 in the control group. The approximately threefold
reduction in total average lesion score observed demonstrates that immunization with
G. anatis OMVs is able to effectively decrease the morbidity of G. anatis infection
in the immunized animals.
Summary/conclusion: Our results show that G. anatis OMVs represent a promising candidate
for the development of cost-effective vaccination strategies for the prevention of
G. anatis infections in a cross-serovar manner. Accordingly, we hypothesize that dose/response
optimization and the enrichment of G. anatis OMVs with selected immunogens should
result in an improvement of the effectiveness of the vaccination regime proposed.
Funding: This research project is being funded by a grant from Huvepharma (https://www.huvepharma.com/).
PS03: EVs in Cardiovascular Disease Chairs: Oh Youn Kim; Caroline ReddelLocation:
Level 3, Hall A15:00–16:00
PS03.01
Serum exosome mediates chronic intermittent hypoxia-associated endothelial dysfunction
through regulating miR-144, −27a/Nrf2 pathway
Huina Zhang
Beijing An Zhen Hospital, Capital Medical University, Beijing, China (People’s Republic)
Introduction: Endothelial dysfunction plays a crucial role in the development of OSAHS-related
vasculopathy, but the mechanisms are not fully understood. Exosomes, abundant in blood,
deliver various molecules to recipient cells. However, whether serum exosomes (SExos)
are involved in chronic intermittent hypoxia (CIH)-associated vasculopathy is largely
unknown.
Methods: SExo was purified by ultracentrifugation. TEM and NTS were used to evaluate
the purity of exosome. Myograph was used to detect endothelial function. Western blotting
and quantitative polymerase chain reaction (qPCR) were used to measure the expression
of protein or miRNA respectively. Confocal microscopy was used to detect the signal
of exosome or oxygen free radical in endothelial cells.
Results: Endothelial dysfunction caused by CIH was related with oxidative stress.
Furthermore, SExos from CIH mouse (CIH SExos) severely impaired endothelial function
and enhanced the oxygen free radical in endothelial cells from normal C57BL/6 mice.
Western blotting showed that the expression of antioxidant transcription factor Nrf2
and its downstream target catalase were significantly decreased in CIH SExos-treated
endothelial cells ex vivo or in vitro. qPCR assay showed significant increasement
of exosomal miR-27a and miR-144 under CIH status. Correspondingly, silencing miR-144
and miR-27a with CIH SExo-packaged antagomiR-27a and antagomiR-144 confirmed the pivotal
role of SExo miR-27a and miR-144 in CIH SExo-inhibited Nrf2 expression, CIH SExo-induced
endothelial dysfunction and the excess oxygen free radical generation in endothelial
cells.
Summary/Conclusion: This study demonstrates the adverse effect of CIH SExo on endothelial
cells, representing a novel cellular mechanism of exosomal miR-27a, −144/Nrf2 pathway
that mediates the development of CIH-associated endothelial dysfunction.
Funding: This study was supported by National Natural Science Foundation of China
(No.81471082, 31741064 and 81470567)
PS03.02
Influence of cardiovascular risk markers on numbers and characterization of circulating
extracellular vesicles
Ruihan Zhou, Dionne Tannetta, Plinio Ferreira; Esra Bozbas, Jon Gibbins, Chris Jones
and Parveen Yaqoob
University of Reading, Reading, UK
Introduction: Extracellular vesicles (EVs) are small plasma membrane-derived vesicles
released from various cells, which potentially affect many pathophysiological processes
involved in cardiovascular diseases (CVDs). However, there is little information about
the relationship between gender, CVD risk markers (Body Mass Index (BMI), blood pressure
(BP), triglyceride level, cholesterol level and HDL level), CVD risk score and circulating
EVs.
Methods: Subjects (n = 27) aged 40–70 years with moderate risk of CVDs (QRISK2 score)
were recruited and assessed for BMI, BP and blood lipid profile. EVs were isolated
from platelet-free plasma by size exclusion chromatography and analysed by nanoparticle
tracking analysis (NTA) and flow cytometry (FCM). NTA measured the concentration and
size distribution of EVs, and EVs were phenotyped by FCM via a 3-colour panel, including
Annexin V (for the majority of circulating EVs), CD41 (for platelet-derived EVs) and
CD105 (for endothelial-derived EVs).
Results: • Subjects unexpectedly fell into two clear groups: high EVs group (total
EV numbers: 4*10^10/mL blood ~ 8*10^10/mL blood, n = 9 or Annexin V+ EV numbers: 2.6*10^7/mL
blood ~ 5*10^7/mL blood, n = 17) and low EVs group (total EV numbers: 1*10^10/mL blood
~ 3.9*10^10/mL blood, n = 18 or Annexin V+ EV numbers: 9*10^6/mL blood ~ 2.5*10^7/mL
blood, n = 10).
• Males accounted for 78% of the subjects in high total EVs group. Overweight subjects
(BMI ≥ 24.9 kg/m^2) contributed to 89% of the subjects with high total EV numbers,
while 93% of the subjects with normal weight were classified into low EVs group. The
high Annexin V+ EVs group had significantly higher diastolic BP levels (p = 0.02)
and higher cholesterol levels (p = 0.03) than those with low EV numbers. Those with
higher total EV numbers had a higher average CVD risk score (p = 0.02).
• Overweight subjects had a significantly higher number of endothelial-derived EVs
than subjects with normal weight (p = 0.02).
Summary/Conclusion: The majority of subjects with high total EV numbers were male.
Overweight contributed to the elevation of total EV and endothelial-derived EV numbers.
Higher BP level, cholesterol level and CVD risk score were associated with higher
numbers of circulating EVs.
Funding: This project is supported by Biotechnology and Biological Sciences Research
Council (BBSRC)–Diet and Health Research Industry Club in UK
PS03.03
Changes in exosome release in ageing: a pilot study in a human model of ischemia reperfusion
Ying Qiu Zhou
a, Liem Nguyena, Michael Madanib, Victor Pretoriusb, Hemal Patelb and David Rotha
aUniversity of California, San Diego, USA; bUniversity of California, San Diego, La
Jolla, USA
Introduction: The growing aged population necessitates better understanding of cellular
and physiological changes in ageing to improve future healthcare delivery and cost.
The role of exosomes, extracellular vesicles carrying biologically active cargo secreted
by almost all cells, may have major impacts on perioperative care and monitoring.
Deep hypothermic circulatory arrest (DHCA) is a profound perioperative stress event
involving hypothermia, arrest of circulation to major organ systems and whole body
ischaemia reperfusion. DHCA is used during pulmonary thromboendarterectomy, for which
the University of California, San Diego, USA, serves as a leading centre. With a patient
age range of 14–80 years old, we use DHCA as a model of whole body ischaemia reperfusion
to test the novel hypothesis that DHCA alters the amount of exosome release, content
and ability of exosomes to affect cellular metabolism and function in an age-dependent
manner.
Methods: Plasma was obtained from patients undergoing DHCA: after induction of anaesthesia
(baseline), at initiation of cardiopulmonary bypass (CPB), completion of cooling,
after circulatory arrests and at chest closure. Exosomes were isolated with ExoQuick.
Nanoparticle tracking analysis (NTA) measured particle concentration. Immunoblotting
and electron microscopy confirm the presence of exosomes. Samples were stored for
proteomic, microRNA and in vitro analysis.
Results: Mean particle sizes at each time point were within the known size distribution
of exosomes. Particle concentration at the completion of cooling was decreased from
baseline. Thereafter, particle concentration showed an increase after DHCA and a further
increase during chest closure at the conclusion of the surgery.
Summary/Conclusion: Our data show that cooling can decrease exosome levels in blood,
while whole body ischaemia reperfusion associated with DHCA in patients may be a stimulus
for exosome release. As more samples are collected, we will assess changes in the
proteome and microRNA content of exosomes before and after DHCA as a function of age.
This model also lends itself well to further detailed investigation of tissue and
organ-specific responses to ischaemia reperfusion in young and aged patients.
Funding: This work was funded by the National Institutes of Health, USA.
PS03.04
Intracardiac extracellular vesicle release in post-infarction diabetic hearts
Stephane Mazlan
a, Vincent Duvala, Cecile Devuea, Michael Robillarda, Chantal Boulangerb, Jean-Sebastien
Silvestrea and Xavier Loyera
aINSERM, Paris, France; bINSERM ‘ParCC’ Paris-Cariovascular Research Center, Hôpital
Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, and Université Sorbonne,
Paris, France
Introduction: Cardiovascular disease (CVD) is the main cause of death in non-communicable
diseases. In response to myocardial infarction (MI), extracellular vesicles (EVs),
including large (lEVs) and small (sEVs), are released within and from the heart to
facilitate intercellular communication and maintain cardiac homeostasis. As diabetes
increases the risk of CVD, the purpose of the study was to investigate how diabetes
influences the release of intracardiac EVs after MI.
Methods: C57BL/6J male mice were fed normal chow diet or high-fat diet (HFD) for 3 months.
HFD-fed mice were glucose intolerant as attested by the measure of GTT above 200 mg/mL.
Mice were then subjected to MI by permanent ligation of the left anterior descending
artery, and sham animals underwent similar surgical procedure without ligation. Left
ventricles from sham or MI mice were then harvested at either 15, 24, 48 or 72 h after
surgery (n = 5 per group at each time point) and processed for EV extraction by differential
centrifugation. lEVs and sEVs were then quantified and analysed via Tunable Resistive
Pulse Sensing Technology (TRPS), flow cytometry and Western blot.
Results: In chow diet-fed mice, release of both lEVs and sEVs was increased at 24
h post-surgery when compared to shams. These findings were in agreement with previous
data obtained in younger control animals. In diabetic mice, lEVs peaked at 24 h post-MI
and this increase was slightly greater than that observed in chow diet-fed animals.
However, there were no differences in sEV release between sham and MI diabetic mice.
TRPS analysis revealed that diabetes does not change EV size (diameter) and population.
Furthermore, both control and diabetic-derived EVs harboured cardiomyocyte marker
(Troponin T) as revealed by Western blot.
Summary/Conclusion: Our results thus show that diabetes modulates the release of both
large and small intracardiac EVs after MI. Further work will be needed to fully investigate
the functional impact of cardiac EVs in the diabetic heart after MI.
Funding: INSERM and ANR-16-CE92-0032-02
PS03.05
Exosomal low-density lipoprotein receptor (LDLR) as a potential biomarker in patients
with coronary artery disease
Dapi Meng Lin. Chiang
a, Liv Weichien Chenb, Michael Pfafflc and Chin-Sheng Linb
aBiovesicle, Taipei, Taiwan (Republic of China); bDivision of Cardiology, Tri-Service
General Hospital, Taiwan & National Defense Medical Center, Taipei City, Taiwan (Republic
of China); cAnimal Physiology and Immunology, School of Life Sciences Weihenstephan,
Technical University of Munich, Freising, Germany
Introduction: Atherosclerosis is one of the key factors contributing to cardiovascular
disease. Exosomes have been documented to be associated with atherosclerosis pathogenesis.
However, the potential exosome-related biomarkers in atherosclerosis patients has
not been analysed and characterized yet. In this study, we aimed for assessing the
potential biomarker in serum exosome for coronary artery disease (CAD).
Methods: Plasma samples were collected from patients undergoing coronary angiography.
To assess exosomal low-density lipoprotein receptor (LDLR) and ATP-binding cassette
transporter A1 (ABCA1) expression, we isolated exosome by incubating glycan recognition
beads, EXÖBead (Biovesicle) with 250 µL pre-cleared plasma from healthy donors (n = 28)
and CAD patients (CADs, n = 26) as manufacturer’s protocol. To confirm the purity
of our isolation, we used NTA and TEM to demonstrate exosome morphology and size distribution,
according to the MISEV guidelines. Exosomal LDLR and ABCA1 protein expressions were
analysed by flow cytometry, FACS. Furthermore, the exosome specific markers CD9, CD63
and CD81 were simultaneously detected in exosome-EXÖBead complexes by multiple fluorescent
antibody staining and FACS. We incorporated 10% exosome-free “foetal bovine serum”
in PBS as the antibody staining negative control.
Results: The exosome size distribution and morphology were similar between the plasma
sample from healthy and CAD groups. The geometric mean fluorescence intensity, MFI
of CD9, CD63, CD81, LDLR and ABCA1 were not different between these two groups. However,
the corrected MFI ratio of LDLR/CD9 in healthy donors was significantly higher compared
to CAD patients (p = 0.044). Similar significant changes in ratio of LDLR/CD63 (p = 0.026)
and LDLR/CD81 (p = 0.027) were also observed. Besides, there is no significant change
in exosomal ABCA1 between healthy donors and CAD patients.
Summary/Conclusion: Declined expressions of LDLR/exosome in patients with CAD were
observed in our study. These results may be an essential clue for exploring the function
of exosomal LDLR in lipid metabolism and atherosclerosis. Further approaches regarding
cell-to-cell communication of exosomal LDLR will be addressed in the future.
PS03.06
Therapeutic EV rescue a deficient hypoxic response in pulmonary arterial hypertension
David Marciano, Rebecca Harper, Vignesh Viswanathan, Marlene Rabinovitch and Michael
Snyder
Stanford University, Stanford, USA
Introduction: Complex gene-environment interactions can determine the penetrance of
a genetic mutation leading to disease. Pulmonary arterial hypertension (PAH) is a
lethal disease that is highly associated with loss-of-function bone morphogenetic
protein receptor II (BMPR2) mutations and persistent hypoxic stress. While these genetic
and environmental determinants of PAH are clearly defined, little is known about how
they are interconnected to potentiate disease.
Methods: Pulmonary arterial endothelial cells (PAEC) were exposed to hypoxia (0.5%
O2) for 24 h and culture media collected. Extracellular vesicles (EVs) were isolated
using differential ultracentrifugation and characterized with electron microscopy
and nanoparticle analysis. qPCR analysis after RNAse digestion was performed to identify
packaged mRNA. EV treatment of mice was administered via tail-vein injection. In vivo
biodistribution was visualized by Gallium-68 labelling coupled with positron emission
tomography (PET) imaging.
Results: Here we report that BMPR2 is induced by hypoxia in PAEC, and loss of BMPR2
partially blocks the release of extracellular vesicles under these conditions. EVs
derived from hypoxic PAEC are enriched with BMPR2 mRNA and can restore abnormal phenotypes
in BMPR2 mutant cells in vitro. BMPR2 knockout mice exposed to intermittent hypoxia
develop PAH phenotypes that are prevented by treatment with hypoxic PAEC derived EV.
Summary/Conclusion: These results show that PAEC-derived EVs are critical for the
maintenance of vascular homeostasis, loss of this signal due to BMPR2 dysfunction
contributes to PAH pathogenesis, and replacement with exogenous EV has therapeutic
potential in PAH.
Funding: F32 HL 132452, NIH NHLBI
PS03.07
Role of extracellular vesicles in cardiovascular toxicity induced by BCR-ABL tyrosine
kinase inhibitors
Dakota D. Gustafson
a, Nazanin Aghelb, Jason Fishc, Diego Delgadob and Jeff Liptond
aDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto,
ON, Canada; bPeter Munk Cardiac Centre, Toronto, Canada; cToronto General Hospital
Research Institute, University Health Network, Toronto, ON, Canada; dPrincess Margaret
Cancer Centre, Toronto, Canada
Introduction: Despite their efficacy as an anti-cancer therapeutic against chronic
myelogenous leukaemia (CML), tyrosine kinase inhibitors (TKIs) can be associated with
deleterious cardiovascular effects. Considerable progress has been made in identifying
the excess risk of cardiovascular events related to TKI exposure; however, the data
on the underlying mechanisms and possible predictive biomarkers are currently inadequate.
To this end, we sought to examine EV-associated miRNAs as a means of elucidating their
potential as effectors and biomarkers of TKI-induced cardiovascular toxicity in CML.
Methods: We obtained informed consent and recruited 24 age- and sex-matched response
stable CML patients either off-TKI (median 32.26 months, n = 6) or on long-term treatment
with imatinib, nilotinib or ponatinib (median 79.01 months, n = 6/group), and assayed
plasma-derived EV-associated miRNAs using the nCounter® Analysis System. Concurrently,
in vitro studies were conducted to examine the responses of iPSC-derived human cardiomyocytes
to plasma-derived EVs using BNP as a surrogate marker of the cardiovascular stress
response. Consent was obtained by the University Health Network Research Ethics Board.
Results: We identified selective dysregulation in each treatment group associated
with CML and as well as specific cardiovascular pathophysiology, e.g. miR-let-7e-5p,
miR-502-5p and miR-548a-5p (p < 0.05). In vitro, we identified a surprising cardioprotective
action of ponatinib-patient EVs on cardiomyocytes, indicated by a significant decrease
in free BNP in the media of cardiomyocytes treated with EVs compared to other treatment
arms (p < 0.01).
Summary/Conclusion: This study represents a novel approach investigating the utility
of EVs and their associated miRNAs as biomarkers and effectors of TKI-induced cardiovascular
toxicity. Our results highlight a distinct profile of miRNAs associated with TKI treatment.
Understanding the complex role of EVs in TKI therapy will elucidate the complexities
of cardiovascular toxicity and aid in tailoring the risk management of individual
patients.
Funding: This project was funded by the Princess Margaret Cancer Centre.
PS03.08
Extracellular vesicles derived from genetically modified human induced pluripotent
stem cells enhance cardiomyogenesis and angiogenesis in vitro and in vivo
Katarzyna Kmiotek-Wasylewska, Sylwia Bobis-Wozowicz, Anna Labedz-Maslowska, Elzbieta
Karnas, Zbigniew Madeja and Ewa Zuba-Surma
Department of Cell Biology, Faculty of Biochemistry, Biophysics and Biotechnology,
Jagiellonian University, Krakow, Poland
Introduction: Extracellular vesicles (EVs) represent population of small circular
membrane vesicles secreted by most cells including stem cells (SCs). It has been reported
that EVs may carry bioactive cargo including proteins, microRNAs and mRNAs. They also
play a crucial role in cell-to-cell communication in both physiological and pathological
conditions.
The aim of this study was to verify the impact of EVs derived from human induced pluripotent
stem (iPS) cells (hiPS-EVs) overexpressing procardiomyogenic miR1 or miR199a, or proangiogenic
miR126, on various properties of human cardiac and endothelial cells.
Methods: hiPS-EVs were isolated from conditioned hiPS culture media by differential
centrifugation including ultracentifugation. Cardiac cells and endothelial cells were
used as target cells in vitro, and their functional properties were evaluated after
hiPS-EVs treatment. The regenerative capacity of hiPS-EVs was also examined in vivo
– in murine model of acute limb ischaemia (LI).
Results: Our data indicate that hiPS-EVs carrying procardio- and proangiogenic miRNAs
may protect cardiac cell types from apoptosis as well as enhance their proliferation,
metabolic activity, migration and cardiomyogenic differentiation. The hiPS-EVs enhanced
also proangiogenic capacity, migration and metabolic activity of HCAEC cells in vitro.
The vesicles also promoted angiogenesis and increased blood flow recovery in murine
ischaemic limb injury model in vivo.
Summary/Conclusion: These results may indicate (i) feasibility of genetic modifications
of EVs enforcing their regenerative proprieties as well as (ii) enhanced activity
of EVs from hiPS cells overexpressing miR1, miR199a and miR126 in regeneration of
ischaemic tissues. We conclude that EVs from genetically modified hiPS cells may represent
new safe tool for tissue repair alternative to whole-cell therapies in vivo.
Funding: This study was funded by NCN and NCBR grants: SONATA BIS-3 (UMO-2013/10/E/NZ3/007500)
and STRATEGMED III (STRATEGMED3/303570/7/NCBR/2017) to EZS and PRELUDIUM-11 (UMO-2016/21/N/NZ3/00363)
to KKW.
PS03.09
Cardioprotective and proangiogenic potential of small extracellular vesicles secreted
from amniotic fluid stem cells
Kaloyan Takov
a, Filipa Vlahovab, Pascale Guillotb, Derek Yellona and Sean Davidsona
aThe Hatter Cardiovascular Institute, University College London, London, UK; bInstitute
for Women’s Health, University College London, London, UK
Introduction: Mesenchymal stem cells (MSCs) exhibit antiapoptotic and proangiogenic
functions in models of myocardial infarction, a common cause of death and disability.
These effects are partially mediated by secreted small extracellular vesicles (sEVs).
Amniotic fluid stem cells (AFSCs) are foetal MSCs with superior functional potential
to adult MSCs. We hypothesized that sEVs released by AFSCs are cardioprotective and
proangiogenic.
Methods: Human AFSC sEVs were isolated from serum-free conditioned medium by size-exclusion
chromatography and characterized using nanoparticle tracking, dot blots, protein and
immunoassays, electron microscopy and protein arrays. Their cardioprotective potential
was examined in models of hypoxia/reoxygenation- and reactive oxygen species-induced
death of primary adult rat cardiomyocytes in vitro. AFSC sEV effects on human endothelial
cell migration, proliferation and signalling pathway activation were also investigated
(using Boyden’s Chamber assay, MTT assay and western blot analysis/phosphokinase arrays,
respectively).
Results: Isolated AFSC sEVs were CD9/CD63/CD81-positive and of high purity (up to
1.2x10^10 particles/µg protein). These vesicles were not cardioprotective in models
of simulated ischaemia/reperfusion injury in primary cardiomyocytes in vitro. Nevertheless,
AFSC sEVs carried promigratory cytokines and angiogenic factors (e.g. SDF-1, MIF,
PTX3) and promoted endothelial cell migration and proliferation in vitro. Pharmacological
inhibition of PI3K (a promigratory signalling pathway) in target endothelial cells
reduced sEV-stimulated migration by 54 ± 15% (p < 0.001). However, sEVs did not induce
phosphorylation of downstream PI3K targets, indicating that sEV effects may be multifactorial
and may involve multiple pathways.
Summary/Conclusion: AFSC sEVs did not have direct protective effects on cardiomyocytes
in vitro but possessed proangiogenic potential which requires, but is not solely dependent
on, PI3K signalling. Ongoing experiments include analyses of the sEV proteome, their
cardioprotective properties in a model of rat myocardial ischaemia/reperfusion injury
in vivo and their role in capillary sprouting from rat aortic explants. Together,
these data will define the potential for using AFSC sEVs as cardioprotective and proangiogenic
therapy.
Funding: BHF
PS03.10
CystatinC and CD14 in plasma extracellular vesicles are associated with both renal
dysfunction and heart failure in patients presenting with dyspnoea
Mirthe Dekker
a, Farahnaz Waissib, Laura Verbree, Irwani Ibrahim, Shirley Ooi, Jiong-Wei Wangc,
Win Kuand, Siew Chanc, Linda Peelene, Diederick Grobbee, A. Mark Richards, Carolyn
Lam, Ya-Nan Zhang, Muhammad I Mazlan, Dominique de Kleijnf
aUMC Utrecht, Utrecht, Netherlands; bUMC Utrecht, Utrecht, Netherlands; cNational
University of Singapore, Singapore; dNational University Hospital, Singapore; eJulius
Center for Health Sciences and Primary Care UMC Utrecht, Utrecht, Netherlands; fUMCU,
Utrecht, Netherlands
Introduction: Heart failure and renal failure commonly coexist: heart failure patients
have higher chance of developing renal failure and vice versa.1,2 Declines in renal
function are associated with the development of ventricular dysfunction and worsen
prognosis in heart failure.3,4 However, underlying pathophysiological mechanisms in
cardiac-renal cross talk are not fully understood1. The role of plasma extracellular
vesicles (EVs) in combined organ failure such as cardiorenal syndrome has not been
investigated. The primary aim of this study is to investigate if the extracellular
vesicle proteins CystatinC, CD14, SerpinG1 and SerpinF2 that have been associated
with heart failure are also associated with renal dysfunction in patients with acute
dyspnoea.
Methods: Blood samples were prospectively collected in 404 patients presenting with
breathlessness at the emergency department at National University Hospital, Singapore.
Renal dysfunction was defined as estimated glomerular filtration rate below 60 mL/min/1.73m2.
The presence of heart failure was independently adjudicated by two clinicians. EVs
were precipitated in 3 sub-fractions from the plasma using dextrane sulphate for the
LDL and HDL plasma-subfractions or ExoQuick. After precipitation, the EVs were lysed
and the four selected proteins were measured quantitatively using immunobead assays
and tested for their associations with renal dysfunction, heart failure and the concurrence
of both conditions using multinomial regression analysis.
Results: CystatinC was associated with renal dysfunction, heart failure and their
combination in all three EV-sub-fractions and in plasma. CD14 was associated with
both renal dysfunction and the combined renal dysfunction and heart failure in all
EV-sub-fractions, and with the presence of heart failure in the HDL-sub-fraction but
these associations were only seen in the EV subfractions and not in plasma.
Summary/Conclusion: We provide the first data showing that EV CystatinC and CD14 are
associated with both renal dysfunction and heart failure in patients presenting with
acute dyspnoea. These data suggest that extracellular vesicle proteins may be involved
in the combined organ failure of the cardiorenal syndrome, and represent possible
targets for prevention or treatment.
PS03.11=OWP1.03
Identification of extracellular vesicles as biomarkers for myocardial infraction by
flow cytometry and automated data processing
Aleksandra Gasecka
1; Edwin van der Pol2; Frank Coumans3; Kinga Pluta4; Grzegorz Opolski4; Krzysztof
J. Filipiak5; Rienk Nieuwland3
11st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland;
2Amsterdam UMC, University of Amsterdam, Department of Biomedical Engineering and
Physics, Amsterdam, Netherlands, Amsterdam, Netherlands; 3Amsterdam UMC, University
of Amsterdam, Laboratory of Experimental Clinical Chemistry, Amsterdam, Netherlands,
Amsterdam, Netherlands; 41st Chair and Department of Cardiology, Medical University
of Warsaw, Poland, Warsaw, Poland; 51st Chair and Department of Cardiology, Medical
University of Warsaw, Poland, Warsaw, USA
Introduction: Acute myocardial infarction (AMI) is a major cause of death. To diagnose
AMI, measuring troponin concentration is the gold standard. Since troponin is unspecific
for AMI, novel biomarkers for AMI are urgently needed. After the onset of AMI, platelets,
endothelial cells and blood cells release specific extracellular vesicles (EVs). Our
aim is to identify these EVs as biomarkers for AMI diagnosis and treatment monitoring.
Methods: The study was approved by the medical ethics committee. Venous blood was
collected 24 hours, 72 hours and 6 months after AMI from fasting patients (n=60, 64.5±10.8
years, 68% male) and healthy controls (n=30, 57.7±6.6 years, 62% male). Flow cytometry
(Apogee A60 Micro) was used to determine plasma concentrations of EVs labelled with
antibodies for activated platelets (CD61, CD62p; PEVs), endothelial cells (CD146;
EEVs) and red blood cells (CD235a; RBC-EVs). Processing of 1,224 flow cytometry data
files was performed using in-house developed, automated software (MATLAB R2018a),
enabling flow rate stabilization, diameter and refractive index determination, MESF
calibration, fluorescent gate determination and statistics reporting.
Results: Between AMI patients and controls, PEV concentrations in plasma were comparable
(p=ns), EEV concentrations increased (p<0.0001), and RBC-EV concentrations decreased
(p<0.0001). Antiplatelet drug ticagrelor decreased concentrations of PEVs (p=0.03),
compared to less potent clopidogrel, but did not affect EEVs and RBC-EVs. In turn,
concentrations of EEVs, but not PEVs and RBC-EVs, positively correlated with the dose
of atorvastatin (p<0.001). The antioxidative β-blocker carvedilol increased concentrations
of RBC-EVs, compared to nebivolol (p=0.05), but did not affect PEVs and EEVs.
Summary/Conclusion: Flow cytometry and automated data processing were used to find
biomarkers for AMI based on EVs in plasma. During treatment, ticagrelor decreased
PEV concentrations, atorvastatin increased EEV concentrations, and carvedilol increased
RBC-EV concentrations, suggesting that EVs might be used to monitor AMI treatment.
AMI patients differed from controls regarding EEV and RBC-EV concentrations, but not
PEVs, likely because blood was collected 24 hours after the start of antiplatelet
therapy. In follow-up studies, it is crucial to collect blood prior to treatment.
PS04: Affinity and Microfluidic Separation Chairs: Kazunari Akiyoshi; Yanling CaiLocation:
Level 3, Hall A15:00–16:00
PS04.01
Isolation of extracellular vesicles from small volume of plasma by microfluidic aqueous
two phase system
Bohoon Han
a, Sumi Kima, Yeseong Choia, Seok Chungb and Ji Yoon Kanga
aKorea Institute of Science and Technology, Seoul, Republic of Korea; bKorea University,
Seoul, Republic of Korea
Introduction: Isolation of extracellular vesicles (EVs) from small volume of sample
is a major issue of point-of-care testing and it leads to great attention in microfluidic
device. However, previous microfluidic immunoaffinity approach has possibility of
the loss of EVs that might have more useful information due to heterogeneity of EVs.
In the case of microfluidic device applying external forces, has drawback in complicated
fabrication process and possibility in deformation of EVs. Therefore, this paper suggests
a microfluidic aqueous two phase system (ATPS) in isolation of EVs from stable laminar
two phase flow with just simple design of chip.
Methods: EV-protein mixture was tested to investigate the partitioning behaviour.
EVs were isolated by ultracentrifuge from human plasma, then bovine serum albumin
was added to prepare EV-protein mixture. Polyethylene glycol (PEG, 3.5 wt%) dissolved
in phosphate-buffered saline was injected to top and bottom inlet. Dextran (DEX, 1.5 wt%)
dissolved in sample was injected to middle inlet. Fluorescence intensities of EV and
albumin were imaged to investigate the partitioning behaviour in real time from EV-protein
mixture. Concentrations of collected EV and albumin were measured to confirm the fluorescence
imaging. Also, same experiment was performed with only PEG without dextran to investigate
the effect of ATPS. EV isolation from human plasma was also performed and characterized
by western blot and atomic force microscopy.
Results: Most of green EVs were remained in middle phase where red BSA seems almost
fully diffused out for the equilibrium state in fluorescence experiment. Microfluidic
ATPS could isolate the EV with 83.43% of recovery efficiency and protein removal of
65.46% from EV-protein mixture. Microfluidic without ATPS could isolate the EV with
recovery rate of 67.14%. Also, EVs were successfully isolated from human plasma with
almost same recovery rate.
Summary/Conclusion: The difference of diffusion velocity in laminar flow was dominant
factor in separating proteins from EVs in our microfluidic ATPS. Other body fluids
will be tested with our modified system. We expect that our device will provide more
useful application in isolation of EVs.
PS04.02
Extracellular vesicle-associated microRNAs show stronger correlations with cardiovascular
disease protein biomarkers than cell-free microRNAs in human plasma
Shi Chen
a, Shu-Chu Shieshb, Gwo-Bin Leec and Chihchen Chena
aInstitution of NanoEngineering and MicroSystems, National Tsing Hua University, Hsinchu,
Taiwan (Republic of China); bDepartment of Medical Laboratory Science and Biotechnology,
National Cheng Kung University, Tainan, Taiwan (Republic of China); cDepartment of
Power Mechanical Engineering, National Tsing Hua University, Hsinchu, Taiwan (Republic
of China)
Introduction: This abstract presents a high-efficiency method utilizing two sets of
magnetic beads to isolate extracellular vesicles (EVs) and EV-associated microRNAs
(EV-miRNAs) from human platelet-poor plasma samples. Our goal is to develop a platform
for risk assessment of cardiovascular diseases (CVDs) and compare the expression levels
of circulating cell-free miRNAs and EV-miRNAs. In contrast to the rapid peaking and
falling of cardiac troponin I (cTN-I), a conventional CVD biomarker, the level of
circulating miR-126 remains downregulated even one week after the onset of acute myocardial
infarction (AMI).
Methods: In this study, we first used anti-CD63 antibody-coated magnetic beads to
separate CD63+ EVs. EV-miRNAs were released after EV lysis and subsequently extracted
by using oligonucleotide-conjugated magnetic beads. Expression levels of cell-free
and EV-associated microRNAs in six clinical plasma samples were quantified using quantitative
reverse transcription polymerase chain reaction (RT-qPCR) with a spike-in exogenous
cel-miR-238 control.
Results: Experimental results showed the levels of miRNAs in CD63+ EVs were ~74% of
cell-free miRNAs in plasma, whereas the miRNA extraction efficiency was >87% and exhibited
no apparent dependence on the concentration of miRNA and the medium evaluated. Compared
with the levels of conventional CVD protein biomarkers, EV-derived miR-126 levels
were negatively correlated with N-terminal pro-b-type natriuretic peptide (NTproBNP)
and cTN-I levels with R^2 = 0.70 and R^2 = 0.61, respectively. In contrast, circulating
total miR-126 levels were only weakly correlated with these biomarkers (R^2 = 0.14,
R^2 = 0.02, respectively).
Summary/Conclusion: We have developed methods to isolate EVs from human plasma samples,
and subsequently to extract miRNAs carried by EVs by using two sets of magnetic beads.
Our preliminary results suggest that EV-associated miR-126 may serve as a better biomarker
than the total circulating miR-126. More clinical samples are currently being investigated.
Funding: Taiwan Ministry of Science & Technology (MOST 106–2221-E-007–003-, MOST 105–2221-E-007–009-,
and MOST 106–2221-E-007–002-) and the Taiwan Ministry of Education (Higher Education
Sprout Project: grant no. 107Q2713E1).
PS04.03
Effective separation of exosomes based on its surface sugar chains using a macroporous
spongy monolith
Takuya Kubo, Raga Ishikawa, Seiya Kato, Toyohiro Naito, Yoshihiro Sasaki, Kazunari
Akiyoshi and Koji Otsuka
Kyoto University, Kyoto, Japan
Introduction: The surface sugar chains on exosomes contribute the communication among
cells. But, in the present separation procedures, the effective separations of exosomes
based on the differences of sugar chains have never reported. We focus on a lectin
affinity chromatography (LAC) with a macroporous spongy monolith (1), which is suitable
for a high throughput and selective separations for biomolecules. In this study, we
prepared a few lectin-immobilized spongy-monolithic columns and evaluated for typical
LAC analyses. Additionally, the columns were applied for the separation of exomes
to determine the fundamental adsorption/desorption conditions.
Methods: Poly(ethylene-co-glycidylmethacrylate) (PEGM)-based spongy monolith (PEGM-SPM)
was packed into columns, and then concanavalin A (ConA) or Sambucus sieboldiana agglutinin
(SSA) was immobilized. Additionally, bovine serum albumin or insulin (Ins) was further
immobilized to block the hydrophobic surface of PEGM-SPM. The obtained columns were
simply analysed by LAC and applied for the separation of exosomes.
Results: As results of LAC evaluations, both ConA-SPM and SSA-SPM showed selective
lectin affinity for the glycoproteins, only the glycoproteins associated to each lectin
were selectively separated from the mixture samples. Additionally, an Ins-SPM allowed
the effective permeability against liposome and exosome. This means that the protein-immobilized
SPM was suitable for the separation media of nanometer sized particles without any
non-specific adsorption. Finally, we demonstrated the selective separation of exosome
due to lectin affinity. As a result, SSA-SPM provided the effective adsorption of
exosome based on the interaction between SSA and sialic acid on exosome.
Summary/Conclusion: According to these results, the newly developed lectin-SPMs can
be used for the separation of exosomes based on the difference of the surface sugar
chains. We believe that the increase of number of lectin-SPMs and other affinity-SPMs
will lead to the detailed classification of exosomes due to its surface chemistry.
(1) Kubota, K.; Kubo, T.; Tanigawa, T; Naito, T.; Otsuka, K. Sci. Rep. 2017, 7, 178.
PS04.04
A microfluidic module for extracellular vesicle separation coupled to microarray-based
phenotyping
Marina Cretich
a, Dario Brambillaa, Alessandro Romanatoa, Maria Teresa Odinolfia, Stephanie Descroixb,
Lucile Alexandreb, Laura Trapiellab, M. Selim Ünlüc, Natasa Zarovnid and Marcella
Chiaria
aConsiglio Nazionale delle Ricerche (CNR), Istituto di Chimica del Riconoscimento
Molecolare (ICRM), Milano, Italy; bCurie Institute, Paris, France; cBoston University,
Boston, USA; dHansaBioMed Life Sciences Ltd, Tallin, Estonia
Introduction: Standard approaches to characterize EVs are usually either low-throughput,
laborious or based on sophisticated equipment not applicable to clinical routines.
An integrated microfluidic platform that isolates and characterizes EVs available
in bodily fluids by combining capture, release and phenotyping of bio-nanoparticles
would significantly accelerate the transition of EV-based research to real clinical
utility. The realization of such a system is the goal of INDEX, a project recently
funded in the frame of Horizon 2020 FET-OPEN programs.
Methods: The platform consists of two modules, one for the extraction of EVs in complex
samples and one for the interferometric label-free identification and visualization
in a disposable cartridge. In order to integrate the two modules, a new approach for
the reversible capture of EVs from serum was developed and demonstrated using the
so called magnetic fluidized bed technology recently developed by Pereiro et al. (Lab
Chip, 2017, 17, 1603–1615). This technology is based on the use of functionalized
magnetic particles to perform a solid phase extraction step. We report on the progress
of the optimization of the technology itself and how it can be used to recover intact
EVs.
Results: In the optimization of the magnetic fluidized bed system as tool for the
isolation and pre-concentration of EVs in plasma/serum patient samples, several steps/issues
have been evaluated including the immobilization chemistry of antibodies on the surface
of magnetic particles for increased EV recovery, the dimensions of the chip, the flow
rate and sample volume. Capture and release efficiency were evaluated by direct on-chip
monitoring of the fluorescence when working with fluorescent samples or by ELISA test.
Capturing and release steps were also monitored on anti-tetraspanins antibody microarrays
by fluorescence and interferometric detection.
Summary/Conclusion: In summary, we have demonstrated that intact EVs can be released
from the first module of the sensing platform and transferred to the second module
devoted to nanoparticle sizing and phenotyping
Funding: This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement no. 766466. INDEX.
PS04.05
Comparison of extracellular vesicles detection by microfluidic plasmonics of gold
nano-island and nanocomposite platforms
Muthukumaran Packirisamy
a, Srinivas Bathinia, Simona Badilescub, Duraichelvan Rajua, Anirban Ghoshc and Rodney
J Ouellettec
aConcordia University, Montreal, Canada; bConcordia University Montreal, Montreal,
Canada; cAtlantic Cancer Research Institute (ACRI), Moncton, Canada
Introduction: Extracellular vesicles (EVs) are groups of nanoscale extracellular communication
organelles in the order of 30–100 nm, which can be used as disease biomarkers for
cancer. In this work, we have developed different platforms for the detection and
characterization of EVs by using a localized surface plasmon resonance (LSPR) method
based on the sensitivity of the gold plasmon band to the environment of gold nanoparticles.
Methods: EVs from breast cancer cell line (MCF7) are detected and characterized by
using a gold nanoparticle-based plasmonic platforms. Here, two different platforms
have been developed, a gold nano-island platform on glass substrate and a gold poly(dimethyl)siloxane
(Au-PDMS) nanocomposite. A plasmonic sensing protocol is established and carried out
by using the two platforms and, subsequently, the procedure is transferred in a microfluidic
environment. Gold nanoparticles are first deposited on glass substrates and annealed
to form gold nano-islands, whereas the gold nanoparticles were in-situ synthesized
in a PDMS matrix by the immersion method. EVs are affinity captured by a peptide (Vn96)
in this protocol. The two platforms were individually bonded to a PDMS sample having
a channel to form a microfluidic device. The entities involved in the biosensing protocol
are flown through the channel, and the absorption spectrum is measured after each
step.
Results: A graph showing the LSPR shift of the gold plasmon band for different concentrations
of EVs is plotted for the two platforms. The exosomes from breast cancer cell line
(MCF7)-conditioned media have been grown in a small bioreactor. Comparable results
in terms of sensitivity have been found for the two platforms.
Summary/Conclusion: Compared to the macro detection method, the microfluidic detection
of EVs proved to be highly reproducible and more sensitive as very small amount of
chemicals and EVs are necessary for the analysis.
PS04.06
Dielectrophoretic nanovesicle sorter
Yong-Sang Ryu
a, Avijit Barikb, Nathan J. Wittenbergb, Daniel A. Mohrb and Sang-Hyun Oh3
aSensor System Research Center, Seoul, Republic of Korea; bUniversity of Minnesota,
Minneapolis, USA; cUniversity of Minnesota, Minneapolis, Minneapolis, USA
Introduction: Extracellular vesicles are membrane-bound particles that play important
roles in cellular communications, packaging of genetic material and waste management.
An important category of extracellular vesicles, exosomes, are only 30-100 nm in size.
To investigate the biological functions of these extracellular vesicles and to use
them for applications in diagnostics and drug delivery, rapid isolation with high
collection efficiency and selectivity is of great importance. Small unilamellar vesicles
(SUVs), as a model type of exosomes, have been extensively exploited to characterize
the role of extracellular vesicles during the processes.
Methods: 2.1. Fabrication of 10 nm-width-gap electrode device
2.2. SUV preparation and size characterization
2.3. Dielectrophoresis on nanogap electrodes
Results: Here we demonstrated that dielectrophoresis (DEP) can be used to collect
and sort sub-100 nm SUVs, a model of exosomes, based on their size and the electrical
properties of their cargo. The DEP platform is based on a 0.8 mm-long, 10 nm-wide
gap between gold electrodes, capable of generating ultra-high electric field gradients
with low voltages. We determine the DEP trapping threshold voltages as a function
of vesicle size for the selective capture. Furthermore, SUVs with different internal
conductivities can be sorted by varying DEP frequency.
3. 1. Dielectrophoretic trapping of SUV and size-dependent sorting
3.2. SUV sorting based on internal conductivity.
Summary/Conclusion: Such differential DEP responses may allow the isolation of membrane-free
macromolecular aggregates in the presence of empty vesicles down to size ranges of
d ≤ 100 nm without labelling processes required for detection methods used with other
separation techniques. Our electronic DEP sorter can readily be applied to diverse
biological materials including viruses, proteoliposomes, functionalized nanobeads,
DNA molecules and other biomolecules.
Funding: This research was supported by grants from the Minnesota Partnership for
Biotechnology and Medical Genomics, MnDrive Research Initiative, NSF through the National
Nanotechnology Coordinated Infrastructure (NNCI) program, and internal project of
KIST.
PS04.07
A novel capture-and-release platform to isolate extracellular vesicle subpopulations
reveals functional heterogeneity among EVs with different surface markers
Olivier G. de Jonga, Mark Tielemansb, Raymond Schiffelersc, Pieter Vaderc and Sander
A. A. Kooijmans
c
aDepartment of Physiology, Anatomy and Genetics, University of Oxford, Utrecht, Netherlands;
bDepartment of Clinical Chemistry and Haematology, University Medical Center Utrecht,
Utrecht, Netherlands; cLaboratory of Clinical Chemistry and Hematology, University
Medical Center Utrecht, Utrecht, Netherlands
Introduction: Extracellular vesicles (EVs) are heterogeneous in terms of size and
molecular composition, which may also reflect functional differences. For example,
given that the EV surface dictates interactions with their environment, EVs with different
surface profiles may be taken up and processed by target cells in different ways.
Unfortunately, tools to isolate and functionally compare EV subpopulations based on
their surface marker expression are currently not available. Here, we describe a novel
capture-and-release platform to separate intact EVs based on specific surface signatures
and compare their properties.
Methods: EVs were isolated from MDA-MB-231 cells using size exclusion chromatography.
EV subpopulations expressing specific surface markers were captured on magnetic beads
and released using a novel release protocol. Released EVs were characterized by western
blotting, nanoparticle tracking analysis (NTA) and transmission electron microscopy
(TEM). Uptake of fluorescently labelled EV subpopulations by various cell types was
examined using flow cytometry.
Results: Isolated MDA-MB-231 EVs showed typical EV properties, including the presence
of EV marker proteins, heterogeneous size distribution (mode size of 120 nm) by NTA
and intact, “cup-shaped” morphology as visualized by TEM. When these EVs were subjected
to the capture-and-release platform, EV subpopulations with different properties were
obtained. Released subpopulations appeared intact as demonstrated by TEM, but differed
in their size distribution. Furthermore, EV subpopulations showed different enrichment/depletion
patterns of canonical EV proteins as shown by western blot. Lastly, uptake of EVs
by target cells differed between EV subpopulations and between target cell types.
Summary/Conclusion: In this work we showcase a novel capture-and-release platform
to separate intact EV subpopulations based on their expression of specific surface
markers. Using a small panel of antibodies against EV surface markers, we show differences
between EV subpopulations in terms of protein composition, size distribution and cellular
uptake by target cells. We anticipate that this tool can help to clarify relationships
between the surface signature of EVs and their functionality, and facilitate the enrichment
of EVs with desirable characteristics for therapeutic purposes.
PS04.08
Nanopillar and nanochannel fabrication via mixed lithography
Sung-Wook Nam
a, Sun-Woong Leea and Moon-Chang Baekb
aSchool of Medicine, Kyungpook National University, Daegu, Republic of Korea; bSchool
of medicine, Kyungpook National University, Daegu, Republic of Korea
Introduction: Extracellular vesicle (EV) sorting and separating by nanostructure is
essential to achieve a size-dependent analysis of protein and miRNA inside the vesicles.
In this regard, implementation of lab-on-a-chip devices having the EV sorting functionality
has been pursued by utilizing the physical properties of the particles.
Methods: Nanopillar array is a useful template for sorting and separating EVs. We
report a method of fabricating nanopillar array coupled with large-scale fluidic structures.
To do this, we introduce mixed lithography by which both nanometer-scale functional
features and large-scale guiding structures are generated in the same level upon 200 mm
silicon wafers.
Results: Upon 200 mm silicon wafer, nanometer features are firstly produced by electron
beam lithography (EBL) in the extremely localized area which is subsequently connected
by the micrometer structures produced by photolithography. By introducing hard-masking
oxide layer, we can create the coupled geometry in the same level structure. For the
nanometer fluidic channels, we examine wetting of a liquid solution containing fluorescent
polystyrene particles.
Summary/Conclusion: We demonstrate EV sorting devices by implementing nanostructures
in lab-on-a-chip structure. Our method may offer a way to produce biochips that have
versatile functions including sorting and separating EVs.
Funding: This research was supported by the Bio & Medical Technology Development Program
of the National Research Foundation (NRF) funded by the Ministry of Science & ICT
(2017M3A9G8083382).
PS04.09
Towards on-chip EVs separation: a lab-on-chip approach
Lyne Pillemont, Daniel Guneysu, Celine Elie-Caillea, Wilfrid Boireaub and Anne-Marie
Gue
c
aFEMTO-ST Institute, Besançon, France; bFEMTO-ST Institute, UBFC, CNRS, Besançon,
France; cCNRS, Toulouse, France
Introduction: Owing to their complexity in size, origin, membrane markers, there is
currently no ideal technology available to relate cell-derived microvesicles (EVs)
structure and functions. All currently available methods (flow-cytometry, DLS, TRPS,
etc.) have limits in their ability to capture the whole diversity of EVs populations
and are not amenable to automation and large-scale analysis of numerous samples. In
that context, the overall objective of this study is to develop a miniaturized platform
allowing the isolation, fractionation and qualification of microvesicles in µL volume.
Methods: Based on previous works (1), we propose a lab-on-chip coupling a hydrodynamic
separation module enabling EVs separation according to their size to an affinity-trapping
chamber compatible with subsequent SPR and AFM characterization. We designed and fabricated
2.5 × 2.5cm chips enabling the separation of vesicles at tunable cut-off (150-900nm).
The proof-of-concept was done using fluorescent calibration particles (polystyrene
and melanin resin nanoparticles) biofunctionalized with proteins and mimicking EVs
in buffer solution.
Results: Sample was introduced into the chip using a syringe pump or a pressure generator
and the filtered sample was simply collected at the chip outlet and redirected towards
a biodetection chamber designed as an array of gold plots functionalized with antibodies.
We demonstrated the high quality separation of 490 nm nanoparticles from 920 nm particles
in concentrated solution (2.109 to 2.1011 particles/µL). Following sorting step, biosynthetic
particles were immunocaptured in a miniaturized module of the NBA platform (2, 3)
for their subsequent analysis.
Summary/Conclusion: We did the proof-of-concept of on-chip nanoparticles separation
and capture demonstrating the ability of miniaturized systems to perform sample fractionation.
The tunable properties of the device open the way to a versatile tool for pre-analytical
steps of EVs, including sorting and concentration, even in complex media.
Funding: ANR: Agence Nationale de la Recherche
PS04.10
Acoustophoretic-based microfluidic platform for sorting extracellular vesicles
Erfan Taatizadeh
a, Arash Dalilib, Nishat Tasnima, Cathie Garnisc, Mads Daugaardd, Isaac Lie, Mina
Hoorfar
f
aUniversity of British Columbia Okanagan, Kelowna, Canada; bUniversity of British
Columbia Okanagan, Kelowna, Canada; cAssociate Professor, Faculty of Medicine, Department
of Surgery, Division of Otolaryngology, University of British Columbia Senior Scientist,
Genetics Unit, Integrative Oncology Department, BC Cancer Research Centre, Vancouver,
Canada; dVancouver Prostate Centre Head, Molecular Pathology & Cell Imaging Core Facility,
Vancouver Prostate Centre Assistant Professor, Department of Urologic Sciences, University
of British Columbia, Vancouver, Canada; eDepartment of Chemistry, University of British
Columbia Okanagan, Kelowna, Canada; fUniversity of British Columbia, Kelowna, Canada
Introduction: Conventional methods used for isolation of extracellular vesicles (EVs)
are time-consuming, produce low purity samples and may change the structure of EVs.
To address these problems, microfluidics-based EV isolation methods have been introduced.
In particular, acoustic-based cell isolation (functioning based on size, density and
compressibility differences of bioparticles and medium) have shown potentials. However,
the geometrical and operational parameters of such a platform still need to be optimized
to produce high throughput and reproducible results. This study focuses on the optimization
of an acoustophoretic-based microfluidic platform using first colloidal particles
following by EVs isolated from culture media from cancer cell lines. The results are
compared against the conventional method to show high yield and purity of the proposed
platform.
Methods: The acoustic pressure field can be generated inside a microchannel by applying
a voltage to patterned interdigital transducers fingers on the surface of piezoelectric
materials. Due to such a field, bioparticles are deflected (and hence sorted) at different
points along the microchannel depending on their volumes. Soft lithography and etching
processes are used for fabrication of microchannel and transducers of the platform.
Results: To optimize the geometry and operational parameters of the platform, polystyrene
(PS) particles are first used as they have similar size, density and compressibility
of the components in the body fluid samples. The results showed that 90% of PS particles
are deflected at a frequency of 26.5 MHz and the input voltage of 10 Vpp. Using these
parameters, we are then able to sort EVs from cell culture media into size ranges
between 500–1000 nm. The size of each sorted vial is characterized by nanoparticle
tracking analysis and shown a size separation resolution of 500 nm and a throughput
of 4 uL/min.
Summary/Conclusion: Acoustofluidics-based separation results show the size separation
resolution of 500 nm and a throughput of 4 uL/min, indicating the protentional of
such a technique as a non-invasive, label-free and effective EV purification method.
Funding: This work was supported by the University of British Columbia Eminence fund.
PS04.11
Proteomic and miRNA analysis of highly purified extracellular vesicles recovery using
immunoaffinity purification and ultracentrifugation from serum, plasma and urine
Ayako Kurimoto, Yuki Kawasaki and Tatsutoshi Inuzuka
Miraca Research Institute G.K., Hachioji-shi, Japan
Introduction: Exosomes, one of extracellular vesicles, are secreted into extracellular
fluids from all types of cells via endosomal pathway and found in most body fluids
including blood and urine. Exosomes are reportedly associated with various disease
conditions including cancer metastasis and vascularization. Although exosomes seem
to be promising biomarkers, methods to isolate and quantify exosomes still remain
controversial. Conventionally used methods include ultracentrifugation (UC), polymer
precipitation and immunoaffinity purification (IP) using surface marker antibodies.
In addition, obtained exosomes from certain types of specimens, urine in particular,
is extremely difficult.
In this study, we aimed to establish a method to efficiently recover exosomes from
serum, plasma and urine using IP and UC method, considering practical use at the clinical
site.
Methods: Antibodies against tetraspanins and IP condition were established and used
to isolate exosomes from serum, plasma and urine. Obtained exosomes were subjected
to immunoblotting, nanoparticle tracking analysis (NTA), proteomic analysis, internalization
assay and 3D-Gene miRNA microarray.
Results: Immunoblotting and NTA revealed the recovery of highly pure exosomes from
serum and plasma with increased efficiency by our IP method. Our method was successful
in recovering exosomes from urine specimens, whereas commercialized antibodies failed
to do so. Internalization assay showed that uptake rate of exosomes isolated from
conditioned medium using our method were similar to that of exosomes isolated using
conventional method. Number of identified proteins has increased, whereas the detection
of nonspecific proteins decreased by our method. Expression profiles of miRNAs from
our obtained exosomes differed from that obtained by conventional isolation method.
Summary/Conclusion: Our established exosome purification methods are capable of efficiently
recovering exosomes from serum and plasma in addition to urine specimens. Our approach
can be readily automated to isolate exosomes from specimens, which could contribute
to therapeutic application of exosomes and biomarker detection.
PS04.12
Capture and release of extracellular vesicles in tens of μL samples for ocular neuroprotection
studies
Yi-Hsun Chen
a, Rong-Kung Tsaib and Chihchen Chena
aInstitution of NanoEngineering and MicroSystems, National Tsing Hua University, Hsinchu,
Taiwan (Republic of China); bInstitute of Eye Research, Buddhist Tzu Chi General Hospital,
Hualien, Taiwan (Republic of China)
Introduction: The incidence of eye diseases is on the rise with increasing longevity
and use of 3C products. However, treatments for several eye diseases, such as vision-threatening
glaucoma and age-related macular lesions, offer only symptomatic control with no curative
options. Extracellular vesicles (EVs) are cell-derived vesicles that have been shown
to play a role in intercellular communication, immune regulation, extracellular matrix
turnover, stem cell division/differentiation, neovascularization and cellular waste
removal. At present, ocular EV studies remain rare mainly due to the challenges associated
with accessing and processing minute ocular samples.
Methods: In this work, we collected EVs from Sprague Dawley rat intraocular samples
after non-arteritic anterior ischaemic optic neuropathy (NAION) induction. 30 μL ocular
fluid collected at day 0, 0.25, 1, 3 and 7 after NAION induction was applied to each
paper-based device. Long-wavelength UV light (360 nm) was utilized to break the photolabile
crosslinker and release captured EVs for subsequent analyses.
Results: RNA molecules contained in captured CD63+ EVs were extracted, and the next
generation sequencing (NGS) results showed that more anti-inflammatory M2 miRNAs were
present in NAION samples than in sham controls. In addition, we have identified 53
miRNAs that showed more than two-fold changes in expression during the natural course
of recovery after NAION. These miRNAs included pro-inflammatory M1-related miRNAs
(miR-184, miR-3473, let-7c-5p, miR-124, miR-125a-5p, miR-210-3p) and anti-inflammatory
M2-related miRNAs (miR-31a-5p, miR-99a-5p, let-7i-5p, miR-204-5p, miR-16-5p). Interestingly,
M1-related miRNAs exhibited a biphasic expression that peaked at day 1 and then elevated
again at day 7, whereas M2-related miRNAs were upregulated at day 7 from NAION to
achieve putative neuroprotection effects.
Summary/Conclusion: We have developed an easy and fast method capable of collecting
and releasing EVs from low-volume samples. The quantity and quality of miRNA extracted
is enough for NGS analysis.
Funding: Taiwan Ministry of Science & Technology (MOST 106–2628-E-007–010-MY3) and
the Taiwan Ministry of Education (Higher Education Sprout Project: Grant No. 107Q2713E1).
PS04.13=OWP3.04
An integrated microfluidic device for selective exosome isolation from human plasma
Hogyeong Gwaka, Junmoo Kimb, Leila Kashefi-Kheyrabadib, Seung-Il Kimb, Kyung-A Hyun
b and Hyo-Il Jungb
aSchool of Mechanical Engineering, Yonsei University, Seoul, Republic of Korea; bYonsei
University, Seoul, Republic of Korea
Introduction: Extracellular vesicles released by many cell types circulate in blood
vessel and play a key role in intercellular communication. Exosomes are 30–150 nm
membrane vesicles and are also shed by both normal and cancer cells. Cancer cells
are known as very heterogeneous, so exosomes are also heterogeneous and have different
surface expression markers. Cancer-derived exosomes contain unique cargo determined
by the molecular characteristics of cancer cells. Therefore, it is very important
to selectively separate exosomes depending on surface expression for downstream analysis.
We designed an integrated microfluidic chip for selective exosome isolation. The microfluidic
chip consists of Hoof Structure (HS) for mixing exosomes and two different sized aptamer-coated
particles and Multi-Orifice Flow Fractionation (MOFF) for separating each particle.
Methods: Biotinylated EpCAM aptamer was immobilized on the surface of 7 μm streptavidin-coated
polystyrene particle and HER2 on 15 μm. The HS has the circular expansion channel
on the 1st layer to generate expansion vortices and the two curvature channels on
the 2nd layer to make chaotic advection. It makes transverse flow and mixes two particles
without particle focusing phenomenon. The 100-nm (exosome), 7-μm and 15-μm fluorescence
particles were used to test mixing performance between exosomes and particles in the
HS. The MOFF was designed by a series of contraction/expansion microchannels for continuous
size-based separation. Separation performance was tested by using the 7-μm and 15-μm
fluorescence microparticles in the MOFF.
Results: The mixing efficiency was the highest at the flow rate 150 μl/min. Each exosome
was continuously captured by aptamer-conjugated particle in the HS channel. The capture
efficiency of EpCAM positive exosome was 96.9% and HER 2 was 68.09%. Two particles
were separated in the integrated microfluidic device at the same flow rate. 96.26%
of 15 μm microparticles were positioned into the centre of the channel, and 89.48%
of 7 μm microparticles were separated on both sides of the channel.
Summary/conclusion: Each exosome was continuously captured by mixing aptamer-conjugated
particle in the HS. Exosome-conjugated microparticles were successfully separated
by inertial force in MOFF. This analysis of each exosome will shed light on diagnosis
and therapy of cancers.
PS05: EV Protein Biomarkers Chairs: Seiko Ikezu; Yusuke YoshiokaLocation: Level 3,
Hall A15:00–16:00
PS05.03
Caveolin-1 reduces in extracellular vesicles derived from lung cancer tissue and plasma
and associates with cancer cell migration
Taixue An
a, Lei Zheng
b, Han Zhangc and Yiyao Huangc
aNan Fang Hospital, Southern Medical University, Guangzhou, China (People’s Republic);
bClinical Laboratory Department, Nanfang Hospital, Southern Medical University, Guangzhou,
China (People’s Republic); cNan Fang Hospital, Southern Medical University, Guangzhou,
China (People’s Republic)
Introduction: Early diagnosis is of significance meaning for lung cancer. Extracellular
vesicles (EVs) are a new kind of diagnostic biomarkers with great potential. However,
the discovery of biomarkers based on EVs remains disturbed by EVs from cells disassociated
with lung cancer. If biomarkers, we suggest, can be screened based on EVs from cancer
tissue and validated in plasma, discovered biomarkers may combine good specificity
and practicability in clinical practice.
Methods: Thirteen Lung cancer tissues and 71 plasma samples (47 early stage lung cancer
patients, 9 advanced stage lung cancer patients and 15 healthy controls) were collected
from Nang Fang Hospital. Our research was approved and supervised by the Medical Ethics
Committee of Nan Fang Hospital. EVs were purified from lung cancer tissues and paracancerous
tissues and characterized by LC MS/MS; protein profiles of two groups were compared
and Caveolin-1 was picked out in differentially expressed proteins. With high-sensitivity
flow cytometry, the diagnostic performance of Caveolin-1 was validated in 79 plasma
samples. In cell line experiments, Caveolin-1 on EVs was blocked by antibody, and
the migration of EVs stimulating cancer cells was evaluated by transwell.
Results: We determined profiles of EVs in lung cancer tissue and paracancerous tissue
separately. Combined bioinformatics analysis and western blotting verification, Caveolin-1
was chosen as candidate biomarker and verified by western blotting in six plasma samples.
Subsequently, Caveolin-1 was evaluated in 79 plasma samples. Caveolin-1 was significantly
decreased in lung cancer patients and the area under curve of ROC reached 0.958 in
diagnosis of cancer patients and healthy controls. Furthermore, we observed the biological
function of Caveolin-1 on EVs with cell line. When cancer cells were co-cultured with
EVs, the movement of cancer cells stimulated by antibody-blocked EVs was increased.
Summary/Conclusion: Our study indicated Caveolin-1 on EVs can inhibit cancer cell
movement. Cancer cells promote the movement of other cells by reducing Caveolin-1
on EVs. Caveolin-1 significantly decreased in cancer tissues and patients’ plasma.
Caveolin-1 may serve as a potential marker for the diagnosis in lung cancer diagnosis.
Funding: This study was supported by grants from the National Natural Science Foundation
of China (81371901).
PS05.04
DNA assembly assisting magnetic fluorescence nanosensor based on aggregation-induced
emission probe/graphene oxide for cancerous exosome analysis
Bo Li, Chunchen Liu, Weilun Pan and Lei Zheng
Clinical Laboratory Department, Nanfang Hospital, Southern Medical University, Guangzhou,
China (People’s Republic)
Introduction: Exosomes are emerging as non-invasive diagnostic biomarkers of cancer
because they carry biomolecules that include proteins and nucleic acids for intercellular
communication. Assessing special exosome surface proteins provides a powerful means
of identifying the origins of their cancerous parental cells. Glypican-1 (GPC-1),
an exosomal membrane protein, was discovered to have much higher expression on the
cancerous exosomes than the noncancerous for the early diagnosis of pancreatic, breast
and colorectal cancer. However, quantification of low concentrations of specific exosomes
present in very small volumes of clinical samples remains a challenge.
Methods: Herein, we proposed a magnetic fluorescence nanosensor based on GPC-1 antibody-functionalized
magnetic microcarriers for GPC-1(+) exosome subpopulation isolation and detection.
And the recognition signal was transformed into the formation of free-state DNA nanostructure
by the trigger containing CD63 aptamer. To increase the sensitivity of this method,
a “Y” shape DNA self-assembly nanostructure amplification strategy was adapted to
assist aggregation-induced emission probe/graphene oxide (AIE/GO) “turn-on” fluorescence
reporting system to realize the label-free and ultracentrifugation-free quantitative
analysis of GPC-1(+) exosome subpopulation of breast cancer in a homogeneous.
Results: We optimized the reaction conditions and evaluated the detection performance
of the method, such as specificity, sensitivity and linear range. Under optimal conditions,
the results show that this magnetic fluorescence nanosensor could distinguish breast
cancer exosomes from five other types of cancerous exosomes, and the linear range
of detection for breast cancer exosomes is estimated to be 7.8 × 104–3.9 × 109 exosomes/µL
with a detection of limit (LOD) of 6.56 × 104 exosomes/µL. We demonstrated the application
of the magnetic fluorescence nanosensor in quantitative detection of exosomes in plasma
samples directly from breast cancer patients.
Summary/Conclusion: This magnetic fluorescence nanosensor is expected to become a
powerful tool for rapid and simple cancer liquid biopsy.
Funding: This study was financed by grants from the National Natural Science Foundation
of China (81371901, 81702100) and the Science and Technology Planning Project of Guangdong
Province (2017A020215123)
PS05.05
Quantitative multiparameter analysis of individual urinary extracellular vesicles
via a laboratory-built nano-flow cytometer
Haisheng Liu
a, Ye Tianb, Shaobin Zhuc and Xiaomei Yana
aDepartment of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen
University, Xiamen, China (People’s Republic); bDepartment of Chemical Biology, College
of Chemistry and Chemical Engineering, Xiamen University, Xiamen, China (People’s
Republic); cNanoFCM Inc., Xiamen, China (People’s Republic)
Introduction: Urinary extracellular vesicles (uEVs) have attracted much attention
as a source of non-invasive biomarkers. To exploit their prominent potential in the
diagnosis of urinary tract diseases including urinary cancers, an in-depth study of
uEVs at the single-particle level is important. Employing a laboratory-built nano-flow
cytometer (nFCM) that facilitates multiparameter analysis of single EVs as small as
40 nm, here we report quantitative measurement of size distribution, particle concentration,
purity, lipid membrane, nucleic acids and surface proteins of uEVs.
Methods: uEVs were isolated from mid-stream urine samples collected from healthy donors
via differential ultracentrifugation (UC). Monodisperse silica nanoparticles were
used as the size reference standards for the size distribution measurement of uEVs
via light scattering detection. By using fluorescent silica nanoparticles of known
particle concentration as the internal standard, particle concentration of uEVs was
measured via single particle enumeration. The purity of uEVs in the isolates was examined
by measuring the particle concentration before and after Triton X-100 treatment. Lipid-membrane
was labelled with PKH26 and PKH67. Subpopulation of uEVs expressing specific surface
proteins were analysed via immunofluorescent staining. SYTO 16, a cell-permeant stain,
was used to stain the nucleic acids of uEVs before and after DNase I treatment.
Results: The concentration of uEVs was determined around 10^9 particles/mL in urine,
and the purity of isolated uEVs via UC was above 90%. Comparing with the light scattering
signal of single EVs, the lipid dye labelling efficiency was found to be around 90%.
Considering the purity of EVs, we conclude that almost all the uEVs can be stained
by lipid dyes. We also found that ~30% of uEVs expressing CD9, CD63, CD81 or TSG101
on their surface. The ratio of uEVs lightened up by SYTO 16 decreased from 16% to
10% after DNase I treatment, which indicates that part of the DNA resides on the outer
membrane surface of uEVs.
Summary/Conclusion: The laboratory-built nFCM is applicable to the multiparameter
biochemical analysis of individual uEVs via protein, lipid and nucleic acid staining.
We expect nFCM will facilitate more in-depth studies of uEVs and aid the development
of clinical diagnosis with uEVs.
PS05.06
Proteomic profiling of urinary exosomes for potential predictors of albuminuria in
subjects with diabetes
Rajni Sharma, Manju Kumari, Bhuvnesh Rai, Aradhana Mohan and Swasti Tiwari
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Introduction: Albuminuria is considered to be an important clinical hallmark for renal
diseases. However, it has limited ability to predict the earliest stages of diabetic
nephropathy. Early biomarker potential of urinary exosomes (UE) for renal disease
has been highlighted by us and others. We carried out proteomic profiling of UE followed
by a longitudinal follow-up study to determine potential predictors of albuminuria
in subjects with type-1 diabetes (T1D).
Methods: In study-1, proteomic profiling of UE from T1D with or without albuminuria
(urine albumin to creatinine ratio between 30–300 mg/g, n = 3/group) was performed
using two-dimensional differential gel electrophoresis (2D-DIGE). Diagnostic potential
of one of the identified UE protein to predict incidence of microalbuminuria was determined.
For this, 29 T1D subjects without albuminuria were followed for ~4.5 years (study-2).
Urine microalbumin, serum creatinine and HbA1C were analysed.
Results: 2D-DIGE revealed a total number of 592 differential protein spots between
T1D subjects with or without albuminuria. The MASCOT search for 26 selected spots
revealed 14 proteins associated with nephropathy, including Wilms’ tumour 1 (WT1)
protein. At the end of 4.5 years of follow-up, 9 subjects (out of total 19) progressed
to albuminuria in WT1-positive group (presence of WT-1 in UE at the time of recruitment)
as opposed to 1 in WT1 negative group. Both groups had statistically similar diabetes
duration, age, % HbA1c and estimated GFR at the baseline.
Summary/Conclusion: Urinary exosomal protein could help in categorizing diabetic subjects
that may go on to develop nephropathy.
Funding: Funded by intramural, DST, Govt. of India.
PS05.07
Identification of exosomal biomarkers in urine for human prostate cancer
Duojia Wu, Ying Zhu, Jie Ni, Julia Beretov, Paul Cozzi, Mark Willcox, Valerie Wasinger,
Bairen Pang, Xupeng Bai, Peter Graham and Yong Li
UNSW (The University of New South Wales), Sydney, Australia
Introduction: Prostate cancer (CaP) is the second leading cause of cancer-related
death in males. Identification of novel biomarkers is important for the early detection
of CaP. Exosomes are small membrane-bound vesicles released from most cell types including
cancer cells. Exosomes play a key role in intercellular signalling and potentially
play a role in tumorigenesis and cancer progression. In this study, we investigated
differential urinary exosomal proteins in CaP patients compared to healthy controls
by mass spectrometry.
Methods: Midstream spot urine samples from CaP (n = 20) and benign prostatic hyperplasia
(BPH; n = 10) patients were obtained, as well as urine from age- and sex-matched controls
(n = 10). Urinary exosomes were isolated using the Total Exosome Isolation Reagent
(invitrogen). The presence of exosomes was evaluated by transmission electron microscopy
(TEM) and nanoparticle tracking analysis (NTA). Exosomal markers including TSG101,
CD9, CD63 and CD81 were validated by western blotting (WB) and flow cytometry (FC).
High-throughput LC-MS/MS-based label-free quantification was performed on Q Exactive
to identify proteins in the exosomes. Three biomarker candidates VCAM1, IL18BP and
S100A6 were selected for further validation in urine exosome samples from a separate
cohort of CaP patients and CaP cell lines by WB.
Results: We successfully isolated exosomes from human urine, which were further validated
by TEM, NTA, WB and FC. In total, 1330 proteins were identified through LC-MS/MS.
Among them, 596 proteins were differentially expressed between CaP and normal controls.
According to statistical analysis, a focus list of 37 proteins, including 17 upregulated
and 20 downregulated proteins was revealed as dysregulated candidates in urinary exosomes
for CaP. The validation of potential biomarkers including VCAM1, IL18BP and S100A6
showed that the levels of these proteins were higher in CaP cell lines including PC-3,
PC-3M, DU145 and LNCaP compared to the normal prostate cell line RWPE-1. In addition,
the expression level of IL18BP was higher in urinary exosomes from CaP patients compared
to healthy controls.
Summary/Conclusion: Urinary exosomes harbour informative proteins that might be used
for the early detection of CaP or monitoring its progression through a non-invasive
way.
Funding: ARC-Linkage Grant
PS05.09
Optimization of exosome isolation and ELISA method for identification of novel cancer
biomarkers
Ju-Hyun Bae
a, Hee-Kyung Jangb, Eun-Ju Imc, Chan-Hyeong Leec and Moon-Chang Baekc
aSchool of Medicine, Kyungpook National University, Daegu, Republic of Korea; bSchool
of medicine, KyungPook National University, Daegu, Republic of Korea; cSchool of medicine,
Kyungpook National University, Daegu, Republic of Korea
Introduction: Exosomes are a type of extracellular vesicles with diameter of 30–150 nm
secreted by cell and circulate in blood abundantly. Especially, cancer-cell-derived
exosomes contain oncogenic molecules that can be novel biomarker for cancer diagnosis.
Recent compelling issue of cancer patients is the immune system that is negatively
regulated by cancer-cell-derived exosomes. Therefore, first we have to optimize exosome
isolation methods and ELISA methods to analyse exosome’s constituents precisely. Through
this method, we can screen several candidates which contain in cancer-cell-derived
exosomes to identify novel biomarkers for cancer prediction.
Methods: Exosomes were isolated from cancer patients’ plasma using serial centrifugation
method. For western blot analysis, we loaded exosomes to observe existence and difference
in the expression of protein between cancer patients’ and healthy controls’. And using
exosomes each well in 96-well plate, sandwich ELISA was performed to measure protein
level of exosomes from cancer patients’ and healthy controls’. We also made mouse
xenograft models to find the correlation between exosomal protein level and tumour
burden.
Results: We optimized isolation method to purify exosomes and to minimize sample variation,
and we optimized ELISA method using well-known exosomal surface biomarkers and confirmed
assay stability. By optimization of exosome isolation and ELISA method, we built finding
system for novel cancer biomarker which is expected significantly overexpressed in
exosomes from cancer patients‘ plasma compared to healthy controls’. In addition,
we checked the level of exosomal surface protein’s correlation with tumour burden,
therefore prove possibility as novel cancer biomarkers.
Summary/Conclusion: Based on our results, we optimized our own finding system and
identified novel cancer biomarkers.
Funding: This research was supported by the Bio & Medical Technology Development Program
of the National Research Foundation (NRF) funded by the Ministry of Science & ICT
(2017M3A9G8083382) and by the National Research Foundation of Korea (NRF) grant funded
by the Korea government (2014R1A5A2009242).
PS05.10
Thyrotropin receptor-positive exosomes alleviate autoantibody-mediated stimulation
of cAMP production
Naoki Edo
a, Kyojiro Kawakamib, Yasunori Fujitab, Koji Moritaa, Kenji Unoa, Kazuhisa Tsukamotoa,
Hiroyuki Onosec, Toshio Ishikawaa, Masafumi Itob
aDepartment of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan;
bResearch Team for Mechanism of Aging, Tokyo Metropolitan Institute of Gerontology,
Itabashi-ku, Japan; cDepartment of Internal Medicine, Kanaji Hospital, Tokyo, Japan
Introduction: Exosomes or extracellular vesicles secreted from cells play a variety
of roles in both physiological and pathological processes. In Graves’ disease (GD),
autoantibodies bind to thyrotropin receptor (TSHR) on thyroid follicular epithelial
cells, stimulating thyroid growth and thyroid hormone synthesis and secretion through
cAMP production. In this study, we examined if exosomes expressing TSHR are secreted
from thyroid cells and defined their roles in GD.
Methods: Exosomes by differential centrifugation from the culture medium of NTHY-ori
3-1 human thyroid follicular epithelial cell line and 8305C, 8505C and FTC133 thyroid
carcinoma cell lines. Western blot analysis was performed to detect TSHR in cell lysates
and exosomes. Human embryonic kidney HEK293 cells (HEK) overexpressing TSHR (HEK/TSHR)
were established for the functional analysis of TSHR exosomes. Using exosomes isolated
from HEK and HEK/TSHR cells, in vitro binding capacity of a human monoclonal autoantibody
(M22) to TSHR exosomes and their effect on M22-mediated stimulation of intracellular
cAMP production in HEK/TSHR cells were studied. Human recombinant TSHR chimera capable
of binding to M22 was used as a positive control.
Results: TSHR was detected in exosomes from cancer cells as well as normal epithelial
cells. The binding assay demonstrated that M22 dose-dependently bound to TSHR exosomes.
M22 stimulated intracellular cAMP production in HEK/TSHR cells in a dose-dependent
manner. Exosomes from HEK/TSHR cells but not those from HEK cells significantly reduced
cAMP production activated by M22 in HEK/TSHR cells. A similar inhibitory effect was
observed for human recombinant TSHR chimera.
Summary/Conclusion: Our results suggest that TSHR exosomes may be secreted from normal
and cancerous thyroid epithelial cells. In the thyroid gland of patients with GD,
TSHR exosomes may exert a decoy effect by sequestering M22, alleviating autoantibody-stimulated
cAMP production.
Funding: There is nothing to disclose.
PS05.11=OWP3.06
In vitro and in vivo investigation of extracellular vesicles (EVs) as biomarker carriers
in the diagnosis of early Alzheimer’s disease
Soraya Moradi-Bachiller
a, Miriam Cianib, Roberta Zanardinib, Luisa Benussib, Roberta Ghidonib, J. Mark Cooperc,
Gianluigi Forlonia and Diego Albania
aDepartment of Neurosciences, Mario Negri Institute for Pharmacological Research IRCCS,
Milan, Italy; bMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di
Dio Fatebenefratelli, Brescia, Italy; cDepartment of Clinical Neurosciences, Faculty
of Brain Sciences, University College London – Institute of Neurology, London, United
Kingdom
Introduction: Extracellular vesicles (EVs) represent an ideal source of biomarkers
due to their role in cellular communication and their ability to carry protein aggregates.
The most investigated EVs are exosomes, active entities secreted from cells and able
to cross the blood–brain barrier. Several neurodegeneration-involved molecules may
undergo intercellular spreading through exosome release. In Alzheimer’s disease (AD),
before clinical signs appear, several proteins implicated in exo- and endocytic pathways
are altered. In this scenario, the identification of a correlation between variations
in proteins carried by EVs and the progression of AD is the main aim of our project.
Methods: We performed exosome isolation and characterization from H4-SW glioma cells
(a cell model featuring mutated β-amyloid overexpression), as well as in mouse- (triple-transgenic
mouse model for familial AD) and human-plasma samples (Mild Cognitive Impairment (MCI)
and AD subjects). In every case a differential centrifugation protocol was applied
and exosomes were then characterized using Nanoparticle Tracking Analysis with the
NanoSight. We then explored exosome content, specifically Amyloid Precursor Protein
(APP) and its proteolytic fragments, Microtubule Associated Protein Tau (tau), Progranulin
(PGRN protein), Soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2)
and α-synuclein (α-syn), using Western blot and ELISA. L1CAM and CD63 were evaluated
to define the neural-derived exosomes amount in human samples.
All the samples were collected after ethical committee approval respecting Helsinki’s
declaration. Informed consents were provided by all the subjects.
Results: Our preliminary results show that APP, PGRN, sTREM2 are carried by H4- and
human plasma-derived EVs. H4-SW cell-culture medium and 3Tg mouse plasma had a decrease
in the EVs number release (≈1*10e8 EVs/ml) in comparison to control (≈7*10e8 EVs/ml).
This decrease was not found in human plasma samples.
Summary/conclusion: EVs purified from H4-glioma cellular AD model, 3xTg mouse-, MCI-
and AD-plasma samples carry proteins relevant for neurodegenerative diseases (NDs).
EVs release is reduced in cellular and animal AD-models.
Funding: Horizon 2020 Marie Sklodowska-Curie Innovative Training Networks – Blood
Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease.
PS06: Advancing EV Studies in Biological Samples Chairs: Peter Kurre; J. Bryan ByrdLocation:
Level 3, Hall A15:00–16:00
PS06.01
AR-V7 in urinary EVs of patients with prostate cancer
Hyun-Kyung Woo
a, Juhee Parkb, Ja Yoon Kuc, Chan Ho Leed, Vijaya Sunkaraa, Hong Koo Hac and Yoon-Kyoung
Choa
aUlsan national institute of science and technology (UNIST), South Korea, Ulsan, Republic
of Korea; bCenter for soft and living matter, institute for basic science (IBS), South
Korea, Ulsan, Republic of Korea; cPusan National University Hospital (PNUH), South
Korea, Busan, Republic of Korea; dDepartment of Urology, Inje University Busan Paik
Hospital, South Korea, Busan, Republic of Korea
Introduction: Prostate cancer is the most common cancer affecting men and a leading
cause of cancer deaths. Almost all patients initially respond to androgen deprivation
therapy but inevitably progress to a lethal stage of disease, termed castration-resistant
prostate cancer (CRPC). Androgen-receptor splice variant (AR-V7) is associated with
CRPC and resistance to anti-androgen therapy. Despite its clinical importance, the
lack of efficient methods for AR-V7 analysis remains a challenge for broader use of
this marker in routine clinical practice. Here we suggest a practical and non-invasive
liquid biopsy method for analysis of AR-V7 in the RNA of urine-derived extracellular
vesicles (EVs) without the need for blood withdrawal.
Methods: Urine samples were collected from patients at Pusan National University Hospital
(PNUH). The study protocol was reviewed and approved by the Institutional Review Board
of PNUH and UNIST, and written informed consent was obtained from all subjects. All
patients that progressed to CRPC underwent docetaxel-based chemotherapy. Using a newly
upgraded centrifugal microfluidic device for size-based EV isolation, rapid enrichment
of EVs (< 30 min) from each 4 mL of urine was accomplished. Followed by mRNA extraction,
and AR-V7 and androgen-receptor full-length (AR-FL) mRNA levels were quantified by
droplet digital polymerase chain reaction (ddPCR). Furthermore, protein and mRNA expression
of EVs isolated from blood plasma are compared together.
Results: Higher AR-V7 and lower AR-FL expression were detected in urine-derived EVs
from 14 patients with CRPC (0–217.0 and 12.9–562.5 copies/mL, respectively) than in
those from 22 patients with hormone-sensitive prostate cancer (HSPC, 0–24.1 and 6.2–9053.6
copies/mL, respectively). Also, we found that AR-V7 transcript levels and the AR-V7/AR-FL
ratio in urinary EVs were higher in patients with advanced prostate cancer.
Summary/Conclusion: This study demonstrates that mRNA of urine-derived EVs is a reliable
source for AR-V7 expression analysis, suggesting a simple and promising approach to
liquid biopsy with a great potential for therapeutic impact on prostate cancer.
Funding: This study is funded by Ministry of Health and Welfare (HI12C1845) and Institute
for Basic Science (IBS-R020-D1), Republic of Korea.
PS06.02
Microvesicles are absorbed on the surface of extracorporeal membrane oxygenation circuit
tubing
Yoichi Iki
a, Shotaro Matsumotob, Michiko Abea, Kieran O’Deac, Hidenobu Shigemitsub, Masao Takatac
and Kenji Wakabayashia
aDepartment of Intensive Care Medicine, Tokyo Medical and Dental University, Tokyo,
Japan; bDepartment of Intensive Care Medicine, Tokyo Medical and Dental University,
Tokyo, Japan; cSection of Anaesthetics, Pain Medicine, and Intensive Care, Imperial
College London, London, UK
Introduction: There is an increasing interest in potential role of microvesicles (MVs)
as non-invasive biomarkers for acute critical care diseases. Clinically, extracorporeal
membrane oxygenation (ECMO) draws attention in critical care, and MVs are considered
to be involved in the development of adverse events in critically ill patients. However,
the dynamics of MVs within ECMO circuit, in particular MV absorption on the biomaterial,
has not been systematically studied. The purpose of this study was to explore whether
MVs are absorbed by ECMO circuit tubing.
Methods: Granulocytes were isolated from healthy volunteer blood using density-gradient
centrifugation. MV production was induced by treatment with calcium ionophore for
20 min, and MVs were quantified on flow cytometry (FACS) based on their size and surface
expression of CD11b and CD66b. MVs were then purified by differential centrifugation
and dissolved with DMEM. Thereafter, 0.5 to 1.0 × 107 MVs were administered to either
ECMO circuit tubing (material group) or Eppendorf tubes (control group) with their
lid removed and re-sealed with paraffin film. MV solution was rotated for 6 h, and
small volume of sample was regularly taken in 1–2 h interval for MV quantification
by FACS.
Results: The number of MVs in the material group was significantly decreased over
time, compared to the control group (64% reduction vs. 22% reduction at 6 h. Significant
interaction (n = 3, p < 0.05) between time and treatment by 2-way repeated measures
ANOVA).
Summary/Conclusion: ECMO circuit is known to absorb bioactive drugs and mediators,
and our results showed that ECMO circuit also impacts on the dynamics of circulating
MVs. Further investigation should explore the effects and mechanisms of MV absorption/production
induced by the biomaterial-cell interaction.
PS06.03
Measurement of physical properties of exosome by atomic force microscope
Akinori Kogure
a, Noriyuki Motohashib, Satoshi Otsukab, Yurika Sawac, Nobuyoshi Kosakad and Takahiro
Ochiyad
aShimadzu Techno-Research, INC, Hadano, Japan; bShimadzu Corporation, Chiyodaku, Japan;
cDepartment of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo
Medical University, Tokyo, Japan; dDepartment of Molecular and Cellular Medicine,
Institute of Medical Science, Tokyo Medical University, Shinjyuku-ku, Japan
Introduction: It has been shown that exoxome can be used as a drug delivery system
(DDS), and exosome in blood / body fluid has been studied as a new diagnosis method
for various diseases. The existence of various proteins and sugar chains such as CD
antigen, integrin and ligand has been confirmed in the membrane of exosome. However,
physical properties of exosome and their contribution for exosome-mediated phenomenon
have not been clarified yet. There are many reports showing the morphology of exosomes
by electron microscopy; however, it is necessary for chemical fixation of sample and
vacuum environment. Therefore, the form of exosome by electron microscopic observation
and the form of exosome in liquid may be different. The AFM is an equipment that can
observe exosome in liquid (physiological saline, culture liquid). In recent years,
biomolecular property measurement by AFM has been increasing (Kogure et al., BPS,
2018).
Methods: We used SPM-9700HT (Shimadzu Corporation) for AFM measurement. Measurement
mode is dynamic mode and force curve mapping measurement. Exosomes were isolated from
human breast cancer cell line (MDA-MB-231) and mouse breast cancer cell line (4T1)
(Kosaka et al., JBC, 2013) by ultracentrifugation.
Results: Physical properties of exosome were measured using AFM observation and force
curve measurement. Exosomes derived from low metastatic strains derived from human
breast cancer cell lines showed a relatively smooth surface. Exosomes derived from
highly metastatic strains have layers or chain-like substances having a thickness
of 10–20 nm. In addition, its physical property was soft. Furthermore, it was found
that exosomes derived from nSMase2 knock-down 4T1 cells are harder than exosome from
wild type or nSMase2 over-expressing 4T1 cells.
Summary/Conclusion: Now, we are investigating how these properties are related to
exosome characteristics in cancer malignancy.
PS06.04
Stability of human salivary extracellular vesicles under gastrointestinal tract conditions
Yuko Ogawa
a, Mamoru Ikemotoa, Yoshihiro Akimotob, Hayato Kawakamic and Ryohei Yanoshitaa
aTeikyo Heisei University, Tokyo, Japan; bKyorin University, Tokyo, Japan; cKyorin
University, Tokyo, Japan
Introduction: Human saliva plays an important role as front-line of body defence.
Extracellular vesicles (EVs) are secreted from various types of cells and it is recognized
that they are involved in intercellular communication via delivering their contents.
We have isolated EVs with dipeptidyl peptidase IV (DPP IV) from human whole saliva,
whereas little is currently known about the fate of secreted salivary EVs. In the
present study, we investigated morphological stability of salivary EVs and chemical
stability of proteins associated with the EVs in simulated gastrointestinal (GI) fluids.
Methods: Human whole saliva was collected from healthy volunteers. Salivary EVs were
separated by size-exclusion chromatography. For simulated gastric fluids or intestinal
fluids treatment, indicated concentration of pepsin (pH3.0) or pancreatin (pH7.4)
was added to EV samples, respectively. For bile acid treatment, sodium cholate (pH7.4)
was added. After the incubation, the treated samples were then subjected to SDS-PAGE,
western blot analysis, DPP IV activity measurement, dynamic light scattering study
or observation by a transmission electron microscope.
Results: Salivary EVs were morphologically stable under simulated gastric fluids with
pepsin and simulated intestinal environment using pancreatin. While some proteins
associated with surface of the EVs, such as mucin 5B and CD9, were digested with these
treatments, inside components such as Alix and TSG101 were resistant. Even though
DPP IV is oriented outside, it was not digested and retained its enzymatic activity.
Thus, membrane integrity was intact and internal components were retained in digestive
enzymes. Morphological changes and solubilization of proteins in the EVs scarcely
occurred after treatment with physiological concentration of sodium cholate. Membrane
integrity was destroyed with increasing concentration of sodium cholate. However,
components of the vesicles were not completely solubilized at higher concentration
of sodium cholate.
Summary/Conclusion: These results suggest that salivary EVs are stable and functional
in GI tract. This study would help to elucidate their potential pathophysiological
roles in GI tract.
Funding: This work was supported by Japan Society for the Promotion of Science (JSPS)
KAKENHI Grant Number 16K08348.
PS06.05
The factor affecting to the accuracy of extracellular small non-coding RNA biomarkers
Yukie Nishiyama, Yumiko Koi, Genki Nishimura, Eri Kojima, Morihito Okada and Hidetoshi
Tahara
Hiroshima University, Hiroshima, Japan
Introduction: Extracellular small non-coding RNAs (ncRNAs), such as microRNAs (miRNAs),
isoforms of microRNAs (isomiRs), tRNA-derived fragments (tRFs) and others, are known
as regulator of gene expression for cell metabolism. They are released into body fluid
from various cells with extracellular vesicles (EVs) including exosomes. In recent
studies, some extracellular miRNAs and tRFs in blood were reported as novel biomarkers
for diseases. In this study, we investigated the factor affecting to the accuracy
of extracellular small ncRNA biomarkers such as miRNA and tRFs for next generation
sequencing (NGS)-based detection.
Methods: Blood was collected from the patients who provided written informed consent
to participate in the study (approved by IRB of Hiroshima University). Serum were
isolated and stored at –80°C. EVs in the cell culture supernatant were collected after
culture in DMEM with FBS followed by one-day additional culture without FBS. Total
small RNAs were purified by using miRNeasy Mini Kit (Qiagen). EVs, including exosomes,
were isolated by using Total Exosome Isolation Kit (Thermo Fisher Scientific). NGS
was performed by using Ion S5 (Thermo Fisher Scientific). We analysed the sequence
data of small ncRNAs (15-55 nt) with software, CLC Genomics and JMP.
Results: We found that most of the extracellular small ncRNAs in serum consisted of
miRNA, isomiRs and tRFs. Especially, most of ncRNAs in EVs were tRFs. Several isomiRs
and tRFs were expressed specifically in serum from cancer patients. Some of them were
also observed in EVs from cultured cancer cell lines. EV-free ncRNAs were decreased,
and ncRNAs with EVs were increased in blood during long 4°C storage after blood sampling.
Summary/Conclusion: The expression profile of the extracellular small ncRNAs is changed
during storage at 4°C after blood sampling. It may affect the accuracy of extracellular
small non-coding RNA biomarkers.
Funding: This research is partially supported by the “Development program of microRNA
measurement technology foundation in body fluid” from Japan Agency for Medical Research
and development, AMED.
PS06.06
Generation of reference material for flow cytometric detection of extracellular vesicles
Anna Nowocin
NIBSC, London, UK
Introduction: Extracellular vesicle (EV)-related technologies have been developing
rapidly over the past few years and substantial growth is expected for the market
as they get integrated into the fields of liquid biopsy, precision and regenerative
medicine. NIBSC as a designated WHO standardization laboratory is actively developing
methods that in the future may allow the production of diagnostic and therapeutic
EV reference material for clinical and pre-clinical use. As flow cytometry enables
characterization of EV populations down to single-event level, it has been adapted
as a meaningful tool in characterizing EV isolates. High-throughput and multiparameter
analysis of EV are crucial to further advance the ability to characterize these particles.
Methods: EVs from plasma samples were isolated using several methods and their morphology
and molecular content was assessed. The effects of freeze-drying were investigated
to explore a possibility of long-term storage of EV-reference material that has been
labelled in that way for flow cytometric analysis.
Results: The populations of submicron EVs could be detected using commercially available
flow cytometers only when fluorescence and not light scatter triggered detection was
used. The labelling with 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester
followed by removal of unbound dye was efficient enough to robustly label single EVs
without generating label-associated artefacts. Freeze-drying process had some effects
on morphology but not molecular content of EV preperations.
Summary/Conclusion: Efficient labelling and preservation of pure populations of EVs
present a viable option for the development of a stable monodispersed reference material
that can be used as positive control or calibrant of flow cytometers used for analysing
submicron populations.
PS06.07
Comparison of serum and plasma as a source of blood extracellular vesicles reveals
possible contamination of serum with platelet-derived particles produced during coagulation
Xiaoman Zhang
a, Toshihide Takeuchib and Yoshitaka Nagaib
aDepartment of Neurotherapeutics, Osaka University Rraduate School of Medicine, Osaka,
Japan; bOsaka University, Suita, Japan
Introduction: Extracellular vesicles (EVs), including exosomes and microvesicles,
are released from cells to extracellular environment, and can be found in several
biological fluids, such as blood, cerebrospinal fluid and urine. Among them, blood-derived
EVs are expected to offer a more efficient and faster diagnostic method for neurologic
diseases than conventional diagnosis. Although serum and plasma are utilized as a
source of blood EVs, it still remains unknown whether there are differences in EVs
derived from serum and plasma. In this study, we performed a series of experiments
to see the differences between serum and plasma EVs.
Methods: Whole blood was obtained from 9-week-old mice. Serum was collected from the
supernatant of the clotted blood. Plasma was collected from the blood treated with
EDTA. EVs were isolated from serum and plasma using ultracentrifugation method. The
morphology of EVs was analysed by electron microscopy, and the particle numbers and
the diameter were measured by nanoparticle tracking analysis (NTA). The protein contents
of EVs were analysed by LC-MS/MS and western blotting.
Results: NTA measurement revealed that the particle numbers in the EV fraction isolated
from serum are ~2-fold larger than those derived from plasma (p < 0.01, Student’s
t-test), while the particle diameter showed no difference between serum and plasma
EVs. LC-MS/MS analysis of EVs identified total 520 proteins, of which 317 proteins
were detected in both serum- and plasma-derived EVs, while 189 proteins and 14 proteins
were detected only in serum- and plasma-derived EVs, respectively. Interestingly,
platelet-associated proteins were specifically detected in serum-derived EVs.
Summary/Conclusion: We found that serum has the larger number of EVs than plasma,
despite of the same volume of blood. The existence of the platelet-specific proteins
detected in serum-derived EVs implies that serum may be contaminated with platelet-derived
nanoparticles, which are reported to be produced during coagulation.
PS06.08
Evaluation of stability maintenance of extracellular vesicles upon storage temperature
and period
Eun Kyoung Shin
a, Jae Min Chab, Mi Jeong Oha, Eun Hee Kima and Oh Young Bangc
aSamsung medical center, Seoul, Republic of Korea; bDepartment of Mechatronics, College
of Engineering, Incheon National University, Incheon, Republic of Korea; cSamsung
medical center, Seoul, Republic of Korea
Introduction: Extracellular vesicles (EVs) secreted from stem cells are bilipid-layered
and nano-sized, retaining medicinal potency equivalent to that of stem cells. As much
interest in clinical use of therapeutic EVs has been increasingly gained in the fields,
however, few studies have been conducted regarding optimal storage and shipping conditions
for EVs, which are critical to commercialize EVs as a medicinal product. In this study,
we tested the maintenance efficiency of EVs in terms of physical stability and proteomic/genomic
contents of EVs in the following storage conditions: (1) 4°C during the 28-day of
short-term period and (2) −80°C during the one-year of long-term period.
Methods: Comprehensively characterized stem cell-derived EVs were stored at 4°C for
28 days and −80°C for one year. During given periods, preserved density and differing
sizes of EVs were evaluated by nanoparticle tracking analysis (NTA) along with quantitative
measurement of variations in total protein and RNA concentrations.
Results: At the 4°C storage condition, concentration and size of EVs were relatively
unvarying for 28 days. In terms of total protein and RNA concentrations, about 3–40%
of decreasing rates were shown during the first week of period, but rest of the amounts
were stably preserved until day 28. At −80°C, EV concentration decreased about 10%
from the initial level during the first two weeks, but rest of the amounts were stably
preserved for one year. Size of EVs was not changing during the long-term period.
In terms of total protein and RNA concentrations, about 50% of decreasing rates were
shown during the first two weeks, but rest of the amounts were stably preserved during
the one year of period.
Summary/Conclusion: While a variety of studies are actively ongoing to reach effective
cell-free treatments using EVs, the information of EV storage provided by our study
would support safe and reliable use of EVs in clinic
Funding: This study was supported by a grant from the Korean Healthcare Technology
R&D Project, Ministry of Health & Welfare (HI17C1256) and Basic Science Research Program,
the Ministry of Science, ICT and Future Planning (2018M3A9H1023675).
PS06.09
Questioning the purity of the media – extracellular small non-coding RNA contaminants
in foetal bovine serum and serum-free media
Bettina I. Mannerström
a, Riku Paananenb, Ahmed Abu-Shahbac, Riitta Seppänen-Kaijansinkkoa and Sippy Kaura
aDepartment of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki
University Hospital, Helsinki, Finland; bHelsinki Eye Lab, Ophthalmology, University
of Helsinki and Helsinki University Hospital, Helsinki, Finland; cDepartment of Oral
and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital,
Helsinki, Finland
Introduction: Extracellular vesicles (EVs) behave as paracrine effectors as they are
released from cells to deliver signals to other cells. They control a diverse range
of biological processes by transferring proteins, lipids and nucleic acids between
cells and are secreted by a wide spectrum of cell types and are found in various biological
fluids. In the research field of EV research, the use of EV-depleted foetal bovine
serum (FBS) for in vitro studies is crucial to eliminate the confounding effects of
media-derived EVs. The current methods to deplete culture media of EVs are lacking
as they do not guarantee an RNA-free preparation.
Methods: In this study we have addressed the RNA contamination issue of EVs in FBS,
ultracentrifugation EV-depleted FBS, commercially available EV-depleted FBS, and in
our recently developed filtration-based EV-depleted FBS. Commercially available serum-free,
xeno-free defined media were also screened for RNA contamination.
Results: Our small non-coding (nc) RNA sequencing data emphasized that all EV-depleted
media contained RNA contaminants. Additionally, defined media contained miRNAs and
other small RNAs, albeit at a much lower level than in serum preparations. Out of
the different FBS preparations studied, our ultrafiltration EV-depleted FBS performed
the best in depleting miRNAs. Certain miRNAs, such as miR-122 and miR-203a, proved
difficult to remove and were present in all media. As compared to miRNAs, other small
RNAs (snRNA, Y RNA, snoRNA and piRNA) were difficult to eliminate from the media.
Summary/Conclusion: Our study showed that even defined media contained trace amounts
of small ncRNA. Therefore, in order to screen for baseline RNA contamination in culturing
media, RNA sequencing data should be carefully controlled by adding a media sample
as a control. This should be a mandatory step before performing cell culture experiments
in order to eliminate the confounding effects of media.
Funding: This research was supported by University of Helsinki project funding, Helsinki
University Hospital State funding for university-level health research, the Finnish
Dental Society Apollonia, Business Finland grant.
PS07: Cellular Uptake of EVs and Membrane Function Chairs: Quan Lu; Nobuyoshi KosakaLocation:
Level 3, Hall A15:00–16:00
PS07.01
A tunable system to visualize retrofusion, a major pathway for exosome uptake
Priscillia C. Perrin
a, Lennert Janssena, Daphne van Elslandb and Jacques Neefjesc
aLeiden University Medical Center, Leiden, Netherlands; bLeiden University Medical
Center, Leiden, Netherlands; cLeiden University Medical Center, Leiden, Netherlands
Introduction: Exosomes constitute a crucial mode of intercellular communication, as
they can travel through extracellular space to transfer various cellular components
from one cell to another. While we understand, to some extent, how exosomal contents
can affect recipient cells, the molecular mechanisms governing exosome uptake are
yet to be unravelled. Upon encounter with a target cell, exosomes may be internalized
and transported to late multivesicular compartments. To avoid imminent degradation
in lysosomes, exosomes must escape the endocytic pathway and fuse back to the limiting
membrane of multivesicular bodies (MVB) through a process referred to as “back-fusion”
or “retrofusion”. Within MVBs, retrofusion of intraluminal vesicles (ILV) can notably
allow recycling of membrane proteins and also lead to cytoplasmic release of endocytosed
viruses. As retrofusion is poorly understood, deciphering its workings would help
unfold a major pathway for exosome uptake.
Methods: To enable exploration of this process and ultimately reveal the molecules
responsible, we created an inducible system allowing quantification of retrofusion
in real time. CD63, a tetraspanin protein localized on both the limiting (LM) and
intraluminal membranes (ILM) of late endosomes, was fused to GFP and stably expressed
in MelJuso cells, along with two inactive fragments of the tobacco etch virus (TEV)
protease. Upon addition of “dimerizer” to the cells, the TEV protease regains activity
and cleaves the GFP off of CD63 exposed on the cytosolic side of the LM. A nuclear
localization signal then directs this newly liberated GFP to the nucleus. When retrofusion
occurs, intraluminal GFP-CD63 repopulates the LM from ILV stores and becomes accessible
for TEV protease cleavage, resulting in the increase of nuclear GFP fluorescence over
time. Concomitant labelling of acidic vesicles with a fluorescent dye allows for quantification
of GFP signal decay specifically from those compartments.
Results: Using this chemically tuneable system, we found that knocking out the lysosomal
integral membrane protein Limp2 partially hampers retrofusion, suggesting that Limp2
may be a major player in this process.
Summary/Conclusion: We further aim to identify other proteins implicated in retrofusion
in order to propose a suitable mechanistic model.
PS07.02
Uptake of EVs derived from cervical cancer patients with precancerous induces HeLa
cell proliferation
Piyatida Molika
a and Raphatphorn Navakanitworakulb
aFaculty of Medicine. Department of Biomedical Science. Prince of Songkhla University,
Maung, Thailand; bFaculty of Medicine. Department of Biomedical Science. Prince of
Songkhla University, Hat Yai, Thailand
Introduction: Precancerous lesion is defined as early biological effects of cells
which occur prior to invasive carcinomas. The lesion is not cancerous and exhibits
variations at the cellular and molecular levels in the pathway leading to cancer.
Current evidence indicates that extracellular vesicles (EVs) can release from most
of the cell types and affect adjacent or distant cells by circulating in all bodily
fluids.
Methods: We collected serum of healthy persons and cervical cancer patients with precancerous
lesions, stage I, stage II and stage III and then counted concentration and size distribution
of the EVs using nanoparticle tracking analysis (NTA). Differential ultracentrifugation
incorporated with size exclusion chromatography was used to isolate and purify EVs
from pooled serum of each sample groups. Moreover, isolated EVs were investigated
their characteristic based on morphology using transmission electron microscope (TEM)
and the expression of CD63, CD81, CD9, and Alix protein markers using western blot
analysis. Live cell imaging machine was used to monitor uptake of EVs derived from
pooled serum of healthy persons or precancerous lesion on HeLa cells.
Results: NTA shows that the concentration of EVs is increased in patients with precancerous
lesion and stage I, and declined in the later stages. We also found that EVs isolated
from serum of healthy and precancerous group are capable of uptake into the cells
within 4 h. Nonetheless, only EVs isolated from precancerous can stimulate HeLa cell
proliferation compared to those isolated from healthy and no EVs treatment group.
Summary/Conclusion: This induction would associate with the biomolecules inside of
EVs. Our further study is addressing to find out both proteins and regulatory molecules
which contribute to cancer progression.
Funding: This work was financially supported by Faculty of Medicine, Prince of Songkhla
University and TRF research grant for new scholar.
PS07.03
Optimized protocol for the quantification of amino acid concentrations in exosomes
Hidehiro Nakamura, Satoko Ueno and Asami Hagiwara
Ajinomoto Co., Inc., Kawasaki-shi, Japan
Introduction: Exosomes contain parent cell-derived molecules including nucleic acids
and metabolites, which are useful as potential biomarkers serving as surrogates of
their cells of origin. Accurate quantification of these molecules in exosomes requires
to minimize the carryover contamination of residual condition medium (CM) or biological
fluids, as they also contain these molecules in high amount. Here, we developed a
method for accurate quantification of amino acids (AAs) in exosomes by optimizing
pre-analytical sample preparation and applying highly sensitive analytical system.
The method enabled us to evaluate the AA profiles of exosomes in comparison with those
of CM and cell extracts or biological fluids.
Methods: Exosomes were isolated from CM of human pancreatic cancer cell line, PANC-1,
or rat serum by combination of ultrafiltration and ultracentrifugation. AAs were extracted
by methanol and analysed by LC-MSMS after pre-column derivatization. AAs concentration
and profile were compared among exosomes, CM and parental cells or serum.
Results: Ultrafiltration was introduced to minimize the effect of carryover contamination
of residual AAs from CM or serum. A minimal amount of exosomes required for AAs quantification
was determined. AA profiles of exosome were different from those of CM and parental
cells or serum. In contrast, some changes of intracellular AA concentrations were
reflected in exosomes.
Summary/Conclusion: We developed the optimized pre-analytical method for AA quantification
in exosomes. This method would be applicable to metabolomics approaches to identify
disease biomarkers or surrogate biomarkers for the metabolic status of cells of origin.
PS07.04
Metabolome analysis of pancreatic cancer-derived extracellular vesicles
Ryosuke Hayasaka, Akiyoshi Hirayama, Sho Tabata, Tomoyoshi Soga and Masaru Tomita
Keio university, Tsuruoka, Japan
Introduction: Extracellular vesicles (EVs) are facilitators of cell-to-cell communication.
Cancer-derived EVs contribute to cancer progressions such as distant metastasis, angiogenesis
and immunosuppression. EVs contain functional cellular components including DNA, mRNA,
microRNA and protein. However, metabolome profiling in cancer-derived EVs remains
largely unexplored. The purpose of this study is to explain comprehensive metabolite
profiling of pancreatic cancer-derived EVs. As a model for studying cancer metabolism,
we evaluate the difference between metabolomic profiles in EVs obtained from cancer
cells cultured in normoxic or hypoxic conditions.
Methods: Pancreatic cancer cell line Panc-1 was cultivated under normoxic (20% O2)
and hypoxic (1% O2) conditions. Cells were sampled using methanol, and EVs were isolated
from conditioned medium using ultracentrifugation. The amount of EVs was determined
by nanoparticle tracking analysis, and the protein level of the CD9 exosomal marker
was measured using enzyme-linked immunosorbent assay (ELISA). Metabolomic analysis
was performed by using capillary ion chromatography-mass spectrometry and liquid chromatography-mass
spectrometry.
Results: We identified more than 180 kinds of metabolites in pancreatic cancer-derived
EVs. Principal component analysis (PCA) of metabolites in EVs showed somewhat differentiated
results between normoxia and hypoxia. Further, the metabolite profiles contained in
the cells and EVs may be different.
Summary/Conclusion: In conclusion, we optimized the collection protocol of EVs from
cultured cell samples for metabolomic analysis. Our results suggested that the metabolic
character in EVs may vary that in cells.
Funding: This study was supported by the Japan Society for the Promotion of Science
KAKENHI Grants and research funds from the Yamagata Prefecture Government and Tsuruoka
City.
PS07.05
Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis
of prostate cancer
Yun Ye
The First Affiliated Hospital of Xi’an Medical University, Xi’an, China (People’s
Republic)
Introduction: Exosomes from cancer cells, which contain microRNA and reach metastasis
loci prior to cancer cells, stimulate the formation of a metastatic microenvironment.
Previous studies have shown that exosomal miR-141-3p is associated with metastatic
prostate cancer (PCa). However, the role and regulatory mechanism of miR-141-3p in
the microenvironment of bone metastases require further study.
Methods: In this study, we performed a series of experiments in vivo and in vitro
to determine whether exosomal miR-141-3p from MDA PCa 2b cells regulates osteoblast
activity to promote osteoblastic metastasis.
Results: We demonstrate that extracts obtained from cell culture supernatants contained
exosomes and that miR-141-3p levels were significantly higher in MDA PCa 2b cell exosomes.
Via confocal imaging, numerous MDA PCa 2 bexosomes were observed to enter osteoblasts,
and miR-141-3p was transferred to osteoblasts through MDA PCa 2b exosomes in vitro.
Exosomal miR-141-3p from MDA PCa 2b promoted osteoblast activity and increased osteoprotegerin
OPG expression. miR-141-3p suppressed the protein levels of the target gene DLC1,
indicating its functional significance in activating the p38MAPK pathway. In animal
experiments, exosomal miR-141-3p had bone-target specificity and promoted osteoblast
activity. Mice injected with miR-141-3p-mimics exosomes developed apparent osteoblastic
bone metastasis.
Summary/Conclusion: Exosomal miR-141-3p from MDA PCa 2b cells promoted osteoblast
activity and regulated the microenvironment of bone metastases, which plays an important
role in the formation of bone metastases and osteogenesis damage in PCa. Clarifying
the specific mechanism of bone metastasis will help generate new possibilities for
the treatment of PCa.
PS07.06
Unrevealed mystery of cell dust: extracellular vesicles and tumour derived exosomes
Deanna Ayupova
a, Thomas Nannb and Renee Gorehamc
aThe MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University
of Wellington, Wellington, New Zealand; bThe Univeristy of Newcastle, Callaghan, Australia;
cVictoria University of Wellington, Wellington, New Zealand
Introduction: Binding exosomes to their target cells is more likely to be determined
by specific interaction(s) of protein(s) enriched in membrane of extracellular vesicles
(EVs) including tumour-derived exosomes (TEX) and cellular proteins. Although the
exact mechanism of EVs action is not fully understood, several studies reported that
TEX can modify tumour microenvironment by transferring non-coding RNAs and miRNA (particularly
miRNA-21 and −29) to target cells. Several studies have showed comparative proteomic
analyses of exosomes and circulating EVs from different biological fluids validating
their respective role as novel biomarkers offering an early, non-invasive method for
cancer diagnosis. Protein profiling and detection conducted by label-free quantification
will contribute to understanding the contents of healthy and tumour-derived exosomes
by identifying their concentration, size distribution, population and composition
enabling characterization of peptide peak intensity. Collected data combined into
a protein library for early diagnosis will result in the improvement of cancer immunotherapy
and new therapeutic targets.
Methods: AB; SEC; IF; NTA;LC-MS; TEM; Flow
Results: According to cell viability assay, exosomes increase cell proliferation after
24 h of treatment for both cell lines: MCF 10 A and A549 for all concentrations of
exosomes (0.125, 0.25, 05, 1 mg/mL). Annexin V/ PI assay was used to define the percentage
of necrotic and apoptotic cell death after treating cancerous and non-tumorigenic
cell lines. Interestingly, the higher percentage of necrotic death (6.45%) was recorded
for THP-1 exosomes conditioned with MCF 10 A, while the smallest number of necrotic
death was noticed for A549 exosomes condition with the same cell line A549 (1.99%).
The TEM analysis showed roughly same size (40–50 nm) of exosomes for all various types
of exosomes used in this study (THP-1, MCF 10 A and A549 exosomes).
Summary/Conclusion: In summary, we can conclude that extracellular vesicles (including
exosomes) derived from mammalian cell including cancerous and non-tumorigenic cell
line increase cell proliferation. That being said, cancerous cell line secrets quiet
a larger amount of extracellular vesicles compared to non-tumorigenic cell line.
Funding: No external fundings.
PS07.07
Surface glycan profiling of extracellular vesicles by lectin array system for biomarker
discovery
Asako Shimoda
a, Shin-ichi Sawadab, Yoshihiro Sasakib and Kazunari Akiyoshib
aKyoto Univerisity, Kyoto, Japan; bKyoto University, Kyoto, Japan
Introduction: Extracellular vesicles (EVs) are known as cellular communicators that
carry their contents including proteins, lipids and nucleic acids. Since cells handover
their biological information to EVs, they can be applicable to cell biomarkers. We
showed that glycans on mesenchymal stem cells (MSCs)-derived EVs play important roles
in cellular recognition using an evanescent-field fluorescence-assisted lectin array
system [1]. Most remarkable feature of this method is that simple, sensitive and real-time
detection of surface glycan patterns on intact EVs. In this study, surface glycan
profiling on EVs from many types of cells was analysed using the lectin array system.
Methods: EVs were isolated from various kinds of mouse and human cells including cancer
cells, undifferentiated and differentiated MSCs, and immune cells by differential
ultracentrifugation. Cy3-labelled EVs and their originating cell membranes (CMs) were
applied to a glass slide with 45 lectins, and fluorescence intensities were detected
using an evanescent-field fluorescence scanner.
Results: Most types of EVs showed higher binding to sialic acids-recognizing lectins
and weaker binding to mannose-binding lectin as compared with their originating CMs.
Hierarchical clustering analysis and principal component analysis were performed to
evaluate whether surface glycans on EVs have their cell specific patterns. The results
indicated that glycan profiling of EVs can be used to classify cell types (normal
or cancer) and they can be further divided into each type of cancer, MSC sources and
cell lineages, indicating that surface glycans on EVs may act as potential biomarkers
of cell state.
Summary/Conclusion: In conclusion, a lectin array method is a powerful tool for comprehensively
glycan analysis of EVs towards biomarker discovery.
PS07.08
Tomato fruit-derived vesicles: isolation, biocargo characterization and the dissection
of different vesicle types
Ramesh Bokkaa;, Gabriella Pocsfalvi
a, Teresa Silvestrea, Immacolata Fiumea, Lilla Turiakb and Tamás Csizmadiac
aExtracellular Vesicles and Mass Spetrometry Group, Institute of Bioscience and BioResosrces
(IBBR) – CNR, Naples, Italy; bHungarian Academy of Sciences, Research Centre for Natural
Sciences, Budapest, Hungary; cEötvös Loránd University, Budapest, Hungary
Introduction: Plant-derived vesicles are receiving considerable attention due to their
potential applications as vectors for the delivery of biologically active substances
in the nutraceutical, cosmetic and pharmaceutical fields. Here, in the first time,
we report the in depth characterization of micro (MVs) and nanovesicles (NVs) enriched
fractions isolated from the pericarp tissue of Solarium lycopersicum with the aim
to develop a new generation, natural vesicles-based delivery vectors. This includes
the setup of a novel GC-MS/MS platform suitable for the characterization of vesicles’
metabolites.
Methods: MV and NV fractions were isolated by differential centrifugation. NVs were
further purified by sucrose gradient ultracentrifugation method. Isolation of NVs
resulted to be troublesome due to the co-purifying pectin substances. Physiochemical
properties of the vesicles were analysed by TEM and DLS, while biocargo composition
was studied by mass spectrometry-based proteomic and metabolomics workflows. Functional
annotation and data mining were performed using Blast2Go software package including
InterPro, enzyme codes, KEGG pathways and GOSlim functions.
Results: The isolation method was improved by differential solubilization using 0.1M
phosphate 10 mM EDTA buffer pH 8, to keep pectin substances in solution allowing by
the efficient purification of NVs. In each sample, approximately 600–800 proteins
and approximately 50 metabolites could be identified. A novel method based on GC-MS/MS
metabolomic profiling of plant-derived vesicles has been developed.
Summary/Conclusion: Protein biocargo of tomato pericarp tissue-derived vesicles reveals
heterogeneous transport and extracellular vesicle subpopulations. More than 340 enzymes
comprising 43 antioxidants identified in tomato nanovesicles may count for its health-promoting
effects in the diet, i.e. protection against cancer, maintenance of healthy blood
pressure and reduction of blood glucose in diabetic patients.
Funding: This project has received funding from the European Union’s Horizon 2020
research and innovation programme under the Marie Skłodowska-Curie grant agreement
number 798576 and FET Open grant agreement number 801338.
PS08: Advances in EV Quantification and Characterization II Chairs: Cecilia Lässer;
Li MinLocation: Level 3, Hall A15:00–16:00
PS08.01
Taxonomy of individual EVs by nanomechanics
Andrea Ridolfia, Marco Brucaleb, Lucia Paolini
c, Costanza Montisd, Debora Bertid, Francesco Valleb and Paolo Bergese
e
aISMN-CNR and CSGI; Department of Chemistry, University of Florence, Firenze, Italy;
bISMN-CNR and CSGI, Bologna, Italy; cDepartment of Molecular and Translational Medicine
and CSGI, Università degli Studi di Brescia, ITALY, Firenze, Italy; dDepartment of
Chemistry and CSGI, University of Florence, Firenze, Italy; eDepartment of Molecular
and Translational Medicine and CSGI, Università degli Studi di Brescia, ITALY, Brescia,
Italy
Introduction: Probing and understanding the physical properties of individual EVs
– as a whole and of their separate components – are fundamental aspects in EV research
that still need to be addressed. We will present our latest results regarding the
nanomechanical characterization of individual EVs via Atomic Force Microscopy-based
Force Spectroscopy (AFM-FS) and discuss their significance and perspectives.
Methods: Our experimental approach entails adsorption of EVs (separated from cell
culture media) on inorganic substrates with controlled surface properties. The response
of each individual EV to an applied mechanical deformation in physiological buffer
is then sampled via liquid AFM-FS. The obtained force curves are finally quantitatively
analysed by dedicated models to obtain the EV “nanomechanical fingerprint”.
Results: The reversible elastic deformation behaviour of an EV in response to the
AFM tip indentation resulted to be the convolution of several characteristics of the
EV. We found that the overall apparent stiffness of an intact EV effectively recapitulates
its mechanical behaviour. We also found first evidences that this property can be
exploited to sort single EVs and that it relates them to other organic envelopes of
similar size and composition, such as viruses and synthetic liposomes.
Summary/Conclusion: These results proof that a nanomechanics-based taxonomy might
be an important tool for advancing characterization and understanding of EVs at the
single vesicle level.
Funding: This research has received funding from the Horizon 2020 Framework Programme
under the grant FETOPEN-801,367 evFOUNDRY.
PS08.02
Electrical characterization of individual exosomes secreted from amyloid beta-treated
neuroblastoma cells via electrostatic force microscopy
Yeseong Choi
a, Sumi Kima, Dae Sung Yoonb and Ji Yoon Kanga
aKorea Institute of Science and Technology, Seoul, Republic of Korea; bSchool of Biomedical
Engineering, Korea University, Seoul, Republic of Korea
Introduction: Exosomes are cell-derived nanovesicles known to provide information
about the state of parent cells. Recently, it has been found that the pathogenic amyloid
beta oligomers (oAβs), known as a biomarker of Alzheimer’s disease (AD), can be propagated
between neighbouring neurons through exosomes. At the same time, there is an increasing
need to introduce a new technique for the characterization of individual exosomes
because of their diversity. In this paper, we used electrostatic force microscopy
(EFM) to demonstrate the effect of oAβ on electrical properties of individual exosomes.
Methods: Different concentrations (30, 150, 750 nM) of oAβs were treated to mouse
neuroblastoma (N2a) cells, and exosomes were harvested from cell culture media through
ultracentrifugation. The electrical properties of exosomes were investigated by using
EFM. For EFM experiment, the 10 μL of each exosome solution was deposited on a fresh
mica substrate for 15 min, washed in PBS and DW order and dried under pure nitrogen
gas.
Results: EFM can visualize the electrostatic force gradient corresponding to the surface
potential of single exosomes. The scatter plot resulted from EFM data analysis showed
a correlation between the size and the charge of exosomes. Moreover, charge density
values, which excludes the influence of size by dividing the charge value by height,
decreased by up to four times depending on the concentration when compared with the
control (−5.95 μV/nm at control, −9.17, −11.1, −23.85 μV/nm at 30, 150, 750 nM, respectively).
It implies that exosomes from oAβ-treated N2a cells have significantly higher negative
surface potential than those from untreated N2a cells.
Summary/Conclusion: This paper proposes a new nano-electrical characterization to
differentiate neuronal exosomes treated by oAβs from untreated ones. It is possible
to use EFM as imaging and analysis tool for single exosome characterization. Furthermore,
it is expected that exosomes associated with AD are isolated from plasma in the diagnosis
of AD according to a surface potential of exosome.
PS08.03
Hybrid plasmonic biomaterial nanofilter scaffold for cancer EV diagnostics based on
surface-enhanced Raman scattering (SERS)
Randy Carney
a, Tatu Rojalina and Sebastian Wachsmann Hogiub
aUC Davis, Davis, USA; bMcGill University, Montreal, Canada
Introduction: New analytical approaches are needed that account for the vast molecular
heterogeneity of nanoscale extracellular vesicles (EVs). Raman spectroscopy is an
attractive technology capable of sensitive molecular fingerprinting of chemical changes
associated with disease. Surface-enhanced Raman Spectroscopy (SERS) overcomes the
inherent weak nature of spontaneous Raman scattering and is proving to be a promising
tool for next-generation clinical diagnostics. The principle of SERS is based on amplification
of Raman scattering using metal surfaces that have a nanoscale roughness with features
of ~20–200 nm. We introduce an inexpensive and flexible SERS substrate based on a
novel biosilica plasmonic nanocomposite that acts as a simultaneous nanofilter and
detection platform for sensitive characterization of tumour-associated EVs.
Methods: A porous biosilica scaffold doped with plasmonic silver nanoparticles can
be simply and easily prepared on office-grade adhesive tape. This nanocomposite deposition
requires no chemical modification of the raw materials. Particles larger than ~100 nm
concentrate on the top surface in close proximity to clusters of plasmonic nanoparticles,
affording usability as a SERS-based sensing platform.
Results: We tested our platform with dozens of samples of tumour-associated EVs enriched
from ovarian cancer patients and healthy controls to demonstrate that SERS imaging
can sensitively detect and identify disease profiles. We found enhancement factors
of more than 10^8-fold compared to spontaneous Raman signatures. Sensitivity and specificity
exceeding 90% was found for human clinical samples using less than 1 μL of minimally
processed plasma, all in just a few seconds using a commercial Raman imaging system.
Summary/Conclusion: We introduce a simple plasmonic composite using readily available
biomaterials and metallic nanoparticles, and demonstrate its efficacy for label-free
sensing of EVs. High chemical specificity afforded by Raman spectroscopy rapidly identified
tumour EVs from healthy controls in clinical samples. Our nanocomposites are inexpensive,
reusable, stable and suitable for low resource environments, with high potential for
translational application of clinical diagnostics using EVs.
Funding: The authors acknowledge funding from the Ovarian Cancer Education and Research
Network (OCERN).
PS08.04
Electrochemical quantification of EVs at physiological concentrations
Pepijn Beekman
a, Dilu Mathewb and Séverine Le Gacc
aWageningen University, Wageningen, Netherlands; bNanoElectronics, University of Twente,
Enschede, The Netherlands, Enschede, Netherlands; cApplied Microfluidics for BioEngineering
Research, University of Twente, The Netherlands, Enschede, Netherlands
Introduction: Tumour-derived extracellular vesicles (tdEVs) are promising markers
for cancer patient management. An advantage of tdEVs over circulating tumour cells
is their higher concentration in patient blood by 3–4 orders of magnitude (∽103–105
tdEVs /ml), giving more robust information while requiring smaller sample sizes. However,
their small size and complex composition of blood samples require sensitive and selective
detection methods. Here, we report electrochemical detection of tdEVs using a nano-interdigitated
electrode array (nIDE) functionalized with cancer-specific antibodies and an antifouling
coating. The detection mechanism is based on enzymatic conversion of aminophenyl phosphate
(APP) by alkaline phosphatase (ALP) followed by redox cycling of the cleaved substrate,
yielding a double signal amplification. The proposed sensing scheme is 10 times more
sensitive than state-of-the-art detection approaches, giving a physiologically relevant
limit of detection (LOD) of 10 EVs/μl.
Methods: nIDEs (120 nm width, 80 nm spacing, 75 nm height) were functionalized with
an amino-undecanethiol monolayer, and reacted with poly(ethylene glycol) diglycidyl
ether. Anti-EpCAM antibodies were next immobilized to subsequently capture tdEVs.
Anti-EpCAM-alkaline phosphatase conjugates were then introduced to yield ALP-tagged
tdEVs. The non-electroactive pAPP was finally used to quantify the ALP concentration.
Results: With increasing tdEV concentration, an increase in redox current was measured,
from 0.35 nA for 10 tdEV/μl to 12.5 nA for 10^5 tdEV/μl (avg., n = 3). Current is
produced by the electroactive cleavage product of APP, which redox cycles between
electrodes. The short migration distance in our nanoelectrode array yielded a factor
∽8 improvement compared to micro-electrodes (3 μm width, spacing). As a negative control,
the experiment was performed with incubation of platelet derived EVs, whereby the
signal did not significantly increase (background current ∽0.15 nA).
Summary/Conclusion: A sensitive sensor was developed for the detection of EVs at unprecedented
low concentrations. With an LOD of 10 tdEVs/μl and high selectivity towards tdEVs,
our platform opens new avenues for screening patient blood samples.
Funding: Funded by NWO Perspectief
PS08.05
The Importance of Orthogonal Techniques in EV Quantification
Jean-Luc Fraikin
a, Franklin Monzonb, Lew Brownb, Mac Baileyb and Ngoc Dob
aSpectradyne LLC, Torrance, USA; bSpectradyne, Torrance, USA
Introduction: As EV research matures, so must measurement technologies. Two simple
experiments are reported that expose a critical failure mode of Nanoparticle Tracking
Analysis (NTA) for quantifying EVs: NTA’s small size limit of detection (LOD) depends
strongly on the composition of the sample, causing 10,000-fold errors within the EV
size range relative to Microfluidic Resistive Pulse Sensing (MRPS) and Tunnelling
Electron Microscopy (TEM). Results show orthogonal methods for EV quantification are
critical.
Methods: Experiment 1: Three sizes of polystyrene particles – 94, 150 and 208 nm diameters
– were measured by NTA and MRPS separately and after mixing in equal parts. The relative
concentration accuracy of NTA and MRPS was assessed as a function of size, and the
LOD evaluated for each sample.
Experiment 2: The striking implications of Experiment 1 were demonstrated in a real-world
sample. Urinary exosomes were measured by NTA, MRPS and the gold standard, Tunnelling
Electron Microscopy (TEM). The accuracy of relative concentration measurements was
assessed for each method.
Results: Experiment 1: Polystyrene standards were accurately quantified by MRPS: Each
component was clearly detected, and the relative concentrations of all were measured
to be approximately equal as intended. NTA showed similar results for the separate
components. However, NTA was unable to detect the 94 nm particles in the mixture and
showed quantification errors at 150 nm diameter.
Experiment 2: MRPS showed the particle size distribution expected: Concentration increased
with decreasing particle size with an approximate power-law dependence on diameter
reported elsewhere in the literature. MRPS was in excellent agreement with TEM. NTA
reported misleading results: A loss of counting efficiency was apparent as high as
200 nm diameter, and led to a 10,000-fold discrepancy by 65 nm. Critically, NTA reported
a prominent peak that does not in fact exist.
Summary/Conclusion: These experiments expose a critical failure mode of NTA: Its LOD
depends strongly on the composition of the sample, with enormous impact for EV measurements.
Critically, a researcher could be severely led astray by the NTA results in isolation,
without an orthogonal technique for reference.
PS08.06
Fourier-transform Infrared Spectroscopy (FT-IR) to fingerprint EV subpopulations as
a whole
Lucia Paolini
a, Stefania Federicib, Giovanni Consolic, Diletta Arceric, Annalisa Radeghierid, Ivano
Alessandrie and Paolo Bergesef
aDepartment of Molecular and Translational Medicine and CSGI, Università degli Studi
di Brescia, ITALY, Firenze, Italy; bDepartment Mechanical and Industrial Engeneering,
University of Brescia, Italy, Brescia, Italy; cDepartment Molecular and Translational
Medicine, University of Brescia, Italy, Brescia, Italy; dDepartment of Molecular and
Translational Medicine and CSGI, Università degli Studi di Brescia, ITALY, Brescia,
Italy; eDepartment of Information Engineering, University of Brescia, Italy, Brescia,
Italy; fDepartment of Molecular and Translational Medicine and CSGI, Università degli
Studi di Brescia, ITALY, Brescia, Italy
Introduction: Characterizing EV subpopulations remains a challenge, which up-to-date
has been tackled through analysis that assess for a single biochemical or biophysical
component of the target subpopulation. However, these approaches may be unsuitable
to describe EV subpopulations defined by higher level of heterogeneity. In our contribution,
we will discuss how Fourier-transform Infrared Spectroscopy (FT-IR) allows to fingerprint
EV subpopulations as a whole, presenting itself as a promising complement/alternative
to describe EV subpopulations
Methods: Medium from murine prostate cancer (TRAMP-C2) and skin melanoma (B16) cell
lines were processed with serial centrifugation: 800g 30’ to enrich large EVs (LEVs),
16,000g 45’ to enrich medium EVs (MEVs) and 100,000g for 4 h to enrich small EVs (SEVs).
LEVs, MEVs and SEVs were characterized for size, purity and EV markers with Atomic
Force Microscopy, colloidal nanoplasmonic assay and Western Blot, respectively. FT-IR
measurements were performed on LEVs, MEVs and SEVs re-suspended in milliQ water and
deposited onto a diamond cell. Spectral regions between 3100–2800 cm-1 and 1880–900 cm-1,
corresponding to lipids and proteins, respectively, were considered, and processed
by Principal Component Analysis (PCA)
Results: PCA was applied to data set of FT-IR spectra (five replicates for each EV
subpopulations) collected for TRAMP and B16 cell line and visualized with scores plots.
LEVs, MEVs and SEVs resulted grouped separately for both considered cell lines. Moreover,
spectra from the same subpopulation, but from different cells are reported in two
distinct groups
Summary/Conclusion: EV subpopulations of different sizes and cellular origin are characterized
by specific FT-IR fingerprint. This offers a proof of concept that FT-IR could be
effectively translated in real scenarios to characterize EVs with different content
and origin
Funding: LP acknowledges the BIOMANE grant (University of Brescia) and evFOUNDRY grant
(H2020-FETOPEN-2016–2017 – Project ID: 801367) for the financial support
PS08.07=OWP1.07
Exploration of the surface modification of outer membrane vesicles
Maximilian Richter
a, Eleonora Diamantib, Anna Hirschb and Gregor Fuhrmannc
aHelmholtz-Institute for Pharmaceutical Research Saarland, Biogenic Nanotherapeutics,
Saarbruecken, Germany; bHelmholtz-Institute for Pharmaceutical Research Saarland,
Drug Design and Optimization, Saarbruecken, Germany; cHelmholtz-Institut for Pharmaceutical
Research Saarland (HIPS), Saarbrücken, Germany
Introduction: Introducing bacteria-binding small molecules to the surface of outer
membrane vesicles (OMVs) could greatly improve their potential for antimicrobial drug
delivery to difficult to treat bacteria. Among the small number of studies on surface
modification of OMVs, very few deal with small molecules. The aim of the present study
is to evaluate different methods of introducing bacteria-specific targeting moieties
to OMVs. We assessed the modification of surface proteins using N-hydroxysuccinimide
(NHS) esters, well established for mammalian extracellular vesicles (EVs), cholesterol
insertion, mainly applied for liposomes and the novel application of diazo-transfer
followed by click-chemistry.
Methods: OMVs were obtained from model Myxobacteria by differential ultracentrifugation
(UC) followed by size exclusion chromatography (SEC). For cholesterol insertion and
NHS ester-modification, purified OMVs were incubated with either cholesteryl PEG 2000
FITC or sulpho cyanine7 NHS ester. For diazo transfer the pellet after UC was incubated
with a diazo transfer agent and the OMVs subsequently conjugated with DBCO-AF594.
Unincorporated dye was removed by SEC. Liposomes were composed of DMPC and DPPC in
2:3 molar ratio. Results represent correlated fluorescence intensity and particle
number.
Results: Treatment with sulpho cyanine7 NHS ester led to the modification with 547 ± 163
molecules per OMVs, compared to 18 ± 1 for the control using sulpho cyanine7 acid.
Cholesterol insertion introduced 4 ± 1 molecules per OMV, compared to 101 ± 23 for
liposomes. First results for the diazo-transfer showed 71 dye-molecules per OMV, with
32 for the control.
Summary/conclusion: Of the three methods, NHS ester-modification displayed the highest
efficiency, similar to published results for mammalian EVs. In comparison, diazo transfer
only yielded ~13% of the dye-molecules per particle. However, there are still many
parameters to be optimized for this method, including OMV concentration and incubation
period. Cholesterol insertion was unsuccessful for OMVs, probably owing to their membrane
structure. In this study, we aim to get important insights into the modification of
OMVs for bacterial targeting and EV-surface engineering in general.
Funding: This project was funded by Studienstiftung des Deutschen Volkes and Bundesministerium
fuer Bildung und Forschung.
PS08.08=OWP2.01
Identification of common EV markers in plasma using high-resolution flow cytometry
Anders Askeland
a, Jaco Bothab, Rikke Wehner Rasmussenb and Aase Handbergb
aAalborg University Hospital, Aalborg, Denmark; bDepartment of Clinical Biochemistry,
Aalborg University Hospital, Aalborg, Denmark, Aalborg, Denmark
Introduction: Recent advancements in flow cytometry (FCM) have led to the development
of high-resolution FCMs dedicated to the analysis of small particles (hFCM). hFCM
studies have predominantly focused on the analysis of EVs expressing phosphatidylserine
(PS). PS is enriched in microvesicles (MVs), wherein it is involved in lipid rearrangements
responsible for MV budding. While PS also is expressed on exosomes, it is unknown
whether it can be used as a universal marker for smaller EVs. In this study, we attempted
to characterize proteins enriched in smaller EVs (CD9, CD63, CD81 and ADAM 10) and
the relative co-expression of PS with each of these markers.
Methods: Flow cytometry analysis was performed on an Apogee A60 Micro-PLUS. In brief,
platelet-poor plasma (PPP) from healthy individuals was stained with lactadherin-FITC
(PS+) and one of several EV surface markers enriched in smaller EVs. To evaluate the
precise differences in PS and specific EV marker expression, the analysis was performed
twice, (1) triggering on lactadherin and (2) each EV marker (CD9-PE, CD81-PE, CD63-PE,
ADAM10-PE), separately. All antibodies were matched with appropriate isotope controls
and centrifuged at 17,000g for 10 min. prior to antibody labelling. EVs were defined
as lactadherin or EV surface marker positive events ≤1000 nm.
Results: Initial results indicate that CD9 is highly expressed on EVs and is not universally
associated to PS. Triggering on PS revealed that 34.7% of all events were CD9 positive
(CD9+|PS+). Conversely, triggering on CD9 resulted in a 2.1-fold increase in total
events, where 17.0% of events were PS+ (CD9+|PS+). Inferring size from silica nanospheres,
it appeared that populations containing CD9 (CD9+|PS+ and CD9+|PS-) were smaller (94.4–99.7%
<180 nm) compared to populations that did not (PS+|CD9-; 85.6% <180 nm & 95.2% <300 nm).
Interestingly, we did not detect CD81, CD63 or ADAM10 on EVs. We hypothesize that
this is due to a low abundance of these markers in PPP from healthy individuals.
Summary/conclusion: Our findings demonstrate that hFCM can be used for the characterization
of smaller EVs in PPP. Furthermore, we find that CD9+ EVs does not universally express
PS. From this point on, we plan to study enrichment of these EV phenotypes following
a number of EV purification protocols and determine whether EV isolation enable a
more extensive characterization of smaller EVs.
PS08.09=OWP2.02
Software to automate calibration and processing of flow cytometry data in clinical
studies
Edwin van der Pol
a, Frank Coumansb, Leonie de Rondc, Aleksandra Gaseckad, Najat Hajjie, Rienk Nieuwlandb
and Ton van Leeuwenf
aAmsterdam UMC, University of Amsterdam, Department of Biomedical Engineering and
Physics, Amsterdam, Netherlands, Amsterdam, Netherlands; bAmsterdam UMC, University
of Amsterdam, Laboratory of Experimental Clinical Chemistry, Amsterdam, Netherlands,
Amsterdam, Netherlands; cAmsterdam University Medical Centers, Amsterdam, USA; d1st
Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland;
eAmsterdam University Medical Centers, Amsterdam, Netherlands; fdAmsterdam UMC, University
of Amsterdam, Department of Biomedical Engineering and Physics, Amsterdam, Netherlands,
Amsterdam, Netherlands
Introduction: In search of new biomarkers, flow cytometers are used in clinical studies
to measure the concentration of specific extracellular vesicles (EVs). Flow cytometers
measure light scattering and fluorescence of single EVs in a fluid stream. However,
to realize data interpretation and comparison, light scattering and fluorescence signals
and the flow rate require calibration. Moreover, flow cytometers generate large datasets.
For example, a clinical study involving 60 patients, 30 controls and 8 antibody labels
covers 1224 data files, >33 gigabytes of data and >0.3 billion events. To manually
calibrate and analyse such a dataset would take days if not weeks and is prone to
human mistakes. Therefore, an urgent need exists for software to automate calibration
and processing of flow cytometry data.
Methods: We have developed software (MATLAB R2018a) to automatically process multiple
.fcs files and (1) relate two scatter signals to the diameter in nm and refractive
index (RI) of EVs, (2) express fluorescence signals in terms of molecules of equivalent
soluble fluorochrome (MESF), (3) export calibrated channels to new .fcs files, (4)
recognize unstable flow rates, (5) determine fluorescence thresholds, (6) apply gates,
(7) create PDFs with scatter plots and (8) report statistics. We are using clinical
studies to validate and apply the software.
Results: Compared to manual thresholding, automatic thresholding results in a systematic
decrease in counts of 10% and a maximum difference of 14% (n = 5). Using a high-end
laptop, data processing takes typically a minute or several seconds per .fcs file
with or without PDF reporting, respectively. Flow rate monitoring is useful for 61%
of the data. The platelet marker CD61 stains 7% of the events with an RI>1.42, which
are lipoproteins, and the concentration of these lipoproteins differed 4000-fold between
individuals.
Summary/conclusion: We have developed software to automate calibration and processing
of flow cytometry data in clinical studies, thereby reducing analyses time, preventing
human mistakes and providing new insights. For example, non-specific labelling of
antibodies to lipoproteins together with variations in lipoprotein concentrations
emphasize the relevance of fasting before venipuncture. Our next step is to extend
the software with machine learning.
Funding: NWO-TTW VENI 15924
PS08.10=OWP2.03
Conventional, high-resolution and imaging flow cytometry: potentials, pitfalls and
solutions for EV characterization
Jaco Botha, Rikke Wehner Rasmussen, Mathilde Sanden and Aase Handberg
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark,
Aalborg, Denmark
Introduction: Flow cytometry (FCM) has long been a preferred method for characterizing
EVs, however their small size have limited the applicability of conventional FCM to
some extent. Thus, high-resolution and imaging FCMs have been developed but not yet
systematically evaluated. The aim of this presentation is to describe the applicability
of high-resolution and imaging FCM in the context of EV characterization and the most
significant pitfalls potentially influencing data interpretation.
Methods: First, we present a side-by-side comparison of three different cytometry
platforms on characterizing EVs from blood plasma regarding sensitivity, resolution
and reproducibility: a conventional FCM, a high-resolution FCM and an imaging FCM.
Next, we demonstrate how different pitfalls can influence the interpretation of results
on the different cytometry platforms. Finally, we propose controls, solutions or workarounds
for understanding and limiting the influence of each of these pitfalls.
Results: (1) High-resolution FCM and imaging FCM displayed greater sensitivity and
resolution compared to conventional FCM when measuring a mixture of nanospheres. Equally,
both methods could detect larger concentrations of specific EV phenotypes than conventional
FCM, where imaging FCM outperformed high-resolution FCM. Within day variability (n = 20
aliquots) was similar for conventional and high-resolution FCM, while imaging FCM
had a markedly larger variability. Between day variability (n = 5 × 5 aliquots) was
similar for all three platforms. (2) The three most substantial pitfalls variably
influencing interpretation of results on the three platforms are non-specific binding
of labels, antibody aggregates and entities in the sample (i.e. lipoproteins) binding
EV-defining dyes. (3) The most important strategies for circumventing these pitfalls
are stringent matching, gating and comparison of antibodies and isotype controls,
high-speed centrifugation of antibodies and labels prior to staining, and the use
and interpretation of stained buffer controls and detergent-treated samples.
Summary/conclusion: High-resolution and imaging FCM hold great potential for EV characterization.
However, increased sensitivity also leads to new artefacts and pitfalls. The solutions
proposed in this presentation provide useful strategies for circumventing these.
PS08.11=OWP2.04
Convolutional neural networks for classification of tumour derived extracellular vesicles
Wooje Lee
a, Aufried Lenferinka, Cees Ottob and Herman Offerhausa
aUniversity of Twente, Enschede, Netherlands; bMedical Cell Biophysics, University
of Twente, Enschede, Netherlands
Introduction: Raman spectroscopy probes molecular vibration and thus reveals chemical
information of a sample without labelling. This optical technique can be used to study
the chemical composition of diverse EVs subtypes. EVs have a complex chemical structure
and heterogeneous nature so that we need a smart way to analyse/classify the obtained
Raman spectra. Machine learning (ML) can be a solution for this problem. ML is a widely
used strategy in the field of computer vision. It is used for recognizing patterns
and images as well as classifying data. In this research, we applied ML to classify
the EVs’ Raman spectra.
Methods: With Raman optical tweezers, we obtained Raman spectra from four EV subtypes
– red blood cell, platelet, PC3 and LNCaP – derived EVs. To classify them by their
origin, we used a convolutional neural network (CNN). We adapted the CNN to one dimensional
spectral data for this application.
The ML algorithm is a data hungry model. The model requires a lot of training data
for accurate prediction. To further increase our substantial dataset, we performed
data augmentation by adding randomly generated Gaussian white noise.
The model has three convolutional layers and fully connected layers with five hidden
layers. The Leaky rectified linear unit and the hyperbolic tangent are used as activation
functions for the convolutional layer and fully connected layer, respectively.
Results: In previous research, we classified EV Raman spectra using principal component
analysis (PCA). PCA was not able to classify raw Raman data, but it can classify preprocessed
data. CNN can classify both raw and preprocessed data with an accuracy of 93% or higher.
It allows to skip the data preprocessing and avoids artefacts and (unintentional)
data biasing by data processing.
Summary/conclusion: We performed Raman experiments on four different EV subtypes.
Because of its complexity, we applied a machine learning technique to classify EV
spectra by their cellular origin. As a result of this approach, we were able to classify
EVs by cellular origin with a classification accuracy of 93%.
Funding: This work is part of the research program [Cancer-ID] with project number
[14197] which is financed by the Netherlands Organization for Scientific Research
(NWO).
PS08.12=OWP2.05
Microfluidic electrochemical aptasensor for detection of breast cancer-derived exosomes
in biofluids
Leila Kashefi-Kheyrabadi, Sudesna Chakravarty, Junmoo Kim, Kyung-A Hyun, Seung-Il
Kim and Hyo-Il Jung
Yonsei University, Seoul, Republic of Korea
Introduction: Exosomes are nanosized extracellular vesicles, which are emerging as
potential non-invasive biomarkers for early diagnosis of cancer. However, the small
size and heterogeneity of the exosomes remain significant challenges to their quantification
in the biofluids. In the present research, a microfluidic electrochemical biosensing
system (MEBS) is introduced to detect ultra-low levels of breast cancer cell-derived
exosomes (BCE).
Methods: Fabrication procedure of MEBS comprises three main steps: first, biosensing
surface was prepared by immobilizing EPCAM binding aptamer (EBA) on a nanostructured
carbon electrode. The nanostructured surface (NS) consists of 2D nanomaterials including
MoS2 nano-sheets, graphene nano-platelets and a well-ordered layer of electrodeposited
gold nanoparticles. The NS was well characterized with FESEM and EDX. FESEM analysis
showed a well-ordered gold nano-structuring for 50 nM of gold solution. Furthermore,
EDAX analysis confirmed >60% coverage of gold nanoparticles on nano-structured surface
compared to bare carbon electrode. At the second step, a herringbone structured microfluidic
channel, which is able to enrich BCE was designed and fabricated. Finally, microfluidic
channel was integrated to biosensing surface. Different concentrations of exosome
solutions was introduced and enriched to biosensing surface (SPCE/NS/GNP/EBA) using
microchannel. After capturing BCEs on the sensing surface a secondary aptamer labelled
with silver nanoparticles (SNPs) as redox reporter was introduced to the sensing surface.
Results: Direct electro-oxidation of SNPs was monitored as analytical signal. The
unique design of microchannel in combining with high-specific interaction between
BCE and EBA provided a high-sensitive detection of BCE as low as ~100 exosomes/μl.
Summary/conclusion: The unique design of MEBS provides a highly sensitive accurate
platform for detection of ultra-low levels of cancer-derived exosomes. This tool holds
great potential for early cancer diagnosis in clinical applications.
PS08.13=OWP2.06
A software suite allowing standardized analysis and reporting of fluorescent and scatter
measurements from flow cytometers
Joshua Welsh and Jennifer C. Jones
Translational Nanobiology Section, Laboratory of Pathology, National Cancer Institute,
National Institutes of Health, Bethesda, USA
Introduction: Single vesicle analysis using flow cytometry is an extremely powerful
technique to allow identification of unique proteins in biological samples, as well
as enumerating the changes in concentrations. While small particle analysis (for viruses
and large microparticles) using flow cytometry has been conducted for several decades,
there is no comprehensive method for standardization of such studies. Therefore, we
developed a suite of flow cytometry post-acquisition analysis software (FCMPASS) tools
that enable the conversion of scatter and fluorescent axes to standardized units using
appropriate controls, writing standardized units to .fcs files for sharing upon publication
with open repositories, and exporting templates of obtained data.
Methods: Standalone software packages for scatter and fluorescent standardization
were built using MATLAB. The scatter software is based upon Mie modelling and is capable
of predicting the optical collection angle of the instrumentation and reporting the
Mie modelling criteria in a standardized way, making it possible to reproduce the
models and flow cytometry settings. Fluorescent standardization data uses least-squares
linear regression to enable conversions of arbitrary unit scales to molecules of equivalent
soluble fluorophore (MESF) using MESF calibration beads.
Results: The FCMPASS software converts arbitrary fluorescence units to MESF units
and writes them to data files for clearer reporting and sharing of data. FCMPASS also
converts arbitrary scatter units to a measurement of scattering cross-section using
modelling software that predicts the collection angle of the instruments and normalizes
the data automatically.
Summary/conclusion: Utilization of our FCMPASS software can help the EV flow cytometry
more easily implement standardization into their experimental analysis and the use
of the output templates can make reporting more consistent. While currently available
MESF controls can be further optimized for small particles, we believe their utilization
along with the other controls and can bring a new era to the reporting of EV research
using flow cytometry. This will be particularly useful for future comparison and validation
of translational studies and will enable better understanding and utilization of EVs
across a broad range of disciplines.
PS08.14
The effect of antibody binding on the zeta potential of extracellular vesicles secreted
by cultured human choriocarcinoma cells
Getnet B. Midekessa
a, Kasun Godakumarab, Ene Reimanna, Janeli Viila, Freddy Lättekivia, Keerthie Dissanayakea,
Sergei Kopanchukc, Lisa Thurstond, Stephen Ebbense, Ago Rinkenc and Toonika Rinkenc
aDepartment of Pathophysiology, Institute of Biomedicine and Translational Medicine,
University of Tartu, Estonia, Tartu, Estonia; bDepartment of Pathophysiology, Institute
of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia, Tartu,
Estonia; cInstitute of Chemistry, University of Tartu, Estonia, Tartu, Estonia; dAcademic
Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism,
Medical School, University of Sheffield, UK, Sheffield, United Kingdom; eDepartment
of Chemical and Biological Engineering, University of Sheffield, UK, Sheffield, United
Kingdom
Introduction: Research on extracellular vesicles (EVs), which include exosomes and
microvesicles, has witnessed an exponential increase in the past decade. EVs are membrane-derived
vesicles, which play vital role in transporting functional molecules to nearby or
distant cells, thus being involved in the intercellular communications. Developing
a reliable and quantitative method for confirming a nanoparticle as an EV is still
challenging. Nanoparticles carry a net surface charge due to the nature of their surface
molecules. We have hypothesized that EVs, which normally carry a negative zeta potential
(ZP), can be identified by the change of net surface charge when bound to EV-specific
antibodies.
Methods: ZP measurements were performed on EVs collected from the conditioned medium
of human choriocarcinoma (JAr) cells grown in EV-depleted media. EVs were purified
using size exclusion chromatography. EV populations were incubated with EV surface
membrane-specific antibodies and the change in the electrokinetic mobility upon the
binding of surface EV proteome with an antibody was measured using nanoparticle tracking
analysis (Zetaview; Particlemetrix, Inning, Germany).
Results: The mean+SEM ZP was −22.1 ± 0.8 mV and −20.5 ± 0.8 mV for non-treated JAr
EVs and immunoglobulin G isotype antibody (control)-treated EVs, respectively, indicating
the absence of influence of nonspecific binding. Whereas the ZP distribution of EVs
incubated with surface exosomal marker antibodies showed a significant positive shift
in the measured values compared to EVs incubated with control antibody. The mean+SEM
ZP values of EVs bound with CD63 and CD81 were 17.2 ± 1.1 mV and −17.8 ± 0.9 mV respectively
(N = 3 biological replicates of minimum 1000 particles measured in each replicate).
Western blot analysis showed particles carrying EV-specific surface markers. Furthermore,
we investigated the other factors that may have a potential effect on the changes
in EV’s electrokinetic mobility such as the concentration of particles and concentration
of the antibody.
Summary/conclusion: The measured antibody-specific changes in ZP values provide an
insight into the nature of the nanoparticle surface antigens in a biological sample.
ZP measurement is a simple, cost-effective and reliable method for profiling EV surface
composition.
PS09: EV Cancer Pathogenesis Chairs: Marta Prieto Vila; Judy YamLocation: Level 3,
Hall A15:00–16:00
PS09.01
Extracellular vesicles secreted from ganglioside GD3-expressing cancer cell lines
contain high levels of integrins: Roles of lipid rafts
Koichi Furukawa
a, Iori Kobayashi, Yoshiki Kodamab, Yuhsuke Ohmic, Satoko Yamamotod, Yuki Ohkawa,
Mariko Kambe, Keiko Furukawaa
aDepartment of Biomedical Sciences, College of Life and Health Sciences, Chubu University,
Nagoya, Japan; bDepartment of Biomedical Sciences, College of Life and Health Sciences,
Chubu University, Kasugai, Japan; cDepartment of Biochemical Sciences, College of
Life and Health Sciences, Chubu University, Kasugai, Japan; dKanazawa Medical University,
Uchinada, Japan
Introduction: Cancer-associated glycosphingolipids have been utilized as tumour markers
and targets of cancer therapy. We have analysed functions of gangliosides in cancers,
and reported that cancer-associated gangliosides enhance malignant properties of cells
by forming complexes with various membrane molecules. In this study, we have examined
contents of extracellular vesicles (ECVs) secreted from ganglioside GD3-expressing
cancer cells to investigate roles of gangliosides in the regulation of ECVs, leading
to the induction of cancer microenvironments and metastasis.
Methods: GD3-positive cells as well as GD3-negative control cells were established
by transfection of GD3 synthase (ST8SIA1) cDNA into melanoma, glioma and small cell
lung cancer (SCLC) cell lines. ECVs were collected from culture supernatants by repeated
ultra-centrifugation. Contents in ECVs were analysed by Western blotting. Roles of
lipid rafts were analysed by treating cells with 1 mM methyl β-cyclodextrin.
Results: In ECVs from GD3-positive melanoma cells, GD3 and ST8SIA1 mRNA were detected
in TLC and by RT-qPCR, respectively. In Western blotting, increased levels of integrin
families were detected in ECVs from GD3-positive melanoma cells compared with those
from GD3-negative cells. Similar increase of integrins was also found in glioma and
SCLC cells. This was contrastive with integrin levels in cell lysates from GD3-positive
and – negative cells, showing almost equivalent levels of integrins regardless of
GD3 expression. Particularly in melanoma cells, levels of integrin α2, β1 and β2 showed
marked increase in GD3-positive cell-derived ECVs. Treatment of GD3-positive melanoma
cells by 1 mM methyl β-cyclodextrin resulted in marked reduction of exosomes and TSG101
in them.
Summary/Conclusion: GD3 expression in cancer cells resulted in increased levels of
integrins in ECVs, suggesting that GD3 and integrins play roles in the malignant properties
of cancers by forming molecular complexes on ECVs. Lipid rafts may play roles as sites
for the complex formation.
Funding: Grants-in-aid from the Ministry of Education, Culture, Sports, Science and
Technology of Japan
PS09.02
Amniotic Epithelial Exosomes Result In Reversal of Epithelial to Mesenchymal Transition
in Hepatocellular Carcinoma Cell Lines
Daniel Huang
a, Fiona Leeb, Lei Zhouc, Nur Halisah Jumatc, Wan Xin Tand, Madelaine Theardyd, Ramanuj
Dasguptae, Yock Young Danf
aNational University Health System, Singapore, Singapore; bGenome Institute of Singapore,
SIngapore, Singapore; cDepartment of Medicine, National University of Singapore, SIngapore,
Singapore; dDepartment of Medicine, National University of Singapore, singapore, Singapore;
dGenome Institute of Singapore, singapore, Singapore; fDepartment of Medicine, National
University Hospital, singapore, Singapore
Introduction: Mesenchymal type hepatocellular carcinoma (HCC) with epithelial to mesenchymal
transition (EMT) constitutes the most aggressive HCC. Our work has shown that exosomes
from amniotic epithelial cells (AECs), an intriguing cell from the epiblast which
can switch between epithelial and mesenchymal phenotype, contain a myriad of growth
and signalling factors that regulate cell differentiation and has immunomodulatory
and antiproliferative properties. We hypothesize that modulation of HCC differentiation
into more differentiated epithelial phenotype via amniotic epithelial cell exosomes
will abrogate aggressive biology.
Methods: Size exclusion chromatography via the use of qEV columns was used to separate
AEC media into exosome (less than 100 nm) and non-exosome fractions (more than 100 nm).
Using the MACSPlex exosome kit, we showed the abundant expression of CD63, CD9 and
CD81 in these AEC exosomes. HUH-7, SK Hep-1 and HLF cell lines were seeded into plates
treated with exosomes, non-exosome fractions and control daily. Proliferation and
migration were assessed over 72 h by Alamar blue, Glo and wound healing assays. Immunofluorescence
for vimentin, E cadherin, KDR and EPCAM were performed to assess for epithelial to
mesenchymal transition (EMT).
Results: The proliferation of all three cell lines were significantly reduced in the
exosome and non-exosome arms compared with control, on both Alamar Blue stain and
Glo assay (all p < 0.05). Wound healing was reduced significantly in the exosome arm
vs. control in Sk-Hep1 and HLF (p = 0.016 and 0.004, respectively), but not in HUH-7
(p = 0.156).
On immunofluorescence, there was upregulation of the epithelial marker E cadherin
in the exosome and non-exosome arms in SK-Hep1 and HUH7, but it was not expressed
in the control arm. E cadherin was upregulated in the cells treated with exosomes
compared to non-exosomes in SK-Hep1 and HUH7. There was downregulation of the mesenchymal
marker vimentin in the HLF cells treated with exosomes and non-exosomes as compared
to control.
Summary/Conclusion: Exosomes have the ability to modulate HCC tumour biology, possibly
by pushing HCC cell lines into mesenchymal epithelial transition to become less proliferative
and motile.
PS09.04
Extracellular vesicles miRNA in mediating EGFR-TKI sensitivity in heterogeneous EGFR-mutant
NSCLC
Chien-Chung Lin
a, Chin-You Wub, Wei-Yuan Changb, Yu-Ting Huangc, Mei-Ling Tsai and Wu-Chou Sud
aDepartment of Internal Medicine, National Cheng Kung University Hospital, Tainan,Taiwan,
Tainan, Taiwan (Republic of China); bInstitute of Clinical Medicine, National Cheng
Kung University College of Medicine and Hospital, Tainan, Taiwan; cDepartment of Seafood
Science, National Kaohsiung University of Science and Technology, Kaohsiung Taiwan;
d1Center of Applied Nanomedicine, 2Department of Internal Medicine, College of Medicine
and Hospital, National Cheng Kung University, Tainan, Taiwan, Tainan, Taiwan (Republic
of China)
Introduction: Tumour heterogeneity has impacts on targeted drug resistance. At lung
cancer, the discordance rates of EGFR mutation implying tumour heterogeneity in metachronous
and synchronous settings were 14.3% and 9.1%, respectively. Extracellular vesicles
(EVs) serve as the transporter of bioactive molecules between cells and become one
of the major mechanisms contributing intratumoural heterogeneity via transferring
genetic information. Since most patients harbouring EGFR mutation showed excellent
response, we hypothesized that EVs mediate the crosstalk between EGFR mutant cell
and EGFR wild type cell contributing the change of sensitivity of EGFR wild type cell
to EGFR-TKI in heterogeneous NSCLC
Methods: We used ultrafiltration (UF) method to isolate the EV. To mimic tumour heterogeneity,
we next tested the significance of EV on EGFRTKI sensitivity of CL1-5 (EGFR-wild)
in co-culture system with PC9 (EGFR-mutant) pretreatment with or without GW4869. To
further evaluate the role of EV in gefitinib resistance, we harvested EV from PC9
cells and evaluated their effect on gefitinib sensitivity of CL1-5 in orthopedic animal
model. We further compared the EV miRNAs from PC9 to those from CL1-5 and identified
a panel of discriminative miRNAs.
Results: The CL1-5 uptake of PKH26 labelled exosomes derived from PC9 cell can be
recorded by time-lapse microscope. And the EGFRDel19 DNA and specific protein can
be detected in recipient wild-type EGFR cells by digital PCR and Western blotting
respectively. We demonstrated that wild-type EGFR lung cancer cell became sensitive
to EGFR-TKI after co-culture with PC9 cell for 48 h and then subjected to gefitinib
for 72 h. However, the pretreatment with GW4869 for 48 h reversed the sensitivity
to EGFR-TKI in co-culture system with PC9. In CL1-5 animal model, neither gefitinib
nor exosome treatment alone inhibited tumour growth compared to control group. Only
combination treatment with exosome and gefitinib delayed tumour growth. Some miRNA
among the panel such as miR-200 family have been identified associated with resistance
to EGFR-TKI
Summary/Conclusion: Our study proposed that in heterogeneous EGFR-mutant NSCLC, tumour
cells share biomolecules such as through local and systemic transfer of EVs, which
may affect cell sensitivity.
Funding: MOST-107-2314-B-006 −069 -
PS09.05
Senescent cells-derived extracellular vesicles repress tumour growth by transferring
miR-127-3p and miR-134-5p.
Megumi Okadaa, Kimiyoshi Yano
a, Shigeyuki Teranishib, Mariko Ikuoc and Hidetoshi Taharac
aHiroshima university, Hiroshima, Japan; bHiroshima university, Yokohama, Japan; cHiroshima
University, Hiroshima, Japan
Introduction: The mechanism called cellular senescence avoids tumourigenesis by arresting
DNA-damaged cells growth. The microRNAs are about 20-nt non-coding RNAs. MiRNAs complementary
bind to target mRNA and suppress their translations and/or stabilities. Cellular miRNAs
play important roles in cellular senescence induction, and termed as senescence associated
miRNAs. MicroRNAs are transferred by extracellular vesicles (EVs), and regulate phenotypes
of recipient cells. However, the roles of EV-miRNAs secreted from senescent cells
are still unclear. In this study, we examined whether EVs and EV-miRNAs secreted from
senescent cells regulate cancer cell’s activities.
Methods: The normal fibroblast TIG-3 was continuously cultured to establish replicative
senescent cells. EVs were collected by ultracentrifugation. Particle numbers and their
size distributions were analysed by a tunable resistive pulse sensing instrument (qNano;
IZON Science). The expressions of exosomal marker proteins were analysed by western
blot. MicroRNA expression profiles were analysed by next-generation sequencing. MicroRNA
and mRNA expressions were quantified by quantitative reverse transcription polymerase
chain reaction.
Results: EV secretion was elaborated in replicative senescent TIG-3 cells. Senescent
cell-derived EVs (S-EVs) treatment repressed growth of breast cancer cell line MDA-MB-231.
The expression of miR-127-3p and miR-134-5p were enriched in S-EVs. Mir-127-3p and
miR-134-5p expressions were increased in S-EVs treated cancer cells. Growth arrest
activity of S-EVs was inhibited by pretreatment of LNA-miRNA inhibitor for miR-127-3p
and miR-134-5p in MDA-MB-231.
Summary/Conclusion: Senescence cell-derived extracellular vesicles inhibited tumour
growth by transferring miR-127-3p and miR-134-5p.
PS09.06
Potential roles of cancer derived extracellular vesicles in lung cancer metastasis
and progression
Wei-Lun Huang
a and Wu-Chou Sub
aCenter of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan, Tainan,
Taiwan (Republic of China); b1Center of Applied Nanomedicine, 2Department of Internal
Medicine, College of Medicine and Hospital, National Cheng Kung University, Tainan,
Taiwan, Tainan, Taiwan (Republic of China)
Introduction: Cells release different types of nanometre sized extracellular vesicles
(EVs) of endosomal and plasma membrane origin consisting into the extracellular environment
to mediate intercellular communication. EVs have been shown to play important roles
in many diseases including tumour. However, the role of EVs in lung cancer is still
not fully understood. In this study, we tried to find out the biological functions
of EVs in lung cancer.
Methods: EVs were isolated from culture supernatants, serum, and malignant pleural
effusion (MPE) using ultra-centrifugation (UC) and ultra-filtration (UF) and then
evaluated by TEM, cryo-EM, and Nanosight. The biological functions of EVs were analysed
in both in vitro cell line model and in vivo animal model.
Results: EVs were isolated from culture supernatants from both cell lines and ex vivo
cultured cancer associated cells, and clinical biofluids using the classical ultra-centrifugation
(UC) method and alternative ultra-filtration (UF) method. The EVs could be uptake
by lung cancer cells and trigger oncogenic signals such as Stat3 and Akt. Previously,
we have shown that IL-6/Stat3/tissue factor (TF)/VEGF pathway plays an important role
in lung cancer angiogenesis and metastasis. Here, we showed that EVs from lung cancer
samples carried high level of VEGF and TF and triggered vascular permeability changes
in both in vitro and in vivo models.
Summary/Conclusion: Using the UC as well as the UF methods, we isolated EVs not only
from culture supernatants but also lung cancer associated clinical samples and showed
that the EVs triggered oncogenic signals in an autocrine/paracrine fashion and increased
vascular permeability. These results may help the understanding of potential roles
of cancer derived extracellular vesicles in lung cancer metastasis and progression.
Funding: This work was financially supported by the Centre of Applied Nanomedicine
from The Featured Areas Research Centre Program within the framework of the Higher
Education Sprout Project by the Ministry of Education in Taiwan, MOHW 106-TDU-B-211–144004
and MOHW 105-TDU-B-211–133016 from the Ministry of Health and Welfare in Taiwan, MOST
106–2314-B-006–040-MY2, and MOST 104-2314-B-006-046-MY3 from the Ministry of Science
and Technology in Taiwan.
PS09.07
Whole transcriptome and miRNome profiling of plasma-derived extracellular vesicles
cargo in haematological malignancies.
Maddalena Arigonia, Federica Riccardoa, Antonella Padellab, Luca Alessadric, Neha
Kulkarnic, Martina Oliveroa, Ana Rodriguez-Vicented, Jesus Hernandez-Rivasd, Giovanni
Martinellib and Raffaele A. Calogero
a
aUniversity of Torino, Torino, Italy; bUniversity of Bologna, Bologna, Italy; cUniversity
of Torino, Torino, USA; dUniversity of Salamanca, Salamanca, Spain
Introduction: Extracellular vesicles (EVs) role in patients with haematological malignancies
has not been investigate as extensively as in solid cancers. In this study, the overall
composition of RNA species content of plasma derived EVs isolated from lymphoid and
myeloid malignancies (B-cell chronic lymphocytic – CLL, acute myeloid – AML, acute
lymphoid – ALL leukemia, monoclonal B-cell lymphocytosis – MBL, myelodisplastic syndrome
– MDS, myeloproliferative neoplasms – MPN) was investigated.
Methods: Participants gave written informed consent in accordance with the Declaration
of Helsinki. EVs were isolated with ExoquickTM (System Biosciences) from plasma collected
from patients and then analysed with Nanosight. Whole transcriptome (WTS) and small
RNA sequencing were performed respectively on 123 and 256 samples. TruSeq stranded
mRNA library preparation kit (Illumina) was used to detect coding and long non-coding
RNAs. Small RNA libraries were prepared using the NebNext kit (NEB). Differential
expression (DE) analysis of RNA species was done with EdgeR Bioconductor package (ANOVA-like)
and DESeq2 implemented in docker4seq package using as reference the expression values
detected in HD.
Results: The analysed EVs have size ranging between 80 and 250 nm. WTS generated,
on average, more than 10 million mapped reads/samples. The RNA cargo was mainly composed
of protein coding genes (95%), and the remaining fraction by lincRNAs and processed
pseudogenes. 48 RNAs were detected as DE comparing diseases to HD. Among them 14 were
mitochondrial pseudogenes over-expressed in all diseases with respect to HD and their
expression is higher in chronic versus acute diseases. Small-RNA seq generated at
least 100,000 mapped reads/samples. Sets of miRNAs able discriminate each disease
from HD were also detected. Further, analysis to detect disease-specific and disease-predictive
signatures are in progress.
Summary/Conclusion: This study gives an overview of plasma derived EVs RNAs cargo
in haematological diseases. The analysis of the common/unique RNA biotypes and the
evaluation of their expression levels among samples, can guide the identification
of patients’ stratification markers. Moreover, this study provides a collection of
EVs-associated RNAs/miRNAs to be used as reference in different applications in liquid
biopsy research.
Funding: FP7 NGS-PTL European grant
PS09.08
The mechanism of non-metastatic contagious carcinogenesis
Tatiana Lopatina
a, Enrica Favarob, Benedetta Bussolatic, Ludmila Danilovad, Tiziana Martonee, Elana
J Fertigd, Renato Romagnolif, Alexander V Favorovd, Maria Felice Brizzig, Giovanni
Camussig and Daria A Gaykalovad
aPostdoc, Turin, Italy; bDepartment of Medical Sciences, University of Turin, Turin,
Italy, Torino, Italy; cDepartment of Molecular Biotechnology and Health Sciences,
University of Turin, Turin, Italy, Turin, Italy; dDepartment of Oncology, The Sidney
Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore,
MD, USA; eUniversity of Turin, Turin, Italy, Torino, Italy; fGeneral Surgery 2U, Liver
Transplantation Center, AOU Città della Salute e della Scienza di Torino, University
of Turin, Turin, Italy; gDepartment of Medical Sciences, University of Turin, Turin,
Italy
Introduction:
Background: Head and neck squamous cell carcinoma (HNSCC) has a high recurrence and
metastatic rate with an unknown mechanism of cancer spread. Tumour inflammation is
the most critical processes of cancer onset, growth and metastasis. By inflammation,
tumour cells can establish an immunosuppressive microenvironment to induce cancer
progression.
Hypothesis: We hypothesize that the release of extracellular vesicles (EVs) by tumour
endothelial cells (TEC) induce reprogramming of immune cells as well as stromal cells
to create an immunosuppressive microenvironment that favour tumour spread. We call
this mechanism as non-metastatic contagious carcinogenesis.
Methods: EVs were collected from primary HNSCC-derived endothelial cells (TEC-EVs)
and were used for stimulation of peripheral blood mononuclear cells (PBMC) and primary
adipose mesenchymal stem cells (ASCs). Regulation of ASC gene expression was investigated
by RNA sequencing and protein array. PBMC stimulated with TEC-EVs were analysed by
ELISA and FACS. The effect of ASCs or PBMC, treated with TEC-EVs, we demonstrated
on tumour cells using various in vitro assays, such as invasion, adhesion or proliferation.
Results: We found and confirmed that TEC-EVs were able to change ASC inflammatory
gene expression within 24–48 h. TEC-EVs were also able to enhance the secretion of
TGFb1 and IL-10 by PBMC and to increase T regulatory cell (Treg) expansion. TEC-EV
carries specific proteins and RNAs relevant for Treg differentiation and immune suppression.
ASCs and PBMC, treated with TEC-EVs, enhanced proliferation of tumour cells, their
adhesion, and invasion, therefore driving non-metastatic cancer spread.
Summary/Conclusion: Conclusions. These data indicate that TEC-EVs are a mechanism
of non-metastatic contagious carcinogenesis that regulates tumour microenvironment
and reprogrammes immune cells to sustain tumour growth and progression.
Funding: NIH fund R21DE025398, Grants from the Associazione Italiana per la Ricerca
sul Cancro (AIRC) projects IG 2015.16973 and IG 2015.17630
PS09.09
Exosomes from mitotic slippage-induced senescent cells stimulate inflammatory response
Rekha Jakhar, Joycelyn Teo and Karen Crasta
Nanyang Technological University Singapore, Singapore, Singapore
Introduction: Microtubule-targeting drugs are the most-commonly used first-line chemotherapy.
We previously showed nocadazole treatment can lead to paracrine pro-tumorigenic effects
via mitotic slippage-induced senescence. Senescent cells exosomes, which role in non-cell
autonomous cell-cell communication. The aim of this study was to decripher effect
of exosomes released from senescent-inflammatory breast cancer cells post-slippage
on recipient normal breast cells.
Methods: MDA-MB-231 and MCF-10A breast cancer cell lines treated with Noc (100 ng/µl)
for 72 h. Conditioned media (CM) was prepared after Noc and DMSO treatment by incubating
cells in growth media containing exosome-depleted FBS for 72 h. CM was then collected
and centrifuged at 500 ×g 10 min, 2000 ×g 30 min and 15,000 ×g 30 min at 4°C to remove
cells and large debris. Supernatant was filtered, exosomes pelleted at 120,000 ×g,
2 h, 4°C, washed with PBS, centrifugation at 100,000 ×g,1 h, 4°C. Exosomes were dissolved
in PBS for whole exosome experiments or processed for total RNA, miRNA and protein
isolation for microRNA profiling, RNA-seq and mass spec.
Results: Mitotic-slippage-induced senescent (MIS) cells activate NFκB pathway and
increase exosome production, assessed via immunoblots of cytoplasmic and nuclear protein
fraction, and IF for p65 localization. We characterized exosomal proteins using TMT
labelling and detected significant upregulation of caveolin-1 in Noc treated exosomes.
Exosomal microRNA also showed significant upregulation of inflammatory pathway-related
genes upon Noc-treatment. Exosomes were transferred from MDA-MB-231 cells after Noc
treatment to the recipient MCF-10A cells. Uptake of MIS-derived exosomes resulted
in transfer of NFκB response in recipient cells.
Summary/Conclusion: Noc treatment leads to MIS and inflammation in MDA-MB-231 cells.
Exosomes released from senescent-inflammatory breast cancer cells contribute to transfer
of soluble factors which activate inflammatory pathway in recipient cells. Hence,
senescence-induced exosomes can transfer therapy-induced immune signalling via non-cell
autonomous mechanisms.
Funding: National Research Foundation Fellowship Singapore MOE AcRF Tier 2015-T1-002-046-01.
PS09.10
Extracellular vesicles from breast cancer cells deliver microRNA-125b to activate
cancer-associated fibroblasts
Minh T. Le
a, Luyen Vua, Boya Penga and Judy Liebermanb
aCity University of Hong Kong, Kowloon, Hong Kong; bBoston Children’s Hospital, Boston,
USA
Introduction: Extracellular vesicles (EVs) are often released by tumour cells for
intercellular communication with other cell types in the tumour niches. However, it
is unclear which cell type is the most frequent recipient of tumour EVs in vivo.
Methods: To analyse the cell types taking up EVs from tumour cells, we created breast
cancer cell lines secreting fluorescent EVs, with CD63-GFP fusion protein or with
surface mCherry. The cells were implanted in the mouse mammary fat pad or tail vein
and the uptake of EVs were analysed in different cell populations of the tumours and
the lungs using FACS. We then purified EVs from breast cancer cells using ultracentrifugation
and profiled miRNAs using sequencing. The abundance of miR-125b was validated in size
exclusion chromatography -purified EVs. The function of miR-125b was analysed by knockdown
or overexpression experiments.
Results: We found that fluorescent EVs from tumour cells are taken up most robustly
by fibroblasts in the tumours or the metastatic lungs. Our RNA sequencing data revealed
that miR-125b is one of the most abundant microRNAs in the EVs from mouse 4T1 and
4TO7 cells. Treatment with 4T1 EVs promotes fibroblast activation in isogenic 4TO7
tumours. This is rescued by knocking down miR-125b in 4T1 EVs; therefore, miR-125b
transfer by EVs is responsible for the fibroblast activation. Similarly, we found
that miR-125b is abundant in EVs from human breast cancer cells. The uptake of EVs
from human breast cancer cells increases cellular levels of miR-125b in the resident
fibroblasts hence upregulates several markers of cancer-associated fibroblasts in
vivo. miR-125b overexpression also upregulates alpha-SMA and promotes invasion of
isolated fibroblasts in vitro. We further identified Tp53 and Tp53inp1 as the targets
of miR-125b that are responsible for the phenotype.
Summary/Conclusion: In summary, our study shows that the delivery of miR-125b in EVs
from breast cancer cells to resident fibroblasts promotes the development of cancer-associated
fibroblasts in the tumour microenvironment.
Funding: This study is supported by City University of Hong Kong (grant 9610343, 9667133
and 7200475), the Hong Kong Health and Medical Research Fund (03141186), the Hong
Kong Research Grants Council (21106616) and the National Natural Science Foundation
of China (81602514 and 81773246).
PS09.11
Carnitine palmitoyltransferase 1 regulates proliferation of prostate cancer cells
under hypoxia via extracellular vesicles-mediated removal of oxidized proteins
Gagan Deep, Leslimar Rios-Colon, Gati Panigrahi, Yixin Su, Kiran Kumar Solingapuram
Sai, Isabel Schlaepfer, Jingyun Lee, Cristina Furdui and Deepak Kumar
Wake Forest Baptist Medical Center, Winston Salem, USA
Introduction: Prostate cancer (PCa) is the most common cancer in men with 164,690
new cases and 29,430 deaths estimated in the USA in 2018. Studies have shown that
hypoxia determines PCa aggressiveness, and poor outcome. We have recently reported
that increased extracellular vesicle (EV) secretion under hypoxia promotes survival
of aggressive PCa cells; here, we focused on underlying molecular mechanism/s.
Methods: PCa cells were cultured under normoxia (~21% O2) or hypoxia (1% O2), and
EVs (exosomes) isolated from the conditioned media by ultracentrifugation. β-oxidation
was measured using a novel PET tracer (18[F]Fluoro-4-thia-oleate), reactive oxygen
species (ROS) levels measured by DCF-DA staining, and oxidized proteins in PCa cells
and EVs were measured using an oxidative stress sensor (BP1:biotin-1,3-cyclopentanedione)
followed by immunoblotting and mass spectrometry (MS). CPT1 knock-down and overexpressing
PCa cells were generated using lentiviral particles.
Results: We identified PCa cell lines (E006AA-hT, MDA PCa 2b, 22Rv1 and WFCB17) with
higher proliferation under hypoxia compared to normoxia. These cells showed increased
lipid uptake and β-oxidation under hypoxia. CPT1 is the main regulator of β-oxidation,
and CPT1 knock-down in PCa cells significantly reduced the viability, clonogenicity
and stemness under hypoxia; while CPT1 overexpression increased the PCa cells proliferation,
clonogenicity and stemness. Both hypoxia and β-oxidation are known to promote oxidative
stress, and we also observed high ROS levels in PCa cells under hypoxia. We also observed
higher amount of oxidized proteins in hypoxic PCa cells, measured by BP1 labelling
and immunoblotting. MS analyses identified the signature of oxidized proteins that
were altered in PCa cells under hypoxia. Interestingly, PCa cells proliferating under
hypoxia secreted increased concentration of EVs, loaded with high amount of oxidized
proteins; while treatment with either exosomes biogenesis inhibitors (GW4869 and DMA)
or antioxidants (N-acetylcysteine and ascorbic acid) strongly reduced the growth of
PCa cells under hypoxia.
Summary/Conclusion: PCa cells could proliferate under hypoxia through CPT1-mediated
increased β-oxidation and via managing high intracellular oxidative stress through
EV-mediated removal of oxidized proteins.
PS10: EV Cancer Pathogenesis II Chairs: Hiroshi Ageta; Ming Jer TangLocation: Level
3, Hall A15:00–16:00
PS10.01
Prostate cancer cells promote bone metastasis through extracellular vesicles
Fumihiko Urabe
a, Nobuyoshi Kosakab, Yusuke Yamamotoc, Takahiro Kimurad, Shin Egawad and Takahiro
Ochiyab
aDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute,
Tokyo, Japan; bDepartment of Molecular and Cellular Medicine, Institute of Medical
Science, Tokyo Medical University, Shinjyuku-ku, Japan; cDivision of Molecular and
Cellular Medicine, National Cancer Center Research Institute, Tokyo, USA; dDepartment
of Urology, The Jikei University School of Medicine, Tokyo, Japan
Introduction: Bone metastasis (BM) is one of the major concerns that causes skeletal-related
events and increases mortality in prostate cancer (PCa) patients. Vicious cycle paradigm
has been proposed to describe how PCa cells educate osteoblasts and osteoclasts (OCs)
to benefit the survival and growth of the PCa cells in the metastatic site. However,
the underlying mechanisms of BM in PCa remain obscure. Here, we show that extracellular
vesicles (EVs) from PCa cells (PCa-EVs) are involved in the vicious cycle, and contribute
to the progression of BM.
Methods: PCa-EVs and normal prostatic epithelial cell (NPE)-derived EVs (NPE-EVs)
were isolated by ultracentrifugation and evaluated their effect on OC differentiation
by Tartrate-resistant acid phosphatase (TRAP) stain. PCa-EVs and NPE-EVs were analyzed
using LC-MS/MS to identify candidate proteins which promote OC differentiation. Then,
a small-scale screening was conducted using siRNA in PCa cells to determine proteins
essential for osteoclastogenesis. The expression level of the specific molecule on
EVs was evaluated in clinical samples.
Results: We found that PCa-EVs promoted OC differentiation in the presence of RANKL.
In addition, RNA sequence analyses confirmed the drastic change of gene expression
essential for osteoclastogenesis in OC precursors. Moreover, we found a specific molecule
on EVs which promote OC differentiation. Elimination of the molecule on PCa-EVs led
to the attenuation of OC differentiation. In addition, overexpression of this molecule
promoted OC differentiation. Finally, we found the molecule on EVs was specifically
detected in plasma-derived exosomes from PCa patients with bone metastasis compared
to non-metastatic PCa patients.
Summary/Conclusion: PCa-EVs synergistically activate osteoclastogenesis with RANKL.
PCa-EVs will be the novel diagnostic and therapeutic target for BM in PCa, leading
the great improvement of quality of life in PCa patients.
PS10.02
Novel Exosomal miRNAs-891-5p as an Indicator of Chemoresistance in Ovarian Cancer
Mona G. Alharbi
a, Carlos Salomon
a, Dominic Guanzona, Andrew Laib, Alexis Salasc, Carlos Palmab, Katherin Scholz-Romerob,
Yaowu Hed, Felipe Zunigae, Lewis Perrinf and John Hooperf
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland
Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University
of Queensland, Brisbane, Australia; bExosome Biology Laboratory, Centre for Clinical
Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane
and Women’s Hospital, The University of Queensland, Brisbane, Australia; cFaculty
of Biological Science, Department of Pharmacology, Universidad de Concepción, Concepción,
Chile; dMater Research Institute-University of Queensland, Translational Research
Institute, Woolloongabba, Australia; eDepartment of Clinical Biochemistry and Immunology,
Faculty of Pharmacy, University of Concepción, Concepción, Chile; fMater Health Services,
South Brisbane, Australia
Introduction: Ovarian cancer patients usually have a poor prognosis and low five year’s
survival rate because it predominantly presents at late stages of the disease. New
approaches are required to develop more effective early detection strategies and real-time
response monitoring to the available treatments. Thus, this study aimed to identify
an exosomal signature which can be used to determine a patient’s response to the chemotherapy.
Methods: A panel of ovarian cancer cell lines were used in this study. Cell migration,
proliferation and apoptosis in response to different concentrations of carboplatin
(0-100 µM) were evaluated using a real-time monitoring system (Incucyte). The miRNA
profile was determined using TruSeq® SmallRNA Library (Illumina). Hierarchical clustering
and principal component analysis (PCA) were used for multi-omics analyses. Subsequently,
candidate miRNAs inducing chemoresistance was confirmed in cells and their exosomes.
Candidate miRNAs (mimic) were incubated on sensitive ovarian cancer cells (CAOV-3)
and cells response to carboplatin was determined. Finally, a set of miRNAs were validated
in circulating exosomes obtained from a small cohort of patients who experience cancer
relapse.
Results: The migration capacity of these cells were associated with cell apoptosis
in response to carboplatin with EC50 (concentration of a drug that gives half-maximal
response) of 12.1 ± 2.6, 9.4 ± 2.2, 4.4 ± 1.5, 4.1 ± 1.6, 4.0 ± 1.9, 2.8 ± 0.9, 1.5 ± 0.6,
0.9 ± 0.2 and 0.7 ± 0.1 for HEY, SKOV-3, OVACR-429, OV90, OVTOKO, OVCAR-420, OVCAR-3,
CAOV-3 and TOVII-2D, respectively. In contrast, the proliferation of these cells was
inversely correlated (p < 0.005) with their migration and EC50. Based on migration,
proliferation and response to carboplatin PCA separated into four distinct groups.
Using miRNA approach, we successfully identified miR-21-5p, 3p and miR-891-5p that
were enriched in resistant cells and their exosomes. Transfected CAOV-3 cells (sensitive
cells) with miRNAs showed a reduction in cells sensitivity to carboplatin. Finally,
we were able to confirm the expression of these miRNAs in plasma from ovarian cancer
patients.
Summary/Conclusion: We suggest that exosomal cargo may be used as prognostic biomarkers
to monitor the response to treatments in patients with ovarian cancer.
PS10.03
Functional analysis of exosomes in cancer metastasis
Yoshiki Kodama
a, Yuhsuke Ohmi
b, Zhang Qingc, Satoko Yamamotod, Keiko Furukawad and Koichi Furukawad
aDepartment of Biomedical Sciences, College of Life and Health Sciences, Chubu University,
Kasugai, Japan; bDepartment of Biochemical Sciences, College of Life and Health Sciences,
Chubu University, Kasugai, Japan; cDepartment of Biochemistry II, Nagoya University
Graduate School of Medicine, Tokyo, Japan; dKanazawa Medical University, Uchinada,
Japan; eDepartment of Biomedical Sciences, College of Life and Health Sciences, Chubu
University, Nagoya, Japan
Introduction: The development of metastasis is a cause of death in many human cancers.
Mechanisms for the acquisition of metastatic potential remain unknown. Recently, it
has been reported that exosomes are a trigger of cancer metastasis. Exosomes are small
vesicles that are secreted from cells and have been found to mediate signal transduction
between neighbouring or distant cells. They have the tendency to specifically interact
with target cells. In the future, it may be possible that exosomes can be used as
biomarkers to predict the metastatic destination.
Methods: Established mouse Lewis lung cancer cells (low or high metastatic sublines)
were examined about proliferation, migration, invasion and gaglioside expression by
MTT assay, trans-well assay and flow-cytometry. Cells were inoculated into the mice
subcutaneously or via tail vein, then tumour and metastatic tissues were observed
by H&E stain. Cells from tumour sites were cultured then examined about proliferation
and invasion ability. Exosomes were isolated from cell culture medium by differential
centrifugation, and used for Western blotting. Cells treated by exosomes were analysed
for malignant properties as described above.
Results: In proliferation, migration, and invasion assay, low metastatic subline showed
lower proliferation, migration, invasion activity than high metastatic sublines. In
flow-cytometry, high metastatic sublines showed decreased GM1 and GD1a expression
levels compared with low metastatic subline. To examine metastatic ability, the cells
were inoculated into mice. After 2–4 weeks, invasive- and metastatic- foci to distant
tissues such as thigh muscle and lung were observed. To examine effects of exosomes
on culture cells, cells were treated with isolated exosomes. As a result, low metastatic
subline treated with high metastatic cell-derived exosomes showed increased proliferation,
migration, and invasion activity, and increased phosphorylation of intracellular signalling
molecules such as paxillin and Erk1/2. In turn, high metastatic subline treated with
low metastatic cell-derived exosomes showed reduced proliferation, migration, and
invasion activity, and phosphorylation of intracellular signalling molecules.
Summary/Conclusion: High metastatic subline-derived exosomes enhanced malignant properties
in low metastatic sublines.
PS10.04
Profiling of circulating exosomal content across epithelial ovarian cancer and the
role of exosomes in tumour progression
Shayna Sharma
a, Andrew Laia, Dominic Guanzonb, Terry Morganc, Lewis Perrind, John Hooperd and Carlos
Salomonb
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland
Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University
of Queensland, Brisbane, Australia; bExosome Biology Laboratory, Centre for Clinical
Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane
and Women’s Hospital, The University of Queensland, Brisbane, Australia; cDepartment
of Pathology and Obstetrics, Oregon Health and Science University, Portland, OR, USA;
dMater Health Services, Brisbane, Australia
Introduction: A significant proportion of patients with epithelial ovarian cancer
(EOC) often present with advanced stage disease, when treatment options are limited.
Therefore, it is essential to gain a better understanding of the tumour microenvironment
to identify potential therapeutic targets. We profiled the exosomal content (miRNAs
and proteins) of patients with EOC and examined the effect of these exosomes on cells
within the tumour microenvironment.
Methods: A cohort of 127 patients were included in this study. Exosomes were isolated
and characterized from plasma obtained at different stages of EOC. A small RNA library
was prepared, and the expression of specific miRNAs was validated using RT-qPCR. The
protein profile was determined using Mass Spectrometry (MS/MS) and SWATH Analysis.
Exosomal proteins and miRNAs were subjected to linear mixed modelling analysis using
the lme4 package in “R”. Fibroblast cells were incubated with patient-derived exosomes
and monitored using the IncuCyte(TM), a live-cell imaging system. Cell proliferation
and migration was determined over the course of the experiment and RNA and proteins
were extracted after 48 hours. The expression of nine specific miRNAs was confirmed
using RT-qPCR and the protein profile determined using MS/MS.
Results: Exosomal miRNAs and proteins demonstrated differential expression with advancing
cancer progression, following at least three distinct patterns of change: increasing,
constant or decreasing rate. Ingenuity Pathway Analysis analysis revealed that the
exosomal content was associated mainly with cell–cell communication and cell migration.
Functional analysis showed that exosomes increase fibroblast migration and proliferation
in association with EOC progression (i.e. Stages I to IV). MS/MS identified 115 proteins
differentially expressed between early stage and advanced stage-exosome treated cells.
A comparison between control cells (no treatment) and treated cells showed a difference
in the expression of 126 proteins, with tumour suppressor, Paired Box 1 and lysosomal
trafficking protein, VPS41 expression, significantly lower in the treated cells (p < 0.05).
Summary/Conclusion: We propose that exosomes present in the circulation of EOC patients
transfer oncogenic cargo to cells present in the tumour microenvironment to promote
cancer progression.
PS10.05
Extracellular vesicle-mediated transmission of bone morphogenic proteins in Acute
Myelogenous Leukaemia
John Butler
a, Ben Doronb, Sherif Abdelhamedc, Peter Kurred and Daniel Markse
aMedical Scientist Training Program, Oregon Health & Science University, Portland,
USA; bHuman Biology Division, Fred Hutch Center for Cancer Research, Seattle, USA;
cKnight Cancer Institute, Oregon Health & Science University, Portland, USA; dChildren’s
Hospital of Philadelphia, Philadelphia, USA; eDepartment of Pediatrics, Oregon Health
& Science University, Portland, USA
Introduction: Acute Myelogenous Leukaemia (AML) is an aggressive cancer originating
from abnormal white blood cells of the bone marrow (BM). AML modifies the BM into
a pro-leukaemic niche in part through the release of extracellular vesicles (EVs).
We previously demonstrated that AML EVs decrease mature blood cell production, and
traffic to stromal cells to induce osteogenesis. We hypothesized that AML cells utilize
EVs to transmit regulatory factors to recipient BM cells to change the cellular composition
of the BM and support cancer progression. Our studies confirmed that AML EVs contain
bone morphogenic protein (BMPs) – historically though to be secreted growth factors
– involved in formation of bone and maintenance of stem cells.
Methods: To identify the association of BMPs with AML EVs, we used both in vitro and
in vivo xenograft models, and a combination of ELISA, flow cytometry, and super resolution
microscopy.
Results: AML cells explanted from the BM display marked ER-stress in comparison to
in vitro cultured cell types as an adaptive response to the tumour microenvironment.
In AML blasts, the expression of BMP-2,4,6,7 mRNA strongly correlated with the activation
of the unfolded protein response pathway (which acts to mitigate ER-stress). Inducing
ER-stress in AML cells in vitro resulted in both an increase in BMP protein as well
as total EVs produced. EVs released from these cells contained ~3-fold more BMP-2,6
over non-stressed cells, whereas the level of free-BMP-2,6 in supernatant remained
unchanged. Exposing these purified EVs to BM stromal cells induced osteogenic differentiation
and apoptosis. Additionally, in ER-stressed AML cells, BMP-2 localizes into CD63+ intracytoplasmic
vesicles – indicative of pre-exosomal multivesicular bodies – further confirming the
EV-BMP association. Thus far, AML cells have been found to release EVs that contain
BMP-2 and −6, while additional BMP types remain to be tested.
Summary/Conclusion: Since we have shown that AML EVs rapidly accumulate within stromal
cells in vitro and in vivo, altering cellular phenotypes, we propose that EVs concentrate
and target functional BMPs directly to these cells to create a pro-leukaemic environment.
EV trafficking of BMPs is a novel signalling mechanism that may explain phenotypic
changes seen in leukaemic BM, and their role in leukaemic progression merits further
study.
PS10.06
Exosomes derived from differentially invasive ovarian cancer cells modulate tumour
growth and metastasis in vivo
Mona G. Alharbi
a, Carlos Salomon
a, Andrew Laib, Yaowu Hec, Felipe Zunigad and John Hoopere
aExosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland
Centre for Clinical Research, Royal Brisbane and Women’s Hospital, The University
of Queensland, Brisbane, Australia; bExosome Biology Laboratory, Centre for Clinical
Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane
and Women’s Hospital, The University of Queensland, Australia; 3Mater Research Institute-University
of Queensland, Translational Research Institute, Brisbane, Australia; dDepartment
of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepción,
Concepción, Chile, Concepción, Chile; eMater Health Services, South Brisbane, Brisbane,
Australia
Introduction: Exosomes have been likened to a “fingerprint” of their originating cells,
as they contain several bioactive molecules which can be delivered to the target cells
at either local or distant locations. The delivery of these biomolecules can cause
changes in gene expression and signalling in the target cells. Hence, in this study,
we aimed to explore the impact of exosomes on tumour growth/metastasis in a xenograft
model and assess the changes in the proteomic content of tumour cells and exosomes
from mice.
Methods: Exosomes were isolated from highly invasive SKOV-3 (exo-SKOV-3) and less
invasive OVCAR-3 (exo-OVCAR-3) ovarian cancer cell lines. Exosomes (10 ug/mL) were
injected into a xenograft model (n = 8/ group), twice a week for 6 weeks and the tumour
growth was monitored using In Vivo Bioluminescence Imaging (IVIS). Tissue and circulating
exosomes obtained from the mice were subjected to a quantitative mass spectrometry
approach SWATH MS/MS, followed by ingenuity pathway analysis (IPA). Finally, we compared
between the protein expressions profiles from the circulating exosomes and metastatic
nodes or tumour growth.
Results: IVIS imaging indicated that the tumour burden in mice injected with exo-OVCAR-3
was higher than in mice injected with exo-SKOV-3 (p = 0.004). However, mice injected
with exo-SKOV-3 had more tumour nodules throughout the peritoneal cavity. Proteomic
analysis of the cancer tissue obtained from mice injected with exo-SKOV-3 compared
to exo-OVCAR-3 identified the differential expression (p < 0.05) of 105 proteins.
Interestingly, the protein profile in tumour tissue obtained from mice injected with
exo-SKOV-3 was associated with the Wnt canonical pathway (β-catenin). Moreover, we
found 36 proteins with differential expression in exosomes from mice treated with
exo-SKOV-3, (p < 0.04). Finally, we identified 29 exosomal proteins that are highly
associated with cancer metastasis and 21 proteins are associated with tumour growth.
Summary/Conclusion: These observations suggest that exosomal signalling plays an important
role in ovarian cancer metastasis.
PS10.07
Cancer-associated fibroblast accelerate cancer metastasis through exosomes
Kim Kimin
a, Yeon Ju Hun
b, Sohn Yeh Jooa, Ruri Leea, Yoo Hye Jua
aUniversity of brain education, Cheon-an, Republic of Korea; bUniversity of British
Columbia, Cheonan, Republic of Korea
Introduction: Exosomes are known to be important mediators between the primary and
secondary sites for tumour progression and metastasis with their microenvironment.
Exosomes released by cancer cells induce the cancer-associated fibroblasts, which
create a niche to development cancer progression, making it more permissive cancer
metastasis.
Methods: We have developed 3D tumour microenvironment model mimicking the interactions
between cells and ECM by injecting of collagen gel for ECM to, and then, the formation
of monolayer of cells for blood vessel. The exosomes were isolated from three different
malignant cancer cells (i.e. from A431, B16BL6 and MDAMB231), and delivered into the
channel in microfluidic device, then created a unidirectional flow by the difference
in pressure gradient. We profile mRNAs of normal cell, CAFs with and without cancer
cells in genetic analysis.
Results: We confirmed that various cancer-derived exosomes differentiated CAFs, facilitating
metastasis in recapitulating the 3D tumour microenvironment in real time. The three
difference CAFs have commonly enriched genes related to extracellular region for cellular
response, and fibrinolysis to degrade ECM for biological process in genetic analysis.
The migrated cancer cells followed by CAFs showed different specific molecular mechanisms,
suggesting that the melanoma cells had MAPK related signalling, the squamous cancer
cells had cell adhesion related signalling, and the breast cancer cells had inflammation,
cytokine related signalling, which may contribute to the invasive progression of cancer.
Summary/Conclusion: The cancer-derived exosomes play an important role in modulating
the tumour microenvironment, and induce CAFs to promote metastasis. The 3D microfluidic
model showed the relationship between the CAFs and cancer cells invasion in real time
in physiological manner and specific mechanism in a genetic manner.
Funding: This work was supported by the Basic Science Research Program through the
National Research Foundation of Korea (NRF) funded by the ministry of Education, Science
and Technology (NRF-2016R1C1B2013345) and Samsung Research Funding Center of Samsung
Electronics under Project Number SRFC-IT1701-00
PS10.09
The miR-27b in breast cancer exosomes
Wen-Hung Kuo
National Taiwan University Hospital, Taipei, Taiwan (Republic of China)
Introduction: miR-27b has been shown to possess anti-tumour growth and anti-drug resistance
activities in associated with breast cancer progression. Loss of miR-27b existed in
the cancer cells can lead to the promotion of cancer cells. However, the precise mechanism
of miR-27b loss is unclear, in particular, involving in tumour microenvironments and
metastasis.
Methods: Here, we attempted to elucidate tumour-derived exosomes bearing miR-27b in
regulating tumour microenvironments via modulation of cancer stem cell growth and
migration.
Results: The expression level of miR-27b was decreased in tumour-derived exosomes
in coincidence with progression of breast cancer, suggesting its negative role in
tumour progression via modulating tumour microenvironments. Consistently, miR-27b
showed a diminished trend in malignant breast cancer cell lines compared with the
control cell line. To further examine the impact of miR27b in tumour microenviroments,
we found that the formation of tumour associated fibroblasts (TAFs) and tumour associated
macrophages (TAMs) were impacted by miR-27+ exosomes. Moreover, the increases in tumour
migration and invasion were observed by miR-27b+ exosomes treated fibroblasts.
Summary/Conclusion: Therefore, we illustrated a simple mechanism of miR-27b attending
in the progression of breast cancer. In the future, the manipulating the existence
of miR-27b may be a novel strategy for breast cancer therapeutic.
PS10.10=OWP1.01
Mir-1227 alters extracellular vesicle shedding
Andrew R. Chin
a, Minyung Kimb, Valentina R. Minciacchic, Tatyana Vagnerb, Javier Mariscalb, Cristiana
Spinellia, Mandana Zandianb, Paolo Gandellinid, Nadia Zaffaronid, Shivani Sharmae,
Sungyong Youb and Dolores Di Vizioa
aCedars Sinai Medical Center, West Hollywood, USA; bCedars Sinai Medical Center, Los
Angeles, USA; cCedars Sinai Medical Center, Frankfurt, Germany; dFondazione IRCCS
Istituto Nazionale Tumori, Milan, USA; eUniversity of California, Los Angeles, Los
Angeles, USA
Introduction: Extracellular vesicles (EV) play a key role in cancer development and
metastasis by influencing the behaviour of the primary tumour and by aiding the establishment
of a pre-metastatic niche in distant organs. This process is due to the EV-mediated
functional transfer of biologically active molecules including microRNA (miRNA). miR-1227
is a poorly characterized miRNA that is enriched in EV secreted by prostate cancer
(PC) cells in comparison to non-tumourigenic prostate epithelial cells. However, the
role of miR-1227 in cancer is poorly understood. Our objective is to determine the
role of miR-1227 in PC.
Methods: RNA sequencing from miR-1227 stably expressing PC cells, RISCTRAP Immunoprecipitation
of miR-1227 bound mRNA, and five different in silico miRNA target prediction methods
were used to identify putative miR-1227 targets. Exosomes and large oncosomes (LO)
were isolated by differential ultracentrifugation followed by density gradient purification.
Atomic force microscopy and TRPS were used to quantify exosomes and LO secreted by
PC cells stably expressing miR-1227 or vector control.
Results: A comparative analysis between different EV subtypes indicates that miR-1227
is enriched in LO, a class of EV that are secreted by highly invasive and metastatic
amoeboid-migrating cells. LO carry more RNA than the more widely studied exosomes
indicating that LO may be a more robust source of EV-encapsulated miRNA. Gene ontology
analysis from miR-1227 targets identified by RNA sequencing from miR-1227 stably expressing
PC cells, RISCTRAP Immunoprecipitation of miR-1227 bound mRNA, and in silico miRNA
target prediction highlighted several genes related to EV secretion. miR-1227 alters
the localization of exosome and LO markers in multiple cancer cell lines, and induces
the shedding of LO while inhibiting the shedding of exosomes. Furthermore, miR-1227
induces the migration of poorly migratory cancer cells and increases the expression
of tumour supportive cytokines.
Summary/conclusion: Together these data hint that miR-1227 may promote prostate cancer
progression through several mechanisms including alteration of EV shedding.
Funding: 2017–2022 R01CA218526 Chesapeake urology associates Sanford J. Siegel, MD
prostate cancer research scholarship Luke wu-jei chang discovery fund PI dod PCRP
award PC150836
PS11: Stem Cells Chairs: Kyoko Hida; Noriko WatanbeLocation: Level 3, Hall A15:00–16:00
PS11.02
Bacterial endotoxin-preconditioned periodontal ligament stem cells induce M1 polarization
of macrophage through extracellular vesicles
Hyejong Kanga, Myung-Ju Leeb, Sang Jung Parkb and Myung-Shin Lee
b
aDankook University Sejong Dental Hospital, Sejong, Republic of Korea; bEulji University
School of Medicine, Daejeon, Republic of Korea
Introduction: Periodontitis is a common disease that characterized by chronic inflammation
and tissue destruction of gums. To resist pathogenic microbes, gingival epithelial
cells and inflammatory cells produce various pro-inflammatory cytokines, chemokines
and enzymes. Human periodontal ligament stem cells (PDLSCs) derived from mature periodontal
ligaments have stem cell properties similar to mesenchymal stem cells. PDLSCs possess
not only differentiation potential to other tissues but also immunomodulatory abilities.
Therefore, PDLSCs might be a vital role in the modulation of immune response. In this
study, we investigated the effect of PDLSCs on the polarization of macrophages.
Methods: The polarization of macrophage cell line, THP-1 cells, was investigated on
the conditioned media or extracellular vesicles (EVs) from PDLSCs that were pretreated
with or without lipopolysaccharide. EVs were isolated from the conditioned media of
PDLSCs by differential centrifugation and characterized. The functions of EVs on macrophage
polarization and underlying mechanisms were analysed by RT-qPCR and ELISA,
Results: While the conditioned media from PDLSCs in normal culture condition did not
affect the polarization of macrophage, lipopolysaccharide (LPS)-preconditioned PDLSCs
induce significant changes in M1 polarization of macrophages. Extracellular vesicles
(EVs) isolated from the conditioned media of LPS- preconditioned PDLSCs by centrifugal
filter device (MWCO 100 kD) or differential centrifugation methods showed strong M1
polarization effect of macrophages. Additionally, M1 polarization was abolished by
DNase I treatment on EVs.
Summary/Conclusion: Our results demonstrated that LPS-stimulated PDLSCs induce M1
polarization of macrophage through EVs, suggesting EVs from PDLSCs might be a potential
therapeutic target for the inflammation in the periodontium.
Funding: This work was supported by the Basic Science Research Program through the
National Research Foundation of Korea (NRF-2017R1A2B4002405).
PS11.03
Hypoxia enhances the angiogenic properties of adipose stem cell-derived extracellular
vesicles in culture
Jolene Phelps, David Hart, Alim Mitha, Neil Duncan and Arindom Sen
University of Calgary, Calgary, Canada
Introduction: The widely recognized benefits of adipose stem cells (ASCs) in regenerative
medicine have at least in part been attributed to the extracellular vesicles (EVs)
that they secrete, which are known to deliver bioactive cargo to target cells. EVs
can be isolated from spent medium following ASC population expansion in culture. It
has been shown that manipulating the culture environment may impact the biological
characteristics of EVs. Here we examined if the angiogenic properties of ASC-derived
EVs are impacted by culture oxygen level, and tested their effect on cerebral microvascular
endothelial cells (CMECs).
Methods: Ethically obtained human ASCs were cultured for 3 days in PPRF-msc6 serum-free
medium under 3% (hypoxic) or 21% (normoxic) headspace O2 conditions. EVs were isolated
from media via ultracentrifugation and evaluated for concentration (nanoparticle tracking
analysis), and angiogenic factor content (Luminex technology). Functional assays (proliferation,
tube formation) were carried out by culturing human CMECs in endothelial basal medium
(EBM-2) supplemented with 2 different concentrations of ASC derived EVs. CMEC proliferation
in tissue culture flasks was quantified using a Cyquant Proliferation Kit. Tube formation
on Matrigel coated plates was quantified using ImageJ software. RT-qPCR was used to
measure angiogenic gene expression levels in ASCs and CMECs for each test condition.
All studies and analyses were carried out in at least triplicate.
Results: Hypoxia upregulated VEGF expression in ASCs 4.47 ± 0.24 fold (p < 0.0015)
compared to normoxia and induced higher EV secretion. EVs obtained from hypoxic ASC
cultures contained higher concentrations of angiogenic proteins VEGF, HGF, PLGF and
follistatin; and reduced concentrations of bFGF, endoglin, IL-6 and IL-8. The presence
of ASC-derived EVs enhanced angiogenesis of CMEC cultures in a dose dependent manner
as measured via enhanced proliferation, tube formation and upregulation of ANG-1,
ET-1, TGF-β and VEGF expression.
Summary/Conclusion: The angiogenic properties of ASC-derived EVs may be enhanced through
hypoxic culture. These EVs are able to promote angiogenesis of CMECs in vitro and
may have utility in the treatment of ischemic injury.
Funding: Natural Sciences and Engineering Research Council of Canada
PS11.06
Production and use of extracellular vesicles-depleted human platelet lysate to improve
large, clinical grade-compatible production of therapeutic human cell-derived extracellular
vesicles
Philippe Mauduit
a, Sylvie Goulinetb, Juliette Peltzerc, Bastien Rivalc, Sebastien Banzetc, Jean-jacques
Latailladec and Georges Uzanb
aInserm, Villejuif, France; bINSERM, villejuif, France; cCTSA, CLAMART, France; dINSERM,
Villejuif, France
Introduction: Human cells use multiple and sophisticated modes of communication. These
include direct cellular communication, secretion of cytokines, chemokines or growth
factors and also production of extracellular vesicles (EV) containing proteins, DNA,
mRNA, miRNA. On the other hand, cell therapy using Mesenchymal Stromal Cells (MSCs)
is getting a growing interest in a wide range of indications in human. In many cases,
a substantial part of the therapeutic effects relies on cell-secreted factors and
the extracellular vesicles (EV) are proposed as a cell-free surrogate for MSCs therapy.
However, culture media commonly used for culturing cells requires serum or platelet
lysate that contains large amounts of EV that cannot be distinguished and separated
from the cell-secreted EV. Purification and characterization of EV therefore needs
the prior elimination of contaminant EV contained in serum or Human Platelet Lysate
(HPL). Serum-free media to produce EV may not be fully satisfactory since they often
limit cell survival. Since regulatory authorities recommend avoiding animal components
and xenobiotic-free culture conditions have to be considered for EV production. HPL
offers such a possibility as it is useful substitute to FBS to isolate, amplify and
maintain human cells.
Therefore, we describe a new procedure for GMP-compatible production of human cells-derived
EV.
Methods: First, a Human Plasma Lysate (HPL) is produced from which the EV are removed
by tangential-flow-filtration resulting in an EV-FREE HPL (EV depletion > 99%). Second,
cells (grown in HPL-supplemented medium) are rinsed and placed in medium added with
EV-FREE HPL. After 72 h, the medium is collected for EV quantification and replaced
by fresh EV-FREE HPL supplemented media for a new production cycle.
Results: This method allows multiple production cycles and improved cell survival,
cellular morphology and EV production. Following 3 × 72 h consecutive production phase,
MSCs amplification would produce 2.4 and 2.7 more EV when incubated in the presence
of, respectively, 5% and 8% EV-free HPL compared to HPL-free medium.
Summary/Conclusion: This process, compatible with the production of large volumes
of conditioned media including in bioreactors, will allow large-scale production of
therapeutic EV.
PS11.07
Synchronized cell differentiation via exosomes
Tomohiro Minakawa; Kae Nakamura and Jun K. Yamashita
aLaboratory of Stem Cell Differentiation, Center for iPS Cell Research and Application
(CiRA), Kyoto University, Kyoto, Japan
Introduction: Embryonic development proceeds in a highly orchestrated manner. It is
assumed that synchronization of a timing of differentiation and cell fate among neighbouring
cells is necessary for proper tissue development. However, the mechanism of synchronization
is still largely unknown.
Methods: A mouse embryonic stem cell (ESC) line PKA-ESC, which can inducibly express
constitutively active protein kinase A (CA-PKA), rapidly differentiates into mesoderm
with PKA activation (depletion of doxycycline (Dox-)). We established a cell-chimeric
culture system using two mouse ESC lines, PKA-ESC and Control-ESC to artificially
generate a gap of timing in differentiation. We cocultured Control ESCs with PKA-ESCs
to observe how they synchronously differentiate by overcoming the gap of timing in
differentiation. Exosomes were collected from PKA-ESCs and added to Control-ESCs or
mouse embryos. miRNA sequencing was performed comparing contents in exosomes from
PKA-ESCs under Dox+ condition: control or Dox- condition: PKA activation, accelerated
differentiation. We also established several ESC lines that encode miRNAs and performed
coculture experiments with control-ESCs.
Results: After Dox-inducible activation of PKA, PKA-ESCs differentiate faster than
Control-ESCs. In the coculture system, the timing of mesoderm differentiation of Control-ESCs
were synchronized with faster differentiating PKA-ESCs (synchronized cell differentiation).
Furthermore, addition of exosomes purified from PKA-ESCs promoted the differentiation
of Control-ESCs. The exosomes also promoted mesoderm differentiation in postimplantation-stage
mouse embryos. We found several miRNAs as the functional molecules in exosomes, and
confirmed that miRNAs overexpressing cells can promote the differentiation of Control-ESCs
in the coculture system.
Summary/Conclusion: We unveiled a novel cellular synchrony phenomenon and its mechanisms
regulated by exosome-mediated cell communication, which would be broadly involved
in tissue development.
Funding: This work was supported by JST CREST Grant Number [JPMJCR17H5 Japan].
PS11.08
Effects of mesenchymal stromal cells licensing on profile of extracellular vesicles
Giuliana Minani Bertolinoa
, Tik Shing Cheungb, Chiara Giacominic, Martin Bornhauserd and Francesco Dazzie
aKing’s College London, London, United Kingdom; bKing’s College London, London, United
Kingdom; cKing’s College London, London, United Kingdom; dKing’s College London; Technische
Universität Dresden, Dresden, Germany; eKing’s College London, London, United Kingdom
Abstract: The roles of mesenchymal stromal cells (MSC) in the immune system are subject
of increasing interest and of widening clinical applications. Recent evidences has
shown that extracellular vesicles (EV) secreted by MSC can share some of the functional
roles of their parental cells, among them the immunosuppression ability. Prior to
exert immunomodulation, MSC effects rely on the presence of inflammatory mediators
in the microenvironment: (1) proinflammatory cytokines such as IFN-γ and TNF-α, and
(2) by the action of inflammatory effector cells which culminates on MSC apoptosis
without the loss of immunomodulatory property. Therefore, we propose that different
licensing of MSC can generate EV with distinct profiles and aspects on the immunomodulation.
Methods: To test this hypothesis, we characterized EV population derived from untreated
MSC, MSC licensed by pro-inflammatory cytokines (IFNγ and TNFα) and from MSC undergoing
apoptosis (anti-Fas antibody). We also isolated and characterized EV from plasma of
Graft-versus-Host Disease (GvHD) patients receiving MSC as therapy (0, 4, 24, 48 h
after MSC injection). EV size, shape and concentration were accessed by NTA and electron
microscopy. MSC and EV surface markers were identified by bead-based flow cytometry.
To study the EV contend, the presence of a panel of regulatory molecules was verified
by qPCR and Western blot.
Results: We found that both MSC treatment generate population of EV heterogeneous
in size, with main range between 100 and 200 nm and bigger vesicles (>500 nm) present
in apoptotic MSC-EV samples. Apoptosis induction significantly increased the particle
release. MSC-derived EV share mRNA and protein with their parental cells, and the
different environment where the MSC is cultivated interfere in the EV content. Moreover,
our preliminary data shown that GvHD patients receiving MSC have increased EV containing
MSC-related suppressive molecules straight after cell infusion.
Summary/conclusion: In summary, our results show that the different environment where
MSC is cultivated interfere on their EV content, and can provide a signature of the
“licensed” MSC. This was further tested in patients undergoing MSC treatment with
a view of identifying biomarkers for pharmacokinetics studies.
Funding: This work was supported by the Bloodwise Specialist Programme and by CAPES
– Brazil.
PS11.09
Effects of mesenchymal stromal cells licensing on profile of extracellular vesicles
Giuliana Minani Bertolino
a, Tik Shing Cheunga, Chiara Giacominia, Martin Bornhauserb and Francesco Dazzia
aKing's College London, London, United Kingdom; bKing's College London; Technische
Universität Dresden, Dresden, Germany
Abstract: The roles of mesenchymal stromal cells (MSC) in the immune system are subject
of increasing interest and of widening clinical applications. Recent evidences has
shown that extracellular vesicles (EV) secreted by MSC can share some of the functional
roles of their parental cells, among them the immunosuppression ability. Prior to
exert immunomodulation, MSC effects rely on the presence of inflammatory mediators
in the microenvironment: (i) proinflammatory cytokines such as IFN-γ and TNF-α, and
(ii) by the action of inflammatory effector cells which culminates on MSC apoptosis
without the loss of immunomodulatory property. Therefore we propose that different
licensing of MSC can generate EV with distinct profiles and aspects on the immunomodulation.
Methods: To test this hypothesis, we characterized EV population derived from untreated
MSC, MSC licensed by pro-inflammatory cytokines (IFNγ and TNFα) and from MSC undergoing
apoptosis (anti-Fas antibody). We also isolated and characterized EV from plasma of
Graft-versus-Host Disease (GvHD) patients receiving MSC as therapy (0h, 4h, 24h, 48h
after MSC injection). EV size, shape and concentration was accessed by NTA and electron
microscopy. MSC and EV surface markers were identified by bead-based flow cytometry.
To study the EV contend, the presence of a panel of regulatory molecules was verified
by qPCR and western blot.
Results: We found that both MSC treatment generate population of EV heterogeneous
in size, with main range between 100 and 200 nm and bigger vesicles (>500 nm) present
in apoptotic MSC-EV samples. Apoptosis induction significantly increased the particle
release. MSC-derived EV share mRNA and protein with their parental cells, and the
different environment where the MSC is cultivated interfere in the EV content. Moreover,
our preliminary data shown that GvHD patients receiving MSC have increased EV containing
MSC-related suppressive molecules straight after cell infusion.
Summary/Conclusion: In summary, our results show that the different environment where
MSC is cultivated interfere on their EV content, and can provide a signature of the
‘licensed’ MSC. This was further tested in patients undergoing MSC treatment with
a view of identifying biomarkers for pharmacokinetics studies.
Funding: This work was supported by the Bloodwise Specialist Programme and by CAPES
– Brazil.
LBS01: Late Breaking- EV Therapeutics Chairs: Xabier Osteikoetxea; Akiko TakahashiLocation:
Level 3, Hall A 15:00–16:00
LBS01.01
Mesenchymal stromal cells derived-extracellular vesicles effect on microglia cells
Dorota Kaniowskaa, Kerstin Wenkb, Franziska Langea, Sebastian Greisera, Ulf-Dietrich
Braumanna and Yarua Jaimes
c
aFraunhofer IZI, Leipzig, Germany; bInstitute for Clinical Immunology, University
of Leipzig, Leipzig, Germany; cISEV, Leipzig, Germany
Introduction: Mesenchymal stromal cells (MSCs) are a heterogeneous population of cells
with very high self‐renewal properties and the capacity to induce tissue regeneration
and reduce inflammation. Extracellular vesicles (EVs) from MSCs have shown to have
immune modulatory properties and given their small size, are good candidates as therapeutic
agents for tissues of difficult access, such as the central nervous system (CNS).
Microglia cells are the CNS immune cells and are involved in the progression of the
degeneration in many neuroinflammatory diseases. We evaluated the interaction of MSC-EVs
with microglia cells and their effect as regulators of activation.
Methods: We have used an in vitro model for stimulation of the BV-2 microglia cell
line and primary cells with lipopolysaccharides (LPS) and amyloid β aggregates. Real
time PCR methods were used to assessed the transcripts upregulation of tumour necrosis
factor (TNF)‐α, Interleukin (IL)‐1β, IL‐6, nitric oxide synthases (iNOS), Prostaglandinendoperoxide
synthase 2 (PTGS2) and chemokine ligand (CCL)‐22. Protein levels of TNF‐α, IL‐1β and
IL‐6 were evaluated by ELISA and cytometric bead arrays. Live cell imaging approaches
were used to evaluate the interaction of MSC-EVs with microglia cells in vitro.
Results: We demonstrated that MSC-EVs are actively internalized by microglia cells.
Moreover, that presence of MSC‐EVs prevents transcription and protein expression of
pro-inflammatory cytokines tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β, IL‐6,
inducible isoform of nitric oxide synthases (iNOS) and prostaglandinendo peroxide
synthase 2 (PTGS2) upregulation by microglia cells towards LPS and amyloid β. Furthermore,
MSC‐EVs suppressed the phosphorylation of the extracellular signal kinases 1/2 (ERK1/2),
c‐Jun N-terminal kinases (JNK) and the p38 MAP kinase (p38) molecules given in response
to LPS stimulation.
Summary/conclusion: MSC‐EVs are strong modulators of microglia activation. The modulatory
activity of MSC-EVs can be of major impact in the treatment of neuroinflammatory diseases.
Funding: This project is co-financed with tax money from the state of Saxony, Germany.
High Performance Center of Chemical and Biosystem Technology: Grant 100312141, Grant
100321061. YJ is financed by a TALENTA Financing award from the Fraunhofer Society.
LBS01.02
Porcine milk exosomes protect intestine against deoxynivalenol damage
Mei-Ying Xiea, Ting Chena and Yong-Liang Zhang
b
aSouth China Agricultural University, Guangzhou, USA; bcollege of animal science,
south china agricultural university, Guangzhou, China (People’s Republic)
Introduction: Deoxynivalenol (DON) serious damage intestinal vulnerable structures
and intestinal integrity. Our previous study showed that exosomes could facilitate
intestinal cell proliferation and neonate intestinal tract development, but the protection
of milk exosomes of damage caused by DON is unclear.
Methods: Neonatal Kunming mice were given 0.4 ml porcine milk exosomes or saline for
3 weeks and then given 2.5 mg/kg bw/day DON for 7 days. Intestinal morphology was
assessed using H&E. Cells viability are tested by MTT, Edu and cell counting assay.
WB, qRT-PCR and immunofluorescence were used to show the effects of porcine milk exosomes
on the damages of intestine and IPEC-J2 cells caused by DON. At last, bioinformatics
Analysis, luciferase reporter assay was to verify the potential targeting relationship
between miRNAs and mRNAs.
Results: Porcine milk exosomes significantly alleviated the negative effects of DON
on body weight and the damage degree of intestinal epithelial. In addition, these
exosomes significantly reversed the inhibition of DON on cell proliferation and intercellular
tight junction-associated proteins, such as levels of β-catenin, p-Akt, cyclinD1 and
claudin1, and decreased the apoptosis-related protein p53 and p21. In vitro, porcine
milk exosomes significantly attenuated the damage of DON on cell viability, proliferation
and tight junctions, consistent with the results in vivo. Our results also indicated
that porcine milk exosomes up-regulate the expression of miR-181a, miR-30c, miR-365-5p
and miR-769-3p in cells and downregulated their targeting genes in p53 pathway, such
as FAS, TP53, SERPINE1.
Summary/conclusion: Porcine milk exosomes protected intestine and IPEC-J2 cells against
DON damage, and encapsulated miRNAs play a role in regulating p53 pathway. Our study
opened a new sight in breast milk exosomes, which may contribute to intestinal health
during the neonatal period
Funding: This work was supported by grants from the National Natural Science Foundation
of China [grant numbers 31472163], and The Chinese National Key Scientific Project
(2016YFD0500503).
LBS01.03
Exosomal PD-L1 embedded with thermoresponsive gel promotes wound healing
Dandan Sua, Zhanxue Xub, Hongbo Chenb, Fang Cheng
b and Xiangyi Caic
aSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University, Guanghzou, China
(People‘s Republic); bSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University,
Guangzhou, China (People‘s Republic); cSchool of pharmaceutical sciences(Shenzhen),
Sun Yat-sen University
Introduction: Wound healing is a complex process involving multiple cell types with
different roles, which is divided into stages of haemostasis, inflammation, proliferation
and remodelling. As many chronic wounds are the result of excessive and chronic inflammation,
we hypothesized that effective wound repair could be achieved by inhibiting overactive
immune cells to the injured skin. The PD-1/PD-L1 immune checkpoint pathway prevents
excessive tissue destruction during inflammatory states, and PD-L1 expression is induced
by pro-inflammatory factors in multiple cell types throughout the body. Interestingly,
recently PD-L1 is found to exists in extracellular vesicles (EVs) as a transmembrane
protein. Thus we would like to test if exosomal PD-L1 would regulate the immunity
and inflammatory response to promote proper wound healing.
Methods: Exosomal PD-L1 were isolated from melanoma cells stimulated with IFN-γ by
differential centrifugation and were characterized by flow cytometry, TEM, DLS, zeta
potential, Western blot and confocal microscopy. Exosomal PD-L1 were administered
in a mouse skin injury model through a thermoresponsive hydrogel, which was gelatinized
at body temperature to preserve exosomal PD-L1 throughout the wound. Flow cytometry
analysis, qPCR, HE staining and immunohistochemical analysis were performed to further
explore the therapeutic effect of exosomal PD-L1 at the tissue levels.
Results: Exosomal PD-L1 in thermoresponsive gel led to a decreased T cell activation,
indicated by CD4, CD8, and IL-2 markers. In the presence of exosomal PD-L1, there
was also an increased expression of growth factors, which significantly promoted wound
contraction and wound re-epithelialization.
Summary/conclusion: Collectively, our current findings suggest that exosomal PD-L1
speeds up wound healing when applying into a novel thermoresponsive gel on top of
the injured skin, which provides a new perspective for using immunotherapy to promote
tissue repair and regeneration.
Funding: F. Cheng would like to thank Sigrid Jusélius foundation, the National Natural
Science Foundation of China (Grant no. 81702750) and the Basic Research Project of
Shenzhen (Grant no. JCY20170818164756460) for funding.
LBS01.05
Intranasal delivery of mesenchymal stem cell derived exosomes loaded with PTEN siRNA
repairs complete spinal cord injury
Shawei Goua, Nisim Peretsb, Oshra Betzerc, Shahar Ben-Shauld, Anton Sheinine, Izhak
MichaelevskiMichaelevskif, Rachela Popovtzerc, Daniel Offen
g and Shulamit Levenbergh
aDepartment of Biomedical Engineering, Technion-Israel Institute of Technology, Israel;
bSagol School of neuroscience, Tel Aviv University, Israel, Tel aviv, Israel; cFaculty
of Engineering and the Institute of Nanotechnology & Advanced Materials, Bar-Ilan
University, Israel, Ramat Gan, USA; dDepartment of Biomedical Engineering, Technion-Israel
Institute of Technology, Haifa, 3200002, Israel, Haifa, Israel; eSagol School of Neuroscience,
Tel Aviv University, Israel., Haifa, Israel; fDepartment of Molecular Biology, Ariel
University, Israel.; gSagol School of neuroscience, Tel Aviv University, Israel, Sacklar
school of medicine, department of human genetics and biochemistry Tel Aviv University,
Israel., Tel Aviv, USA; hDepartment of Biomedical Engineering, Technion-Israel Institute
of Technology, Israel, Haifa, Israel
Introduction: Complete spinal cord injury (SCI) is a debilitating disease which usually
leads to permanent functional impairments, with various complications and limited
spontaneous recovery or efficient treatment. Here, we report that in rats with complete
SCI, intranasal administrations of mesenchymal stem cells-derived exosomes (MSC-Exo)
could penetrate the blood brain barrier, home selectively to the spinal cord lesion,
and show affinity to neurons within the lesion. When these exosomes were loaded with
phosphatase and tensin homolog small interfering RNA, termed ExoPTEN, they migrated
from the nose and silenced PTEN expression in the lesion. Furthermore, the loaded
exosomes promoted robust axonal regeneration and angiogenesis, accompanied with decreased
astrogliosis and microgliosis. Moreover, the intranasal ExoPTEN treatment partially
restored electrophysiological and structural integrity, and most importantly, enabled
remarkable functional recovery. This rapid, non-invasive approach, using cell-free
nano-swimmers carrying molecules to target pathophysiological mechanisms, suggests
novel strategy for clinical translation to SCI and beyond.
Methods: MSC-exo were extracted from Human bone marrow mesenchymal stem cells. All
rats had complete transection of the spinal cord. MSC-exo were loaded with co-incubation
together with siRNA for PTEN conjugated to cholesterol. The MSC-exo were given by
intranasal administration 1–4 h post SCI.
Results: Here we show that SCI rats that were intranasally treated with MSC-exo present
functional improvement in motor and sensory output. The MSC-exo were homed in the
SCI area and led to reduction in inflammatory markers, increased angiogenesis and
regrowth of transected axons. MRI and electrophysiological measurements were done
to show the axonal recovery and signal transduction
Summary/conclusion: Exosomes derived from Human bone marrow mesenchymal stem cells
and loaded with inhibitor molecule for PTEN pathway were found efficient in ameliorating
complete transection of the spinal cord via intranasal administration, including remarkable
functional improvement.
LBS01.06
ASC-EXOSOME as a potential therapeutic for atopic dermatitis
Byong Seung Choa, Jin Ock Kimb, Dae Hyun Haa and Yong Weon Yi
a
aExocobio Inc., Seoul, Republic of Korea; bExocobio Inc, Seoul, Republic of Korea
Introduction: Atopic dermatitis (AD) is an inflammatory disease that has rapidly increased
in the prevalence in recent decades. Despite the high demand for AD therapy, current
treatment options are limited and have potentially harmful side effects. Recently,
several clinical studies highlighted human mesenchymal stem cells (MSCs) as novel
potential therapeutics for suppressing allergic progress in the AD, and the majority
of their therapeutic effects is mediated their secretome which contains exosomes.
There are, however, several drawbacks for the therapeutic use of MSCs, such as poor
engraftment efficiency, non-specific differentiation, and short half-life, etc. Otherwise,
exosomes can be off-the-shelf since they are not live, expecting to overcome the limitations
of MSC easily and become powerful alternative therapeutics. Here, we investigated
the therapeutic effects of exosome from adipose tissue-derived MSC (ASC-EXOSOME) on
atopic dermatitis in two in vivo models.
Methods: ASC originated from adipose tissue of a healthy donor. ASC-EXOSOME was isolated
from ASC conditioned media through a sequential filtration method. AD-like skin lesions
were induced in mice by applying house dust mite antigen or a chemical irritant. After
administration of ASC-EXOSOME either subcutaneously or intravenously the anti-inflammatory
effects were demonstrated by measuring serum IgE level, immunostaining of immune cells,
real-time PCR, etc.
Results: Systemic administration of ASC-EXOSOME dose-dependently lowered serum IgE
level and the number of eosinophils in AD mice blood, and reduced mast cell infiltration
and up-regulated mRNA levels of IL-4, IL-31, IL-23 and TNF-α in the skin lesions compared
to AD control. Skin barrier function was also improved by ASC-EXOSOME.
Summary/conclusion: Systemic administration of ASC-EXOSOME dose-dependently lowered
serum IgE level and the number of eosinophils in AD mice blood, and reduced mast cell
infiltration and up-regulated mRNA levels of IL-4, IL-31, IL-23, and TNF-α in the
skin lesions compared to AD control. Skin barrier function was also improved by ASC-EXOSOME.
LBS01.07
Porcine milk exosome miRNAs attenuate lipopolysaccharide-induced apoptosis by inhibiting
TLR4/NF-κB and P53 pathways
Yong-Liang Zhang
a, Mei-Ying Xieb and Ting Chenb
aCollege of Animal Science, South China Agricultural University, Guangzhou, China
(People‘s Republic); bSouth China agricultural university, Guangzhou, USA
Introduction: Intestinal epithelial cells are important for pathogen infection. LPS
is an endotoxin and induces intestine inflammation. Milk exosomes improve the intestine
development and immune system of newborn. The objective of this study is to investigate
the protective mechanisms of porcine milk exosomes in rescuing LPS-induced intestinal
epithelium injuries.
Methods: Both in vivo and in vitro tests were carried out to confirm protection of
porcine milk exosome on LPS induced injury to intestine.
Results: In vivo, exosomes protected the jejunum integrity and health from LPS damage
through H&E results and attenuated LPS-induced pro-inflammatory factors secretion
through ELISA results. In vitro, we got similar results in the intestinal epithelial
cell line IPEC-J2. Bioinformatics analyses and cell experiments results shown exosome
miR-4334, miR-219 reduced pro-inflammatory responses and miR-338 inhibited LPS-induced
apoptosis of intestinal epithelial cells via TLR4/MyD88/NF-κB and P53 pathway, respectively.
Co-transfection of those three miRNAs had the best effect on resisting LPS-induced
IPEC-J2 apoptosis than any one of these three miRNAs.
Summary/conclusion: In conclusion, porcine milk exosomes protected the intestine against
LPS-induced injury through decreasing cell inflammatory and resisting cell apoptosis
by exosome miRNAs. This study expands our understanding of bioactive molecules in
milk and provides new strategies for developing functional foods in the future.
Funding: This work was supported by grants from the National Natural Science Foundation
of China [grant numbers 31472163], and The Chinese National Key Scientific Project
(2016YFD0500503).
LBS01.08
Extracellular vesicles from mesenchymal stromal cells for the treatment of radiological
burns
Juliette Peltzer
a, Stephane Flamantb, Philippe Mauduitc, Sylvie Goulinetc, Bastien Rivala, Jean-jacques
Latailladed, Georges Uzanc, Sebastien Banzete and Radia Tamaratb
aInstitut de Recherche Biomédicale des Armées, INSERM UMR-MD-1197, Clamart, USA; bInstitut
de Radioprotection et Sûreté Nucléaire (IRSN), Fontenay aux Roses, France; cINSERM
UMR-MD-1197, Villejuif, France; dInstitut de Recherche Biomédicale des Armées, INSERM
UMR-MD-1197, Clamart, France; eInstitut de Recherche Biomédicale des Armées, INSERM
UMR-MD-1197, CLAMART, France
Introduction: High-dose acute radiation accidents of industrial and medical origin
and the risk of a terrorist act (NRBC) have been taken into consideration for some
years. The work carried out by our teams led to a new therapeutic approach for the
management of victims of accidental irradiation, consisting of autologous Mesenchymal
Stromal Cells (MSCs) injection associated with reparative surgery. Preclinical studies
showed that MSCs, mainly by their secretory activity, contribute to control inflammation,
promote angiogenesis and tissue regeneration. MSC-derived extracellular vesicles (MSC-EVs)
might be key mediators of MSC function. This project aims to propose an innovative
therapy product based on the use of Extracellular Vesicles (EVs) for the treatment
of radiological burns following accidental irradiation.
Methods: MSCs were grown until reaching 80% confluence, then moved to EV collection
medium for 72 h. EVs were purified by tangential flow filtration followed by size
exclusion chromatography and characterized by Nanoparticle tracking analysis. MSC-EVs
were evaluated in vitro in an inflammatory assay using human monocytic THP-1 cells
treated with lipopolysaccharide, with or without co-culture with MSCs or EVs. The
level of pro-inflammatory TNFα in the culture supernatant was measured by ELISA assay.
EVs were also evaluated in vivo using a mouse model of acute hind limb radiation injury.
Cell therapy products (1x106 MSCs or a range of 2.45E+10, 4.90E+10 or 9.80E+10 MSC-EVs/animal)
were intramuscularly injected 14 days post-irradiation. Macroscopic analysis of injury
was performed at regular intervals.
Results: Preliminary results showed an immunomodulatory effect of MSCs-EVs, as shown
by their ability to reduce TNFα secretion by THP-1 cells in response to LPS. Moreover,
in vivo results showed a decrease of injury score in animals injected with the highest
EV concentration at day 10 and 14 post-injection.
Summary/conclusion: These preliminary results suggest a beneficial effect of MSC-EVs
on the healing process of cutaneous radiation syndrome and could represent a valuable
therapeutic alternative in the context of radiological emergency. Further exploration
of the molecular mechanisms is now necessary.
Funding: French Direction Générale de l‘Armement, under contract ANR-16-ASTR-0024
LBS01.09
Adipose-derived stem cells enhance chondrogenesis and cartilaginous matrix synthesis
of articular chondrocytes is mediated by extracellular vesicles
Shun-Cheng Wu, Jhen-Wei Chen, Che-Wei Wu, Chung-Hwan Chen, Je-Ken Chang and Mei-Ling
Ho
Orthopaedic Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung,
Taiwan (Republic of China)
Introduction: To date, mesenchymal stem cells including adipose-derived stem cells
(ADSCs) have been intensively investigated as a cell-based therapy to treat articular
cartilage damages in both animal and human studies. However, the detailed mechanism
of how ADSCs regenerate the damaged articular cartilage remains unclear. Increasingly,
studies present evidence that ADSCs mediate tissue repair via secretion of trophic
factors on damaged tissue. In this study, we test the hypothesis that ADSCs-derived
extracellular vesicles (EVs) enhances chondrogenesis and matrix synthesis of human
articular chondrocytes.
Methods: Human ADSCs were labelled with CM-DiI and then pre-cultured in DMEM supplemented
with 2% FBS for 48 h to induce EVs release. After induce EVs release, the conditioned
medium derived from pre-cultured with ADSCs were isolated, and then was used to treat
articular chondrocytes. There were three groups in the study: (1) Control: articular
chondrocytes treated with DMEM supplemented with 2% FBS without pre-cultured with
ADSCs, (2) Conditioned medium: articular chondrocytes treated with DMEM supplemented
with 2% FBS, which is pre-cultured with ADSCs, (3) Conditioned medium remove EVs:
articular chondrocytes treated with conditioned medium, which the EVs were removed
by ultracentrifugation. At the indicated time point, the chondrocytes were harvested
for further analysis including cell proliferation, chondrogenic gene expressions (Collagen
type II), and cartilaginous matrix synthesis (Glycosaminoglycan synthesis).
Results: Intercellular communication occurs through EVs. EVs transferred into chondrocytes
can be found in the conditioned medium group. However, there is no EVs transfer in
the conditioned medium removed EVs. There is no significant difference in cell proliferation
of chondrocytes among three groups. The chondrogenic gene expression and cartilaginous
matrix synthesis of chondrocyte is significantly enhanced in conditioned medium group
when compared with control group. Moreover, there is no significant difference between
control and conditioned medium removed EV groups.
Summary/conclusion: ADSCs enhances chondrogenesis and matrix synthesis of human articular
chondrocytes is mediated by EVs
LBS01.10
Application of milk exosome for leaping cosmeceutical materials.
Gna Ahn
a, Yang-Hoon Kimb and Ji-Young Ahnb
aChungbuk National University, Cheong-ju, Republic of Korea; bSchool of Biological
Sciences, Chungbuk National University, Cheongju, Republic of Korea
Introduction: Milk is one of the best exosome materials widely used as an ingredient
in various foods. Although the antibacterial effect present in milk has been long
known, however studies related to the antibacterial activity associated with milk
exosomes are fairly limited. The purpose of this study is to suggest the possibility
of using the antimicrobial effect of milk exosomes in cosmeceutical field.
Methods: Commercially available non-fat milk-based on Pasteur treatment was used.
Milk was centrifuged at 210,000 g for 70 min at 4℃. TEM and cryo-EM was used to determine
the shape of milk exosomes and its size was measured using qNano (iZon, Australia).
For antimicrobial activity test, Staphylococcus aureus (S. aureus) was cultured in
LB broth medium at 37℃, O/N. The seed culture ratio (1/100, 1/1000) and different
exosome concentration were inoculated and growth was confirmed by time.
Results: The average size of the MiExo obtained was 120 ~ 140 nm. Both TEM and cryo-EM
image showed a typical exosome shape morphology. The Western blotting confirmed the
detection of TSG101 marker, which is a representative marker of MiExo. The antimicrobial
activity of S. aureus was determined at different conditions. It exhibited 2.5 times
antimicrobial effect when the MiExo and the bacteria were inoculated together at an
early stage in log phage (10^8 CFU/mL). Based on the inoculation dilution factor(DF),
very high antimicrobial effect of approximately 19 times was observed for 1/1000 DF
as compared to the 1/100 DF. S. aureus hardly grew in the experiment group with 1/1000
DF. The antimicrobial efficacy based on the amount of exosome was 13 times higher
for 10^11 particles as compared to 10^6 particles.
Summary/conclusion: The extraction of MiExo and its antimicrobial effect was determined.
The antimicrobial effect of MiExo performed in this study is considered to be stable
with low side effects and has great potential as a superior natural material in the
future cosmeceutical market.
Funding: This work was carried out with the support of “Cooperative Research Program
for Agriculture Science & Technology Development (Project No. PJ012653)” Rural Development
Administration Republic of Korea.
LBS01.11
Control of neural stem cell differentiation to generate defined exosome populations
Nicola Goddard
a, Daniel Bracewellb, Randolph Cortelingc, Simon Youltonc and Ivan Walld
aUniversity College London, Brentwood, United Kingdom; bUniversity College London,
London, United Kingdom; cReNeuron Limited, Pencoed Business Park, Pencoed, Bridgend,
Wales, CF35 5HY, United Kingdom, Bridgend, United Kingdom; dUniversity College London,
Birmingham, United Kingdom
Introduction: Exosomes derived from the clinical grade neural stem cell line CTX (ReNeuron)
are the basis of a new class of therapy for the treatment of degenerative disorders.
Since exosomes contain a subset of molecules derived from their parent cell, progenitor
and differentiated CTX may generate exosomes with diverse phenotypes. It is vital
that these are well characterized to allow robust manufacture and isolation of particular
exosome populations and to understand their implications in therapeutic applications
Methods: Screening of support matrices (microcarriers) and substrates for growing
CTX was performed in a bespoke microfluidic device for 7 days. Cells were then fixed
and stained before applying automated imaging and analysis to determine the differentiated
state of the cells. The process was repeated with a reduced panel of matrix/substrate
combinations to study differentiation and exosome agonists for a period of 6 weeks
as a means to accelerate CTX differentiation and increase exosome production. The
conditions selected for each cell type were validated in a model bioreactor system
at the 0.1L scale and the resultant exosomes characterized in terms of particle number,
size distribution, miRNA content and CD markers
Results: The microfluidic screening approach allows the study of a panel of 336 matrix,
substrate, differentiation agonist and exosome agonist/antagonist combinations enabling
the experimental space to be reduced by >98% prior to any scale-up activities, thereby
minimising experimental time, cost and risk of failure. Our validation successfully
achieved our target cell population of 60,000 cells/cm2 in 4 days and found that the
resultant exosomes had miRNA and CD marker profiles dependent on stage of differentiation
of the culture
Summary/conclusion: CTX were successfully adapted for growth on microcarriers in a
suspension bioreactor system to provide a scalable platform for progenitor and differentiated
CTX-derived exosome production. The exosome characteristics change in terms of both
CD markers and miRNA profile according to the differentiated state of their parent
cell. This has implications on not only their therapeutic function and potency but
also the design of processes for their manufacture and purification in order to deliver
consistent product profile
Funding: Innovate UK
LBS01.12
Engineered stem cell membrane-cloaked gold nanorods for efficient cancer therapy
Won-Kyu Rhim
a, Kyungwon Koa, Soo-Hong Leeb, Wooram Parka and Dong Keun Hanc
aBiomedical science, CHA university, seongnam, Republic of Korea; bDongguk University,
goyang, Republic of Korea; cBiomedical science, seongnam, Republic of Korea
Introduction: Faced with various limitations in how functionalization of nanoparticles‘
surfaces with synthetic organic materials, researchers have begun to envision strategies
for using bioinspired materials as an alternative. In particular, nanoparticles require
many improvements in vivo to increase stability, enhance circulation time and distribution
and improve dissolution. For this reason, directly transferring the cell membrane
to the surface of the nanoparticles, the complexity of the lipid, protein and carbohydrate-containing
cell membranes can be faithfully maintained, allowing the coated nanoparticles to
have characteristics that appear to the source cell. The behaviour of cells in vivo
is usually determined by cell membrane proteins. This method of directly coating the
cell membrane also has the same characteristics of nanoparticles depending on the
characteristics of the source cells.
Methods: First, in order to coat the cell membrane, the capped CTAB for the surface
stabilization of the gold nanorod was replaced with a negatively charged citrate.
And, extracted stem cell membranes are engineered using lipid-tethered peptide for
enhancing targeting specificity to cancer cell. Engineered cell membrane was cloaked
onto the surface of gold nanorods using simple bath sonication. It can be confirmed
that the stem cell membrane is well-coated on the surface of gold nanorod through
various analysis including, zeta potential, TEM, PAGE gel and Western blotting, etc.
Results: Citrate-capped gold nanorods are characterized using zeta potential and TEM.
And, zeta potential of well-established cell membrane-cloaked gold nanorods is similar
to that of cell membrane. Cell membrane coating onto gold nanorods is also visualized
using TEM with negative staining. After cell membrane coating, the protein marker
in the cell membrane is detected identically to the cell membrane, but the nuclear
marker is not detected in Western blotting analysis.
Summary/conclusion: Cell membrane coating is a platform technology that provides an
easy top-down method for designing nanocarriers with surfaces that replicate very
complex and diverse functions needed for effective bio-interfacing and give nanoparticles
more functional.
Funding: This study was supported by the National Research Foundation of Korea (NRF)
Grants funded by MEST (NRF-2017R1A6A3A040123620)
LBS02: Late Breaking- EVs in Intercellular and Interorganism Communication Chairs:
Hanne Winther-Larsen; Kallen SullivanLocation: Level 3, Hall A15:00–16:00
LBS02.01=OWP1.14
Annexin V binding modulates the response of macrophages to mesenchymal stromal cell-derived
extracellular vesicles
Michele Grassi
a, Michela Pozzobonb, Melania Scarpac, Damiana Incendid, Alessia Giarraputoe, Anna
Maria Tolomeoa, Marcin Jurgaf, Andrea Porzionatog and Maurizio Muracah
aDepartment of Women’s and Children’s Health – University of Padova, Padova, Italy;
bUniversity of Padova, Padova, Italy; cIstituto Oncologico Veneto IOV-IRCCS, Padova,
Italy; dUniversity di Padova Department DNS, Padova, Italy; eUniversity of Padova,
Padova, Italy; fThe Cell Factory, Niel, Belgium; gDepartment of Neuroscience, University
of Padua, Padova, Italy, Padova, Italy; hUniversity of Padova, Italy, Padova, Italy
Introduction: We have previously shown that Annexin a5 (An5) binding to mesenchymal
stromal cell-derived extracellular vesicles (MSC-EVs) enhances the anti-inflammatory
properties of these nanoparticles in an animal model of colitis. However, the mechanisms
underlying these effects are unknown. Here, we investigated the immunoregulatory effect
of MSC-EVs with and without An5 binding on activated macrophages in vitro.
Methods: Macrophages were isolated from mouse bone marrow and activated by INFgamma
and LPS. Clinical grade Wharton Jelly-derived MSC-EVs were obtained from The Cell
Factory (Esperite NV, Niel, Belgium) and quantified by Resistive Pulse Sensing analysis.
5,0E+05 macrophages were incubated with PBS (vehicle only, control, group 1) 5,0E+08
MSC-EVs (group 2), 5,0E+08 MSC-EVs added with 2 ug An5 (group 3) or with 2 ug free
An5 (group 4). After 24 h, the cells were analysed by flow cytometry and RNA was extracted
for RT-PCR analysis.
Results: Incubation with MSC-EVs significantly increased only the expression of IL-10
in IFNgamma/LPS-activated macrophages. Incubation with An5-MSC-EVs resulted in a significant
induction in the expression of both pro- and anti-inflammatory cytokines, including
TNFalfa, IL-1Beta, IL-6, IL-10 and TGFbeta1. Incubation with free An5 induced only
pro-inflammatory cytokines without affecting IL-10 and TGFbeta1 expression. The iNOS2/Arg1
ratio was reduced in both EV-treated groups, indicating a shift from M1 to M2 polarization.
Summary/conclusion: In conclusion, both MSC-EVs and An5-MSC-EVs shift the macrophage
phenotype from M1 to M2. The combined induction of TGFbeta1 and IL-10, observed only
in An5-MSC-EV-stimulated macrophages, might be related to the immune-modulating characteristics
of these modified EVs that contribute to the therapeutic effects observed in vivo.
Funding: The BROAD MEDICAL RESEARCH PROGRAM AT CCFA supported this work
LBS02.02
PD-L1/CTLA-4 nanovesicles have an immunosuppressive effect on a mouse skin graft model
Zhanxue Xua, Xiangyi Caib, Fang Chenga and Hongbo Chen
a
aSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University, Guangzhou, China
(People‘s Republic); bSchool of pharmaceutical sciences(Shenzhen), Sun Yat-sen University
Introduction: Skin transplantation has been employed to serious injuries, but a potent
inflammatory immune response often leads to rejection of allogeneic skin grafts. T-cell
activation by immune allorecognition is a major cause to trigger acute rejection.
Immune checkpoint pathways such as the programmed death-1 (PD-1)/programmed death-ligand
1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)/Cluster of differentiation
80 (CD80) provide an immunosuppressive environment, preventing excessive tissue destruction
due to inflammatory immune response. Thus we would like to see if bioengineering cell
membrane derived nanovesicles (NVs) to display PD-L1 and CTLA-4 would reduce immunological
rejection through enhancing PD-1/PD-L1 and CTLA-4/CD80 immune inhibitory axis.
Methods: We established HEK 293T cells that stably express PD-L1/CTLA-4 on the cell
membranes and prepared cell membrane nanovesicles. Confocal microscopy and immunoprecipitation
analysis were used to determine the interaction of PD-1/PD-L1 and CTLA-4/CD80 on the
cell membrane. After that, T-cell activation and proliferation were examined by flow
cytometry analysis of a panel of markers. Finally, we tested the effect of PD-L1/CTLA-4
NVs on relieving skin grafting in vivo.
Results: We successfully engineered cell membrane derived nanovesicles to display
PD-L1/CTLA-4, which were characterized by transmission electron microscopy and Western
blotting In addition, confocal microscopy showed that PD-L1/CTLA-4 NVs can interact
with PD-1 of and CD80 of target cells. Furthermore, PD-L1/CTLA-4 NVs led to reduction
of T cells activation and proliferation. Finally, compared to control mice, the skin-grafting
mice had a high response rate to relieve immunologic rejection when treated with PD-L1/CTLA-4
NVs.
Summary/conclusion: As a summary, NVs containing dual molecular targets PD-L1/CTLA-4
exhibit strong immune inhibitory effect, promoting the healing of grafting skin. Thus,
PD-L1/CTLA-4 dual immune blockade by nanovesicles provides a promising strategy to
inhibit skin graft rejection.
LBS02.03
Exosome-mediated horizontal gene transfer: a possible driving force behind mammalian
genome evolution & a new risk for genome editing
Ryuichi Ono
a, Yukuto Yasuhikob, Ken-ichi Aisakib, Satoshi Kitajimac, Jun Kannod and Yoko Hirabayashib
aDivision of Cellular & Molecular Toxicology, Biological Safety Research Center, National
Institute of Health Sciences (NIHS), Kawasaki, Japan; bNational Institute of Health
Sciences (NIHS), Kawasaki, Japan; cNational Institute of Health Sciences (NIHS), Kawasaki,
USA; dJapan Bioassay Research Center, Kawasaki, USA
Introduction: The CRISPR-Cas9 system has been successfully applied in many organisms
as a powerful genome editing tool. We have previously reported that unintentional
DNA sequences derived from retrotransposons, genomic DNA, mRNA and vectors are captured
at double-strand breaks (DSBs) sites when DSBs are introduced by the CRISPR-Cas9 system.
Therefore, it is possible that unintentional insertions associated with DSB repair
represent a potential risk for human genome editing gene therapies. To address this
possibility, comprehensive sequencing of DSB sites was performed, and we found that
bovine DNA fragments were captured at DSB sites in fertilized mouse eggs and cell
lines.
Methods: We determined the lengths of the indels introduced by the CRISPR-Cas9 system
in vivo and in vitro by deep sequencing of PCR products amplified with two primers
across the target DSB site.
All animal studies were conducted in accordance with the guidelines approved by the
animal care committee of the National Institute of Health Sciences.
Results: To determine the origin of bovine DNA fragments, we used goat serum, rabbit
serum, and exosome-free FBS instead of FBS in the cell culture medium. Goat BovB and
rabbit LINE1 sequences were horizontally transferred to DSB sites, however, almost
no bovine DNA sequences were captured, suggesting that these horizontal gene transfers
were mediated by exosomes.
Summary/conclusion: We demonstrated that horizontal gene transfer assisted by CRISPR-Cas9
occurs in NIH-3T3 cells and mouse embryos. This phenomenon might be the driving force
behind mammalian genome evolution. In fact, mice with fusions between the murine Peg10 gene
and a bovine SINE were obtained. A number of possible trans-species horizontal gene
transfer events have been reported in mammals. Exosomes are present in all fluids
from living animals, including seawater and breathing mammals, suggesting that exosome-mediated
horizontal gene transfer is the driving force behind mammalian genome evolution. The
findings of this study also highlight an emerging new risk for this leading-edge technology.
Funding: AMED (18mk0104073j0103 &18ak0101093j001), Health Sciences Research Grants
from the Ministry of Health, Labor, and Welfare, Japan (H30-KAGAKU-IPPAN-002 & H30-KAGAKU-SHITEI-001),
and JSPS (26430183 and 18K19315)
LBS02.04
Comparative studies on in vitro and in vivo inflammatory activities of extracellular
vesicles and soluble factors derived from bacteria
Kim Sang soo
a, Jaewook Leeb, Park Kyong-Suc and Yong Song Ghoa
aDepartment of Life Sciences, Pohang University of Science and Technology, Pohang,
Republic of Korea; bDepartment of Life Sciences, Pohang University of Science and
Technology (POSTECH), Pohang, Republic of Korea; cDepartment of Life Sciences, Pohang
University of Science and Technology (POSTECH) (graduate), Pohang, Republic of Korea
Introduction: Soluble factors released by cells play important roles in intercellular
communication. However, extracellular vesicles (EVs) have recently attracted much
attention as intercellular communicasomes, complex extracellular organelles that mediate
intercellular communication. While it has been reported that EV-associated molecules
elicit greater activities than soluble forms, no studies have compared the activities
of EVs as a whole with soluble factors. In this study, EVs and soluble factors derived
from bacteria were compared with regard to local and systemic inflammatory activities.
Methods: Escherichia coli was cultured in a chemically defined medium, and conditioned
medium (CM) was harvested from the culture. EVs and soluble factors (CM-EVs) were
isolated from 3 kDa cut-off concentrated CM by ultracentrifugation. RAW264.7 cells
were treated with EVs and CM-EVs, then the release of TNF-α and IL-6 were measured
with ELISA. In addition, wild-type mice were intraperitoneally administered with EVs
and CM-EVs, and septic signs were observed. Inflammatory indices including the concentrations
of TNF-α and IL-6 as well as the numbers of infiltrated immune cells were also assessed
from the peritoneal lavage fluid, serum and bronchoalveolar lavage fluid.
Results: EVs mediated the release of IL-6 from RAW264.7 cells in vitro, with greater
extent than CM-EVs. Unlike CM-EVs, EVs mediated systemic septic symptoms including
hypothermia, eye exudate formation and leukopenia. While both EVs and CM-EVs mediated
immune cell infiltration into the peritoneum, EVs mediated the elevation of the concentrations
of TNF-α and IL-6 in the peritoneal lavage fluid, more efficiently than CM-EVs. In
addition, EVs mediated the elevation of the concentrations of TNF-α and IL-6 in the
serum, whereas, CM-EVs did not. More importantly, EVs mediated immune cell infiltration
as well as the elevation of the concentrations of TNF-α and IL-6 in the bronchoalveolar
lavage fluid, whereas CM-EVs did not.
Summary/conclusion: Although EVs and soluble factors mediated local inflammatory responses,
only EVs can act as long-range effectors in systemic inflammatory responses, suggesting
EVs as new therapeutic targets for infectious diseases.
LBS02.05
Gram-negative bacterial extracellular vesicles promote angiogenesis by inducing interleukin-6
Jaemin Lee
a, Jaewook Leeb, Tae-Young Rohc and Yong Song Ghod
aPohang University of Science and Technology, Pohang, Republic of Korea; bDepartment
of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Republic
of Korea; cDiv. of IBB, Dept of Life Sciences, Pohang University of Science and Technology
(POSTECH), Pohang, Republic of Korea; dDepartment of Life Sciences, Pohang University
of Science and Technology, Pohang, Republic of Korea
Introduction: Angiogenesis, the formation of blood vessels from pre-existing vasculature,
is an essential complex process for multiple pathophysiological conditions including
bacterial infection, inflammatory diseases and bacterial sepsis. Several pathological
functions of Gram-negative bacterial extracellular vesicles (EVs), also known as outer
membrane vesicles have been shown to induce local inflammation, systemic inflammation,
and septic shock, and so on. However, no studies have assessed the effects of Gram-negative
bacterial EVs on angiogenesis.
Methods: Escherichia coli EVs were subcutaneously administered to wild-type mice,
along with Matrigels. The Matrigels were subjected to whole mount immunostaining,
and vascular area was measured. As macrophages are involved in angiogenesis, macrophage
infiltration was also assessed in the Matrigels. Peritoneal macrophages from wild-type
mice were treated with E. coli EVs, and the conditioned media were treated to endothelial
cells to measure cell migration. Furthermore, to show the role of interleukin-6 (IL-6)
on angiogenesis, E. coli EVs were subcutaneously administered to wild-type and IL-6
knock-out mice, along with Matrigels. Then, the Matrigels were subjected to whole
mount immunostaining, and vascular area was measured. In addition, peritoneal macrophages
from wild-type and IL-6 knock-out mice were treated with E. coli EVs, and the conditioned
media from the macrophages were treated to endothelial cells to measure cell migration.
Results: E. coli EVs promoted in vivo angiogenesis and macrophage infiltration in
wild-type mice. Peritoneal macrophages from wild-type mice, treated with E. coli EVs,
mediated endothelial cell migration in vitro. However, E. coli EVs did not promote
angiogenesis and macrophage infiltration in IL-6 knock-out mice. Furthermore, peritoneal
macrophages from IL-6 knock-out mice, treated with E. coli EVs, did not mediate endothelial
cell migration.
Summary/conclusion: Gram-negative bacterial EVs have potent angiogenic activities
by promoting macrophage infiltration and inducing IL-6. These findings provide insights
into the effects of Gram-negative bacterial EVs on bacterial infection-related pathological
diseases including bacterial infection, inflammatory diseases, and bacterial sepsis.
LBS02.06
Dendritic cell derived-exosomes activate immune systems by transferring exosome involved
factors to T cell
Masakatsu Takanashi
a, Shinobu Uedaa, Katsuko Sudob and Masahiko Kurodaa
aDepartment of Molecular Pathology, Tokyo Medical University, Tokyo, Japan; bAnimal
Research Center, Tokyo Medical University, Tokyo, Japan
Introduction: Exosomes released from dendritic cells (DCs) are responsible for the
persistence of antigen presentation. So, we considered that whether DCs-derived exosomes
could induce suppress cancer cells and more effective response of an immune system
and what factors in exosomes-involved DCs can activate T cells.
Methods: Luciferase gene transferred-3LL cells (murine lung cancer cell line derived
C57BL/6) were injected into C57BL/6J mice by intraperitoneal administration. And then,
DCs, DCs-exosomes or 3LL-exosomes were weekly administrated to lung cancer-bearing
mice. The exosomes derived from DCs decreased lung cancer cell growth compared with
DCs, DCs-exosomes and non-treated. We evaluated mRNA expressions differences in between
LPS-treatment DCs and none treatment DCs with DNA microarray analysis.
Results: DNA microarray analysis data showed that 44 genes increased as ratio LPS-treated
DC mRNA vs non-treatment DC one. Western blot analysis showed one of the genes contained
higher in exosomes derived from LPS-treatment DCs than that derived from non-treatments.
Summary/conclusion: This gene induces T cell proliferation and signals for T cell
maturation. We concluded that DCs derived-exosomes activate anticancer immune systems
by transferring exosome-involved the factor to T cells.
LBS02.07
Crosstalk between endoplasmic reticulum stress and autophagy in kidney diseases
Yuh-Feng Lina and Hui-Wen Chiu
b
aTaipei Medical University, Taipei, Taiwan (Republic of China); bGraduate Institute
of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
(Republic of China)
Introduction: The endoplasmic reticulum (ER) regulates several cellular functions,
including the protein biosynthesis, folding, trafficking and modification. The accumulation
of unfolded or misfolded proteins causes a form of cellular stress that has been termed
ER stress. ER stress activates the unfolded protein response (UPR) signalling network
which serves as an adaptive response. The potential benefit of maintaining ER homeostasis
modulates ER stress status to protect the kidney against various pathogenic environments.
Furthermore, ER stress induces autophagy in mammalian cells. The ER stress-induced
autophagy offers protection from oxidative-induced cytotoxicity and ameliorated kidney
injury. In this study, we understand the mechanism modulated the regulation of UPR
and autophagy in kidney cells.
Methods: We examined cytotoxicity of ER stress inducers (tunicamycin (TM) or thapsigargin
(TG)) in human kidney cells HK-2. To analyse low doses TM or TG induces autophagy
using immunofluorescence microscopy, transmission electron microscopy and Western
blot analysis. Also, to investigate TM or TG inhibits oxidative stress through the
induction of autophagy. In addition, we established an adenine-induced chronic kidney
disease (CKD) mice model. The effectiveness of TM or TG was investigated in CKD mice
model.
Results: Low concentrations of TM and TG did not affect cell viability in HK-2 cells.
TM and TG induced UPR pathway and autophagy. Furthermore, TM and TG inhibited oxidative
stress‐induced cell death. The inhibition of autophagy can increase cytotoxicity in
HK-2 cells. Therefore, TM- and TG-induced autophagy palys a protective role. The inflammasome
and cytokine synthesis were suppressed after treatment with TM and TG. In addition,
HK-2 stimulated with TM or TG had increased production of exosomes. In the model of
adenine diet-induced CKD, TM and TG ameliorated renal dysfunction and injury through
the induction of ER stress and autophagy.
Summary/conclusion: These results suggest that TM and TG protected kidney cells against
oxidative stress‐induced cell death and inhibited inflammatory effect. ER stress-induced
autophagy may be a pro-survival role. However, the complete mechanism of how TM and
TG regulate exosomes is yet unknown and need further investigation.
LBS02.08
Extracellular Vesicle-induced protein phosphorylation: Rapid activation of epithelial-mesenchymal
transition pathways in lung epithelial cell
Ganesh Shelke
a, Yin Yananb, Cecilia Lasserc, Hjalmar Brismard and Jan Lötvalle
aSahlgrenska Cancer Center/Department of Surgery, Institute of Clinical Sciences,
University of Gothenburg, Gothenburg, Sweden., Gothenburg, Sweden; bDepartment of
Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University, School of
Medicine 80 South Chongqing Road, Shanghai 200025 China, Shenghai, China (People‘s
Republic); cKrefting Research Centre/University of Gothenburg1 Krefting Research Centre,
Dept of Internal medicine and clinical nutrition, Institute of Medicine, University
of Gothenburg, Sweden, Gothenburg, Sweden; dScience for Life Laboratory, Dept. of
Applied Physics, Royal Institute of Technology, PO Box 1031, 17121, Solna, Sweden,
Solna, Stockholm, Sweden; eKrefting Research Centre, Institute of Medicine at the
Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden, Gothenburg, Sweden
Introduction: Extracellular vesicles are important mediators of cell-to-cell communication.
With their bioactive cargos including proteins, lipids and nucleic acids, they can
alter the fate of a recipient cell. Mast-cells and lung epithelium exists in close
physical proximity and activity in mast cells is reflected in epithelial cells. In
this study, we hypothesized that mast cell-derived EVs alter recipient epithelial
cells by inducing phosphorylation of multiple proteins.
Methods: Mast cells derived-EVs (HMC1.1) were obtained by differential ultracentrifugation.
We determined the early protein phosphorylation induced by EVs, in recipient cell
A549 cells using phospho-protein microarray (Sciomics), and determined the longer-term
effects on RNA transcripts and protein changes in epithelial cells.
Results: Prolonged exposure of EVs altered cellular morphology of recipient epithelial
A549 cells. This was in line with changes in the transcript that are known to activate
epithelial-mesenchymal transition (EMT), including increased levels of TWIST1, MMP9,
TGFB1, and BMP-7. This was also reflected at the protein levels in recipient cells;
e.g downregulation of CDH1 and upregulation of MMP. By contrast, EMT inducing transcription
factor Slug-Snail was upregulated. To determine any rapid responses 30 minutes after
EV treatment we performed phospho-protein microarray of recipient cells. In-silico
analysis of phospho-proteome revealed proteins in signalling networks that are part
of the PI3K-Akt pathway or cytokine receptor interactions. Interestingly, a protein
involved in regulating focal adhesion and tight junctions was phosphorylated in these
experiments; e.g. CLDN1, OCLN, and ACTN1. Finally, we validated one of the well-studied
EMT-regulating pathway (TGFβ signalling) in both A549 and BEAS-2B cell lines.
Summary/conclusion: Mast cell-derived EV facilitates activation of EMT in lung epithelial
cells, which is closely associated to EMT-associated protein phosphorylation. This
study highlights the component of signalling pathways that are rapidly phosphorylated
in recipient cells with the contact of EVs.
Funding: VBG group Herman Krefting Foundation, Swedish Cancer Foundation, Swedish
Research Council, and Heart and Lung Foundation, EAACI, AG Foundation, Lundgren Foundation,
Sahlgrenska University Hospital, and Sahlgrenska Academy.
LBS02.09
Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic
pulmonary fibrosis
Mitsuhiro Yamada
a, Tomonori Makiguchia, Yusuke Yoshiokab, Takahiro Ochiyac and Masakazu Ichinosea
aDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine,
Sendai, Japan; bTokyo Medical University, Tokyo, Japan; cDepartment of Molecular and
Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo,
Japan
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung
disease for which no treatment is capable of providing a complete cure. The median
survival for IPF patients from the time of diagnosis is approximately 3 years. IPF
patients differ in terms of the disease progression rate and prognosis, complicating
the prediction of survival. The identification of prognostic predictors for IPF is
important for determining who requires the most intensive therapies. In this study,
we explored the possibility that microRNAs of serum EVs changed during lung fibrosis
and could serve as prognostic biomarkers of IPF.
Methods: To determine target microRNAs in IPF, we measured serum EV microRNA expression
profiles using microRNA PCR arrays in a bleomycin mouse lung fibrosis model. Secondly,
we enrolled 41 IPF patients and conducted a 60-month prospective cohort study. Expression
of serum EV miR-21-5p was normalized by dividing by the EV amount. The relative amount
of EVs was measured using the ExoScreen method. We calculated the correlations between
baseline serum EV miR-21-5p expression and other clinical variables. Furthermore,
we determined if serum EV miR-21-5p can predict mortality during 60 months using the
Cox hazard model. According to the median level, we divided the IPF patients into
two groups. Then we compared the survival rate during 60 months between the two groups
using the Kaplan-Meier method.
Results: Serum EV miR-21-5p was elevated in both the acute inflammatory phase (day
7) and the chronic fibrotic phase (day 28) in the mouse model. In the clinical setting,
serum EV miR-21-5p was significantly higher in IPF patients than in control subjects.
The baseline serum EV miR-21-5p was correlated with the rate of decline in vital capacity
over 6 months. Furthermore, serum EV miR-21-5p was independently associated with mortality
during the following 60 months, even after adjustment for other variables. In the
survival analysis, IPF patients whose baseline serum EV miR-21-5p was high had a significantly
poorer prognosis over 60 months.
Summary/conclusion: Our results may suggest that serum EV miR-21-5p has potential
as a prognostic biomarker for IPF.
Funding: This work was supported by Grants-in-Aid for Scientific Research (24591148
and 15K09206 to M Yamada) from the Japan Society for the Promotion of Science (JSPS).
LBS02.10
Extracellular vesicles subpopulations: who are the key players in vascular inflammation?
Baharak Hosseinkhania, Sören Kuypers
a, Nynke Van den Akkerb, Daniel Molinb and Luc Michielsa
aHasselt University, Martelarenlaan 42, B-3500 Hasselt, Belgium, Diepenbeek, Belgium;
bMaastricht University, dept. Of Physiology, Cardiovascular Research Institute Maastricht
(CARIM), Universiteitssingel 50, 6200 MD Maastricht, The Netherlands, Maastricht,
Netherlands
Introduction: Current conceptual insights on the mechanistic aspect of cell signalling
by discovering extracellular vesicles (EV) have shed light on the pathological understanding
of chronic inflammatory diseases. The biological function of EV bulk in the progression
of inflammation-associated disorders has become clear, the protein composition and
function of the disease-specific subsets are often hampered by undesirable EV co-isolates.
Thus, there is an urgent need to isolate certain subpopulations to generate a disease-relevant
signature while retaining their functional integrity. Therefore, we aimed to fractionate
the inflammation associated-EV subsets based on two important characteristics (sedimentation
and surface markers) and subsequently profiling the immunomodulatory protein content.
Methods: TEM, NTA and Western blot were used to characterize the purified inflammation‐associated
EV subsets from TNF-α treated HUVEC based on their sedimentation speeds (10K and 110K)
and surface markers (CDs and ICAM-1). Protein arrays were used to discover the immunomodulatory
content of subsets. In addition, functional integrity of the EV subpopulations was
assessed using migration cell based assays.
Results: We demonstrated that HUVEC upon inflammation release two distinct populations
of heterogeneous EV, differing in size and quantity. The immunoaffinity of these two
populations towards EV classical markers (a cocktail of CD9, CD63 and CD81) and an
inflammatory-associated marker revealed that the circulating form of ICAM-1 is abundantly
docked on the membrane of large EV, thus offering a potentially promising biomarker
for immunocapturing of EV subsets. Moreover, protein profiling of EV size-based populations
and their inflammation-associated EV subsets showed that the patterns of cytokines
and adhesion markers were significantly different. In cell-based assays, EV of different
sizes work synergistically in accelerating the vascular inflammation.
Summary/conclusion: A procedure of two purification steps resulted in purer inflammation-associated
EV isolates, allowing a better understanding of their biology and functions at the
onset of vascular inflammation.
Funding: This work was co-financed by the EU through the Interreg IV Flanders-the
Netherlands project Interreg V Flanders-the Netherlands project Trans Tech Diagnostics
(TTD).
LBS03: Late Breaking- EV Biogenesis, Loading, and Uptake Chairs: Samarjit Das; Wang
JiangLocation: Level 3, Hall A15:00–16:00
LBS03.01=OWP1.15
Membrane-radiolabelled exosomes for comparative biodistribution analysis in immunocompetent
and immunodeficient mice – A novel and universal approach
Farid N. Faruqua, Julie Wanga, Lizhou Xub, Luke McNicklea, Ming-Yiu Chonga, Mark Gurneyc,
Aled Claytonc, Lesley A. Smythd, Robert Hidera, Jane Sosabowskie and Khuloud Al-Jamal
a
aKing‘s College London, London, United Kingdom; bSchool of Cancer and Pharmaceutical
Sciences, King‘s College London, London, United Kingdom; cCardiff University, Cardiff,
United Kingdom; dUniversity of East London, London, United Kingdom; eQueen Mary University
of London, London, United Kingdom
Introduction: Exosomes have gained interest as novel drug nanocarriers due to their
biological origin and role in intercellular biomolecule delivery. In-depth knowledge
of their in vivo biodistribution is therefore essential. This work aimed to develop
a reliable and universal method to radiolabel exosomes to study in vivo biodistribution
in mice.
Methods: Melanoma (B16F10 cells)-derived exosomes (ExoB16) were isolated and characterized
for size, yield, purity, exosomal markers and morphology using Nanoparticle Tracking
Analysis (NTA), protein measurements, flow cytometry and electron microscopy. Two
radiolabelling approaches were explored – intraluminal labelling (111Indium entrapment
via tropolone shuttling); and membrane labelling (111Indium chelation by covalently
attached bifunctional chelator). Labelling efficiency and stability was assessed by
gel filtration and thin layer chromatography. Melanoma-bearing immunocompetent (C57BL/6)
and immunodeficient (NSG) mice were injected intravenously with radiolabelled ExoB16
(1x1011 particles) followed by metabolic cages study, whole body SPECT-CT imaging
and ex vivo gamma counting at 1, 4 and 24 h post-injection.
Results: Membrane-labelled ExoB16 (ML-ExoB16) showed superior radiolabelling efficiency
and radiochemical stability compared to intraluminal-labelled ExoB16 (IL-ExoB16).
Both IL- and ML-ExoB16 showed prominent accumulation in liver and spleen. IL-ExoB16
showed higher tumour accumulation than ML- ExoB16 (6.7% and 0,6% ID/g tissue, respectively),
with the former showing similar value as its free tracer ([111]Trop). The superior
stability of the membrane-labelling approach rendered its result more reliable and
was used to compare ExoB16 biodistribution in melanoma-bearing immunocompromized (NSG)
mice. Similar biodistribution profile was observed in both C57BL/6 and NSG mice, where
prominent accumulation was seen in liver and spleen, apart from the lower tumour accumulation
observed in the NSG mice.
Summary/conclusion: Membrane radiolabelling of exosomes is a reliable approach that
allows for both live imaging and quantitative biodistribution studies to be performed
on potentially all exosome types without engineering parent cells.
LBS03.02
Rala and ralb finely tune EVs biogenesis and promote metastasis
Vincent Hyenne
a, Shima Ghoroghib, Olivier Lefebvreb and Jacky G. Goetzb
aINSERM U1109/CNRS, Strasbourg, France; bINSERM U1109, Strasbourg, France
Introduction: Tumour extracellular vesicles (EVs) promote tumour progression. However,
their behaviour in body fluids remains mysterious. In addition, further understanding
of molecular mechanisms driving their biogenesis is needed to develop strategies aiming
to impair their tumorigenic potential. We recently showed that the zebrafish embryo
can be used to track and assess the function of circulating tumour EVs in vivo and
provide a high-resolution description of their dissemination and uptake (Hyenne et
al., Dev Cell, 19). We provided a first description of tumour EVs’ hemodynamic behaviour
and showed that they are rapidly taken up by endothelial cells and blood patrolling
macrophages and subsequently stored in degradative compartments.
Methods: In addition, we recently investigated the molecular mechanisms of EV release
in a tumorigenic context, using a mouse model of breast cancer carcinoma.
Results: We observed that depletion of either RalA or RalB GTPases decreases levels
of EVs’ secretion (Hyenne et al. JCB 15) and modifies their protein and RNA content.
We further showed that RalA and B are required to properly localize PLD1 on MVBs thereby
inducing EVs biogenesis. Interestingly, EVs secreted from RalA and RalB depleted cells
are less prone to endothelial permeabilization in vitro. Finally, RalA and RalB depletion
significantly impairs lung metastasis in a syngeneic model of breast carcinoma suggesting
that RalA/B controls lung metastatis by tuning the levels and contents of tEVs.
Summary/conclusion: Overall, our recent works proves the usefulness and prospects
of zebrafish embryo to track tumour EVs and dissect their role in metastatic niches
formation in vivo. It further provides new mechanistic information as to how RalA
and RalB control the biogenesis of potent tumour-promoting EVs.
LBS03.03
In vivo visualization of extracellular vesicles released from mature osteoblasts by
intravital multiphoton microscopy
Hiroki Mizuno, Maki Uenaka and Masaru Ishii
Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier
Biosciences, Osaka University, Osaka, Japan, Suita, Japan
Introduction: Bone remodelling is essential for maintaining bone architecture and
systemic mineral homeostasis throughout life. In the process, the formation of bone
matrix by osteoblasts follows the removal of mineralized bone by osteoclasts. Despite
intensive investigations on understanding their functions, the detailed mechanisms
on their dynamic nature in vivo remain unknown. In this study we especially focus
on the dynamics of mature osteoblasts which replenish bone matrices during homeostasis.
Methods: To understand the cellular dynamics of mature osteoblasts in vivo, here we
established a reporter system where mature osteoblasts express enhanced cyan fluorescent
protein (ECFP). We could visualize their dynamic nature in vivo by using intravital
multiphoton microscopy for live bone tissues which we have originally developed so
far.
Results: We detected that mature osteoblasts spontaneously release large extracellular
vesicles (EVs), whose sizes are from 0.2 to 1 µm, and those are also taken up by mature
osteoblasts. Such phenomenon could also be reconstituted in mature osteoblasts cultured
ex vivo. Further analyses are currently ongoing in order to analyse the physiological
and pathophysiological functions of these vesicles.
Summary/conclusion: This is the first study detecting the real dynamic nature of microvesicles
in vivo, which are actively released from mature osteoblasts in the bone cavity. We
think these microvesicles are important regulators for normal bone homeostasis as
well as pathological remodelling.
LBS03.04
New products from donated blood – unravelling the potential of blood cell derived
EVs
Ulla Impola
a, Sami Valkonenb and Saara Laitinenb
aBlood Service, Finnish Red Cross, Helsinki, Finland; bBlood Service Finnish Red Cross,
Helsinki, Finland
Introduction: Extracellular vesicles (EV) originated from different cell types have
recently been under intense investigation. Platelet EVs constitute the major fraction
of EVs in the circulating plasma, however, there are only a few studies characterizing
the populations of platelet concentrate derived EVs in more detail. Few recent publications
show that plasma EVs can target specifically into certain mononuclear cell populations
but little is known about their biological function, signalling and communication.
As just recently addressed by Onodi et al., EV purification has major challenges as
majority of EVs from plasma has lipoprotein particles and the abundant plasma proteins
as impurities complicating the study of the role of pure EVs. We have previously shown
that platelet concentrates used for transfusions contain increasing amount of EVs
after longer storage period. It is important to study these platelet-EVs in more detail
in order to understand their role in product functionality.
Methods: Excess platelet concentrates not needed for the clinical use were obtained
from the Finnish Red Cross Blood Service. All donated blood products used for research
were obtained from healthy volunteers who had given their informed consent. In our
ongoing work we compared ultracentrifugation based isolation methods and size exclusion
chromatography in order to collect differing populations of platelet concentrate derived
EVs. EVs are further labelled with fluorescent surface protein, lipid and RNA markers
and studied using Amnis ImageStream®X Mark II Imaging Flow Cytometer. Purity and characteristics
of these isolated EVs are compared and their targeting into different mononuclear
cells as well as their immunological relevance are investigated.
Results: Based on our results we are able to say that we get a pure population of
EVs with low contamination of lipid or plasma protein impurities. The main population
of the platelet concentrate derived EVs are platelet derived and thus CD41 positive,
however, the origin of EVs differ as well as their cargo indicating differences in
their immunological functions.
Summary/conclusion: Our aim is to find previously ignored, new applications for donated
blood components and to identify the potential EV population to be utilized either
as therapeutic components in tissue repair or as drug delivery vehicles.
LBS03.05
The effect of rhinovirus type 16 derived microvesicles on the growth of hela cells
Roberta Cordeiro Freezor
a, Gary McLeanb and Sheelagh Heughc
aLondon Metropolitan University, London, United Kingdom; bSupporting PhD supervisor,
London, United Kingdom; cPhD supervisor, London, United Kingdom
Introduction: Belonging to group A, Rhinovirus Type 16 (HRV16) uses the receptor Intercellular
Adhesion Molecule (ICAM) 1 to enter cells. Studies demonstrated Extracellular Vesicles
(EV) discharge from viral infected cells harbour and distribute regulatory factors
to recipient cells. These include viral RNA and proteins, viral and cellular miRNA,
as well as host functional genetic elements to nearby cells, leading to the production
of infections particles and modulating cellular responses including the spread or
limitation of infection conditional on the type of pathogen and target cells. Here,
we demostrate that HRV16 derived microvesicles (HRV16MV) infect HeLa cells at a higher
rate than HRV16 particles.
Methods: HRV16MV were extracted from HeLa cells after 24 h of HRV16 infection (MOI
0.2) via ultracentrifugation. Quantified by Flow cytometry, HeLaMV control (HelaMVc)
and HRV16MV were added to each well containing the HeLa cells treated with CGM (exosome
free). The plates were incubated at 37°C in a 5% CO2 and left untreated for 24 h.
HeLa cells control samples were observed against MV treated cells and the concentration/mL
and % viability were determined every 4 h after 12 h incubation period to determine
the effect of MV on the growth of the cell line.
Results: HRV16MV treated cells showed a growth decline after 16 h into the experiment,
which suggests a faster infection rate (P**) when compared to HRV16 infection. Both,
HRV16 and HRV16MV treated cells demonstrated a decline in % viability (P>**) after
16 h of infection in comparison to HeLaMVc. However, despite a slight decrease in
in the growth rate of HRV16MV treated cells no statistical significance was observed
in % viability between samples.
Summary/conclusion: HRV16MV treated cells showed an advanced infection rate of treated
HeLa cells. HRV16 genome encodes two proteases specifically, 2A and 3C as well as
a precursor protease, 3CD. These proteases are necessary for adequate virus replication,
for the precise localisation of proteins during infection and for the temporal regulation
of 2A and 3CD/3C protease activities during HRV16 infection. Therefore, these proteases
may be hypothesized to be embedded in HRV16MV suggesting that they could potentially
be hijacked by the virus to spread infection.
LBS03.06
A highly efficient cell‐free protein synthesis system from plasmid DNA.
Hyangsu Nam
University of Seoul, Seoul, Republic of Korea
Introduction: Protein is essential molecules that play many critical roles in the
body. Activity and interaction of gene encoding proteins are recognized as a key element
of pharmaceutical and biomaterials. However, since the general protein production
method is performed through microorganisms and cell culture processes that require
a lot of time and labour, it is not only decomposed and deformed by enzymes produced
by cell growth but also has a limit to producing a large amount of protein. This study
reports a DNA hydrogel that can induce excessive protein without lives cells using
denatured DNA plasmid. This novel synthesis method improved the efficiency of protein
expression through Rolling circle amplification that repetitive sequencing of nucleotides
for protein expression in plasmid DNA that codes a specific gene. Notably, our synthesized
DNA plasmid gel expressed large scale green fluorescence protein (GFP) than wild type.
In addition, DNA gel has the strength of having a physical characteristic and being
able to express the specific protein in a specific area. Novel large-scale protein
expression method using cell-free DNA gel has great potential as a biomaterial for
therapeutic protein delivery. In addition, this method can be applied mRNA manipulation,
which plays a major role in transmitting proteins, can be used to transfer particles
using RCA method and to produce vesicles containing proteins by putting them in vesicles.
Methods: The plasmid pT7CEF1-Chis was prepared Thermofisher. Linear single stranded
circular DNA oligonucleotides from denatured DNA plasmid were incubated with T4 polymerase
at 30℃ 72 h with dNTPs.
Results: We developed the periodically repeated nucleotides through RCA process band
its cell-free largescale protein expression system. The synthesized plasmid DNA hydrogel
has stable formation and having a high efficiency to express specific protein.
Summary/conclusion: In this study, we developed cell-free protein expression method,
which were synthesized by a uniquely designed RCA method, as a protein therapeutics
platform technology. The cell-free protein producing DNA plasmid gel can be considered
as a potential candidate for protein delivery.
LBS03.07
Targeting mevalonate pathway with low doses of valproic acid reduces large EVs shedding
in different solid tumours
Chiara Ciardiello
a, Rossella Migliorinoa, Federica Iannellia, Maria S. Rocaa, Francesca Bruzzesea,
Biagio Puccia, Susan Costantinia, Elena Di Gennaroa, Alessandra Leonea and Alfredo
Budillonb
aExperimental Pharmacology Unit, Istituto Nazionale Tumori – IRCCS- Fondazione G.
Pascale, Napoli, Italy; bIstituto Nazionale Tumori – IRCCS- Fondazione G. Pascale,
Napoli, Italy
Introduction: Epithelial to mesenchymal transition (EMT) as well as mesenchymal to
amoeboid transition (MAT) are linked with increased cancer cell motility and stemness,
MAT being also described to favour large extracellular vesicles (EVs) shedding. Recently,
both these phenotypic changes were associated to metabolic control involving the mevalonate
pathway (MVP), a key controller of lipid metabolism but also a regulator of cell structure
and signalling. valproic acid (VPA), an antiepileptic and a well-known histone deacetylase
inhibitor, showed antitumor activity and capability to augment anticancer efficacies
of other therapeutic approaches (i.e. ionizing radiation, chemotherapy, immunotherapy).
Methods: Two different isogenic models developed by our group were used: prostate
cancer DU145 cells and their derived more aggressive subline DU145R80 selected as
resistant to MVP-pathway inhibitors and enriched in stem markers; the colorectal cancer
CO147 primary cell line, cultured either as differentiated cells or as cancer stem
cells enriched spheres. Western blotting and metabolomics were performed to monitor
MVP modulation upon VPA treatment (0.5-1 mM). Large EVs were isolated from cell media
by discontinuous density gradient ultra-centrifugations and measured by Tunable resistive
pulse sensing or flow cytometry VPA-treated or untreated cells.
Results: Both DU145R80 cells and CO147 cultured as spheres showed enriched stem like
features and higher large EVs shedding, compared to parental DU145 and differentiated
CO147 cells, respectively. At very low doses, VPA reduced large EVs shedding in both
DU145R80 and CO147 sphere cultures, compared to the untreated cells, without affecting
cells viability. Mechanistically, preliminary data suggest that VPA-induced effect
is mediated by MVP pathway modulation.
Summary/conclusion: Our results describe for the first time a novel anticancer potential
of VPA, being able to impact cancer cell to cell communication by reducing the shedding
of large EVs.
Funding: AIRC FIRC
LBS03.08
The role of glycogen synthase kinase 3 beta in the biogenesis of extracellular vesicles
by modulating microtubule dynamics
Seoyoon Bae
a, Eun-Jeong Choia, Kwan Soo Hongb and Yong Song Ghoa
aDepartment of Life Sciences, Pohang University of Science and Technology, Pohang,
Republic of Korea; bBioimaging Research Team, Korea Basic Science Institute, Cheongju,
Republic of Korea
Introduction: Extracellular vesicles (EVs) are spherical, bilayered membranous vesicles
secreted by all living cells. EVs harbour various bioactive materials, and play diverse
roles in biological processes such as tumour progression. There are several reports
studied on the proteins involved in EV biogenesis mainly focused on the proteins involved
in vesicle trafficking. However, proteins regulating EV biogenesis are still unclear.
As most cellular processes are regulated by protein phosphorylation, which is regulated
by kinases and phosphatases, identifying kinases and phosphatases involved in EV biogenesis
helps to understand EV-mediated pathophysiological functions.
Methods: To identify kinases and phosphatases involved in EV biogenesis, a total of
76 kinase inhibitors and 33 phosphatase inhibitors were treated to A549 cells. The
amounts of CD81, an EV-enriched protein, were quantified from the conditioned media
to show alterations in EV biogenesis. To further verify the role of glycogen synthase
kinase 3 beta (GSK3β) in EV biogenesis, stable cell lines expressing wild-type, constitutively
active mutant, and dominant-negative mutant GSK3β were established, and alterations
in EV biogenesis were measured in these cell lines. As microtubule dynamics affects
EV biogenesis, changes in microtubule dynamics were also assessed in these cell lines.
Results: Among the kinase and phosphatase inhibitors, an inhibitor of GSK3β and calcineurin
decreased and increased EV biogenesis, respectively. EV biogenesis was increased in
the conditioned media from cells expressing constitutively active mutant GSK3β, and
decreased in the conditioned media from cells expressing dominant-negative mutant
GSK3β, when compared with cells expressing wild-type GSK3β. Microtubules were more
disorganized in cells expressing constitutively active mutant GSK3β, and more aligned
in cells expressing dominant-negative mutant GSK3β, when compared with cells expressing
wild-type GSK3β.
Summary/conclusion: By high-throughput screening of kinase/phosphatase inhibitors,
we identified GSK3β as a positive regulator of EV biogenesis by modulating microtubule
dynamics. These observations suggest that GSK3β as a novel therapeutic target against
several diseases by modulating EV biogenesis.
LBS03.09
Post-translational modifications affects trafficking of hyaluronan synthase 2 and
the release of extracellular vesicles
Raquel Maria. Melero
a, Uma Thanigai Arasub, Riikka Kärnäb, Sanna Oikarib, Kirsi Rillab, Davide Vigettic,
Alberto G. Passic, Heldin Paraskevid, Tammi Markkue and Ashik Jawahar Deene
aCEU-San Pablo, Boadilla, Spain; bInstitute of Biomedicine, University of Eastern
Finland, Kuopio, Finland., Kuopio, Finland; cDepartment of Medicine and Surgery, University
of Insubria, Varese, Italy., Varese, Italy; dDepartment of Medical Biochemistry and
Microbiology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden; eInstitute of
Biomedicine, University of Eastern Finland, Kuopio, Finland, Kuopio, Finland
Introduction: Hyaluronan synthase 2 (HAS2) is the major producer of Hyaluronan (HA)
in adult vertebrates. Its enhanced expression has been lately related within the apical
filopodia growth and the budding of extracellular vesicles (EVs). Moreover, a fraction
of HAS enzymes are secreted from PM into extracellular vesicles (EVs), often covered
by HA. We studied whether the mutations blocking post-translational modifications
on HAS2 also affected the EVs released.
Methods: Site-directed mutagenesis was used to block ubiquitination (K190R), and phosphorylation
(T110A)
HA was measured using ELSA
Isolation of EV secreted by HAS2-transfected cells was performed using ultracentrifugation
Analysis of extracellular vesicles (EV) was performed with a Nanoparticle Tracking
Analyzer and 3D culture
Results: Cell cultures transfected with HAS2 wt secreted ~50% more EVs as compared
to mock controls. Similar stimulation of EV secretion was found with K190R, while
non-increase of EVs occurred with T110A. These results lead us to two conclusions.
First, PM residence of HAS2 is likely required for the stimulation of EV secretion.
And second, HA synthesis is not strictly necessary for EV secretion, since K190R is
enzymatically inactive. Cells were grown in a 3D matrix to check if K190R was entering
itself in the vesicles. The data show that HAS2 wt and K190R, but not T110A were present
in the EVs. This indicates that the mechanism of HAS2 stimulation of EVs involves
HAS2 incorporation in them, and without the involvement of HA. Unexpectedly, 4-MU
(HA synthesis inhibitor 4-MU) blocked the shedding of all transfected HAS2 and its
mutants.
Summary/conclusion: Our data show that an enzymatically inactive HAS2 residing in
PM (K190R) enhanced EV secretion to the same extent as HAS2 wt, while it did not induce
the PM protrusions. Just the insertion of HAS2 in PM must, therefore, trigger a signal
or structural alteration in the membrane that facilitates its inclusion in, and shedding
of the EVs.
Another interesting finding was that while HA was not necessary for EV formation,
the HA synthesis inhibitor 4-MU blocked HAS2 insertion in the EVs. This may represent
yet another mechanism of HA synthesis inhibition by 4-MU. Exploring the mechanism
of the block and its importance in HA synthesis and EV shedding will be interesting
targets of future studies, especially in cancer epidemiology.
LBS03.10
Improving the stability of the large extracellular loop of human tetraspanin CD81
Stefan Vogt
a, Gordana Wozniak-Knoppb, Gerhard Stadlmayrb, Katharina Stadlbauerb, Florian Rükerc
and Johannes Grillarid
aDepartment of Biotechnology, University of Natural Resources and Life Sciences (BOKU),
Vienna, Muthgasse 18, 1190 Vienna, Austria, Vienna, Austria; bChristian Doppler Laboratory
for Innovative Immunotherapeutics, Department of Biotechnology, University of Natural
Resources and Life Sciences, Vienna (BOKU),Muthgasse 18, A-1190 Vienna, Austria, Wien,
Austria; cChristian Doppler Laboratory for Innovative Immunotherapeutics, Department
of Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU),
Muthgasse 18, A-1190 Vienna, Austria, Wien, Austria; dEvercyte GmbH, Muthgasse 18,
A-1190 Vienna, Austria, Wien, Austria
Introduction: Members of tetraspanin protein family are abundant on the surface of
nearly every type of extracellular vesicles (EVs) and are therefore attractive targets
for modification, leading to transformation of the EVs into a targeted drug delivery
system. The engineering of tetraspanin extracellular domains as independent folding
units towards specific antigen recognition is therefore of particular interest.
Methods: We have applied rigid body protein modelling approach to design more stable
mutants of large extracellular loop (LEL) of human tetraspanin protein CD81. Proteins
were expressed in ExpiCHO expression system and IMAC-purified. Their stability was
examined using DSC and the protein fold integrity assessed with HPLC-SEC in native
conditions and reactivity with structurally dependent binding anti-CD81 antibody.
Mutants based on such stabilized scaffolds were engrafted with human transferrin receptor
(hTfr) specific peptide at different positions, tested for their biophysical properties
and internalization in vitro.
Results: In order to enhance the tolerance for modification we successfully identified
positions that could accommodate pairs of point mutations to cysteine residues, leading
to de novo disulphide bridges in the human CD81 LEL. We achieved an increased thermal
stability with a shift in melting temperature (Tm) of up to 25°C in mutants with one
additional disulphide bridge. Mutants harbouring a combination of 2 engineered disulphide
bonds showed an increased Tm of up to 43°C.
The graft of a hTFR-binding peptide into the D-Helix of the wild-type LEL resulted
in a protein that still exhibited a compact fold. When the same peptide sequence was
inserted between the helices A and B, the mutant showed an aberrant profile in SEC,
which could be cured by using a scaffold variant with a stabilized LEL backbone. Additionally,
both peptide-grafted proteins revealed increased internalization into hTFR-overexpressing
SK-BR-3 breast cancer cells compared to the respective wild-type proteins.
Summary/conclusion: These results define important requirements for improving the
amenability of tetraspanins, in particular CD81 LEL, for their engineering into a
more versatile protein scaffold, which should empower the design of antigen-binding
tetraspanins as targeting moieties of EVs and functionalize them as a drug delivery
vehicle.
LBS03.11
Comparison of exosomes and ferritin protein nanocages for the delivery of membrane
protein theraqeutics
Eunji Cho, Gi-Hoon Nam, Jiyoung Goo, Cherlhyun Jeong, Yoosoo Yang and In-San Kim
Center for Theragnosis, Korea Institute of Science and Technology, Seoul, Republic
of Korea
Introduction: Exosomes are small membrane vesicles secreted by most cell types that
plays an important role in intercellular communication. Due to the characteristic
of transferring their biomacromolecules, exosomes have potential as a new alternative
for delivering protein therapeutics. Here, we investigate whether exosomes provide
crucial advantages over other nanoparticles, in particular protein nanocage formulations,
as a delivery system for membrane protein therapeutics. We characterized membrane-scaffold–based
exosomes and protein-scaffold–based ferritin nanocages, both harbouring SIRPα (signal
regulatory protein α), an antagonist of CD47 on tumour cells.
Methods: For preparing exo-SIRPα, HEK293T cells were transiently transfected with
desirable plasmid DNA. Following a further incubation for 48 h, the supernatants of
transfected HEK293T cells were harvested and subjected to a serial centrifugation
protocol (300 × g for 10 min, 2000 × g for 10 min and 10,000 × g for 30 min) to remove
debris. Then, exosomes were isolated from the cell culture medium by ultracentrifugation
(150,000×g for 2 h). Ferritin-SIRPα and monomer SIRPα proteins were purified through
an Ni-NTA chromatography step. For the impartial comparison, we adjusted the same
amount of SIRPα proteins of 2 nanocages in all experiments.
Results: Exo-SIRPα exceeds Ferritin-SIRPα in all experiments, cell binding ability,
enhancing phagocytic function of bone marrow derived macrophage, in vivo anti-tumour
effect and tumour specific immune response. Exosome-SIRPα shows better feasibility
compared to ferritin-SIRPα; five-folds higher in the aspect of cell binding ability,
three folds higher of phagocytosic activity and 4 folds higher in the case of tumour
growth inhibition.
Summary/conclusion: We compared the efficacy of two nanoparticles and concluded that
exosome has more advantages in delivering membrane proteins for therapeutic purpose.
Our findings highlight the ability of exosomes to display native membrane proteins
on their surface – a significant advantage of this delivery system – and suggest that
CD47 blockade by exosome-mediated SIRPα delivery is superior to that mediated by a
protein scaffold.
LBS03.12
Cell-specific growth surface topography optimization for extracellular vesicle studies
Colin L. Hiseya, Cherie Blenkironb and Larry Chamleyc
aUniversity of Auckland, Grafton, New Zealand; bThe University of Auckland, Auckland,
New Zealand; cThe University of Auckland
Introduction: While patient fluid samples provide valuable insight into the role of
EVs in human health, their limited supply and heterogeneous nature make them impractical
for basic studies. Conditioned media provides a consistent and limitless supply of
EVs from a known cell type, but large volumes are required to generate adequate numbers
of EVs. Also, little is known about how factors in the cellular microenvironment,
like surface topography, affect the EVs due to a lack of accessible biomimetic cell
culture systems. We present a unique cell culture dish covered in microtrack patterns
and demonstrate that this biomimicry affects the EVs produced by cancer cells.
Methods: Microtrack patterns were fabricated using photolithography. Soft lithography
was used to create microtrack moulds, which were spincoated with polystyrene and stamped
onto 150 mm petri dishes. Oxygen plasma and UV sterilisation were used to prepare
the surfaces for cell growth. MCF7 breast cancer cells were seeded and cell viability
and morphology were quantified. Live cells stained with Calcein-AM were imaged and
their morphology was quantified using FIJI. Cytoskeletal structure was imaged using
DAPI, TRITC-phalloidin and anti-vinculin/FITC-IgG. Cells were cultured in EV-depleted
media for the last 48h and EVs from smooth (control) and patterned dishes were isolated
using Vivaspin ultrafiltration and sequential ultracentrifugation. Finally, EV structural
integrity, concentration and size distribution were characterized using TEM and nanoparticle
tracking analysis.
Results: MCF7 cells cultured on microtrack dishes demonstrated similar viability to
smooth surfaces. Cell morphologies on microtracks had higher average aspect ratios
and less circularity (p < .05), as well as greater actin cytoskeletal alignment. Early
nanoparticle tracking analysis results indicate that cells cultured on fibrous surfaces
release more EVs than EVs from smooth surfaces and these results are currently being
further corroborated.
Summary/conclusion: This type of patterned growth surface could have implications
in both EV biomimicry and biomanufacturing. While it appears that simple surface patterning
with microtracks could simply and inexpensively improve EV-yield from cell cultures,
we are now exploring whether it also affects their biomimicry.
LBS03.13
Development of engineered extracellular vesicles expressing immune checkpoint protein
PD-1 by fusion with liposomes
Raga Ishikawa
a, Shosuke Yoshidab, Shin-ichi Sawadaa, Sada-atsu Mukaia, Yoshihiro Sasakia and Kazunari
Akiyoshia
aKyoto University, Kyoto, Japan; bNara Institute of Science and Technology, Ikoma,
Japan
Introduction: Extracellular vesicles (EVs) can potentially be used in biomedical applications
in drug delivery system. However, many problems still remain, such as equipping EVs
with active targeting ability and controlling the encapsulation of therapeutic drugs
in EVs. We have developed a new method for the preparation of the functional EVs that
display exogeneous membrane proteins using the baculovirus-expression system. In addition,
we have proposed that EV – liposome hybrids were prepared by membrane fusion between
liposomes and EVs containing fusogenic viral glycoprotein 64 (gp64). Here, we report
preparation of new hybrid EVs expressing immune checkpoint protein PD-1 by this method
and evaluation of the functions such as the specific interaction with cancer cells
Methods: The cDNA of PD-1 on a baculovirus vector was transfected into Sf9 insect
cells, and EVs that were expressed PD-1 on the surface were collected by ultra-centrifugation.
The hybrid EVs were prepared by membrane fusion between PD-1 EVs and FITC-Dextran
loaded-liposomes at the acidic condition. PD-1 and gp64 expression on PD-1 EVs and
PD-1 hybrid EVs were detected by Western blotting. PD-1 hybrid EVs were incubated
with Hela cells, and cellular uptake of PD-1 hybrid EVs was observed by confocal laser
scanning microscopy (CLSM).
Results: As results of Western blotting, PD-1 and gp64 were detected on EVs and also
hybrid EVs prepared at acidic pH. Membrane fusion between EVs containing gp64 and
liposomes proceeded only under the acidic pH. Interaction between PD-1 hybrid EVs
and PD-L1-expressing cancer cells was investigated by CLSM. The PD-1 hybrid EVs effectively
internalized into the cells via interaction with PD-L1, and FITC-dextran (as a model
of drug) loaded into PD-1 hybrid EVs was efficiently delivered into the cells.
Summary/conclusion: In summary, we prepared PD-1 hybrid EVs by using baculovirus-expression
system and membrane fusion with functional liposomes. This method provides a new strategy
for engineering EVs.
LBS03.14
Carcinogenesis and exosome packaging
Parul Katoch
a, Jessica Rodrigueza, Mark Floryb, Randall Armstrongb and Thuy Ngob
aOregon Health and Science University, Portland, USA; bOHSU, portland, USA
Introduction: Identification of cancer-specific biomarkers on exosomes has evaded
researchers for years and poses an enormous roadblock towards developing effective
diagnostic tools for early cancer detection. This is mainly due to the lack of a unique
exosome marker. Therefore, if we intend to use exosomes as cancer biomarkers in liquid
biopy we need to identify unique markers present on the exosomes or associated with
them in cancer. Thus, we aim to delineate molecular mechanisms employed during exosome
packaging and cargo-loading. We hypothesize that cancer cell employ distinct molecular
machineries to package protein-cargo vs RNA-cargo into exosomes. We further postulate
that understanding the packaging proteins involved in this cargo-specific packaging
will reveal key stages of biogenesis and will aid in identifying unique markers associated
with exosomes during carcinogenesis.
Methods: Recombinant DNA technology, confocal, super-resolution imaging, ultracentrifugation,
ultrafiltration and size exclusion columns, nanoparticle-tracking analysis electron
microscopy, high-resolution flow cytometry and Western blotting
Results: We have generated an in-vitro cell culture system comprised of lung-cancer
cell lines BEAS2-B and A549. The former represents early stage indolent disease while
the latter represents late stage aggressive disease. The culture system is genetically
engineered to stably express tagged components of an exosome, namely- lipid bilayer
(Td-Tomato-tagged myristoylation sequence), transmembrane cargo protein (EGFP-tagged
α5β6 integrin) and an RNA molecule (metabolically labelled). Exosomes generated by
the system are isolated and characterized.
Summary/conclusion: Thus, we have generated a unique tool, with which we aim to identify
– a) unique patterns of cargo packaging within these exosomes and b) to elucidate
the proteins involved in this directed packaging. Research undertaken in this project
will provide new and exciting avenues to detect signs of early cancer progression
holds immense potential for identifying cancer biomarkers.
Funding: CEDAR (Cancer Early Detection Advanced Research Center), Knight Cancer Institute)
Symposium Session 26: Flow Cytometric Analysis of EVs Chairs: Xiaomei Yan; Joshua
WelshLocation: Level 3, Hall B 16:00–17:00
OS26.01
Influence of lipoprotein particles in extracellular vesicle analysis by single particle
flow cytometry
Estefanía Lozano-Andrés
a, Sten F. Libregtsb, Ger Arkesteijnb and Marca H. M. Waubenc
aDeaprtment of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht
University, Utrecht, Netherlands; bFaculty of Veterinary Medicine, Utrecht University,
Utrecht, Netherlands; cDepartment of Biochemistry & Cell Biology, Faculty of Veterinary
Medicine, Utrecht University, Utrecht, Netherlands
Introduction: High-resolution flow cytometry (FC) allows for the detection of single
extracellular vesicles (EV) and enables quantitative and qualitative characterization.
EV in plasma has been associated with diseases, making them attractive for diagnosis
and prognosis of patients. However, the presence of lipoprotein particles (LPP) in
plasma may hamper robust flow cytometric analysis of EV. We here investigated the
interference of these particles when generic fluorescent dyes are used for labelling
and detection of EV by FC.
Methods: To define the impact of LPP on fluorescence-based FC–detection of EV, commercially
available LPP preparations, EV isolated from conditioned media of the mouse 4T1 mammary
carcinoma cell line, and platelet-poor plasma samples from healthy fastened human
donors were stained with PKH67 and CFSE. EV was isolated from samples by differential
ultracentrifugation or size-exclusion chromatography (SEC). Stained LPP, plasma EV
and 4T1 EV were succumbed to density gradient floatation, after which FC-analysis
was performed using a BD Influx that was optimized for detection of submicron-sized
particles.
Results: We found that both PKH67 and CFSE have the capacity to label various types
of LPP. When analysed by FC, fluorescently labelled LPP and EV are hard to discriminate
based on fluorescent and light scatter signals. Interestingly however, both dyes show
a different staining pattern for LPP and are indicative for the type of LPP analysed.
In addition, we demonstrated that LPP show different sensitivity to detergent lysis
when compared to EV. Finally, using spike-in experiments we found that the presence
of LPP can obscure generic fluorescent labelling of EV, highlighting the need for
proper EV isolation and purification when human plasma is used in generic fluorescent-based
FC-detection of EV.
Summary/Conclusion: In order to perform reliable and reproducible fluorescent-based
FC-analysis of single EV from human plasma, either EV-specific fluorescent dyes or
labels should be used or plasma samples should be carefully cleared from particles
prone to incorporate the generic dye.
Funding: European Union’s Horizon 2020 research and innovation programme under the
Marie Skłodowska-Curie grant agreement No [722148] and STW-Perspectief Cancer-ID grant
[14,191].
OS26.02
Single-particle analysis of exosome DNA/RNA abundance, identity and location via a
laboratory-built nano-flow cytometer
Xiaomei Yan
a, Haisheng Liua, Ye Tianb and Shaobin Zhuc
aDepartment of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen
University, Xiamen, China (People’s Republic); bDepartment of Chemical Biology, College
of Chemistry and Chemical Engineering, Xiamen University, Xiamen, China; cNanoFCM
Inc., Xiamen, China (People’s Republic)
Introduction: Through packing and transferring nucleic acids including genomic DNA,
mitochondrial DNA, microRNA, mRNA and long noncoding RNA, exosomes play important
roles in maintaining cellular homeostasis, priming immune system and regulating tumour
progression. However, the abundance, identity (single stranded or double stranded)
and location (surface-bound or inside) of nucleic acids in single exosomes is still
a conundrum. Herein, a laboratory-built nano-flow cytometer (nFCM) that enables multiparameter
analysis of single exosomes as small as 40 nm is used to investigate the features
of exosomal nucleic acids.
Methods: Exosomes derived from a colorectal cancer cell line (HCT15) and a normal
colon fibroblast cell line (CCD-18Co) were isolated by differential ultracentrifugation.
The location and identity of DNA/RNA was examined by measuring the fluorescence signals
of single exosomes upon nucleic acid labelling with SYTO 16 or SYTO RNASelect dye
before and after enzymatic digestion with DNase I, dsDNase, S1 nuclease and RNase
A, respectively. To achieve a selective labelling for DNA/RNA, ethynyl-modified dUTP
(EdU)/ethynyl-modified UTP (EU) were incorporated into the newly synthesized DNA/RNA
by metabolic biosynthetic pathway followed by chemoselective coupling with azide-AF488
via click chemistry.
Results: We found that the majority of exosomal DNA reside on the outer surface of
exosomes via bound with membrane proteins and most of DNA are dsDNA. Meanwhile, almost
all the RNA are encapsulated inside exosomes. Through correlation analysis with side
scattering signals of single exosomes, it was identified that most of the luminal
DNA are associated with large size exosomes and surface-adhering DNA mainly exist
on small size exosomes; yet the particle size of RNA containing exosomes ranges from
small to large sizes. Because exosomes maintain cellular homeostasis by excreting
harmful cytoplasmic DNA from cells, the effect of anti-tumour agents such as etoposide,
topotecan, SN-38 and cisplatin on the abundance and location change of exosomal DNA
will be reported.
Summary/Conclusion: nFCM provides a straightforward and practical approach for the
location and identity studies of nucleic acids in individual exosomes, which will
be very helpful in the illustration of exosome-mediated, nucleic acids-based intercellular
communication.
OS26.03
Using a combination of bead-based flow cytometry and imaging flow cytometry to understand
Extracellular Vesicle heterogeneity
André Görgens
a, Beklem Bostancioglub, Daniel Hageyb, Joshua Welshc, Maximilian Kordesd, Björn Evertssone,
Manuela Gustafssonb, Jennifer C. Jonesc, Oscar Wiklanderb and Samir El Andaloussif
aKarolinska Institutet, Department of Laboratory Medicine, Stockholm, Sweden; bClinical
Research Center, Department for Laboratory Medicine, Karolinska Institutet, Stockholm,
Sweden; cTranslational Nanobiology Section, Laboratory of Pathology, National Cancer
Institute, National Institutes of Health, Bethesda, MD, USA; dDepartment of Clinical
Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm,
Sweden; eDepartment of Clinical Neuroscience, Karolinska Institutet, Karolinska University
Hospital, Stockholm, Sweden; fDepartment of Laboratory Medicine, Clinical Research
Center, Karolinska Institutet, Sweden, Stockholm
Introduction: Extracellular vesicles (EVs) are secreted by all cell types and can
be found in all body fluids. They can be roughly classified based on their size and
origin as exosomes (70–150 nm) and microvesicles (100 nm to 1 µm). However, it is
nowadays commonly accepted in the field that there is a much higher degree of EV heterogeneity
within these two subgroups. Also, their content, protein composition and surface signature
likely is dependent on multiple parameters like the cell’s metabolic or immunological
status. Moreover, the protein composition and surface marker signature of EVs is further
dependent on the cell type releasing them. Accordingly, EVs secreted by different
normal cell types or malignant cells also will display distinct surface profiles.
Until today, only few EV surface markers have been related to specific cell sources.
Methods: We have recently optimized two flow cytometry based methods for EV surface
marker analysis, a multiplex bead-based approach which allows robust identification
of co-expressed surface marker combinations (Wiklander et al, 2018) and a method using
imaging flow cytometry to quantify EV subsets at the single vesicle level (Görgens
et al, in revision).
Results: Here, we combined both flow cytometric approaches aiming to identify EV surface
marker combinations being specific for EVs from specific cell types and/or disease-related
cells such as cancer cells. We first used the multiplex bead-based assay to screen
EVs isolated from 40+ different immortalized human cell lines from different tissues.
Next, we have applied the same screening technology to assess surface signatures of
EVs derived from diverse biological fluids of human healthy donors in order to identify
differential surface marker combinations between different body fluids and estimate
general donor-to-donor variation within respective sample groups. Validation of identified
EV surface signatures by high resolution single vesicle imaging flow cytometry and
other methods is currently ongoing.
Summary/Conclusion: We will show preliminary data resulting from this approach and
propose that the identification of specific EV surface marker combinations will be
highly relevant to further understand the molecular content and related functions
of subsets of EVs in health and disease.
OS26.04
A single extracellular vesicle (EV) flow cytometry approach to reveal EV heterogeneity
Wenwan Zhong and Kaizhu Guo
University of California, Riverside, CA, USA
Introduction: To reveal the clear correlation between extracellular vesicle (EV) functions
and molecular signatures, the only effective approach is to analyse the molecular
profile of individual EVs. Flow cytometry (FC) has been widely employed to distinguish
different cell types in mixed populations, but the sizes of EVs fall well below the
detection limit of conventional flow cytometers, making it impossible to do single-EV
analysis without significant instrumentation development.
Methods: We innovatively solve this difficulty by amplifying the size of each EV by
DNA nanostructures so that they can be analysed in conventional flow cytometers. In
this approach, either an aptamer or an antibody is employed to recognize the specific
surface marker on each EV, and initiate construction of a large DNA nanostructure
by hybridization chain reaction. The resultant structure not only enlarges the overall
size of the single EV, but also can bind to multiple fluorophores to amplify the signal
from the few number of molecules on the EV surface, enabling visualization of single
EVs in a conventional flow cytometer.
Results: We have successfully demonstrated counting single EVs in the FACSCanto after
a one-pot reaction, and multiple surface markers can be simultaneously targeted to
differentiate EV sub-groups based on their surface protein signature. While aptamers
provide a cleaner background for detection, the large selection of antibodies makes
it applicable for diverse surface markers on the EVs for sub-grouping. We have been
applying this technique to analyse EVs produced from different breast cancer cell
lines, as well as the EVs in patients’ sera.
Summary/Conclusion: In summary, we have developed a single-EV FC analysis technique
to visualize single EV in a conventional flow cytometer. Our technique enables study
of single EVs using this widely available instrument to gain in-depth insights into
the molecular signatures of EV sub-populations at the single EV level. Targeting multiple
markers greatly improves differentiation of EV sub-populations. The high simplicity
of our method and its good adaptivity to clinical labs will be highly beneficial for
screening for effective EV markers for liquid biopsy applications.
Funding: NIH-NCI
Symposium Session 27: Non-mammalian EVs Chairs: Richard Ferrero; J. Max SilvermanLocation:
Level B1, Hall B 16:00–17:00
OS27.01
Extracellular vesicles released by commensal Lactobacillus suppress HIV-1 infection
Rogers A. Nahui Palomino
a, Christophe Vanpouillea, Peter Backlundb, Carola Parolinc, Luca Laghid, Beatrice
Vitalic and Leonid Margolisa
aSection of Intercellular Interaction, Eunice Kennedy Shriver National Institute of
Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA;
bBiomedical Mass Spectrometry Facility, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, National Institutes of Health, Bethesda, MD,
USA; cDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy;
dCentre of Foodomics, Department of Agro-Food Science and Technology, University of
Bologna, Bologna, Italy
Introduction: The vaginal microbiota, mostly dominated by Lactobacillus spp. plays
a key role in preventing from numerous uro-pathogens’ infections, in particular from
HIV-1. Recently, we demonstrated that Lactobacillus of various strains inhibit HIV-1
replication in human cervico-vaginal and tonsillar tissues ex vivo providing an experimental
system to study mechanisms of this phenomenon. A growing body of evidences suggest
that any kind of cells, including bacteria communicate to each other through extracellular
vesicles (EVs). Here, we investigated whether the protective anti-HIV effect of lactobacilli
is mediated by EVs released by these bacteria.
Methods: EVs were isolated from four strains of Lactobacillus cultures, previously
isolated from vaginas of healthy women, by ultracentrifugation. Vesicles’ sizes and
concentrations were evaluated using NanoSight. Human cervico-vaginal and tonsillar
tissues ex vivo, as well as cell lines were treated with Lactobacillus-derived EVs,
infected with HIV-1 and virus replication was assessed by measuring the released capsidic
protein p24 using Luminex. Protein and metabolite cargo of bacterial EVs were detected
by LC/MS/MS and 1H-NMR analysis, respectively.
Results: EVs released by L. crispatus BC3 and L. gasseri BC12 protected human cervico-vaginal
and tonsillar tissues ex vivo as well as isolated mammalian cells from HIV-1 infection
by at least 50%. This protection was not due to cytostatic or cytotoxic EV-effects
but rather was associated with the decrease of viral attachment to the target cell
and viral entry as demonstrated in TZM-bl and MT-4 cell assays. Metabolomic analysis
showed 42 molecules associated with EVs including amino acids, alcohols, ketones and
monosaccharides. Proteomic analysis showed the presence of several bacterial proteins
in EVs that may be associated with the anti-HIV effect.
Summary/Conclusion: Our findings demonstrate that the protective effect of Lactobacillus
against HIV transmission is, in part, mediated by EVs released by these commensal
bacteria. This finding may lead to new strategies to prevent male-to-female sexual
HIV transmission.
OS27.02
Extracellular vesicles of the human gut microbiota: do you hear me host?
Anna Kaisanlahti
a, Anatoliy Samoylenkob, Genevieve Bartb, Johanna Korvalaa, Annastiina Rytkönenc,
Artem Zhyvolozhnyic, Ilkka Miinalainenc, Leo Lahtid, Seppo Vainioe and Justus Reunanenf
aBiocenter Oulu/Cancer and Translational Medicine Research Unit, University of Oulu,
Oulu, Finland; bUniversity of Oulu, Biocenter Oulu, Laboratory of developmental Biology,
Oulu, Finland; cBiocenter Oulu, University of Oulu, Oulu, Finland; dDepartment of
Mathematics and Statistics, University of Turku, Turku, Finland; eUniversity of Oulu,
Biocenter Oulu, Laboratory of Developmental Biology, Oulu, Finland; fUniversity of
Oulu, Biocenter Oulu, Cancer and Translational Medicine Research Unit, Oulu, Finland
Introduction: Microbial populations colonize the whole length of the human gastrointestinal
track. Changes in composition and function of the gut microbiota have been linked
with numerous pathologies, underlining the importance of the host-microbiota co-operation,
although quite little is known of the mechanism of communication between microbiota
and distal organs. Our aim was to describe EV secretion in healthy human gut, explore
the contribution of different bacteria to EV secretion and characterize the cargo
of gut microbiota EVs, our hypothesis being that EVs are one of the major communication
systems between human gut microbiota and the host.
Methods: Gut microbiota EVs were isolated with a combination of commercial kits and
centrifugation methods from 20 faecal samples from healthy donors. Presence of EVs
was assessed with transmission electron microscopy (TEM). Proteins and RNA were isolated
from the obtained vesicles and analysed with LC-ESI-MS/MS (Turku Proteomics Facility)
and Illumina550 sequencing (Biocenter Oulu Sequencing Centre). DNA was isolated from
the faecal samples and analysed with 16S rRNA sequencing (Institute of Biotechnology,
University of Helsinki) along with intact faeces-derived vesicles to allow comparison
of taxonomic profiles.
Results: Populations of faecal EVs were detected with TEM, with a size ranging from
50 to 200 nm. On average, 184 bacterial proteins and 56 human proteins were identified
per sample. Taken together, the data describes presence of 1194 distinct bacterial
proteins and 264 human proteins in faecal EVs. On functional level, the majority of
bacterial EV proteins of the gut seem to consist of outer membrane proteins relating
to metabolism, bacterial invasion and transport. Data for RNA cargo analysis is pending.
In terms of bacterial EV proteins, the data suggests the most diverse secretion from
phyla bacteroidetes and firmicutes. Taxonomic profiles analysed by 16S rRNA sequencing
demonstrated differences in the bacterial composition of the faecal samples and faeces-derived
EVs: proteobacteria, while present in small abundancies in faeces, was one of the
most predominant phyla found in faeces-derived EVs.
Summary/Conclusion: Human gut microbiota actively secretes EVs with range of protein
and RNA cargo which biological significance in human health and disease needs to be
studied further.
Funding: Academy of Finland
OS27.03
Preparation, characterization and cellular interaction of edible plant-derived nanoparticles
Daisuke Sasaki
a, Kosuke Kusamorib and Makiya Nishikawab
aFaculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan; bTokyo
University of Science, Noda, Japan
Introduction: Nanoparticles, including liposomes, polymeric micelles and animal cell-derived
extracellular vesicles (EVs), are promising carriers for bioactive molecules. Recently,
edible plant-derived nanoparticles are expected to be a novel class of nanoparticles,
because they have advantages in terms of mass production and cost-effectiveness. However,
their pharmaceutical and biological characteristics need to be evaluated prior to
their application and use in clinical practice. In this study, we selected corn as
an edible plant, and prepared corn-derived nanoparticles (cNPs). Then, we evaluated
their property and interaction with cells.
Methods: Corn was put in a blender with distilled water to obtain juice. The juice
was separated by centrifugation and ultra-centrifugation (UC), and the pellet after
UC at 100,000 g was collected as cNPs. The yield of the cNPs was evaluated by the
protein amount measured using Bradford assay. The size and zeta potential of the cNPs
were measured by a zeta sizer. To evaluate the effect of the cNPs on cells, three
types of cell lines, i.e. murine fibroblast NIH3T3 cells, murine macrophage-like RAW264.7
cells, and murine colon adenocarcinoma colon26 cells, were selected. Cells were added
with cNPs and incubated at 37°C for 24 h. The cell viability was evaluated by using
CCK8 assay. Separately, the cNPs were labelled with DiI and labelled cNPs were added
to cells. After incubation, we observed the cells by confocal microscopy.
Results: About 10 mg cNPs were obtained from 100 g plants, indicating that cNPs can
be obtained with high yield compared with EVs. The size of the cNPs was about 200 nm.
In addition, the zeta potential was a negative charge (about −15 mV), which is comparable
to that of EVs. Low concentrations of cNPs hardly affected the viability of the cells.
Confocal microscopy showed that DiI-labelled cNPs were taken up by RAW264.7 cells.
The results of onion- or orange-derived NPs will also be presented.
Summary/Conclusion: We succeeded in preparing cNPs in large scale and revealed that
the particulate properties of the cNPs are comparable to those of EVs. We also demonstrated
that cNPs can be efficiently taken up by RAW264.7 cells. These results raise a possibility
that cNPs can be used as carriers for bioactive molecules to such cells.
OS27.04
Biophysical and electrochemical characterization of redox-active extracellular vesicles
from Shewanella oneidensis
Lori Zacharoff
a,Shuai Xua, Grace Chonga, Lauren Ann Metskasb, Poorna Subramanianb, Grant Jensenb
and Moh El-Naggara
aUniversity of Southern California, Los Angeles, CA, USA; 2California Institute of
Technology, Pasadena, CA, USA
Introduction: Production of bacterial extracellular vesicles has been observed in
marine and freshwater systems and in laboratory cultures. However, little is known
about the function and mechanism of vesiculation in these nonpathogenic contexts.
In addition to vesicles, the Gram-negative bacterium, Shewanella oneidensis also produces
chains of outer-membrane vesicles that are proposed to function as bacterial nanowires
for electron transport to solid-phase electron acceptors ranging from minerals to
electrodes. A previous report demonstrated mineral reduction by isolated S. oneidensis
vesicles. Many basic questions remain about the function and biogenesis of these structures,
particularly during metal and electrode respiration.
Methods: Here we report the purification and characterization of outer membrane vesicles
from S. oneidensis. Preliminary analyses using dynamic light scattering, fluorescence
microscopy, cryoelectron microscopy, and proteomics, confirm the size, content and
reproducibility of purified vesicles.
Results: Proteomic data suggest that some proteins are selectively loaded into vesicles
with the assistance of a novel BAR domain protein. Electrochemical analysis of surface
deposited vesicles reveals the signatures of known outer-membrane multiheme cytochromes.
Summary/Conclusion: These results have implications for the role of vesicles and vesicle
chains during respiration of iron oxides and anodes. Excitingly, this research suggest
that a BAR domain protein provides the mechanistic relationship between vesicles and
the outer membrane extensions known as nanowires
Funding: US DOE Division of Chemical Sciences, Geociences and Biosciences, Office
of Basic Energy Science DE-FG02-13ER16415 National Science Foundation grant DEB-1542527
Symposium Session 28: EVs in Kidney and Urological Diseases Chairs: Uta Erdbrügger;
Juan Falcon-PerezLocation: Level B1, Hall A 16:00–17:00
OS28.01
Single MSC EV analysis for characterizing a subpopulation having therapeutic effects
in AKI model
Hyejin Kang
a, Chungmin Hanb, Jongok Pyoc and Jaesung Parkd
aPohang University of Science and Technology, Pohang, Republic of Korea; bPohang University
of Science and Technology, Pohang, Republic of Korea; cEXOSOMEplus, Seoul, Republic
of Korea; dDepartment of Mechanical Engineering, POSTECH, Pohang, Republic of Korea
Introduction: Therapeutic applications of MSCEVs have been extensively studied. Previous
MSCEV studies demonstrated that MSCEVs showed various effects depending on how they
were prepared. Recent studies suggested that this diversity might result from the
heterogeneity of isolated EV populations. However, because of the absent of a proper
EV subpopulation analysis method, no studies have succeeded to characterize an effective
subpopulation from whole EV populations. We analysed the subpopulations of MSCEVs
prepared by different isolation methods using a single EV analysis method. We assessed
the correlation between the therapeutic effectiveness and MSC EV subpopulations using
mouse acute kidney injury (AKI) model
Methods: EVs were prepared from hMSC conditioned media using different isolation methods:
differential centrifugation, density gradient centrifugation and polymeric methods.
A part of EVs were analysed using a TIRF microscopy based single EV analysis method,
which can provide quantitative subpopulation information characterized by up to four
different marker expressions. EVs were applied to an AKI model to assess their therapeutic
effectiveness.
Results: EVs prepared by different isolation methods showed different subpopulation
characteristics. The numbers of lipid marker positive EVs were different depending
on their isolation method. Overall expression profile of three representative EV specific
marker (CD9, 63 and 81) were also different depending on their isolation methods.
EVs expressing more EV-specific markers were found to be more effective in mouse AKI
models.
Summary/Conclusion: We demonstrated that the subpopulation composition of EVs prepared
by different isolation methods were different. The numbers of EVs positive for multiple
markers varied depending on the isolation methods. The relationship between therapeutic
effectiveness and EV subpopulation marker expression were tested using an AKI model.
EV subpopulation using four different EV-specific markers might be a useful tool for
assessing the quality of isolated EVs in terms of their therapeutic effectiveness.
Funding: This work was supported by the KHIDI grant [HI16C2221] and supported by NRF
grant [NRF-2018R1A2B3006280] funded by the Korean government.
OS28.02
Urinary microvesicular biomarkers for delayed graft function and overall outcome after
living donor kidney transplantation
Fabian Braun
a, Markus Rinschenb, Ingo Plagmannb, Corinna Kleinc, Denise Buchnerd, Roger Wahbad,
Dirk Stippeld, Christine Kurschatb, Bernhard Schermerb, Andreas Beyerc, Thomas Benzingb
and Roman-Ulrich Müllerb
aIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg,
Germany; bDepartment II of Internal Medicine and Center for Molecular Medicine Cologne,
University of Cologne, Germany, Cologne, Germany; cCologne Excellence Cluster on Cellular
Stress Responses in Aging-Associated Diseases, University of Cologne, Germany, Cologne,
Germany; dDepartment of General, Visceral and Cancer Surgery, Division of Transplantation
Surgery, Transplant Center Cologne, University of Cologne, Cologne, Germany
Introduction: With a cargo of specific proteins and nucleic acids, urinary microvesicles
represent a potential source for cellular material, that can be isolated easily and
non-invasively. Yet, their clinical implementation in nephrology remains scarce with
kidney biopsies still being the gold standard procedure in most diagnoses. We hypothesize
that the addition of non-invasive biomarkers could benefit this invasive method with
the potential risk of a sampling error.
Methods: With differential (ultra-)centrifugation, we isolated urinary microvesicles
from living kidney transplant recipients and their donors over the course of 40 kidney
transplantations. Whole urine samples were collected on day −1 (donor sample), 0,
1 and 3 months after transplantation (recipient sample). Microvesicular protein content
was measured using quantitative mass spectrometry. We detected proteins, which linearly
change their abundance in correspondence to clinical parameters, e.g. glomerular filtration
rate (GFR) at 6 and 12 Months after transplantation in a set of 20 transplantations,
by linear regression models. These results were validated in a targeted proteomic
screen in a cohort of 20 additional transplantations.
Results: We identified >1500 proteins present in at least 50% of the first sample
set. Hierarchical clustering analysis depicted a clear clustering by time point of
urine collection. Microvesicular proteins of glomerular (e.g. nephrin, podocin) or
tubular origin (e.g. V-ATPase and Slc transporters) were regulated distinctly over
the course of transplantation. Overall, specific proteomic time course patterns were
apparent over the course of transplantation. Depending on low statistical error and
high stability in a leave-one-out cross-validation of the linear models correlating
to GFR values after transplantation, we created a list of 64 candidate proteins. Validation
of these revealed PEPCK as a urinary microvesicular protein associated with GFR 12 months
after transplantation.
Summary/Conclusion: With this study, we present the first analysis of the changes
in the human urinary microvesicular proteome over the course of kidney transplantation.
We believe, the validated biomarkers of all 40 Transplantations to hold the potential
to further aid the diagnosis of graft survival.
Funding: MIWF Nachwuchsgruppen.NRW
OS28.03
Exosomal miRNA-19b-3p of tubular epithelial cell promotes M1 macrophage activation
in kidney injury
Ye Feng
a, Linli Lvb, Taotao Tangc and Bi-Cheng Liua
aInstitute of Nephrology, Southeast University, Nanjing, China (People’s Republic);
bInstitute of Nephrology, Zhongda Hospitial, Southeast University, Nanjing, China
(People’s Republic); cInstitute of Nephrology, Zhongda Hospital, Southeast University
School of Medicine, Nanjing, China (People’s Republic)
Introduction: Tubulointerstitial inflammation is a common characteristic for acute
and chronic kidney injury. However, the mechanism by which the initial injury on tubular
epithelial cells (TECs) drives interstitial inflammation remains unclear. Here we
set out to characterize the miRNA profile of kidney exosomes and aim to explore the
role of exosomal miRNAs derived from TECs in the development of tubulointerstitial
inflammation.
Methods: Exosomes were isolated from kidney and characterized via electron microscopy
and nanoparticle analysis. We examined expression profiles of miRNAs in kidney exosomes
from LPS-induced kidney injury model by Exiqon microarray. Putative targets of miRNA
were predicted by TargetScan. Chronic proteinuric kidney disease model was induced
by adriamycin(ADR) administration. Exosomes purified from TECs were added to macrophages
or intrarenal injected to mice to determine its effects both in vitro and in vivo.
Results: Global miRNA expression profiling on renal exosomes was examined in LPS-induced
AKI model and miR-19b-3p was identified as the most remarkable miRNA increased in
TEC-derived exosomes compared with controls. Similar results were found in ADR-induced
chronic proteinuric kidney disease model in which exosomal miR-19b-3p was markedly
released. Interestingly, once released, TEC-derived exosomal miR-19b-3p was internalized
by macrophages, leading to M1 phenotype polarization through targeting NF-κB/SOCS-1.
Importantly, the pathogenic role of exosomal miR-19b-3p in initiating renal inflammation
was revealed by the ability of adoptive transfer of purified TEC-derived exosomes
to cause tubulointerstitial inflammation in mice, which was reversed by inhibition
of miR-19b-3p. Clinically, high levels of miR-19b-3p were found in urinary exosomes
and correlated with the severity of tubulointerstitial inflammation in patients with
diabetic nephropathy. Thus, our studies demonstrated exosomal miR-19b-3p mediated
the communication between injured TECs and macrophages, leading to M1 macrophage activation.
Summary/Conclusion: Exosome/miR-19b-3p/SOCS1 axis played a critical pathologic role
in tubulointerstitial inflammation that might represent a new therapeutic target for
kidney disease.
OS28.04
A urine exosome RNA signature for prediction of high-grade prostate cancer: clinical
validation in over 1,000 biopsy naïve patients
Robert Kitchen
a, Phillipp Torklerb, James McKiernanc, Michael Donovand, Mikkel Noerholmb, Peter
Carrolle and Johan Skogf
aExosome Diagnostics, Inc, Waltham, MA, USA; bExosome Diagnostics, GmbH, Martinsried,
Germany; cColumbia University, Department of Urology, New York, NY, USA; dDepartment
of Pathology, Mount Sinai, New York, NY, USA; eUniversity of California San Francisco,
San Francisco, CA, USA; fExosome Diagnostics, Inc., Waltham, MA, USA
Introduction: Discriminating indolent from clinically significant prostate cancer
(PCa) prior to initial biopsy remains an important clinical and health economic issue.
We have previously described the ExoDx Prostate(IntelliScore) (EPI) assay for discriminating
high- vs low-grade prostate cancers using RNA extracted from urine exosomes. However
proving efficacy and facilitating clinical adoption of a diagnostic assay requires
extensive validation in prospectively collected patient cohorts. Here we compare performance
of the EPI urine exosome assay vs. the Prostate Cancer Prevention Trial-Risk Calculator
2.0 (PCPT-RC) for discriminating high-grade from low-grade PCa and benign disease
on initial biopsy.
Methods: We collected data from two distinct validation cohorts (N = 519 and 503,
respectively) representing 1022 subjects and compared EPI test results with biopsy
outcomes. Eligible subjects were selected by age (>50-years) and PSA concentration
(2–10 ng/mL), and were scheduled for initial prostate needle biopsy. Test performance
was reported using the area under the receiver operating characteristic curve (AUC),
negative and positive predictive value (NPV; PPV), sensitivity, and specificity. Outcome
was based on Gleason Score (GS) for discriminating high- (GS≥7) from low-grade (GS = 6)
and benign disease on initial biopsy.
Results: In this diverse cohort of 1022 biopsy naïve patients (mean age: 64 years,
mean PSA: 5.6 ng/mL, ethnicity: 16% African, 71% Caucasian) we observed a 51% positive
biopsy rate (30% GS≥7, 13% GS≥4 + 3). Performance of the EPI test (AUC = 0.70) was
superior to PSA (AUC = 0.56), and PCPT-RC (AUC = 0.6; all p-values<0.001) for discriminating
high- from low-grade PCa and benign disease. Using the previously validated cut-point
of 15.6 (or alternative 20) would avoid 30% (or 43%) of unnecessary biopsies, with
an NPV of 90% for both cut-points and miss only 7.5% (or 12%) of high-grade PCa patients.
Summary/Conclusion: EPI is a non-invasive 3-gene urine exosome RNA expression assay
that we have now successfully validated in over 1000 patients to discriminate high-
from low-grade PCa and benign disease. EPI identifies high-risk patients better than
any current standard of care and provides a valuable tool for shared decision making
so the right patients are sent for biopsy.
Symposium Session 29: Late Breaking- EV Therapeutics Chairs: Masahiko Kuroda; Carolina
SoekmadjiLocation: Level B1, Lecture Room 08:30–09:30
LB01.01
First-in-human application of umbilical cord mesenchymal stromal cell-derived exosomes
for the prevention of fibrosis following cochlear implant surgery
Athanasia Warneckea, Jennifer Schulzea, Julia Hollerwegerb, Teresa Lassacherb, Karin
Pachlerb, Heide-Marie Binderb, Alexandre Desgeorgesb, Gerhard Weidlerb, Magdalena
Mayrb, Pasquale Romanellic, Sebastien Couillard-despresc, Hinrich Staeckerd, Jennifer
Nelson-Brantleyd, Andreas Trawegere, Eva Rohdeb and Mario Gimona
f
aKlinik für Hals-, Nasen-, Ohrenheilkunde, Hannover Medical School, Hannover, GERMANY,
Hannover, Germany; bSCI-TReCS GMP Unit at Paracelsus Medical University, Salzburg,
AUSTRIA, Salzburg, Austria; cInstitute of Experimental Neuroregeneration, Paracelsus
Medical University, Salzburg,, Salzburg, Austria; dAuditory & Vestibular Neuroscience
Laboratory, University of Kansas Medical Center, Kansas City,, Kansas City, USA; eInstitute
of Tendon and Bone Regeneration, Paracelsus Medical University, Salzburg, AUSTRIA,
Salzburg, Austria; fGMP Unit at Paracelsus Medical University, Salzburg, AUSTRIA,
Salzburg, Austria
Introduction: Cochlear implantation (CI) can restore hearing perception by bypassing
the auditory hair cells (HC) and directly stimulating the spiral ganglion neurons
(SGN). Insertion of an electrode array into the cochlea is associated with robust
early and chronic inflammatory responses that promote intra-cochlear fibrosis and
loss of HC and SGN. Conservation of residual hearing and prevention of fibrous tissue
deposition around the electrode are thus major challenges in CI surgery.
Methods: We have manufactured GMP-compliant umbilical cord (UC)-MSC- derived extracellular
vesicles/exosomes (EVs) and subjected such preparations to a series of in vivo and
in vitro assays. Animal studies included both systemic and local injection for the
improvement of seemingly unrelated indications such as critical size bone defects,
partial tendon rupture and spinal cord injury in a rat contusion-model.
Results: In all cases EV application resulted in a significant modulation of immune
reaction, overall reduced inflammation and scar reduction as evidenced by a reduction
in ECM deposition. In an in vitro spiral ganglion neuron protection assay UC-MSC-EVs
outperformed the current best-in-class soluble neuroprotective factor, BDNF. In vivo
application of EVs in mice challenged by noise trauma resulted in significant protection
of hearing when compared to untreated controls. Reduction of impedance as a measure
for current resistance and fibrotic tissue formation around the electrode array were
observed in a model of implantation trauma in guinea pigs implanted with an electrode
array. After careful consideration of the medical history of a patient requiring CI
surgery an experimental healing attempt was performed and the patient received a single
intra-cochlear injection of 5 × 109 EVs (total) prior to electrode insertion. The
application was tolerated well, no adverse reactions were recorded and robust auditory
sensation was detected 6 weeks post surgery.
Summary/conclusion: Based on these initial safety data on the local application of
EVs in the inner ear, a phase 1/2a clinical trial is currently in preparation to further
evaluate the neuroprotective, immunomodulatory and anti-fibrotic potential of UC-MSC-EVs.
Funding: “Exothera” IT-AT 1036 (EU), Project “ExtraNeu” (Land Salzburg)
LB01.03
Engineering of ARMMs for efficient delivery of Cas9 genome editors
Qiyu Wanga and Quan Lu
b
aQilu Pharma, Boston, USA; bHarvard University, Boston, USA
Introduction: Our previous studies have shown that the arrestin domain containing
protein 1 (ARRDC1) drives the formation of extracellular vesicles known as ARMMs (ARRDC1-mediated
microvesicles) (Nabhan J et al., PNAS 2012) and that these vesicles can be harnessed
to package and deliver a variety of molecular cargos such as protein, RNA and the
genome editor Cas9 (Wang Q and Lu Q, Nat Commun 2018). In the published packaging
and delivery study, we used the full-length ARRDC1 protein (433 amino acids at ~46
kD) to recruit the molecular cargos into the vesicles, either through a direct fusion
or via a protein-protein interaction module. Because ARRDC1 protein itself is packaged
into ARMMs and because the size of the vesicles is limited (~80–100 nm), a smaller
ARRDC1 protein that can still function in driving budding would potentially increase
the number of cargos that can be packaged into the vesicles. Moreover, a smaller ARRDC1
may allow the recruitment of a relatively large cargo molecule.
Methods: We used protein engineering to identify a minimal ARRDC1 protein that can
drive the formation of ARMMs. We then fused the minimal ARRDC1 to multiple proteins
including the genome-editor Cas9 and tested the packaging and delivery efficiency
of the fusion protein.
Results: Here we will present new data that identified a minimal ARRDC1 protein that
contains an arrestin domain, PSAP and PPXY motifs. The minimal ARRDC1 is able to drive
ARMM budding as efficiently as the full-length ARRDC1. We further present evidence
that the minimal ARRDC1 protein can efficiently package cargos such as the relatively
large Cas9/gRNA complex. In particular, we showed that the minimal ARRDC1 can package
Cas9/gRNA into ARMMs through direction fusion whereas the full length ARRDC1 failed
to.
Summary/conclusion: These results indicate that ARMMs formed by the minimal ARRDC1
may be used as a novel efficient therapeutic delivery platform for the Cas9-based
gene editors.
LB01.04
Microvesicle-mediated delivery of minicircle DNA results in effective gene-directed
enzyme prodrug cancer therapy
Masamitsu Kanada
a, Bryan Kimb, Jonathan Hardyc, John Ronaldd, Michael Bachmanne, Matthew Bernardf,
Gloria Perezg, Ahmed Zareag, Jessie Geh, Alicia Withrowi, Sherif Ibrahimg, Victoria
Toomajianj, Sanjiv Gambhirk, Ramasamy Paulmuruganl and Christopher Contagm
aInstitute for Quantitative Health Science and Engineering (IQ), Dept. of Pharmacology
& Toxicology, Michigan State University, East Lansing, USA; bDept. of Chemistry, UC
Santa Cruz, Santa Cruz, USA; cInstitute for Quantitative Health Science and Engineering
(IQ), Dept. of Microbiology & Molecular Genetics, Michigan State University, East
Lansing, USA; dRobarts Research Institute, Western University, Lawson Health Research
Institute, London, Canada; eAssociate Professor, Institute for Quantitative Health
Science and Engineering (IQ), Dept. of Microbiology & Molecular Genetics, Michigan
State University, East Lansing, USA; fAssistant Professor, Institute for Quantitative
Health Science and Engineering (IQ), Dept. of Pharmacology & Toxicology, Michigan
State University, East Lansing, USA; gInstitute for Quantitative Health Science and
Engineering (IQ), Michigan State University, East Lansing, USA; hDept. of Radiology,
Stanford University, Palo Alto, USA; iCenter for Advanced Microscopy, Michigan State
University, East Lansing, USA; jInstitute for Quantitative Health Science and Engineering
(IQ), Dept of Biomedical Engineering, Michigan State University, East Lansing, USA;
kDepts. of Radiology, Bioengineering, and Materials Science, and Molecular Imaging
Program at Stanford (MIPS), Stanford University, East Lansing, USA; lDept. of Radiology,
Molecular Imaging Program at Stanford (MIPS), Stanford University, Palo Alto, USA;
mInstitute for Quantitative Health Science and Engineering (IQ), Depts of Microbiology
& Molecular Genetics, Biomedical Engineering, Michigan State UniversityMichigan State
University, East Lansing, USA
Introduction: An emerging approach for cancer treatment employs the use of extracellular
vesicles (EVs), specifically exosomes and microvesicles, as delivery vehicles.
Methods: We previously demonstrated that microvesicles can functionally deliver plasmid
DNA to cells and showed that plasmid size and sequence determine, in part, the efficiency
of delivery. Delivery vehicles comprised of microvesicles loaded with engineered minicircle
DNA (MC) encoding prodrug converting enzymes were developed here as a cancer therapy
in mammary carcinoma models.
Results: We demonstrated that MCs were loaded into shed microvesicles with greater
efficiency than their parental plasmid counterparts and that microvesicle-mediated
MC delivery led to significantly higher and more prolonged transgene expression in
recipient cells than did microvesicles loaded with the parental plasmid. Microvesicles
loaded with MCs encoding a thymidine kinase (TK)/nitroreductase (NTR) fusion protein
produced TK-NTR expression in mammary carcinoma cells. In vivo delivery of TK-NTR
and administration of prodrugs led to the effective killing of both targeted cells
and surrounding tumour cells via TK-NTR-mediated conversion of prodrugs to active
cytotoxic agents. The efficiency of killing non-transfected bystander/neighbouring
cells was assessed in mouse models and determined to require one in 100 cancer cells
to be targeted.
Summary/conclusion: These results suggest that MC delivery via microvesicles can mediate
gene transfer to an extent that enables effective prodrug conversion and tumour cell
death such that it comprises a promising approach to cancer therapy. To understand
the mechanism of this microvesicle-mediated enzyme prodrug therapy, we are currently
assessing recipient cells in the tumour microenvironment.
Funding: This work was funded in part through a generous gift from the Chambers Family
Foundation for Excellence in Pediatrics Research (to C.H.C.), Grant 1UH2TR000902-01
from the National Institutes of Health (to C.H.C.), and the Child Health Research
Institute at Stanford University (to C.H.C.). Start-up fund from Michigan State University
(to M.K.)
Symposium Session 30: Late Breaking- EVs and Cancer Chairs: Suvendra Bhattacharyya;
Vincent HyenneLocation: Level B1, Hall B 08:30–09:30
LB02.01
Extremely-large extracellular vesicles (elevs) aid invasiveness of rasv12 tumour cell
dissemination
Jiae Lee and Young Kwon
University of Washington, Seattle, USA
Introduction: Cancer cell dissemination has been recognized for the association with
cancer recurrence, invasion and metastasis, however, the exact molecular mechanism
is not fully understood. Most of the previous studies were conducted in cell culture,
which is difficult to track the consequence of disseminated cells. Moreover, the lack
of a simple yet conserved model system deferred genome-wide screening. Therefore,
we established an in vivo cell dissemination model in Drosophila.
Methods: We express mutant Ras (RasV12) in adult Drosophila midgut intestinal stem
cells (ISCs) and enteroblasts (EBs) using the conditional GAL4 driver esgts (esg-GAL4,
tub-GAL80ts, UAS-GFP).
Results: When RasV12 is expressed in ISCs and EBs, tumour rapidly proliferates, then
become eliminated. Cellular processes protrude while damaging and invading the surrounding
visceral muscle fibres, and intact cells can completely disseminate. Interestingly,
we observed with ex vivo live imaging that RasV12 cells produce large blebs and release
extracellular vesicles. The average size of these vesicles was bigger than exosomes
(<100 nm) and microvesicles (100–1000 nm), so we refer them as extremely-large extracellular
vesicles (ELEVs). Additionally, GFP-positive particles were detected in haemolymph
prepared from RasV12 flies but not from controls assuring that ELEVs were also produced
in vivo. Of note, we found that metastatic RasV12, scrib-/- disc tumours also produced
ELEVs. Thus, we propose that the generation of ELEVs is a characteristic of invasive
tumours in Drosophila. Interestingly, these ELEVs are reminiscent of large oncosomes
or cytoplasts, which have been implicated in the invasive behaviour of cancer cells.
Summary/conclusion: This model shares many known aspects of tumour cell dissemination
implied from the studies in mammalian systems. We plan to utilize this unique system
to elucidate the molecular mechanism for cell dissemination and ELEVs production using
vast genetic tools available in Drosophila.
LB02.02
House dust extracellular vesicles promote tumour metastasis to the lungs by inducing
tumour necrosis factor-α
Nhung Thi Hong. Dinh
a, Jaewook Leeb, Jaemin Leec, Gyeongyun God, Kim Sang sood, Seoyoon Baed, Yein June,
Tae Young Rohf and Yong Song Ghod
aPostech, Pohang, Republic of Korea; bDepartment of Life Sciences, Pohang University
of Science and Technology (POSTECH), Pohang, Republic of Korea; cPohang University
of Science and Technology, Pohang, Republic of Korea; dDepartment of Life Sciences,
Pohang University of Science and Technology, Pohang, Republic of Korea; ePohang University
of Science and Technology (POSTECH), Pohang, Republic of Korea; fDepartment of Life
Sciences, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu,
Pohang 37673, Republic of Korea, Pohang, Republic of Korea
Introduction: Air pollution is associated with multiple pulmonary disorders. As a
part of pollutant air, house dust harbours several biological contaminants including
extracellular vesicles (EVs). House dust EVs have been shown to induce pulmonary inflammation,
but no studies have assessed the effect of dust EVs on tumour metastasis to the lungs.
Methods: EVs were isolated from house dust using buoyant density gradient ultracentrifugation.
Isolated dust EVs were characterized with transmission electron microscopy and dynamic
light scattering. To assess the role of dust EVs in tumour metastasis, dust EVs were
intranasally administered to mice, followed by intravenous injection of tumour cells
after 1 day. At 2 weeks after tumour introduction, lungs were harvested from mice
to measure metastasis by counting metastatic colonies. To investigate the mechanism,
the lungs were collected at 12 h or 24 h after tumour cell introduction to access
tumour cell infiltration into the lungs by immunohistochemistry. Furthermore, lung
lysates were prepared from mice intranasally administered with dust EVs to examine
tumour necrosis factor-α (TNF-α) production and their effect on tumour cell migration.
Finally, TNF-α knock-out mice were used to show the importance of TNF-α in dust EV-induced
tumour metastasis.
Results: House dust EVs had membrane-enclosed structures with an average diameter
of 129.6 ± 4.5 nm, as observed by transmission electron microscopy and dynamic light
scattering. Dust EVs significantly promoted tumour metastasis to the lungs. The mechanism
study showed that these EVs enhanced tumour cell infiltration into the lungs. Although
dust EVs did not directly mediate tumour cell migration, lung lysates from dust EV-treated
mice could promote this migratory effect. In addition, the concentration of TNF-α
was increased in lung lysates by treating dust EVs. Finally, TNF-α knock-out mice
treated with dust EVs could not promote tumour metastasis to the lungs.
Summary/conclusion: House dust harboured significant amounts of EVs which could promote
tumour metastasis by inducing TNF-α. These findings provide mechanistic insights into
the effect of house dust on tumour metastasis to the lungs.
LB02.03
Modeling tumour: key issues of cell communication by mean of EVs in a three-dimensional
environment and the impact on biomarker discovery
Richa Khandurya, Liliia Paniushkinaa, Andreas Kellerb, Tanja Gajney-Schleichera and
Irina Nazarenko
c
aMedical Center Univeristy of Freiburg, Freiburg, Germany; bSaarland University, Saabruecken,
Germany; cMedical Center University of Freiburg, Freiburg, Germany
Introduction: The impact of growth architecture on intercellular communication, including
EV release, cargo, and function was not examined in many details. In our recent work,
we described a new model for efficient EV production in a three-dimensional environment.
Cells growing in 3D produced an increased number of small EVs, which differed in their
miRNA and protein profiles from the EVs, released by the cells grown under conventional
conditions. In the current work, we describe the impact of growth architecture on
EV heterogeneity and their content respecting recruitment of activated oncogenes and
mutated products on EVs.
Methods: EVs of different size were isolated by subsequent sedimentation by 5000 ×g
(EV5), 12000 ×g (EV12) and small EVs, purified by size exclusion chromatography (SEC).
Subsequently, iodixanol gradient centrifugation was performed. These EV populations
were separated from 2D and 3D cell cultures and characterized respecting their size
using NTA, DLS, and TRPS. Surface proteins were examined using beads-assisted flow
cytometry. Subsequently, DNA and RNA were isolated, and the number of mutated oncogenes
to different EV populations was assessed using ddPCR.
Results: In all models, including prostate, breast, colorectal and gastric cancer,
3D environment caused a considerable shift in EV size distribution. Specific changes
in EV surface protein profiles and distribution of oncogenic DNA and RNA among EV
populations was observed. These changes varied between different tumour types. Comparison
with the delivery of mutated oncogenes among EV populations in the blood of patients
revealed that EVs released from in 3D resemble closer the content of EVs isolated
from the blood of tumour patients.
Summary/conclusion: Here, we present a unique model applicable to study the EV heterogeneity
under conditions mimicking physiological tumour microenvironment. It can serve as
a new tool for drug screening and biomarker search, representing a new reliable model
for EV-based liquid biopsy.
Funding: H2020 MSCA-ITN „Train-EV“, Project 722148; BMBF “EXONANSENS”, Project 01DJ51206.
LB02.04
Secretion mechanisms of wnt proteins
Alena Ivanova
a, Jan Wintera, Oksana Voloshanenkoa, Kathrin Glaesera, Steffen Scholppb, Ulrike Engelc,
Clotilde Theryd and Michael Boutrose
aGerman Cancer Research Center, Division of Signaling and Functional Genomics, Heidelberg,
Germany, Heidelberg, Germany; bLiving Systems Institute, School of Biosciences, College
of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom,
Exeter, United Kingdom; cNikon Imaging Center at Heidelberg University and Centre
for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany, Heideberg,
Germany; dInstitut Curie, PSL Research University, INSERM U932, Immunity and Cancer,
Paris, France, Paris, France; eDepartment of Cell and Molecular Biology, Medical Faculty
Mannheim, Heidelberg University, Heidelberg Germany, Heidelberg, Germany
Introduction: Wnt signalling pathways play important roles in development and diseases
of multicellular organisms. Key players in intercellular signalling – Wnt proteins
– travel through extracellular space, but since lipid modifications renders them insoluble,
they use special carriers. According to the current understanding of Wnt secretion,
to contact neighbouring cells Wnt proteins can diffuse using heparan sulphate proteoglycan
chains on the cell surface or they can be transported on filopodia. Additionally,
Wnt ligands can be solubilized and travel in the intracellular space by creating lipoprotein
particles. Wnts can be recycled through the endosomal compartment and secreted on
exosomes. It is been a long debate which secretory mechanism is preferred by Wnt ligands
and which forms of secreted Wnt proteins maintain signalling activity. We aimed to
dissect the very complex Wnt secretion network to identify new regulators specific
for the certain secretion roots.
Methods: We first, performed focused RNAi screen to identify new components of Wnt
secretory pathway. By activating Wnt pathway either in the secreting cell or at the
receptor level we manage to distinguish between proteins that involved only in the
secretory part of the pathway or play role in the receiving cells. At the next step,
we used array CRISPR/Cas9 screening approach for targeted disruption of genes together
with canonical Wnt activity assay to confirm that identified genes are required for
the secretion of functional Wnt proteins.
Results: With the described approach, a panel of 83 possible secretory factors have
been tested. Among the others we found a protein that involved in the filopodia formation
process. Identified protein regulates number and length of cell filopodia. Beyond
this, only a few other proteins have been described so far to regulate specialized
filopodia like cytonemes. Additionally, we observed that Wnt proteins travel across
filopodia being packed on vesicle-like structures.
Summary/conclusion: For the first time a forward genetic screen allowed to identify
new components that are important for filopodia associated Wnt signalling. Surprisingly,
Wnt ligands use vesicles as carries for transport across cell protrusions. These findings
add another piece of evidence that microvesicles and filopodia plays a significant
role in the distribution of Wnt ligands.
Symposium Session 31: Late Breaking- EV Biomarkers Chairs: Johannes Grillari; Mariko
IkuoLocation: Level B1, Hall A 08:30–09:30
LB03.02
Assessing the value of extracellular vesicles‘ DNA and proteins as biomarkers in metastatic
breast cancer
Mercedes Tkach
a, Caroline Hegob, Clotilde Therya and Charlotte Proudhonb
aInstitut Curie, PSL Research University, INSERM U932, Immunity and Cancer, Paris,
France, Paris, France; bInstitut Curie, PSL Research University, SiRIC, Laboratory
of circulating tumor biomarkers, Paris, France, Paris, France
Introduction: Analysis of cell-free circulating tumour DNA (ctDNA) and cancer-specific
extracellular vesicles (EVs) in patients’ blood have been widely explored as biomarkers
for cancer detection and disease follow up. These non-invasive biomarkers represent
a promising tool for real-time monitoring of treatment efficacy. Particularly, tumour-derived
EVs contain specific protein cargo and nucleic acids, which are protected from degradation.
However, most of the protocols used to isolate EVs co-isolate other nucleic acids
carriers and the actual value of EV-associated nucleic acids as robust biomarkers
remain unclear. Here, we assessed the clinical validity of nucleic acids specifically
derived from EV-enriched fractions in comparison to non-EV fractions and total plasma
as a source of specific and sensitive biomarkers in breast cancer.
Methods: Healthy donors or metastatic breast cancer patient’s plasma (collected under
patient written consent) was subjected to size exclusion chromatography to separate
EVs (EV fraction) from other circulating components (soluble fraction). We quantified
different DNA species present in these fractions as compared to total plasma. Nuclear
and mitochondrial DNA (gDNA and mtDNA) were quantified by qPCR. Tumour specific nuclear
alleles were detected by droplet digital PCR targeting known point mutations (previously
identified from the tumour of each patient). Finally, 37 EV proteins were analysed
using the MACSPlex Exosome Kit (Miltenyi).
Results: gDNA and mtDNA were both detected in EV fractions. However, gDNA content
(total or mutant alleles) detected in the EV fractions was lower than in the soluble
fractions and total plasma. In contrast, mtDNA was preferentially enriched in EV fractions.
We observed similar levels of mtDNA or gDNA in cancer patients and healthy donors
in the EV fractions, whereas in total plasma, gDNA was increased in cancer patients.
In addition, several membrane proteins were significantly enriched or exclusively
present in cancer patients EVs compared to healthy donors.
Summary/conclusion: Our findings provide evidence that the detection of DNA within
total circulating EV does not provide added value as compared to the whole plasma.
However, analysis of a subtype of EV-associated proteins may reliably identify cancer
patients.
Funding: INCa-11548, ARC PGA1 RF20180206962
LB03.03
A novel strategy for early detection of clinically significant prostate cancer by
high-throughput palmitoyl-proteomics of extracellular vesicles
Dolores Di Vizio
a, Javier Mariscalb, Tatyana Vagnerb, Minyung Kimb, Bo Zhouc, Desmond PINKd, Andrew
Chinb, Mandana Zandianb, John Lewise, Michael Freemanb, Stephen Freedlandb, Sungyong
Youb, Wei Yangb and Andries Zijlstraf
aCedars Sinai Medical Center, West Hollywood, USA; bCedars Sinai Medical Center, Los
Angeles, USA; c1Cedars Sinai Medical Center, Los Angeles, USA; dNanostics and University
of Alberta, Nashville, USA; eNanostics, Nashville, USA; fVanderbilt University Medical
Center, Nashville, USA
Introduction: Early diagnosis of lethal prostate cancer (PC) is critical for treatment
stratification. Extracellular Vesicles (EVs) are an appealing source of circulating
biomarkers. We sought to perform a state-of-the-art palmitoyl proteome to identify
markers of aggressive PC because we noticed an enrichment for putative palmitoylated
proteins in EVs in comparison with cells, and because most of the plasma proteins
that contaminate the EV preps are not palmitoylated. Palmitoylation is a post-translational
modification that anchors proteins transiently to the membrane. We reasoned that this
could be a mechanism to anchor proteins temporary to the membrane and shed them in
EVs.
Methods: Discontinuous centrifugation gradient, tunable resistive pulse sensing (QNano),
next-generation PalmPISC for highly selective enrichment of palmitoyl-proteins, 2D
LC-MS/MS for deep proteomics profiling, Nano-Flow Cytometry (Apogee), Western blotting.
Results: We isolated large and small EVs from PC3 cells and confirmed their biochemical
and biophysical identity. We observed enrichment of distinct palmitoyl-proteins in
both populations of EVs versus the cells of origin. Pathway analysis demonstrated
a strong association between large EV cargo and protein localization and small EV
cargo and metabolic activity. Interestingly, palmitoyl-CD63 was enriched in large
EVs while the total protein is enriched in small EVs. Similarly, palmitoyl-HSPA5 was
enriched in small EVs, while the total protein is enriched in large EVs. This result
suggests that the palmitoyl proteome might reveal a pool of markers that would not
be identified otherwise. The Six Transmembrane Epithelial Antigen Prostate 1 (STEAP1)
was enriched in EVs from aggressive cancer cells but not in the cell themselves, suggesting
that it might be shed and thus identified in plasma of patients with aggressive disease
even if it is not enriched in the tumour tissue. We interrogated a cohort of benign
(n = 30), low Gleason Score (GS) (n = 30) and high GS (n = 30) patients. The number
of samples with detectable STEAP1 expression was negligible in men with benign disease,
and a significantly more frequent event in patients with high vs low GS.
Summary/conclusion: This study suggests that identification of bonafide palmitoylated
proteins in EVs represents a viable liquid biopsy to identify lethal prostate cancer.
LB03.04
Circulating exosomal PD-L1 as a marker for the follow up of melanoma patients
Jessica Gobbo
a, Marine Cordonnierb, Charlée Nardinc, Gaetan Chanteloupb, Valentin Derangéred, Marie-Paule
Algrose, Aurelie Bertautd, Laurent Arnouldd, Carmen Garridob and François Aubinc
aCentre Georges-Francois Leclerc, dijon, France; binserm1231, dijon, France; cCHU
Besançon, besançon, France; dCGFL, dijon, France; eCHU Besançon, besancon, France
Introduction: In the era of effective molecular targeted treatments and immunotherapies,
there is an urgent need to implement the use of circulating biomarkers in the clinic
to facilitate personalized therapy and predict treatment response. We conducted a
prospective study to demonstrate the involvement of circulating PD-L1 exosomes in
melanoma patients.
Methods: One hundred melanoma patients were included. Exosomes were isolated by ultracentrifugation
and evaluated by nanoparticle tracking analysis using a NTA technology. Isolated exosomes
were tested for the expression of exosomal markers such as TSG101. PD-L1 expression
in plasma and in melanoma plasma-derived exosomes (ExoPD-L1) was measured using an
enzyme-linked immunosorbent assay.
Results: First, ExoPD-L1 was assessed in melanoma cell lines. ExoPD-L1 have a role
in cancer immunosuppression mediated by T-cells since they were as efficient as cancer
cells to inhibit T-cells activation. In melanoma patients, ExoPD-L1 (median 64,26 pg/mL)
was significantly higher than free PD-L1 in the plasma which was barely detectable
(0,1 pg/mL). Furthermore, ExoPD-L1 was detected in all patients whereas only 67% of
the tumours were positive for PD-L1. Although baseline ExoPD-L1 levels were not associated
with clinicopathologic characteristics and tumour burden, ExoPD-L1 variations (ΔExoPD-L1)
after treatment correlated with tumour response and survival. A ΔExoPD-L1 cut-off
of > 100 was defined, yielding a 83% sensitivity, a 70% specificity, a 91% positive
predictive value and a 54% negative predictive values for disease progression. The
use of this cut-off allowed stratification in two groups of patients statistically
different in terms of overall survival and progression free survival.
Summary/conclusion: PD-L1 level in circulating exosomes may be a more reliable marker
than PD-L1 expression in tumour tissue. Circulating exosomal PD-L1 monitoring may
be a promising biomarker to predict tumour response and the clinical outcome.
Symposium Session 32: Late Breaking- EV Labeling, Separation, and Detection Chairs:
Elisa Lazaro-Ibanez; Ryou-u TakahashiLocation: Level B1, Lecture Room 09:30–10:15
LB04.01
A microfluidic device with nanoscale surface topology and functionalized with lipid
nanoprobes for extracellular vesicle isolation and clinical cancer diagnosis
Yuan Wana, Mackenzie Maurerb, Hong-Zhang Heb, Yi-Qiu Xiab, Wen-Long Zhangb, Si-Jie
Haob, Nelson Yeec and Siyang Zheng
b
aBinghamton University, State University of New York, Binghamton, USA; bThe Pennsylvania
State University, University Park, USA; cPenn State College of Medicine, Hershey,
USA
Introduction: Extracellular vesicles (EVs) are cell-derived, lipid membrane enclosed
particles. Tumour cell-derived are increasingly recognized for their pathophysiological
contributions and potential towards cancer diagnosis and treatment monitoring. However,
clinical translation of EVs has been limited by technological challenges for EV isolation.
A rapid, high-throughput, and on-chip EV isolation technology is critical for EV-based
cancer diagnosis.
Methods: We report a lipid nanoprobe-functionalized nanostructured silica microfluidic
device that can be used in combination with nucleic acid extraction, and digital droplet
polymerase chain reaction (ddPCR) for EV isolation, enrichment, and DNA mutation detection
from clinical plasma samples for cancer diagnosis. The device consists of EV-size-matched
silica nanostructures, surface-grafted lipid nanoprobes and a polydimethylsiloxane
(PDMS) herringbone micromixer chamber. Plasma samples are collected from either cell
lines or clinical samples (IRB approved and patients consented). As plasma flows through
the microfluidic device, the EVs are isolated. EV DNA is then extracted and pathological
mutations are detected with ddPCR.
Results: The microfluidic device removes 96.5% plasma proteins. The limit of detection
of a KRAS mutation from plasma EV by ddPCR is 0.01% mutant allele fraction (MAF).
The device is validated in a pilot clinical study for pancreatic cancer diagnosis.
Clinical samples with known KRAS mutations in the tissue were validated with the device.
ddPCR indicated MAF of 1.8%, 10.1%, and 22.3%, respectively, from DNA extracted from
plasma EV, while none were detected in healthy controls.
Summary/conclusion: This new platform suggests that MAF of EV-derived DNA can have
large patient variability that may depend on cancer type, stage, progression, or other
pathophysiological factors. These results support the need for a rapid and reliable
EV isolation technique, such as this reported device.
Funding: This work was supported by the National Cancer Institute of the US National
Institutes of Health under grant number 1R01CA230339 to S. Y. Zheng.
LB04.02
Asparagine-linked glycosylation amplifies the heterogeneity of tumour extracellular
vesicles
Yoichiro Harada
a, Kazuki Nakajimab, Nobuyoshi Kosakac, Tomoko Fukushiged, Kiyotaka Kondoa, Junichi
Seinoe, Tadashi Suzukie, Hiromasa Inouea, Takuro Kanekuraf, Takahiro Ochiyac and Ikuro
Maruyamaa
aKagoshima University Medical and Dental Sciences, Kagoshima, Japan; bFujita Health
University, Aichi, Japan; cDepartment of Molecular and Cellular Medicine, Institute
of Medical Science, Tokyo Medical University, Tokyo, Japan; dKagoshima Univeristy
Medical and Dental Sciences, Kagoshima, Japan; eRIKEN, Saitama, Japan
Introduction: Tumour cells secrete heterogeneous populations of extracellular vesicles
(EVs) carrying distinct proteins. However, the molecular underpinnings that regulate
such EV heterogeneity remain largely elusive. Tumours consume a large quantity of
glucose through glycolysis for the synthesis of various bioactive metabolites.
Methods: EVs were prepared from conditioned medium of mouse B16-F10 melanoma cells
by differential centrifugation. The number of EVs secreted, their cargo proteins and
intracellular carbohydrate metabolism were analysed.
Results: Here, we show that 2-DG, a glycolysis inhibitor, suppressed secretion of
melanoma EVs independently of its glycolysis blockade action. 2-DG-sensitive EVs were
enriched with asparagine (N)-linked glycosylated proteins, while 2-DG-resistant EVs
contained intrinsically non-glycosylated proteins. Metabolic conversion of 2-DG to
artificial nucleotide sugars via glycolysis branches induced degradation of N-linked
glycan precursors and hypoglycosylation of multiple glycoproteins. Mutagenesis at
N-linked glycosylation sites of an EV cargo protein or pharmacological inhibition
of N-glycosylation reaction by oligosaccharyltransferase was sufficient to suppress
secretion of N-linked glycosylated proteins by EVs.
Summary/conclusion: This study establishes N-linked glycosylation as a key posttranslational
modification that influences the heterogeneity of tumour-derived EVs.
LB04.03
Characterization of fluorescent plasma evs following 5-ALA use in malignant gliomas.
Leonora Balaj
a, Pamela Jonesb, Anudeep Yekulab and Bob Carterb
aMassachusetts General Hospital, Boston, USA; bMGH, Boston, USA
Introduction: Malignant gliomas are rapidly progressive brain tumours with very high
morbidity and mortality. The recent FDA approval of 5-aminolevulinic acid (5-ALA,
Gliolan) provides the neurosurgeon with real-time fluorescent delineation of malignant
tissue which allows a significantly higher rate of complete resections of malignant
gliomas and longer progression-free survival compared to conventional white-light
resections. We sought to determine whether fluorescent EVs would be released in the
plasma of these patients.
Methods: Here, we characterize EVs isolated from glioma cell lines treated with 5-ALA
for 24 h. We also evaluated plasma-derived EVs from glioma patients following preoperative
oral administration of 5-ALA. We used a highly sensitive fluorescence-based analysis
known as Amnis ISX mkII imaging flow cytometer to measure fluorescent signals from
individual nanoparticles with the added value of being able to individually visualize
particles being measured.
Results: We first compared the rate of EVs released from glioma cells treated with
5-ALA and determined a significant number of fluorescent EVs released within hours
of exposure to 5-ALA, while the healthy human brain microvascular endothelial cells
(HBMVEC) did not release any fluorescent EVs. We also compared the direct analysis
of conditioned media to that of EVs purified by a commercial kit and determined that
the extra exposure to light of EVs with the commercial kit leads to a significant
loss of fluorescent EVs. To confirm our findings we exposed 5-ALA EVs to white light
for 20 min and compared the number of fluorescent events before and after exposure
to light, and determined a > 98% loss of fluorescent EVs. Finally, a comparison of
the plasma samples from glioma patients collected upon administration of 5-ALA revealed
that we can reliably detect fluorescent EVs in the plasma of these patients when the
primary tumour fluoresces, while these events were undetectable in the cases where
the primary tumour did not fluoresce. Furthermore, these events were undetectable
upon tumour resection.
Summary/conclusion: This study is as a proof of concept to determine our ability to
utilize fluorescent based tumour-specific EV characterization to aid in the diagnostics
and prognostics of gliomas.
Funding: CA069246 CA230697 TR000931
Symposium Session 33: Late Breaking- From Biogenesis to Uptake Chairs: Yutaka Naito;
Ganesh ShelkeLocation: Level B1, Hall B 09:30–10:15
LB05.01
Reassessment of exosome composition
Dennis Jeppesen
a, Aidan Fenixb, Jeffrey Franklina, James Higginbothama, Qin Zhanga, Leonard Romec,
Dylan Burnetteb and Robert Coffeya
aVanderbilt University Medical Center, Nashville, USA; bVanderbilt University School
of Medicine, Nashville, USA; cDavid Geffen School of Medicine, University of California,
Los Angeles, USA
Introduction: The heterogeneity of extracellular vesicles (EVs) and presence of non-vesicular
extracellular nanoparticles pose major obstacles to our understanding of the composition
and functional properties of distinct secreted components. Greater precision in assigning
RNA, DNA and protein to their correct extracellular compartments and identifying their
mechanisms of secretion is crucial for identification of biomarkers and design of
future drug interventions.
Methods: We have employed high-resolution density gradient fractionation and direct
immunoaffinity capture (DIC) to precisely characterize the RNA, DNA, and protein constituents
of exosomes and other non-vesicle material. Proteomics and RNA-Seq analyses were performed
on purified small EVs and extracellular non-vesicular material. DIC was used to specifically
isolate exosomes from other types of small EVs and was performed without ultracentrifugation
and with capture beads targeting the classical exosomal tetraspanins CD63, CD81 and
CD9. Biochemical analysis and structured illumination microscopy were used to examine
secretion and presence of extracellular DNA.
Results: Extracellular RNA, RNA-binding proteins and other cellular proteins are differentially
expressed in exosomes and non-vesicle compartments. Argonaute 1–4, glycolytic enzymes
and cytoskeletal proteins were not detected in exosomes. We further demonstrate that
small EVs are not vehicles of active DNA release. Instead, we propose a new model
for active secretion of extracellular DNA through an autophagy- and multivesicular
endosome-dependent but exosome-independent mechanism.
Summary/conclusion: This study demonstrates the need for a reassessment of exosome
composition and offers a framework for a clearer understanding of EV and extracellular
nanoparticle heterogeneity.
Funding: This study was part of the NIH Extracellular RNA Communication Consortium
paper package and was supported by the NIH Common Fund’s exRNA Communication Program.
The work was funded by NIH grants The work was funded by NIH grants F31 HL136081 to
Aidan M. Fenix, R35 GM125028 to Dylan T. Burnette, and R35 CA197570 and U19 CA179514
to Robert J. Coffey
LB05.02
Biofunctional peptide-modified extracellular vesicles for targeted intracellular delivery
Ikuhiko Nakase
Graduate School of Science, Osaka Prefecture University, Sakai-Shi, Japan
Introduction: Our research group is developing therapeutic techniques based on extracellular
vesicles (exosomes, EVs) and peptide chemistry to deliver therapeutic/diagnostic molecules
into targeted cells. Because of pharmaceutical advantages of the EVs as carriers for
intracellular delivery of therapeutic molecules, we are trying to develop methodology
to easily modify biofunctional peptides on exosomal membranes for receptor target
and enhanced cellular uptake of the EVs. In this presentation, modification techniques
using biofunctional peptides such as arginine-rich cell-penetrating peptides (CPPs,
macropinocytosis induction) [1], artificial coiled-coil peptides (receptor target)
[2], membrane fusion peptides (cytosolic release) will be introduced [3, 4]. And newly
developed exosomes decorated with cell-penetrating sC18 peptides [5], which are derived
from cationic antimicrobial protein, CAP18, will be also presented and discussed for
cancer targeting.
Methods: For cellular uptake assessments of EVs, we used CD63 (EV marker protein)-GFP-fusion
protein expressed EVs. All biofunctional peptides were synthesized by Fmoc solid-phase
methods.
Results: Macropinocytosis has been shown to be very important for cellular EV uptake
[1]. Therefore, our research group developed the methods for modification of arginine-rich
CPPs on EV membranes using chemical linkers or acylation technique, which can induce
clustering of proteoglycans (e.g. syndecan-4) and macropinocytosis signal transduction
[1]. In the research of artificial coiled-coil peptides, the artificial leucine zipper
peptide-modified EVs recognize the peptide-tagged receptor expression on targeted
cells [2]. Stearylation of branched sC18 peptides were easily modified on the EVs
by their insertion of hydrophobic moiety in EV membranes, resulted in effective induction
of macropinocytosis and cancer cellular uptake.
Summary/conclusion: These experimental techniques will contribute to development for
the EV-based targeted intracellular delivery systems.
Reference: [1] I. Nakase, et al. Sci. Rep. 6, 34937 (2016), [2] I. Nakase, et al.
Chem. Commun. 53, 317 (2017), [3] I. Nakase, et al. Sci. Rep. 5, 10112 (2015), [4]
M. Akishiba, et al. Nat. Chem. 9, 751 (2017), [5] A. Gronewold, et al. ChrmMedChem.
12, 42 (2017)
LB05.03
Virus protein pX facilitates naked particles of hepatitis A virus to acquire an exosome-derived
membrane by interacting with ESCRT-associated protein ALIX
Wang Jiang
a, Pengjuan Mab, Libin Dengb and Gang Longb
aInstititut Pasteur of Shanghai, Shanghai, USA; bInstitut Pasteur of Shanghai, Shanghai,
China (People‘s Republic)
Introduction: Hepatitis A virus (HAV), a classically-thought non-enveloped virus,
has recently been found to release majorly in the form of quasi-enveloped HAV (eHAV)
by hijacking the host’s endosomal sorting complexes required for transport (ESCRT)
complexes. Compared to the non-enveloped virion, eHAV exclusively contains a viral
protein pX.
Methods: Differential centrifugation and iodixanol-based gradient centrifugation were
used to isolate different types of EVs. Western-blot, Nanoparticle tracking analysis,
and immune-electron microscopy were used to analyse EVs and HAV virus particles. Fluorescence
microscopy in live-cell and immune-electron microscopy was used to identify the exosome-like
biogenesis of eGFP-pX. Co-IP was performed in 293T cells. Amino-acids truncation and
mutation in pX were performed in order to find the novel functional domain of pX.
Results: Fusing pX to eGFP could guide eGFP into exosomes through directing eGFP into
multivesicular bodies (MVBs). Simultaneously, the release of ALIX, an MVBs maker protein,
is enhanced and co-IP assay confirms the direct interaction between pX and V domain
of ALIX. Furthermore, deleting C-terminal half of pX abolishes eHAV release and the
interaction between HAV virion and ALIX. Consistently, the C-terminal half of pX alone
is sufficient to load eGFP into exosomes by interacting with ALIX. On the other side,
we find there is a novel nucleus export signal (NES) motif MMSRIAAGD in its N-terminal
12 amino-acids, which was previously reported essential for virion assembly
Summary/conclusion: Here, we find that pX is required for eHAV release and contains
a novel nucleus export signal (NES) in its N-terminal. To conclude, pX plays important
roles in HAV assembly and release through two independent domains: the N-terminal
domain containing a novel NES, and the C-terminal half domain associated with the
membrane envelopment via the interaction with ALIX. Thus, pX may have the potential
for protein loading into exosomes in the future.
Funding: This work was supported by the national natural Science Foundation of China
(81772200).
Symposium Session 34: Late Breaking- EV Signatures and Function Chairs: Ter-Ovanesyan;
Yusuke YoshiokaLocation: Level B1, Hall A 09:30–10:15
LB06.01
Proteomic and miRNA transcriptome analysis revealed an association between circulating
exosomal miRNAs and insulin sensitivity in gestational diabetes mellitus during gestation
Soumyalekshmi Naira, Dominic Guanzonb, Andrew Laic, Katherin Scholz-Romeroc, Carlos
Palmac, Jezid Mirandad, Fatima Crispie, David McIntyref, Martha Lappasg and Carlos
Salomon
b
aExosome Biology Laboratory, Centre for Clinical Diagnostics, UQ centre for Clinical
Research, Royal Brisbane and Women‘s Hospital, Faculty of Medicine + Biomedical Sciences,
The University of Queensland, Brisbane, Australia; bExosome Biology Laboratory, Centre
for Clinical Diagnostics, University of Queensland Centre for Clinical Research, Royal
Brisbane and Women’s Hospital, The University of Queensland, Brisbane QLD 4029, Australia.,
Brisbane, Australia; cExosome Biology Laboratory, Centre for Clinical Diagnostics,
University of Queensland Centre for Clinical Research, Royal Brisbane and Women’s
Hospital, The University of Queensland, Brisbane QLD 4029, Australia, Brisbane, Australia;
dFetal i + D Fetal Medicine Research Center, BCNatal – Barcelona Center for Maternal-Fetal
and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Deu), ICGON, IDIBAPS,
Universitat de Barcelona, Spain, Barcelona, Spain; eFetal i + D Fetal Medicine Research
Center, BCNatal – Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital
Clínic and Hospital Sant Joan de Deu), ICGON, IDIBAPS, Universitat de Barcelona, Spain.,
Barcelona, Spain; fMater Research, Faculty of Medicine, University of Queensland,
Mater Health, South Brisbane, Australia., Brisbane, Australia; gUniversity of Melbourne,
Department of Obstetrics and Gynaecology, Australia. Mercy Hospital for Women, 163
Studley Road, Heidelberg, Victoria 3084, Australia., Brisbane, Australia
Introduction: Gestational Diabetes Mellitus (GDM) is the most common medical complication
in pregnancy, with short and long term metabolic effects in mothers and offsprings.
We comprehensively analysed the exosomal miRNA profile across gestation in normal
glucose tolerant (NGT) and women with GDM and determined the signalling pathways associated
with changes in miRNA profile.
Methods: Exosomes were isolated from plasma samples collected at three time points
during pregnancy from NGT and GDM women. Using a small RNA library and linear mixed
modelling analysis, the miRNA profiles across gestation in NGT, GDM and NGT vs GDM
were identified in a discovery cohort and the expression of candidate miRNAs were
measured using qRT-PCR in a validation cohort. Further, we characterized the changes
in the proteomic profile in skeletal muscles obtained from GDM patients compared to
NGT controls, using a quantitative, data-independent acquisition mass spectrometric
approach and finally integrated the exosomal miRNA and skeletal muscle protein expression
profiles to identify miRNA-targeted networks.
Results: A total of 279 (NGT), 308 (GDM) and 175 (NGT vs GDM) miRNAs were significantly
changing in expression across gestation. 6 miRNAs (hsa-miR-92a-3p, hsa-miR-10a-5p,
hsa-miR-151b, hsa-miR-16–2-3p, hsa-miR-1910-5p and hsa-miR-423-5p) were confirmed
to be differentially expressed in GDM. Proteomic characterization revealed 55 proteins
to be differentially expressed in GDM skeletal muscles compared to NGT. The exosomal
miRNAs upregulated in GDM target some of these differentially expressed proteins (Serine/Threonine
Protein Phosphatase 6 (PPP6), Chloride Intracellular Channel Protein 4 (CLIC4) and
Actin Related Protein Complex 2 (ARPC2)) in skeletal muscles in GDM and associated
with pathways regulating glucose metabolism and insulin signalling (such as STAT 3
pathway).
Summary/conclusion: The miRNA content in maternal circulating exosomes differs across
gestation in GDM patients compared to NGT and target specific proteins and pathways
in skeletal muscle. This suggests that exosomes may be involved in maternal metabolic
adaptation to pregnancy through the delivery of bioactive miRNAs.
Funding: Diabetes Australia, Lions Medical Research Foundation, NHMRC; 1114013, and
FONDECYT 1170809.
LB06.02
Extracellular vesicles from induced neurons trigger epigenetic silencing of a brain
neurotransmitter
Glenn McConkey
a, Isra Alsaadyb, Ellie Tedfordc and Norhidayah Badyad
aUniversity of Leeds, Leeds, United Kingdom; bUniversity of King Abdulaziz, Leeds,
United Kingdom; cUniversity of Cambridge, Cambridge, United Kingdom; dUniversity of
Leeds, Leeds, United Kingdom
Introduction: Our new breakthrough finding is that extracellular vesicles (EVs) injected
into the brain specifically down-regulated production of the neurotransmitter norepinephrine
suppressing transcription of the DBH gene and hypermethylation of the gene’s promoter.
DBH produces norepinephrine from dopamine in neurons. Previous studies found EVs regulate
immune responses via PTGS but regulating neurons and epigenetic changes have not been
described. DNA methylation in neurons is involved in memory and neurological disorders
(Science 2018 361 (6409)). These observations concur with our recent study that found
central noradrenergic signalling is suppressed in the brains of infected rodents and
in neurons (Infect Immun 2019 87(2)) for this parasite that causes movement disorders
and is associated with neurological disorders.
Methods: Neuronal cells were induced by infection with the neurotropic protozoan Toxoplasma
gondii and EVs purified on sucrose gradients. EVs, characterized by TEM, were used
to treat rat and human neuronal cells and DBH mRNA and nascent DBH gene transcription
were measured. DNA methylation was measured by MSRE-qPCR. Induced EVs were injected
into the locus co-eruleus of rats and DBH gene expression was monitored.
Results: We found that EVs purified from infected neuronal cultures (43 ± 5 nm) specifically
caused transcriptional gene silencing (TGS) and DNA methylation in noradrenergic neurons.
The induced EVs down-regulated DBH gene expression >200-fold and, surprisingly, the
down-regulation was at transcriptional level. The EVs also caused an epigenetic change;
specifically inducing DNA hypermethylation of the DBH gene. Intracerebral injection
of induced EVs into rats down-regulated DBH expression. We are currently identifying
the RNA responsible as the down-regulation was disabled by degradation of the small
RNAs in the EVs.
Summary/conclusion: This is the first study to find transcriptional gene silencing
of a neurotransmitter in the brain by EVs and DNA hypermethylation in the neurons.
This research will enhance our understanding of neurological disorders (ie. schizophrenia,
epilepsy, drug addiction) and how memory works. The role of EVs in regulating neurotransmission
in the brain will be presented.
LB06.03
Extracellular vesicles from human iPS-derived cardiovascular progenitors do not trigger
an immune response in the infarcted heart
Bruna Lima Correa
a, Nadia EL-Haraneb, Ingrid Gomezb, Hocine Rachidc, José Vilard, Manon Desgrese, Valérie
Bellamye, Laetitia Pidiale, Paul Alayrace, Dominique Charronf, Nisa Renaultg, Reem
Al-Daccakh, Jean-Sebastien Silvestree and Philippe Menaschéi
aINSERM U970 – PARCC, Paris, France; bINSERM U970 – PARCC, PARIS, France; cINSTITUT
CURIE, Paris, France; dINSERM U970 – PARCC, Paris, French Guiana; eINSERM U970 – PARCC,
paris, France; fAssistance Publique – HÔPITAL SAINT-LOUIS -Immunology, Paris, France;
gFUJIFILM Cellular Dynamics, Inc., Madison, USA; hINSERM· UMRS 976, Paris, France;
iAssistance Publique – Hôpital Européen Georges Pompidou- Cardiology and INSERM U970
– PARCC, Paris, France
Introduction: Extracellular vesicles (EV) recapitulate most of the cardioprotective
effects of stem cells but their immunological impact remains poorly understood.
Hypothesis: Immune response to EV may be beneficial rather than deleterious for the
infarcted heart.
Methods: EV secreted from human-induced pluripotent stem cells [EV-hPg-iPS] were first
assessed in vitro for the expression of immune and stem cell markers by flow cytometry
and their cross-talk with allogeneic T and NK cells, was determined by mixed lymphocyte
reactions (MLR). Then, 70 immunocompetent mice underwent a myocardial infarction and
surviving mice were injected intramyocardially (under echo guidance) with EV-hPg-iPS,
hPg-iPS or PBS either acutely (n = 6) or chronically (n = 6), i.e., 3 days and 3 weeks
after infarction, respectively. Immune responses were monitored 3 days after treatment
in all mice. Eighteen additional animals were sham-operated and also injected after
3 weeks with EV-hPg-iPS, hPg-iPS or PBS. Pro- and anti-inflammatory cytokines were
measured in heart tissue and plasma by a bead-based multiplex immunoassay (n = 6/group).
Results: EV-hPg-iPS expressed stem cell markers (SSEA-1, CD15, CD133) and low levels
of HLA class I and PD-L1. MLR and in vivo studies demonstrated that EV do not activate
an adaptive allogeneic immune response since they failed to induce proliferation of
allogeneic CD8+ or CD4 + T cells. In contrast to their parental cells, EV did not
induce NK cell degranulation either. While injection of hPg-iPS or their EV at the
chronic post infarction stage did not affect the number of T cells, B cells, and macrophages
in cardiac tissue, spleen, bone marrow and blood, they significantly decreased the
circulating levels of the pro-inflammatory cytokines IL-1α and IFN-γ compared to the
control group (PBS). However, at the acute stage, and in contrast to PBS, EV significantly
reduced the number of monocytes High (M1 macrophage precursor), M1 macrophages, and
neutrophils as well as the circulating levels of the pro-inflammatory cytokines IL-1α,
IL-2 and IL-8 while it significantly increased those of IL-10.
Summary/conclusion: EV-hPg-iPS look immunologically neutral in vitro and in vivo and
seem even able to mitigate the infarct-related inflammatory response.
Funding: INSERM, LabexRevive, APHP, University Paris Descartes, Fondation de France,
FRM